Citrus Sinensis ID: 036172

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520--
Protein Sequence
MSVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDNEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYLKEEQD
Secondary Structure (PSIPRED)
ccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccccEEEEEccccccccccHHHHHHHHHHHcccccccccEEEEEEEccEEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccHHHHHHHHHHHHcccccccccccccccHHHccHHHHccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHcccHHHHHHHcHEEEccccccccHcHcccccEEcEEEEEccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccccccEEcHHHHHHHHccccHHHEEEccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEccccccEEcccccccEEEEEEEEccccccHHHHHcccccccccHHHHHHEEEHHHccccccccccccccHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MSVVEWAIGlhsrsssiasqgnkiefdctktdstdsslerdnefstrqiihgtedastdggrnsideekyrnpcaseeactvregisidqneeytstvdygwpllrisapetsdslrdcedktllnqstsptphsqinsfspktenpfqmdipcsegkydentltpSTELFLKLVSSRCRQFSYEELKQATSQFSSawndfssevditssleqksittlngvciednylilvsdflpkgsleeslhgageqsvlpwgVRFEVAVAIAEALNYLhsecsrpvihrdvkssnillssdfqpqlsdfglaiwgptdsthmiredvvgtfgyiapeylmhgkvsdkidVYSFGVVLLELLsgrrpigfknlkgpeslvkwakpilkngdtetlldpklsneyDNAQMQRMLLAANLcinqspqlrpnMGQVLKLLRgathatdwvdrhaddilgsgiqfqedddcqkfsskphldfpildidleatspssiytksfsgtgekptsligterTQHRKLKDYLKEEQD
Flexible Loop (DISEMBL)
MSVVEWAIglhsrsssiasqgnkiefdctktdstdsslerdnefstrqiihgtedastdggrnsideekyrnpcaseeactvregisidqneeytstvdygwPLLRISAPETSDSLRDCEDKTllnqstsptphsqinsfspktenpFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSgrrpigfknlkgpeslvkwakpilkngdtetlldpKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSiytksfsgtgekptsligtertqhrklkdylkeeqd
Low Complexity Region (SEG)
MSVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDNEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYLKEEQD
Disordered region (IsUnstruct)
*****WAI***********************************************************************CTVREGISIDQNEEYTSTVDYGWPLLRI************************************************************TELFLKLVSSRCRQFSYEELKQA**QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD**L**EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDL*******************************************
Disordered Region (DISOPRED)
*S*VEWAIGLH*************************************************************************************************************************************ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQ*******A**DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF*NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT***************************************************************************************
Disordered Region (DISEMBL)
MSVVEWAIGLHSRSSSIASQGNKIEFDCTK***********NEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLRDCEDKTLLN**************SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYLKEEQD
Disordered Region (DISPRO)
*SVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDNEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACT************************************************************PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA****************************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDNEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYLKEEQD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	522	2.2.26 [Sep-21-2011]
Q5XF57	579	Probable receptor-like se	no	no	0.660	0.595	0.339	6e-57
Q9LK03	717	Proline-rich receptor-lik	no	no	0.488	0.355	0.416	2e-56
Q9LV48	652	Proline-rich receptor-lik	no	no	0.515	0.412	0.378	2e-55
Q8H1D6	467	Receptor-like cytosolic s	no	no	0.438	0.490	0.429	5e-55
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.486	0.495	0.403	2e-54
Q9SGY7	718	Putative proline-rich rec	no	no	0.465	0.338	0.417	5e-54
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.503	0.386	0.411	4e-53
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.440	0.323	0.427	4e-52
Q9C660	762	Proline-rich receptor-lik	no	no	0.473	0.324	0.418	4e-52
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.436	0.495	0.452	2e-51

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  222 bits (565), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 134/395 (33%), Positives = 200/395 (50%), Gaps = 50/395 (12%)

Query: 80  CTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQINS 139
           C     IS+D N E  S       L R S   + D         + +   SP+   +  S
Sbjct: 159 CYSDSAISLDINSEKYSPRSVLNTLSRDSLSSSGDDASSFNGSMVSSSFASPSDKPKHKS 218

Query: 140 FSP-KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSA- 197
            SP K  +   M+ P  + +  E    P  +  ++        F+Y E+ +AT+ F    
Sbjct: 219 ISPYKFISSLIMNSPLRKWRGSETKNKPKPQPLIQC-------FTYNEISKATNDFHQGN 271

Query: 198 ---------------WN--------------------DFSSEVDITSSLEQKSITTLNGV 222
                          W+                    +F +E+ I S +   +   L G 
Sbjct: 272 IVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGC 331

Query: 223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVI 282
           C+E   L LV  F   G+L  +LH   E   L W VR+++AV +A  L+YLH  C+  +I
Sbjct: 332 CVEKG-LYLVFRFSENGTLYSALH-ENENGSLDWPVRYKIAVGVARGLHYLHKRCNHRII 389

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           HRD+KSSN+LL  D++PQ++DFGLA W P   TH     V GTFGY+APE LM G + +K
Sbjct: 390 HRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEK 449

Query: 343 IDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ 402
            D+Y+FG++LLE+++GRRP+        + ++ WAKP ++ G+T  L+DPKL ++YD+ Q
Sbjct: 450 TDIYAFGILLLEIITGRRPVN----PTQKHILLWAKPAMETGNTSELVDPKLQDKYDDQQ 505

Query: 403 MQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA 437
           M +++L A+ C+ QSP LRP M QVL+LL     A
Sbjct: 506 MNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEA 540

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  220 bits (561), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 110/264 (41%), Positives = 165/264 (62%), Gaps = 9/264 (3%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           ++ + ++LK+ +SQ      +F +EV I S +  + +  L G CI D   +LV +F+P  
Sbjct: 377 KEVAVKQLKEGSSQ---GEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNN 433

Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +LE  LHG G +  + W  R ++AV  A+ L+YLH  C+  +IHRD+K+SNIL+   F+ 
Sbjct: 434 TLEFHLHGKG-RPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEA 492

Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +++DFGLA      +TH +   V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GR
Sbjct: 493 KVADFGLAKIASDTNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGR 551

Query: 360 RPIGFKNLKGPESLVKWAKPILKN----GDTETLLDPKLSNEYDNAQMQRMLLAANLCIN 415
           RPI   N+    SLV WA+P+L      G+ E ++D KL+NEYD  +M RM+  A  C+ 
Sbjct: 552 RPIDVNNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVR 611

Query: 416 QSPQLRPNMGQVLKLLRGATHATD 439
            +   RP M QV ++L G    +D
Sbjct: 612 STAPRRPRMDQVARVLEGNISPSD 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  217 bits (552), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 118/312 (37%), Positives = 175/312 (56%), Gaps = 43/312 (13%)

Query: 166 PSTELFLKLVSSRCRQFSYEELKQATSQFSSA---------------------------- 197
           PS  L L    S    F+YEEL +AT+ FS A                            
Sbjct: 255 PSPGLVLGFSKS---TFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311

Query: 198 ------WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ 251
                   +F +EV+I S +  + + +L G C+     +LV +F+P  +LE  LHG G +
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKG-R 370

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
             + W  R ++A+  A+ L+YLH +C+  +IHRD+K+SNIL+   F+ +++DFGLA    
Sbjct: 371 PTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS 430

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
             +TH +   V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GRRP+   N+   +
Sbjct: 431 DTNTH-VSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDD 489

Query: 372 SLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
           SLV WA+P+L    + GD E L D K+ NEYD  +M RM+  A  C+  S + RP M Q+
Sbjct: 490 SLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQI 549

Query: 428 LKLLRGATHATD 439
           ++ L G    +D
Sbjct: 550 VRALEGNVSLSD 561

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1

 Score =  216 bits (549), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 101/235 (42%), Positives = 157/235 (66%), Gaps = 6/235 (2%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +DF SE+ I + +   +   L G    D  L  V ++ P GSL   L G+ E   L W +
Sbjct: 195 SDFLSELGIIAHVNHPNAARLRGFS-SDRGLHFVLEYAPYGSLASMLFGSEE--CLEWKI 251

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R++VA+ IA+ L+YLH+ C R +IHRD+K+SNILL+ D++ Q+SDFGLA W P +  H +
Sbjct: 252 RYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHV 311

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
              + GTFGY+APEY MHG V +KIDV++FGV+LLE+++ RR +   +    +S+V WAK
Sbjct: 312 VFPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAV---DTASRQSIVAWAK 368

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG 433
           P L+    E ++DP+L N ++  +MQR++L A++C++    +RP+M ++++LLRG
Sbjct: 369 PFLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRG 423

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  213 bits (543), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 106/263 (40%), Positives = 169/263 (64%), Gaps = 9/263 (3%)

Query: 181 QFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS 240
           + + ++LK  ++Q      +F +EV+I S +  +++ +L G CI     +LV +F+P  +
Sbjct: 207 EVAVKQLKVGSAQ---GEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNT 263

Query: 241 LEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
           LE  LHG G  + + W +R ++AV+ ++ L+YLH  C+  +IHRD+K++NIL+   F+ +
Sbjct: 264 LEFHLHGKGRPT-MEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAK 322

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR 360
           ++DFGLA      +TH +   V+GTFGY+APEY   GK+++K DVYSFGVVLLEL++GRR
Sbjct: 323 VADFGLAKIALDTNTH-VSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRR 381

Query: 361 PIGFKNLKGPESLVKWAKPI----LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQ 416
           P+   N+   +SLV WA+P+    L+  + E L D KL+NEYD  +M RM+  A  C+  
Sbjct: 382 PVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRY 441

Query: 417 SPQLRPNMGQVLKLLRGATHATD 439
           + + RP M QV+++L G    +D
Sbjct: 442 TARRRPRMDQVVRVLEGNISPSD 464

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  212 bits (540), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 104/249 (41%), Positives = 157/249 (63%), Gaps = 6/249 (2%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           +KQ  S  +  + +F +EV+I S +  + + +L G CI + +  L+ +F+P  +L+  LH
Sbjct: 397 IKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLH 456

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G     VL W  R  +A+  A+ L YLH +C   +IHRD+KSSNILL  +F+ Q++DFGL
Sbjct: 457 GK-NLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGL 515

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           A    T  +H I   V+GTFGY+APEY   GK++D+ DV+SFGVVLLEL++GR+P+    
Sbjct: 516 ARLNDTAQSH-ISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQ 574

Query: 367 LKGPESLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP 422
             G ESLV+WA+P L    + GD   ++DP+L N+Y  +++ +M+  A  C+  S   RP
Sbjct: 575 PLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRP 634

Query: 423 NMGQVLKLL 431
            M QV++ L
Sbjct: 635 RMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  209 bits (532), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 112/272 (41%), Positives = 163/272 (59%), Gaps = 9/272 (3%)

Query: 173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
           K V S  R+ + ++LK   SQ      +F +EV+I S +  + + TL G CI + + +LV
Sbjct: 355 KGVLSDGREVAVKQLKIGGSQ---GEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLV 411

Query: 233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
            D++P  +L   LH  G + V+ W  R  VA   A  + YLH +C   +IHRD+KSSNIL
Sbjct: 412 YDYVPNNTLHYHLHAPG-RPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 470

Query: 293 LSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVV 351
           L + F+  ++DFGLA I    D    +   V+GTFGY+APEY   GK+S+K DVYS+GV+
Sbjct: 471 LDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVI 530

Query: 352 LLELLSGRRPIGFKNLKGPESLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRML 407
           LLEL++GR+P+      G ESLV+WA+P+L    +N + + L+DP+L   +   +M RM+
Sbjct: 531 LLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMV 590

Query: 408 LAANLCINQSPQLRPNMGQVLKLLRGATHATD 439
            AA  C+  S   RP M QV++ L     ATD
Sbjct: 591 EAAAACVRHSAAKRPKMSQVVRALDTLEEATD 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  206 bits (524), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 101/236 (42%), Positives = 151/236 (63%), Gaps = 6/236 (2%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F +EV+I S +  + + +L G CI D+  +L+ +++P  +LE  LHG G + VL W  R
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKG-RPVLEWARR 451

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A+  A+ L YLH +C   +IHRD+KS+NILL  +F+ Q++DFGLA    +  TH + 
Sbjct: 452 VRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTH-VS 510

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
             V+GTFGY+APEY   GK++D+ DV+SFGVVLLEL++GR+P+      G ESLV+WA+P
Sbjct: 511 TRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARP 570

Query: 380 IL----KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
           +L    + GD   L+D +L   Y   ++ RM+  A  C+  S   RP M QV++ L
Sbjct: 571 LLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  206 bits (523), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 158/265 (59%), Gaps = 18/265 (6%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F +EVD  S +  +++ ++ G CI +N  +L+ D++P  +L   LH AG    L W  R
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG-LDWATR 528

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A   A  L YLH +C   +IHRD+KSSNILL ++F   +SDFGLA      +TH I 
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTH-IT 587

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
             V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GR+P+      G ESLV+WA+P
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647

Query: 380 ILKNGDTET-----LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA 434
           +L N  TET     L DPKL   Y   +M RM+ AA  CI  S   RP M Q+++     
Sbjct: 648 LLSNA-TETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAF--- 703

Query: 435 THATDWVDRHADDILGSGIQFQEDD 459
                  D  A++ L +G++  E +
Sbjct: 704 -------DSLAEEDLTNGMRLGESE 721

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  204 bits (519), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 106/234 (45%), Positives = 144/234 (61%), Gaps = 6/234 (2%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F SE+ I + ++  +     G CIE   + LV    P GSL   LHG  +   L W  R
Sbjct: 184 EFLSELGIIAHVDHPNTAKFIGCCIEGG-MHLVFRLSPLGSLGSLLHGPSKYK-LTWSRR 241

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           + VA+  A+ L YLH  C R +IHRD+K+ NILL+ DFQPQ+ DFGLA W P   TH   
Sbjct: 242 YNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNV 301

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
               GTFGY APEY MHG V +K DV++FGV+LLEL++G   +     +  +SLV WAKP
Sbjct: 302 SKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQSLVLWAKP 357

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG 433
           +L+    + L+DP L +EY+  ++ R+   A+LCI+QS  LRP M QV++LL G
Sbjct: 358 LLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLG 411

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	522
224065767	825	predicted protein [Populus trichocarpa]	0.890	0.563	0.444	1e-112
255539004	716	conserved hypothetical protein [Ricinus	0.938	0.684	0.440	1e-109
317106599	681	JHL20J20.14 [Jatropha curcas]	0.925	0.709	0.438	1e-108
225457909	761	PREDICTED: uncharacterized protein LOC10	0.911	0.625	0.418	1e-106
255587135	622	ATP binding protein, putative [Ricinus c	0.737	0.618	0.483	2e-97
449448572	828	PREDICTED: probable LRR receptor-like se	0.952	0.600	0.400	4e-96
359474848	625	PREDICTED: wall-associated receptor kina	0.593	0.496	0.524	1e-95
297744611	658	unnamed protein product [Vitis vinifera]	0.593	0.471	0.524	1e-95
147768429	693	hypothetical protein VITISV_026641 [Viti	0.593	0.447	0.524	1e-95
224078315	678	predicted protein [Populus trichocarpa]	0.735	0.566	0.474	1e-95

>gi|224065767|ref|XP_002301959.1| predicted protein [Populus trichocarpa] gi|222843685|gb|EEE81232.1| predicted protein [Populus trichocarpa]

 Score =  412 bits (1058), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 242/544 (44%), Positives = 320/544 (58%), Gaps = 79/544 (14%)

Query: 43  EFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGW 102
           E +  Q+ H +E+ S DG  N  D      P  S     V     + +N   +     GW
Sbjct: 295 EGTVIQLFHTSENRSRDGSSNGEDARFGFKPEVSSHPDYV-----LTKNSTRSGP---GW 346

Query: 103 PLLRISAPETSDSLRDCEDK---------TLLNQSTSPTPHSQINSFSPKTENPFQMDIP 153
           PLLR+    + +S ++ + +         +L ++S   T   QI+  S + E+  +  + 
Sbjct: 347 PLLRVKTSASLESFQESQAEKFSVVQWVSSLTDRSEEATTKFQIDFVSKEVESYVENKM- 405

Query: 154 CSEGKYDENT---------LTPSTELFLKLVSSRCRQFSYEELKQATSQFSS-------- 196
              G  D+N          L    + F K+ +S C+QF YEELK+AT QFSS        
Sbjct: 406 --RGYKDKNMGACLAAPMKLPKKMDCFFKVCTSGCKQFGYEELKRATRQFSSENFVGEGG 463

Query: 197 -------------------------AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
                                    AW+DFS E+DI SSL+ K IT L G+C+EDN+LIL
Sbjct: 464 CSNVYKGYLPGGKQVAVKILKQYKEAWSDFSLEIDIMSSLKHKHITPLIGICVEDNHLIL 523

Query: 232 VSDFLPKGSLEESLHG------------AGE--QSVLPWGVRFEVAVAIAEALNYLHSEC 277
           V DFL +GSL+E L G            AG+  +SVLPW VRF+VA+AIAEALN+LH+EC
Sbjct: 524 VYDFLSQGSLDERLQGKNKCSYSSVNGDAGKRRKSVLPWKVRFKVAIAIAEALNHLHNEC 583

Query: 278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG 337
           SRPVIHRDVKSSNILLS DFQPQLSDFGLAIWGP DS + I  DVVGTFGYIAPEY M+G
Sbjct: 584 SRPVIHRDVKSSNILLSKDFQPQLSDFGLAIWGPADSAYAIHSDVVGTFGYIAPEYFMNG 643

Query: 338 KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE 397
           +VSDKIDVYSFG+VLLELL+G++PI  K+LKG ESL+KWA P+L++G+ + LLDPK +  
Sbjct: 644 RVSDKIDVYSFGIVLLELLTGKKPIISKDLKGQESLIKWATPLLESGNLKALLDPKTNGN 703

Query: 398 YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQE 457
           +D  QMQRM+LAA LC+ Q+ +LRP + Q+L+LLRG     +WV+ +A+D+  S  + + 
Sbjct: 704 FDVVQMQRMVLAATLCVRQTARLRPKISQILELLRGEKDEGEWVNSYANDLKKSSDE-EL 762

Query: 458 DDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYL 517
           DD    F  KP L+   L ++ +  S SS+ T S S       S  G  R     L+DYL
Sbjct: 763 DDLFLDFGCKPGLETSFLQLNDDDASHSSVDTASLSRVDVTTPSRAG--RKSRSMLRDYL 820

Query: 518 KEEQ 521
           KE Q
Sbjct: 821 KESQ 824

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255539004|ref|XP_002510567.1| conserved hypothetical protein [Ricinus communis] gi|223551268|gb|EEF52754.1| conserved hypothetical protein [Ricinus communis]

 Score =  400 bits (1028), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 252/572 (44%), Positives = 329/572 (57%), Gaps = 82/572 (14%)

Query: 1   MSVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDNEFSTRQ--IIHGTEDAST 58
           MS++EW + L  R S    Q N+I+ D   +D  +       E S R+  I+ G++D S 
Sbjct: 177 MSLMEWLMNLPRRCSDTTMQ-NQIDLD---SDEANMFFNDKMEDSMRKESIVEGSDDGSI 232

Query: 59  DGGRNSIDEEKYRNPCASEEACTVRE--GISIDQNEEYTSTVDYGWPLLRISAPETSDSL 116
           +      ++E+Y +         ++E    S+ +  E ++ +  GWPLL I    T DS 
Sbjct: 233 NR-----EDEEYNH---------IQEFSSGSVSEFAEESTQLTLGWPLLHIKTFATVDSP 278

Query: 117 RDCEDKTLL---------NQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKYDENTLTPS 167
            + E    L          QS   TP S+INS   + E+  + D    E   ++   T  
Sbjct: 279 GEPEPSNELVATCIMSEPTQSMQDTPESEINSSFKRVESSTEKDFCYWEAPGEQ---TKK 335

Query: 168 TELFLKLVSSRCRQFSYEELKQATSQFSS------------------------------- 196
            +L  K  SS C+QFS+EEL++AT  FSS                               
Sbjct: 336 AKLVQKFKSSGCKQFSFEELEKATRSFSSENLIGEGGCSYVYKGSLRWGKLVAVKVLKHY 395

Query: 197 --AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
             AW+DFS EVDI SSL+ K IT L GVCIED +LILV +FL KGSLEESL G  E+S+L
Sbjct: 396 KEAWSDFSLEVDIVSSLKHKHITHLIGVCIEDYHLILVYNFLSKGSLEESLQGHTEKSIL 455

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
           PW +RF+VA+A+AEAL+YLH+ECSRPVIHRDVKSSNILLSS+FQPQLSDFGLA WGP DS
Sbjct: 456 PWKMRFKVAIAVAEALDYLHNECSRPVIHRDVKSSNILLSSEFQPQLSDFGLAAWGPKDS 515

Query: 315 THMIREDVV----GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
            +MI  DVV     +  YIAPEY M+G+VSDK D+YSFG+VLLELL+G++PI  K LKG 
Sbjct: 516 AYMISNDVVEHLDTSXXYIAPEYFMNGRVSDKTDIYSFGIVLLELLTGKKPISCKGLKGH 575

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
           ESLVKWA P+L++G+ + L+DP LS EYD  QM +M+LAANLCI QSP+LRP   Q+LKL
Sbjct: 576 ESLVKWATPLLESGNLDALVDPMLSEEYDVTQMHKMVLAANLCIKQSPRLRPKANQILKL 635

Query: 431 LRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTK 490
           LR      +W   + +D + S  + +      K   K   D   L +D +A S  S    
Sbjct: 636 LREDKDVGEWKSTYDNDQIESTNE-EVGHLSAKLDHKSCSDSSSLVLDDDAASLISTDMT 694

Query: 491 SFSGTGEKPTSLIGTERTQHRKLKDYLKEEQD 522
           S S  G +          QH KLKDYL+E  D
Sbjct: 695 SLSSVGYR----------QHLKLKDYLQELLD 716

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|317106599|dbj|BAJ53107.1| JHL20J20.14 [Jatropha curcas]

 Score =  399 bits (1025), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 249/568 (43%), Positives = 323/568 (56%), Gaps = 85/568 (14%)

Query: 1   MSVVEWAIGLHSRSSSIASQ----GNKIEFDCTKTDSTDSSLERDNEFSTRQIIHGTEDA 56
           MS+ EW + L +RS     Q     N  E + T    T+  +  D + S  Q+I+   + 
Sbjct: 153 MSITEWVMNLPTRSCDTIMQKQSDSNSEETNITLDLKTEDYIVNDGQNSF-QVINSYGNE 211

Query: 57  STDGGRNSIDEEK-YRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDS 115
           S D   N  DEE        SEE+  +R                 GWPLLR+    TSDS
Sbjct: 212 SVDRSSNREDEESGLMQEILSEESTQLR----------------LGWPLLRVKTSATSDS 255

Query: 116 LRDCEDKTLL---NQSTSPTPHSQIN----SFSPKTENPFQMDIPCSEGKYDENTLTPST 168
           L + E   +     QST  TP S I+          E   ++  P  +   +E       
Sbjct: 256 LGESEASKMRIANCQSTEATPKSPIDLPFKEVQSSPEKQIRLAAPREQPMKEE------- 308

Query: 169 ELFLKLVSSRCRQFSYEELKQATSQFSS-------------------------------- 196
            L LKL SS C+QF YEELK+AT +FS+                                
Sbjct: 309 -LVLKLKSSGCKQFRYEELKRATHKFSTENLIGEGGCSDVYKGRLGLGKLVAVKVLKQYK 367

Query: 197 -AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
            AWNDF  EVDI SSL+ K IT L GVCI+DN+LILV DFL KG+LEE L G  E+S+LP
Sbjct: 368 EAWNDFFLEVDIMSSLKHKHITHLIGVCIDDNHLILVYDFLSKGTLEERLQGQSEKSILP 427

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           W VRF+VA+A+AEAL+YLHS C   VIHRDVKSSNILLSSDFQPQLSDFG A W    + 
Sbjct: 428 WKVRFKVAIAVAEALHYLHSSC--LVIHRDVKSSNILLSSDFQPQLSDFGCATWNLKAAG 485

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK 375
           + I  D+VGTFGYIAPEY MHG+VSDK D+YSFG+VLLELL+G++PI   + KG ESLVK
Sbjct: 486 YTISNDIVGTFGYIAPEYFMHGRVSDKTDIYSFGIVLLELLTGKKPISSNSSKGQESLVK 545

Query: 376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT 435
           WA P+L++G+ E L+DPKL  E+D AQM+R +LAA LCI Q P+LRP   Q+LKLLR   
Sbjct: 546 WAMPLLESGNLEALVDPKLGEEFDIAQMERTVLAATLCIKQLPRLRPKASQILKLLR-EE 604

Query: 436 HATDWVDRHADDILGSGIQFQEDDDCQ-KFSSKPHLDFPILDIDLEATSPSSIYTKSFSG 494
              +W++ + +D+  S   ++E DD      ++P  D  +L  D +A+S + +      G
Sbjct: 605 KIEEWMNYYVNDLPESS--YEEFDDIHPAIVNRPSSDLSVLVSDDDASSLNIL------G 656

Query: 495 TGEKPTSLIGTERTQHRKLKDYLKEEQD 522
             +  TS+   E++Q  +LKDYLK  QD
Sbjct: 657 DTKSVTSI---EQSQRFRLKDYLKVRQD 681

Source: Jatropha curcas

Species: Jatropha curcas

Genus: Jatropha

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225457909|ref|XP_002279454.1| PREDICTED: uncharacterized protein LOC100264402 [Vitis vinifera] gi|302142699|emb|CBI19902.3| unnamed protein product [Vitis vinifera]

 Score =  393 bits (1010), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 243/580 (41%), Positives = 325/580 (56%), Gaps = 104/580 (17%)

Query: 1   MSVVEWAIGLHSRSSSIASQGNKIEFDCTKTDSTDSSLERDN---EFSTRQIIHGTEDAS 57
           +SVV+W + L +RS  +  +        T+ +  D+S+  D    E ++ Q++  +E  S
Sbjct: 223 LSVVQWVMSLPNRSCPVIMR--------TQNEENDNSIVHDEWEIETTSVQVVQTSEGKS 274

Query: 58  TDGGRNSIDEEKYRNPCASEEACTVREGISID-----QNEEYTSTVDY-----------G 101
             G  N  DE        S +A    E  S+D     +NE++    +Y           G
Sbjct: 275 LYG--NQKDEN------LSLQAIQASEDKSMDGSENTENEDFGHASEYKGQVCLQQSMLG 326

Query: 102 WPLLRISAPETSDSLRDCE--DKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKY 159
           WPLL+ +A  T ++ R+ +  +K  + Q     P          T     ++   ++ + 
Sbjct: 327 WPLLQKTASATPEAFRESKLANKLSVVQWAMKLPDRNQIGLGSNTIESTPLERETNDSEV 386

Query: 160 DENTL-TPSTELFL-------KLVSSRCRQFSYEELKQATSQFSS--------------- 196
           +EN + +P+    L       K  SS CR FSYEELK+ATSQFSS               
Sbjct: 387 NENNINSPAVSAKLPKELDLHKTNSSGCRWFSYEELKRATSQFSSENLIGEGGCSSVYKG 446

Query: 197 ------------------AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
                             AWN+FS E++IT+SL  K I  L G+C+ED++LI V DF+PK
Sbjct: 447 HLPCGQPVAVKISKSYKEAWNNFSQEINITTSLNHKYIAPLIGICVEDSHLISVYDFVPK 506

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSLEE+LHG     VLPW VRF+VAV +AEALNYLH ECS PVIHRD+KSSNILLS DFQ
Sbjct: 507 GSLEENLHG---DRVLPWEVRFKVAVVVAEALNYLHDECSPPVIHRDIKSSNILLSDDFQ 563

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           PQLSDFGLAI GPTDST ++  DVVGTFGYI+PEY MHG+VSDKID+YSFGVVLLELLSG
Sbjct: 564 PQLSDFGLAIMGPTDSTEILDSDVVGTFGYISPEYFMHGRVSDKIDIYSFGVVLLELLSG 623

Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSP 418
           RRPI  K L    SLVKWAKPIL++GD E L+DP L  ++D+ QM R++LAA  CIN+S 
Sbjct: 624 RRPINSKTLTEEASLVKWAKPILESGDLEALVDPNLDGKFDSVQMHRVVLAATSCINESA 683

Query: 419 QLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDID 478
           +LRP   Q+LKLLRG     +W   H  ++   G +  ++ D Q  S       P+LD++
Sbjct: 684 ELRPKGSQILKLLRGEKDGEEWFKMHVKELKERGKREDDEFDLQLISK------PLLDVE 737

Query: 479 LEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRKLKDYLK 518
              TS +                    E+ +H  L++YLK
Sbjct: 738 DYITSHN-----------------CAAEQRKHFTLEEYLK 760

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587135|ref|XP_002534152.1| ATP binding protein, putative [Ricinus communis] gi|223525787|gb|EEF28235.1| ATP binding protein, putative [Ricinus communis]

 Score =  363 bits (931), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 207/428 (48%), Positives = 268/428 (62%), Gaps = 43/428 (10%)

Query: 101 GWPLLRISAPETSDSLRDCEDKTL---LNQSTSPTPHSQINSFSPKTENPFQMDI---PC 154
           GWPLLR ++   +++L+  E   +   +N     +    + SF  +     + DI     
Sbjct: 174 GWPLLRRASSVRAETLQARELSVVQWAMNLPIRSSLKHPLGSFIERASEGERSDILEESS 233

Query: 155 SEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS------------------ 196
           S   Y    L    E+ LK  SS C+ FSYE LK ATS+F S                  
Sbjct: 234 SNSSYASGELQNGLEILLKAHSSNCKWFSYEVLKTATSKFCSGNLIGMGGCNRVYKGTLP 293

Query: 197 ---------------AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL 241
                          A  DF+ EV+I SSL  K IT L GVCI+D  LI V D++ KGSL
Sbjct: 294 DGKLVAVKIRNSSEEAMKDFAQEVEIISSLNHKYITRLTGVCIKDFDLISVYDYISKGSL 353

Query: 242 EESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
           EE LHG   E+S L W +RF +A+ IAEALNYLH+ECSRPVIHRDVKSSNILLS++F+PQ
Sbjct: 354 EEILHGNNKEKSALSWELRFSIAIKIAEALNYLHNECSRPVIHRDVKSSNILLSNEFEPQ 413

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR 360
           LSDFGLAIWGPT S+ MI+ DVVGTFGY+APEY M+GK+SDKIDVY+FGVV+LELLSGR+
Sbjct: 414 LSDFGLAIWGPTSSSFMIQGDVVGTFGYLAPEYFMYGKLSDKIDVYAFGVVILELLSGRK 473

Query: 361 PIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL 420
           PI ++   G ESLV WAKPI+++G+   +LDP L   +D AQM+RM+LAANLCI ++ +L
Sbjct: 474 PIVYETPNGQESLVMWAKPIIESGNARGILDPSLDENFDEAQMRRMVLAANLCITRAARL 533

Query: 421 RPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSS-KPHLDFPILDIDL 479
           RP + +VLKLLRG   A  WV     D+     +   DD+    SS + HL+  +LD+D 
Sbjct: 534 RPKISEVLKLLRGDKDAATWVTLRNKDL--DDPEKDLDDEVYPNSSPELHLNLALLDVDD 591

Query: 480 EATSPSSI 487
           ++TS SS+
Sbjct: 592 DSTSFSSL 599

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448572|ref|XP_004142040.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g59680-like [Cucumis sativus]

 Score =  358 bits (919), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 228/569 (40%), Positives = 314/569 (55%), Gaps = 72/569 (12%)

Query: 1   MSVVEWAIGLHSRSSS-IASQGNKIEFDCTKT--DSTDSSLERDNEFSTRQIIHGTEDAS 57
           +SVV+W + L +RS + I    N +  +  K    +    +E  N    +      ED+ 
Sbjct: 279 VSVVQWVMSLPNRSGAGIPKSQNDMTLEIPKICLQNKSEGMEETNHLVLQNFGDEAEDS- 337

Query: 58  TDGGRNSIDEEKYRNPCASEEACTVREGISIDQNEEYTSTVDYGWPLLRISAPETSDSLR 117
                   DE        +E     + G+S+    +       GWPL   +  E SDSL+
Sbjct: 338 --------DENLKGGELVNEFKHNAKMGLSVSFIVKEFQQEMPGWPLRPDALSERSDSLQ 389

Query: 118 DCEDK---------TLLNQSTSPTPHSQINSFSPK-TENPFQMDIPCSEGKYDENTL--- 164
           + E+          ++ N++      SQI S +    E   ++    SE K  EN +   
Sbjct: 390 ESEETDIQEGDSETSISNRTIDTNLESQIGSVAKNLKEREERVIFFHSEEKSIENNIFKI 449

Query: 165 -TPSTELFLKLVSSRCRQFSYEELKQATSQFSS--------------------------- 196
            +   E  +K+  S C+ FSY ELK ATS FS+                           
Sbjct: 450 ASKQLEFPIKMNQSVCKCFSYAELKMATSNFSAENLIGEGGYSAVYKGCLLDGTSVVVKV 509

Query: 197 ------AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE 250
                 A ++F  E++I SS++   IT   GVC+E+ +LI V D+ P+GSLEE+LHG   
Sbjct: 510 LKSYKDARDNFLLELNIVSSIKHNHITPPIGVCMENEHLISVYDYFPEGSLEENLHGQSG 569

Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
           +S + W +RF+VA+A+AEALNYLH+E S PVIHRDVKSSN+LLS  FQPQLSDFGLA+WG
Sbjct: 570 RSKIQWEMRFKVAIAVAEALNYLHNERSSPVIHRDVKSSNVLLSEKFQPQLSDFGLAMWG 629

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
           PTDS ++I  DVVGTFGYIAPEYLMHGK+SDKID+Y+FG+VLLELLSGRRPI F   +G 
Sbjct: 630 PTDSPYVINTDVVGTFGYIAPEYLMHGKLSDKIDIYAFGIVLLELLSGRRPIDFGVAEGQ 689

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
            SLV WAK +L + + + L+DP +  ++++ Q+QR++LAA LCIN S +LRPN  ++LKL
Sbjct: 690 RSLVLWAKEVLNSENPKALMDPNMDIKFNDDQVQRVVLAATLCINASARLRPNASEILKL 749

Query: 431 LRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTK 490
           L+G     D+++      L        DD   KF SKP L F + DID + T PSS    
Sbjct: 750 LKGEARVDDFINFPGSKEL---TDHDIDDIFPKFMSKPSLSFALRDIDNDCT-PSSNANT 805

Query: 491 SFSGTGEKPTSLIGTERTQHRKLKDYLKE 519
           + +   +KP  L         KLKDYLKE
Sbjct: 806 TSNTMVKKPGRL---------KLKDYLKE 825

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474848|ref|XP_002277797.2| PREDICTED: wall-associated receptor kinase 5-like [Vitis vinifera]

 Score =  357 bits (915), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 183/349 (52%), Positives = 240/349 (68%), Gaps = 39/349 (11%)

Query: 176 SSRCRQFSYEELKQATSQFSS---------------------------------AWNDFS 202
           SS CR FS+E LK +TSQFSS                                 AW DF+
Sbjct: 256 SSDCRWFSHEVLKASTSQFSSENLIGKGGCNRVYKGILPNSKQVAVKVLKSSKEAWKDFA 315

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFE 261
            EV+I SSL+ + I  L G+C+ED++LI V +F  +GSLEE+LHG+   +S L W VRF 
Sbjct: 316 MEVNIMSSLKHRHIAPLLGICLEDSHLISVYEFFSRGSLEENLHGSIKHKSALSWEVRFN 375

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +AV +AEALNYLH+ECS+PVIHRD+KSSNILLS+DF+PQL+DFGLAIWGPT S+ +   D
Sbjct: 376 LAVGVAEALNYLHNECSKPVIHRDIKSSNILLSNDFEPQLADFGLAIWGPTTSSFLTHGD 435

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           VVGTFGY+APEY M+GKVSDKIDVYSFGVVLLELLSGR+PIG ++ KG ESLV WAKPIL
Sbjct: 436 VVGTFGYLAPEYFMYGKVSDKIDVYSFGVVLLELLSGRKPIGSESPKGQESLVMWAKPIL 495

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV 441
           ++G+  +++DP L  ++D  QMQR +LAA LCI Q+ + RP + Q+LKLLRG      WV
Sbjct: 496 ESGNLRSIMDPDLDGKFDEVQMQRTVLAATLCITQAARRRPKISQILKLLRGEKDVAKWV 555

Query: 442 DRHADDILGSGIQFQEDDDCQKF---SSKPHLDFPILDIDLEATSPSSI 487
           +   +D     ++ Q+++D + +   S++ HL   +LD+D   TS SS+
Sbjct: 556 NSQIED--QHDLENQDENDDEVYPDSSAESHLGLALLDVDDNFTSFSSM 602

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297744611|emb|CBI37873.3| unnamed protein product [Vitis vinifera]

 Score =  357 bits (915), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 183/349 (52%), Positives = 240/349 (68%), Gaps = 39/349 (11%)

Query: 176 SSRCRQFSYEELKQATSQFSS---------------------------------AWNDFS 202
           SS CR FS+E LK +TSQFSS                                 AW DF+
Sbjct: 289 SSDCRWFSHEVLKASTSQFSSENLIGKGGCNRVYKGILPNSKQVAVKVLKSSKEAWKDFA 348

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFE 261
            EV+I SSL+ + I  L G+C+ED++LI V +F  +GSLEE+LHG+   +S L W VRF 
Sbjct: 349 MEVNIMSSLKHRHIAPLLGICLEDSHLISVYEFFSRGSLEENLHGSIKHKSALSWEVRFN 408

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +AV +AEALNYLH+ECS+PVIHRD+KSSNILLS+DF+PQL+DFGLAIWGPT S+ +   D
Sbjct: 409 LAVGVAEALNYLHNECSKPVIHRDIKSSNILLSNDFEPQLADFGLAIWGPTTSSFLTHGD 468

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           VVGTFGY+APEY M+GKVSDKIDVYSFGVVLLELLSGR+PIG ++ KG ESLV WAKPIL
Sbjct: 469 VVGTFGYLAPEYFMYGKVSDKIDVYSFGVVLLELLSGRKPIGSESPKGQESLVMWAKPIL 528

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV 441
           ++G+  +++DP L  ++D  QMQR +LAA LCI Q+ + RP + Q+LKLLRG      WV
Sbjct: 529 ESGNLRSIMDPDLDGKFDEVQMQRTVLAATLCITQAARRRPKISQILKLLRGEKDVAKWV 588

Query: 442 DRHADDILGSGIQFQEDDDCQKF---SSKPHLDFPILDIDLEATSPSSI 487
           +   +D     ++ Q+++D + +   S++ HL   +LD+D   TS SS+
Sbjct: 589 NSQIED--QHDLENQDENDDEVYPDSSAESHLGLALLDVDDNFTSFSSM 635

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147768429|emb|CAN73629.1| hypothetical protein VITISV_026641 [Vitis vinifera]

 Score =  357 bits (915), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 183/349 (52%), Positives = 240/349 (68%), Gaps = 39/349 (11%)

Query: 176 SSRCRQFSYEELKQATSQFSS---------------------------------AWNDFS 202
           SS CR FS+E LK +TSQFSS                                 AW DF+
Sbjct: 324 SSDCRWFSHEVLKXSTSQFSSENLIGKGGCNRVYKGILPNSKQVAVKVLKSSKEAWKDFA 383

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFE 261
            EV+I SSL+ + I  L G+C+ED++LI V +F  +GSLEE+LHG+   +S L W VRF 
Sbjct: 384 MEVNIMSSLKHRHIAPLLGICLEDSHLISVYEFFSRGSLEENLHGSIKHKSALSWEVRFN 443

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +AV +AEALNYLH+ECS+PVIHRD+KSSNILLS+DF+PQL+DFGLAIWGPT S+ +   D
Sbjct: 444 LAVGVAEALNYLHNECSKPVIHRDIKSSNILLSNDFEPQLADFGLAIWGPTTSSFLTHGD 503

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           VVGTFGY+APEY M+GKVSDKIDVYSFGVVLLELLSGR+PIG ++ KG ESLV WAKPIL
Sbjct: 504 VVGTFGYLAPEYFMYGKVSDKIDVYSFGVVLLELLSGRKPIGSESPKGQESLVMWAKPIL 563

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV 441
           ++G+  +++DP L  ++D  QMQR +LAA LCI Q+ + RP + Q+LKLLRG      WV
Sbjct: 564 ESGNLRSIMDPDLDGKFDEVQMQRXVLAATLCITQAARRRPKISQILKLLRGEKDVAKWV 623

Query: 442 DRHADDILGSGIQFQEDDDCQKF---SSKPHLDFPILDIDLEATSPSSI 487
           +   +D     ++ Q+++D + +   S++ HL   +LD+D   TS SS+
Sbjct: 624 NSQIED--QHDLENQDENDDEVYPDSSAESHLGLALLDVDDNFTSFSSM 670

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078315|ref|XP_002305520.1| predicted protein [Populus trichocarpa] gi|222848484|gb|EEE86031.1| predicted protein [Populus trichocarpa]

 Score =  356 bits (914), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 202/426 (47%), Positives = 266/426 (62%), Gaps = 42/426 (9%)

Query: 101 GWPLLR-ISAPETSDSLRDCE----DKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCS 155
           GWPLLR +++    + +R          L ++S+   P  ++++F  + ++    +I  S
Sbjct: 233 GWPLLRRVNSAIPQNYVRQLSVVQWAMALPDRSSLQNP--RMSNFEEREKSKILEEINKS 290

Query: 156 EGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS------------------- 196
                   L    ++ LK  SS C+ FSYE LK ATS FSS                   
Sbjct: 291 SSSA-LGELENGLDILLKASSSSCKWFSYEVLKGATSSFSSENLFGKGGCNRVYKGVLPD 349

Query: 197 --------------AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE 242
                         A  DF+ EV I SSL  K IT L G CI+D  LI V DF  KGSLE
Sbjct: 350 GKPVAVKVQKSSQEAMKDFAHEVAIISSLNHKHITPLLGFCIKDTVLISVYDFFSKGSLE 409

Query: 243 ESLHG-AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
           E+LHG + E+S L W +RF++AV IAEAL YLH+ECSRPVIHRD+KSSNILLS  F+PQL
Sbjct: 410 ENLHGKSKEKSPLSWEMRFDIAVKIAEALYYLHNECSRPVIHRDIKSSNILLSDGFEPQL 469

Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           SDFG+AIWGPT ++ + + +VVGTFGY+APEY M+GKVSDKIDVY+FGVVLLELLSGRRP
Sbjct: 470 SDFGMAIWGPTTTSFVTQGEVVGTFGYLAPEYFMYGKVSDKIDVYAFGVVLLELLSGRRP 529

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
           I  ++ KG ESLV WAKPIL++GD + L+DP L+  +D  QMQRM+LAA  CI ++ +LR
Sbjct: 530 ISSESTKGQESLVMWAKPILESGDAKGLVDPNLNGNFDEVQMQRMVLAATHCITRAARLR 589

Query: 422 PNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEA 481
           P M ++LKLLRG T   +WV+    D      Q  +D+     S++ HL   +LD+D ++
Sbjct: 590 PKMSEILKLLRGDTELEEWVNPQNKDPRDQENQDNDDEVYPSSSAELHLSLALLDVDDDS 649

Query: 482 TSPSSI 487
           TS SS+
Sbjct: 650 TSFSSL 655

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	522
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.563	0.370	0.526	2.5e-81
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.549	0.379	0.487	1.5e-79
TAIR|locus:2160801	705	AT5G63940 [Arabidopsis thalian	0.547	0.405	0.484	5.9e-74
TAIR|locus:2059919	617	AT2G16750 [Arabidopsis thalian	0.724	0.612	0.418	2.4e-69
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.480	0.433	0.418	2.9e-58
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.501	0.384	0.417	3.1e-57
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.595	0.480	0.356	8.8e-57
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.595	0.476	0.356	3.8e-56
TAIR|locus:2026925	708	PERK9 "proline-rich extensin-l	0.434	0.320	0.431	7.9e-55
TAIR|locus:2028967	467	AT1G66460 [Arabidopsis thalian	0.473	0.528	0.447	1.1e-54

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 776 (278.2 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
 Identities = 157/298 (52%), Positives = 207/298 (69%)

Query:   193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS 252
             Q     NDF +E++I ++L  K+I +L G C ED+ L+LV ++L +GSLEE+LHG  +  
Sbjct:   477 QTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDP 536

Query:   253 V-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
             +   W  R++VAV +AEAL+YLH+  S+PVIHRDVKSSNILLS DF+PQLSDFGLA W  
Sbjct:   537 LAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWAS 596

Query:   312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
               +TH+I  DV GTFGY+APEY M+GKV+DKIDVY+FGVVLLELLSGR+PI     KG E
Sbjct:   597 ISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQE 656

Query:   372 SLVKWAKPILKNGDTETLLDPKL--SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             SLV WAKPIL +G    LLDP L  +N  ++ QMQRM LAA LCI +SPQ RP M  VLK
Sbjct:   657 SLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLK 716

Query:   430 LLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSI 487
             LL+G     +W  +  +       +  +D+ CQ+ + + HL+  +LD++ ++ S  SI
Sbjct:   717 LLKGDEDTLEWAMQQVNSSSEES-EMLKDEQCQRSNLQSHLNLALLDVEDDSISMGSI 773

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 720 (258.5 bits), Expect = 1.5e-79, Sum P(3) = 1.5e-79
 Identities = 141/289 (48%), Positives = 201/289 (69%)

Query:   200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-LPWGV 258
             DF +E+DI ++L  K++ +L G C E+N L+LV ++L +GSLEE+LHG  +  V   W  
Sbjct:   448 DFVAEIDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNE 507

Query:   259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             R++VAV IAEAL+YLH++  +PVIHRDVKSSNILLS DF+PQLSDFGLA W    +T +I
Sbjct:   508 RYKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQII 567

Query:   319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
               DV GTFGY+APEY M+GK+++KIDVY++GVVLLELLSGR+P+  ++ K  +SLV WAK
Sbjct:   568 CSDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAK 627

Query:   379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT 438
             PIL + +   LLD  L ++ ++ QM++M LAA LCI  +PQ RP MG VL+LL+G     
Sbjct:   628 PILDDKEYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEML 687

Query:   439 DWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSI 487
              W      + L   +  + D+  ++ + + HL+   LD++ ++ S  S+
Sbjct:   688 KWAKLQVSNPLEDSMLLK-DEKLRRSNLQSHLNLAFLDMEDDSLSMGSM 735

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 143/295 (48%), Positives = 197/295 (66%)

Query:   200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-LPWGV 258
             +F  E+++ +S+  K+I +L G C E+N L+LV D+LP+GSLEE+LHG  + +    W  
Sbjct:   401 EFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWME 460

Query:   259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             R++VAV +AEAL+YLH+     VIHRDVKSSN+LL+ DF+PQLSDFG A    + S H+ 
Sbjct:   461 RYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASSTSQHVA 520

Query:   319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
               D+ GTFGY+APEY MHGKV+DKIDVY+FGVVLLEL+SGR+PI     KG ESLV WA 
Sbjct:   521 GGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQESLVLWAN 580

Query:   379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT 438
             PIL +G    LLDP L N+  N  ++++LLAA LCI ++P  RP +G VLK+L+G   AT
Sbjct:   581 PILDSGKFAQLLDPSLENDNSNDLIEKLLLAATLCIKRTPHDRPQIGLVLKILQGEEEAT 640

Query:   439 DWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFS 493
             +W  +         ++  ED      + + H++  +LD++ +A S SS    S S
Sbjct:   641 EWGKQQ--------VRASEDVSAYLTNIESHINLALLDLEDDAASDSSPEASSIS 687

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 169/404 (41%), Positives = 233/404 (57%)

Query:   101 GWPLLRISAPETSDSLRDCEDKTLLNQSTS-PT--PH--SQI--NSFSPKTENPFQMDIP 153
             GWPLLR S   T          +++N   S P   PH  +Q    SF  K       DI 
Sbjct:   203 GWPLLRTSTLATPMVQHQTRKISVVNWVMSLPERFPHHPNQTCQQSFCDKQLKDILKDIN 262

Query:   154 CSEGKYDE-NTLTPSTELFLKLVSSRCRQF--SYEE------LKQATSQFSSAWNDFSSE 204
                  YD   T T    L   +    C +    + E      +K        A  +F  E
Sbjct:   263 -RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHE 321

Query:   205 VDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAV 264
             V I SSL   +I+ L GVC+  N LI V +   KGSLEE+L G   + VL W  R ++A+
Sbjct:   322 VSIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQG---KHVLRWEERLKIAI 378

Query:   265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
              + EAL+YLH++CS PVIHRDVKSSN+LLS +F+PQLSDFGL++WG     + I+ DVVG
Sbjct:   379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438

Query:   325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG 384
             TFGY+APEY M+GKVSDK+DVY+FGVVLLEL+SGR  I   + +G ESLV WAKP+++ G
Sbjct:   439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498

Query:   385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH 444
             + + LLDP ++  +D  Q  +M+LAA  C+ ++   RPN+ ++LKLLRG    + WV   
Sbjct:   499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVKIE 558

Query:   445 ADDILGSGIQFQEDDDCQKFSSKPHLDFPILDI-DLEATSPSSI 487
              DD  G    F +D+     +++ HL   ++D+ D ++ S SS+
Sbjct:   559 EDDEDG----F-DDEVYPNSNTELHLSLAMVDVEDNDSVSNSSL 597

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 554 (200.1 bits), Expect = 2.9e-58, Sum P(2) = 2.9e-58
 Identities = 108/258 (41%), Positives = 162/258 (62%)

Query:   180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
             R+ + + L + +   +    +F +E+ I S +   +   L G C+E   L LV  F   G
Sbjct:   290 RRIAVKRLAKESGDMNKE-KEFLTELGIISHVSHPNTALLLGCCVEKG-LYLVFRFSENG 347

Query:   240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
             +L  +LH   E   L W VR+++AV +A  L+YLH  C+  +IHRD+KSSN+LL  D++P
Sbjct:   348 TLYSALH-ENENGSLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEP 406

Query:   300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             Q++DFGLA W P   TH     V GTFGY+APE LM G + +K D+Y+FG++LLE+++GR
Sbjct:   407 QITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGR 466

Query:   360 RPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQ 419
             RP+        + ++ WAKP ++ G+T  L+DPKL ++YD+ QM +++L A+ C+ QSP 
Sbjct:   467 RPVN----PTQKHILLWAKPAMETGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPI 522

Query:   420 LRPNMGQVLKLLRGATHA 437
             LRP M QVL+LL     A
Sbjct:   523 LRPTMTQVLELLTNGNEA 540

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 522 (188.8 bits), Expect = 3.1e-57, Sum P(3) = 3.1e-57
 Identities = 114/273 (41%), Positives = 166/273 (60%)

Query:   173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
             K V S  R+ + ++LK   SQ      +F +EV+I S +  + + TL G CI + + +LV
Sbjct:   355 KGVLSDGREVAVKQLKIGGSQGE---REFKAEVEIISRVHHRHLVTLVGYCISEQHRLLV 411

Query:   233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
              D++P  +L   LH  G + V+ W  R  VA   A  + YLH +C   +IHRD+KSSNIL
Sbjct:   412 YDYVPNNTLHYHLHAPG-RPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 470

Query:   293 LSSDFQPQLSDFGLA-IWGPTD-STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
             L + F+  ++DFGLA I    D +TH +   V+GTFGY+APEY   GK+S+K DVYS+GV
Sbjct:   471 LDNSFEALVADFGLAKIAQELDLNTH-VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGV 529

Query:   351 VLLELLSGRRPIGFKNLKGPESLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRM 406
             +LLEL++GR+P+      G ESLV+WA+P+L    +N + + L+DP+L   +   +M RM
Sbjct:   530 ILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRM 589

Query:   407 LLAANLCINQSPQLRPNMGQVLKLLRGATHATD 439
             + AA  C+  S   RP M QV++ L     ATD
Sbjct:   590 VEAAAACVRHSAAKRPKMSQVVRALDTLEEATD 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 546 (197.3 bits), Expect = 8.8e-57, Sum P(2) = 8.8e-57
 Identities = 118/331 (35%), Positives = 191/331 (57%)

Query:   180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
             ++ + ++LK  + Q      +F +EV+I S +  + + +L G CI     +LV +F+P  
Sbjct:   298 KEVAVKQLKVGSGQGE---REFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNN 354

Query:   240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
             +LE  LHG G  + + W  R ++A+  A+ L+YLH +C+  +IHRD+K+SNIL+   F+ 
Sbjct:   355 NLELHLHGEGRPT-MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEA 413

Query:   300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             +++DFGLA      +TH +   V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GR
Sbjct:   414 KVADFGLAKIASDTNTH-VSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGR 472

Query:   360 RPIGFKNLKGPESLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCIN 415
             RP+   N+   +SLV WA+P+L    + GD E L D K++N YD  +M RM+  A  C+ 
Sbjct:   473 RPVDANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVR 532

Query:   416 QSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPIL 475
              S + RP M Q+++ L G    +D         L  G++  + +    +      D    
Sbjct:   533 HSARRRPRMSQIVRALEGNVSLSD---------LNEGMRPGQSNVYSSYGGSTDYDSSQY 583

Query:   476 DIDLEATSPSSIYTKSFSGTGE--KPTSLIG 504
             + D++     ++ T+ ++ TGE   PTS  G
Sbjct:   584 NEDMKKFRKMALGTQEYNATGEYSNPTSDYG 614

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 541 (195.5 bits), Expect = 3.8e-56, Sum P(2) = 3.8e-56
 Identities = 118/331 (35%), Positives = 188/331 (56%)

Query:   180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
             ++ + ++LK  + Q      +F +EV+I S +  + + +L G C+     +LV +F+P  
Sbjct:   303 KEVAVKQLKAGSGQGE---REFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNN 359

Query:   240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
             +LE  LHG G  + + W  R ++A+  A+ L+YLH +C+  +IHRD+K+SNIL+   F+ 
Sbjct:   360 NLEFHLHGKGRPT-MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEA 418

Query:   300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             +++DFGLA      +TH +   V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GR
Sbjct:   419 KVADFGLAKIASDTNTH-VSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGR 477

Query:   360 RPIGFKNLKGPESLVKWAKPIL----KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCIN 415
             RP+   N+   +SLV WA+P+L    + GD E L D K+ NEYD  +M RM+  A  C+ 
Sbjct:   478 RPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVR 537

Query:   416 QSPQLRPNMGQVLKLLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKPHLDFPIL 475
              S + RP M Q+++ L G    +D         L  G++    +    +      D    
Sbjct:   538 HSARRRPRMSQIVRALEGNVSLSD---------LNEGMRPGHSNVYSSYGGSTDYDTSQY 588

Query:   476 DIDLEATSPSSIYTKSFSGTGE--KPTSLIG 504
             + D+      ++ T+ +  TGE   PTS  G
Sbjct:   589 NDDMIKFRKMALGTQEYGTTGEYSNPTSDYG 619

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 501 (181.4 bits), Expect = 7.9e-55, Sum P(3) = 7.9e-55
 Identities = 101/234 (43%), Positives = 148/234 (63%)

Query:   200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
             +F +EV+  S +  + + ++ G CI  +  +L+ D++    L   LHG  E+SVL W  R
Sbjct:   417 EFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHG--EKSVLDWATR 474

Query:   260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
              ++A   A  L YLH +C   +IHRD+KSSNILL  +F  ++SDFGLA      +TH I 
Sbjct:   475 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTH-IT 533

Query:   320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
               V+GTFGY+APEY   GK+++K DV+SFGVVLLEL++GR+P+      G ESLV+WA+P
Sbjct:   534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593

Query:   380 ILKNG-DTE---TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             ++ +  +TE   +L DPKL   Y  ++M RM+ AA  C+      RP MGQ+++
Sbjct:   594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVR 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028967 AT1G66460 [Arabidopsis thaliana (taxid:3702)]

 Score = 537 (194.1 bits), Expect = 1.1e-54, Sum P(2) = 1.1e-54
 Identities = 115/257 (44%), Positives = 159/257 (61%)

Query:   187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL 245
             +K+   +   +   F  E+ I SSL   ++  L G CI+ D  L LV  ++  GSLE  L
Sbjct:   157 IKRLDKKDKESPKSFCRELMIASSLNSPNVVPLLGFCIDPDQGLFLVYKYVSGGSLERFL 216

Query:   246 HGAGEQSV------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
             H   ++        LPW  R++VA+ IA+A+ YLH+   + V+HRD+K SNILLSS+  P
Sbjct:   217 HDKKKKKSRKTPLNLPWSTRYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSNKIP 276

Query:   300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             +L DFGLA W    S   + + V GTFGY+APEY  HGK+SDK DVY+FGVVLLEL++GR
Sbjct:   277 KLCDFGLATWTAAPSVPFLCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGR 336

Query:   360 RPIGFKNLKGPESLVKWAKPILKNG--DTETLLDPKLS-NEYDNAQMQRMLLAANLCINQ 416
             +PI  +   G E+LV WAKP+L  G   TE LLDP+L     ++A M+RM+ AA  C+  
Sbjct:   337 KPIEARRPSGEENLVVWAKPLLHRGIEATEELLDPRLKCTRKNSASMERMIRAAAACVIN 396

Query:   417 SPQLRPNMGQVLKLLRG 433
                 RP M ++L +L+G
Sbjct:   397 EESRRPGMKEILSILKG 413

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	522
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-35
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.002
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  138 bits (351), Expect = 1e-37
 Identities = 70/231 (30%), Positives = 108/231 (46%), Gaps = 25/231 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
            E+ I   L   +I  L     + ++L LV ++   G L + L   G    L      ++
Sbjct: 47  REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKI 103

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A+ I   L YLHS     +IHRD+K  NILL  +   +++DFGLA      S+ +     
Sbjct: 104 ALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTF 158

Query: 323 VGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           VGT  Y+APE L+ G     K+DV+S GV+L ELL+G+ P  F      + L      I 
Sbjct: 159 VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQL----IR 212

Query: 382 KNGDTETLLD-PKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVLK 429
           +        D PK S+  + A+  +++ L       N+ P  RP   ++L+
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCL-------NKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (332), Expect = 5e-35
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 24/228 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
            E+ I   L+  +I  L  V  +++ L LV ++   G L + L   G  S      RF  
Sbjct: 46  REIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--EDEARF-Y 102

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED 321
              I  AL YLHS   + ++HRD+K  NILL  D   +L+DFGLA    P +        
Sbjct: 103 LRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT----T 155

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
            VGT  Y+APE L+       +D++S GV+L ELL+G+ P       G + L++  K I 
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIG 210

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           K        +  +S E       + L+     + + P+ R    + L+
Sbjct: 211 KPKPPFPPPEWDISPEA------KDLI--RKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  128 bits (324), Expect = 2e-34
 Identities = 60/166 (36%), Positives = 89/166 (53%), Gaps = 9/166 (5%)

Query: 192 SQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ 251
              SS   +   E++I   L   +I  L GV  ++N+L LV ++   GSL++ L     +
Sbjct: 29  EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK--ENE 86

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLAIWG 310
             L       + + I E L YLH   S  +IHRD+K  NILL SD  + +L+DFGL+   
Sbjct: 87  GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSK-- 141

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLEL 355
              S   + + +VGT  Y+APE L+  G  S+K D++S GV+L EL
Sbjct: 142 LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  115 bits (290), Expect = 3e-29
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 36/245 (14%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
                +F  E  I   L+  +I  L GVC E+  L++V +++P G L + L     +  L
Sbjct: 42  EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-EL 100

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                   A+ IA  + YL S   +  IHRD+ + N L+  +   ++SDFGL+     D 
Sbjct: 101 SLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157

Query: 315 THM-------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKN 366
            +        IR        ++APE L  GK + K DV+SFGV+L E+ + G  P  +  
Sbjct: 158 YYKVKGGKLPIR--------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPG 207

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
           +   E         LK G    L  P          M +       C  + P+ RP   +
Sbjct: 208 MSNAE-----VLEYLKKG--YRLPKPPNCPPELYKLMLQ-------CWAEDPEDRPTFSE 253

Query: 427 VLKLL 431
           ++++L
Sbjct: 254 LVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  115 bits (290), Expect = 4e-29
 Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 37/245 (15%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
                +F  E  I   L+  ++  L GVC E+  L +V +++  G L   L     +  L
Sbjct: 42  EQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--L 99

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                   A+ IA  + YL S   +  IHRD+ + N L+  +   ++SDFGL+     D 
Sbjct: 100 SLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156

Query: 315 THM-------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKN 366
            +        IR        ++APE L  GK + K DV+SFGV+L E+ + G +P  +  
Sbjct: 157 YYRKRGGKLPIR--------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPG 206

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
           +   E         LKNG    L  P          M +       C  + P+ RP   +
Sbjct: 207 MSNEE-----VLEYLKNG--YRLPQPPNCPPELYDLMLQ-------CWAEDPEDRPTFSE 252

Query: 427 VLKLL 431
           ++++L
Sbjct: 253 LVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 1e-27
 Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 24/246 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK+  S       +F  E  I   L   +I  L GVC +   L +V++++P G L + L 
Sbjct: 36  LKEGAS--EEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR 93

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
             GE+  L      ++A+ IA+ + YL S   +  +HRD+ + N L++ +   ++SDFGL
Sbjct: 94  KHGEKLTLKD--LLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGL 148

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFK 365
           +     D  +  R        ++APE L  GK + K DV+SFGV+L E+ + G +P  + 
Sbjct: 149 SRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--YP 206

Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
            +   E +++     L++G    L  P    E    ++  ++L    C    P+ RP   
Sbjct: 207 GMS-NEEVLEL----LEDG--YRLPRP----ENCPDELYELML---QCWAYDPEDRPTFS 252

Query: 426 QVLKLL 431
           ++++ L
Sbjct: 253 ELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 8e-27
 Identities = 70/261 (26%), Positives = 115/261 (44%), Gaps = 44/261 (16%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----- 241
           LK+  S       DF  E  +   L   ++  L GVC E+  L LV +++  G L     
Sbjct: 31  LKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88

Query: 242 -EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
               +  + E+S L        A+ IA+ + YL S   +  +HRD+ + N L+  D   +
Sbjct: 89  KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVK 145

Query: 301 LSDFGLAIWGPTDSTHM--------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVL 352
           +SDFGL+     D  +         IR        ++APE L  G  + K DV+SFGV+L
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLPIR--------WMAPESLKDGIFTSKSDVWSFGVLL 197

Query: 353 LELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAAN 411
            E+ + G  P  +  L   E ++++    L+ G    L  P    EY   ++  ++L   
Sbjct: 198 WEIFTLGATP--YPGLS-NEEVLEY----LRKG--YRLPKP----EYCPDELYELML--- 241

Query: 412 LCINQSPQLRPNMGQVLKLLR 432
            C    P+ RP   ++++ L 
Sbjct: 242 SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  111 bits (277), Expect = 9e-27
 Identities = 84/344 (24%), Positives = 127/344 (36%), Gaps = 18/344 (5%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPK 238
           +  + + L +     S     F  E+ I +SL    +I  L     ++  L LV +++  
Sbjct: 23  KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-F 297
           GSLE+ L   G +  L       +   I  AL YLH   S+ +IHRD+K  NILL  D  
Sbjct: 83  GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGR 139

Query: 298 QPQLSDFGLAIW----GPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGV 350
             +L DFGLA      G T S   +    VGT GY+APE L+       S   D++S G+
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199

Query: 351 VLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA 410
            L ELL+G  P  F+  K   +  +  K IL+            SN    ++    LL  
Sbjct: 200 TLYELLTGLPP--FEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLL-- 255

Query: 411 NLCINQSPQLRPNMGQVLK--LLRGATHATDWVDRHADDILGSGIQFQEDDDCQKFSSKP 468
              + + P+ R +    L   LL         +         + ++       +   S  
Sbjct: 256 KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315

Query: 469 HLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQHRK 512
           +             S  S        +     S      T   K
Sbjct: 316 NSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSK 359

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (252), Expect = 8e-24
 Identities = 57/166 (34%), Positives = 88/166 (53%), Gaps = 8/166 (4%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           +DF  E++I  +L+ ++I    GVC +     L L+ ++LP GSL + L    +Q  L  
Sbjct: 51  SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR 110

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST- 315
            + F  +  I + ++YL S   +  IHRD+ + NIL+ S+   ++SDFGLA   P D   
Sbjct: 111 LLLF--SSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           + ++E       + APE L   K S   DV+SFGV L EL +   P
Sbjct: 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =   99 bits (250), Expect = 9e-24
 Identities = 69/243 (28%), Positives = 113/243 (46%), Gaps = 34/243 (13%)

Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS 252
           +         +E+ I    +  +I    G  ++ + L +V +F   GSL++ L       
Sbjct: 36  ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---- 91

Query: 253 VLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA 307
                   E  +A     + + L YLHS     +IHRD+K++NILL+SD + +L DFGL+
Sbjct: 92  ---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS 145

Query: 308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
                 S    R  +VGT  ++APE +       K D++S G+  +EL  G+ P  +  L
Sbjct: 146 A---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP--YSEL 200

Query: 368 KGPESLVKWAKPILKNGDTETLLDP-KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
              ++L K    I  NG    L +P K S+E+ +      L     C+ ++P+ RP   Q
Sbjct: 201 PPMKALFK----IATNG-PPGLRNPEKWSDEFKD-----FL---KKCLQKNPEKRPTAEQ 247

Query: 427 VLK 429
           +LK
Sbjct: 248 LLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 33/242 (13%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           ++   EV   S     ++       +  + L LV  +L  GSL + +     +S  P G 
Sbjct: 44  DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM-----KSSYPRGG 98

Query: 259 RFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW--GP 311
             E  +A     + + L YLHS      IHRD+K+ NILL  D   +++DFG++      
Sbjct: 99  LDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADG 155

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
            D T  +R+  VGT  ++APE +      D K D++SFG+  +EL +G  P  +      
Sbjct: 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP--YSKYPPM 213

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQ---RMLLAANLCINQSPQLRPNMGQV 427
           + L+      L+N        P L    D  +     R +++  LC+ + P  RP   ++
Sbjct: 214 KVLML----TLQND------PPSLETGADYKKYSKSFRKMIS--LCLQKDPSKRPTAEEL 261

Query: 428 LK 429
           LK
Sbjct: 262 LK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 23/184 (12%)

Query: 186 ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI--EDNYLILVSDFLPKGSLEE 243
           EL   + +   A      E+ I SSL+  +I    G     E N L +  +++  GSL  
Sbjct: 34  ELSGDSEEELEA---LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS 90

Query: 244 SLHGAGEQSVLPWGVRFEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDF 297
            L   G         +    V       I E L YLHS     ++HRD+K +NIL+ SD 
Sbjct: 91  LLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDG 138

Query: 298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             +L+DFG A       T      V GT  ++APE +   +     D++S G  ++E+ +
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198

Query: 358 GRRP 361
           G+ P
Sbjct: 199 GKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.1 bits (248), Expect = 2e-23
 Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 42/239 (17%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-------EQSVLP 255
           +EV I   L   +I        E   L +V ++   G L + +           E+ +L 
Sbjct: 48  NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTD- 313
           W   F   V +  AL YLHS   R ++HRD+K  NI L+S+   +L DFG++ +   T  
Sbjct: 108 W---F---VQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158

Query: 314 --STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
              T      VVGT  Y++PE   +   + K D++S G VL EL + + P   +NL    
Sbjct: 159 LAKT------VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--- 209

Query: 372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
            L      ILK G       P + ++Y + +++ ++   +  + + P+ RP++ Q+L+ 
Sbjct: 210 ELA---LKILK-GQY-----PPIPSQYSS-ELRNLV---SSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 71/239 (29%), Positives = 108/239 (45%), Gaps = 22/239 (9%)

Query: 191 TSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE 250
           + + S   +DF  E  I  SL+ +++  L GV +  + L++V++  P GSL + L     
Sbjct: 33  SDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDA- 90

Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
                     + AV IA  + YL S   +  IHRD+ + NILL+SD + ++ DFGL    
Sbjct: 91  LGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Query: 311 PTDSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK 368
           P +  H +  E +   F + APE L     S   DV+ FGV L E+ + G  P  +  L 
Sbjct: 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLS 205

Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
           G + L    K I K G  E L  P+   +     M +       C   +P  RP    +
Sbjct: 206 GSQIL----KKIDKEG--ERLERPEACPQDIYNVMLQ-------CWAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 52/164 (31%), Positives = 90/164 (54%), Gaps = 14/164 (8%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E  + ++L   ++  L GV ++ N L +V++++ KGSL + L   G ++V+    + 
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQL 105

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A+ + E + YL     +  +HRD+ + N+L+S D   ++SDFGLA     +++   + 
Sbjct: 106 GFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLA----KEAS---QG 155

Query: 321 DVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
              G     + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 70/256 (27%), Positives = 114/256 (44%), Gaps = 42/256 (16%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           +Q S E++K+       A      E+D+  +L+  +I    G     + L ++ ++   G
Sbjct: 31  KQISLEKIKE------EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84

Query: 240 SLEESLHGAGEQSVLPWGVRF---EVAVAIA---EALNYLHSECSRPVIHRDVKSSNILL 293
           SL + +   G          F    VAV +    + L YLH +    VIHRD+K++NIL 
Sbjct: 85  SLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILT 132

Query: 294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLL 353
           + D   +L+DFG+A     +        VVGT  ++APE +     S   D++S G  ++
Sbjct: 133 TKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190

Query: 354 ELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLC 413
           ELL+G  P  + +L    +L +  +      D    L   +S E  +  MQ        C
Sbjct: 191 ELLTGNPP--YYDLNPMAALFRIVQ------DDHPPLPEGISPELKDFLMQ--------C 234

Query: 414 INQSPQLRPNMGQVLK 429
             + P LRP   Q+LK
Sbjct: 235 FQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 46/266 (17%)

Query: 184 YEELKQATSQFSSA----------WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS 233
           Y+   + T  F++A            DF  E+DI S  +  +I  L      +N L ++ 
Sbjct: 22  YKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81

Query: 234 DFLPKGSL----EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS 289
           +F   G+L     E   G  E  +        V   + EALN+LHS     VIHRD+K+ 
Sbjct: 82  EFCDGGALDSIMLELERGLTEPQIRY------VCRQMLEALNFLHS---HKVIHRDLKAG 132

Query: 290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-----KID 344
           NILL+ D   +L+DFG++      ST   R+  +GT  ++APE +      D     K D
Sbjct: 133 NILLTLDGDVKLADFGVSAKN--KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKAD 190

Query: 345 VYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDP-KLSNEYDNAQM 403
           ++S G+ L+EL     P     L     L+K  K      +  TL  P K S+ +++   
Sbjct: 191 IWSLGITLIELAQMEPP--HHELNPMRVLLKILK-----SEPPTLDQPSKWSSSFND--- 240

Query: 404 QRMLLAANLCINQSPQLRPNMGQVLK 429
               L +  C+ + P  RP   ++LK
Sbjct: 241 ---FLKS--CLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 24/230 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
            E+DI        I    G    +  + +  +++  GSL++ L     Q  +P  +  ++
Sbjct: 48  RELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV--QGRIPERILGKI 105

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR--- 319
           AVA+ + L YLH +    +IHRDVK SNIL++S  Q +L DFG+       S  ++    
Sbjct: 106 AVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGV-------SGQLVNSLA 156

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
           +  VGT  Y+APE +     S K D++S G+ L+EL +GR P   +N   P+ + +  + 
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN-DPPDGIFELLQY 215

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           I+ N        P+L +   +   Q  +   NLC+ + P+ RP+  ++L+
Sbjct: 216 IV-NEPP-----PRLPSGKFSPDFQDFV---NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 47/195 (24%), Positives = 94/195 (48%), Gaps = 17/195 (8%)

Query: 186 ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
            L++ TS  ++   +   E  + +S++   +  L G+C+    + L++  +P G L + +
Sbjct: 43  VLREETSPKAN--KEILDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYV 99

Query: 246 H----GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
                  G Q +L W V+      IA+ ++YL     + ++HRD+ + N+L+ +    ++
Sbjct: 100 RNHKDNIGSQYLLNWCVQ------IAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKI 150

Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +DFGLA     D      E       ++A E ++H   + K DV+S+GV + EL++ G +
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Query: 361 PIGFKNLKGPESLVK 375
           P           L++
Sbjct: 211 PYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 4e-20
 Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 10/137 (7%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWG-VRFEVAVAIAEALNYLHSECSRPVIHR 284
           +  L LV ++ P G L   L    ++        RF  A  I  AL YLHS     +I+R
Sbjct: 65  EEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAA-EIVLALEYLHS---LGIIYR 117

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
           D+K  NILL +D   +L+DFGLA    ++ +        GT  Y+APE L+       +D
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 345 VYSFGVVLLELLSGRRP 361
            +S GV+L E+L+G+ P
Sbjct: 176 WWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 18/164 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  EV     L  K + +L  VC     + ++++ + KGSL   L  + E  VLP    
Sbjct: 48  DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASL 106

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  +AE + YL     +  IHRD+ + NIL+  D   +++DFGLA         +I+
Sbjct: 107 IDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLA--------RLIK 155

Query: 320 EDVVGT------FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           EDV  +      + + APE   HG  S K DV+SFG++L E+ +
Sbjct: 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 7e-20
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 25/261 (9%)

Query: 181 QFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS 240
           QF  +E+    S  SS   D          L+  +I  L G+C  +    L+ +++   +
Sbjct: 717 QFVVKEINDVNSIPSSEIADMGK-------LQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769

Query: 241 LEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
           L E L        L W  R ++A+ IA+AL +LH  CS  V+  ++    I++    +P 
Sbjct: 770 LSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR 360
           L    L     TD+   I         Y+APE      +++K D+Y FG++L+ELL+G+ 
Sbjct: 824 LR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876

Query: 361 PIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE---YDNAQMQRMLLAANLCINQS 417
           P   +      S+V+WA+    +   +  +DP +  +     N  ++ M LA + C    
Sbjct: 877 PADAE-FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH-CTATD 934

Query: 418 PQLRPNMGQVLKLLRGATHAT 438
           P  RP    VLK L  A+ ++
Sbjct: 935 PTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 33/229 (14%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ I        I +  G  + +N + +  +F+  GSL+      G   V   G   ++A
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG---KIA 109

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
           VA+ E L YL++     ++HRD+K SNIL++S  Q +L DFG++     +  + I +  V
Sbjct: 110 VAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFV 163

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN 383
           GT  Y++PE +  GK + K DV+S G+ ++EL  G+ P  F N+                
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD---------- 213

Query: 384 GDTETLLD----------PKLSNEYDNAQMQRMLLAANLCINQSPQLRP 422
            D   +LD          P+L +      ++  +   + C+ + P  RP
Sbjct: 214 -DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV---DACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 58/165 (35%), Positives = 89/165 (53%), Gaps = 17/165 (10%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-LPWGVR 259
           F  E  + + L  K++  L GV I  N L +V + + KG+L   L   G   V +   ++
Sbjct: 46  FLEETAVMTKLHHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP--TDSTHM 317
           F  ++ +AE + YL S   + ++HRD+ + NIL+S D   ++SDFGLA  G    D++ +
Sbjct: 105 F--SLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
                     + APE L H K S K DV+S+GV+L E+ S GR P
Sbjct: 160 -------PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 29/230 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ I    +  +I       +  + L +V +++  GSL + +     Q+ +         
Sbjct: 65  EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAY 120

Query: 264 VA--IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V   + + L YLHS   + VIHRD+KS NILLS D   +L+DFG A     + +   R  
Sbjct: 121 VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNS 175

Query: 322 VVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP-IGFKNLKGPESLVKWAKP 379
           VVGT  ++APE ++  K    K+D++S G++ +E+  G  P +    L+    +     P
Sbjct: 176 VVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP 234

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            LKN +       K S E      +  L   N C+ + P+ RP+  ++L+
Sbjct: 235 PLKNPE-------KWSPE-----FKDFL---NKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 56/162 (34%), Positives = 90/162 (55%), Gaps = 8/162 (4%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
            D   E++I  +L  ++I    G+C ED  N + L+ +FLP GSL+E L     +  L  
Sbjct: 51  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ 110

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
            +++  AV I + ++YL S   R  +HRD+ + N+L+ S+ Q ++ DFGL     TD  +
Sbjct: 111 QLKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165

Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             +++D+     + APE L+  K     DV+SFGV L ELL+
Sbjct: 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 15/174 (8%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRF 260
           E  I   L    +  L     ++  + LV D L  G L   L       E+ V  W    
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW---- 105

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
                I  AL YLHS   + +IHRD+K  NILL       ++DF +A     D+   +  
Sbjct: 106 --ICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
              GT GY+APE L     S  +D +S GV   E L G+RP    +    + + 
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL------------ 245
             +F  E ++ S L+  +I  L GVC ++    ++ ++L  G L E L            
Sbjct: 52  QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 246 -HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
                 +S L       +A+ IA  + YL    S   +HRD+ + N L+      ++SDF
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDF 168

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP-I 362
           GL+    +   + ++   +    ++ PE +++GK + + D++SFGVVL E+ S G +P  
Sbjct: 169 GLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Query: 363 GFKN 366
           GF N
Sbjct: 229 GFSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 12/164 (7%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EVD+  SL+  +I    G C++DN + +  +F+P GS+   L+  G    LP  V  +  
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYT 108

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTH--MI 318
             I + + YLH+ C   V+HRD+K +N++L  +   +L DFG A    W     TH  M+
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           +  + GT  ++APE +       K D++S G  + E+ +G+ P+
Sbjct: 166 KS-MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 57/167 (34%), Positives = 81/167 (48%), Gaps = 16/167 (9%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH--GAGEQSVLPWGVRF 260
           +E DI S  +   +  L         L LV ++LP G L   L   G+ ++ V     R 
Sbjct: 42  TERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----ARI 97

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +A  I  AL YLHS     +IHRD+K  NIL+ S+   +L+DFGL+  G       + +
Sbjct: 98  YIA-EIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153

Query: 321 D------VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           D      +VGT  YIAPE ++    S  +D +S G +L E L G  P
Sbjct: 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 41/199 (20%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK+  S    A  DF  E ++ ++ + ++I    GVC E +  I+V +++  G L + L 
Sbjct: 43  LKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLR 100

Query: 247 GAGEQSVLPWGVR-----------FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS 295
             G  +                   ++AV IA  + YL    S+  +HRD+ + N L+  
Sbjct: 101 SHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGY 157

Query: 296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY------------IAPEYLMHGKVSDKI 343
           D   ++ DFG           M R DV  T  Y            + PE +M+ K + + 
Sbjct: 158 DLVVKIGDFG-----------MSR-DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 205

Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+SFGVVL E+ + G++P
Sbjct: 206 DVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 20/183 (10%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +DF  E  +   L   ++  L GVC +   + +V++++  G L   L     +  L    
Sbjct: 44  DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEW 101

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             ++   + EA+ YL S      IHRD+ + N L+  D   ++SDFGLA        +++
Sbjct: 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLA-------RYVL 151

Query: 319 REDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLKGP 370
            +    + G      +  PE   + + S K DV+SFGV++ E+ S G+ P   F N +  
Sbjct: 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211

Query: 371 ESL 373
           ES+
Sbjct: 212 ESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 23/227 (10%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF--E 261
           E+    S E   +    G   ++  + +V +++  GSL + L     + V          
Sbjct: 49  ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAY 103

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +A  I + L+YLH++  R +IHRD+K SN+L++S  + +++DFG++     ++T      
Sbjct: 104 IARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGIS--KVLENTLDQCNT 159

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
            VGT  Y++PE +     S   D++S G+ LLE   G+ P           L++     +
Sbjct: 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AI 215

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            +G       P L  E  + + +  +   + C+ + P+ RP+  ++L
Sbjct: 216 CDGP-----PPSLPAEEFSPEFRDFI---SACLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 11/164 (6%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
            E+ +   L+  ++    GV +    + +  ++   G+LEE L       +L   V    
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVY 104

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRE 320
            + + E L YLHS     ++HRD+K +NI L  +   +L DFG A  +   T +     +
Sbjct: 105 TLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161

Query: 321 DVVGTFGYIAPEYLMHGKVSDK---IDVYSFGVVLLELLSGRRP 361
            + GT  Y+APE +  GK        D++S G V+LE+ +G+RP
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 69/252 (27%), Positives = 119/252 (47%), Gaps = 33/252 (13%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGV 258
           D   E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L  G  +++ +   +
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL 107

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R      I + L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G    T + 
Sbjct: 108 R-----EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIK 157

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
           R   VGT  ++APE +       K D++S G+  +EL  G  P    +      L+    
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN 217

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK---LLRGA- 434
           P            P L   Y    ++  + A   C+N+ P  RP   ++LK   ++R A 
Sbjct: 218 P------------PTLEGNYSKP-LKEFVEA---CLNKEPSFRPTAKELLKHKFIVRFAK 261

Query: 435 --THATDWVDRH 444
             ++ T+ +DR+
Sbjct: 262 KTSYLTELIDRY 273

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 34/238 (14%)

Query: 200 DFSSEVDITSSLEQ---KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           D   EV + S L Q    +IT   G  ++   L ++ ++   GS+  +L  AG     P 
Sbjct: 45  DIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAG-----PI 98

Query: 257 GVRFEVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
             ++ ++V I E   AL Y+H      VIHRD+K++NIL+++    +L DFG+A     +
Sbjct: 99  AEKY-ISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA--ALLN 152

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
                R   VGT  ++APE +  GK  D K D++S G+ + E+ +G  P    +      
Sbjct: 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM 212

Query: 373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
           L+  +KP            P+L +   +  ++  + A   C+++ P+ R +  ++LK 
Sbjct: 213 LIPKSKP------------PRLEDNGYSKLLREFVAA---CLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 53/163 (32%), Positives = 87/163 (53%), Gaps = 11/163 (6%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL     
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCL 104

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            + ++ + EA+ YL +      +HRD+ + N+L+S D   ++SDFGL     T      +
Sbjct: 105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQ 156

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 8/161 (4%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L LV ++LP GSL + L    E+      
Sbjct: 51  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL 110

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH- 316
           + +  A  I + + YL S   +  +HRD+ + NIL+ S+ + ++ DFGL    P D  + 
Sbjct: 111 LLY--ASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY 165

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            +RE       + APE L   K S   DV+SFGVVL EL +
Sbjct: 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 58/170 (34%), Positives = 84/170 (49%), Gaps = 17/170 (10%)

Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESL--HGA 248
           Q +S W     E++I  +L  ++I    G C E     L L+ +++P GSL + L  H  
Sbjct: 48  QNTSGW---KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL 104

Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
               +L +      A  I E + YLHS+     IHRD+ + N+LL +D   ++ DFGLA 
Sbjct: 105 NLAQLLLF------AQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Query: 309 WGPT-DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             P     + +RED      + A E L   K S   DV+SFGV L ELL+
Sbjct: 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 24/151 (15%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V ++ P G L + +   G         RF  A  I  AL YLHS   + +IHRD+K 
Sbjct: 77  LYFVLEYAPNGELLQYIRKYGSLDEK--CTRFYAA-EILLALEYLHS---KGIIHRDLKP 130

Query: 289 SNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED-----------------VVGTFGYIA 330
            NILL  D   +++DFG A +  P  S    + D                  VGT  Y++
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190

Query: 331 PEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           PE L         D+++ G ++ ++L+G+ P
Sbjct: 191 PELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 33/234 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D   E+ + S  +   +T   G  ++   L ++ ++L  GS  + L         P+   
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFD-E 100

Query: 260 FEVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           F++A  + E    L+YLHSE     IHRD+K++N+LLS     +L+DFG+A  G    T 
Sbjct: 101 FQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQ 155

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG-FKNLKGPESLVK 375
           + R   VGT  ++APE +       K D++S G+  +EL  G  P      ++    + K
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215

Query: 376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
              P L    ++         E+ +A           C+N+ P  RP   ++LK
Sbjct: 216 NNPPTLTGEFSKPF------KEFIDA-----------CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 69/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  + + L+   I  L GVC  +  L+LV +  P G L + L    E  V      
Sbjct: 42  EFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL--- 97

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            E+A  +A  + YL  E    V HRD+ + N+LL +  Q ++SDFG++      S +   
Sbjct: 98  KELAHQVAMGMAYL--ESKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154

Query: 320 EDVVGTFG-----YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL 373
                T G     + APE + +GK S K DV+S+GV L E  S G +P  +  +KG E +
Sbjct: 155 T----TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVI 208

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
                  L++G  E L  P+   +   + M         C    P+ RP   ++    R
Sbjct: 209 AM-----LESG--ERLPRPEECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 51/168 (30%), Positives = 89/168 (52%), Gaps = 22/168 (13%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAGEQSVLPWGVRF 260
           SE++    L+  +I    G    + YL +  +++P GS+   L  +G  E+ +    VRF
Sbjct: 57  SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRF 112

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-----IWGPTDST 315
                + E L YLHS   + ++HRD+K+ N+L+ +D   ++SDFG++     I+    + 
Sbjct: 113 -FTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 316 HMIREDVVGTFGYIAPE--YLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            M      G+  ++APE  +      S K+D++S G V+LE+ +GRRP
Sbjct: 169 SM-----QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)

Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH----GAGEQSVLPWGVRFEVAVA 265
           SL+   I  L G+C     L LV+   P GSL + +         Q +L W V+      
Sbjct: 65  SLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------ 117

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           IA+ + YL       ++HR++ + NILL SD   Q++DFG+A     D       +    
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             ++A E ++ G+ + + DV+S+GV + E++S G  P
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 24/228 (10%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  + + L+   I       ++   L +V ++   G L + L        LP    +   
Sbjct: 49  EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFF 107

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
           + I   L +LHS   + ++HRD+KS N+ L +    ++ D G+A +             +
Sbjct: 108 IQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANTI 161

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           VGT  Y++PE       ++K DV++ GVVL E  +G+ P          +       I++
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD------ANNQGALILKIIR 215

Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
                  + P +S  Y     Q +    + C+ +  + RP+  Q+L+ 
Sbjct: 216 G------VFPPVSQMYSQQLAQLI----DQCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 50/226 (22%), Positives = 105/226 (46%), Gaps = 24/226 (10%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFEV 262
           E+ I +S+   +I +     ++ N L +V ++ P G L +++     ++ ++P    + +
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
            + +   L  LH    + ++HRD+KS+NILL ++   ++ D G++          + +  
Sbjct: 109 FIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGIS----KVLKKNMAKTQ 161

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           +GT  Y+APE       S K D++S G +L E+ +   P   ++++     V+  K    
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--- 218

Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
                    P +   Y +  +Q  + +    +   P+LRPN  ++L
Sbjct: 219 ---------PPIPPIY-SQDLQNFIRS---MLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 53/173 (30%), Positives = 96/173 (55%), Gaps = 11/173 (6%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F +E ++  +L+   +  L+ V  ++   I +++F+ KGSL + L    G +  LP  + 
Sbjct: 48  FLAEANVMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLID 106

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + ++     R  IHRD++++NIL+S+    +++DFGLA     D+ +  R
Sbjct: 107 F--SAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAR 160

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           E       + APE +  G  + K DV+SFG++L+E+++ GR P  +  +  PE
Sbjct: 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGV 258
           D   E+ + S  +   IT   G  ++   L ++ ++L  GS  + L  G  E++ +   +
Sbjct: 48  DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATIL 107

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R      I + L+YLHSE     IHRD+K++N+LLS     +L+DFG+A  G    T + 
Sbjct: 108 R-----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIK 157

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
           R   VGT  ++APE +       K D++S G+  +EL  G  P    +L     L     
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--NSDLHPMRVLFL--- 212

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            I KN        P L  +Y     + +      C+N+ P+ RP   ++LK
Sbjct: 213 -IPKNS------PPTLEGQYSKPFKEFV----EACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   S      IT   G  ++ + L ++ ++   GS  + L    +   L       +A
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLD---ETYIA 101

Query: 264 VAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             + E    L YLH E     IHRD+K++NILLS +   +L+DFG++  G   ST   R 
Sbjct: 102 FILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRN 156

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             VGT  ++APE +      +K D++S G+  +EL  G  P
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 5/156 (3%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q  +   V 
Sbjct: 48  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVL 106

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 107 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 162

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 20/197 (10%)

Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
           LKL   +    + + LK  +S       DF +E  I    +  +I  L GV  +   +++
Sbjct: 25  LKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82

Query: 232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           +++++  GSL++ L     +     G    +   IA  + YL        +HRD+ + NI
Sbjct: 83  ITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNI 137

Query: 292 LLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDV 345
           L++S+   ++SDFGL+     +++T+  +       G I     APE + + K +   DV
Sbjct: 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKG------GKIPIRWTAPEAIAYRKFTSASDV 191

Query: 346 YSFGVVLLELLS-GRRP 361
           +SFG+V+ E++S G RP
Sbjct: 192 WSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 56/166 (33%), Positives = 86/166 (51%), Gaps = 10/166 (6%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
             F  E  I   L    +  L  VC E+  + +V++++ KGSL + L   GE   L    
Sbjct: 46  EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQ 104

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTH 316
             ++A  IAE + YL S   R  IHRD+ + NIL+  +   +++DFGLA  I    D  +
Sbjct: 105 LVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLI---EDDEY 158

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             RE       + APE   +G+ + K DV+SFG++L E+++ GR P
Sbjct: 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 59/234 (25%), Positives = 113/234 (48%), Gaps = 21/234 (8%)

Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLP 255
           A  D   E+D+   L+  ++       IE+N L +V +    G L   + H   ++ ++P
Sbjct: 45  ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
               ++  V +  AL ++HS   + ++HRD+K +N+ +++    +L D GL  +    S 
Sbjct: 105 ERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 159

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
                 +VGT  Y++PE  +H    + K D++S G +L E+ + + P  F   K   +L 
Sbjct: 160 TTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDK--MNLY 214

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
              K I +  D      P L  ++ + +++ ++   + CIN  P+ RP++  VL
Sbjct: 215 SLCKKI-EKCDY-----PPLPADHYSEELRDLV---SRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 59/239 (24%), Positives = 116/239 (48%), Gaps = 19/239 (7%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSV 253
           + A  D   E+D+   L   ++       IEDN L +V +    G L   + H   ++ +
Sbjct: 43  AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 102

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P    ++  V +  AL ++HS   R V+HRD+K +N+ +++    +L D GL  +  + 
Sbjct: 103 IPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           +T      +VGT  Y++PE +     + K D++S G +L E+ + + P  + +     SL
Sbjct: 160 TTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSL 216

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
            K           E    P L +++ + ++++++   N+CIN  P+ RP++  V  + +
Sbjct: 217 CK---------KIEQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 36/240 (15%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           D+  E++I ++     I  L G    D  L ++ +F P G+++  +     G  E  +  
Sbjct: 55  DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ- 113

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                 +   + EAL YLHS     +IHRD+K+ N+LL+ D   +L+DFG++       T
Sbjct: 114 -----VICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKT 163

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
              R+  +GT  ++APE +M   + D     K D++S G+ L+E+     P     L   
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--HHELNPM 221

Query: 371 ESLVKWAKPILKNGDTETLLDP-KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             L+K AK      +  TL  P K S E+ +      L  A   +++ P+ RP+  Q+L+
Sbjct: 222 RVLLKIAK-----SEPPTLSQPSKWSMEFRD-----FLKTA---LDKHPETRPSAAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 14/159 (8%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           SE++I    +   I    G    +N + + ++F+  GSL+  ++       +P  V   +
Sbjct: 48  SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRI 100

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           AVA+ + L YL    S  ++HRDVK SN+L+++  Q +L DFG++    T   + I +  
Sbjct: 101 AVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTY 153

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           VGT  Y+APE +   +     DV+S G+  +EL  GR P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 45/138 (32%), Positives = 75/138 (54%), Gaps = 15/138 (10%)

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  ++++A+   L YL  +    ++HRDVK SNIL++S  +
Sbjct: 84  GSLDQVLKKAGR---IPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGE 138

Query: 299 PQLSDFGLAIWGPTDSTHMIRE---DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
            +L DFG+       S  +I       VGT  Y++PE L     + + D++S G+ L+E+
Sbjct: 139 IKLCDFGV-------SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Query: 356 LSGRRPIGFKNLKGPESL 373
             GR PI   + K  E++
Sbjct: 192 AIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 62/185 (33%), Positives = 90/185 (48%), Gaps = 24/185 (12%)

Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +    + I  L+    +D YL +V +++P G L  
Sbjct: 79  FEMIKRSDSAF------FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV- 131

Query: 244 SLHGAGEQSVLP--WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
           +L    +   +P  W  RF  A  +  AL+ +HS      IHRDVK  N+LL      +L
Sbjct: 132 NLMSNYD---IPEKWA-RFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 183

Query: 302 SDFGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELL 356
           +DFG  +    D+  M+R D  VGT  YI+PE L      G    + D +S GV L E+L
Sbjct: 184 ADFGTCM--KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Query: 357 SGRRP 361
            G  P
Sbjct: 242 VGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 6e-15
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 14/102 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW----GPTDSTHMIRED 321
           + E L YLHS     ++HRD+K SNIL+++D   +L+DFGLA         D T     +
Sbjct: 109 LLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT-----N 160

Query: 322 VVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
            V T  Y  PE L+       ++D++S G +L EL  G +PI
Sbjct: 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 18/138 (13%)

Query: 227 NYLILVSDFLPKGSLEESLHGAGEQSVLP--WGVRFEVAVAIAEALNYLHSECSRPVIHR 284
           +YL LV ++L  G     +   G    LP  W  ++     +   +  LH    R +IHR
Sbjct: 70  DYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQY--IAEVVLGVEDLHQ---RGIIHR 121

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI- 343
           D+K  N+L+      +L+DFGL+  G      +  +  VGT  Y+APE ++ G   DK+ 
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL-GVGDDKMS 174

Query: 344 DVYSFGVVLLELLSGRRP 361
           D +S G V+ E L G  P
Sbjct: 175 DWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 5/92 (5%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L YLHS      IHRD+K+ NILL+ + Q +L+DFG++  G    T   R  V+GT  ++
Sbjct: 112 LEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWM 166

Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           APE +     ++K D++S G+  +E+  G+ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 53/172 (30%), Positives = 89/172 (51%), Gaps = 22/172 (12%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWG 257
            DF +E  I   L    +  L  VC  +  + +V++ +  GSL E L G AG    LP  
Sbjct: 46  KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL 105

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
           +  ++A  +A  + YL +   +  IHRD+ + N+L+  +   +++DFGLA         +
Sbjct: 106 I--DMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLA--------RV 152

Query: 318 IREDV----VGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           I+ED+     G      + APE  ++ + S K DV+SFG++L E+++ GR P
Sbjct: 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 62/188 (32%), Positives = 101/188 (53%), Gaps = 27/188 (14%)

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP-TDSTHMIR 319
           ++AV+I +AL YLHS+ S  VIHRDVK SN+L++ + Q +L DFG  I G   DS  + +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG--ISGYLVDS--VAK 160

Query: 320 EDVVGTFGYIAPEYL---MHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLV 374
               G   Y+APE +   ++ K  D K DV+S G+ ++EL +GR P  + + K P + L 
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP--YDSWKTPFQQL- 217

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA 434
              K +++         P+L  E  + + Q  +   N C+ ++ + RPN  ++L+     
Sbjct: 218 ---KQVVEEP------SPQLPAEKFSPEFQDFV---NKCLKKNYKERPNYPELLQHPFFE 265

Query: 435 THATDWVD 442
            H +   D
Sbjct: 266 LHLSKNTD 273

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 19/185 (10%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL------------ 245
           W +F  E  + + L   +I  L GV  ++  + ++ ++L +G L E L            
Sbjct: 51  WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 246 --HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
                  +S L  G    +A+ IA  + YL S      +H+D+ + NIL+      ++SD
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISD 167

Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP- 361
            GL+    +   + ++   +    ++ PE +M+GK S   D++SFGVVL E+ S G +P 
Sbjct: 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 362 IGFKN 366
            GF N
Sbjct: 228 YGFSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 12/187 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK    +  S  ++   E +I   L+   I  + GVC E   L+LV +    G L + L 
Sbjct: 30  LKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLS 86

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G  ++  +      E+   ++  + YL     +  +HRD+ + N+LL +    ++SDFGL
Sbjct: 87  GKKDE--ITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGL 141

Query: 307 A-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGF 364
           +   G  DS +  R        + APE +   K S + DV+S+G+ + E  S G++P  +
Sbjct: 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP--Y 199

Query: 365 KNLKGPE 371
           K +KGPE
Sbjct: 200 KKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 17/195 (8%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
            + + + LKQ +    +    F +E ++   L+   +  L  V  ++   I +++++  G
Sbjct: 31  TKVAIKSLKQGSMSPEA----FLAEANLMKQLQHPRLVRLYAVVTQEPIYI-ITEYMENG 85

Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           SL + L    E   L      ++A  IAE + ++     +  IHRD++++NIL+S     
Sbjct: 86  SLVDFLK-TPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCC 141

Query: 300 QLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA  I    D+ +  RE       + APE + +G  + K DV+SFG++L E+++
Sbjct: 142 KIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198

Query: 358 -GRRPIGFKNLKGPE 371
            GR P  +  +  PE
Sbjct: 199 YGRIP--YPGMTNPE 211

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 22/233 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D  +E+ I S L+  +I       ++DN L++  ++   G+L + +    +  +    + 
Sbjct: 45  DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMV 103

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
                 I  A++Y+H      ++HRD+K+ NI L+     +L DFG++    ++ +    
Sbjct: 104 LWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA-- 158

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
           E VVGT  Y++PE     K + K D+++ G VL ELL+ +R     N      +VK    
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVK---- 212

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
            +  G+   ++       Y ++++  ++ +    + Q P+ RP   +VL    
Sbjct: 213 -IVQGNYTPVVSV-----Y-SSELISLVHS---LLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 47/163 (28%), Positives = 90/163 (55%), Gaps = 8/163 (4%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E ++  +L+   +  L  V  ++  + ++++++ KGSL + L    G + +LP  + 
Sbjct: 48  FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + Y+     +  IHRD++++N+L+S     +++DFGLA     D+ +  R
Sbjct: 108 F--SAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAR 161

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           E       + APE +  G  + K DV+SFG++L E+++ G+ P
Sbjct: 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 50/186 (26%), Positives = 93/186 (50%), Gaps = 17/186 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK A+    +A  DF  E ++ ++L+ + I    GVC+E + LI+V +++  G L + L 
Sbjct: 43  LKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR 99

Query: 247 GAGEQSV----------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD 296
             G  +V          L       +A  IA  + YL    S+  +HRD+ + N L+  +
Sbjct: 100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGEN 156

Query: 297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL 356
              ++ DFG++    +   + +    +    ++ PE +M+ K + + DV+S GVVL E+ 
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Query: 357 S-GRRP 361
           + G++P
Sbjct: 217 TYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 17/172 (9%)

Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 135

Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 192

Query: 340 SDKIDVYSFGVVLLELLSGRRPIGFKN-LKGPESLVKWAKPILKNGDTETLL 390
             K+D++S G++ +E++ G  P   +N L+    +     P L+N +  + +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 46/267 (17%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDF-LPKGSLEE 243
           +++  +  Q +  W D   EV     L+  +     G  ++++   LV ++ L   S   
Sbjct: 52  KKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLL 111

Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
            +H    Q V       E+A     AL    YLHS     +IHRD+K+ NILL+   Q +
Sbjct: 112 EVHKKPLQEV-------EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVK 161

Query: 301 LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELL 356
           L+DFG A    P +S        VGT  ++APE ++    G+   K+DV+S G+  +E L
Sbjct: 162 LADFGSASKSSPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-L 213

Query: 357 SGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQ 416
           + R+P  F N+    +L   A+      D+ TL     SNE+ ++  +  +   + C+ +
Sbjct: 214 AERKPPLF-NMNAMSALYHIAQ-----NDSPTL----QSNEWTDS-FRGFV---DYCLQK 259

Query: 417 SPQLRPNMGQVLKLLRGATHATDWVDR 443
            PQ RP   ++L+      H     DR
Sbjct: 260 IPQERPASAELLR------HDFVRRDR 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 46/180 (25%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL- 254
           +A  DF  E ++ ++L+ + I    GVC + + LI+V +++  G L + L   G  +++ 
Sbjct: 49  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108

Query: 255 ----PWGVRFE--------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
               P   + E        +A  IA  + YL    S+  +HRD+ + N L+ ++   ++ 
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIG 165

Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           DFG++    +   + +    +    ++ PE +M+ K + + DV+SFGV+L E+ + G++P
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 19/178 (10%)

Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL-------------E 242
           +A NDF  EV I S L+  +I  L GVC++++ L ++++++  G L             E
Sbjct: 61  NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120

Query: 243 ESLHGAGEQSVLP---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
                      LP   +     VA+ IA  + YL    S   +HRD+ + N L+  +   
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177

Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFG++        + I+   V    ++A E ++ GK +   DV++FGV L E+L 
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 40/105 (38%), Positives = 58/105 (55%), Gaps = 15/105 (14%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +A ++ + L+YLHS   R +IHRD+K SNILL+   Q +L DFG+       S  ++   
Sbjct: 110 IAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELV-NS 158

Query: 322 VVGTFG----YIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           + GTF     Y+APE +     S   DV+S G+ LLE+   R P 
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 47/136 (34%), Positives = 67/136 (49%), Gaps = 25/136 (18%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IW-GPTDSTHMI 318
           A  I   L +LH    R +I+RD+K  N+LL S+   +++DFG+    I  G T ST   
Sbjct: 102 AAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--- 155

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKN 366
                GT  YIAPE L +      +D ++ GV+L E+L+G+ P            I    
Sbjct: 156 ---FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212

Query: 367 LKGPESLVKWAKPILK 382
           ++ P  L K AK ILK
Sbjct: 213 VRYPRWLSKEAKSILK 228

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 26/174 (14%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP-TDSTHMIRE 320
           + VAI +AL+YL  +    VIHRDVK SNILL +    +L DFG++  G   DS    + 
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDS--KAKT 172

Query: 321 DVVGTFGYIAPEYL----MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLVK 375
              G   Y+APE +     + K   + DV+S G+ L+EL +G+ P  +KN K   E L K
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP--YKNCKTEFEVLTK 230

Query: 376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
               IL+         P L      +      +  +LC+ +  + RP   ++L+
Sbjct: 231 ----ILQEE------PPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 54/163 (33%), Positives = 88/163 (53%), Gaps = 9/163 (5%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVR 259
           F  E  I   L    +  L  V  E+   I V++F+ KGSL + L  G G+   LP  V 
Sbjct: 48  FLQEAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLV- 105

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA+ + Y+        IHRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 106 -DMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTAR 160

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL++ GR P
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 269 ALNYLH--SECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF 326
           AL   H  S+    V+HRD+K +NI L ++   +L DFGLA            +  VGT 
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--KILGHDSSFAKTYVGTP 174

Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            Y++PE L H    +K D++S G ++ EL +   P
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 36/100 (36%), Positives = 63/100 (63%), Gaps = 5/100 (5%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL++LH+   + VIHRD+KS +ILL+SD + +LSDFG             R+ 
Sbjct: 120 VCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKS 174

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 47/164 (28%), Positives = 92/164 (56%), Gaps = 14/164 (8%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFE 261
           E+ +   L+ ++I    G  ++ ++L +  +++P GS+   L  +GA E++++   VR  
Sbjct: 56  EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-- 113

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI--- 318
               I + LNYLH+   R +IHRD+K +NIL+ +    ++SDFG++     +S       
Sbjct: 114 ---QILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 319 -REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            R  + G+  ++APE +     + K D++S G +++E+L+G+ P
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 72/252 (28%), Positives = 112/252 (44%), Gaps = 46/252 (18%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-- 245
           KQ+  +    W D   EV     L   +     G  + ++   LV ++   GS  + L  
Sbjct: 53  KQSNEK----WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEV 107

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
           H    Q V       E+A     AL    YLHS      IHRD+K+ NILL+     +L+
Sbjct: 108 HKKPLQEV-------EIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLA 157

Query: 303 DFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSG 358
           DFG A +  P +S        VGT  ++APE ++    G+   K+DV+S G+  +E L+ 
Sbjct: 158 DFGSASLVSPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAE 209

Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSP 418
           R+P  F N+    +L   A+      D+ TL     S+ + N          + C+ + P
Sbjct: 210 RKPPLF-NMNAMSALYHIAQ-----NDSPTLSSNDWSDYFRN--------FVDSCLQKIP 255

Query: 419 QLRPNMGQVLKL 430
           Q RP+  ++LK 
Sbjct: 256 QDRPSSEELLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 7/133 (5%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L LV   +  G L+  ++  GE         F  A  I   L +LH    R +++RD+K 
Sbjct: 68  LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQ---RRIVYRDLKP 123

Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            N+LL      ++SD GLA+          R    GT GY+APE L        +D ++ 
Sbjct: 124 ENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 349 GVVLLELLSGRRP 361
           G  L E+++GR P
Sbjct: 181 GCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 7/96 (7%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVG 324
           I   L YLHS     ++HRD+K  N+L++S+   ++ DFGLA +  P +S HM +E  V 
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE--VV 166

Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE LM  +  +  +D++S G +  ELL  R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 56/237 (23%), Positives = 114/237 (48%), Gaps = 19/237 (8%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSV 253
           + A  D   E+D+   L   ++       IEDN L +V +    G L + + +   ++ +
Sbjct: 43  AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL 102

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P    ++  V +  A+ ++HS   R V+HRD+K +N+ +++    +L D GL  +  + 
Sbjct: 103 IPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           +T      +VGT  Y++PE +     + K D++S G +L E+ + + P     +    +L
Sbjct: 160 TTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NL 213

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
               + I      E    P L  E+ + +++ ++   ++CI   P  RP++G V ++
Sbjct: 214 FSLCQKI------EQCDYPPLPTEHYSEKLRELV---SMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 13/163 (7%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH--GAGEQSVLPWGVRFE 261
           E+ + + L    I  + G   ED++  L  +++  GS+   L   GA +++V+   + + 
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---INY- 108

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH--MI 318
               +   L+YLH      +IHRDVK +N+L+ S  Q  +++DFG A       T     
Sbjct: 109 -TEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +  ++GT  ++APE L   +     DV+S G V++E+ + + P
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 11/189 (5%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           N    E+ +        I    G    D  + +  + +  GSL++ L    E   +P  +
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEI 104

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             +V++A+   L YL  +    ++HRDVK SNIL++S  + +L DFG++          +
Sbjct: 105 LGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
               VGT  Y++PE L     S + D++S G+ L+EL  GR PI   + K  E++  + +
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGR 216

Query: 379 PILKNGDTE 387
           P++   + E
Sbjct: 217 PVVDGEEGE 225

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 47/165 (28%), Positives = 67/165 (40%), Gaps = 37/165 (22%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLP--WGVRFEVAVAIAEALNYLHSECSRPVIH 283
           + +L LV +++P G L   L     + V P     RF +A  +  AL+ +H       IH
Sbjct: 73  EEHLYLVMEYMPGGDLMNLLI---RKDVFPEET-ARFYIAELVL-ALDSVHK---LGFIH 124

Query: 284 RDVKSSNILLSSDFQPQLSDFGLA---------------------------IWGPTDSTH 316
           RD+K  NIL+ +D   +L+DFGL                                     
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +     VGT  YIAPE L       + D +S GV+L E+L G  P
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 9/163 (5%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVR 259
           F  E  I   L    +  L  V  E+   I V++++ KGSL + L  G G    LP  V 
Sbjct: 48  FLEEAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNLV- 105

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  +A  + Y+        IHRD++S+NIL+      +++DFGLA     D+ +  R
Sbjct: 106 -DMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTAR 160

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL++ GR P
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 17/167 (10%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+   I V++++ KGSL + L G  G+   LP  V 
Sbjct: 48  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106

Query: 260 FEVAVA----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
               +A      E +NY         +HRD++++NIL+  +   +++DFGLA     D+ 
Sbjct: 107 MAAQIASGMAYVERMNY---------VHRDLRAANILVGENLVCKVADFGLARL-IEDNE 156

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +  R+       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 13/166 (7%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  +   L    +  L GVC E + + LV +F+  G L + L    ++        
Sbjct: 45  DFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETL 102

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD---STH 316
             + + + E + YL S     VIHRD+ + N L+  +   ++SDFG+  +   D   S+ 
Sbjct: 103 LGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             +  V     + +PE     K S K DV+SFGV++ E+ S G+ P
Sbjct: 160 GTKFPV----KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 27/178 (15%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGE 250
           S + ++F  E  +   L  + +  L GVC +   + +V++++  G L     E       
Sbjct: 40  SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP 99

Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
             +L      E+   + E + YL S   +  IHRD+ + N L+      ++SDFGL    
Sbjct: 100 SQLL------EMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGL---- 146

Query: 311 PTDSTHMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
              S +++ ++   + G      +  PE L++ K S K DV++FGV++ E+ S G+ P
Sbjct: 147 ---SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 26/228 (11%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +   L   +I       +ED  L++V ++ P G+L E +      S+L        
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHF 106

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPTDSTHMIRED 321
            V I  AL+++H+   + ++HRD+K+ NILL       ++ DFG++    + S       
Sbjct: 107 FVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--- 160

Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
           VVGT  YI+PE L  GK  + K D+++ G VL EL S +R     NL  P  ++K    I
Sbjct: 161 VVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PALVLK----I 213

Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           +    T   +  + S +       R L+ + L  N  P  RP + Q++
Sbjct: 214 MSG--TFAPISDRYSPDL------RQLILSML--NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 12/172 (6%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL---------EESL 245
            +A NDF  E+ I S L+  +I  L GVC+ D+ L ++++++  G L         E + 
Sbjct: 58  KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
             A     +       +AV IA  + YL    S   +HRD+ + N L+ + +  +++DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           ++    +   + I+   V    ++A E ++ GK +   DV++FGV L E+ +
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 49/286 (17%)

Query: 164 LTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAW----------NDFSSEVDITSSLEQ 213
           + PS   F+K + S   QF    L +  +Q   A            DF  E  +   L  
Sbjct: 1   INPSELTFMKELGSG--QFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH 58

Query: 214 KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYL 273
             +  L GVC +   L +V++F+  G L   L     Q  L   +   +   + E + YL
Sbjct: 59  PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 274 HSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG------ 327
                   IHRD+ + N L+SS    ++SDFG+         +++ ++   + G      
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVLDDEYTSSSGAKFPVK 166

Query: 328 YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLKGPESLVKWAKPILKNGD 385
           +  PE     K S K DV+SFGV++ E+ + G+ P     N +  E + +  +       
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------- 219

Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
              L  PKL++      M         C ++ P+ RP   ++L+ +
Sbjct: 220 ---LYRPKLASMTVYEVMYS-------CWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 53/188 (28%), Positives = 93/188 (49%), Gaps = 19/188 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL- 245
           LK+A+    SA  DF  E ++ + L+ + I    GVC E   L++V +++  G L   L 
Sbjct: 43  LKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLR 99

Query: 246 -HG------AGEQSV----LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
            HG      AG + V    L  G    +A  IA  + YL    S   +HRD+ + N L+ 
Sbjct: 100 SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVG 156

Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
                ++ DFG++    +   + +    +    ++ PE +++ K + + D++SFGVVL E
Sbjct: 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216

Query: 355 LLS-GRRP 361
           + + G++P
Sbjct: 217 IFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 23/185 (12%)

Query: 250 EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW 309
            +SV+P  +  ++AVA  +ALNYL  E    +IHRDVK SNILL  +   +L DFG  I 
Sbjct: 100 LKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG--IS 155

Query: 310 GP-TDSTHMIREDVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPI-GF 364
           G   DS    R+   G   Y+APE +          + DV+S G+ L E+ +G+ P   +
Sbjct: 156 GQLVDSIAKTRD--AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213

Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
            ++    + V    P            P LSN  +       +   NLC+ +    RP  
Sbjct: 214 NSVFDQLTQVVKGDP------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKY 261

Query: 425 GQVLK 429
            ++L+
Sbjct: 262 KELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 9/164 (5%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           N    E+ +        I    G    D  + +  + +  GSL++ L  AG    +P  +
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQI 104

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             +V++A+ + L YL  +    ++HRDVK SNIL++S  + +L DFG++          +
Sbjct: 105 LGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               VGT  Y++PE L     S + D++S G+ L+E+  GR PI
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 50/174 (28%), Positives = 89/174 (51%), Gaps = 25/174 (14%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWG 257
            DF SE  I       +I  L GV  +    +++++++  G+L++ L    GE S     
Sbjct: 51  QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL- 109

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
               +   IA  + YL S+ +   +HRD+ + NIL++S+ + ++SDFGL        + +
Sbjct: 110 --VGMLRGIAAGMKYL-SDMN--YVHRDLAARNILVNSNLECKVSDFGL--------SRV 156

Query: 318 IREDVVGTFG---------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           + +D  GT+          + APE + + K +   DV+SFG+V+ E++S G RP
Sbjct: 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 9/157 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V      L LV +F+    L + +     Q  LP  +     
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDR--QRGLPESLIKSYL 104

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             + + L + HS     ++HRD+K  N+L++++   +L+DFGLA      S        V
Sbjct: 105 YQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLA--RSFGSPVRPYTHYV 159

Query: 324 GTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
            T  Y APE L+  K  S  +D++S G +  ELLS R
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 36/100 (36%), Positives = 63/100 (63%), Gaps = 5/100 (5%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +++  AL+YLH++    VIHRD+KS +ILL+SD + +LSDFG       +     R+ 
Sbjct: 123 VCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKS 177

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 17/220 (7%)

Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---Q 136

Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 193

Query: 340 SDKIDVYSFGVVLLELLSGRRPIGFKN-LKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
             K+D++S G++ +E++ G  P   +N L+    +     P L+N +  + +     N  
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT 438
            +  +++   A  L  +Q  ++   +  +  L+  A  AT
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 17/170 (10%)

Query: 201 FSSEVDITSSLEQKSITTL--NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           F  E  + + L   +I  L  +G       L  V +++P  +L E L   G    LP G 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADG---ALPAGE 80

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-SDFQP--QLSDFGLAIWGP---- 311
              + + + +AL   H+   + ++HRD+K  NI++S +  +P  ++ DFG+    P    
Sbjct: 81  TGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137

Query: 312 TDSTHMIRE-DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR 360
            D   + R  +V+GT  Y APE L    V+   D+Y++G++ LE L+G+R
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 37/100 (37%), Positives = 61/100 (61%), Gaps = 5/100 (5%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V  ++ +AL YLHS+    VIHRD+KS +ILL+ D + +LSDFG       D     R+ 
Sbjct: 122 VCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS 176

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 17/170 (10%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL---HGA--GEQSVLPWGV 258
           EV + + ++  +I T      E+  L +V ++   G L + +    G    E  +L W V
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-PQLSDFGLAIWGPTDSTHM 317
           +      I+  L ++H    R ++HRD+KS NI LS +    +L DFG+A     DS  +
Sbjct: 109 Q------ISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMEL 158

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
                VGT  Y++PE   +   ++K D++S G VL EL + + P    NL
Sbjct: 159 AYT-CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 35/232 (15%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ + S L+  +I    G   E++ L +  + +P GSL + L          +G   E  
Sbjct: 52  EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK--------KYGSFPEPV 103

Query: 264 VA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           +      I   L YLH    R  +HRD+K +NIL+ ++   +L+DFG+A           
Sbjct: 104 IRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSF 157

Query: 319 REDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            +   G+  ++APE +   G      D++S G  +LE+ +G+ P  +  L+G  ++ K  
Sbjct: 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQLEGVAAVFK-- 213

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             I ++ +   + D  LS+E  +  ++        C+ + P LRP   ++L+
Sbjct: 214 --IGRSKELPPIPD-HLSDEAKDFILK--------CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 37/191 (19%)

Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
           CR     +LK+           F  E +I    +  +I  L GVC++   + +V + +P 
Sbjct: 27  CRSTLPPDLKR----------KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL   L     +  L      ++++  A  + YL S+     IHRD+ + N L+  +  
Sbjct: 77  GSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNV 131

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFG-----------YIAPEYLMHGKVSDKIDVYS 347
            ++SDFG           M RE+  G +            + APE L +G+ + + DV+S
Sbjct: 132 LKISDFG-----------MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWS 180

Query: 348 FGVVLLELLSG 358
           +G++L E  S 
Sbjct: 181 YGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 28/167 (16%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG---SLEESLHGAGEQSV--LPWGV 258
           EV +   L  ++I  L         L LV +++ +     LE S  G    +V    W  
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-- 107

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTH 316
                  + +A+ Y HS     +IHRD+K  NIL+S     +L DFG A  +     S  
Sbjct: 108 ------QLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158

Query: 317 MIREDVVGTFGYIAPEYL----MHGKVSDKIDVYSFGVVLLELLSGR 359
               D V T  Y APE L     +GK    +DV++ G ++ ELL G 
Sbjct: 159 T---DYVATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 16/170 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-----GEQSVLPWGV 258
           EV + S+++  +I        E+  L +V D+   G L + ++        E  +L W V
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           +      I  AL ++H    R ++HRD+KS NI L+ D   +L DFG+A     +ST  +
Sbjct: 109 Q------ICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIA--RVLNSTVEL 157

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
               +GT  Y++PE   +   ++K D+++ G VL E+ + +      N+K
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 25/228 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 120

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 121 VCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           +VGT  ++APE +       ++D++S G++++E++ G  P  + N    E  +K  K I 
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP--YFN----EPPLKAMKMIR 229

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            N      L PKL N +  +   +  L   L   + P  R    ++LK
Sbjct: 230 DN------LPPKLKNLHKVSPSLKGFLDRLLV--RDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.1 bits (163), Expect = 3e-12
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 16/142 (11%)

Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL++LHS     
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---Q 135

Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 192

Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 20/170 (11%)

Query: 211 LEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEAL 270
           +  K I  L GVC+ D   I+V +F+  G L+  +H   +    PW  +F+VA  +A AL
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118

Query: 271 NYLHSECSRPVIHRDVKSSNILLS-----SDFQP--QLSDFGLAIWGPTDSTHMIREDVV 323
           +YL     + ++H +V + NILL+      +  P  +LSD G+ I      T + R++ V
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI------TVLSRQECV 169

Query: 324 GTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLEL-LSGRRPIGFKNLKGPE 371
               +IAPE +   K  S   D +SFG  L E+  +G  P+  K L   E
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 11/170 (6%)

Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAGEQSV 253
           +A NDF  E+ I S L+  +I  L  VCI  + L ++++++  G L + L  H   E + 
Sbjct: 61  NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120

Query: 254 ------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA 307
                 + +     +A  IA  + YL    S   +HRD+ + N L+  ++  +++DFG++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
               +   + I+   V    +++ E ++ GK +   DV++FGV L E+L+
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 49/167 (29%), Positives = 90/167 (53%), Gaps = 11/167 (6%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGV 258
           DF SE  I    +  +I  L GV  +   ++++++F+  G+L+  L    G+ +V+    
Sbjct: 51  DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-- 108

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL SE +   +HRD+ + NIL++S+   ++SDFGL+ +   D++   
Sbjct: 109 -VGMLRGIAAGMKYL-SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164

Query: 319 REDVVG---TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +G      + APE + + K +   DV+S+G+V+ E++S G RP
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 15/167 (8%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH----GAGEQSVLP 255
           +F  E  I +S++   +  L GVC+    + LV+  +P G L + +H      G Q +L 
Sbjct: 55  EFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN 113

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           W       V IA+ + YL     R ++HRD+ + N+L+ S    +++DFGLA     D  
Sbjct: 114 W------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +       ++A E + + K + + DV+S+GV + EL++ G +P
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 17/128 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +   GT
Sbjct: 104 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 158

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESL 373
             Y+APE L        +D +  GVV+ E++ GR P            I  + ++ P +L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 218

Query: 374 VKWAKPIL 381
              AK +L
Sbjct: 219 SPEAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 5e-12
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 10/94 (10%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE--DVVGTF 326
            L Y HS     ++HRD+K  NIL++ D   +L+DFGLA          +R     V T 
Sbjct: 110 GLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLA----RAFGIPLRTYTHEVVTL 162

Query: 327 GYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
            Y APE L+  K  S  +D++S G +  E+++G+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 4/96 (4%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGT 159

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             Y+APE L        +D +  GVV+ E++ GR P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 12/176 (6%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAGEQS 252
            +A  DF  EV I S L   +I  L GVC  D  L ++ +++  G L + L  H A    
Sbjct: 60  DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119

Query: 253 V------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           +      L +     +A  IA  + YL    S   +HRD+ + N L+  ++  +++DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +    +   + ++        ++A E ++ GK + K DV++FGV L E+L+  R  
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.3 bits (161), Expect = 6e-12
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 45/277 (16%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDF-LPKGSLEE 243
           +++  +  Q +  W D   EV     ++  +     G  + ++   LV ++ L   S   
Sbjct: 56  KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLL 115

Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
            +H    Q V       E+A     AL    YLHS     +IHRD+K+ NILL+   Q +
Sbjct: 116 EVHKKPLQEV-------EIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165

Query: 301 LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELL 356
           L+DFG A I  P +S        VGT  ++APE ++    G+   K+DV+S G+  +E L
Sbjct: 166 LADFGSASIASPANS-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-L 217

Query: 357 SGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQ 416
           + R+P  F N+    +L   A+      ++ TL   + S+ + N          + C+ +
Sbjct: 218 AERKPPLF-NMNAMSALYHIAQ-----NESPTLQSNEWSDYFRN--------FVDSCLQK 263

Query: 417 SPQLRPNMGQVLKLL-----RGATHATDWVDRHADDI 448
            PQ RP   ++LK +     R  T   D + R  D +
Sbjct: 264 IPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAV 300

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.3 bits (160), Expect = 8e-12
 Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 11/107 (10%)

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHM 317
           RF +A  +  A  YLH+   R +I+RD+K  N+LL S+   +L DFG A        T  
Sbjct: 96  RFYIACVV-LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Query: 318 IREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIG 363
                 GT  Y+APE ++  K  D  +D +S G++L ELL+GR P G
Sbjct: 152 F----CGTPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFG 193

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 79  FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 132

Query: 244 --SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
             S +   E+    W   +   V +A  L+ +HS     +IHRDVK  N+LL      +L
Sbjct: 133 LMSNYDVPEK----WAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKL 183

Query: 302 SDFGLAIWGPTDSTHMIREDV-VGTFGYIAPEYLMH----GKVSDKIDVYSFGVVLLELL 356
           +DFG  +    D T M+R D  VGT  YI+PE L      G    + D +S GV L E+L
Sbjct: 184 ADFGTCM--KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Query: 357 SGRRPIGFKNLKGPESLV 374
            G  P    +L G  S +
Sbjct: 242 VGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 23/135 (17%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIR 319
           A  IA  L +LHS   + +I+RD+K  N++L ++   +++DFG+    I+G   +     
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT----- 158

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNL 367
               GT  YIAPE + +      +D ++FGV+L E+L+G+ P            I   N+
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218

Query: 368 KGPESLVKWAKPILK 382
             P+SL K A  I K
Sbjct: 219 SYPKSLSKEAVSICK 233

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 44/131 (33%), Positives = 67/131 (51%), Gaps = 17/131 (12%)

Query: 261 EVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDS 314
           EV V IAE   AL++LH      +I+RD+K  NILL S+    L+DFGL+   +    + 
Sbjct: 106 EVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Query: 315 THMIREDVVGTFGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +       GT  Y+APE +  G       +D +S GV+  ELL+G  P      +  +S
Sbjct: 163 AY----SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Query: 373 LVKWAKPILKN 383
            +  ++ ILK+
Sbjct: 219 EI--SRRILKS 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 14/136 (10%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPW-GVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
           L  V +F+  G L   +     Q  LP    RF  +  I+ ALN+LH    R +I+RD+K
Sbjct: 71  LFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALNFLHE---RGIIYRDLK 123

Query: 288 SSNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDV 345
             N+LL ++   +L+D+G+   G  P D+T        GT  YIAPE L        +D 
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF----CGTPNYIAPEILRGEDYGFSVDW 179

Query: 346 YSFGVVLLELLSGRRP 361
           ++ GV++ E+++GR P
Sbjct: 180 WALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 28/144 (19%)

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA------IAEALNYLHSECSRPV 281
           +L  V ++L  G L   +  +G         RF+ A A      I   L +LH    + +
Sbjct: 70  HLFFVMEYLNGGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHK---KGI 117

Query: 282 IHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF----GYIAPEYLMHG 337
           I+RD+K  N+LL  D   +++DFG+         +M  E    TF     YIAPE L   
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMC------KENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 338 KVSDKIDVYSFGVVLLELLSGRRP 361
           K ++ +D +SFGV+L E+L G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 40/95 (42%), Positives = 56/95 (58%), Gaps = 7/95 (7%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGT 325
           AL Y+HS     VIHRD+K SNILL+SD + +L+DFGLA        +  + +  D V T
Sbjct: 119 ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 326 FGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
             Y APE L+      K +D++S G +L E+L G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 5/94 (5%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFG 327
           A++++HS   + +IHRD+KS+NILL S+   +L DFG + ++  T S  + R    GT  
Sbjct: 155 AVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPY 210

Query: 328 YIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           Y+APE       S K D++S GV+L ELL+ +RP
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 9/94 (9%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGY 328
           L++LH+ C   ++HRD+K  NIL++S  Q +L+DFGLA I+    S  M    VV T  Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWY 173

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            APE L+    +  +D++S G +  E+   R+P+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 12/161 (7%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D+  E+DI +S +  +I  L      +N L ++ +F   G+++  +    E+ +    +R
Sbjct: 48  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIR 106

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             V     EALNYLH      +IHRD+K+ NIL + D   +L+DFG++       T   R
Sbjct: 107 V-VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRR 160

Query: 320 EDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLEL 355
           +  +GT  ++APE +M     D     K DV+S G+ L+E+
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 33/170 (19%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I  S+    +  L G   +D+ L LV +++P G L   L  +G         RF  
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---------RFPE 100

Query: 263 AVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS 314
            VA      +  AL YLHS     +++RD+K  N+LL SD   +++DFG A  +      
Sbjct: 101 PVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGR 154

Query: 315 THMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP 361
           T+ +     GT  Y+APE ++   +GK    +D ++ G+++ E+L+G  P
Sbjct: 155 TYTL----CGTPEYLAPEIILSKGYGK---AVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
           +L LV   +  G L+  ++  GE+ +    V    A  I   + +LHS     +++RD+K
Sbjct: 67  HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA-QITCGILHLHS---MDIVYRDMK 122

Query: 288 SSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYS 347
             N+LL      +LSD GLA+      T   R    GT GY+APE L     S  +D ++
Sbjct: 123 PENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEPYSYPVDWFA 179

Query: 348 FGVVLLELLSGRRPIGFKNLK 368
            G  + E+++GR P  FK+ K
Sbjct: 180 MGCSIYEMVAGRTP--FKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            +++LHS     ++HRD+K  NIL++SD Q +++DFGLA      S  M    VV T  Y
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA---RIYSFEMALTSVVVTLWY 172

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            APE L+    +  +D++S G +  EL   RRP+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 54/197 (27%), Positives = 77/197 (39%), Gaps = 45/197 (22%)

Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
            +E +I ++L+   + TL      + YL LV D+ P G L   L     Q     G    
Sbjct: 49  LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ---RQP----GKCLS 101

Query: 262 VAVA---IAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
             VA    AE   AL YLH      +++RD+K  NILL       LSDF L+     +  
Sbjct: 102 EEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158

Query: 316 HMIRE---------------------------DVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            + +                              VGT  YIAPE +        +D ++ 
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218

Query: 349 GVVLLELLSGRRPIGFK 365
           G++L E+L G  P  FK
Sbjct: 219 GILLYEMLYGTTP--FK 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 17/182 (9%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL--- 241
           +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L   
Sbjct: 42  KELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 98

Query: 242 -EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
             E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +    +
Sbjct: 99  VREHKDNIGSQYLLNW------CVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVK 149

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GR 359
           ++DFGLA     D      E       ++A E ++H   + + DV+S+GV + EL++ G 
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209

Query: 360 RP 361
           +P
Sbjct: 210 KP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 14/185 (7%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           +Q  ++     T +  +A      E+ +  +L+ + I    G   +D  L +  +++P G
Sbjct: 33  KQVPFDPDSPETKKEVNA---LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGG 89

Query: 240 SLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF 297
           S+++ L  +GA  ++V     R      I E + YLHS     ++HRD+K +NIL  S  
Sbjct: 90  SVKDQLKAYGALTETVTRKYTR-----QILEGVEYLHSN---MIVHRDIKGANILRDSAG 141

Query: 298 QPQLSDFGLAIWGPTDSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL 356
             +L DFG +    T  +     + V GT  +++PE +       K DV+S G  ++E+L
Sbjct: 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201

Query: 357 SGRRP 361
           + + P
Sbjct: 202 TEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 16/164 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           E+ I   L  K +   N V   D++L+     +V ++L  GSL + +     ++ +    
Sbjct: 61  ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQ 116

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHM 317
              V     +AL +LH+     VIHRD+KS N+LL  D   +L+DFG  A   P  S   
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            R  +VGT  ++APE +       K+D++S G++ +E++ G  P
Sbjct: 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 43/128 (33%), Positives = 66/128 (51%), Gaps = 17/128 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHS     +++RD+K  N++L  D   +++DFGL   G TD+  M  +   GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM--KTFCGT 158

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESL 373
             Y+APE L        +D +  GVV+ E++ GR P            I  +++K P +L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218

Query: 374 VKWAKPIL 381
              AK +L
Sbjct: 219 SADAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 37/223 (16%)

Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL 293
           +++  GSL++   G      +P  V   +  A+ + L +L  E +  +IHRDVK +N+L+
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV 136

Query: 294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI------DVYS 347
           + + Q +L DFG++  G   ++  + +  +G   Y+APE +  G  +         DV+S
Sbjct: 137 NGNGQVKLCDFGVS--GNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192

Query: 348 FGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI--LKNGDTETLLDPKLSNEY-DNAQMQ 404
            G+ +LE+  GR P        PE+       +  + +GD      P L + Y D+AQ  
Sbjct: 193 LGLSILEMALGRYPYP------PETYANIFAQLSAIVDGDP-----PTLPSGYSDDAQD- 240

Query: 405 RMLLAANLCINQSPQLRPNMGQVL------KLLRGATHATDWV 441
                   C+N+ P  RP   Q+L      K         +WV
Sbjct: 241 ----FVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 37/246 (15%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-------AGEQ 251
            +F +E  +        +  L GV       ++V + + KG L+  L             
Sbjct: 54  IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IW 309
                    ++A  IA+ + YL +   +  +HRD+ + N +++ D   ++ DFG+   I+
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170

Query: 310 GPTDSTHMIREDVVGTFG--YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP-IGFK 365
                T   R+   G     ++APE L  G  + K DV+SFGVVL E+ +   +P  G  
Sbjct: 171 ----ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
           N    E ++K+   ++  G     LD   +      ++ RM      C   +P++RP   
Sbjct: 227 N----EEVLKF---VIDGG----HLDLPENCPDKLLELMRM------CWQYNPKMRPTFL 269

Query: 426 QVLKLL 431
           +++  L
Sbjct: 270 EIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 9/101 (8%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG--PTDSTHMIRE 320
           +  I+ ALNYLH    R +I+RD+K  N+LL S+   +L+D+G+   G  P D+T     
Sbjct: 102 SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----S 154

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              GT  YIAPE L        +D ++ GV++ E+++GR P
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 48/140 (34%), Positives = 72/140 (51%), Gaps = 27/140 (19%)

Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL 293
           +F+  GSLE + H A EQ +       +VA  I   + YLH    R ++HRD+K SN+L+
Sbjct: 152 EFMDGGSLEGT-HIADEQFLA------DVARQILSGIAYLHR---RHIVHRDIKPSNLLI 201

Query: 294 SSDFQPQLSDFGLA-----IWGPTDSTHMIREDVVGTFGYIAPEY----LMHGKVSDKI- 343
           +S    +++DFG++        P +S+       VGT  Y++PE     L HG       
Sbjct: 202 NSAKNVKIADFGVSRILAQTMDPCNSS-------VGTIAYMSPERINTDLNHGAYDGYAG 254

Query: 344 DVYSFGVVLLELLSGRRPIG 363
           D++S GV +LE   GR P G
Sbjct: 255 DIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 46/135 (34%), Positives = 72/135 (53%), Gaps = 12/135 (8%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L LV +++  G L    H   ++ +     RF  A  I  ALN+LH    R +I+RD+K 
Sbjct: 71  LFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHE---RGIIYRDLKL 124

Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+LL +D   +L+D+G+   G  P D+T        GT  YIAPE L   +    +D +
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF----CGTPNYIAPEILRGEEYGFSVDWW 180

Query: 347 SFGVVLLELLSGRRP 361
           + GV++ E+++GR P
Sbjct: 181 ALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 42/100 (42%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPT-DSTHMIREDVV 323
           I   L Y+HS     V+HRD+K SN+LL+++   ++ DFGLA I  P  D T  + E  V
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YV 170

Query: 324 GTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPI 362
            T  Y APE +++ K   K ID++S G +L E+LS  RP+
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 10/101 (9%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
               L YLH      VIHRD+K  NILL+ + + +L DFG++     DST   R   +GT
Sbjct: 122 TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGT 176

Query: 326 FGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRP 361
             ++APE +   +  D     + DV+S G+  +EL  G+ P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.7 bits (156), Expect = 5e-11
 Identities = 41/97 (42%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTF 326
            L YLHS     VIHRD+K SNIL++S+   ++ DFGLA  +    D    + E VV T 
Sbjct: 115 GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TR 170

Query: 327 GYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPI 362
            Y APE L+      K ID++S G +  ELL  R+P+
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 43/148 (29%), Positives = 64/148 (43%), Gaps = 36/148 (24%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLA--IWGPTDSTHMIR 319
           I   ++YLHS     V+HRD+K +NIL+  +   +    + D GLA     P     +  
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP--LAD 171

Query: 320 ED-VVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            D VV T  Y APE L+  +   K ID+++ G +  ELL+                    
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-------------------L 212

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQR 405
           +PI K G        K SN +   Q++R
Sbjct: 213 EPIFK-GREA---KIKKSNPFQRDQLER 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 50/135 (37%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V D++  G L    H   E+S      RF  A  IA AL YLHS     +I+RD+K 
Sbjct: 71  LYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNIIYRDLKP 124

Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            NILL S     L+DFGL   G   + +T        GT  Y+APE L        +D +
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF----CGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 347 SFGVVLLELLSGRRP 361
             G VL E+L G  P
Sbjct: 181 CLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 12/97 (12%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI--REDVVGTFG 327
           L YLH       IHRD+K +NILL+ D   +L+DFG++       T  I  R+  +GT  
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPY 166

Query: 328 YIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRP 361
           ++APE       G    K D+++ G+  +EL   + P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 29/176 (16%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +   +    I  L     +  +L ++ +++P G L   L  +G         RF  
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---------RFSN 100

Query: 263 AVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           +        I  AL YLHS   + +++RD+K  NILL  +   +L+DFG A     D T 
Sbjct: 101 STGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTW 156

Query: 317 MIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
            +     GT  Y+APE +    H K    +D ++ G+++ E+L G  P    N  G
Sbjct: 157 TL----CGTPEYLAPEVIQSKGHNKA---VDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 12/183 (6%)

Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
           C++   + +K+   + S A N    E  I   +  + + +L       + L LV   +  
Sbjct: 30  CKKLEKKRIKKRKGE-SMALN----EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           G L+  ++  GE      G     A  I   L  LH E    +++RD+K  NILL     
Sbjct: 85  GDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGH 140

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            ++SD GLA+  P   T   R   VGT GY+APE + + + +   D ++ G +L E+++G
Sbjct: 141 IRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197

Query: 359 RRP 361
           + P
Sbjct: 198 QSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L YLHS     ++HRD+K +N+L++SD   +L+DFGLA    + +  M  + VV T  Y
Sbjct: 114 GLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ-VV-TRWY 168

Query: 329 IAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
            APE L   +     +D++S G +  ELL  R P 
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 32/183 (17%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG--VRFE 261
           E+ + S L+ ++I    G   E+ +  +  + +P GSL   L          WG     E
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-------WGPLKDNE 107

Query: 262 VAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFG----LAIWGP 311
             +      I E L YLH      ++HRD+K  N+L+++     ++SDFG    LA   P
Sbjct: 108 QTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
              T        GT  Y+APE +  G        D++S G  ++E+ +G+ P  F  L  
Sbjct: 165 CTET------FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGE 216

Query: 370 PES 372
           P++
Sbjct: 217 PQA 219

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 56/168 (33%), Positives = 84/168 (50%), Gaps = 15/168 (8%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV-R 259
           F  E ++  + + + ITTL+    ++NYL LV D+   G L   L    ++  LP  + R
Sbjct: 48  FREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR--LPEDMAR 105

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F     IAE +  +HS      +HRD+K  N+LL  +   +L+DFG  +    D T  ++
Sbjct: 106 F----YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQ 159

Query: 320 EDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRP 361
             V VGT  YI+PE L       GK   + D +S GV + E+L G  P
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 79  FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 132

Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            +       V     RF  A  +  AL+ +HS      IHRDVK  N+LL      +L+D
Sbjct: 133 LM---SNYDVPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185

Query: 304 FGLAIWGPTDSTHMIREDV-VGTFGYIAPEYLMH----GKVSDKIDVYSFGVVLLELLSG 358
           FG  +    +   M+R D  VGT  YI+PE L      G    + D +S GV L E+L G
Sbjct: 186 FGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDN 400
             P    +L G  S +   K  L   D     D  +S E  N
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLTFPD-----DNDISKEAKN 280

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 17/169 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF SE  I    +  +I  L GV  +   +++V++++  GSL+  L     Q  +   V 
Sbjct: 51  DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV- 109

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +   IA  + YL S+     +HRD+ + NIL++S+   ++SDFGL+     D      
Sbjct: 110 -GMLRGIASGMKYL-SDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP----- 160

Query: 320 EDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           E    T G      + APE + + K +   DV+S+G+V+ E++S G RP
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 56/168 (33%), Positives = 88/168 (52%), Gaps = 17/168 (10%)

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
           YLIL  DFL  G L   L  + E       V+F +A  +A AL++LHS     +I+RD+K
Sbjct: 74  YLIL--DFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLHS---LGIIYRDLK 125

Query: 288 SSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE--DVVGTFGYIAPEYLMHGKVSDKIDV 345
             NILL  +   +L+DFGL+     +S    ++     GT  Y+APE +     +   D 
Sbjct: 126 PENILLDEEGHIKLTDFGLS----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 181

Query: 346 YSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK---PILKNGDTETLL 390
           +SFGV++ E+L+G  P   K+ K   +++  AK   P   + + ++LL
Sbjct: 182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 16/159 (10%)

Query: 210 SLEQKSITTLNGVCI-----EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAV 264
           + E  ++  L  VC       +  L LV + + +  L   L    E  V    ++ ++  
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMF 117

Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVV 323
            +   L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA I+    S  M    VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVV 170

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            T  Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 17/128 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL YLHS     V++RD+K  N++L  D   +++DFGL   G +D   M  +   GT
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 158

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESL 373
             Y+APE L        +D +  GVV+ E++ GR P            I  + ++ P +L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218

Query: 374 VKWAKPIL 381
              AK +L
Sbjct: 219 SPEAKSLL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 46/256 (17%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDF-LPKGSLEE 243
           +++  +  Q +  W D   EV     L   +     G  + ++   LV ++ L   S   
Sbjct: 46  KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 105

Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
            +H    Q V       E+A     AL    YLHS     +IHRDVK+ NILLS     +
Sbjct: 106 EVHKKPLQEV-------EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155

Query: 301 LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELL 356
           L DFG A I  P +         VGT  ++APE ++    G+   K+DV+S G+  +E L
Sbjct: 156 LGDFGSASIMAPANX-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-L 207

Query: 357 SGRRPIGFKNLKGPESLVKWAK---PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLC 413
           + R+P  F N+    +L   A+   P L++G          S  + N          + C
Sbjct: 208 AERKPPLF-NMNAMSALYHIAQNESPALQSG--------HWSEYFRN--------FVDSC 250

Query: 414 INQSPQLRPNMGQVLK 429
           + + PQ RP    +LK
Sbjct: 251 LQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 13/103 (12%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I   L +LHS   + +++RD+K  NILL +D   +++DFG+         +M+ +  
Sbjct: 102 AAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMC------KENMLGDAK 152

Query: 323 VGTF----GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             TF     YIAPE L+  K +  +D +SFGV+L E+L G+ P
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 32/240 (13%)

Query: 195 SSAWNDFSSEVDIT-SSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV 253
             +  D  SEV I    L   +I       +E++ L +V D +    L E  +   E+  
Sbjct: 49  DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-- 106

Query: 254 LPWGVRFE------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA 307
                RF       + V +  AL YLH E  + ++HRD+  +NI+L  D +  ++DFGLA
Sbjct: 107 ---KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161

Query: 308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
                         VVGT  Y  PE + +    +K DV++FG +L ++ + + P    N 
Sbjct: 162 ---KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN- 217

Query: 368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
                ++  A  I+     E L +   S        + +      C+    + RP++ QV
Sbjct: 218 -----MLSLATKIV-EAVYEPLPEGMYS--------EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 13/164 (7%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG- 257
               +E DI ++ + + +  L     +D YL L  +++P G     L+  G   VL    
Sbjct: 46  RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDH 102

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
            RF +A    EA++ LH       IHRD+K  N L+ +    +L+DFGL+    T     
Sbjct: 103 ARFYMAEMF-EAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
               VVG+  Y+APE L        +D +S G +L E L G  P
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 37/94 (39%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L Y+HS     V+HRD+K SN+LL+++   ++ DFGLA    T        + V T  Y 
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA--RTTSEKGDFMTEYVVTRWYR 175

Query: 330 APEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPI 362
           APE L++  + +  IDV+S G +  ELL GR+P+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 39/101 (38%), Positives = 59/101 (58%), Gaps = 10/101 (9%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW---GPTDSTHMIREDVVGT 325
            L Y+HS     V+HRD+K  N+L+++D + ++ DFGLA      P ++   + E  V T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVAT 172

Query: 326 FGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPIGFK 365
             Y APE ++     +  IDV+S G +L ELL GR+P+ FK
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV-FK 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 41/236 (17%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE---ESLHGAG----EQSVLPW 256
           E  + S L+  +I   +   +E +   +++++     L+   E L   G    E  V  W
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS 314
            ++  + V      +Y+H    R ++HRD+K+ NI L ++   ++ DFG++  + G  D 
Sbjct: 112 FIQLLLGV------HYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD- 160

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP-IGFKNLKGPESL 373
              +     GT  Y++PE L H     K D++S G +L E+        G   L     +
Sbjct: 161 ---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           V+        G T +L  P+  +   N+ MQ ML       N+ P LRP+  ++L+
Sbjct: 218 VE--------GPTPSL--PETYSRQLNSIMQSML-------NKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 37/178 (20%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+  +  L+  +I       I D+ L +VS  +  GS E+ L     ++  P G+  E+A
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL-----KTHFPEGLP-ELA 102

Query: 264 VA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           +A     +  AL+Y+HS+     IHR VK+S+ILLS D +  LS    ++        MI
Sbjct: 103 IAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSV-------SMI 152

Query: 319 ----REDVVGTFG--------YIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRP 361
               R+ VV  F         +++PE L   + G  ++K D+YS G+   EL +G  P
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 26/144 (18%)

Query: 227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV------AVAIAEALNYLHSECSRP 280
            +L  V +FL  G L   +   G         RF++      A  I   L +LHS   + 
Sbjct: 69  EHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHS---KG 116

Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLMHG 337
           +I+RD+K  N++L  D   +++DFG+    ++G   ++        GT  YIAPE L   
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-----CGTPDYIAPEILQGL 171

Query: 338 KVSDKIDVYSFGVVLLELLSGRRP 361
           K +  +D +SFGV+L E+L G+ P
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 49/148 (33%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   ++     +RF  A  I   L ++H+   R V++RD+
Sbjct: 72  LSFILDLMNGGDLHYHLSQHGVFSEA----EMRF-YAAEIILGLEHMHN---RFVVYRDL 123

Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA     D +       VGT GY+APE L  G   D   D 
Sbjct: 124 KPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 179

Query: 346 YSFGVVLLELLSGRRPIGFKNLKGPESL 373
           +S G +L +LL G  P  F+  K  +  
Sbjct: 180 FSLGCMLFKLLRGHSP--FRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 18/188 (9%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN---YLILVSDFL 236
           +Q  ++     TS+  SA      E+ +  +L+ + I    G C+ D     L +  +++
Sbjct: 33  KQVQFDPESPETSKEVSA---LECEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYM 88

Query: 237 PKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD 296
           P GS+++ L   G    L   V  +    I E ++YLHS     ++HRD+K +NIL  S 
Sbjct: 89  PGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSA 142

Query: 297 FQPQLSDFGLAIWGPT---DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLL 353
              +L DFG +    T     T +    V GT  +++PE +       K DV+S G  ++
Sbjct: 143 GNVKLGDFGASKRLQTICMSGTGI--RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVV 200

Query: 354 ELLSGRRP 361
           E+L+ + P
Sbjct: 201 EMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 13/99 (13%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTD-STHMIREDVVGT 325
           L Y+HS     VIHRD+K SN+L++ D + ++ DFG+A      PT+    M   + V T
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT--EYVAT 174

Query: 326 FGYIAPEYL--MHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y APE L  +    +  ID++S G +  E+L GRR +
Sbjct: 175 RWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 15/98 (15%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS--THMIREDVV 323
           + + Y+H+     ++HRD+K +N+L+S+D   +++DFGLA           +H      V
Sbjct: 110 KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-----V 161

Query: 324 GTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGR 359
            T  Y APE L++G  K    +D+++ G +  ELL+G 
Sbjct: 162 ATRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 19/170 (11%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E D+  + + + ITTL+    ++N L LV D+   G L  +L    E  +     RF
Sbjct: 48  FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARF 106

Query: 261 ---EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              E+ +AI ++++ LH       +HRD+K  NIL+  +   +L+DFG  +    D T  
Sbjct: 107 YLAEMVIAI-DSVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-- 157

Query: 318 IREDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRP 361
           ++  V VGT  YI+PE L       GK   + D +S GV + E+L G  P
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 6/111 (5%)

Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            I E L YLH++    +IHRDVK+ NI ++   Q  + D G A +       +    + G
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAG 218

Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK 375
           T    APE L   K + K D++S G+VL E+L+    I       PE  VK
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269

Length = 357

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 27/178 (15%)

Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG----AGEQSV 253
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L        E   
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127

Query: 254 LPWGVRFE---------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
            P  V  E          A  +A  + YL    S+  IHRD+ + N+L++ D   +++DF
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 305 GLAIWGPTDSTHMIREDVVGTFG-----YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           GLA        H I      T G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 185 GLA-----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 41/124 (33%), Positives = 57/124 (45%), Gaps = 22/124 (17%)

Query: 241 LEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
           LE++  G  E  +       ++     +A+N+ H       IHRDVK  NIL++   Q +
Sbjct: 90  LEKNPRGVPEHLIK------KIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIK 140

Query: 301 LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLE 354
           L DFG A I       +    D V T  Y APE L    V D      +DV++ G V  E
Sbjct: 141 LCDFGFARILTGPGDDYT---DYVATRWYRAPELL----VGDTQYGPPVDVWAIGCVFAE 193

Query: 355 LLSG 358
           LL+G
Sbjct: 194 LLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 49/135 (36%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V D++  G L    H   E+  L    RF  A  +A A+ YLHS     +I+RD+K 
Sbjct: 71  LYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLHSL---NIIYRDLKP 124

Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            NILL S     L+DFGL   G  P ++T        GT  Y+APE L        +D +
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGVEPEETTSTF----CGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 347 SFGVVLLELLSGRRP 361
             G VL E+L G  P
Sbjct: 181 CLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 57/233 (24%), Positives = 107/233 (45%), Gaps = 25/233 (10%)

Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           SE+ I S L   ++I  L G C     +++++++   G L   L    E  +    +   
Sbjct: 87  SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LS 145

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            +  +A+ + +L    S+  IHRD+ + N+LL+     ++ DFGLA     DS ++++ +
Sbjct: 146 FSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLV--KWAK 378
                 ++APE + +   + + DV+S+G++L E+ S G  P        P   V  K+ K
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-------PGMPVDSKFYK 255

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            I K G    +  P+ +       M+        C +  P  RP   Q+++L+
Sbjct: 256 LI-KEG--YRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG 327
             L YLH      +IHRD+K SN+LL+     +++DFGLA      +  M     V T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLW 173

Query: 328 YIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
           Y APE L+        ID+++ G +L ELL+ +
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 12/96 (12%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THMIREDVVG 324
             + +LH      ++HRD+K+SN+LL++    ++ DFGLA  +G P    T +    VV 
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL----VV- 168

Query: 325 TFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
           T  Y APE L+  K  S  ID++S G +  ELL+ +
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 35/192 (18%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I  AL+ +HS     ++HRD+KS+NI L      +L DFG +    +DS  + +     G
Sbjct: 178 IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCG 233

Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG 384
           T  Y+APE     + S K D++S GV+L ELL+  RP      KGP              
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP-----FKGPSQ------------ 276

Query: 385 DTETLLDPKLSNEYD------NAQMQRMLLAANLCINQSPQLRPNMGQVL--KLLRGATH 436
               ++   L  +YD      ++ M+ +L   +  ++++P LRP   Q+L  + L+   +
Sbjct: 277 --REIMQQVLYGKYDPFPCPVSSGMKALL---DPLLSKNPALRPTTQQLLHTEFLKYVAN 331

Query: 437 ATDWVDRHADDI 448
               + RH++ I
Sbjct: 332 LFQDIVRHSETI 343

Length = 478

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 16/106 (15%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IW---------GPTDSTHM 317
           E +NYLH   +  ++HRD+K++NIL+ +    +++DFGLA  +         G    T  
Sbjct: 126 EGINYLH--ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 318 IREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
               VV T  Y  PE L+  +  +  +D++  G V  E+ + RRPI
Sbjct: 183 YTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 25/136 (18%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IW-GPTDSTHMI 318
           A  IA  L +LHS   + +I+RD+K  N++L S+   +++DFG+    +W G T  T   
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--- 160

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKN 366
                GT  YIAPE + +      +D ++FGV+L E+L+G+ P            I   N
Sbjct: 161 ---FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217

Query: 367 LKGPESLVKWAKPILK 382
           +  P+S+ K A  I K
Sbjct: 218 VAYPKSMSKEAVAICK 233

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 21/171 (12%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV-R 259
           F  E D+  + +++ IT L+    ++N L LV D+   G L   L    ++  LP  + R
Sbjct: 48  FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMAR 105

Query: 260 F---EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           F   E+ +AI ++++ L        +HRD+K  N+LL  +   +L+DFG  +    D T 
Sbjct: 106 FYLAEMVLAI-DSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT- 157

Query: 317 MIREDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRP 361
            ++ +V VGT  YI+PE L       G+   + D +S GV + E+L G  P
Sbjct: 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 47/136 (34%), Positives = 65/136 (47%), Gaps = 15/136 (11%)

Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   +  +    RF  A  I   L ++H+   R V++RD+
Sbjct: 72  LCFILDLMNGGDLHYHLSQHGVFSEKEM----RF-YATEIILGLEHMHN---RFVVYRDL 123

Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA     D +       VGT GY+APE L  G   D   D 
Sbjct: 124 KPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 346 YSFGVVLLELLSGRRP 361
           +S G +L +LL G  P
Sbjct: 180 FSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 16/166 (9%)

Query: 216 ITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVLPWGVRFEVAVAIAEALN 271
           +  L G+C+    + LV+  +P G L     E+    G Q +L W       V IA+ ++
Sbjct: 71  VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMS 123

Query: 272 YLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAP 331
           YL  E  R ++HRD+ + N+L+ S    +++DFGLA     D T    +       ++A 
Sbjct: 124 YL--EEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 332 EYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLKGPESLVK 375
           E ++H + + + DV+S+GV + EL++ G +P  G    + P+ L K
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-THMIREDVVGTFG 327
           AL Y+H+     V HRD+K  NIL ++D + ++ DFGLA     D+ T +   D V T  
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 328 YIAPEYL--MHGKVSDKIDVYSFGVVLLELLSGR 359
           Y APE       K +  ID++S G +  E+L+G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 13/172 (7%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  + S+    +I  L GVC+ +    ++ + +  G L   L  A  +   P  + 
Sbjct: 45  EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104

Query: 260 F----EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQPQLSDFGLAIWG 310
                ++ + +A+   YL        IHRD+ + N L+S      D   ++ DFGLA   
Sbjct: 105 LKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
                +    + +    ++APE L+ GK + + DV+SFGV++ E+L+ G++P
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 26/180 (14%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE-----------SLHG 247
            DF  E  + +  +  +I  L GVC     + L+ +++  G L E           SL  
Sbjct: 53  ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112

Query: 248 AGEQSVLPWGVR--------FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +   +                 +A  +A  + YL SE  R  +HRD+ + N L+  +   
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL-SE--RKFVHRDLATRNCLVGENMVV 169

Query: 300 QLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGL+  I+   D       D +    ++ PE + + + + + DV+++GVVL E+ S
Sbjct: 170 KIADFGLSRNIYS-ADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 29/200 (14%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           ++++ +E++   S  SSA  D   E  + + ++  +I         D +L +V ++   G
Sbjct: 26  QKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83

Query: 240 SLEESLHGA-----GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
            L + +         E ++L W V+  + V       ++H    + V+HRD+KS NI L+
Sbjct: 84  DLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIHE---KRVLHRDIKSKNIFLT 134

Query: 295 SDFQPQLSDFG----LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
            + + +L DFG    L   G    T+      VGT  Y+ PE   +   ++K D++S G 
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYVPPEIWENMPYNNKSDIWSLGC 188

Query: 351 VLLELLSGRRPI---GFKNL 367
           +L EL + + P     +KNL
Sbjct: 189 ILYELCTLKHPFQANSWKNL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 26/167 (15%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F SE  I    +  +I  L GVC +   + +V + +P G     L    ++      V+F
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A+  A  + YL S   +  IHRD+ + N L+  +   ++SDFG           M R+
Sbjct: 99  --ALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFG-----------MSRQ 142

Query: 321 DVVGTFG----------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +  G +           + APE L +G+ S + DV+S+G++L E  S
Sbjct: 143 EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 5/104 (4%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I  AL +LH    + +I+RD+K  N+LL  +   +L+DFG+   G  +         
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTF 156

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
            GT  YIAPE L        +D ++ GV+L E+L G  P   +N
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 44/243 (18%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E  I       +I  L GVC +   + +V + +  G     L   G +  L      
Sbjct: 40  FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELI 97

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++    A  + YL S+     IHRD+ + N L++     ++SDFG           M RE
Sbjct: 98  QMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFG-----------MSRE 143

Query: 321 DVVGTFG-----------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK 368
           +  G +            + APE L +G+ S + DV+SFG++L E  S G  P  + NL 
Sbjct: 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP--YANLS 201

Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             ++     +  ++ G    L  P+L  +     M+R       C    P  RP+   V 
Sbjct: 202 NQQT-----REAIEQG--VRLPCPELCPDAVYRLMER-------CWEYDPGQRPSFSTVH 247

Query: 429 KLL 431
           + L
Sbjct: 248 QEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 50/135 (37%), Positives = 65/135 (48%), Gaps = 12/135 (8%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V DF+  G L    H   E+S      RF  A  IA AL YLHS     +++RD+K 
Sbjct: 71  LYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAA-EIASALGYLHS---INIVYRDLKP 124

Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            NILL S     L+DFGL   G   +D+T        GT  Y+APE +      + +D +
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF----CGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 347 SFGVVLLELLSGRRP 361
             G VL E+L G  P
Sbjct: 181 CLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 27/177 (15%)

Query: 200 DFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG----------- 247
           D  SE+++   + + K+I  L GVC ++  L ++ ++  KG+L E L             
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 248 --AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                +  L +      A  +A  + YL S   R  IHRD+ + N+L++ D   +++DFG
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 306 LAIWGPTDSTHMIREDVVGTFG-----YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           LA        H I      + G     ++APE L     + + DV+SFG+++ E+ +
Sbjct: 180 LA-----RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 30/241 (12%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           +F  E+D+   L  K++  L G+C E     ++ ++   G L++ L        +    P
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 256 WGVRFEVAVA--IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
              + +VA+   IA  +++L +  +R  +HRD+ + N L+SS  + ++S   L+      
Sbjct: 114 LSTKQKVALCTQIALGMDHLSN--AR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES 372
             + +R  ++    ++APE +     S K DV+SFGV++ E+ + G  P  F  L   E 
Sbjct: 171 EYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEV 227

Query: 373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVLKL 430
           L +     L+ G  E    P            M R       C   +P+ RP+  +++  
Sbjct: 228 LNR-----LQAGKLEL---PVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSA 272

Query: 431 L 431
           L
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 16/106 (15%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST------HMIRE-- 320
           AL YLH+     ++HRD+K  N+L++S    +L+DFGL+  G    T      H+ ++  
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 321 -----DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                 V GT  YIAPE ++       +D ++ G++L E L G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG 327
           E LNY H    +  +HRD+K SNILL++  Q +L+DFGLA    ++ +      V+ T  
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182

Query: 328 YIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           Y  PE L+   +    IDV+S G +L EL + ++PI
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 31/179 (17%)

Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL------------- 245
           D  SE+++   + + K+I  L GVC ++  L +V ++   G+L + L             
Sbjct: 61  DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 246 --HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
                 E       V F  A  +A  + +L    S+  IHRD+ + N+L++ D   +++D
Sbjct: 121 DPRPPEETLTQKDLVSF--AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIAD 175

Query: 304 FGLAIWGPTDSTHMI---REDVVGTFGY--IAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           FGLA        H I   R+   G      +APE L     + + DV+SFGV+L E+ +
Sbjct: 176 FGLA-----RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 13/97 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L Y+HS     +IHRD+K SNI ++ D + ++ DFGLA     + T       V T
Sbjct: 127 ILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVAT 178

Query: 326 FGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +   MH   +  +D++S G ++ ELL+G+
Sbjct: 179 RWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 48/140 (34%), Positives = 68/140 (48%), Gaps = 30/140 (21%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV-- 323
           I+ AL +LH +    +I+RD+K  NILL +    +L+DFGL           I E  V  
Sbjct: 109 ISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC-------KESIHEGTVTH 158

Query: 324 ---GTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
              GT  Y+APE LM   HGK    +D +S G ++ ++L+G  P   +N K      K  
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKA---VDWWSLGALMYDMLTGAPPFTAENRK------KTI 209

Query: 378 KPILKNGDTETLLDPKLSNE 397
             ILK    +  L P L+ E
Sbjct: 210 DKILKG---KLNLPPYLTPE 226

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 45/134 (33%), Positives = 67/134 (50%), Gaps = 14/134 (10%)

Query: 258 VRF---EVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
            RF   EV +   E   AL +LH      +I+RD+K  NILL S+    L+DFGL+    
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVS-DK-IDVYSFGVVLLELLSGRRPIGFKNLKG 369
            D          GT  Y+AP+ +  G    DK +D +S GV++ ELL+G  P      K 
Sbjct: 157 EDEVERAY-SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215

Query: 370 PESLVKWAKPILKN 383
            ++ +  ++ ILK+
Sbjct: 216 SQAEI--SRRILKS 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 4e-09
 Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 23/103 (22%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE----- 320
           I + L ++H        HRD+K  N+L+S     +++DFGLA           RE     
Sbjct: 108 ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA-----------REIRSRP 153

Query: 321 ---DVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
              D V T  Y APE L+     S  +D+++ G ++ EL + R
Sbjct: 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 17/132 (12%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I+  L +LH    R +I+RD+K  N++L S+   +++DFG+      D   +     
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTF 161

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGP 370
            GT  YIAPE + +      +D +++GV+L E+L+G+ P            I   N+  P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221

Query: 371 ESLVKWAKPILK 382
           +SL K A  I K
Sbjct: 222 KSLSKEAVSICK 233

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 12/183 (6%)

Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
           C++   + +K+   + S A N    E  I   +  + +  L       + L LV   +  
Sbjct: 30  CKRLEKKRIKKRKGE-SMALN----EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           G L+  ++  G          F  A  I   L  LH E     ++RD+K  NILL     
Sbjct: 85  GDLKFHIYNMGNPGFEEERALF-YAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGH 140

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            ++SD GLA+  P   +   R   VGT GY+APE L + + +   D +  G ++ E++ G
Sbjct: 141 IRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197

Query: 359 RRP 361
           + P
Sbjct: 198 QSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 5/99 (5%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  +  AL +LH      VI+RD+K  NILL ++   +L+DFG+   G  +   +     
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTF 156

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            GT  YIAPE L   +    +D ++ GV++ E+++G+ P
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 11/114 (9%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I   L  LH E    +++RD+K  NILL      ++SD GLA+  P   T   R   
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR--- 161

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW 376
           VGT GY+APE + + + +   D +  G ++ E++ G+ P      +  +  VK 
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP-----FRQRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 24/174 (13%)

Query: 200 DFSSEVDITSSLEQK-SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL +  ++ P G+L + L  +          
Sbjct: 48  DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107

Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
              G  S L      + A  +A  + YL     +  IHRD+ + N+L+  +   +++DFG
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 306 LAIWGPTDSTHMIREDVVGTFG--YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   + K DV+SFGV+L E++S
Sbjct: 165 L-----SRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 44/158 (27%), Positives = 84/158 (53%), Gaps = 9/158 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L+ ++I  L+ V   +N L+LV +++ K  L++ +   G +  L         
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + + + H      V+HRD+K  N+L++   + +L+DFGLA  +G   +T     +V
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEV 161

Query: 323 VGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
           V T  Y AP+ L+  +  S  ID++S G ++ E+++GR
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E  I    +   I  L GV   +N + +V +  P G L   L     +  L      
Sbjct: 54  FLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQV--NKYSLDLASLI 110

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             +  ++ AL YL S   +  +HRD+ + N+L+SS    +L DFGL+ +   D ++    
Sbjct: 111 LYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKAS 166

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E+L  G +P  G KN
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 11/164 (6%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E       +  +I  L GV    N +++V++++  G+L+  L     Q  L  G   
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLM 110

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   +A  + YL SE     +H+ + +  +L++SD   ++S F        D +  I  
Sbjct: 111 GMLPGLASGMKYL-SEMG--YVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYT 164

Query: 321 DVVG--TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            + G     + APE + +   S   DV+SFG+V+ E++S G RP
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 26/135 (19%)

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
           VRF     I  AL +LH      +++RD+K  NILL S+    L+DFGL       S   
Sbjct: 107 VRFYSG-EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGL-------SKEF 155

Query: 318 IRED------VVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
           + E+        GT  Y+APE +     HGK    +D +S G+++ ELL+G  P   +  
Sbjct: 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGE 212

Query: 368 KGPESLVKWAKPILK 382
           +  +S V  ++ ILK
Sbjct: 213 RNTQSEV--SRRILK 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/140 (35%), Positives = 63/140 (45%), Gaps = 12/140 (8%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V D++  G L    H   E+  L    RF  A  IA AL YLHS     +++RD+K 
Sbjct: 71  LYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKP 124

Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            NILL S     L+DFGL         +T        GT  Y+APE L        +D +
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGTTSTF----CGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 347 SFGVVLLELLSGRRPIGFKN 366
             G VL E+L G  P   +N
Sbjct: 181 CLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 21/143 (14%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSR 279
           D+ L LV+D++  G L   L   G         RF    A   IAE   AL +LH     
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKY--- 115

Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
            +++RD+K  NILL +     L DFGL+      + +       GT  Y+APE L+  K 
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 340 SDK-IDVYSFGVVLLELLSGRRP 361
             K +D +S GV++ E+  G  P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 52/273 (19%)

Query: 168 TELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN 227
           TE+ LK++    R +S E   +A S              + S L  K +    GVC+  +
Sbjct: 28  TEVLLKVLDKSHRNYS-ESFFEAAS--------------MMSQLSHKHLVLNYGVCVCGD 72

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
             I+V +++  GSL+  L        + W  + EVA  +A AL++L     + + H +V 
Sbjct: 73  ESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE---DKGLTHGNVC 127

Query: 288 SSNILL------SSDFQP--QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK- 338
           + N+LL       +   P  +LSD G++I      T + +E ++    ++ PE + + + 
Sbjct: 128 AKNVLLIREEDRKTGNPPFIKLSDPGISI------TVLPKEILLERIPWVPPECIENPQN 181

Query: 339 VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
           +S   D +SFG  L E+ SG    G K    P S +   K +    D   L  PK +   
Sbjct: 182 LSLAADKWSFGTTLWEIFSG----GDK----PLSALDSQKKLQFYEDRHQLPAPKWT--- 230

Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                  +    N C++  P  RP+   +++ L
Sbjct: 231 ------ELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---VAVAIAEALNYLHSECSRPVIHRD 285
           L LV +    GS+ + + G      L  G R E   +A  + EAL  L        IHRD
Sbjct: 95  LWLVLELCNGGSVTDLVKG-----FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149

Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL-----MHGKVS 340
           VK +NILL+++   +L DFG++      ST + R   VGT  ++APE +     +     
Sbjct: 150 VKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD 207

Query: 341 DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKL-SNEYD 399
            + DV+S G+  +EL  G  P+   +L    +L K     +      TL  P+L SNE++
Sbjct: 208 ARCDVWSLGITAIELGDGDPPLA--DLHPMRALFK-----IPRNPPPTLHQPELWSNEFN 260

Query: 400 NAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           +            C+ +  + RP +  +L+
Sbjct: 261 D--------FIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 15/169 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIED---NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           N    E+ +  +L  + I    G C+ D     L +  + +P GS+++ L   G    L 
Sbjct: 49  NALECEIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALT 104

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT--- 312
             V  +    I E ++YLHS     ++HRD+K +NIL  S    +L DFG +    T   
Sbjct: 105 ENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             T M  + V GT  +++PE +       K D++S G  ++E+L+ + P
Sbjct: 162 SGTGM--KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 26/176 (14%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F     + S +    +  ++GVC+  +  I+V +F+  G L+  L    E+  +P   + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKI 120

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-----SDFQP--QLSDFGLAIWGPTD 313
            VA  +A AL+YL     + ++H +V + NILL+         P  +LSD G++      
Sbjct: 121 TVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----- 172

Query: 314 STHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLEL-------LSGRRP 361
            T + RE+ V    +IAPE +  G  +S   D +SFG  LLE+       L  R P
Sbjct: 173 -TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 10/131 (7%)

Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS 340
           +++RD+K  NILL      ++SD GLA+  P   T   R   VGT GY+APE + + K +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEVINNEKYT 179

Query: 341 DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDN 400
              D +  G ++ E++ G+ P  F+  K     VK  +   +  + +     K S   D 
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP--FRKRK---ERVKREEVDRRVKEDQEEYSEKFSE--DA 232

Query: 401 AQMQRMLLAAN 411
             + RMLL  N
Sbjct: 233 KSICRMLLTKN 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 15/163 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL    L++ +  +    + P  ++    
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK-SYL 105

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THMIRE 320
             + + + Y HS     V+HRD+K  N+L+  +   +L+DFGLA  +G P  + TH    
Sbjct: 106 YQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---- 158

Query: 321 DVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
           +VV T  Y APE L+  +  S  +D++S G +  E+++ RRP+
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 16/187 (8%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED---NYLILVSDFL 236
           +Q  ++   Q TS+     N    E+ +  +L    I    G C+ D     L +  +++
Sbjct: 33  KQVPFDPDSQETSK---EVNALECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYM 88

Query: 237 PKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD 296
           P GS+++ L   G    L   V       I + ++YLHS     ++HRD+K +NIL  S 
Sbjct: 89  PGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSA 142

Query: 297 FQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
              +L DFG +  I     S   I+  V GT  +++PE +       K DV+S    ++E
Sbjct: 143 GNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201

Query: 355 LLSGRRP 361
           +L+ + P
Sbjct: 202 MLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-----H---GAGE- 250
           +F  E  + S L+  +I  L GV  ++  L ++  +     L E L     H   G+ + 
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 251 ----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               +S L       +   IA  + +L S     V+H+D+ + N+L+      ++SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP-IGF 364
                    + +  + +    +++PE +M+GK S   D++S+GVVL E+ S G +P  G+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230

Query: 365 KN 366
            N
Sbjct: 231 SN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 183

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++ G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 5/96 (5%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L +LH    R +I+RD+K  N+LL +D   ++SD GLA+      +    +   GT
Sbjct: 106 IISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAGT 160

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            G++APE L   +    +D ++ GV L E+++ R P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 11/112 (9%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T+ +    V T  Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYY 188

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            APE ++     + +D++S G ++ EL+ G         +G + + +W K I
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVI-----FQGTDHIDQWNKVI 235

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 17/161 (10%)

Query: 213 QKSITTLNGVCIE------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAI 266
            ++I T  G  I+      D+ L LV +F   GS+ + +      ++    + + +   I
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREI 120

Query: 267 AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF 326
              L++LH      VIHRD+K  N+LL+ + + +L DFG++     D T   R   +GT 
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTP 175

Query: 327 GYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPI 362
            ++APE +   +  D     K D++S G+  +E+  G  P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 14/163 (8%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L+  +I  L  V ++++ L L+ +FL    L++ L    +   +   +     
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL 107

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL--AIWGPTDS-THMIRE 320
             I + + + HS   R V+HRD+K  N+L+ +    +L+DFGL  A   P    TH    
Sbjct: 108 YQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH---- 160

Query: 321 DVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPI 362
           +VV T  Y APE L+   + S  +D++S G +  E+ + ++P+
Sbjct: 161 EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 9/157 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV +   L+  +I TL+ +   D  L LV ++L K  L++ +   G  +++         
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFL 110

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             I   L Y H    R V+HRD+K  N+L++   + +L+DFGLA    +  T     +VV
Sbjct: 111 YQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV 166

Query: 324 GTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGR 359
            T  Y  P+ L+   + S +ID++  G +  E+ SGR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 42/173 (24%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
           ++NYL L+ ++LP G +   L    + +      RF     IAE +  + S      IHR
Sbjct: 72  DENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRF----YIAETILAIDSIHKLGYIHR 125

Query: 285 DVKSSNILLSSDFQPQLSDFGL---------------------AIWGPTDSTHMIRED-- 321
           D+K  N+LL +    +LSDFGL                     + +    S  M  +   
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185

Query: 322 -------------VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                         VGT  YIAPE  +    + + D +S GV++ E+L G  P
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 37/252 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 55  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWG 310
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+   I+ 
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 170

Query: 311 PTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKN 366
               T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N
Sbjct: 171 ---ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
               E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +
Sbjct: 228 ----EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLE 270

Query: 427 VLKLLRGATHAT 438
           ++ LL+   H +
Sbjct: 271 IVNLLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L  +          
Sbjct: 53  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 112

Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHRD+ + NIL+  ++  +++DFG
Sbjct: 113 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 169

Query: 306 LAIWGPTDSTHMIREDVVGTFG--YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   +   DV+S+GV+L E++S
Sbjct: 170 L-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 17/163 (10%)

Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E  I   L    I  +     ++N +  + +F+  G L   L  AG     P  V   
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKF 122

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
               +  A  YLHS   + +I+RD+K  N+LL +    +++DFG A     D T  +   
Sbjct: 123 YHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTL--- 175

Query: 322 VVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP 361
             GT  Y+APE +    HGK    +D ++ GV+L E ++G  P
Sbjct: 176 -CGTPEYLAPEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 21/120 (17%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW---------------- 309
           I   + Y+HS   + V+HRD+K  NILL    +  + D+G AI+                
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
               S+  I   +VGT  Y+APE L+    S+  D+Y+ GV+L ++L+   P  ++  KG
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236

Length = 932

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 27/178 (15%)

Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE------- 250
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L            
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 251 ------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
                 +  L +      A  +A  + YL    S+  IHRD+ + N+L++ D   +++DF
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 305 GLAIWGPTDSTHMIREDVVGTFG-----YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           GLA        H I      T G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 179 GLA-----RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 17/175 (9%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES 244
           EE+K+ T +          E+ +  +L+Q++I  L         L LV +++ K  LE  
Sbjct: 41  EEVKETTLR----------ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-- 88

Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L       V P  VR  +   I +A+++ H      ++HRD+K  N+L+S +   +L DF
Sbjct: 89  LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF 144

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           G A    ++ ++    + V T  Y +PE L+       +D++S G +L EL  G+
Sbjct: 145 GFA-RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L  +          
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100

Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHRD+ + NIL+  ++  +++DFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157

Query: 306 LAIWGPTDSTHMIREDVVGTFG--YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   +   DV+S+GV+L E++S
Sbjct: 158 L-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 10/99 (10%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L +LH+     +IHRDVK +NILL+++   +L DFG++      ST + R   VGT  +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFW 194

Query: 329 IAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPI 362
           +APE +   +  D     + DV+S G+  +EL  G  P+
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 47/193 (24%), Positives = 86/193 (44%), Gaps = 28/193 (14%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----- 241
           LK+  S   S   D  SE ++   +    +  L G C +D  L+L+ ++   GSL     
Sbjct: 38  LKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR 95

Query: 242 -----------------EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
                               L    E++ L  G     A  I+  + YL +E    ++HR
Sbjct: 96  ESRKVGPSYLGSDGNRNSSYLDNPDERA-LTMGDLISFAWQISRGMQYL-AEMK--LVHR 151

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
           D+ + N+L++   + ++SDFGL+     + +++ R        ++A E L     + + D
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211

Query: 345 VYSFGVVLLELLS 357
           V+SFGV+L E+++
Sbjct: 212 VWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 20/173 (11%)

Query: 199 NDFS---SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           +DFS    E+ +    +  +I    G  +    L +  ++   GSL++  H  G  S L 
Sbjct: 48  DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL- 106

Query: 256 WGVRFEVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                ++A    E L    YLHS   +  +HRD+K +NILL+ +   +L+DFG+A     
Sbjct: 107 -----QIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVA--AKI 156

Query: 313 DSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPI 362
            +T   R+  +GT  ++APE      +G  +   D+++ G+  +EL   + P+
Sbjct: 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 31/179 (17%)

Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G+
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPGM 120

Query: 259 RFEVAVA------------------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
            +   +A                  +A  + YL    S+  IHRD+ + N+L++ +   +
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 177

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           ++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 178 IADFGLA--RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 24/173 (13%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG---SLEESLHGAGEQSVLPWG 257
           F  E DI S      I  L     + + L LV ++ P G   SL        ++ +    
Sbjct: 48  FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---- 103

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
            +F +A  +  A++ +H       +HRD+K  N+L+      +L+DFG A     +   +
Sbjct: 104 AQFYLA-ELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MV 158

Query: 318 IREDVVGTFGYIAPEYL---------MHGKVSDKIDVYSFGVVLLELLSGRRP 361
             +  VGT  YIAPE L          +G    + D +S GV+  E++ GR P
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 25/164 (15%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK---GSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L  +++  L  V      L LV +F+       LE+  +G  E  V       
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR------ 103

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMI 318
           +    I   + + HS     +IHRD+K  NIL+S     +L DFG A  +  P +    +
Sbjct: 104 KYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----V 156

Query: 319 REDVVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSG 358
             D V T  Y APE L+    +G+    +D+++ G ++ E+L+G
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L Y+HS     V+HRD+K SNIL++ +   ++ DFGLA     D   M     V T
Sbjct: 117 ILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA--RIQDP-QMT--GYVST 168

Query: 326 FGYIAPE-YLMHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE  L   K   ++D++S G +  E+L G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 13/97 (13%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IW-GPTDSTHMIREDVVG 324
            L YLH      +++RD+K  N+LL ++   +++DFGL    +  G   ST        G
Sbjct: 113 GLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST------FCG 163

Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           T  ++APE L     +  +D +  GV++ E+L G  P
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQ--SVLPWGVRFEVAVAIAEALNYLHSECSRPVI 282
           ED  L +V  F   G L    H   EQ   +LP     E  V IA AL YLH +    ++
Sbjct: 71  EDGLLYIVMGFCEGGDL---YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HIL 124

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           HRD+K+ N+ L+     ++ D G+A     ++   +   ++GT  Y++PE   +   + K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIA--RVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 343 IDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ 402
            DV++ G  + E+ + +      N K   SLV            E  L P +  +Y    
Sbjct: 183 SDVWALGCCVYEMATLKHAF---NAKDMNSLVYRI--------IEGKL-PPMPKDYSPEL 230

Query: 403 MQRMLLAANLCINQSPQLRPNMGQVLK 429
            +  L+A  L   + P+ RP++  +L+
Sbjct: 231 GE--LIATMLS--KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 19/167 (11%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A  + +L    SR  IHRD+ + NILLS +   ++ DFGLA     D  ++ +      
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG 384
             ++APE +     + + DV+SFGV+L E+ S G  P  +  ++  E   +  K      
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--YPGVQINEEFCQRLK------ 291

Query: 385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
           D   +  P    E    ++ R++LA   C    P+ RP    ++++L
Sbjct: 292 DGTRMRAP----ENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 9/157 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV +   L+  +I TL+ +   +  L LV ++L K  L++ L   G  S+    V+    
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKL-FL 110

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             +   LNY H    R V+HRD+K  N+L++   + +L+DFGLA    +  T     +VV
Sbjct: 111 FQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV 166

Query: 324 GTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
            T  Y  P+ L+     S +ID++  G +  E+ +GR
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 13/97 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T
Sbjct: 129 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVAT 180

Query: 326 FGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +   MH   +  +D++S G ++ ELL+GR
Sbjct: 181 RWYRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 4/95 (4%)

Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
           ++  A+ YLH      +IHRD+K+ NI ++      L DFG A + P D          G
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAG 245

Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           T    APE L        +D++S G+VL E+ +  
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 14/165 (8%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG-------SLEESLHGAGEQS 252
           +F +E  +        +  L GV  +    +++ + + +G       SL   +     Q+
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 253 VLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 169

Query: 313 DSTHMIREDVVGTFG--YIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 13/171 (7%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E ++   L+   I  + G+C E    +LV +    G L + L     + V    +  E+ 
Sbjct: 46  EANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNIT-ELV 101

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  +  +    
Sbjct: 102 HQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-KAKTH 157

Query: 324 GTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           G +   + APE + + K S K DV+SFGV++ E  S G++P  +K +KG E
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 37/107 (34%), Positives = 48/107 (44%), Gaps = 7/107 (6%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV--VGT 325
           EAL YLH    R +IHRDVK+ NI L       L DFG A     D+     +     GT
Sbjct: 196 EALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC--KLDAHPDTPQCYGWSGT 250

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
               +PE L       K D++S G+VL E+      +  K +K   S
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297

Length = 392

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 11/162 (6%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +    +  +I    G  +  + L +  +F   GSL++  H  G  S        ++A
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES------QIA 109

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
               E L  L+   S+  +HRD+K +NILL+ +   +L+DFG++      +T   R+  +
Sbjct: 110 YVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFI 167

Query: 324 GTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           GT  ++APE       G  +   D+++ G+  +EL   + P+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ +++L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G++L E+ S    +G     G     K+ K I K G 
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSSPYPGMPVDSKFYKMI-KEGY 334

Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E   ++M  ++ +   C +  P  RP   Q+++L+
Sbjct: 335 R------MLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 17/173 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE----ESLHGAGEQSVLP 255
           DF  E  I S    ++I  L GV  E     ++ + +  G L+    E+       S L 
Sbjct: 55  DFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLA--IW 309
                  A  +A+   YL        IHRD+ + N LL+    P     ++DFG+A  I+
Sbjct: 115 MKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIY 170

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               S +      +    ++ PE  + G  + K DV+SFGV+L E+ S G  P
Sbjct: 171 RA--SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 42/202 (20%)

Query: 215 SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH 274
           S+TTL G        +L+ D++  G L + L   G+ S     V+  +   + EALN LH
Sbjct: 77  SVTTLKGH-------VLIMDYIKDGDLFDLLKKEGKLSEAE--VKK-IIRQLVEALNDLH 126

Query: 275 SECSRPVIHRDVKSSNILLS-SDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPE 332
                 +IH D+K  N+L   +  +  L D+GL  I G T S +    D  GT  Y +PE
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-TPSCY----D--GTLDYFSPE 176

Query: 333 YLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG----PESLVK-WAKPILKNGDTE 387
            +         D ++ GV+  ELL+G+ P  FK  +      ESL+K   K +       
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHP--FKEDEDEELDLESLLKRQQKKL------- 227

Query: 388 TLLDPKLSNEYDNAQM--QRML 407
               P + N   NA    Q ML
Sbjct: 228 ----PFIKNVSKNANDFVQSML 245

Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 14/160 (8%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +  L++ +  +   S +P  +     
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS-PLSGIPLPLIKSYL 106

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THMIRE 320
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G P  + TH    
Sbjct: 107 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 159

Query: 321 DVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
           +VV T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 160 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 19/167 (11%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS +   ++ DFGLA     D  ++ + D    
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG 384
             ++APE +     + + DV+SFGV+L E+ S G  P  +  +K  E   +     LK G
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRR----LKEG 298

Query: 385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                     + +Y   +M + +L    C +  P  RP   ++++ L
Sbjct: 299 TRMR------APDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 17/162 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           SE  I + +       L G   +++YL LV +F+  G     L         P  V    
Sbjct: 80  SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFY 136

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I     YL S     +++RD+K  N+LL  D   +++DFG A    T +  +     
Sbjct: 137 AAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL----- 188

Query: 323 VGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP 361
            GT  YIAPE L+   HGK +   D ++ G+ + E+L G  P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
            D+ L LV +F   GS+ + +      ++    + + +   I   L +LH+     VIHR
Sbjct: 90  HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAH---KVIHR 145

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD--- 341
           D+K  N+LL+ + + +L DFG++     D T   R   +GT  ++APE +   +  D   
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 203

Query: 342 --KIDVYSFGVVLLELLSGRRPI 362
             + D++S G+  +E+  G  P+
Sbjct: 204 DYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV +  +L+  +I TL+ +   +  L LV ++L    L++ L   G    +   V+    
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH-NVKI-FM 109

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             +   L+Y H    R ++HRD+K  N+L++   + +L+DFGLA    +  T     +VV
Sbjct: 110 FQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV 165

Query: 324 GTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
            T  Y  P+ L+   + S  ID++  G +L E+ +GR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 4/97 (4%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ +++L    S+  IHRDV + N+LL+     ++ DFGLA     DS ++++ +    
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             ++APE +     + + DV+S+G++L E+ S G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDF----LPKGSLEESLHGAGEQSVLPWGVR 259
           E+ +   L+ K+I  L  V   D  L LV ++    L K    +S +G  +  ++     
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKK--YFDSCNGDIDPEIVK---- 102

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDSTHM 317
                 + + L + HS     V+HRD+K  N+L++ + + +L+DFGLA  +G P      
Sbjct: 103 -SFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--- 155

Query: 318 IREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              +VV T  Y  P+ L   K+    ID++S G +  EL +  RP+
Sbjct: 156 YSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 30/80 (37%), Positives = 46/80 (57%)

Query: 278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG 337
           SR  IHRD+ + NILLS +   ++ DFGLA     D  ++ + D      ++APE +   
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 338 KVSDKIDVYSFGVVLLELLS 357
             + + DV+SFGV+L E+ S
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 32/175 (18%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ I + ++ ++I  L  V +E +++ LV D +    L++         V+   +R   +
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK---------VVDRKIRLTES 119

Query: 264 ------VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-------IWG 310
                 + I   LN LH       +HRD+  +NI ++S    +++DFGLA          
Sbjct: 120 QVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 311 PT--DSTHMIREDV---VGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
               D T   RE++   V T  Y APE LM   K    +D++S G +  ELL+G+
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 13/97 (13%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF-- 326
           AL  LH      VI+RD+K  NILL       L DFGL         +M  +D   TF  
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLC------KLNMKDDDKTNTFCG 155

Query: 327 --GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              Y+APE L+    +  +D ++ GV+L E+L+G  P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 184

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 239

Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 240 EFMKKLQPTVRNYVEN 255

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 27/242 (11%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL---HGAGEQSVLPWG 257
           F  EV     L   ++    G CIE    +LV +F P G L+  L    G   Q      
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-D 100

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
           V   +A  +A  L +LH       IH D+   N  L++D   ++ D+GLA+    +  ++
Sbjct: 101 VLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157

Query: 318 IREDVVGTFGYIAPEY-------LMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
            ++       ++APE        L+    + K +++S GV + EL +   +P  + +L  
Sbjct: 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSD 215

Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            + L    K +++  D + L  P+L  +Y +   + M           P+ RP   +V +
Sbjct: 216 EQVL----KQVVREQDIK-LPKPQLDLKYSDRWYEVMQFCW-----LDPETRPTAEEVHE 265

Query: 430 LL 431
           LL
Sbjct: 266 LL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 13/101 (12%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGT 325
             L Y+H      ++HRD+K++NIL++ D   +L+DFGLA       +S      + V T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 326 FGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y  PE L+    +G     ID++  G ++ E+ + R PI
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 49/183 (26%), Positives = 73/183 (39%), Gaps = 57/183 (31%)

Query: 225 EDNYLILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVI 282
           + + L  V D++P G +   L   G  E+ +     RF +A  +  A+  +H       I
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIA-ELTCAIESVHK---MGFI 123

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAI----------WGPTDSTHMIRED----------- 321
           HRD+K  NIL+  D   +L+DFGL            +   D  H  R+D           
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD--HH-RQDSMEPSEEWSEI 180

Query: 322 -----------------------VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
                                  +VGT  YIAPE L+    +   D +S GV+L E+L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 359 RRP 361
           + P
Sbjct: 241 QPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 13/93 (13%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y 
Sbjct: 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRWYR 182

Query: 330 APEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
           APE +   MH   +  +D++S G ++ ELL G+
Sbjct: 183 APEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 21/176 (11%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYL------ILVSDFLPKGSLEESLHGA--GEQ 251
           +F SE       +  ++  L GVC E + L      +++  F+  G L   L  +  G  
Sbjct: 47  EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106

Query: 252 SV-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--I 308
              LP     +  V IA  + YL    +R  IHRD+ + N +L  D    ++DFGL+  I
Sbjct: 107 PEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163

Query: 309 WGPT--DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +         + +  V     +IA E L     + K DV++FGV + E+ + G+ P
Sbjct: 164 YSGDYYRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE-DVVGTFG 327
           A+ Y+H    + +IHRD+K  NI L+ D +  L DFG A+  P +      +   VGT  
Sbjct: 279 AVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKEREAFDYGWVGTVA 333

Query: 328 YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             +PE L      +  D++S G++LL++LS
Sbjct: 334 TNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 22/163 (13%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
             S  D+T  +   S+T LN V I   Y+            E  L    EQ  L      
Sbjct: 72  GPSGSDLTEDV--GSLTELNSVYIVQEYM------------ETDLANVLEQGPLSEEHAR 117

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPTDSTH--M 317
                +   L Y+HS     V+HRD+K +N+ +++ D   ++ DFGLA       +H   
Sbjct: 118 LFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
           + E +V  + Y +P  L+      K ID+++ G +  E+L+G+
Sbjct: 175 LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 50/204 (24%), Positives = 76/204 (37%), Gaps = 51/204 (25%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E DI +  + + +  L     + + L  V D++P G +   L   G   + P  +    
Sbjct: 50  AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDL---A 103

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI-------------- 308
              IAE    + S      IHRD+K  NIL+  D   +L+DFGL                
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163

Query: 309 -------------WGPTDS------------------THMIREDVVGTFGYIAPEYLMHG 337
                        WG   +                     +   +VGT  YIAPE L+  
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223

Query: 338 KVSDKIDVYSFGVVLLELLSGRRP 361
             +   D +S GV+L E+L G+ P
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 67/280 (23%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
               +EV ++      +I T   V    ++L ++S F+  GS    L     ++  P G+
Sbjct: 44  KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL-----KTYFPEGM 98

Query: 259 RFEVAVAI----AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD----FGLAIWG 310
              +   I       LNYLH       IHR++K+S+IL+S D    LS     + L   G
Sbjct: 99  SEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155

Query: 311 ---------PTDSTHMIREDVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSG 358
                    P  ST ++         +++PE L   ++G  + K D+YS G+   EL +G
Sbjct: 156 QKAKVVYDFPQFSTSVLP--------WLSPELLRQDLYG-YNVKSDIYSVGITACELATG 206

Query: 359 RRPIG--------FKNLKGP-------------ESLVKWAK---------PILKNGDTET 388
           R P           + LKGP             ES +K ++          ++  G T+T
Sbjct: 207 RVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQT 266

Query: 389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           +   +L                 LC+ Q P+ RP+   +L
Sbjct: 267 MTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L Y H    R V+HRD+K  N+L+S   + +L+DFGLA    +  +     +VV T  Y 
Sbjct: 116 LAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYSNEVV-TLWYR 170

Query: 330 APEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
            P+ L+   + S  +D++  G +  E+ +GR
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 53/205 (25%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV-RFE 261
           +E DI +  + + +  L     + + L  V D++P G +   L       V P  + RF 
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFY 106

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI---WGPTDSTHM- 317
           +A  +  A+  +H       IHRD+K  NIL+  D   +L+DFGL     W      +  
Sbjct: 107 IA-ELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162

Query: 318 ---IRED--------------------------------------VVGTFGYIAPEYLMH 336
              IR+D                                      +VGT  YIAPE L+ 
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP 361
              +   D +S GV+L E+L G+ P
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 3/93 (3%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           VA  +  A++Y+H E    +IHRD+K+ N+L++      L DFG A +     +      
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
           + GT    APE L     +  +D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 23/200 (11%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG--AGEQSVLPWGV 258
           F  E     SL+  ++    G C E    +LV +F P G L+  L      E        
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +A  IA  L +LH       IH D+   N LL++D   ++ D+GL+     +  ++ 
Sbjct: 102 LQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158

Query: 319 REDVVGTFGYIAPEYL--MHGKV-----SDKIDVYSFGVVLLELLS-GRRPIGFKNLKGP 370
            + +     +IAPE +  +HG +     + + +V+S GV + EL   G +P  +++L   
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP--YRHLSDE 216

Query: 371 ESL--------VKWAKPILK 382
           + L        +K  KP LK
Sbjct: 217 QVLTYTVREQQLKLPKPRLK 236

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 39/166 (23%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L L+ +FLP G +   L    + ++     +F +A  +  A++ +H       IHRD+K 
Sbjct: 76  LYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVL-AIDSIHQ---LGFIHRDIKP 129

Query: 289 SNILLSSDFQPQLSDFGLAIW----------------GPTDST----------------- 315
            N+LL S    +LSDFGL                    P+D T                 
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             +    VGT  YIAPE  M    +   D +S GV++ E+L G  P
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 31/98 (31%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI-WGPTDSTHMIR 319
            +A+ IA  ++YLH    R VIH+D+ + N ++  + Q +++D  L+    P D  H + 
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD-YHCLG 176

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           ++      ++A E L++ + S   DV+SFGV+L EL++
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 13/93 (13%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L Y+HS     +IHRD+K  N+ ++ D + ++ DFGLA     + T       V T  Y 
Sbjct: 130 LKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYR 181

Query: 330 APEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
           APE +   MH   +  +D++S G ++ E+L+G+
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 13/97 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + L Y+H+     +IHRD+K  N+ ++ D + ++ DFGLA    TDS        V T
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA--RQTDSE---MTGYVVT 178

Query: 326 FGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +   MH   +  +D++S G ++ E+L+G+
Sbjct: 179 RWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 29/91 (31%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L+Y+H    R ++HRD+K  N+L+S   + +L+DFGLA    +  +H    +VV T  Y
Sbjct: 115 GLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLWY 169

Query: 329 IAPEYLMHG-KVSDKIDVYSFGVVLLELLSG 358
             P+ L+   + S  +D++  G + +E++ G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 15/99 (15%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-------IWGPTDSTHMI 318
           +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA        +   + T   
Sbjct: 107 VAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG-A 162

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +  V     ++A E L   K + K DV+SFGV+L EL++
Sbjct: 163 KLPV----KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L Y+H    + ++HRD+K  N+L+S   + +L+DFGLA      S     E  V T  Y 
Sbjct: 116 LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--VVTLWYR 170

Query: 330 APEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
            P+ L+     S  +D++  G + +E+L G+
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 36/204 (17%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFE 261
           E+ ++      +I       I DN L +V+ F+  GS ++ +  H     S L       
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY--- 105

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI--- 318
           +   + +AL+Y+H       +HR VK+S+IL+S D +  LS       G   +  MI   
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS-------GLRSNLSMINHG 155

Query: 319 -REDVVGTF--------GYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
            R  VV  F         +++PE L         K D+YS G+   EL +G  P  FK++
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP--FKDM 213

Query: 368 KGPESLVKWAKPILKNGDTETLLD 391
              + L++       NG    LLD
Sbjct: 214 PATQMLLEKL-----NGTVPCLLD 232

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 46.3 bits (109), Expect = 4e-05
 Identities = 41/139 (29%), Positives = 61/139 (43%), Gaps = 35/139 (25%)

Query: 269 ALNYLHSECSRP----VIHRDVKSSNILLSSDFQ-----------------PQLSDFGLA 307
           AL Y H+    P    V+HRD+K  NI LS+  +                  ++ DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS--DKIDVYSFGVVLLELLSGRRPI--- 362
                     +    VGT  Y +PE L+H   S  DK D+++ G ++ EL SG+ P    
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246

Query: 363 -GFKNL-----KGPESLVK 375
             F  L     +GP+  +K
Sbjct: 247 NNFSQLISELKRGPDLPIK 265

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 44/166 (26%), Positives = 62/166 (37%), Gaps = 39/166 (23%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L L+ +FLP G +   L      S             IAE +  + +      IHRD+K 
Sbjct: 76  LYLIMEFLPGGDMMTLLMKKDTLS------EEATQFYIAETVLAIDAIHQLGFIHRDIKP 129

Query: 289 SNILLSSDFQPQLSDFGLAIW----------------GPTD-----------------ST 315
            N+LL +    +LSDFGL                    P+D                 + 
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             +    VGT  YIAPE  M    +   D +S GV++ E+L G  P
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 34/110 (30%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----FQPQLSDFGLAIW 309
           LP G+   +   I + ++YLH+     V+HRD+K +NIL+  +     + +++D G A  
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 310 GPTDSTHMIRED-VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLS 357
             +    +   D VV TF Y APE L+  +  +  ID+++ G +  ELL+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 17/178 (9%)

Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDN------YLILVSDFLPKGSLEESL--HG 247
           S   DF SE       +  ++  L GVC++          +++  F+  G L   L    
Sbjct: 42  SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101

Query: 248 AGEQSV-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
            G+    LP  +  +    IA  + YL    S+  IHRD+ + N +L+ +    ++DFGL
Sbjct: 102 LGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGL 158

Query: 307 AIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +      +    R+  +      +IA E L     + K DV+SFGV + E+ + G+ P
Sbjct: 159 S--KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 47/182 (25%), Positives = 64/182 (35%), Gaps = 55/182 (30%)

Query: 227 NYLILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
            YL L+ +FLP G L   L  +    + V     RF +A  +  A+  +H       IHR
Sbjct: 74  QYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVL-AIEAVHK---LGFIHR 125

Query: 285 DVKSSNILLSSDFQPQLSDFGL-----------------------------------AIW 309
           D+K  NIL+      +LSDFGL                                   +I 
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185

Query: 310 GPTDSTHMIRE----------DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
               S   I              VGT  YIAPE  +      + D +S G ++ E L G 
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245

Query: 360 RP 361
            P
Sbjct: 246 PP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 13/99 (13%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLS-SDFQPQLSDFGLA-IWG-PTDS-THMIRED 321
           I   + Y HS     V+HRD+K  N+L+       +L+DFGLA  +G P  + TH    +
Sbjct: 111 ILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH----E 163

Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           VV T  Y APE L+  +  S  +D++S G +  E+++ +
Sbjct: 164 VV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A  + +L    S+  +HRD+ + N+L+      ++ DFGLA     DS ++ +      
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE + +   +   DV+SFG++L E+ +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A  + +L    S+  +HRD+ + N+LL+     ++ DFGLA     DS ++ +      
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     +   DV+S+G++L E+ S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 30/84 (35%), Positives = 48/84 (57%), Gaps = 12/84 (14%)

Query: 227 NYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIH 283
           N + LV ++L  G ++  LH  G   E       V++   VA+A  L+YLH      +IH
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYISEVALA--LDYLHRH---GIIH 127

Query: 284 RDVKSSNILLSSDFQPQLSDFGLA 307
           RD+K  N+L+S++   +L+DFGL+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 36/261 (13%)

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL--- 241
           +ELK   S  S   N+F  + D    L+  +I    G C+E    +LV ++   G L   
Sbjct: 28  KELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSY 85

Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
              E+      +  +L       +A  IA  + ++H       +H D+   N  L+SD  
Sbjct: 86  LSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLT 137

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL--MHGKV-----SDKIDVYSFGVV 351
            ++ D+G+      +      +D      ++APE +   HG +     +   +V++ GV 
Sbjct: 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT 197

Query: 352 LLELL-SGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA 410
           L EL  +  +P  + +L   E L      ++K+   + L  P+L   Y     +R     
Sbjct: 198 LWELFENAAQP--YSHLSDREVLNH----VIKDQQVK-LFKPQLELPYS----ERWYEVL 246

Query: 411 NLCINQSPQLRPNMGQVLKLL 431
             C   SP+ R    +V +LL
Sbjct: 247 QFCW-LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
           +L+++H      + HRD+K  NIL+  D   +L+DFG        S     E  + T  Y
Sbjct: 112 SLDHMHR---NGIFHRDIKPENILIKDDIL-KLADFGSC--RGIYSKPPYTE-YISTRWY 164

Query: 329 IAPEYLM-HGKVSDKIDVYSFGVVLLELLS 357
            APE L+  G    K+D+++ G V  E+LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 33/110 (30%), Positives = 58/110 (52%), Gaps = 9/110 (8%)

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----FQPQLSDFGLAIW 309
           LP  +   +   I + ++YLH+     V+HRD+K +NIL+  +     + +++D G A  
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 310 GPTDSTHMIRED-VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLS 357
             +    +   D VV TF Y APE L+  +  +  ID+++ G +  ELL+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.9 bits (96), Expect = 9e-04
 Identities = 37/173 (21%), Positives = 83/173 (47%), Gaps = 18/173 (10%)

Query: 201 FSSEVDITSSLEQKSITTLNG----VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
             +E+     ++  +I  + G    +  +   L L+ ++  +G L E L    E+  L +
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKD-LSF 121

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             + ++A+   + L  L+   ++P  ++++ S + L++ +++ ++   GL       S+ 
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLE---KILSSP 176

Query: 317 MIREDVVGTFGYIAPEYL--MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
             +   V    Y + + L  +  + + K D+YS GVVL E+ +G+ P  F+NL
Sbjct: 177 PFKN--VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP--FENL 225

Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 12/113 (10%)

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGP 311
           LP        + IA  + YL S   +  IHRD+ + N +L+ +    ++DFGL+  I+  
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIY-- 164

Query: 312 TDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             S    R+         ++A E L     +   DV++FGV + E+++ G+ P
Sbjct: 165 --SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 10/86 (11%)

Query: 278 SRPVIHRDVKSSNILLSSDFQP-QLSDFGL--AIWGPTDS-THMIREDVVGTFGYIAPEY 333
              V+HRD+K  N+L+       +++D GL  A   P  S TH I      T  Y APE 
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TLWYRAPEV 182

Query: 334 LMHGK-VSDKIDVYSFGVVLLELLSG 358
           L+     S  +D++S G +  E+   
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	522
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.73
PRK10345	210	hypothetical protein; Provisional	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
smart00090	237	RIO RIO-like kinase.	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.48
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.09
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.92
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.9
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.87
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.77
KOG3087	229	consensus Serine/threonine protein kinase [General	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.71
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.69
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.66
COG4248	637	Uncharacterized protein with protein kinase and he	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.57
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.52
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.23
PRK09902	216	hypothetical protein; Provisional	98.13
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.12
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.8
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.61
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.46
PF01636	239	APH: Phosphotransferase enzyme family This family	97.42
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.26
PRK10593	297	hypothetical protein; Provisional	97.12
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.09
PLN02876	822	acyl-CoA dehydrogenase	97.05
KOG1235	538	consensus Predicted unusual protein kinase [Genera	96.87
PF01657	106	Stress-antifung: Salt stress response/antifungal;	96.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.78
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.61
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.59
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.56
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.36
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.27
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.18
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.12
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.7
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.55
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.71
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.47
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.3
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.08
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.73
PLN02236	344	choline kinase	93.43
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	93.34
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	92.0
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	91.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.16
PRK05231	319	homoserine kinase; Provisional	90.68
PLN02756	418	S-methyl-5-thioribose kinase	89.66
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	89.63
PTZ00384	383	choline kinase; Provisional	88.45
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	88.24
PRK10271	188	thiK thiamine kinase; Provisional	87.93
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	87.24
COG2334	331	Putative homoserine kinase type II (protein kinase	85.86
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	85.79
KOG2270	520	consensus Serine/threonine protein kinase involved	85.47

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-50  Score=413.47  Aligned_cols=276  Identities=41%  Similarity=0.735  Sum_probs=238.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|.-...||+|+||.||++.-..         ...+|+|.+......  . ..+|.+|+.+|.+++|||+|+|+|||.
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~---------~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSD---------GTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECC---------CCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            4677778899999999999887432         256666644332211  0 456999999999999999999999999


Q ss_pred             eCC-EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +.+ ..+|||||+++|+|.++|+..... .++|..+++|+.++|+||+|||..+...||||||||+|||||.++++||+|
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            998 599999999999999999976433 799999999999999999999998877899999999999999999999999


Q ss_pred             cCccccCCC-CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPT-DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~-~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+|+..+. .......  ..||.+|+|||++..+.++.|+|||||||+++||+||+.|.+.........++.|+++.+.
T Consensus       221 FGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            999977665 2222111  1799999999999999999999999999999999999999887766667779999999999


Q ss_pred             CCCcccccCCccc-ccccH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLS-NEYDN-AQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+.+..++||.+. ..+.. ....++..++.+|++.+|..||+|.+|+++|+.+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9999999999987 66664 68888999999999999999999999999996654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=373.96  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=217.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+..+....||+|..|+||++.++.        +.+.||+|.+....  .....+++.+|++++++.+|||||.+||.|.
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~--------t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKP--------TGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcC--------CCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            3467888999999999999998754        78899999883322  2335678999999999999999999999999


Q ss_pred             eCC-EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .++ .+.|+||||++|||++++...   +.+++...-+|+.+|++||.|||+.  ++||||||||+|||++..|.+||||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence            998 499999999999999999854   3499999999999999999999964  8999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL--KGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~  381 (522)
                      ||.+......    ....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||.....  .....+..++   .
T Consensus       223 FGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v  295 (364)
T KOG0581|consen  223 FGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---V  295 (364)
T ss_pred             ccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---h
Confidence            9999765544    34567899999999999999999999999999999999999999976421  1222222211   1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHAD  446 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~  446 (522)
                      .+ ..     |.+...   ..+.++..++..||++||.+||++.|+++        |+|+++...
T Consensus       296 ~~-pp-----P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--------Hpfi~~~~~  343 (364)
T KOG0581|consen  296 DE-PP-----PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ--------HPFIKKFED  343 (364)
T ss_pred             cC-CC-----CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc--------CHHHhhccc
Confidence            11 11     222221   35678999999999999999999999997        999887543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-47  Score=379.36  Aligned_cols=264  Identities=24%  Similarity=0.339  Sum_probs=215.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch----HHHHHHHHHHHHhhCCCCCccee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS----AWNDFSSEVDITSSLEQKSITTL  219 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~----~~~~f~~Ev~iL~~L~HpnIv~l  219 (522)
                      ....|.+.+.||.|+||.|.++..        ..+++.||+|.+.+.......    ......+|++||++|+|||||++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e--------~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYE--------KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEE--------cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            346789999999999999888765        458999999998775544322    22345799999999999999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---  296 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---  296 (522)
                      ++++......|+||||++||+|.+.+-.+   +.+.+..-..++.|++.||.|||+   +||+||||||+|||+..+   
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcc
Confidence            99999999999999999999999999854   358888889999999999999999   999999999999999766   


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV---SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      ..+||+|||+|+......   ..+..+||+.|.|||++.++.+   ..|.|+||+|||||-+++|.+||.......  ++
T Consensus       316 ~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl  390 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL  390 (475)
T ss_pred             eEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH
Confidence            789999999998876433   2346799999999999976653   458899999999999999999997554332  11


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+    .+..|.+..      .+.......++..++|.+||..||++|||+.|+|+        |+|++..
T Consensus       391 ~e----QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--------hpW~~~~  443 (475)
T KOG0615|consen  391 KE----QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN--------HPWFKDA  443 (475)
T ss_pred             HH----HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--------Chhhhcc
Confidence            11    112222211      12334567788999999999999999999999998        9998854

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-46  Score=389.23  Aligned_cols=257  Identities=23%  Similarity=0.329  Sum_probs=218.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|+..+.||+|||+.+|.+.+.+        ++..||.|.+.+..-.-....+.+.+||+|.++|+|||||+++++|++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~--------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED   89 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD--------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED   89 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC--------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence            789999999999999999988754        567788887777655555678899999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+++|||.|+|+.++|..++++   ++.+++.+++.+++||+.||.|||+   .+|||||||..|+||+++.++||+|||
T Consensus        90 s~nVYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   90 SNNVYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             CCceEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999983   4469999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +|.........  ....+|||.|+|||++.....+..+||||+|||+|-|+.|++||+....++.-.-+....       
T Consensus       164 LAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------  234 (592)
T KOG0575|consen  164 LATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------  234 (592)
T ss_pred             eeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------
Confidence            99776644222  335799999999999999899999999999999999999999998665433322222111       


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                                -..+...+....+||.++|+.||.+|||+++|+.        |+|+..
T Consensus       235 ----------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--------h~Ff~~  274 (592)
T KOG0575|consen  235 ----------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD--------HPFFKS  274 (592)
T ss_pred             ----------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--------CHhhhC
Confidence                      1122245567788999999999999999999997        777733

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-46  Score=354.90  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=215.5

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE-
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG-  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~-  221 (522)
                      .....|++.++||.|.||+||++....        ++..+|.|.+. -..-...+.++...|+.+|++|+|||||++++ 
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~--------~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~   86 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLL--------DGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAH   86 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeecc--------Ccchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHH
Confidence            345689999999999999999988653        56677777766 33333447788999999999999999999999 


Q ss_pred             EEEeCCE-EEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCEEeccCCCCceeccCCCc
Q 036172          222 VCIEDNY-LILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECS-RPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       222 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~-~giiHrDIkp~NILl~~~~~  298 (522)
                      -+.+++. ++||||||.+|+|..+++.. ..++.+++.++|+++.|++.||..+|+... .-|+||||||.||+|+.+|.
T Consensus        87 ~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   87 SFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             hhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence            4555544 89999999999999999864 345579999999999999999999998432 24999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||+++++......  ....+|||.||+||.+...+|+.|+||||+||++|||+.-+.||...+   ..++..   
T Consensus       167 vKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~---  238 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCK---  238 (375)
T ss_pred             eeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHH---
Confidence            999999999988765433  346789999999999999999999999999999999999999997652   222222   


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                       .+..++...+        .+..++..+..+|..|+..||+.||+...++..++..
T Consensus       239 -KI~qgd~~~~--------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  239 -KIEQGDYPPL--------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             -HHHcCCCCCC--------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence             2333433222        1245778899999999999999999976666666554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=360.88  Aligned_cols=208  Identities=25%  Similarity=0.398  Sum_probs=183.3

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|.+.++||.|+||.||++.++.        ....+|+|.+.+..- .....+.+..|+.+|+.++|||||.++++
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~--------~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~   77 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKK--------SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDC   77 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEecc--------CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEE
Confidence            356789999999999999999998764        447788888776542 23356778999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC------
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD------  296 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~------  296 (522)
                      +..++.+|||||||.||+|.++++.++   .+++.++..++.||+.||++||+   ++||||||||+||||+..      
T Consensus        78 ~~~~~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   78 IEDDDFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             EecCCeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCC
Confidence            999999999999999999999999654   59999999999999999999999   999999999999999865      


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK  368 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~  368 (522)
                      -.+||+|||+|+......-   ....+|++.|||||+++.++|+.|+|+||+|+|+|++++|+.||...+..
T Consensus       152 ~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             ceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            4689999999998775432   34668999999999999999999999999999999999999999865543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=371.67  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=204.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      ...+...||.|+||+||.+......         .+++|.+......... .++|.+|+.+|++|+|||||+++|+|.+.
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~---------~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTD---------VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCce---------eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3445566999999999987644211         1344443332222222 67899999999999999999999999998


Q ss_pred             C-EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-EEeccCCCCceeccCCC-ceEEee
Q 036172          227 N-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP-VIHRDVKSSNILLSSDF-QPQLSD  303 (522)
Q Consensus       227 ~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g-iiHrDIkp~NILl~~~~-~~kL~D  303 (522)
                      . .++|||||+++|+|.++++.. .+..+++..++.++.+|++|+.|||+   .+ ||||||||+|||++.++ ++||+|
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECC
Confidence            7 799999999999999999874 34569999999999999999999999   77 99999999999999997 999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM--HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||+++......  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....      ...+....
T Consensus       188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~  259 (362)
T KOG0192|consen  188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVV  259 (362)
T ss_pred             Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH
Confidence            99997655432  1122368999999999998  56899999999999999999999999975543      11111111


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ..+.         ....+...+..+..++..||+.||..||++.+|+..|+.+..
T Consensus       260 ~~~~---------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  260 VGGL---------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             hcCC---------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            1111         122222356778889999999999999999999999998753

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=349.26  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=211.1

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      .....|++.++||.|+||.|++++..        .+.+.||+|.|+++...-....+...+|..||.+++||+||+++-.
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~--------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys   93 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKK--------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS   93 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEc--------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe
Confidence            34578999999999999999998875        3789999999999888777788899999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      |.+.+.+|||+||+.||.|..+|++.+   .+++..+.-++..|+.||.|||+   .+||||||||+|||||.+|+++|+
T Consensus        94 FQt~~kLylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   94 FQTEEKLYLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             cccCCeEEEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEe
Confidence            999999999999999999999999543   59999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++..-....  ....++||+.|||||++.+..|+..+|-||||+++|||++|.+||...+.....      ..+..
T Consensus       168 DFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~~  239 (357)
T KOG0598|consen  168 DFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKILK  239 (357)
T ss_pred             ccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHhc
Confidence            9999975433322  233579999999999999999999999999999999999999999766533222      22211


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP  422 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP  422 (522)
                      . +         ....+........+++...|+.||++|.
T Consensus       240 ~-k---------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  240 G-K---------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C-c---------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            1 1         0111222445788899999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=355.49  Aligned_cols=257  Identities=24%  Similarity=0.317  Sum_probs=216.0

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceee
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLN  220 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~  220 (522)
                      .+..++|.+++.||+|+|++|++|...+        +.+.||+|++.+....-...++-...|-++|.+| .||.|++|+
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~--------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy  140 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA--------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY  140 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC--------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE
Confidence            4567899999999999999999998764        7889999999876665555667778899999999 999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      ..|.++..+|+|+||+++|+|.++|++.+   .|++.....++.+|+.||+|||+   +|||||||||+|||||.++++|
T Consensus       141 ~TFQD~~sLYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  141 FTFQDEESLYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             EEeecccceEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEE
Confidence            99999999999999999999999999654   49999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCC-----------ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          301 LSDFGLAIWGPTDSTH-----------MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       301 L~DFGla~~~~~~~~~-----------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      |+|||.|+.+......           .....++||..|.+||++..+..+..+|||+|||+||+|+.|.+||...+.-.
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            9999999876543222           11245899999999999999999999999999999999999999997554221


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..      ..++.           +.-.++...++...+|+.+.|..||.+|+++++|-+
T Consensus       295 iF------qkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  295 IF------QKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HH------HHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            11      11110           112223334467888999999999999999988886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=362.46  Aligned_cols=257  Identities=28%  Similarity=0.418  Sum_probs=207.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..+++++.||+|-||.|+++....         ...+++|.++..+-    ..++|.+|+.+|++|+|+|||+++|+|..
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~---------~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG---------STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC---------CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            356778999999999999987542         22455555554321    34789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.++||||||+.|+|.++|+.. .+..+...+.+.++.|||+|++||++   +++|||||.+.||||+++..+||+|||
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccc
Confidence            99999999999999999999973 34469999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +|+....+. ........-...|.|||.+..++++.|||||||||+||||+| |+.||......+   ++.    .+..|
T Consensus       349 LAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~----~le~G  420 (468)
T KOG0197|consen  349 LARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE----LLERG  420 (468)
T ss_pred             cccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH----HHhcc
Confidence            999444332 222333445778999999999999999999999999999999 999986543221   111    12222


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .         +-..+..++..+.+++..||+.+|++|||+..+...|+....
T Consensus       421 y---------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  421 Y---------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             C---------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            1         222234467789999999999999999999999998887653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=347.98  Aligned_cols=262  Identities=22%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|...+.||+|+||.||++....        ++..+|+|++.....   ...+.+.+|+.+|++|+|||||+++|...
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~--------~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~   84 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKK--------TGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSS   84 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecC--------CCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccc
Confidence            4578899999999999999998754        356677777655421   12677999999999999999999999855


Q ss_pred             eCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CCceEE
Q 036172          225 EDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQL  301 (522)
Q Consensus       225 ~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~~~kL  301 (522)
                      ...  .++++|||+++|+|.+++.+.+.  .+++..+..+..|+++||.|||+   +||+||||||+|||++. ++.+||
T Consensus        85 ~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~Kl  159 (313)
T KOG0198|consen   85 SRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKL  159 (313)
T ss_pred             cccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEe
Confidence            444  79999999999999999997653  59999999999999999999999   99999999999999999 799999


Q ss_pred             eecCccccCCC-CCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          302 SDFGLAIWGPT-DSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       302 ~DFGla~~~~~-~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      +|||++..... ...........||+.|||||++..+. ...++|||||||+++||+||..||... ..    ...+...
T Consensus       160 aDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~----~~~~~~~  234 (313)
T KOG0198|consen  160 ADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE----EAEALLL  234 (313)
T ss_pred             ccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc----hHHHHHH
Confidence            99999976553 11112233578999999999998643 345999999999999999999999753 11    1111111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .......         +.++...+....+++.+|+..+|.+|||+.++|+        |+|.+..
T Consensus       235 ig~~~~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--------hpf~~~~  282 (313)
T KOG0198|consen  235 IGREDSL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE--------HPFLKQN  282 (313)
T ss_pred             HhccCCC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh--------Chhhhcc
Confidence            1111111         1233345667888999999999999999999998        7776554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=353.83  Aligned_cols=260  Identities=22%  Similarity=0.327  Sum_probs=210.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-c-chHHHHHHHHHHHHhhCC-CCCccee
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-F-SSAWNDFSSEVDITSSLE-QKSITTL  219 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-~-~~~~~~f~~Ev~iL~~L~-HpnIv~l  219 (522)
                      ...++|++++.||+|+||+|+++.+..        +.+.+|+|.+.+.... . ....+.+.+|+.++++++ ||||+++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~--------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL--------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc--------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence            456799999999999999999997653        3366777755543221 1 124456678999999998 9999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-Cc
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQ  298 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~  298 (522)
                      +.++.....+++||||+.||+|.+++...   ..+.+..+..++.|++.|++|||+   +||+||||||+|||++.+ ++
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCC
Confidence            99999999999999999999999999863   358999999999999999999999   999999999999999999 99


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VS-DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      +||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...   +.  
T Consensus       160 ~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~--  232 (370)
T KOG0583|consen  160 LKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY--  232 (370)
T ss_pred             EEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH--
Confidence            9999999998764  1222334668999999999998877 75 79999999999999999999998632211   11  


Q ss_pred             hhhhhcCCCcccccCCcccccccHHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQ-MQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .. +..+.+          .++... +..+..++.+||..||.+|+++.+|++        ++|++.
T Consensus       233 -~k-i~~~~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--------h~w~~~  280 (370)
T KOG0583|consen  233 -RK-IRKGEF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE--------HPWFQK  280 (370)
T ss_pred             -HH-HhcCCc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--------Chhhcc
Confidence             11 111111          111112 567888999999999999999999997        999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-42  Score=351.13  Aligned_cols=268  Identities=23%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.++||.|+||.||++......   ....++.+++|.++...  .....+.+.+|+.++.++ +||||++++++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGID---KKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccC---Ccccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            468999999999999999998642110   11245567888775322  223456799999999999 999999999998


Q ss_pred             EeC-CEEEEEEecCCCCCHHHHhhccCC----------------------------------------------------
Q 036172          224 IED-NYLILVSDFLPKGSLEESLHGAGE----------------------------------------------------  250 (522)
Q Consensus       224 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  250 (522)
                      ... +.+++||||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            864 468999999999999999975321                                                    


Q ss_pred             -------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccc
Q 036172          251 -------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV  323 (522)
Q Consensus       251 -------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  323 (522)
                             ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...............
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  237 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR  237 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence                   1347888999999999999999999   999999999999999999999999999997654333222223345


Q ss_pred             cCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHH
Q 036172          324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ  402 (522)
Q Consensus       324 gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  402 (522)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.......  .+..    .+..+....         .+...
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~~~---------~~~~~  302 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGTRMR---------APENA  302 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCCCCC---------CCCCC
Confidence            6788999999998899999999999999999997 999997543221  1111    111111111         01123


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          403 MQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       403 ~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=348.20  Aligned_cols=266  Identities=20%  Similarity=0.222  Sum_probs=208.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~  222 (522)
                      ...+|.+.++||.|+||.||+++..+        ....+|+|.+|+.--...+.  -=++|+..|++|+ |||||++.++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~--------~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Ev   77 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKE--------TGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEV   77 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecC--------CCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHH
Confidence            35789999999999999999998765        55668999888754432221  1258999999998 9999999999


Q ss_pred             EEeCC-EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          223 CIEDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       223 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      +.+.. .+++|||||+. +|.++++.+  ++.|++..+..|+.||+.||+|+|.   +|+.|||+||+|||+..+..+||
T Consensus        78 i~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKi  151 (538)
T KOG0661|consen   78 IRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKI  151 (538)
T ss_pred             hhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEe
Confidence            99987 99999999976 999999875  5579999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH-Hhhh-
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV-KWAK-  378 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~-~~~~-  378 (522)
                      +|||+|+........   +..+.|.+|.|||++ ..+-|+.+.||||+|||++|+.+-++.|.+.+..++..-+ .... 
T Consensus       152 aDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt  228 (538)
T KOG0661|consen  152 ADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT  228 (538)
T ss_pred             cccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence            999999876655443   356789999999997 5677999999999999999999999998765533322111 1000 


Q ss_pred             hh---hcC---------CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 PI---LKN---------GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ~~---~~~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +.   +..         -.+.....-.+..-. ...+.+..+++.+|+..||.+|||+.+.++
T Consensus       229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CccccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            00   000         011111111111112 225678899999999999999999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.9e-42  Score=331.16  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=208.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|+...++|+|+||.|++|++++        +++.+|+|......+ .....+-.++|+++|++|+|+|+|.++.+|..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~--------TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD--------TGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC--------cccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            468889999999999999999876        677777777654222 22234557899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...++||+|||+. ++.+-|.....  .++...+.+++.|++.|+.|+|+   +++|||||||+||||+.++.+||||||
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccch
Confidence            9999999999988 66666665433  38999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh-------
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA-------  377 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~-------  377 (522)
                      +|+........  -++.+.|.+|.|||.+.+ -+|....||||+||++.||++|.+.|.....-++-..+...       
T Consensus       147 FAR~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr  224 (396)
T KOG0593|consen  147 FARTLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR  224 (396)
T ss_pred             hhHhhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence            99877642222  236688999999999987 67999999999999999999999999876544332222110       


Q ss_pred             -------hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          378 -------KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       378 -------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                             .+.+..-.+++.-++.....--+....-+++++..||+.||.+|++-++++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                   0111111222222222222222334567899999999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-41  Score=365.45  Aligned_cols=269  Identities=24%  Similarity=0.385  Sum_probs=220.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++.+..+.||+|+||.||+++--.   -........||+|.||....+  .+.++|++|+++|..|+|||||+|+|+|.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~---l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYG---LLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccC---CCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3456777899999999999987321   111335568899999876653  37899999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC-----------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE-----------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      +++.+++|+|||..|||.++|..+..           ...|+..+.+.|+.|||.|+.||-+   +.+|||||-..|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhcee
Confidence            99999999999999999999986521           2238889999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhh
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES  372 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~  372 (522)
                      .++..|||+|||+++-.-............-..+|||||.++.+++|.+||||||||||||+++ |+.||.....++.  
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--  714 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--  714 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence            9999999999999976555444433334455789999999999999999999999999999999 9999865433221  


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                       +    ..++.|.+.         ..+...+.++..|+..||+.+|.+||+++||-.+|+.....
T Consensus       715 -I----e~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  715 -I----ECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -H----HHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence             1    223344332         23445778999999999999999999999999999876543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.5e-41  Score=336.65  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=205.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|++.+.||+|+||.||++....        ..+.+++|.+.+...........+.+|+.++++++|+||+++++++.++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA--------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec--------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            47889999999999999987543        3456666655443322223445688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999999998886542 2358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........   .....||..|+|||++.+..++.++|||||||++|+|++|+.||............   .......  
T Consensus       149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~--  220 (285)
T cd05631         149 AVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED--  220 (285)
T ss_pred             cEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc--
Confidence            976543221   12346899999999999999999999999999999999999999755432211111   1111110  


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCcccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~~  444 (522)
                              ...++...+..+.+++.+||+.||.+||+     ++++++        |+|+..-
T Consensus       221 --------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~--------h~~~~~~  267 (285)
T cd05631         221 --------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ--------HPIFKNI  267 (285)
T ss_pred             --------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc--------CHhhcCC
Confidence                    01112234457888999999999999997     788886        8887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=333.05  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=210.5

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      +-....|++...||.|.-+.||++....        ....+|+|.+.-...+.  .++.+.+|+..++.++||||++++.
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p--------~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~   91 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIP--------TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHC   91 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecc--------cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEE
Confidence            3356789999999999999999887543        33566666554333322  4788999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .|..+..+|+||.||.+||+.+++...-.. .+++..+..|+.++++||.|||.   +|.||||||+.||||+.+|.+||
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkL  167 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKL  167 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEE
Confidence            999999999999999999999999876433 39999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCC-CCccc-cccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          302 SDFGLAIWGPTDS-THMIR-EDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       302 ~DFGla~~~~~~~-~~~~~-~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +|||.+....... ..... +...||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+  ...+..  
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~--  243 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLL--  243 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHH--
Confidence            9999986544332 22222 56789999999999644  4599999999999999999999999964332  111111  


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         ...+....+.-..+..+........+..++..||++||.+|||++++++
T Consensus       244 ---tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  244 ---TLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ---HhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence               1122222222222233333445668999999999999999999999997

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-41  Score=350.75  Aligned_cols=266  Identities=23%  Similarity=0.285  Sum_probs=222.4

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ....+.|++++.||.|+-|.|.++++.+        +++..|+|.+.+...--......+.+|+-||+-+.||||+++|+
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~--------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd   79 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAE--------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYD   79 (786)
T ss_pred             cccccceeccccccCCCCceehhhhccc--------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeee
Confidence            3456889999999999999988888765        67788888887765444445667889999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++++..++|+|.||+++|-|.+++-.++   .+++.++.+++.||+.|+.|+|.   .+|+|||+||+|+|||..+++||
T Consensus        80 Vwe~~~~lylvlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKI  153 (786)
T KOG0588|consen   80 VWENKQHLYLVLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKI  153 (786)
T ss_pred             eeccCceEEEEEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEee
Confidence            9999999999999999999999998554   59999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||+|..-..+..   ....+|.+.|+|||++++.+| ..++||||.|||||.|+||+.||+..+   ...+...    
T Consensus       154 ADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlK----  223 (786)
T KOG0588|consen  154 ADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLK----  223 (786)
T ss_pred             eccceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHH----
Confidence            99999965444332   235589999999999999988 579999999999999999999998443   2222222    


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHADDIL  449 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~~~~  449 (522)
                      +..|.+          +.+...+.+..+|+.+||..||..|.|+.||++        |+|+........
T Consensus       224 V~~G~f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--------HP~l~g~~~~~~  274 (786)
T KOG0588|consen  224 VQRGVF----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK--------HPFLSGYTSLPS  274 (786)
T ss_pred             HHcCcc----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh--------CchhhcCCCCCh
Confidence            222322          223445667888999999999999999999998        999887665443

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=343.95  Aligned_cols=262  Identities=23%  Similarity=0.279  Sum_probs=208.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++....        ..+.+++|.+++.........+.+.+|+.++.+++||||+++++++.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~   72 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD--------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD   72 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC--------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence            479999999999999999987643        455677777665544334456789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          73 DEYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCc
Confidence            99999999999999999999743   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||....................   
T Consensus       147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (333)
T cd05600         147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---  218 (333)
T ss_pred             CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---
Confidence            9975543     12345799999999999988999999999999999999999999975432221111110000000   


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .....++      ....+..+.+++.+||..+|.+||++.+|++        ++|+..
T Consensus       219 ~~~~~~~------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~--------h~~~~~  262 (333)
T cd05600         219 RPVYDDP------RFNLSDEAWDLITKLINDPSRRFGSLEDIKN--------HPFFKE  262 (333)
T ss_pred             CCCCCcc------ccccCHHHHHHHHHHhhChhhhcCCHHHHHh--------CcccCC
Confidence            0000000      1123567888999999999999999999998        777764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-41  Score=342.29  Aligned_cols=283  Identities=19%  Similarity=0.246  Sum_probs=214.8

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      .+.....|+.+.+||+|+||.||++++.+        +++.||+|.+...... .....-..+||.||++|+||||++|.
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~--------tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~  182 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLE--------TGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLE  182 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecc--------cCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCccccee
Confidence            34445689999999999999999998765        6777777776543311 11234467899999999999999999


Q ss_pred             EEEEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          221 GVCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       221 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      +...+.  +.+|||+|||++ +|.-++...  ...|++.++..++.||+.||.|+|.   +||+|||||.+|||||.+|.
T Consensus       183 eivt~~~~~siYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~  256 (560)
T KOG0600|consen  183 EIVTSKLSGSIYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGV  256 (560)
T ss_pred             eEEEecCCceEEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCC
Confidence            999977  789999999988 999999853  3359999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||+|+++........+ ..+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|++.|.....-.+-..+-..
T Consensus       257 LKiaDFGLAr~y~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl  335 (560)
T KOG0600|consen  257 LKIADFGLARFYTPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL  335 (560)
T ss_pred             EEeccccceeeccCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence            999999999987766544433 45679999999999875 5999999999999999999999998766533222211110


Q ss_pred             h-----hhhcCCCcc--cccCCccc-----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          378 K-----PILKNGDTE--TLLDPKLS-----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       378 ~-----~~~~~~~~~--~~~d~~l~-----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      .     ..+...++.  ..+.+...     .+.....+...++|+..+|..||.+|.|+.++|+        .+|+...+
T Consensus       336 cGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--------seyF~t~p  407 (560)
T KOG0600|consen  336 CGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--------SEYFTTEP  407 (560)
T ss_pred             hCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--------CcccccCC
Confidence            0     001111111  11111110     1111223456788999999999999999999997        66665444


Q ss_pred             cc
Q 036172          446 DD  447 (522)
Q Consensus       446 ~~  447 (522)
                      ..
T Consensus       408 ~~  409 (560)
T KOG0600|consen  408 LP  409 (560)
T ss_pred             CC
Confidence            33

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-40  Score=335.07  Aligned_cols=275  Identities=23%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             CCCceeeecccccccccccccCchhHH--------HHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELF--------LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~--------~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      .++|++.++||+|+||.||++......        ..........+++|.+....  ......+|.+|+.++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            468999999999999999998643210        01112233457777665321  23356789999999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEecCCCCCHHHHhhccC----------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 036172          217 TTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG----------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRP  280 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g  280 (522)
                      +++++++.+.+..++||||+++|+|.+++....                ....+++..++.++.|++.||.|||+   .+
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LN  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CC
Confidence            999999999999999999999999999986531                11247888999999999999999999   99


Q ss_pred             EEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc--C
Q 036172          281 VIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS--G  358 (522)
Q Consensus       281 iiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt--G  358 (522)
                      |+||||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999976544332222233456789999999988899999999999999999987  5


Q ss_pred             CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ..||.....   ...................      ...+...+..+.+++.+||+.+|.+|||+.+|.+.|++
T Consensus       239 ~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTD---EQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCH---HHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            566654321   1222222222111110000      00111234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=338.05  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=203.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ..+.+++|.+...........+.+.+|+.++++++||||+++++++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI--------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD   72 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC--------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc
Confidence            368999999999999999987643        345566665543222122345678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          73 QRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecC
Confidence            99999999999999999999753   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.......     ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .+...   .. .+.
T Consensus       147 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~---i~-~~~  214 (291)
T cd05612         147 FAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEK---IL-AGK  214 (291)
T ss_pred             cchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HH-hCC
Confidence            997653321     1346899999999998888999999999999999999999999654321   11111   11 111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .          .++......+.+++.+||+.||.+||+     ++++++        |+|+..
T Consensus       215 ~----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~--------h~~~~~  259 (291)
T cd05612         215 L----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN--------HRWFKS  259 (291)
T ss_pred             c----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc--------CccccC
Confidence            0          111122456888999999999999995     888886        889864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=317.21  Aligned_cols=260  Identities=20%  Similarity=0.270  Sum_probs=214.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|+..+.||.|+||.|.+++.+.        ++..||+|.|.+...---..++...+|-.+|+.+.||+++++++.|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~--------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKH--------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEcc--------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            45789999999999999999988754        5788999988776665556778889999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+++|+||||++||-|..+|++.+   .+++..++-++.||+.||+|||+   .+|++|||||+|||||.+|.+||+|
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEe
Confidence            99999999999999999999999654   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+|+.....     +-..+||+.|+|||.+....+..++|-|||||++|||+.|.+||...+...     . ...++ .
T Consensus       188 FGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----i-Y~KI~-~  255 (355)
T KOG0616|consen  188 FGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----I-YEKIL-E  255 (355)
T ss_pred             ccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----H-HHHHH-h
Confidence            9999776554     235689999999999999999999999999999999999999997655411     1 11111 1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ++          -.++......+.+|+...|+.|-.+|- ++.   .-- .....|+|++.
T Consensus       256 ~~----------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlk---nG~-~dIk~H~wF~~  302 (355)
T KOG0616|consen  256 GK----------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLK---NGV-EDIKNHPWFKG  302 (355)
T ss_pred             Cc----------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcC---CCc-cccccCccccc
Confidence            11          123334455788899999999999992 111   000 12245889874

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=342.00  Aligned_cols=256  Identities=20%  Similarity=0.271  Sum_probs=206.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||.|+||.||++....        ..+.+++|.+++.........+.+.+|+.++++++||||+++++++
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   87 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKG--------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF   87 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECC--------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45789999999999999999987643        3456666665443322233567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         88 QDENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             EcCCEEEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999854   348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++......     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   .....   . +..
T Consensus       162 fg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~---~-i~~  229 (329)
T PTZ00263        162 FGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYE---K-ILA  229 (329)
T ss_pred             ccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHH---H-Hhc
Confidence            99997654322     134689999999999988899999999999999999999999964321   11111   1 111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +...          ++......+.+++.+||+.||.+||+     +.+++.        |+|+..
T Consensus       230 ~~~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~--------hp~f~~  276 (329)
T PTZ00263        230 GRLK----------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN--------HPYFHG  276 (329)
T ss_pred             CCcC----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc--------CCccCC
Confidence            1110          11113356788999999999999997     688886        888765

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-40  Score=339.87  Aligned_cols=250  Identities=21%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++.+..        .++.+++|.+++...........+.+|+.++++++||||+++++++..++.+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   73 (323)
T cd05571           2 LLGKGTFGKVILVREKA--------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFV   73 (323)
T ss_pred             eeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEE
Confidence            58999999999987543        4567777776654433344567889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        74 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          74 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            9999999999999753   358999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDP  392 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  392 (522)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+....    ..+..      
T Consensus       148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~----~~~~~------  212 (323)
T cd05571         148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI----LMEEI------  212 (323)
T ss_pred             CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH----HcCCC------
Confidence            211  12245799999999999988999999999999999999999999964321   1111111    11110      


Q ss_pred             cccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          393 KLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       393 ~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                          .++......+.+++.+||+.||.+||     ++.++++        |+|+..
T Consensus       213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~--------h~~f~~  256 (323)
T cd05571         213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME--------HRFFAS  256 (323)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc--------CCCcCC
Confidence                11122345788899999999999999     8999986        788765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=311.44  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=218.0

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      .....++|+++++||.|.||.||++....        +...+|+|++.+....-....+++.+|++|-+.|+||||+++|
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekk--------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY   88 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKK--------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLY   88 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeecc--------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence            45567899999999999999999987643        5566677776655544444567899999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      ++|.+....||++||.++|.|...|.... ...+++.....++.|++.||.|+|.   ++||||||||+|+|++..+.+|
T Consensus        89 ~~fhd~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lk  164 (281)
T KOG0580|consen   89 GYFHDSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELK  164 (281)
T ss_pred             hheeccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCee
Confidence            99999999999999999999999998542 3358999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||.+...+..    .....+||..|++||...+...+.+.|+|++|++.||++.|.+||......   ...+.....
T Consensus       165 iAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k~  237 (281)
T KOG0580|consen  165 IADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRKV  237 (281)
T ss_pred             ccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHHc
Confidence            9999999765532    234568999999999999999999999999999999999999999765411   111111100


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                                    ...++...+....++|.+|+..+|.+|.+..|+++        |+|+...
T Consensus       238 --------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~--------hpwI~a~  279 (281)
T KOG0580|consen  238 --------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD--------HPWIVAN  279 (281)
T ss_pred             --------------cccCCcccChhHHHHHHHHhccCccccccHHHHhh--------hHHHHhc
Confidence                          11222345567888999999999999999999998        8887643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-40  Score=336.92  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=216.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|+++++||+|+||.||+|+.+.        ++..||+|.|++..---...++..+.|-.||....+|+||+++-.|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~--------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKD--------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEcc--------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            45789999999999999999998754        7899999999997766666888999999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+..++||||||++||++..+|...   ..|++..+..++.+++.||..||+   .|+|||||||+|+|||..|++||+|
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecc
Confidence            9999999999999999999999954   469999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCC--------------------CCCCcc-------------------------ccccccCCCCCChhhhccCC
Q 036172          304 FGLAIWGPT--------------------DSTHMI-------------------------REDVVGTFGYIAPEYLMHGK  338 (522)
Q Consensus       304 FGla~~~~~--------------------~~~~~~-------------------------~~~~~gt~~Y~APE~~~~~~  338 (522)
                      ||++.-...                    ......                         ....+|||.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999832111                    000000                         01247999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh-hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcC
Q 036172          339 VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQS  417 (522)
Q Consensus       339 ~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~d  417 (522)
                      |+..+|.||||||+||||.|.+||....+... ..++.|...+....              ......+..+||.+||. |
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-C
Confidence            99999999999999999999999987665432 23444433221100              11123677889999999 9


Q ss_pred             CCCCCC---HHHHHHHHhccccCCcccccc
Q 036172          418 PQLRPN---MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       418 P~~RPs---~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      |.+|.-   +.||-+        |+|++.-
T Consensus       430 ~~~RLG~~G~~EIK~--------HPfF~~v  451 (550)
T KOG0605|consen  430 PENRLGSKGAEEIKK--------HPFFKGV  451 (550)
T ss_pred             HHHhcCcccHHHHhc--------CCccccC
Confidence            999974   666654        8887753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-40  Score=329.42  Aligned_cols=268  Identities=21%  Similarity=0.207  Sum_probs=199.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.++.... .....+.+.+|+.++++++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE--------TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC--------CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            479999999999999999987643        344566665543221 12245678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||++++.|..+...   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999999999998777655432   2348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh-hh------
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW-AK------  378 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~-~~------  378 (522)
                      ++......... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.............. ..      
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07848         146 FARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             Ccccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence            99765433221 11234689999999999888899999999999999999999999975432111100000 00      


Q ss_pred             --hhhcCCCcccccCCcc------cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 --PILKNGDTETLLDPKL------SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 --~~~~~~~~~~~~d~~l------~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        .............+..      ...+....+..+.+++.+||+.||.+|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              0000000000000100      01111224567999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-39  Score=334.04  Aligned_cols=270  Identities=21%  Similarity=0.307  Sum_probs=204.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ....+++|.+....  .....++|.+|+++|++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP--------SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC--------CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            4789999999999999999987643        33445555443211  1224567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Df  148 (331)
T cd06649          74 SDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDF  148 (331)
T ss_pred             ECCEEEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccC
Confidence            999999999999999999999753   3489999999999999999999982  36999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh-hhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP-ILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~-~~~~  383 (522)
                      |++.......    .....|++.|+|||++.+..++.++|||||||++|||++|+.||.......   +...... ....
T Consensus       149 g~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~  221 (331)
T cd06649         149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDG  221 (331)
T ss_pred             cccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhccccccc
Confidence            9986553322    123468999999999998899999999999999999999999996443211   1111100 0000


Q ss_pred             CC-ccc--------------------------------ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          384 GD-TET--------------------------------LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       384 ~~-~~~--------------------------------~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      .. ...                                +................+.+++.+||+.||++|||+.+|++ 
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~-  300 (331)
T cd06649         222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN-  300 (331)
T ss_pred             ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc-
Confidence            00 000                                00000000001123467899999999999999999999997 


Q ss_pred             HhccccCCcccccc
Q 036172          431 LRGATHATDWVDRH  444 (522)
Q Consensus       431 L~~~~~~~~~~~~~  444 (522)
                             |+|++..
T Consensus       301 -------h~~~~~~  307 (331)
T cd06649         301 -------HTFIKRS  307 (331)
T ss_pred             -------ChHHhhc
Confidence                   8887653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-40  Score=314.03  Aligned_cols=272  Identities=23%  Similarity=0.257  Sum_probs=214.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHH-HHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAW-NDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~-~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+|...++||+|.||.||++.+.+        +++.+|+|.++..  ++.+.+ ....+|++.|+.++|+||+.++++|.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~--------t~~~VAIKKIkl~--~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~   71 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE--------TGKRVAIKKIKLG--NAKDGINRTALREIKLLQELKHPNIIELIDVFP   71 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC--------CCcEEEEEEeecc--ccccCccHHHHHHHHHHHHccCcchhhhhhhcc
Confidence            478899999999999999998754        6777888887653  333322 35789999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+.+.||+||++. +|+..++..  ...++...+..++.++++||+|||.   +.|+||||||.|+|++.+|.+||+||
T Consensus        72 ~~~~l~lVfEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   72 HKSNLSLVFEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             CCCceEEEEEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecc
Confidence            99999999999977 999999864  4469999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+|+.+.........  .+-|.+|.|||.+.+. .|+...||||.|||+.||+.|.+-|...+.  .+++...+.. +..
T Consensus       146 GLAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~-LGT  220 (318)
T KOG0659|consen  146 GLARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRA-LGT  220 (318)
T ss_pred             cchhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHH-cCC
Confidence            999988765544332  2679999999998775 599999999999999999999888765543  3333322211 111


Q ss_pred             CC------cccc--------cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccccc
Q 036172          384 GD------TETL--------LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHAD  446 (522)
Q Consensus       384 ~~------~~~~--------~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~  446 (522)
                      ..      ...+        +.+...............+++..||..||.+|++++|+++        ++|+...+.
T Consensus       221 P~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--------~~yf~~~P~  289 (318)
T KOG0659|consen  221 PTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--------HPYFKSLPL  289 (318)
T ss_pred             CCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--------chhhhcCCC
Confidence            00      0000        1111112133345566799999999999999999999998        888876543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-40  Score=338.69  Aligned_cols=258  Identities=20%  Similarity=0.257  Sum_probs=204.4

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.++||.|+||.||++....       .....+++|.+.+.........+.+.+|+.+++.++||||++++++
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~   99 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKN-------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS   99 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEEC-------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            345689999999999999999986432       1223455555433322223356778999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        100 FKDESYLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999999854   358999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||......   .....    +.
T Consensus       174 DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~----i~  241 (340)
T PTZ00426        174 DFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQK----IL  241 (340)
T ss_pred             cCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHH----Hh
Confidence            999997654321     2357999999999998888999999999999999999999999654321   11111    11


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .+..          .++......+.+++.+||+.+|.+|+     +++++++        |+|+..
T Consensus       242 ~~~~----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~--------hp~f~~  289 (340)
T PTZ00426        242 EGII----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE--------HPWFGN  289 (340)
T ss_pred             cCCC----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc--------CCCcCC
Confidence            1111          01112234577899999999999995     8999886        888764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-40  Score=345.62  Aligned_cols=266  Identities=22%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.++||.|+||.||++.....   ........+++|.++...  .....+.+.+|+.+|+.+ +||||++++++|
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~---~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL---FKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc---ccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            45899999999999999999863211   112345567777775322  233457899999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-----------------------------------------------------
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-----------------------------------------------------  250 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  250 (522)
                      .+++..++||||+++|+|.+++.....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            999999999999999999999964321                                                     


Q ss_pred             -------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          251 -------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       251 -------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                                         ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                               1247889999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||......  .......    ..+...  .
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~~--~  337 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYRM--L  337 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCccC--C
Confidence            4333222223345678999999999999999999999999999998 88898643221  1222221    111100  0


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .       +...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       338 ~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 S-------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            0       11123578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-39  Score=324.93  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=207.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++.......   ......+++|.++..  ......++|.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE---RLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC---CcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            478999999999999999986432110   123345666666432  223345779999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      .+..+++|||+++|+|.+++.....             ...+++..++.++.|++.||.|||+   .+++|+||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEE
Confidence            9999999999999999999975421             1358899999999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChh
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE  371 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~  371 (522)
                      +++++.++|+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||......   
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---  233 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---  233 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999975543322222233456889999999988899999999999999999998 99998654322   


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .+...    +..+...         ..+...+..+.+++.+||+.||.+||++.+|++.|++
T Consensus       234 ~~~~~----i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 EVIEM----IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHH----HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            12211    1111111         1123355788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-40  Score=332.59  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=199.4

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||+|+||.||++.+..        +.+.+++|.+++...........+.+|+.++.+++||||+++++++.+++..++||
T Consensus         1 lg~G~~g~Vy~~~~~~--------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   72 (312)
T cd05585           1 IGKGSFGKVMQVRKRD--------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVL   72 (312)
T ss_pred             CCcCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEE
Confidence            6999999999987643        45667777765544333445678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        73 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          73 AFINGGELFHHLQRE---GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            999999999999753   348999999999999999999999   99999999999999999999999999998754322


Q ss_pred             CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCc
Q 036172          314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPK  393 (522)
Q Consensus       314 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  393 (522)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ......... .        
T Consensus       147 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~-~--------  209 (312)
T cd05585         147 DD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQE-P--------  209 (312)
T ss_pred             CC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC-C--------
Confidence            21  123457999999999999989999999999999999999999999643211      111111111 0        


Q ss_pred             ccccccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHHhccccCCcccccc
Q 036172          394 LSNEYDNAQMQRMLLAANLCINQSPQLRPN---MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       394 l~~~~~~~~~~~l~~li~~CL~~dP~~RPs---~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        ..++......+.+++.+||+.||.+||+   +.+++.        |+|+...
T Consensus       210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~--------hp~~~~~  253 (312)
T cd05585         210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN--------HPFFSQL  253 (312)
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc--------CCCcCCC
Confidence              0111223456888999999999999985   566665        7887653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-40  Score=324.81  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=214.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..-+|++.++||.|+||.|-++..        ...++.+|+|.|++........+-.+.+|++||+.|+||||+.+|.+|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e--------~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF  122 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYE--------HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF  122 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhh--------ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence            345899999999999999877664        347899999999998887777788899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +..+.+.|||||..+|.|.+|+...+   .|++.++.+++.||+.|+.|+|.   ++++|||||.+|||||.++++||+|
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeec
Confidence            99999999999999999999998654   59999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++..+......   ..++|.+-|.+||.+.+.+| .+..|-|||||+||-|+.|..||+..+..   .++.    .+.
T Consensus       197 FGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr----QIs  266 (668)
T KOG0611|consen  197 FGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR----QIS  266 (668)
T ss_pred             cchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH----Hhh
Confidence            9999776654432   35799999999999988887 57899999999999999999999865432   2222    223


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .|.+.+.-           .+....-||++||..||.+|-|+.+|..
T Consensus       267 ~GaYrEP~-----------~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  267 RGAYREPE-----------TPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             cccccCCC-----------CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            33332221           1223455899999999999999999987

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-40  Score=344.66  Aligned_cols=267  Identities=22%  Similarity=0.359  Sum_probs=205.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.+.||+|+||.||++.......   ......|++|.++...  .....+.+.+|+.+++.+ +|+|||+++++|
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK---EDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc---ccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            4579999999999999999876432111   1234457777765422  223456799999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC------------------------------------------------------
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG------------------------------------------------------  249 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------  249 (522)
                      ...+..++||||+++|+|.++++...                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999986421                                                      


Q ss_pred             -------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCC
Q 036172          250 -------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH  316 (522)
Q Consensus       250 -------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~  316 (522)
                                   ....+++..++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         01247888999999999999999999   99999999999999999999999999999765443322


Q ss_pred             ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccc
Q 036172          317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLS  395 (522)
Q Consensus       317 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  395 (522)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......  .....    ...+.     .+.  
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~~-----~~~--  335 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRGY-----QMS--  335 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHccc-----Ccc--
Confidence            22223345678999999988899999999999999999997 999986543211  11111    11110     000  


Q ss_pred             ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          396 NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       396 ~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                        .+...+..+.+++.+||+.+|.+||++.+|+++|+++
T Consensus       336 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         336 --RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0111245788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=338.93  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=210.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|.+...||+|+||.||+++.+.        +...||+|.+.+...+. ...+.+.+|++|+++|+|||||.++++|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~--------t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY--------TIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc--------ceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            578899999999999999988643        56677777776644432 356779999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ..++++|+||+.| +|..+|...+   .++++.+..|+.+++.||.|||+   .+|+|||+||.|||++.++.+|+||||
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhh
Confidence            9999999999977 9999998543   49999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +|+......  .....+.||+.|||||.+.++.|+..+|+||+||++||+++|++||-..      ++...++.+..+. 
T Consensus       146 ~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~-  216 (808)
T KOG0597|consen  146 LARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP-  216 (808)
T ss_pred             hhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC-
Confidence            998766543  3345678999999999999999999999999999999999999999533      3333333333221 


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                ...+......+..++...|.+||.+|.+..+++.
T Consensus       217 ----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 ----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                      1122355678899999999999999999999996

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=339.36  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=208.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++.+..        ..+.+++|.+++...........+.+|+.++..++||||+++++++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD--------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD   72 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC--------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec
Confidence            479999999999999999988643        456777777765443333466789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          73 EEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             CCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCC
Confidence            99999999999999999999854   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---------------------------CCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          306 LAIWGPTDS---------------------------THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       306 la~~~~~~~---------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                      ++.......                           .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            997654432                           01112345789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhccccC
Q 036172          359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-MGQVLKLLRGATHA  437 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-~~eVl~~L~~~~~~  437 (522)
                      +.||.......   ..   .........  +..|.     ....+..+.+++..||. +|.+||+ +.++++        
T Consensus       227 ~~Pf~~~~~~~---~~---~~i~~~~~~--~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~--------  284 (350)
T cd05573         227 FPPFYSDTLQE---TY---NKIINWKES--LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS--------  284 (350)
T ss_pred             CCCCCCCCHHH---HH---HHHhccCCc--ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc--------
Confidence            99997544211   11   111110000  00000     00135678889999997 9999999 999997        


Q ss_pred             Cccccc
Q 036172          438 TDWVDR  443 (522)
Q Consensus       438 ~~~~~~  443 (522)
                      |+|++.
T Consensus       285 hp~~~~  290 (350)
T cd05573         285 HPFFKG  290 (350)
T ss_pred             CCCcCC
Confidence            788764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9e-40  Score=334.80  Aligned_cols=251  Identities=21%  Similarity=0.301  Sum_probs=198.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++.+..        ..+.+++|.+++..........++.+|+++++.++||||+++++++..++.+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv   73 (325)
T cd05594           2 LLGKGTFGKVILVKEKA--------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV   73 (325)
T ss_pred             eeeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEE
Confidence            58999999999987543        4566777766554333334567788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++|+|..++...   ..+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        74 ~E~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          74 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999999999988743   3589999999999999999999962  6899999999999999999999999999865332


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDP  392 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  392 (522)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ......    .....      
T Consensus       149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i----~~~~~------  213 (325)
T cd05594         149 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI----LMEEI------  213 (325)
T ss_pred             CCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHH----hcCCC------
Confidence            2211  12346999999999999889999999999999999999999999654321   111111    00000      


Q ss_pred             cccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          393 KLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       393 ~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                          .++......+.+++.+||+.||.+|+     ++.++++        |+|+..
T Consensus       214 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~--------h~~~~~  257 (325)
T cd05594         214 ----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ--------HKFFAG  257 (325)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc--------CCCcCC
Confidence                01112345678899999999999996     8999987        777664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-38  Score=335.64  Aligned_cols=267  Identities=17%  Similarity=0.184  Sum_probs=201.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|...         .+.+.+|+.+|++|+|||||++++++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~--------~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~  152 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNK--------TCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTF  152 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECC--------CCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEE
Confidence            34689999999999999999987643        56677777543         24578999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+...++|+|++. ++|..++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       153 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        153 TYNKFTCLILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EECCeeEEEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEe
Confidence            99999999999995 6999888743   348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-----hhhHHHhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG-----PESLVKWAK  378 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-----~~~l~~~~~  378 (522)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||-......     ...+.....
T Consensus       226 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~  304 (391)
T PHA03212        226 FGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR  304 (391)
T ss_pred             CCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence            999965332211 11224579999999999998899999999999999999999998864321100     011111000


Q ss_pred             hhhcC-CC--------cc---------cccCCcccc--cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          379 PILKN-GD--------TE---------TLLDPKLSN--EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       379 ~~~~~-~~--------~~---------~~~d~~l~~--~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      ..-.. ..        ..         ....+....  ......+..+.+++.+||+.||.+|||+.|+++        +
T Consensus       305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--------h  376 (391)
T PHA03212        305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--------F  376 (391)
T ss_pred             HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--------C
Confidence            00000 00        00         000000000  001124567889999999999999999999997        8


Q ss_pred             ccccc
Q 036172          439 DWVDR  443 (522)
Q Consensus       439 ~~~~~  443 (522)
                      +|++.
T Consensus       377 p~f~~  381 (391)
T PHA03212        377 AAFQD  381 (391)
T ss_pred             hhhcc
Confidence            89865

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-39  Score=327.05  Aligned_cols=267  Identities=21%  Similarity=0.261  Sum_probs=198.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++....        +.+.+++|.++....  ......+.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKL--------TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIH   73 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECC--------CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3579999999999999999986532        455677776643221  223456789999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||+++ +|.+++...+  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          74 TERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             CCCeEEEEEeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcC
Confidence            99999999999975 9999887543  347899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh-----
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK-----  378 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~-----  378 (522)
                      |+++........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||................     
T Consensus       148 G~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         148 GLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             cceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            999654332211  123467999999999865 468999999999999999999999997544322111110000     


Q ss_pred             ---hhh-cCCCcccccCCcccc----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 ---PIL-KNGDTETLLDPKLSN----EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ---~~~-~~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         +.. ..........+....    .........+.+++.+||+.||.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000 000001111111100    001112356789999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-39  Score=322.92  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||+|+||.||++....        +.+.+++|.+.+.........+.+..|+.++++++||||+++++++..+...++||
T Consensus         1 lg~G~~g~Vy~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   72 (280)
T cd05608           1 LGKGGFGEVSACQMRA--------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVM   72 (280)
T ss_pred             CCCCCceeEEEEEEcc--------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEE
Confidence            6999999999987643        45667777765544333345577889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          234 DFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       234 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      ||+++|+|.+++... .....+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.....
T Consensus        73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            999999999888543 233458999999999999999999999   9999999999999999999999999999976543


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDP  392 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  392 (522)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  ........ .        
T Consensus       150 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~-~--------  216 (280)
T cd05608         150 GQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILN-D--------  216 (280)
T ss_pred             CCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcc-c--------
Confidence            3221  223578999999999999999999999999999999999999997543221111  10111110 0        


Q ss_pred             cccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          393 KLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       393 ~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                        ...++...+..+.+++.+||+.||.+||     +++++++        |+|++.
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~--------h~~~~~  262 (280)
T cd05608         217 --SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--------HPLFRD  262 (280)
T ss_pred             --CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc--------Chhhhc
Confidence              0111223456788899999999999999     7788886        888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.6e-40  Score=335.37  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=199.5

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++.+..        ..+.+++|.+++...........+.+|+.+++.++||||+++++++..++.+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   73 (328)
T cd05593           2 LLGKGTFGKVILVREKA--------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFV   73 (328)
T ss_pred             eeeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEE
Confidence            58999999999987643        4566777776654433344567889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        74 ~Ey~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          74 MEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            9999999999998743   358999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDP  392 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  392 (522)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .....   ... ...      
T Consensus       148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~---~~~-~~~------  212 (328)
T cd05593         148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILM-EDI------  212 (328)
T ss_pred             ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHH---hcc-CCc------
Confidence            211  122356999999999999889999999999999999999999999643321   11111   111 100      


Q ss_pred             cccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          393 KLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       393 ~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                          .++......+.+++.+||+.||.+||     ++.++++        |+|+..
T Consensus       213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~--------h~~~~~  256 (328)
T cd05593         213 ----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR--------HSFFTG  256 (328)
T ss_pred             ----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc--------CCCcCC
Confidence                11122345688899999999999997     8999986        677653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=324.38  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=206.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||+|+||.||++.+..        +.+.+++|.+.............+.+|+.++++++||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA--------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC--------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC
Confidence            48899999999999999987542        4556777766543322223446688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          73 DALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999999999887542 2358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........   ....|++.|+|||++.+..++.++|||||||++|||++|+.||...........   ....+...  
T Consensus       149 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~--  220 (285)
T cd05605         149 AVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKED--  220 (285)
T ss_pred             ceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhc--
Confidence            9765432221   234689999999999888899999999999999999999999975432211111   11111110  


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                              ...++...+..+.+++.+||+.||.+||     ++.++++        ++|+..
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~--------~~~~~~  266 (285)
T cd05605         221 --------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA--------HPFFRT  266 (285)
T ss_pred             --------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc--------CcCccC
Confidence                    1112223456788999999999999999     8889887        788764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-39  Score=334.19  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      +.||+|+||.||++.+..        .+..+++|.+++...........+.+|+.++++++||||+++++++..++.+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l   72 (323)
T cd05595           1 KLLGKGTFGKVILVREKA--------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   72 (323)
T ss_pred             CeeeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEE
Confidence            358999999999987643        456677776655443333456778899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|..++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        73 v~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          73 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            99999999999988743   358999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......   .. ...     
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~---~~-~~~-----  212 (323)
T cd05595         147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI---LM-EEI-----  212 (323)
T ss_pred             CCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---hc-CCC-----
Confidence            2211  112356899999999999889999999999999999999999999644321   111111   10 000     


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                           .++...+..+.+++.+||+.||.+||     ++.++++        |+|+..
T Consensus       213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~--------h~~~~~  256 (323)
T cd05595         213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--------HRFFLS  256 (323)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc--------CCCcCC
Confidence                 01112345678899999999999998     8999987        777664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-39  Score=332.84  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=203.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      +|++.++||+|+||.||++....     .....+.+++|.+++... ......+.+.+|+.++.++ +||||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT-----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc-----cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence            48899999999999999976432     123456666666544321 1223456788999999999 6999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeC
Confidence            999999999999999999999743   348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||............  ...... 
T Consensus       150 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~-  225 (332)
T cd05614         150 GLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK-  225 (332)
T ss_pred             cCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-
Confidence            9997543322211 2245799999999999765 4788999999999999999999999654332221111  111111 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                            .++.+    +...+..+.+++.+||+.||.+||     +++++++        |+|++.
T Consensus       226 ------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~--------h~~~~~  272 (332)
T cd05614         226 ------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE--------HPFFKG  272 (332)
T ss_pred             ------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc--------CCCcCC
Confidence                  01111    112345678899999999999999     7888887        888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=339.03  Aligned_cols=263  Identities=21%  Similarity=0.283  Sum_probs=204.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++.+..        ..+.+++|.+++...........+.+|+.++..++||||+++++++.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD--------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD   72 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence            479999999999999999987643        456677777665433233456778999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||
T Consensus        73 ~~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          73 ENYLYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             CCeEEEEECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecc
Confidence            99999999999999999999753   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCc------------------------------------cccccccCCCCCChhhhccCCCCchhhHHHHH
Q 036172          306 LAIWGPTDSTHM------------------------------------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFG  349 (522)
Q Consensus       306 la~~~~~~~~~~------------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlG  349 (522)
                      ++..........                                    ......||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            986543211000                                    00124699999999999988999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC---HHH
Q 036172          350 VVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN---MGQ  426 (522)
Q Consensus       350 vvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs---~~e  426 (522)
                      |++|||++|..||......   ....   ...........  +.     ....+..+.+++.+|+. +|.+|++   +.+
T Consensus       227 ~il~el~~G~~Pf~~~~~~---~~~~---~i~~~~~~~~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQ---ETYR---KIINWKETLQF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHH---HHHH---HHHcCCCccCC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            9999999999999754321   1111   11110000000  00     01124567788888996 9999998   999


Q ss_pred             HHHHHhccccCCcccccc
Q 036172          427 VLKLLRGATHATDWVDRH  444 (522)
Q Consensus       427 Vl~~L~~~~~~~~~~~~~  444 (522)
                      +++        |+|++..
T Consensus       293 ll~--------h~~~~~~  302 (364)
T cd05599         293 IKS--------HPFFKGV  302 (364)
T ss_pred             Hhc--------CCCcCCC
Confidence            987        8887653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-39  Score=333.75  Aligned_cols=273  Identities=20%  Similarity=0.266  Sum_probs=199.8

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||+|+||.||++.+..        ....+++|.++..... .....++.+|+.++++++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH--------TGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC--------CCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            58999999999999999987543        4566777766543222 12345789999999999999999999998643


Q ss_pred             -----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          227 -----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       227 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                           ..+++||||+. ++|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          72 SRREFKDIYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             CCCCCceEEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEE
Confidence                 35899999995 6999998743   348999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCC-CccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh-
Q 036172          302 SDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA-  377 (522)
Q Consensus       302 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~-  377 (522)
                      +|||+++....... ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||............... 
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~  224 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL  224 (338)
T ss_pred             ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999975433221 112234578999999999865  67899999999999999999999999654321111000000 


Q ss_pred             -------hhhhcCCCcccc---cCCccccc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          378 -------KPILKNGDTETL---LDPKLSNE---YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       378 -------~~~~~~~~~~~~---~d~~l~~~---~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                             ...+........   +.+.....   ........+.+++.+||+.+|.+||++.++++        ++|++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--------hp~f~~  295 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--------DPYFKG  295 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--------Cchhhh
Confidence                   000000000000   00000000   00112356788999999999999999999997        899865

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-39  Score=339.50  Aligned_cols=263  Identities=21%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++++.||+|+||.||++....        +.+.+++|.+.+.........+.+.+|+.++++++||||+++++++.+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVD--------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            368999999999999999987543        456777777655333333456789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCc
Confidence            99999999999999999999753   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC---------------------------------------------CccccccccCCCCCChhhhccCCCC
Q 036172          306 LAIWGPTDST---------------------------------------------HMIREDVVGTFGYIAPEYLMHGKVS  340 (522)
Q Consensus       306 la~~~~~~~~---------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s  340 (522)
                      ++........                                             ........||+.|+|||++.+..++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT  226 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence            9753311000                                             0001234699999999999888899


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHH--hhhcCC
Q 036172          341 DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL--CINQSP  418 (522)
Q Consensus       341 ~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--CL~~dP  418 (522)
                      .++|||||||++|||++|..||.........  ..    ..........  +   .  ....+..+.+++.+  |+..+|
T Consensus       227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~----i~~~~~~~~~--~---~--~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQ--LK----VINWENTLHI--P---P--QVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             CccceeehhhHHHHHHhCCCCCcCCCHHHHH--HH----HHccccccCC--C---C--CCCCCHHHHHHHHHHccCcccc
Confidence            9999999999999999999999754322111  10    0000000000  0   0  01123456667766  556677


Q ss_pred             CCCCCHHHHHHHHhccccCCccccc
Q 036172          419 QLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       419 ~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..||++.+|+.        |+|+..
T Consensus       294 ~~R~~~~~~l~--------hp~f~~  310 (381)
T cd05626         294 LGRNGADDIKA--------HPFFSE  310 (381)
T ss_pred             cCCCCHHHHhc--------CcccCC
Confidence            77999999997        888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.1e-39  Score=324.70  Aligned_cols=249  Identities=16%  Similarity=0.224  Sum_probs=197.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe----CC
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE----DN  227 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~----~~  227 (522)
                      ..||+|+++.||++..          +++.+++|.++..........+.|.+|+.+|++++|||||++++++.+    ..
T Consensus        26 ~~i~~g~~~~v~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~   95 (283)
T PHA02988         26 VLIKENDQNSIYKGIF----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP   95 (283)
T ss_pred             eEEeeCCceEEEEEEE----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence            5689999999999764          245667776665444444446789999999999999999999999987    35


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      .+++||||+++|+|.+++...   ..+++...+.++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++
T Consensus        96 ~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         96 RLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             ceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchH
Confidence            789999999999999999853   3589999999999999999999972  47889999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +.......     ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||......   .+....   ...+.
T Consensus       171 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i---~~~~~  239 (283)
T PHA02988        171 KILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLI---INKNN  239 (283)
T ss_pred             hhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhcCC
Confidence            75433221     2367899999999976  67999999999999999999999999754321   111111   11111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .     +    ..+...+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       240 ~-----~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 S-----L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             C-----C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            0     0    111124567889999999999999999999999997653

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-39  Score=338.93  Aligned_cols=262  Identities=20%  Similarity=0.251  Sum_probs=201.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.++||+|+||.||++.+..        ..+.+++|.+.+.........+.+.+|+++|++++||||+++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD--------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD   72 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC--------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            479999999999999999987643        456777777655433223345778999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999999753   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC-----------------------------------------CccccccccCCCCCChhhhccCCCCchhh
Q 036172          306 LAIWGPTDST-----------------------------------------HMIREDVVGTFGYIAPEYLMHGKVSDKID  344 (522)
Q Consensus       306 la~~~~~~~~-----------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksD  344 (522)
                      ++..+.....                                         ........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            9743210000                                         00011346999999999999889999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC--
Q 036172          345 VYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP--  422 (522)
Q Consensus       345 VwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP--  422 (522)
                      ||||||++|||++|+.||...........      .........  .+.     ....+..+.+++.+|+ .+|.+|+  
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~~~~~--~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAETQLK------VINWETTLH--IPS-----QAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHHHHHH------HhccCcccc--CCC-----CCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999999999999999975432211110      000000000  000     0112345666777765 5999999  


Q ss_pred             -CHHHHHHHHhccccCCccccc
Q 036172          423 -NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       423 -s~~eVl~~L~~~~~~~~~~~~  443 (522)
                       ++.++++        |+|++.
T Consensus       293 ~t~~ell~--------h~~~~~  306 (376)
T cd05598         293 NGADEIKA--------HPFFKG  306 (376)
T ss_pred             CCHHHHhC--------CCCcCC
Confidence             8999997        888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=335.15  Aligned_cols=257  Identities=20%  Similarity=0.279  Sum_probs=198.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.++||.|+||.||++....        ..+.+++|.+....  .....+.|.+|++++++++|+||+++++++.
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  142 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRP--------TGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFD  142 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECC--------CCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence            4578999999999999999987542        34566766653211  1224567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+..       ...+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       143 ~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        143 HNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             cCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccc
Confidence            999999999999999986532       25677888999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |+++.......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+..... 
T Consensus       213 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-  289 (353)
T PLN00034        213 GVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-  289 (353)
T ss_pred             ccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-
Confidence            99976543221  1123478999999998743     224568999999999999999999997433322222211110 


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        . ..         ...........+.+++.+||+.||.+||++.||++        |+|+...
T Consensus       290 --~-~~---------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--------hp~~~~~  334 (353)
T PLN00034        290 --M-SQ---------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--------HPFILRA  334 (353)
T ss_pred             --c-cC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--------CcccccC
Confidence              0 00         01111224467889999999999999999999998        8998764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1e-38  Score=323.25  Aligned_cols=272  Identities=18%  Similarity=0.222  Sum_probs=200.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        +.+.+++|.++....  ......+.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV--------NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIH   73 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC--------CCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEe
Confidence            4689999999999999999987642        455677776653221  223346788999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++...++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          74 TKETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             cCCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCC
Confidence            9999999999995 58888887532  348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++........  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.....  ..............
T Consensus       148 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~  223 (303)
T cd07869         148 GLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGT  223 (303)
T ss_pred             CcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCC
Confidence            99865432221  1123468999999999865 4578999999999999999999999975321  11111111000000


Q ss_pred             CC---cc-----cccCC---------ccccccc-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GD---TE-----TLLDP---------KLSNEYD-NAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~---~~-----~~~d~---------~l~~~~~-~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..   ..     ....+         .+..... ......+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--------h~~f~~~  294 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--------HEYFSDL  294 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--------CcccccC
Confidence            00   00     00000         0000000 011246778999999999999999999997        9998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=339.49  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=203.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|....+||+|+-|.||++....        ....+|+|.+....   ....+-+.+|+.+|+.++|+|||++++.|.
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~--------~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl  340 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKIS--------TKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYL  340 (550)
T ss_pred             hhhhcchhhhccccccceeeeeecc--------CCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhc
Confidence            4578889999999999999987543        23334444432211   123456889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+.+++||||++||+|.+.+...    .+++.++..|+.+++.||+|||.   ++|+|||||.+|||++.+|.+||+||
T Consensus       341 v~deLWVVMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  341 VGDELWVVMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             ccceeEEEEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeee
Confidence            999999999999999999999643    49999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|..+.....  .+...+||+.|||||++....|..|.||||||++++||+-|.+||-..++-.  .+..    +...|
T Consensus       414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--AlyL----Ia~ng  485 (550)
T KOG0578|consen  414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYL----IATNG  485 (550)
T ss_pred             eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--HHHH----HhhcC
Confidence            99976655443  3456789999999999999999999999999999999999999985432211  1111    11111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      . .       ....+...+..+.+|+.+||+.|+.+||++.|+|+
T Consensus       486 ~-P-------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 T-P-------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             C-C-------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1 1       12223446678999999999999999999999998

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-39  Score=320.05  Aligned_cols=261  Identities=19%  Similarity=0.272  Sum_probs=202.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....     .......+++|.++....  ......|.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKL-----PSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEec-----CCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            3579999999999999999975321     122345666666654221  224467999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.++++||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          77 RGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             cCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCC
Confidence            9999999999999999999997542  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||......   .+....    ..
T Consensus       152 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~  223 (266)
T cd05064         152 RRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV----ED  223 (266)
T ss_pred             cccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HC
Confidence            987543222111 1112245678999999999999999999999999999875 99998644221   122111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      +...         ..+...+..+.+++.+||+.+|.+||++.+|++.|.+.
T Consensus       224 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 GFRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1110         01122455788899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.1e-39  Score=333.84  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=199.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++.+..        ..+.+++|.+.+...........+.+|+.++.+++||||+++++.+.+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~   72 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD--------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD   72 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC--------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            368999999999999999987542        456677777655433333355778999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          73 KLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             CCeEEEEEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeecc
Confidence            99999999999999999999853   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCC---------------------------------ccccccccCCCCCChhhhccCCCCchhhHHHHHHHH
Q 036172          306 LAIWGPTDSTH---------------------------------MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVL  352 (522)
Q Consensus       306 la~~~~~~~~~---------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl  352 (522)
                      +++........                                 .......||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            98654321100                                 001234799999999999998999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 036172          353 LELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCIN--QSPQLRPNMGQVLKL  430 (522)
Q Consensus       353 ~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~--~dP~~RPs~~eVl~~  430 (522)
                      |||++|+.||.......   .....   .. ......+.+..      .....+.+++.+++.  .++..||++.+|++ 
T Consensus       227 ~ell~G~~Pf~~~~~~~---~~~~i---~~-~~~~~~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~-  292 (363)
T cd05628         227 YEMLIGYPPFCSETPQE---TYKKV---MN-WKETLIFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKT-  292 (363)
T ss_pred             HHHHhCCCCCCCCCHHH---HHHHH---Hc-CcCcccCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC-
Confidence            99999999996543211   11111   11 00000011100      122345556655433  34446799999987 


Q ss_pred             HhccccCCcccccc
Q 036172          431 LRGATHATDWVDRH  444 (522)
Q Consensus       431 L~~~~~~~~~~~~~  444 (522)
                             |+|+..-
T Consensus       293 -------hp~f~~~  299 (363)
T cd05628         293 -------NPFFEGV  299 (363)
T ss_pred             -------CCCCCCC
Confidence                   8887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3e-39  Score=331.29  Aligned_cols=262  Identities=21%  Similarity=0.242  Sum_probs=206.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.+++.........+.|.+|+.+++.++||||+++++++.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~   72 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA--------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD   72 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            469999999999999999987543        456677777766544344466789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          73 KDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             CCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCC
Confidence            999999999999999999998642  359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ++......... ......||+.|+|||++.      ...++.++|||||||++|+|++|+.||.......      ....
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~  220 (330)
T cd05601         148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNN  220 (330)
T ss_pred             CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHH
Confidence            99765443222 222346899999999986      4567899999999999999999999996543211      1111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..........  +     .....+..+.+++..||. +|.+||++.+++.        |+|+..
T Consensus       221 i~~~~~~~~~--~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~--------h~~~~~  268 (330)
T cd05601         221 IMNFQRFLKF--P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC--------HPFFSK  268 (330)
T ss_pred             HHcCCCccCC--C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC--------CCCcCC
Confidence            1111111110  0     011234567889999997 9999999999986        888764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=330.30  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=204.5

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc------h-----HHHHHHHHHHHHh
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS------S-----AWNDFSSEVDITS  209 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~------~-----~~~~f~~Ev~iL~  209 (522)
                      ..+..|.|++.+.||.|.||.|.++.+..        ..+.+|+|.|.+....-.      .     ..++..+|+.||+
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~--------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK  163 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEV--------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK  163 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecC--------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence            44567899999999999999999987543        445556555543221110      0     3468999999999


Q ss_pred             hCCCCCcceeeEEEEeC--CEEEEEEecCCCCCHHHHhhccCCCCC-CChHHHHHHHHHHHHHHHHHHhcCCCCEEeccC
Q 036172          210 SLEQKSITTLNGVCIED--NYLILVSDFLPKGSLEESLHGAGEQSV-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV  286 (522)
Q Consensus       210 ~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDI  286 (522)
                      +|.|||||+|+.+..+.  ..+|||+|||..|.+...=    .... +++.++++++.+++.||.|||.   +|||||||
T Consensus       164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDI  236 (576)
T KOG0585|consen  164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDI  236 (576)
T ss_pred             hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeecccc
Confidence            99999999999999865  6899999999988775533    2233 9999999999999999999999   99999999


Q ss_pred             CCCceeccCCCceEEeecCccccCCCCCCC---ccccccccCCCCCChhhhccCC----CCchhhHHHHHHHHHHHHcCC
Q 036172          287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTH---MIREDVVGTFGYIAPEYLMHGK----VSDKIDVYSFGVVLLELLSGR  359 (522)
Q Consensus       287 kp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~eLltG~  359 (522)
                      ||+|+||+.+|++||+|||.+..++.....   .......||+.|+|||...++.    .+.+.||||+||+||.|+.|+
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~  316 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ  316 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence            999999999999999999999766443211   1122468999999999987643    367899999999999999999


Q ss_pred             CCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          360 RPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       360 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      .||-...      .......+..         ..+......+....+.+||.++|.+||.+|.++.+|..        |+
T Consensus       317 ~PF~~~~------~~~l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--------Hp  373 (576)
T KOG0585|consen  317 LPFFDDF------ELELFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL--------HP  373 (576)
T ss_pred             CCcccch------HHHHHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee--------cc
Confidence            9995432      1111111111         11111112235567889999999999999999999876        99


Q ss_pred             cccccc
Q 036172          440 WVDRHA  445 (522)
Q Consensus       440 ~~~~~~  445 (522)
                      |+....
T Consensus       374 wvt~~g  379 (576)
T KOG0585|consen  374 WVTRDG  379 (576)
T ss_pred             eeccCC
Confidence            987764

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=338.00  Aligned_cols=262  Identities=21%  Similarity=0.279  Sum_probs=201.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++.+..        ..+.+++|.+.+.........+.+.+|++++++++||||+++++++.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~   72 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD--------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD   72 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC--------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            479999999999999999987543        456677776654332223356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +..+|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          73 AQYLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             CCeeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999999743   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC-------------C--------------------------------ccccccccCCCCCChhhhccCCCC
Q 036172          306 LAIWGPTDST-------------H--------------------------------MIREDVVGTFGYIAPEYLMHGKVS  340 (522)
Q Consensus       306 la~~~~~~~~-------------~--------------------------------~~~~~~~gt~~Y~APE~~~~~~~s  340 (522)
                      +++.+.....             .                                .......||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            9853211000             0                                000124699999999999988999


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC
Q 036172          341 DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL  420 (522)
Q Consensus       341 ~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~  420 (522)
                      .++|||||||++|||++|..||.......   ...   ..........+  |.     .......+.+++.+||. +|.+
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~--p~-----~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSHE---TYR---KIINWRETLYF--PD-----DIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCC--CC-----CCCCCHHHHHHHHHHhc-CHhh
Confidence            99999999999999999999996543211   111   11110000000  10     01134567889999997 6776


Q ss_pred             C---CCHHHHHHHHhccccCCccccc
Q 036172          421 R---PNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       421 R---Ps~~eVl~~L~~~~~~~~~~~~  443 (522)
                      |   |++.+++.        |+|+..
T Consensus       293 r~~r~~~~~~l~--------hp~~~~  310 (377)
T cd05629         293 RLGRGGAHEIKS--------HPFFRG  310 (377)
T ss_pred             cCCCCCHHHHhc--------CCCcCC
Confidence            5   59999997        888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-39  Score=339.27  Aligned_cols=262  Identities=21%  Similarity=0.273  Sum_probs=200.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|+++++||+|+||.||++.+..        ..+.+++|.+.+.........+.+.+|+.++++++|||||++++++.+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~--------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVD--------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECC--------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            368999999999999999987543        456677777665443344466789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECC
Confidence            99999999999999999999754   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---------------------------------------------CCccccccccCCCCCChhhhccCCCC
Q 036172          306 LAIWGPTDS---------------------------------------------THMIREDVVGTFGYIAPEYLMHGKVS  340 (522)
Q Consensus       306 la~~~~~~~---------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s  340 (522)
                      ++..+....                                             .........||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT  226 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence            975321100                                             00001234689999999999988999


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC
Q 036172          341 DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL  420 (522)
Q Consensus       341 ~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~  420 (522)
                      .++|||||||++|||++|+.||.......  ....    .........  .|     ..........+++.+|+ .+|.+
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~~----i~~~~~~~~--~p-----~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         227 QLCDWWSVGVILYEMLVGQPPFLAQTPLE--TQMK----VINWQTSLH--IP-----PQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             CeeeEEechHHHHHHHhCCCCCCCCCHHH--HHHH----HHccCCCcC--CC-----CcccCCHHHHHHHHHHc-cCHhH
Confidence            99999999999999999999997543211  1111    111000000  00     01112345666676665 59999


Q ss_pred             CCC---HHHHHHHHhccccCCccccc
Q 036172          421 RPN---MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       421 RPs---~~eVl~~L~~~~~~~~~~~~  443 (522)
                      |++   +.++++        |+|++.
T Consensus       293 R~~~~~~~ei~~--------hp~f~~  310 (382)
T cd05625         293 RLGKNGADEIKA--------HPFFKT  310 (382)
T ss_pred             cCCCCCHHHHhc--------CCCcCC
Confidence            997   888876        788765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.7e-39  Score=329.33  Aligned_cols=273  Identities=22%  Similarity=0.294  Sum_probs=202.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++.+..        ....++.|.+....  .....+.|.+|++++++++||||++++++|.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~--------~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP--------SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC--------CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence            4789999999999999999987542        23344444333211  1124567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          74 SDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             ECCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeC
Confidence            999999999999999999999753   3489999999999999999999972  47999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh-hcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI-LKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~-~~~  383 (522)
                      |++.......    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.................. ...
T Consensus       149 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (333)
T cd06650         149 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE  224 (333)
T ss_pred             Ccchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence            9986543321    12346899999999998888999999999999999999999999754332211111000000 000


Q ss_pred             ----------CCcccccCCcc-----------------cccc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 ----------GDTETLLDPKL-----------------SNEY-DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ----------~~~~~~~d~~l-----------------~~~~-~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                                +.......+..                 .... .......+.+++.+||+.||.+||++.+++.      
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~------  298 (333)
T cd06650         225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV------  298 (333)
T ss_pred             cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh------
Confidence                      00000000000                 0000 0012356889999999999999999999997      


Q ss_pred             cCCcccccc
Q 036172          436 HATDWVDRH  444 (522)
Q Consensus       436 ~~~~~~~~~  444 (522)
                        ++|++..
T Consensus       299 --h~~~~~~  305 (333)
T cd06650         299 --HAFIKRS  305 (333)
T ss_pred             --CHHHhcC
Confidence              8887643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6e-39  Score=319.97  Aligned_cols=265  Identities=24%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|.+.+.||+|+||.||++.....   ......+.+++|.++....  .+..+.|.+|++++++++|+||+++++++.
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHL---EPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCT   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccc---cCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence            35688999999999999999875331   0113456677776654322  235678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC-----------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE-----------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      .....++||||+++++|.+++...+.           ...+++..+..++.|++.||.|||+   .+++||||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEE
Confidence            99999999999999999999975421           2348899999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhh
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES  372 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~  372 (522)
                      +.++.++|+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||.....   ..
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~  232 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EE  232 (280)
T ss_pred             cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence            9999999999999875433222222223356788999999999999999999999999999998 9999864332   12


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ......    .+....         .+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus       233 ~~~~~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 VIECIT----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            222111    111111         111234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=332.46  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.....||.|.||.||++.+..        +.+.+|+|.+.-...  .+.+++.++|+.+|.+++++||.++|+.+.
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~--------t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl   81 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNK--------TKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYL   81 (467)
T ss_pred             ccccccchhccccccceeeeeeecc--------ccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence            3467778999999999999988765        456666666544332  346788999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+..++++||||.||++.+.|..   ...+.+..+.-++++++.||.|||.   .+.+|||||+.|||+..+|.+||+||
T Consensus        82 ~g~~LwiiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~Df  155 (467)
T KOG0201|consen   82 KGTKLWIIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADF  155 (467)
T ss_pred             ecccHHHHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEec
Confidence            99999999999999999999984   3346888888999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |.+.........  ...++||+.|||||++....|+.|+||||||++.+||++|.+|+....+.                
T Consensus       156 gVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------  217 (467)
T KOG0201|consen  156 GVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------  217 (467)
T ss_pred             ceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------
Confidence            999765554332  35789999999999999889999999999999999999999998654331                


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .+..++.....+.+.......+.+++..||++||+.||++.++++
T Consensus       218 rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  218 RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111122222222333345667999999999999999999999997

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-39  Score=329.27  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=196.7

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHH---hhCCCCCcceeeEEEE
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDIT---SSLEQKSITTLNGVCI  224 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL---~~L~HpnIv~l~~~~~  224 (522)
                      |++.+.||+|+||.||++....        ..+.+++|.+++.........+.+.+|++++   ++++||||+++++++.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~   72 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK--------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ   72 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE
Confidence            7789999999999999987542        4456666666543322223455677776665   5678999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+..++||||+++|+|..++..    ..+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        73 ~~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          73 TEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcc
Confidence            99999999999999999988863    249999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++.......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......   ....   .... +
T Consensus       146 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~---~i~~-~  216 (324)
T cd05589         146 GLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFD---SIVN-D  216 (324)
T ss_pred             cCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-C
Confidence            99864322211  123457899999999999889999999999999999999999999654321   1111   1111 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..          .++...+..+.+++.+||+.||.+||     ++.++++        ++|++.
T Consensus       217 ~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~--------~~~f~~  262 (324)
T cd05589         217 EV----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK--------QPFFRD  262 (324)
T ss_pred             CC----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh--------CCCcCC
Confidence            10          01112345678899999999999999     5667765        777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.3e-39  Score=329.32  Aligned_cols=258  Identities=19%  Similarity=0.301  Sum_probs=200.8

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+.+|..++.++ +||||+++++++.+.+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~--------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~   72 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK--------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF   72 (329)
T ss_pred             CeEeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE
Confidence            358999999999987543        4566777777665443344567789999999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          73 FVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            999999999999988743   359999999999999999999999   99999999999999999999999999998642


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--hhhHHHhhhhhhcCCCccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG--PESLVKWAKPILKNGDTET  388 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~  388 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+....+.....  
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  222 (329)
T cd05588         147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--  222 (329)
T ss_pred             ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--
Confidence            22111  1224578999999999999899999999999999999999999996432211  11111111111111111  


Q ss_pred             ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHHHhccccCCccccc
Q 036172          389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN------MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       389 ~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs------~~eVl~~L~~~~~~~~~~~~  443 (522)
                              ..+...+..+.+++.+||+.||.+||+      +.++++        |+|+..
T Consensus       223 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~--------hp~~~~  267 (329)
T cd05588         223 --------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS--------HPFFRN  267 (329)
T ss_pred             --------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc--------CCCCCC
Confidence                    011123456888999999999999997      677775        888754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=303.22  Aligned_cols=266  Identities=19%  Similarity=0.291  Sum_probs=208.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      .+.+||++.+.||+|||+-|+++++.        .+.+.+|+|.+.   ..+.+..+..++|++..++++|||+++++++
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~--------s~~~~YAlKkI~---c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh   86 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGL--------STGHLYALKKIL---CHSQEDIEEALREIDNHRKFNSPNVLRLVDH   86 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeeccc--------Ccccchhhheee---ccchHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence            45689999999999999999999854        366777766553   3345577889999999999999999999998


Q ss_pred             EEeCC-----EEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          223 CIEDN-----YLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       223 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      ...+.     ..||+++|...|+|.+.+.... ++..+++.+++.|+.++++||.+||+.. .+++||||||.|||+.+.
T Consensus        87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~  165 (302)
T KOG2345|consen   87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDS  165 (302)
T ss_pred             HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCC
Confidence            87543     4999999999999999998763 3447999999999999999999999921 249999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCccc-------cccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIR-------EDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~-------~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      +.++|.|||.+...+........       ..-..|..|.|||.+.   +...+.++|||||||+||.|+.|..||+..-
T Consensus       166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence            99999999999654432211110       1234789999999984   4557899999999999999999999996322


Q ss_pred             CCChhhHHHhhhhhhcCCCc-ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          367 LKGPESLVKWAKPILKNGDT-ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ..              .+.+ .....+.+.-......+..+.+++++||+.||.+||++.+++..++..
T Consensus       246 ~~--------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  246 QQ--------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             hc--------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            11              1111 111222222222233678899999999999999999999999988764

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.3e-39  Score=319.61  Aligned_cols=265  Identities=17%  Similarity=0.302  Sum_probs=202.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||.|+||.||++.......   ......+++|.+....  ......+|.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~---~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVK---DEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCC---CCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4689999999999999999876432111   1233456666554321  2224567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC-------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE-------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ++...++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCC
Confidence            99999999999999999999975321       2246788999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~  376 (522)
                      .++|+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.....   ......
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~  233 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF  233 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence            999999999875543322222222345788999999988889999999999999999999 7888864322   111111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .    ..+.....         +...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       234 ~----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 V----MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             H----HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1    11111110         11234568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=339.18  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=203.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +...+...||.|+||+||++..-.           .||+|.|+..... .+..+.|++|+.+|++-+|.||+-+.|+|..
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG-----------dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG-----------DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             HHhhccceeccccccceeeccccc-----------ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            345778999999999999998432           2333333332222 2367899999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++. .||+-+|+|-+|..+|+...  ..|...+.+.|+.|++.|+.|||.   ++|||||||..|||+.++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence            887 99999999999999999754  349999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++.....-..........|...|||||++..   .+|+..+||||||+|+|||++|..||....   .++++-.    +.
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifm----VG  606 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFM----VG  606 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEE----ec
Confidence            9954333222222334568889999999863   468999999999999999999999997322   1121111    11


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .|-    +.|.+ .......++.|.+|+..||.+++++||.+.+|+..|+....
T Consensus       607 rG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            110    11111 11223456789999999999999999999999998887754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.5e-39  Score=321.43  Aligned_cols=266  Identities=22%  Similarity=0.258  Sum_probs=192.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceeeEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLNGV  222 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~~~  222 (522)
                      .+|++.+.||+|+||.||++.+..       ...+.+++|.++..... ......+.+|+.+++.+   +||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK-------NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC-------CCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            379999999999999999987532       12344555554332211 11234566777777766   69999999999


Q ss_pred             EEe-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          223 CIE-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       223 ~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      |..     ...+++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~  147 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSG  147 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCC
Confidence            862     456899999996 59999997543 2348999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||+++......   ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......  .+....
T Consensus       148 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~  222 (290)
T cd07862         148 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKIL  222 (290)
T ss_pred             CEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHH
Confidence            99999999997654331   1224568999999999988889999999999999999999999997543221  111111


Q ss_pred             hhhh--cCCCc-------ccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          378 KPIL--KNGDT-------ETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       378 ~~~~--~~~~~-------~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ....  .....       ...+.+..   ........+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000  00000       00000000   00111123456788999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=342.81  Aligned_cols=256  Identities=21%  Similarity=0.253  Sum_probs=199.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.+.+.||.|+||.||++.....       ....+++|.+.   .........+.+|+.+|+.++|||||++++++.
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~-------~~~~vv~K~~~---~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~  135 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSD-------PKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFK  135 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCC-------CCeEEEEEEcc---cCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            34599999999999999999865421       12233333221   111224456888999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .++.++|||||+++|+|.+++... .....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~D  212 (478)
T PTZ00267        136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGD  212 (478)
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEe
Confidence            999999999999999999988653 234458999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+..   ... .
T Consensus       213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~---~~~-~  285 (478)
T PTZ00267        213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQ---QVL-Y  285 (478)
T ss_pred             CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-h
Confidence            9999766543332233355799999999999988999999999999999999999999964321   11111   111 1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +....         .+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       286 ~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 GKYDP---------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCC---------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11110         11123457889999999999999999999975

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8e-39  Score=327.62  Aligned_cols=256  Identities=19%  Similarity=0.271  Sum_probs=200.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCC-CcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQK-SITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hp-nIv~l~~~~~~  225 (522)
                      +|++.+.||+|+||.||++....        ..+.+++|.+++.........+.+..|+.++..+.|+ +|+++++++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   72 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG--------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   72 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Confidence            48899999999999999987543        4556777776654433344567889999999999765 68899999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          73 MDRLYFVMEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            99999999999999999999753   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ........    ...
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~----~~~  217 (324)
T cd05587         147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIM----EHN  217 (324)
T ss_pred             cceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH----cCC
Confidence            9864322111  12245689999999999988999999999999999999999999964431   11111111    110


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~~L~~~~~~~~~~~~  443 (522)
                                ..++...+..+.+++.+||+.||.+||+.     .++++        |+|+..
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~--------hp~~~~  262 (324)
T cd05587         218 ----------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE--------HAFFRR  262 (324)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc--------CCCcCC
Confidence                      01111234567889999999999999986     45554        666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=333.84  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=211.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.+++.+|.|+||.+++++++.        ..+.+.+|++.-+... ........+|+.++++++|||||.+.+.+.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~--------~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~hP~iv~y~ds~~   73 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKS--------DDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLLHPNIVEYKDSFE   73 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhcc--------CCceEEEEEEeccccC-chhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence            3679999999999999988877653        3446666666543332 223447789999999999999999999999


Q ss_pred             eCCE-EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDNY-LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +++. ++|||+||+||+|.+.+.... +..++++.++.++.|++.|+.|||+   ..|+|||||+.|||++.++.++|+|
T Consensus        74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   74 EDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             cCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecc
Confidence            9887 999999999999999998764 4569999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+|+.......  ....+.||+.||.||.+.+.+|..|+|||||||++|||++-+.+|...+...   ++....+..  
T Consensus       150 fGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~~--  222 (426)
T KOG0589|consen  150 FGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRGL--  222 (426)
T ss_pred             hhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhcc--
Confidence            999988766542  2235789999999999999999999999999999999999999998665433   222111111  


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                                 ....+..++..+..++..||..+|..||++.++|..
T Consensus       223 -----------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                       122344567789999999999999999999999974

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-38  Score=317.47  Aligned_cols=263  Identities=22%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.+.||+|+||.||++.....    .......+++|.++...  ......+|.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   78 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP----GMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ   78 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC----CCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence            4688999999999999999864210    11234566666665322  23345789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCC--------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGE--------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      +...++||||+++++|.+++.....              ...+++..++.++.|++.||.|||+   ++++||||||+||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~ni  155 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNI  155 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceE
Confidence            9999999999999999999863321              2347889999999999999999999   9999999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGP  370 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~  370 (522)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....   
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---  232 (283)
T cd05090         156 LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---  232 (283)
T ss_pred             EEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999999999999999976543322222233446778999999988889999999999999999998 9999854321   


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ..+....    .......         .+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       233 ~~~~~~~----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMV----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHH----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111    1111110         111234578889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-38  Score=313.56  Aligned_cols=263  Identities=22%  Similarity=0.337  Sum_probs=206.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ..+.+++|.++...........+|.+|++++++++||||+++++++.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL--------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE   73 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC--------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence            579999999999999999987542        345566665443222223355679999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECcc
Confidence            999999999999999999886432 23458899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++........  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+....    ...
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~----~~~  223 (267)
T cd08228         151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI----EQC  223 (267)
T ss_pred             ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH----hcC
Confidence            99876543321  112346888999999998888999999999999999999999998543221 11122111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...        .......+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus       224 ~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 DYP--------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCC--------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111        111123456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.5e-39  Score=337.89  Aligned_cols=268  Identities=21%  Similarity=0.299  Sum_probs=206.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~  223 (522)
                      .++|+++++||+|+||.||.+......   .......+++|.++..  ......+.|.+|+.+|+++. |||||+++++|
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLS---RSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccC---CCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            568999999999999999988653211   1122345677766432  12234578999999999995 99999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-----------------------------------------------------
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-----------------------------------------------------  250 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  250 (522)
                      .+.+.++|||||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999999865310                                                     


Q ss_pred             ----------------------------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          251 ----------------------------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       251 ----------------------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                                                              ...+++..++.++.|++.||.|||+   .+|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHh
Confidence                                                    1247888899999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999976544333222333457788999999988889999999999999999997 999986432111


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        .+..    ....+..         ...+...+..+.+++.+||+.+|.+||++.+|.++|+...
T Consensus       348 --~~~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYN----KIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHH----HHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              1111    1111110         0111234567889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5e-39  Score=335.62  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|.+.+....-....+.|.+|+.+++.++||||+++++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKS--------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            34689999999999999999987643        4556777766443322223445688999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+++||||+++|+|.+++...    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEe
Confidence            9999999999999999999999743    38889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG----KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||++........ .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......   .   ...
T Consensus       186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~  258 (370)
T cd05596         186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSK  258 (370)
T ss_pred             ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H---HHH
Confidence            999976543221 112245799999999998653    47899999999999999999999997543211   1   111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..........  +   .  ....+..+.+++.+||+.+|.+  ||++.++++        |+|++..
T Consensus       259 i~~~~~~~~~--~---~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~--------h~~~~~~  310 (370)
T cd05596         259 IMDHKNSLTF--P---D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS--------HPFFKND  310 (370)
T ss_pred             HHcCCCcCCC--C---C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc--------CcccCCC
Confidence            1111100000  0   0  1123467888999999999988  999999997        8887653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.3e-39  Score=327.59  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+.+|..++..+ +||||+++++++...+.++
T Consensus         1 ~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   72 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE--------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF   72 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC--------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEE
Confidence            358999999999987543        4567777776654433334667888999999887 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        73 iv~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          73 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999999999999998754   348999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+...   .. .+..    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~---i~-~~~~----  213 (320)
T cd05590         147 IFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEA---IL-NDEV----  213 (320)
T ss_pred             CcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH---Hh-cCCC----
Confidence            22211  122457899999999999888999999999999999999999999654321   11111   11 1111    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM------GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~------~eVl~~L~~~~~~~~~~~~  443 (522)
                            ..+...+..+.+++.+||+.||.+||++      .+++.        |+|+..
T Consensus       214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~--------h~~f~~  258 (320)
T cd05590         214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR--------HPFFKE  258 (320)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc--------CCCcCC
Confidence                  0111234567889999999999999998      55654        888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-38  Score=329.04  Aligned_cols=267  Identities=23%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      .+|++.+.||.|+||.||++.....   ....+++.+++|.++...  .....+.+.+|+.++.++ +|+||++++++|.
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGI---EKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHhhhhcccccCcCceEEecccccc---ccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            5899999999999999999864321   112346778888765321  223456788999999999 8999999999887


Q ss_pred             eC-CEEEEEEecCCCCCHHHHhhccCC-----------------------------------------------------
Q 036172          225 ED-NYLILVSDFLPKGSLEESLHGAGE-----------------------------------------------------  250 (522)
Q Consensus       225 ~~-~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  250 (522)
                      .. ..+++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            54 678999999999999999864311                                                     


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccC
Q 036172          251 -----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT  325 (522)
Q Consensus       251 -----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  325 (522)
                           ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++................++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                 1258999999999999999999999   99999999999999999999999999999765443333333344567


Q ss_pred             CCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHH
Q 036172          326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQ  404 (522)
Q Consensus       326 ~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  404 (522)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.......  .+..    .+..+....         .+.....
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~~~---------~~~~~~~  303 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGTRMR---------APEYATP  303 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccCCCC---------CCccCCH
Confidence            88999999999999999999999999999998 999986532211  1111    111111110         0112345


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          405 RMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       405 ~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.5e-39  Score=326.56  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=191.9

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+..|..++..+ +||||+++++++..++.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~   72 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG--------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence            368999999999987543        4556777766554433334556677788888765 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          73 FVMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            999999999999999753   248999999999999999999999   99999999999999999999999999999754


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+....   .. ..     
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i---~~-~~-----  212 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSI---LN-DR-----  212 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHH---Hc-CC-----
Confidence            3322  122345789999999999988899999999999999999999999975432   1111111   11 00     


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG-QVLK  429 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~-eVl~  429 (522)
                       +    .++......+.+++.+||+.+|.+||++. ++++
T Consensus       213 -~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         213 -P----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             0    11122345678899999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-38  Score=317.37  Aligned_cols=275  Identities=25%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             CCc-eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPF-QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y-~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ++| ++.+.||.|+||.||++....    ........+++|.++...  .......|.+|++++++++||||+++++++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDP----ANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCS   76 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEcc----ccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            455 899999999999998764221    112234566777665432  1234567899999999999999999999987


Q ss_pred             eC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          225 ED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      ..  ..+++||||+++++|.+++...    .+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          77 EQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             cCCCceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEe
Confidence            54  4689999999999999999743    38999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||++.......... ......++..|+|||.+....++.++||||||+++|+|++|..||....... ...........
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~  228 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM  228 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc
Confidence            999997655432211 1122345677999999988889999999999999999999999986432111 11111110000


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ........++.......+...+..+.+++.+||+.+|.+||++++|++.|+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00011111111111112223456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-38  Score=324.76  Aligned_cols=263  Identities=20%  Similarity=0.304  Sum_probs=203.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||++......    ......+++|.++...  .....++|.+|+.+++.++||||++++|+|.
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~   79 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEG----EKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL   79 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCC----CccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence            467999999999999999998643210    1112346666665322  2234578999999999999999999999998


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .. ..++|+||+++|+|.+++....  ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        80 ~~-~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~Df  153 (316)
T cd05108          80 TS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDF  153 (316)
T ss_pred             CC-CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccc
Confidence            75 5679999999999999998642  348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   .+...    ...
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~----~~~  226 (316)
T cd05108         154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEK  226 (316)
T ss_pred             cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HhC
Confidence            99987654433322223345678999999999999999999999999999998 99998643211   11111    111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....  .       +......+..++.+||..+|.+||++.+|+..|....
T Consensus       227 ~~~~~--~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         227 GERLP--Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CCCCC--C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11100  0       1112346788999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-38  Score=316.41  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=197.3

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||.|+||.||++....        .++.+++|.+.+.........+.+..|++++++++||||+++++++..+...++||
T Consensus         1 lg~G~~g~Vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~   72 (277)
T cd05607           1 LGKGGFGEVCAVQVKN--------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVM   72 (277)
T ss_pred             CCCCCceEEEEEEEcc--------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEE
Confidence            6999999999987543        34556665554333222223455677999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        73 e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          73 SLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             ecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9999999999886543 2348999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCc
Q 036172          314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPK  393 (522)
Q Consensus       314 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  393 (522)
                      ..   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  ......... .....     
T Consensus       149 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~~-----  217 (277)
T cd05607         149 KT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE-DEVKF-----  217 (277)
T ss_pred             ce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc-ccccc-----
Confidence            21   12346899999999998888999999999999999999999998643321111  111111111 11000     


Q ss_pred             ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          394 LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       394 l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .   ....+..+.+++.+||+.||.+||++.|+++.+.    .|+|++.
T Consensus       218 -~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~----~h~~f~~  259 (277)
T cd05607         218 -E---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR----KHEFFKT  259 (277)
T ss_pred             -c---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh----cChhhcC
Confidence             0   0123456889999999999999999977764333    3888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-38  Score=327.01  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+.+|+.++.++ +||||+++++++..++.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   72 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK--------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   72 (329)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEE
Confidence            358999999999987543        4566777777655444444567788999999887 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        73 lv~E~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          73 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999999999999988743   358999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--hhhHHHhhhhhhcCCCccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG--PESLVKWAKPILKNGDTET  388 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~  388 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+....+.....  
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--  222 (329)
T cd05618         147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--  222 (329)
T ss_pred             cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--
Confidence            22111  1224578999999999999999999999999999999999999996322111  11111111111111111  


Q ss_pred             ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHHHhccccCCcccccc
Q 036172          389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN------MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       389 ~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs------~~eVl~~L~~~~~~~~~~~~~  444 (522)
                              .++......+.+++.+||+.||.+||+      +.++++        |+|++..
T Consensus       223 --------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~--------hp~f~~~  268 (329)
T cd05618         223 --------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--------HPFFRNV  268 (329)
T ss_pred             --------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc--------CCCCCCC
Confidence                    112223456788999999999999998      467665        8887653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.7e-38  Score=317.81  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=204.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        ..+.+++|.+.+...........+.+|+.++++++|+||+++++.+.++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA--------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC--------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence            47888999999999999987653        4556666665443333333446688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          73 DALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999865432 348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........   ....|+..|+|||++.+..++.++||||||+++|+|++|+.||..............   .....  
T Consensus       149 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~~--  220 (285)
T cd05630         149 AVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKEV--  220 (285)
T ss_pred             eeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhhh--
Confidence            8654433221   234689999999999988999999999999999999999999975432211111110   00000  


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                              ...+.......+.+++.+||+.||.+||+     +.++++        |+|+..
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~--------h~~~~~  266 (285)
T cd05630         221 --------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE--------HPLFKQ  266 (285)
T ss_pred             --------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc--------Chhhhc
Confidence                    00111223456788999999999999999     889987        888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.7e-39  Score=327.75  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=198.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      ++||+|+||.||++.....     ....+.+++|.+++... ........+.+|+.+|++++||||+++++++..++.++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG-----ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEccc-----CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEE
Confidence            5699999999999864321     23456677776654322 11223456889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+.+..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            999999999999999753   348889999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ..... .+..    
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~---~~~~~-~~~~----  217 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KT---IDKIL-KGKL----  217 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HH---HHHHH-cCCC----
Confidence            32221  122357899999999998888999999999999999999999999654321   11   11111 1111    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                            ..+......+.+++.+||+.+|.+||     ++.++++        ++|++.
T Consensus       218 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~--------h~~~~~  261 (323)
T cd05584         218 ------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS--------HPFFRH  261 (323)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc--------CCCcCC
Confidence                  01112345678899999999999999     8888887        777754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.7e-39  Score=326.59  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+..|.+++..+ +||||+++++++..++.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~   72 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG--------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF   72 (321)
T ss_pred             CccccCCCeEEEEEEECC--------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEE
Confidence            358999999999987542        4566777776654433344567788999999877 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        73 lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          73 FVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999998743   348999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ......   ... +..   .
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~---i~~-~~~---~  214 (321)
T cd05591         147 ILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFES---ILH-DDV---L  214 (321)
T ss_pred             ccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHH---HHc-CCC---C
Confidence            32221  12245689999999999988999999999999999999999999975432   111111   111 110   0


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCC-------CHHHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-------NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-------s~~eVl~~L~~~~~~~~~~~~  443 (522)
                             ++......+.+++.+||+.+|.+||       ++.++++        ++|+..
T Consensus       215 -------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~--------hp~~~~  259 (321)
T cd05591         215 -------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ--------HPFFKE  259 (321)
T ss_pred             -------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc--------CCccCC
Confidence                   1111345678899999999999999       7888886        777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=317.02  Aligned_cols=273  Identities=23%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             CCCceeeecccccccccccccCchhHHH------HhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcce
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFL------KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITT  218 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~------~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~  218 (522)
                      .++|++.++||+|+||.||++.......      .........+++|.+...  ......+.|.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4689999999999999999987542110      001112234566655421  12335568999999999999999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCC---------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGE---------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +++++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||.|||+   .+++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChh
Confidence            99999999999999999999999999964321         1237889999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS--GRRPIGFKNL  367 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~Pf~~~~~  367 (522)
                      ||+++.++.+||+|||++................++..|+|||++..+.++.++|||||||++++|++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999976543322222223345778999999988899999999999999999998  5566653321


Q ss_pred             CChhhHHHhhhhhhcC-CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          368 KGPESLVKWAKPILKN-GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                         ............. +.......       +...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 ---EQVIENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               1122111111111 11000000       1113457999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-38  Score=319.19  Aligned_cols=268  Identities=23%  Similarity=0.373  Sum_probs=205.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|.+.+.||.|+||.||++......   .......+++|.++.   ......+.|.+|+.++++++|+||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS---PTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC---CCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            56889999999999999998642110   011223344444322   112244679999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      +...++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+   ++++||||||+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  155 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCL  155 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEE
Confidence            9999999999999999999975421             2348999999999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChh
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE  371 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~  371 (522)
                      ++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......   
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---  232 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---  232 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999975544332222233456788999999988889999999999999999999 99998643321   


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      .....    ...+.....         ....+..+.+++.+||+.+|.+||++.+|++.|+.+...+
T Consensus       233 ~~~~~----~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         233 EVIEC----ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             HHHHH----HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            11111    111111111         1123457889999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-38  Score=318.62  Aligned_cols=267  Identities=22%  Similarity=0.388  Sum_probs=206.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.+.+.||+|+||.||++......   .......+++|.+....   ....+.|.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~---~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLC---PEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV   77 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCC---CCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            357899999999999999998642210   11223345555554322   224567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG----------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      ..+..++||||+++++|.+++...+          ....+++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~  154 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVG  154 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEc
Confidence            9999999999999999999997542          12248999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhH
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL  373 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l  373 (522)
                      +++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......   ..
T Consensus       155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~  231 (288)
T cd05093         155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV  231 (288)
T ss_pred             cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            999999999999976543332222223446788999999988889999999999999999998 99998644321   11


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...    +..+.....     .    ...+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       232 ~~~----i~~~~~~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         232 IEC----ITQGRVLQR-----P----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHH----HHcCCcCCC-----C----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            111    111111111     1    1133568999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=314.38  Aligned_cols=261  Identities=21%  Similarity=0.326  Sum_probs=204.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++.....     ......+++|.++...  ......+|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLP-----GKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccC-----CCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            5789999999999999999875421     1123345555543321  23355789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccc
Confidence            999999999999999999997643  258999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+....    ..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~  224 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDG  224 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcC
Confidence            9987653222222223345678999999988889999999999999999998 9999854321   1121111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...    +     .+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       225 ~~~----~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 YRL----P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCC----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000    0     0112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-38  Score=333.34  Aligned_cols=263  Identities=22%  Similarity=0.275  Sum_probs=202.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        ..+.+++|.+.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKS--------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4689999999999999999987643        45566666654433222234566889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999643    38899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG----KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |++........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.......      .....
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i  259 (370)
T cd05621         187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKI  259 (370)
T ss_pred             ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence            99976543221 122345799999999998653    37889999999999999999999996543211      11111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .........     .  .....+..+.+++..||..++.+  ||++.++++        |+|++..
T Consensus       260 ~~~~~~~~~-----p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--------hp~~~~~  310 (370)
T cd05621         260 MDHKNSLNF-----P--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--------HPFFKND  310 (370)
T ss_pred             HhCCcccCC-----C--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--------CcccCCC
Confidence            111110000     0  01123456778888899755543  899999997        8888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-38  Score=317.27  Aligned_cols=274  Identities=22%  Similarity=0.348  Sum_probs=206.7

Q ss_pred             CCCceeeecccccccccccccCchhHHH--------HhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFL--------KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~--------~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      .++|++.+.||+|+||.||++.......        .........+++|.+.....  ....++|.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence            4689999999999999999986542111        11122234566666543222  1356789999999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEecCCCCCHHHHhhccC--------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          217 TTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG--------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                      +++++++..++..++||||+++++|.+++....        ....+++..++.++.|++.||.|||+   .+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccch
Confidence            999999999999999999999999999997643        11258999999999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS--GRRPIGFKN  366 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~Pf~~~~  366 (522)
                      +||+++.++.++|+|||+++...............++..|+|||++.++.++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999876543332222334456788999999988889999999999999999998  677775332


Q ss_pred             CCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                         .....................      ..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 ---DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               112222222221111111111      111123467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-38  Score=330.12  Aligned_cols=271  Identities=19%  Similarity=0.224  Sum_probs=202.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++....      ....+.+++|.+...        +.+.+|+++|++++|||||++++++.
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~------~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~  156 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHG------DEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYR  156 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcC------CccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence            4589999999999999999985422      123344555544321        23568999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .....++|||++. ++|.+++..   ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.++|+||
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccC
Confidence            9999999999995 589998853   3359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++................||+.|+|||++....++.++|||||||++|||++|+.||..................+...
T Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~  309 (392)
T PHA03207        230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH  309 (392)
T ss_pred             ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence            99976554433333334679999999999998899999999999999999999999996554332211111111111100


Q ss_pred             Cc-----------------ccccCCccc-ccc--cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          385 DT-----------------ETLLDPKLS-NEY--DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~-----------------~~~~d~~l~-~~~--~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..                 .....+... ...  .......+.+++.+||..||.+||++.+++.        ++|+...
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--------~p~f~~~  381 (392)
T PHA03207        310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--------LPLFTKE  381 (392)
T ss_pred             ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--------Cchhhcc
Confidence            00                 000000000 000  0012346778999999999999999999998        8898754

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-38  Score=318.92  Aligned_cols=268  Identities=24%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.......   ......+++|.++...  ......++.+|+.+++++ +|+||++++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~---~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDN---PNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCC---CCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34689999999999999999987543210   1233456666554321  123456799999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhcc-------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGA-------------GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +..++.+++||||+++|+|.+++...             .....+++..++.++.|++.||.|||+   .+|+||||||+
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~  161 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAAR  161 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCcccccccee
Confidence            99999999999999999999999743             123458999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      ||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999999976544322222222345678999999988889999999999999999998 99998643321


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .   ....    ...+..         ...+...+..+.+++.+||..+|.+|||+.+|++.|+.+.
T Consensus       242 ~---~~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 E---LFKL----LKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H---HHHH----HHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1   1111    111110         0111123457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-38  Score=324.95  Aligned_cols=251  Identities=20%  Similarity=0.264  Sum_probs=200.5

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ....+++|.+++...........+.+|..++..+ +||||+++++++...+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~   72 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG--------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF   72 (318)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence            358999999999987542        4566777777665444444567788999999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          73 FVMEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999999999999998754   249999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+....    .....    
T Consensus       147 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i----~~~~~----  213 (318)
T cd05570         147 ILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSI----LEDEV----  213 (318)
T ss_pred             CcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHH----HcCCC----
Confidence            22211  12234689999999999999999999999999999999999999964431   1111111    11110    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~~L~~~~~~~~~~~~  443 (522)
                            .++...+..+.+++.+||+.||.+||++     .++++        ++|++.
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~--------~~~~~~  257 (318)
T cd05570         214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG--------HPFFRE  257 (318)
T ss_pred             ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc--------CCCcCC
Confidence                  0111234578899999999999999999     88876        788765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-38  Score=317.32  Aligned_cols=265  Identities=24%  Similarity=0.341  Sum_probs=203.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||+|+||.||++.......   ......+++|.+....  .....++|.+|+.+++.++||||+++++.+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG---RAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC---CCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence            47889999999999999986532110   1122345555443211  123457899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccC---------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEecc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAG---------------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD  285 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrD  285 (522)
                      +..++||||+++|+|.+++....                     ....+++..++.++.|++.||.|||+   .+++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhh
Confidence            99999999999999999986421                     12348899999999999999999999   9999999


Q ss_pred             CCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 036172          286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGF  364 (522)
Q Consensus       286 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~  364 (522)
                      |||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++++|++ |..||..
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999975543332222223356778999999988889999999999999999998 9999864


Q ss_pred             CCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..   ...+........         ..    ..+...+..+.+++..||+.+|.+||++.+|++.|+++.
T Consensus       233 ~~---~~~~~~~~~~~~---------~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         233 IA---PERLFNLLKTGY---------RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CC---HHHHHHHHhCCC---------CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            32   222222221110         00    011123457889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.1e-38  Score=311.83  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=201.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|.+.++||+|+||.||++....        ....+++|.++..    ....++|.+|++++++++||||+++++++..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK--------YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec--------CCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            468899999999999999977532        3445555554421    2245679999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCc
Confidence            999999999999999999997543 2358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   ......    ..+
T Consensus       150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~  221 (263)
T cd05052         150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKG  221 (263)
T ss_pred             cccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCC
Confidence            99765443221 1112234668999999988899999999999999999998 99998643321   111111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .         ....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       222 ~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 Y---------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            0         0111122346788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-39  Score=319.27  Aligned_cols=257  Identities=30%  Similarity=0.461  Sum_probs=194.2

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      .+.+.||.|.||.||++....    ........+++|.++.  ....+..++|.+|++++++++||||++++|++...+.
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~----~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~   75 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ----KDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP   75 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES----TTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS
T ss_pred             EEeeEEccCCCcEEEEEEEEc----ccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccc
Confidence            456789999999999987652    1233445566666532  1122347889999999999999999999999998888


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      .++||||+++|+|.++|... ....+++..++.|+.|++.||.|||+   .+++|++|+++||+++.++.+||+|||++.
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             cccccccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            99999999999999999976 23459999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       309 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      ...................|+|||.+....++.++||||||+++|||++ |+.||....   ...+....    ..+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~----~~~~~~  224 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKL----KQGQRL  224 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHH----HTTEET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----cccccc
Confidence            7633332233334467789999999999889999999999999999999 788875432   22222211    111111


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                               ..+...+..+..++..||..+|.+||++.+|++.|
T Consensus       225 ---------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                     11122345688899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-38  Score=325.44  Aligned_cols=245  Identities=20%  Similarity=0.282  Sum_probs=194.7

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~  225 (522)
                      +|++.+.||+|+||.||++....        ..+.+++|.+++.........+.+..|..++..+ +|++|+++++++..
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   72 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG--------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT   72 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence            48899999999999999987543        4456677766554333334556788899999888 68999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          73 MDRLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCC
Confidence            99999999999999999998753   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.....   . ..
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~---~-~~  217 (323)
T cd05616         147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM---E-HN  217 (323)
T ss_pred             CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH---h-CC
Confidence            9865332211  12245789999999999999999999999999999999999999965432   12221111   1 11


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM  424 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~  424 (522)
                      .          .++...+..+.+++.+||+.+|.+|++.
T Consensus       218 ~----------~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 V----------AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C----------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            0          1112234577889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-38  Score=311.21  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=192.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||.|+||.||++....        ..+.+++|.+....  ..+....|.+|++++++++||||+++++++......++|
T Consensus         2 ~lg~g~~g~vy~~~~~~--------~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           2 RIGRGNFGEVFSGRLRA--------DNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             ccCcccCccEEEEEEec--------CCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            58999999999987643        34455555443211  123456799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++++|.+++...+  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        72 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          72 MELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             EeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccc
Confidence            99999999999997532  348999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      ............+..|+|||.+.++.++.++||||||+++|+|++ |..||......   .....    .....      
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~----~~~~~------  213 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREA----IEQGV------  213 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHH----HHcCC------
Confidence            211111111223467999999988889999999999999999998 88888543211   11111    11110      


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                         ....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       214 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 ---RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence               00111223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.2e-38  Score=308.70  Aligned_cols=263  Identities=21%  Similarity=0.352  Sum_probs=209.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.++..........+++.+|++++++++|+||+++++++..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~   73 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL--------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE   73 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC--------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            579999999999999999987542        455677776654333333456789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          226 DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++..++||||+++|+|.+++... .....+++..++.++.+++.||.|||+   .+++||||+|+||+++.++.++|+||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEecc
Confidence            99999999999999999998753 223458999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++.........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......    ....... +..+
T Consensus       151 ~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~  223 (267)
T cd08224         151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEKC  223 (267)
T ss_pred             ceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hhcC
Confidence            998765433221  12346888999999998888999999999999999999999998644321    1111111 1111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .....     .   ....+..+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       224 ~~~~~-----~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 DYPPL-----P---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCC-----C---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11111     0   113445788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=339.06  Aligned_cols=266  Identities=24%  Similarity=0.312  Sum_probs=207.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+..+.++||+|+||.||++.-.....    .....+|+|..+.......++.++|++|++++++++|||||++||++..
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~----~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNG----FKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCC----ceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            344566999999999999987432100    0111166666654333445688999999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...++||||+|.||+|.++|+..+.  .++..+++.++.+.+.||+|||+   .++|||||-.+|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence            9999999999999999999997543  59999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +++.......  ......-...|+|||.+..+.++.++|||||||++||+++ |..||.......   +..++   ...+
T Consensus       308 Ls~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---~~~~  379 (474)
T KOG0194|consen  308 LSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---VKNG  379 (474)
T ss_pred             cccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH---HhcC
Confidence            9865441111  1112235678999999999999999999999999999999 888986543221   11111   1111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      .         ....+...+..+..++.+||..+|++||+|.++.+.|+.+...
T Consensus       380 ~---------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  380 Y---------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             c---------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            1         1111223456778888999999999999999999999887643

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-38  Score=341.89  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=203.7

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++....        ..+.|++|.+..... .......+.+|+.++..++|+||+++++.
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~--------~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~   99 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVS--------DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHED   99 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcC--------CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence            345799999999999999999987543        456677776543211 12345678999999999999999999987


Q ss_pred             EEeCC--------EEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          223 CIEDN--------YLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       223 ~~~~~--------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      +....        .+++||||+++|+|.+++... .....+++..+..++.|++.||.|||+   .+|+||||||+|||+
T Consensus       100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl  176 (496)
T PTZ00283        100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILL  176 (496)
T ss_pred             eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEE
Confidence            76432        478999999999999999754 233468999999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+
T Consensus       177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~  253 (496)
T PTZ00283        177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEV  253 (496)
T ss_pred             eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHH
Confidence            99999999999999765543333333356799999999999998999999999999999999999999965322   111


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .   .... .+....         .+...+..+.+++.+||+.+|.+||++.++++
T Consensus       254 ~---~~~~-~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        254 M---HKTL-AGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             H---HHHh-cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            1   1111 111111         11223467889999999999999999999986

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-38  Score=324.76  Aligned_cols=259  Identities=20%  Similarity=0.264  Sum_probs=199.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+.+|+.++.++ +||||+++++++.+.+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   72 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK--------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF   72 (327)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE
Confidence            369999999999987543        4556666666554333334567789999999998 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          73 LVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999999999999988743   349999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+..........    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  220 (327)
T cd05617         147 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----  220 (327)
T ss_pred             cCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----
Confidence            22111  122457999999999999999999999999999999999999999643322211111111111111110    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhccccCCcccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM------GQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~------~eVl~~L~~~~~~~~~~~~~  444 (522)
                            ..+...+..+.+++.+||+.||.+||++      .++++        |+|++.-
T Consensus       221 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~--------h~~f~~~  266 (327)
T cd05617         221 ------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS--------HTFFRSI  266 (327)
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc--------CCCCCCC
Confidence                  1112234567889999999999999985      46654        7777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-38  Score=312.32  Aligned_cols=255  Identities=21%  Similarity=0.362  Sum_probs=200.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++....         ...+++|.++...    ...+.|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN---------STKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC---------CceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4679999999999999999986432         2234555443211    13467999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCC
Confidence            9999999999999999999997542 3358899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++......... ......++..|+|||++..+.++.++|||||||++|+|++ |..||......   .......    .
T Consensus       148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~  219 (261)
T cd05072         148 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ----R  219 (261)
T ss_pred             ccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH----c
Confidence            999765433221 1122345678999999988889999999999999999998 99998643211   1111111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +...    +.     ....+..+.+++.+||..+|++||++++|++.|+.
T Consensus       220 ~~~~----~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 GYRM----PR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCC----CC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1100    00     11234568889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=327.43  Aligned_cols=263  Identities=24%  Similarity=0.297  Sum_probs=221.6

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~  221 (522)
                      .....|++.+.||.|.||.||.+....        +++.+|+|.+++.........+.+.+|+.||++|. |||||.+++
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~--------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~  103 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKS--------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD  103 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecC--------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            345689999999999999999998754        47888888887777665556788999999999997 999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC----C
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----F  297 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~----~  297 (522)
                      ++.+...+++|||++.||.|.+.+...    .+++..+..++.|++.++.|||+   .||+||||||+|+|+...    +
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCC
Confidence            999999999999999999999999865    29999999999999999999999   999999999999999643    4


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+|++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||..........     
T Consensus       177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----  248 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----  248 (382)
T ss_pred             cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----
Confidence            799999999988766   223346799999999999998999999999999999999999999997554322221     


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .+..++.      ..........+....+++..|+..||..|+|+.++|+        |+|+...
T Consensus       249 --~i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--------HpWi~~~  299 (382)
T KOG0032|consen  249 --AILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--------HPWIKSI  299 (382)
T ss_pred             --HHHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--------CccccCC
Confidence              1122222      1223333445778899999999999999999999998        8998764

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-38  Score=323.90  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        ..+.+++|.+++.........+.+..|..++..+ +||||+++++++.+.+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~   72 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG--------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF   72 (316)
T ss_pred             CeeeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE
Confidence            358999999999987643        4556777766554433334556778888888875 9999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        73 lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          73 FVMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999999999999753   348999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.....    ...     
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~----~~~-----  212 (316)
T cd05619         147 MLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR----MDN-----  212 (316)
T ss_pred             CCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCC-----
Confidence            22211  12245689999999999988999999999999999999999999965432   11211111    110     


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG-QVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~-eVl~~L~~~~~~~~~~~~  443 (522)
                       +.    ++......+.+++.+||+.+|.+||++. ++++        ++|+..
T Consensus       213 -~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~--------h~~~~~  253 (316)
T cd05619         213 -PC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ--------HPFFRE  253 (316)
T ss_pred             -CC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc--------CcccCC
Confidence             10    1112345678899999999999999997 5654        666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=301.25  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=210.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      -...|++-..||.|.|+.|+++.+..        +++.|+.|.+....-.. ...+++.+|++|-+.|+|||||++.+.+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~--------tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti   79 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKT--------TGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSI   79 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhcc--------chHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence            45679999999999999988876544        67778888775433222 2678899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---CceE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---FQPQ  300 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---~~~k  300 (522)
                      .+.+..|||+|++.|++|..-+-.+   ..+++..+-..+.||+++|.|+|.   ++|||||+||.|+++...   --+|
T Consensus        80 ~~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vK  153 (355)
T KOG0033|consen   80 QEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVK  153 (355)
T ss_pred             cccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCcee
Confidence            9999999999999999997666532   458899999999999999999999   999999999999999543   3599


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||+|.......   .-....|||+|||||++...+|+..+|||+.|||||-|+.|.+||...+   ...+.+.+   
T Consensus       154 L~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I---  224 (355)
T KOG0033|consen  154 LADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQI---  224 (355)
T ss_pred             ecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHH---
Confidence            99999998766322   2235689999999999999999999999999999999999999996532   12222211   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                       ..+.+.      ..+..-....+...+|+++||..||.+|.|+.|.|+        |+|++...
T Consensus       225 -~~g~yd------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~--------HpWi~~r~  274 (355)
T KOG0033|consen  225 -KAGAYD------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK--------HPWICNRE  274 (355)
T ss_pred             -hccccC------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC--------CchhcchH
Confidence             111111      111122234567888999999999999999999998        99988653

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-37  Score=313.43  Aligned_cols=275  Identities=20%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             CCCceeeecccccccccccccCchhHHH--------HhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFL--------KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~--------~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      .++|++.++||+|+||.||++.......        .........+++|.++...  .....++|.+|+.++++++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence            3579999999999999999986432110        0112223456666655321  23356789999999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCC--------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          217 TTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE--------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                      +++++++..++..++||||+++|+|.+++.....        ...+++..++.++.|++.||.|||+   .+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCh
Confidence            9999999999999999999999999999976421        1247788999999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS--GRRPIGFKN  366 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~Pf~~~~  366 (522)
                      +|||++.++.++|+|||++................++..|+|||....+.++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999999975543322222222345678999999988899999999999999999998  677875432


Q ss_pred             CCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ..   ............... ....+.     +...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       239 ~~---~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 DE---QVIENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hH---HHHHHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            21   111111111111100 000010     11233678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-38  Score=310.82  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=196.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||+|+||.||++....         ...+++|.++...    ...++|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~---------~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA---------QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ   70 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc---------CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEcc
Confidence            468899999999999999986532         2245555443211    123578999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||
T Consensus        71 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          71 QKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCC
Confidence            999999999999999999997532  248999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ........    .+
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~----~~  217 (256)
T cd05114         146 MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS----RG  217 (256)
T ss_pred             CccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CC
Confidence            98755332211 1112245668999999988889999999999999999999 8999864432   12222111    11


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      ..  ...+.       ..+..+.+++.+||+.+|.+||++.+|++.|
T Consensus       218 ~~--~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 FR--LYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CC--CCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            10  11111       1235688999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-38  Score=323.66  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=196.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        +...+++|.+++.........+.+..|..++..+ +||||+++++++.+.+.++
T Consensus         1 ~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   72 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG--------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF   72 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE
Confidence            368999999999987643        4566777776654433334556778898888765 9999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++..
T Consensus        73 lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          73 FVMEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEECCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999999999999998753   348999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.....    ...     
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~----~~~-----  212 (316)
T cd05620         147 VFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIR----VDT-----  212 (316)
T ss_pred             ccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCC-----
Confidence            22111  12345789999999999999999999999999999999999999964432   12221111    110     


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG-QVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~-eVl~~L~~~~~~~~~~~~  443 (522)
                       +..    +......+.+++.+||+.||.+||++. ++++        |+|++.
T Consensus       213 -~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~--------h~~f~~  253 (316)
T cd05620         213 -PHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRG--------HPFFKT  253 (316)
T ss_pred             -CCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc--------CCCcCC
Confidence             111    111345678899999999999999984 6664        677654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=314.83  Aligned_cols=264  Identities=19%  Similarity=0.307  Sum_probs=204.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.......   ......+++|.+...  ........|.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK---GEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC---CCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            4689999999999999999987543211   123455666665321  12234567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC-------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE-------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      .....++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCC
Confidence            99999999999999999999975421       2247889999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||.....   ......
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHH
Confidence            999999999875543322222223456789999999988889999999999999999998 9999864332   222221


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ..    .+.....         +...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       234 ~~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VI----DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             Hh----cCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11    1111111         1112567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-38  Score=320.53  Aligned_cols=270  Identities=24%  Similarity=0.373  Sum_probs=205.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|.+.++||+|+||.||++...... .........+++|.++..  .......++.+|+.+++++ +||||+++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~-~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLD-KEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccC-CcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            368999999999999999998653210 001123345666655432  1223456799999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      ..++..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence            999999999999999999999976421             1248899999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      |+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.....  
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence            9999999999999999876543221111112234568999999988889999999999999999998 8889864321  


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       ..+....    ..+..         ...+...+..+.+++.+||..+|.+||++.+|++.|+.+..
T Consensus       249 -~~~~~~~----~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 -EELFKLL----KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -HHHHHHH----HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence             1221111    11111         01112234678889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-38  Score=315.19  Aligned_cols=263  Identities=23%  Similarity=0.377  Sum_probs=201.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.++||+|+||.||++.....   ........+++|.++...   ....+.|.+|++++++++|+||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL---LPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC---CCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            4688899999999999999853211   112233445555554332   2245689999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCC------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGE------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      ....++||||+++|+|.+++.....            ...+++..++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~  155 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLV  155 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEE
Confidence            9999999999999999999975431            1348899999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhh
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES  372 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~  372 (522)
                      ++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......   .
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  232 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---E  232 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---H
Confidence            9999999999999865543322222223345788999999988899999999999999999998 99998543221   1


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .....    ..+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       233 ~~~~~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 AIECI----TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHH----HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11111    111100         0011234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.2e-38  Score=310.51  Aligned_cols=263  Identities=23%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ..+.+++|.+...........++|.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL--------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE   73 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC--------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence            468899999999999999987543        345566665543222223345789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          226 DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999999999998743 223458999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++.........  .....++..|+|||++.+..++.++||||||+++|+|++|..||...... ........    ...
T Consensus       151 g~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~~  223 (267)
T cd08229         151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI----EQC  223 (267)
T ss_pred             hhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhh----hcC
Confidence            998765443221  12346889999999998888999999999999999999999998643221 11111111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .     .+...   ....+..+.+++.+||+.+|.+|||+.+|++.+++.
T Consensus       224 ~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 D-----YPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C-----CCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            0     11111   122456788999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=334.85  Aligned_cols=249  Identities=20%  Similarity=0.288  Sum_probs=210.6

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceee
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLN  220 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~  220 (522)
                      +-...+|.+.++||+|+||+|++++.+        .+...||+|.||+...-..+.++..+.|.+|+... +||.+++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k--------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~  435 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELK--------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF  435 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEc--------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence            345678999999999999999998754        36779999999998888888999999999999988 699999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      .+|....++|+||||+.||++..+.+    ...|++..+.-++..|+.||.|||+   ++||+||||.+|||||.+|.+|
T Consensus       436 ~~fQT~~~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  436 SCFQTKEHLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             cccccCCeEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEE
Confidence            99999999999999999999554443    2349999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||+++......  .....++||+.|||||++.+..|+.++|-|||||+||||+.|..||...+.++...-      +
T Consensus       509 iADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds------I  580 (694)
T KOG0694|consen  509 IADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS------I  580 (694)
T ss_pred             ecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------H
Confidence            99999997544322  234578999999999999999999999999999999999999999986543322111      1


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM  424 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~  424 (522)
                      +..           ...++...+.+.+.++.++|.++|++|.-+
T Consensus       581 ~~d-----------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VND-----------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcC-----------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111           123444567788899999999999999865

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=336.63  Aligned_cols=267  Identities=18%  Similarity=0.259  Sum_probs=195.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||++....        ..+.+|+|.+...       .....+|+.+|++++|||||++++++.
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~  129 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID--------TSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYY  129 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC--------CCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEe
Confidence            4679999999999999999987543        3456666654321       123457999999999999999999875


Q ss_pred             eC--------CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          225 ED--------NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       225 ~~--------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ..        ..+++||||+++ +|.+++... .....+++..++.++.||+.||.|||+   .+|+||||||+|||++.
T Consensus       130 ~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~  205 (440)
T PTZ00036        130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDP  205 (440)
T ss_pred             ecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcC
Confidence            32        257799999975 787777542 233469999999999999999999999   99999999999999986


Q ss_pred             CC-ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          296 DF-QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       296 ~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      ++ .+||+|||+++........   ....||+.|+|||++.+. .++.++|||||||++|||++|.+||......  ..+
T Consensus       206 ~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~  280 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQL  280 (440)
T ss_pred             CCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH
Confidence            65 7999999999765433221   234689999999998664 6899999999999999999999999754322  111


Q ss_pred             HHhhhhh--------------hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          374 VKWAKPI--------------LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       374 ~~~~~~~--------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      .......              ...-.........+...++...+..+.+|+.+||+.||.+|||+.++++        |+
T Consensus       281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--------hp  352 (440)
T PTZ00036        281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--------DP  352 (440)
T ss_pred             HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--------Ch
Confidence            1111100              0000011111111111122233467889999999999999999999997        88


Q ss_pred             cccc
Q 036172          440 WVDR  443 (522)
Q Consensus       440 ~~~~  443 (522)
                      |+..
T Consensus       353 ~f~~  356 (440)
T PTZ00036        353 FFDD  356 (440)
T ss_pred             hHHh
Confidence            8754

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-38  Score=307.28  Aligned_cols=278  Identities=19%  Similarity=0.208  Sum_probs=212.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh--hccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT--SQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t--~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ..+.|++..+|++|+||.||+++++.        +...||+|.++...  ..|.   ---++||.+|.+++|||||.+-.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~--------t~eIVALKr~kmekek~GFP---ItsLREIniLl~~~H~NIV~vkE  142 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKK--------TDEIVALKRLKMEKEKEGFP---ITSLREINILLKARHPNIVEVKE  142 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCC--------cceeEEeeecccccccCCCc---chhHHHHHHHHhcCCCCeeeeEE
Confidence            34679999999999999999988754        67788888776433  2221   13468999999999999999999


Q ss_pred             EEEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          222 VCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       222 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      +..-.  +.+|||||||+. +|..++...+  .+|...++.-++.|+++||+|||.   +.|+|||||++|+|+...|.+
T Consensus       143 VVvG~~~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~l  216 (419)
T KOG0663|consen  143 VVVGSNMDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGIL  216 (419)
T ss_pred             EEeccccceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcE
Confidence            88743  679999999987 9999998764  359999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh--
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW--  376 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~--  376 (522)
                      ||+|||+|+.+.......+  ..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++.|.....-++-..+-.  
T Consensus       217 KiaDFGLAR~ygsp~k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll  294 (419)
T KOG0663|consen  217 KIADFGLAREYGSPLKPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL  294 (419)
T ss_pred             EecccchhhhhcCCcccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence            9999999998877643332  45779999999999775 589999999999999999999999876654333221111  


Q ss_pred             ------hhhhhcCC------CcccccCCcccccccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 ------AKPILKNG------DTETLLDPKLSNEYDNA-QMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ------~~~~~~~~------~~~~~~d~~l~~~~~~~-~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                            .|+.+..-      ......-..+...+... ..+.-.+++..+|..||.+|.|+++.|+        |.|+..
T Consensus       295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--------h~~F~e  366 (419)
T KOG0663|consen  295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--------HEYFRE  366 (419)
T ss_pred             CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--------cccccc
Confidence                  11111000      00000111122222222 3456778999999999999999999998        999987


Q ss_pred             ccccc
Q 036172          444 HADDI  448 (522)
Q Consensus       444 ~~~~~  448 (522)
                      .+-..
T Consensus       367 ~P~p~  371 (419)
T KOG0663|consen  367 TPLPI  371 (419)
T ss_pred             CCCCC
Confidence            65433

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=341.77  Aligned_cols=269  Identities=21%  Similarity=0.267  Sum_probs=212.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE-
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV-  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~-  222 (522)
                      ..+++|.+.|-+|||+.||+++....        +..||+|.+-.   +...+.+...+||++|++| .|+|||.+++. 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~--------~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKG--------GKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCC--------Cceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            44788999999999999999987542        26677665532   3556888999999999999 59999999993 


Q ss_pred             EEe---C---CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          223 CIE---D---NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       223 ~~~---~---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      ...   +   -.++|+||||.||+|-|++..+...+ |++.++++|+.++++|+++||. +..+|||||||-+||||..+
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~  182 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSAD  182 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCC
Confidence            221   1   35899999999999999998764333 9999999999999999999998 34679999999999999999


Q ss_pred             CceEEeecCccccCCCCC-CCc----ccc--ccccCCCCCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDS-THM----IRE--DVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~-~~~----~~~--~~~gt~~Y~APE~~---~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      +..||||||.+.-.-... ...    ...  ...-|+.|+|||.+   .+...++|+|||+|||+||-|+....||+...
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            999999999984221111 100    000  12468999999997   56678999999999999999999999997432


Q ss_pred             CCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                                         ...+++....-.....++..|.+||..||+.||.+||++-+|+..+-.+.....|+..-.
T Consensus       263 -------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  263 -------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             -------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                               112222222222234688999999999999999999999999999999988888876543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.7e-38  Score=314.31  Aligned_cols=262  Identities=19%  Similarity=0.264  Sum_probs=203.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|+..+.||.|+||.||++....        ..+.+++|.+.............+.+|++++++++|+||+++++++..+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA--------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC--------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            47888999999999999987543        3556666665443322223445688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|.+++...+ ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCc
Confidence            99999999999999999887543 2359999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........   ....|+..|+|||++.+..++.++||||||+++|+|++|..||.........  .. ......... 
T Consensus       149 ~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~-~~~~~~~~~-  221 (285)
T cd05632         149 AVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EE-VDRRVLETE-  221 (285)
T ss_pred             ceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHhhhccc-
Confidence            8654432211   2346899999999998888999999999999999999999999754321111  11 111111110 


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCcccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~~  444 (522)
                               ..+.......+.+++..||+.+|.+||+     +.+++.        ++|++..
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~--------~~~~~~~  267 (285)
T cd05632         222 ---------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR--------HPFFRNM  267 (285)
T ss_pred             ---------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc--------ChhhhcC
Confidence                     0111223456788999999999999999     667776        7787654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-38  Score=316.25  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.++||.|+||.||++......   .......+++|.++....  ....+.|.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTA---PGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCC---CCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            46888999999999999998643211   012345567776653221  2245679999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      ....++++||+++++|.+++....             ....+++..+..++.|++.||.|||+   .+++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil  156 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheE
Confidence            999999999999999999985321             12348889999999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChh
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE  371 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~  371 (522)
                      +++++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.....   .
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~  233 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q  233 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H
Confidence            99999999999999876543332222233456789999999988889999999999999999998 8888864322   1


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .+...    +..+...         ..+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       234 ~~~~~----i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DVIEM----IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHH----HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111    1111111         1112244568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=325.38  Aligned_cols=240  Identities=28%  Similarity=0.391  Sum_probs=196.3

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEE
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      .+.||.|+-|.||+++-.          .+.||+|.++..          =..+|+-|++|+||||+.+.|+|.....++
T Consensus       129 LeWlGSGaQGAVF~Grl~----------netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH----------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hhhhccCcccceeeeecc----------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            456999999999998743          244555554421          135788999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      ||||||..|-|.++|+.   ...++......|..+||.|+.|||.   +.|||||||.-||||..+..+||+|||-++..
T Consensus       189 IiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999984   4458889999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ....+   .-.++||..|||||++.+.+.+.|+||||||||||||+||..||..-...    .+.     +.-|      
T Consensus       263 ~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AII-----wGVG------  324 (904)
T KOG4721|consen  263 SDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AII-----WGVG------  324 (904)
T ss_pred             hhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeE-----Eecc------
Confidence            55433   33578999999999999999999999999999999999999998632211    111     1111      


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...+....+..+++.|..|+++||+..|.+||++.+|+..|+=.
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            11122334455677899999999999999999999999887643

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=311.32  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--ccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--QFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      +.|++.+.||+|+||.||++....        ..+.+++|.+.....  ......+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~--------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   73 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD--------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL   73 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC--------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE
Confidence            468999999999999999986542        344555554432111  1122456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .++...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        74 ~~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          74 RDDETLSIFMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             ccCCeEEEEEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence            9999999999999999999999753   348899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCcc-ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ......    ...
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~----~~~  221 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--MAAIFK----IAT  221 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--HHHHHH----Hhc
Confidence            999865433211111 1234578899999999888899999999999999999999999864321  111111    011


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...         ....+......+.+++.+||..+|.+||++.++++
T Consensus       222 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         222 QPT---------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            100         01112234456888999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-38  Score=328.78  Aligned_cols=262  Identities=20%  Similarity=0.261  Sum_probs=200.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||+|+||.||++....        ..+.+++|.+.+...........+.+|+.++.+++||||+++++.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   72 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD--------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD   72 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            368999999999999999987643        455667666654333333456788999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          73 KRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             CCEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999999743   348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCC---------------------------------ccccccccCCCCCChhhhccCCCCchhhHHHHHHHH
Q 036172          306 LAIWGPTDSTH---------------------------------MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVL  352 (522)
Q Consensus       306 la~~~~~~~~~---------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl  352 (522)
                      ++.........                                 .......||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98644221100                                 001134699999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 036172          353 LELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN---MGQVLK  429 (522)
Q Consensus       353 ~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs---~~eVl~  429 (522)
                      |||++|+.||........   ..   .... ......+.+.      ......+.+++.+|+ .+|.+|++   +.++++
T Consensus       227 yel~tG~~Pf~~~~~~~~---~~---~i~~-~~~~~~~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         227 YEMLIGYPPFCSETPQET---YR---KVMN-WKETLVFPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             eecccCCCCCCCCCHHHH---HH---HHHc-CCCceecCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999999999975432211   11   1111 0000001110      012345677777766 49999985   667765


Q ss_pred             HHhccccCCccccc
Q 036172          430 LLRGATHATDWVDR  443 (522)
Q Consensus       430 ~L~~~~~~~~~~~~  443 (522)
                              |+|++.
T Consensus       293 --------hp~f~~  298 (360)
T cd05627         293 --------HPFFEG  298 (360)
T ss_pred             --------CCCCCC
Confidence                    888775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-38  Score=329.91  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=200.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        ..+.+++|.+.+.........+.+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~--------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKS--------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECC--------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4789999999999999999987643        44566666554332222234566889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999999743    38889999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG----KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |++........ .......||+.|+|||++...    .++.++|||||||++|||++|+.||......      .....+
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKI  259 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            99976543221 112345799999999998653    3789999999999999999999999754321      111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..........+       ....+..+.+++..||..++.+  ||++.+|++        |+|++..
T Consensus       260 ~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~--------h~~~~~~  310 (371)
T cd05622         260 MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--------HLFFKND  310 (371)
T ss_pred             HcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc--------CcccCCC
Confidence            11111111111       1124456788999999844433  789999987        6776553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.3e-38  Score=310.82  Aligned_cols=260  Identities=22%  Similarity=0.295  Sum_probs=195.9

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC--
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED--  226 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~--  226 (522)
                      .+++.||+|+||.||++.....      .....+++|.++... ......+.|.+|+.++++++||||+++++++...  
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~------~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQD------DSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             ccccccCcccCceEEEeEEccC------CCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence            4678899999999999875431      112234555443321 1223467899999999999999999999988642  


Q ss_pred             ----CEEEEEEecCCCCCHHHHhhcc---CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          227 ----NYLILVSDFLPKGSLEESLHGA---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       227 ----~~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                          ...++||||+++|+|.+++...   .....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus        75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCE
Confidence                3578999999999999987532   123358999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+...  
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~--  226 (272)
T cd05075         152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDY--  226 (272)
T ss_pred             EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--
Confidence            9999999976544332211223346778999999988889999999999999999999 8899864321   112111  


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                        +..+....         .....+..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       227 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 --LRQGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              11111111         0112345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=312.09  Aligned_cols=274  Identities=20%  Similarity=0.232  Sum_probs=210.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|...++||.|+||.|..+.+..        ++..+|+|.+..+-.+. ...++-.+|+++|+.++|+||+.+++++.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~--------t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~   91 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKR--------TGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFR   91 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcC--------CCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence            4567778999999999988776644        55788888776444332 24577889999999999999999999987


Q ss_pred             e-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 E-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      .     -+.+|+|+|+|+ .+|...++..   ..++...+..+++|+++||.|+|+   .+|+||||||+|+|++.+..+
T Consensus        92 p~~~~~f~DvYiV~elMe-tDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   92 PPSRDKFNDVYLVFELME-TDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             cccccccceeEEehhHHh-hHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCE
Confidence            5     367999999994 5999999843   349999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh-
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA-  377 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~-  377 (522)
                      ||+|||+|+..........-+..+.|.+|.|||.+. ...|+.+.||||+|||+.||++|++.|.+.+.-.+-.++... 
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            999999998776542222224567899999999975 457999999999999999999999999877654433332211 


Q ss_pred             ----------------hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          378 ----------------KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       378 ----------------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                                      .+.+..-  .. ..+.......+......++++.+||..||.+|+|++|.|+        |+++
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~sl--p~-~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--------hPYl  313 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSL--PQ-IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--------HPYL  313 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhC--CC-CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--------Chhh
Confidence                            1111100  00 0000001111123456788999999999999999999997        8887


Q ss_pred             cccc
Q 036172          442 DRHA  445 (522)
Q Consensus       442 ~~~~  445 (522)
                      ....
T Consensus       314 ~~~h  317 (359)
T KOG0660|consen  314 APYH  317 (359)
T ss_pred             hhhc
Confidence            6543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.9e-38  Score=317.21  Aligned_cols=270  Identities=22%  Similarity=0.356  Sum_probs=206.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ...+|.+.+.||+|+||.||++....... ........+++|.++...  .....+++.+|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDK-DKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCC-CCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            45689999999999999999886321100 001223456666554321  223557899999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +......++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+   .+++||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccc
Confidence            9999999999999999999999976421             2347889999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      ||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||..... 
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-  245 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  245 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence            99999999999999999976644332222223345678999999988889999999999999999998 7888754321 


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        ..+...    +..+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       246 --~~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 --EELFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHHHHH----HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              111111    1111110         011123467888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=310.42  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++++.||+|+||.||++.....     ......+++|.++... ......+.|.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD-----DGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC-----CCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            57888999999999999864321     1123456666654321 12234578999999999999999999999987655


Q ss_pred             E------EEEEEecCCCCCHHHHhhccC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          228 Y------LILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       228 ~------~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      .      .++||||+++|+|..++....   ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMT  151 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCe
Confidence            4      799999999999999986531   22358999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.....   ..+....
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~  228 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL  228 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence            99999999976544332222222345678999999988889999999999999999999 8899854321   1122211


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .    .+....         .+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus       229 ~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 R----HGNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             H----cCCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1    111111         1122345789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.6e-38  Score=314.93  Aligned_cols=272  Identities=18%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++.......   ......+++|.++...  ......+|.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIK---GEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCC---CCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4689999999999999999986432110   1123455666543211  1223456889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC-------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE-------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +....++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCC
Confidence            99999999999999999999975321       2335677889999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~  376 (522)
                      .++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.....   ......
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~  233 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKF  233 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence            999999999875543322222222345678999999998899999999999999999998 7888864321   111111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .   .. +....         .+...+..+.+++.+||+.+|.+||++.++++.|++..  ++|++
T Consensus       234 ~---~~-~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~--~~~~~  284 (288)
T cd05061         234 V---MD-GGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL--HPSFP  284 (288)
T ss_pred             H---Hc-CCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc--CCCCC
Confidence            1   11 11110         01122457899999999999999999999999998875  44543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-38  Score=318.91  Aligned_cols=274  Identities=21%  Similarity=0.262  Sum_probs=202.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++....        ..+.+++|.++....  ......+.+|+.++++++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKL--------TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVH   74 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecC--------CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEe
Confidence            3679999999999999999986532        345667776654322  123346788999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||+++ +|.+++...+  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Df  148 (309)
T cd07872          75 TDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADF  148 (309)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcc
Confidence            99999999999975 8988887542  348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh-----
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK-----  378 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~-----  378 (522)
                      |++.........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||................     
T Consensus       149 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  226 (309)
T cd07872         149 GLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE  226 (309)
T ss_pred             ccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            998654332211  123467899999999865 458999999999999999999999997554322211111100     


Q ss_pred             ---hhhcCC-CcccccCCccc----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 ---PILKNG-DTETLLDPKLS----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ---~~~~~~-~~~~~~d~~l~----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         +.+... .....-.+...    .......+..+.+++.+||+.||.+|||+.++++        ++|++.-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--------h~~~~~~  292 (309)
T cd07872         227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--------HAYFRSL  292 (309)
T ss_pred             HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--------Chhhhhc
Confidence               000000 00000000000    0001123456789999999999999999999997        8898753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.8e-38  Score=323.49  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=193.6

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHH-HHhhCCCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVD-ITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++....        .++.+++|.+.+.........+++..|.. +++.++||||+++++++.+.+..+
T Consensus         1 ~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~   72 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA--------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY   72 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE
Confidence            358999999999987643        45667777665443333334456666665 467899999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        73 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          73 FVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEcCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999999999999999753   358999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+.   ..... +..    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~-~~~----  213 (323)
T cd05575         147 IEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY---DNILN-KPL----  213 (323)
T ss_pred             ccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH---HHHHc-CCC----
Confidence            22211  122456899999999999989999999999999999999999999654321   111   11111 110    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH----HHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG----QVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~----eVl~~L~~~~~~~~~~~~  443 (522)
                        .+    ....+..+.+++.+||+.+|.+||++.    ++++        ++|+..
T Consensus       214 --~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~--------~~~~~~  256 (323)
T cd05575         214 --RL----KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN--------HVFFSS  256 (323)
T ss_pred             --CC----CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc--------CCCcCC
Confidence              01    112345688899999999999999985    4443        777654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.8e-38  Score=321.36  Aligned_cols=246  Identities=20%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~~  225 (522)
                      +|+..+.||+|+||.||++....        +.+.+++|.+++.........+.+..|..++..+. |++|+++++++.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   72 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG--------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT   72 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec
Confidence            47888999999999999987643        45677777766544333345677889999999885 5778899999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+.+++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          73 VDRLYFVMEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccc
Confidence            99999999999999999999753   349999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+.....   . ..
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~-~~  217 (323)
T cd05615         147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM---E-HN  217 (323)
T ss_pred             cccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h-CC
Confidence            9865332211  12245689999999999988899999999999999999999999965432   12221111   1 11


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG  425 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~  425 (522)
                      .          .++...+..+.+++.+||+.+|.+|++..
T Consensus       218 ~----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         218 V----------SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             C----------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            0          11122345678899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-37  Score=311.63  Aligned_cols=263  Identities=20%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.+.||.|+||.||++........    ....+++|.+...  .......++..|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~----~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDS----IKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCc----eeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            35789999999999999999875321100    1112444443221  11224567888999999999999999999986


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      . ...++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+||
T Consensus        80 ~-~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Df  153 (279)
T cd05111          80 G-ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADF  153 (279)
T ss_pred             C-CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCC
Confidence            4 55788999999999999997542  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............++..|+|||++.++.++.++||||||+++||+++ |..||.......   ....    +..
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~  226 (279)
T cd05111         154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEK  226 (279)
T ss_pred             ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHC
Confidence            99976544332222234457789999999988899999999999999999998 999986543221   1111    122


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....  .+..       ....+..++.+||..+|.+||++.++++.|....
T Consensus       227 ~~~~~--~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         227 GERLA--QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCcCC--CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            21111  1111       2245677899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-37  Score=315.06  Aligned_cols=261  Identities=22%  Similarity=0.312  Sum_probs=197.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      ++|++.+.||.|+||.||++.....      .....+++|.++...  .....++|.+|+.+++++ +||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD------GLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC------CCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            5789999999999999999864321      111122333333211  122456799999999999 7999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      ..+..++||||+++|+|.+++....             ....+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Ni  150 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNV  150 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceE
Confidence            9999999999999999999997532             11348899999999999999999999   9999999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGP  370 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~  370 (522)
                      |++.++.+||+|||++........   ......+..|+|||++....++.++|||||||++|||++ |..||......  
T Consensus       151 ll~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--  225 (297)
T cd05089         151 LVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--  225 (297)
T ss_pred             EECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999854322111   111123567999999988889999999999999999997 99998644321  


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       .+....    ..+.     .    ...+...+..+.+++.+||+.+|.+||++.+|++.|..+..
T Consensus       226 -~~~~~~----~~~~-----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         226 -ELYEKL----PQGY-----R----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             -HHHHHH----hcCC-----C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             111111    1110     0    01111234568889999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-38  Score=322.08  Aligned_cols=264  Identities=22%  Similarity=0.269  Sum_probs=199.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.+.+.........+.|.+|+.++..++|+||+++++++.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN--------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD   72 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC--------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            479999999999999999987543        345667776654322223355678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++|+|.+++....  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999999997532  348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ++......... ......||+.|+|||++..     +.++.++|||||||++|+|++|+.||......      ......
T Consensus       148 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i  220 (331)
T cd05597         148 SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKI  220 (331)
T ss_pred             ceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHH
Confidence            98654432221 1123468999999999863     45788999999999999999999999643321      111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQ--SPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~--dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ........+ .+.     ....+..+.+++.+||..  ++..||++.++++        |+|+..
T Consensus       221 ~~~~~~~~~-~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~--------hp~~~~  271 (331)
T cd05597         221 MNHKEHFQF-PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD--------HPFFEG  271 (331)
T ss_pred             HcCCCcccC-CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--------CCCCCC
Confidence            111111111 000     011345667778777654  3444889999998        888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.9e-37  Score=315.07  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=200.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++.+..        +...+++|.++...  ......++.+|++++++++||||+++++++.+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~--------~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   70 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP--------SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS   70 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC--------CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            368999999999999999987543        22334444433211  11234678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.  .+++|+||||+|||++.++.++|+|||
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCC
Confidence            99999999999999999999754   3489999999999999999999972  589999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.......    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus       146 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  221 (308)
T cd06615         146 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE  221 (308)
T ss_pred             Ccccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence            986543321    1234688999999999888899999999999999999999999864432211111110000000000


Q ss_pred             c------c------------------cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          386 T------E------------------TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       386 ~------~------------------~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .      .                  ....+.+.   .......+.+++.+||..+|.+||++.+|++        ++|+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--------~~~~  290 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK--------HPFI  290 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhc--------Chhh
Confidence            0      0                  00000000   0013456889999999999999999999998        8887


Q ss_pred             cc
Q 036172          442 DR  443 (522)
Q Consensus       442 ~~  443 (522)
                      ..
T Consensus       291 ~~  292 (308)
T cd06615         291 KR  292 (308)
T ss_pred             hh
Confidence            64

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-37  Score=310.35  Aligned_cols=264  Identities=22%  Similarity=0.273  Sum_probs=199.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|++.+.||.|+||.||++.......   ......+++|.+...  ........|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG---DAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC---CCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4679999999999999999987543100   012334444443321  11223467999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---  297 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---  297 (522)
                      +....++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+   .+++||||||+||+++.++   
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCc
Confidence            99999999999999999999976532    1258999999999999999999999   9999999999999998754   


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |+.||......   .+...
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~  233 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF  233 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            599999999976533221111112234568999999998999999999999999999997 99998754322   11111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      .   ......          ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 ~---~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 V---TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             H---HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1   111110          111223457888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.7e-38  Score=318.80  Aligned_cols=267  Identities=22%  Similarity=0.344  Sum_probs=205.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.....   ........+++|.++...  .....+.|.+|+.+++++ +||||++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGL---SKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecC---CCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            346899999999999999998764210   011223456666554321  223457899999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +...+..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+   .+++|+||||+|||++.++.++|+
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEEC
Confidence            999999999999999999999997542 2348999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||++................++..|+|||.+....++.++|||||||++|+|++ |..||......  .......    
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~----  257 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLI----  257 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHH----
Confidence            9999976544332222223356788999999988889999999999999999998 99998643321  1111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ..+...         ..+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       258 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111100         00112245788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.5e-38  Score=308.11  Aligned_cols=255  Identities=26%  Similarity=0.363  Sum_probs=202.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.++||.|+||.||++....         .+.+++|.++...   ....+++.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   72 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN---------RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCS   72 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC---------CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEe
Confidence            3579999999999999999987542         3445555544321   223567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          73 VGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             cCCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccc
Confidence            9999999999999999999998643 3358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++.........  .....++..|+|||.+....++.++||||||+++|+|++ |+.||.....   .........    
T Consensus       149 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----  219 (261)
T cd05148         149 GLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITA----  219 (261)
T ss_pred             cchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHh----
Confidence            999765432211  113345778999999988889999999999999999998 8999864431   112111111    


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +..         ...+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       220 ~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         220 GYR---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            100         01112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-38  Score=324.68  Aligned_cols=244  Identities=25%  Similarity=0.287  Sum_probs=191.5

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      +.||+|+||.||++....     ....++.+++|.+++..... .....+.+|++++++++||||+++++++.+++.+++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~-----~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT-----GPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEec-----cCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            569999999999876431     12345667777665543321 234567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        76 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          76 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            99999999999999743   358999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.....   ......   ... ...     
T Consensus       150 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~---i~~-~~~-----  215 (318)
T cd05582         150 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTM---ILK-AKL-----  215 (318)
T ss_pred             CCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHH---HHc-CCC-----
Confidence            32211  2245789999999999888899999999999999999999999965321   111111   111 110     


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ  426 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~e  426 (522)
                           ..+...+..+.+++.+||+.||.+||++.+
T Consensus       216 -----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 111123456788999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-37  Score=303.85  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|.+.+.||+|+||.||++....        ....+++|.+..... .....+++.+|++++++++||||+++++++.++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA--------DKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC--------CCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47888999999999999987543        344555555432211 123457899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEccccc
Confidence            99999999999999999998642 3458999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....|++.|+|||++.+..++.++||||||+++++|++|+.||....   ........    ..+..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~----~~~~~  218 (256)
T cd08529         148 AKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI----IRGVF  218 (256)
T ss_pred             ceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCC
Confidence            8765443221  223468899999999998889999999999999999999999996543   11111111    11111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .         .........+.+++.+||+.+|++||++.+|++
T Consensus       219 ~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         219 P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            1         111134567899999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-37  Score=329.37  Aligned_cols=269  Identities=16%  Similarity=0.174  Sum_probs=199.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ....|.+.+.||.|+||.||++.+..        ..+.+++|..         ....+.+|+++|++|+|+|||++++++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~--------~~~~vavK~~---------~~~~~~~E~~iL~~L~HpnIv~l~~~~  229 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPD--------YPQRVVVKAG---------WYASSVHEARLLRRLSHPAVLALLDVR  229 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECC--------CCCEEEEecc---------cccCHHHHHHHHHHCCCCCCCcEEEEE
Confidence            35689999999999999999987643        3445565532         123467899999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..++..++|||++. ++|.+++....  ..+++..++.|+.|++.||.|||+   .+|+||||||+||||+.++.+||+|
T Consensus       230 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        230 VVGGLTCLVLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EECCEEEEEEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcc
Confidence            99999999999995 69999886532  259999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCCC----hhhHHHhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF-KNLKG----PESLVKWAK  378 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~-~~~~~----~~~l~~~~~  378 (522)
                      ||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+-. .....    ...+.....
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            9999765443222222345799999999999999999999999999999999998766422 11111    111221111


Q ss_pred             hhhc-CCCcccccC----------------Ccccc-ccc--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          379 PILK-NGDTETLLD----------------PKLSN-EYD--NAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       379 ~~~~-~~~~~~~~d----------------~~l~~-~~~--~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      .... .........                +.... .+.  ......+.+|+.+||+.||.+|||+.|||+        +
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~--------h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR--------L  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh--------C
Confidence            1000 000000000                00000 000  012246788999999999999999999998        8


Q ss_pred             ccccc
Q 036172          439 DWVDR  443 (522)
Q Consensus       439 ~~~~~  443 (522)
                      +|++.
T Consensus       456 p~f~~  460 (461)
T PHA03211        456 PLFQS  460 (461)
T ss_pred             cccCC
Confidence            88753

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-37  Score=306.66  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=194.8

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++....      ......+++|.++... ......++|.+|+.++++++||||+++++++.. ...++|
T Consensus         2 ~lg~G~~g~v~~~~~~~------~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM------KKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEec------CCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEE
Confidence            58999999999975321      2344567777665322 223356789999999999999999999999864 567899


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||+   ++++||||||.||+++.++.+||+|||++.....
T Consensus        74 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          74 MELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            9999999999999743   348999999999999999999999   9999999999999999999999999999976544


Q ss_pred             CCCCcc-ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          313 DSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       313 ~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ...... .....++..|+|||.+....++.++|||||||++|||++ |..||......   .+....    ..+....  
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i----~~~~~~~--  218 (257)
T cd05116         148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI----ESGERME--  218 (257)
T ss_pred             CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCCCCC--
Confidence            332211 112234578999999988889999999999999999998 99999653221   122211    1111111  


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                             .+...+..+.+++.+||+.||.+||++.+|.+.|++.
T Consensus       219 -------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 -------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                   1112345788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=307.26  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=199.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||.|+||.||++....         .+.+++|.++...    ...++|.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN---------TTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCT   71 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC---------CeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence            3579999999999999999876422         2345555554321    13467899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          72 LEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             cCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCc
Confidence            9999999999999999999997643 3358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++......... .......+..|+|||++.+..++.++||||||+++|+|++ |+.||.....   ..+....    ..
T Consensus       148 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~  219 (261)
T cd05068         148 GLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQV----DQ  219 (261)
T ss_pred             ceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----Hc
Confidence            999766532211 1111223457999999988889999999999999999999 9999864321   1111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ....         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       220 ~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         220 GYRM---------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCC---------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1000         0111234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-37  Score=316.90  Aligned_cols=269  Identities=23%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ..+|.+.++||+|+||.||++.+..... ........+++|.++..  .......+|.+|+.+++++ +||||+++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDK-SRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCC-ccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            4689999999999999999987532111 01122344555554421  1233567799999999999 699999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      ..++.+++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+   .+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecccccee
Confidence            999999999999999999999975321             2348899999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      ||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|+|++ |..||...... 
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999976543222111112234567999999988889999999999999999999 89998543221 


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        .+...    ...+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|++..
T Consensus       244 --~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 --ELFKL----LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             --HHHHH----HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence              11111    1111110         111123457888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8e-38  Score=313.02  Aligned_cols=269  Identities=26%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||.+....    ......+.+++|.++...   ....+.|.+|++++++++||||+++++++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDP----LQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCY   75 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecC----CcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence            3579999999999999999875321    113345567777654322   234578999999999999999999999876


Q ss_pred             eC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          225 ED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      ..  ..+++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~  150 (284)
T cd05081          76 SAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIG  150 (284)
T ss_pred             cCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEEC
Confidence            43  56899999999999999997532  348999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCcc-ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh---------h
Q 036172          303 DFGLAIWGPTDSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE---------S  372 (522)
Q Consensus       303 DFGla~~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~---------~  372 (522)
                      |||++........... .....++..|+|||++.+..++.++||||||++++||++|..|+......-..         .
T Consensus       151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd05081         151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM  230 (284)
T ss_pred             CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence            9999976644332211 11123345699999998888999999999999999999988775432111000         0


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...........+.         ........+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000011100         0011122345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-37  Score=312.60  Aligned_cols=264  Identities=20%  Similarity=0.232  Sum_probs=193.8

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceeeEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLNGVC  223 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~~~~  223 (522)
                      +|++.+.||+|+||.||++.+..        +.+.+++|.++...... .....+.+|+.+++++   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH--------SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC--------CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            58999999999999999987643        45667777665432211 1223456777777766   799999999998


Q ss_pred             Ee-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IE-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..     ....++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~  146 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQ  146 (288)
T ss_pred             ccccCCCCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCC
Confidence            74     2468999999975 8999887543 2348999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||++........   .....|+..|+|||++.+..++.++|||||||++|+|++|++||.......  .+.....
T Consensus       147 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~  221 (288)
T cd07863         147 VKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD  221 (288)
T ss_pred             EEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH
Confidence            99999999976543221   123468999999999988889999999999999999999999986443211  1111110


Q ss_pred             hhh--cCCCc-------ccccCCc---ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 PIL--KNGDT-------ETLLDPK---LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ~~~--~~~~~-------~~~~d~~---l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...  .....       ...+.+.   ............+.+++.+||+.||.+|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000  00000       0000000   001111234467889999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-38  Score=317.42  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=198.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      -++|++.+.||.|+||.||++.....      .....++++.++...  ......+|.+|++++.++ +||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~------~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~   77 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKD------GLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC   77 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccC------CceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            46899999999999999999975421      111122333322111  123456789999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      .+++.+++||||+++|+|.+++...+             ....+++..++.++.|++.||+|||+   ++++||||||+|
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~N  154 (303)
T cd05088          78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN  154 (303)
T ss_pred             CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchhe
Confidence            99999999999999999999997542             12358899999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      ||++.++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||+| |..||...... 
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  230 (303)
T cd05088         155 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-  230 (303)
T ss_pred             EEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-
Confidence            999999999999999985322111   1111234667999999988889999999999999999998 99998643321 


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        .......    .+.         ....+...+..+.+++.+||+.+|.+||++.+++..|..+.
T Consensus       231 --~~~~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         231 --ELYEKLP----QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             --HHHHHHh----cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1111111    110         00011123456888999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-37  Score=322.30  Aligned_cols=271  Identities=20%  Similarity=0.209  Sum_probs=199.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||.|+||.||++.+..        ....+++|.+..... .....+++.+|+.+++.++||||+++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTV--------LGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcC--------CCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            45789999999999999999987543        455667776643321 123456788999999999999999999998


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ..+++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~  160 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC  160 (359)
T ss_pred             ccCCCccccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCC
Confidence            754      357999999965 67776642     37889999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh------
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE------  371 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~------  371 (522)
                      .+||+|||+++.......   .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.....      
T Consensus       161 ~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~  237 (359)
T cd07876         161 TLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ  237 (359)
T ss_pred             CEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999999965433221   12346899999999999889999999999999999999999999754321100      


Q ss_pred             ------hHH----HhhhhhhcCC-Cc-----ccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          372 ------SLV----KWAKPILKNG-DT-----ETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       372 ------~l~----~~~~~~~~~~-~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                            ...    .......... ..     ......-.   ...........+.+++.+||+.||.+|||+.|+++   
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~---  314 (359)
T cd07876         238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR---  314 (359)
T ss_pred             cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc---
Confidence                  000    0000000000 00     00000000   00011122456889999999999999999999997   


Q ss_pred             ccccCCccccc
Q 036172          433 GATHATDWVDR  443 (522)
Q Consensus       433 ~~~~~~~~~~~  443 (522)
                           |+|+..
T Consensus       315 -----hp~~~~  320 (359)
T cd07876         315 -----HPYITV  320 (359)
T ss_pred             -----Cchhhh
Confidence                 888764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-37  Score=318.48  Aligned_cols=240  Identities=23%  Similarity=0.264  Sum_probs=185.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHH-HHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVD-ITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      .||.|+||.||++.+..        ..+.+++|.+.+..........++.+|.. +++.++||||+++++++.+.+..++
T Consensus         2 ~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l   73 (321)
T cd05603           2 VIGKGSFGKVLLAKRKS--------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF   73 (321)
T ss_pred             eeeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE
Confidence            58999999999987643        34556666554332222233455666665 5788999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        74 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          74 VLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             EEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            99999999999988743   348899999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      ....  ......||+.|+|||.+.+..++.++|||||||++|||++|..||...+.   ..+..   .... ...     
T Consensus       148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~i~~-~~~-----  213 (321)
T cd05603         148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYD---NILH-KPL-----  213 (321)
T ss_pred             CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHH---HHhc-CCC-----
Confidence            2211  12345789999999999888899999999999999999999999965431   11111   1111 100     


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG  425 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~  425 (522)
                           ..+......+.+++.+||+.+|.+||++.
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 -----QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                 11112345688899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-37  Score=319.35  Aligned_cols=272  Identities=24%  Similarity=0.362  Sum_probs=205.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ..+|+++++||+|+||.||++........ .......+++|.++..  ......++|.+|+.+++++ +||||++++++|
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~-~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKD-KPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCc-cCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            45799999999999999999865321100 0112234555544421  1123467899999999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      ..++..++||||+++|+|.+++....             ....+++..+..++.|++.||.|||+   .+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence            99999999999999999999997532             12348889999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999976543322221222334567999999998899999999999999999998 8888864321  


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                       ..+....    ..+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       243 -~~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 -EELFKLL----KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -HHHHHHH----HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence             1111111    111110         011123457889999999999999999999999998876433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-37  Score=323.04  Aligned_cols=264  Identities=19%  Similarity=0.216  Sum_probs=192.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||+|+||.||++....        ....+++|...+         .....|+.++++++||||+++++++..
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~valK~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPG--------QPDPVVLKIGQK---------GTTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECC--------CCceEEEEeCCc---------cccHHHHHHHHhCCCCCCcChhheEEe
Confidence            579999999999999999987542        334555553211         224569999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+. ++|.+++...  ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       129 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        129 GAITCMVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             CCeeEEEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCc
Confidence            999999999995 5899988753  2358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCCCChh-------hHHHhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI-GFKNLKGPE-------SLVKWA  377 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf-~~~~~~~~~-------~l~~~~  377 (522)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||+++..|+ .........       .+....
T Consensus       203 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~  279 (357)
T PHA03209        203 AAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII  279 (357)
T ss_pred             cccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence            9965332221   12346899999999999889999999999999999999865554 322211111       111111


Q ss_pred             hhhh-cCCCcc---------cccCC--cc---cccc----cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          378 KPIL-KNGDTE---------TLLDP--KL---SNEY----DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       378 ~~~~-~~~~~~---------~~~d~--~l---~~~~----~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      .... ......         ..++.  ..   ...+    ....+..+.++|.+||+.||.+|||+.||++        |
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~--------h  351 (357)
T PHA03209        280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN--------Y  351 (357)
T ss_pred             HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc--------C
Confidence            0000 000000         00000  00   0000    0012334566999999999999999999998        8


Q ss_pred             ccccc
Q 036172          439 DWVDR  443 (522)
Q Consensus       439 ~~~~~  443 (522)
                      +|++.
T Consensus       352 p~f~~  356 (357)
T PHA03209        352 PMFAQ  356 (357)
T ss_pred             chhcc
Confidence            88763

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.9e-38  Score=325.72  Aligned_cols=271  Identities=18%  Similarity=0.251  Sum_probs=200.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|++.++||+|+||.||++.+..        ..+.+++|.+.....+ ....+++.+|+++++.++||||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR--------DGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC--------CCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            37889999999999999987532        4566777766432211 12456789999999999999999999999877


Q ss_pred             C-----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          227 N-----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       227 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      +     ..++||||+. ++|.+++...   ..+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL  144 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKI  144 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEe
Confidence            6     8999999996 5888888643   359999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh----
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW----  376 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~----  376 (522)
                      +|||+++......... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+..    
T Consensus       145 ~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         145 CDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             ccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999997654332211 1234678999999998764 478999999999999999999999975442211111100    


Q ss_pred             ------------hhhhh-cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 ------------AKPIL-KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ------------~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                                  ....+ ......... +. ...........+.+++.+||+.||.+|||+.++++        ++|+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--------hp~~~~  293 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSL-PV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA--------HPYLDE  293 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCch-HH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc--------CHhhCC
Confidence                        00000 000000000 00 00011122457889999999999999999999997        888765


Q ss_pred             c
Q 036172          444 H  444 (522)
Q Consensus       444 ~  444 (522)
                      .
T Consensus       294 ~  294 (372)
T cd07853         294 G  294 (372)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-38  Score=309.85  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=194.2

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++++.||+|+||.||++....        ....+++|.+....... .......+|+.++++++||||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~--------~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK--------NGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT--------TTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEECC--------CCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccc
Confidence            7899999999999999998654        33344444433221111 11223456999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||+++++|.+++..   ...+++..++.++.|++.||.+||+   .+++|+||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             cccccccccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            99999999999999999983   2348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh-hhhhhcCCC
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW-AKPILKNGD  385 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~-~~~~~~~~~  385 (522)
                      .....  .........++..|+|||.+. +..++.++||||||+++++|++|..||.............. .......  
T Consensus       146 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  221 (260)
T PF00069_consen  146 VKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--  221 (260)
T ss_dssp             EESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--
T ss_pred             ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--
Confidence            75411  122233457899999999998 78899999999999999999999999875411111111111 1000000  


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                               ...........+.+++..||+.||.+||++.++++
T Consensus       222 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 ---------SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---------HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---------cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     00000001268999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=351.30  Aligned_cols=268  Identities=22%  Similarity=0.332  Sum_probs=213.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...-.+.+.||.|.||.||.+.-.......   ..-.+++|.|++..+.  ....+|.+|..+|+.++|||||+++|+|.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~---~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV---SPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCc---cceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            345678899999999999998744321111   1345777777765543  36789999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG----EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +....+|++|||++|+|..+|+..+    ....++....+.++.+||+|..||++   +++|||||..+|+||+....+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence            9999999999999999999998752    13458999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |+|||+|+-..............-...|||||.++.+.++.|+|||||||++||++| |..||...+....  +    ..
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~----~~  916 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--L----LD  916 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--H----HH
Confidence            999999984333222222222244578999999999999999999999999999999 9999875442221  1    11


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ....|.          -..+..++..+.+++.+||+.+|++||++..|++.+..+..
T Consensus       917 ~~~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  917 VLEGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HHhCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            223331          12234466788899999999999999999999998877653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-37  Score=309.37  Aligned_cols=265  Identities=18%  Similarity=0.209  Sum_probs=196.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||+|+||.||++....        ....+++|.++.... .....+.+.+|+.++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK--------TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC--------CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            48899999999999999987542        345566666543221 122346788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||++ ++|.+++........+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccc
Confidence            99999999997 5999988765444569999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh-----
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI-----  380 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----  380 (522)
                      +.........  .....+++.|+|||.+.+. .++.++||||||+++++|++|+.||......  ..........     
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~  223 (285)
T cd07861         148 ARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTE  223 (285)
T ss_pred             eeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCCh
Confidence            8654332211  1223568899999998654 4789999999999999999999999643211  1111100000     


Q ss_pred             --hcC----C----CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 --LKN----G----DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 --~~~----~----~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        +..    .    .......... .......+..+.+++.+||+.||.+|||+.+|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000    0    0000000000 0001123467789999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-37  Score=307.12  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=196.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||+|+||.||++....         ...+++|.++...  .  ..++|.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~---------~~~~aik~~~~~~--~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG---------QYDVAIKMIKEGS--M--SEDEFIEEAKVMMKLSHEKLVQLYGVCTK   70 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC---------CCcEEEEEcCCCc--c--cHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            568999999999999999986432         1235555443211  1  23578999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++||||+++|+|.+++.....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          71 QRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             CCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCc
Confidence            9999999999999999999975432  58999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      .++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......    ..+
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~  217 (256)
T cd05113         146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV----SQG  217 (256)
T ss_pred             cceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----hcC
Confidence            98755432211 1112345678999999988889999999999999999998 99998643321   111111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ....  .       +...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       218 ~~~~--~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 LRLY--R-------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCC--C-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1100  0       0112467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-37  Score=314.20  Aligned_cols=274  Identities=21%  Similarity=0.251  Sum_probs=201.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ....+++|.++....  ......+.+|+.++++++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~   74 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKL--------TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIH   74 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcC--------CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEe
Confidence            4679999999999999999986532        345566666543221  123356788999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  148 (301)
T cd07873          75 TEKSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADF  148 (301)
T ss_pred             cCCeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcC
Confidence            9999999999997 59999887542  348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh-----
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK-----  378 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~-----  378 (522)
                      |++.........  .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||................     
T Consensus       149 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  226 (301)
T cd07873         149 GLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE  226 (301)
T ss_pred             cchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999654332211  1233578899999998654 47889999999999999999999997544321111110000     


Q ss_pred             ---h-hhcCCCcccccCCcccc----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 ---P-ILKNGDTETLLDPKLSN----EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ---~-~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         + ..........-.+....    ......+..+.+++.+||+.||.+|||+.++++        ++|++.-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~--------h~~f~~~  292 (301)
T cd07873         227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK--------HPYFHCL  292 (301)
T ss_pred             hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--------Ccccccc
Confidence               0 00000000000011100    011123456789999999999999999999998        8887643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-37  Score=306.07  Aligned_cols=255  Identities=22%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....         ...+++|.++....    ..++|.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG---------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS   71 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC---------CceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence            4679999999999999999986532         12366666653222    2357899999999999999999999875


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~df  146 (262)
T cd05071          72 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADF  146 (262)
T ss_pred             C-CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccC
Confidence            4 56799999999999999997542 2358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |.+......... ......++..|+|||+..+..++.++||||||+++|+|++ |..||......   ....   . ...
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~-~~~  218 (262)
T cd05071         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-VER  218 (262)
T ss_pred             Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---H-Hhc
Confidence            999765433221 1123346778999999988899999999999999999999 88888644321   1111   1 111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      +..         .......+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       219 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 GYR---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            100         011123456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.8e-37  Score=303.29  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ..+.+++|.+....     ..++|.+|++++++++||||+++++++.
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~   68 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKE--------TGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYF   68 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcC--------CCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeee
Confidence            4689999999999999999987543        23455655554322     1578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++...++++||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          69 KNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             cCCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999999999999997532  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++........  ......++..|+|||++.+..++.++||||||+++|+|++|+.||........  ...     ....
T Consensus       144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~-----~~~~  214 (256)
T cd06612         144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM-----IPNK  214 (256)
T ss_pred             ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh-----hccC
Confidence            99976544321  12234578899999999888899999999999999999999999864322111  000     0000


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..     +  ....+......+.+++.+||+.+|.+||++.+|++
T Consensus       215 ~~-----~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PP-----P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CC-----C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00     0  01112234467889999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.6e-37  Score=308.18  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|++.++||.|+||.||++.+..        ....+++|.+...  ......++|.+|++++++++||||+++++++..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLL--------TRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcC--------CCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            57889999999999999986542        3455666654321  1223456799999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|..+.       .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             CEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            9999999999999997653       27888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-hHHHhhhhhhcCCC
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-SLVKWAKPILKNGD  385 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~  385 (522)
                      +.......    .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ....... ......
T Consensus       142 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  216 (279)
T cd06619         142 STQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDED  216 (279)
T ss_pred             ceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccC
Confidence            96543322    22346899999999998888999999999999999999999998643211110 0001111 011110


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .     +.+.   .......+.+++.+||+.+|.+||++.++++        ++|+...
T Consensus       217 ~-----~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~--------~~~~~~~  259 (279)
T cd06619         217 P-----PVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMD--------HPFIVQY  259 (279)
T ss_pred             C-----CCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc--------Ccccccc
Confidence            0     0100   1113356888999999999999999999997        7887543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-37  Score=331.30  Aligned_cols=287  Identities=17%  Similarity=0.167  Sum_probs=197.1

Q ss_pred             CCCceeeecccccccccccccCchhHHH------Hhhcc-cCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFL------KLVSS-RCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSIT  217 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~------~~~~~-~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv  217 (522)
                      .++|+++++||+|+||.||++.......      ..... .......+.+.+...........|.+|+.+|++++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999875321110      00000 1112222222222223334567899999999999999999


Q ss_pred             eeeEEEEeCCEEEEEEecCCCCCHHHHhhccCC--CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          218 TLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE--QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       218 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ++++++...+..++|++++. ++|.+++.....  ........+..++.||+.||.|||+   ++|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence            99999999999999999995 588887754311  1223456778899999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCChhhHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP-IGFKNLKGPESLV  374 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~P-f~~~~~~~~~~l~  374 (522)
                      ++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ |..........+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999766443221 12235799999999999999999999999999999999998754 4332222222222


Q ss_pred             Hhhhhhhc-CCCccc-------ccCC----ccccccc-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          375 KWAKPILK-NGDTET-------LLDP----KLSNEYD-----NAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       375 ~~~~~~~~-~~~~~~-------~~d~----~l~~~~~-----~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      ........ ...+..       .++.    .......     ......+.+++.+||+.||.+|||+.|++.        
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~--------  453 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA--------  453 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh--------
Confidence            21111000 000000       0000    0000000     012245677899999999999999999997        


Q ss_pred             Ccccccc
Q 036172          438 TDWVDRH  444 (522)
Q Consensus       438 ~~~~~~~  444 (522)
                      ++|+...
T Consensus       454 hp~f~~~  460 (501)
T PHA03210        454 LPLFSAE  460 (501)
T ss_pred             ChhhhcC
Confidence            8887543

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=304.03  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=202.0

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||.|+||.||++......     .....+++|.+.......  ..+.+.+|+++++.++|+||+++++++......++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~-----~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD-----GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCC-----CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence            36899999999998765311     234566666665433221  46789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCC------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          232 VSDFLPKGSLEESLHGAGE------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ||||+++++|.+++.....      ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccc
Confidence            9999999999999986421      2569999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      .+................++..|+|||.+....++.++||||||+++|+|++ |..||.....   ..+.....    .+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~~  223 (262)
T cd00192         151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLR----KG  223 (262)
T ss_pred             cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cC
Confidence            9977665432222334567889999999988889999999999999999999 6999875421   11211111    11


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ..         ...+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       224 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 YR---------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC---------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11         0111223567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-37  Score=310.32  Aligned_cols=265  Identities=20%  Similarity=0.354  Sum_probs=202.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++..+||.|+||.||++......   .......+++|.+....  .....++|.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL---PYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC---CCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            468999999999999999998743100   01233456666654322  1234577999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC-------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEecc
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG-------------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD  285 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrD  285 (522)
                      ++...++||||+++|+|.+++....                   ....+++..++.++.|++.||.|||+   .+++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeeccc
Confidence            9999999999999999999997431                   11247888999999999999999999   9999999


Q ss_pred             CCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 036172          286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGF  364 (522)
Q Consensus       286 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~  364 (522)
                      |||+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999865433322111222345677999999988899999999999999999998 8888753


Q ss_pred             CCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ...   ......    +..+....         .+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus       236 ~~~---~~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAH---EEVIYY----VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCH---HHHHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            321   112111    11222111         011234578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-37  Score=309.23  Aligned_cols=263  Identities=18%  Similarity=0.269  Sum_probs=201.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++......    ......+++|.++...  .....+++.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~----~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDG----ENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICL   79 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCC----CccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence            467999999999999999998743210    0011235555554321  2334578999999999999999999999997


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .. ..+++|||+++|+|.+++....  ..+++..++.++.|++.||.|||+   ++++||||||+|||+++++.+||+||
T Consensus        80 ~~-~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          80 TS-TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             CC-CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCC
Confidence            64 5689999999999999997532  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+..+.    ..
T Consensus       154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~  226 (279)
T cd05109         154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EK  226 (279)
T ss_pred             CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HC
Confidence            99976654332222222345678999999988889999999999999999998 9999864321   1222211    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....         .+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus       227 ~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         227 GERLP---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CCcCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11111         01123456888999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-37  Score=328.89  Aligned_cols=267  Identities=21%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~  223 (522)
                      .++|.++++||+|+||.||++......   .....+.+++|.++...  .....+.|.+|+++|.++. |||||+++++|
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~---~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLS---HSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCC---CCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            356888999999999999998753210   12234567888776422  2334567999999999997 99999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-----------------------------------------------------
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-----------------------------------------------------  250 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  250 (522)
                      ...+..++||||+++|+|.++++..+.                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999975321                                                     


Q ss_pred             ------------------------------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          251 ------------------------------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       251 ------------------------------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                                                                ...+++..++.++.|++.||.|||+   .+++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCc
Confidence                                                      1246778889999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNL  367 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~  367 (522)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976543322222223456788999999988889999999999999999998 8999864321


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ..  .....    +..+..  .       ..+...+..+.+++.+||..+|.+||++.+|++.|+..
T Consensus       348 ~~--~~~~~----~~~~~~--~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 NE--QFYNA----IKRGYR--M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             hH--HHHHH----HHcCCC--C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11  11111    111110  0       01112346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=311.06  Aligned_cols=259  Identities=22%  Similarity=0.256  Sum_probs=211.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||.|.-|+|||++...        ....||+|.+.+..-.-.....+...|-+||+.++||.++.||+.+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~--------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRG--------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecC--------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            34689999999999999999998653        4478999988776665566778899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+...|||||||+||+|..+++++. .+.+++..+.-++..++.||+|||.   .|||.|||||+||||.++|++.|+|
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeee
Confidence            99999999999999999999998763 4569999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCC--------------------------------C-C---------------------CccccccccCCCCC
Q 036172          304 FGLAIWGPTD--------------------------------S-T---------------------HMIREDVVGTFGYI  329 (522)
Q Consensus       304 FGla~~~~~~--------------------------------~-~---------------------~~~~~~~~gt~~Y~  329 (522)
                      |.++......                                . .                     ......++||-.|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            9988432110                                0 0                     01123467999999


Q ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHH
Q 036172          330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLA  409 (522)
Q Consensus       330 APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  409 (522)
                      |||++.+...+.++|-|+|||++|||+.|..||...+....  +...+..-             +.-......+....+|
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NIv~~~-------------l~Fp~~~~vs~~akDL  367 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNIVGQP-------------LKFPEEPEVSSAAKDL  367 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHHhcCC-------------CcCCCCCcchhHHHHH
Confidence            99999999999999999999999999999999987654332  22211111             1111111456778999


Q ss_pred             HHHhhhcCCCCCCC----HHHHHH
Q 036172          410 ANLCINQSPQLRPN----MGQVLK  429 (522)
Q Consensus       410 i~~CL~~dP~~RPs----~~eVl~  429 (522)
                      |++.|.+||.+|.-    +.||-+
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHHHhccChhhhhccccchHHhhc
Confidence            99999999999997    777765

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6e-37  Score=303.75  Aligned_cols=258  Identities=22%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||.|+||.||++.......  .......+++|.+.+...  .....+|.+|+.++++++||||+++++++......++|
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~--~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILG--PGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             ccccccceeEEeeeeccccc--Ccccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            58999999999987643210  012335677777754321  23456899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccC----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-----ceEEee
Q 036172          233 SDFLPKGSLEESLHGAG----EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-----QPQLSD  303 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-----~~kL~D  303 (522)
                      |||+++++|.+++....    ....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999997532    22348899999999999999999999   9999999999999999877     899999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++................++..|+|||++.++.++.++|||||||++|+|++ |..||.....   ........    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----  227 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----  227 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----
Confidence            999965543322222223345788999999999999999999999999999998 9999864321   11111111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .+.         ....+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       228 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            110         001122345678899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-37  Score=319.59  Aligned_cols=264  Identities=22%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++....        ..+.+++|.+.+...........|.+|+.++..++|+||+++++++.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN--------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD   72 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC--------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence            368999999999999999987543        345666666544322222345668899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+.+++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999997532  248999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ++........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......      .....
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i  220 (332)
T cd05623         148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI  220 (332)
T ss_pred             hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHH
Confidence            9865433221 1122346999999999986     3467899999999999999999999996432111      11111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQ--LRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~--~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ........ + +.    .....+..+.+++.+|+..++.  .||++.++++        |+|+..
T Consensus       221 ~~~~~~~~-~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~--------h~~f~~  271 (332)
T cd05623         221 MNHKERFQ-F-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ--------HPFFTG  271 (332)
T ss_pred             hCCCcccc-C-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC--------CCCcCC
Confidence            11110000 0 00    0112345677788888755444  4789999997        888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-37  Score=308.36  Aligned_cols=266  Identities=20%  Similarity=0.270  Sum_probs=204.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||.+......    ......+++|.++..  ......+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~----~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEK----PGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCC----CCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            468999999999999999998765310    112334444444321  12234677899999999999999999999987


Q ss_pred             e-CCEEEEEEecCCCCCHHHHhhccCCC-----CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 E-DNYLILVSDFLPKGSLEESLHGAGEQ-----SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~-~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      . +...+++++|+++|+|.+++......     ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCc
Confidence            6 46789999999999999999764322     458999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||.....   ..+..+.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH
Confidence            99999999976543332222223456778999999988889999999999999999999 9999864322   2222221


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .    .+..  .   .    .....+..+.+++.+||..+|++|||+.+|++.|+...
T Consensus       233 ~----~~~~--~---~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 K----DGYR--L---A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             H----cCCC--C---C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1    1110  0   0    01113456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-37  Score=320.37  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=199.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.+.+...........|.+|+.++..++|+||+++++++.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~   72 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH--------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD   72 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            479999999999999999987543        455666666544322223345678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          73 ENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEecc
Confidence            999999999999999999998532  348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ++......... ......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||.......   .   ....
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~i  220 (331)
T cd05624         148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKI  220 (331)
T ss_pred             ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---H---HHHH
Confidence            99765433221 1123469999999999865     567899999999999999999999996433211   1   1111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ........ +.+.     ....+..+.+++.+||...+.+  |+++.++++        |+|++.
T Consensus       221 ~~~~~~~~-~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~--------h~~f~~  271 (331)
T cd05624         221 MNHEERFQ-FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK--------HAFFEG  271 (331)
T ss_pred             HcCCCccc-CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc--------CCCcCC
Confidence            11110000 0000     1123456788899988865544  468888876        777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.2e-38  Score=321.18  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=193.3

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHH-HhhCCCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI-TSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~i-L~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++.+..        .++.+++|.+.+..........++..|..+ ++.++||||+++++++..++..+
T Consensus         1 ~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~   72 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL--------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLY   72 (325)
T ss_pred             CceeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEE
Confidence            358999999999987543        456677776654333223344566667654 67789999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|..++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          73 FVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999999999999988743   358999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+.   ..... ...  .+
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~---~~~~~-~~~--~~  215 (325)
T cd05604         147 IAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMY---DNILH-KPL--VL  215 (325)
T ss_pred             CCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHH---HHHHc-CCc--cC
Confidence            22211  122457999999999999999999999999999999999999999654321   111   11111 110  11


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .+        ..+..+.+++.+||+.+|.+||++.+.++.+.    .|+|+..
T Consensus       216 ~~--------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~----~h~~f~~  256 (325)
T cd05604         216 RP--------GASLTAWSILEELLEKDRQRRLGAKEDFLEIQ----EHPFFES  256 (325)
T ss_pred             CC--------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh----cCCCcCC
Confidence            11        13346778999999999999998864333222    2667654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=305.22  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=195.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||+|+||.||++....         ...+++|.+.+...    ...+|.+|++++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~---------~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG---------KIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTK   70 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC---------CccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            458899999999999999986431         23344444332111    23568899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++++|.+++....  ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          71 QRPIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcc
Confidence            999999999999999999997543  258999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......    ..+
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~  217 (256)
T cd05059         146 LARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESV----SAG  217 (256)
T ss_pred             cceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHH----HcC
Confidence            98765432211 1112234567999999988899999999999999999999 89998643321   111111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      .     ..    ..+...+..+.+++.+||..+|++||++.+|++.|
T Consensus       218 ~-----~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 Y-----RL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             C-----cC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0     00    01112355788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.7e-37  Score=305.69  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||.|+||.||++.....     ......+++|.++...  .....+.|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP-----GKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK   76 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC-----CCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            5789999999999999999865321     1122244444443211  12245689999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.+++....  ..+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.++|+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCC
Confidence            999999999999999999997543  348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccc-cccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          306 LAIWGPTDSTHMIR-EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       306 la~~~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ++............ ....++..|+|||++.+..++.++||||||+++|++++ |..||......   .......    .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~  224 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----E  224 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----C
Confidence            99766543322111 11233568999999998889999999999999999887 99998644321   1221111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      +..  .  +     .....+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       225 ~~~--~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GYR--L--P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCc--C--C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            100  0  0     0112345678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=320.18  Aligned_cols=250  Identities=22%  Similarity=0.280  Sum_probs=190.2

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceeeEEEEeCCEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~~~~~~~~~~~  230 (522)
                      ||+|+||.||++.+..        ..+.+++|.+.+...........+..|..++.++   +||||+++++++.+...++
T Consensus         1 lG~G~~g~Vy~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~   72 (330)
T cd05586           1 IGKGTFGQVYQVRKKD--------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLY   72 (330)
T ss_pred             CCCCCceEEEEEEECC--------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEE
Confidence            7999999999987643        3455666655432222223445667788888766   7999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++...
T Consensus        73 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          73 LVTDYMSGGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEcCCCCChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            999999999999998743   358999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETL  389 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (522)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......   .+..   . +..+.. .+
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~---~-i~~~~~-~~  216 (330)
T cd05586         147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYR---N-IAFGKV-RF  216 (330)
T ss_pred             CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHH---H-HHcCCC-CC
Confidence            32221  12345799999999998765 4799999999999999999999999654321   1111   1 111111 00


Q ss_pred             cCCcccccccHHHHHHHHHHHHHhhhcCCCCCC----CHHHHHHHHhccccCCccccc
Q 036172          390 LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       390 ~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                           ..   ......+.+++.+||+.||.+||    ++.++++        |+|+..
T Consensus       217 -----~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~--------h~~~~~  258 (330)
T cd05586         217 -----PK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE--------HPFFAD  258 (330)
T ss_pred             -----CC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc--------CccccC
Confidence                 00   11345677899999999999998    5666665        788764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-37  Score=305.37  Aligned_cols=253  Identities=21%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc------chHHHHHHHHHHHHhhCCCCCcceee
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF------SSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~------~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      +|.+...||.|+||.||++.+..        ..+.+++|.+.......      ....+.+.+|+.++++++||||++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS--------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYL   72 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC--------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            57888999999999999987532        23344544433221111      12346789999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +++.+.+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          73 GSSLDADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EEEEeCCccEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEE
Confidence            9999999999999999999999999754   348999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCc----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          301 LSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      |+|||+++.........    ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ...... 
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-  223 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFK-  223 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHH-
Confidence            99999997654321111    11234578899999999888899999999999999999999999964321  111110 


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         . ...     ..+    ..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       224 ---~-~~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 ---I-GEN-----ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---H-hcc-----CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               0 000     111    112234467888999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-37  Score=315.08  Aligned_cols=200  Identities=22%  Similarity=0.348  Sum_probs=158.7

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe--CCE
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNY  228 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~--~~~  228 (522)
                      +++||+|+||.||++....      ....+.+++|.++...     ....+.+|+.++++++||||+++++++..  +..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~------~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD------GKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRK   74 (317)
T ss_pred             ccccccCCCeEEEEEEEcc------CCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence            4679999999999987532      2234566666554211     22457889999999999999999999864  467


Q ss_pred             EEEEEecCCCCCHHHHhhccC------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec----cCCCc
Q 036172          229 LILVSDFLPKGSLEESLHGAG------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL----SSDFQ  298 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl----~~~~~  298 (522)
                      +++||||+.+ +|.+++....      ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~  150 (317)
T cd07868          75 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             EEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCc
Confidence            8999999954 8988876321      12358999999999999999999999   999999999999999    45678


Q ss_pred             eEEeecCccccCCCCCCC-ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          299 PQLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      +||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            999999999765443221 112345789999999998764 5899999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-37  Score=304.50  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=199.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++.+..        ..+.+++|.++...  .....+.+.+|+.++++++|+||+++++.+.++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   70 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN--------SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD   70 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC--------CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence            58899999999999999987543        34556666543211  123557888999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          71 GHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCc
Confidence            99999999999999999887532 2348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....|++.|+|||++.+..++.++||||||+++|+|++|..||......   ....   . +..+..
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~  217 (255)
T cd08219         147 ARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLIL---K-VCQGSY  217 (255)
T ss_pred             ceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHH---H-HhcCCC
Confidence            8655432211  12346889999999998888999999999999999999999999643211   1111   1 111111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      ..         .+...+..+.+++.+||+.+|.+||++.+|+..
T Consensus       218 ~~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KP---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CC---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11         112234568889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-37  Score=320.28  Aligned_cols=268  Identities=24%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.++||.|+||.||++....+.   ....++.+++|.++...  .......+.+|+.++.++ +||||+++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID---KTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC---ccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            358999999999999999998643210   12346678888775322  233457799999999999 789999999988


Q ss_pred             EeC-CEEEEEEecCCCCCHHHHhhccCC----------------------------------------------------
Q 036172          224 IED-NYLILVSDFLPKGSLEESLHGAGE----------------------------------------------------  250 (522)
Q Consensus       224 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  250 (522)
                      ... ...++||||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            754 578999999999999999875311                                                    


Q ss_pred             ------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCcc
Q 036172          251 ------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI  318 (522)
Q Consensus       251 ------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  318 (522)
                                  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  237 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  237 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence                        1237888899999999999999999   9999999999999999999999999999976543322222


Q ss_pred             ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccccc
Q 036172          319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE  397 (522)
Q Consensus       319 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  397 (522)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ..+...    ...+.....  +     
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~----~~~~~~~~~--~-----  304 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LKEGTRMRA--P-----  304 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHH----HhccCCCCC--C-----
Confidence            223346678999999988889999999999999999997 99998643221  111111    111111100  1     


Q ss_pred             ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          398 YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       398 ~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        ......+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus       305 --~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         305 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              112346888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-37  Score=303.77  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=191.6

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++....      ......+++|.++...  .....++|.+|+.++++++||||+++++++.. ...++|
T Consensus         2 ~ig~G~~g~v~~~~~~~------~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv   72 (257)
T cd05115           2 ELGSGNFGCVKKGVYKM------RKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLV   72 (257)
T ss_pred             ccCCCCcccEEEEEEec------CCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEE
Confidence            38999999999875321      1123345555554322  12345679999999999999999999998864 578999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        73 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          73 MEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            9999999999999753  2358999999999999999999999   9999999999999999999999999999975543


Q ss_pred             CCCCcc-ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          313 DSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       313 ~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ...... .....++..|+|||.+....++.++||||||+++|++++ |..||......   .....    +..+...   
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~---  217 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSF----IEQGKRL---  217 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCC---
Confidence            322111 111233578999999988889999999999999999996 99998643221   11111    1111111   


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                            ..+...+..+.+++.+||..+|++||++.+|.+.|+..
T Consensus       218 ------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 ------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                  11122356788899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-37  Score=305.41  Aligned_cols=257  Identities=22%  Similarity=0.327  Sum_probs=187.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++.....      .....+++|.+...  ........|.+|+.+++.++||||+++++.+.+....++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~------~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv   73 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG------MSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV   73 (269)
T ss_pred             cCCccCCceEEEEEEecC------CCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence            589999999999753221      12234455544321  1223456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCC--CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          233 SDFLPKGSLEESLHGAGE--QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      |||+++|+|.+++.....  ....++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEecccccccc
Confidence            999999999999976432  2235678889999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCCccccccccCCCCCChhhhcc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMH-------GKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      .............++..|+|||++..       ..++.++|||||||++|||++ |..||.....  ...+..    ...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~----~~~  224 (269)
T cd05042         151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQ----VVR  224 (269)
T ss_pred             ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHH----Hhh
Confidence            33222111223346778999999743       356889999999999999999 7888864321  111111    111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      .. ...+..+.+.    ...+..+..++..|+ .||.+||++++|++.|.
T Consensus       225 ~~-~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 EQ-DIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cc-CccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11 1112222222    223456677888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-37  Score=302.85  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=195.6

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||+|+||.||++.....     ......+++|.+......  ...+++.+|+.+++++.||||+++++++. ....++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~-----~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK-----SGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeecc-----CCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEE
Confidence            3699999999998864221     112345666665533222  35578999999999999999999999876 456799


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||.   .+++|+||||+|||++.++.+||+|||+++...
T Consensus        73 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          73 VMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             EEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceee
Confidence            999999999999998543   58999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCCCcc-ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccc
Q 036172          312 TDSTHMI-REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETL  389 (522)
Q Consensus       312 ~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (522)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+.....    .+...  
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~--  217 (257)
T cd05060         147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERL--  217 (257)
T ss_pred             cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcC--
Confidence            4332211 111224567999999988889999999999999999998 9999864322   22222221    11110  


Q ss_pred             cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          390 LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       390 ~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                             ..+...+..+.+++.+||..+|.+||++.+|++.|++..
T Consensus       218 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 -------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                   111123457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-37  Score=319.47  Aligned_cols=271  Identities=19%  Similarity=0.211  Sum_probs=199.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+..... .....+++.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAV--------LDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecC--------CCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            45789999999999999999987532        345566665543221 122456788999999999999999999998


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ...++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~  156 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC  156 (355)
T ss_pred             eccccccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCC
Confidence            643      357999999965 77777752     38899999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHH-
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVK-  375 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~-  375 (522)
                      .+||+|||+++.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ... 
T Consensus       157 ~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (355)
T cd07874         157 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_pred             CEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999999976443221   123468999999999988889999999999999999999999997543211100 000 


Q ss_pred             --------------hhhhhhcC-CCcccccCCcc--------cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          376 --------------WAKPILKN-GDTETLLDPKL--------SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       376 --------------~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                                    ........ .....+..+..        ...........+.+++.+||+.||.+|||+.|+++   
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~---  310 (355)
T cd07874         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ---  310 (355)
T ss_pred             hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc---
Confidence                          00000000 00000000000        00111123456789999999999999999999997   


Q ss_pred             ccccCCccccc
Q 036172          433 GATHATDWVDR  443 (522)
Q Consensus       433 ~~~~~~~~~~~  443 (522)
                           |+|+..
T Consensus       311 -----hp~~~~  316 (355)
T cd07874         311 -----HPYINV  316 (355)
T ss_pred             -----Ccchhc
Confidence                 888763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-37  Score=309.22  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||+|+||.||++....        ....+++|.++...  .......|.+|+.++++++||||+++++++..+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~--------~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRP--------TGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcC--------CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            68899999999999999987542        34566666554321  122457899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+++||||+++++|..++........+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence            99999999999999999987542234589999999999999999999962  5899999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK------VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +........    ....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||........   .......
T Consensus       150 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~  222 (286)
T cd06622         150 SGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAI  222 (286)
T ss_pred             cccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHH
Confidence            865433221    2345788999999985443      48899999999999999999999965332211   1111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..+..         ...+......+.+++.+||+.+|.+||++.+++.        ++|+...
T Consensus       223 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--------~~~~~~~  268 (286)
T cd06622         223 -VDGDP---------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--------HPWLVKY  268 (286)
T ss_pred             -hhcCC---------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--------Chhhhhc
Confidence             11111         1122235567888999999999999999999997        7886554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=306.94  Aligned_cols=263  Identities=19%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||++......    ......+++|.++....  .....+|.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEG----EKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICL   79 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCC----CCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            468999999999999999998743210    11123455555443221  335578999999999999999999999998


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      . ...++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        80 ~-~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          80 S-SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             c-CceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCC
Confidence            7 78899999999999999998642  248999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............++..|+|||.+....++.++||||||+++||+++ |+.||......   .+.....    .
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~  226 (279)
T cd05057         154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLE----K  226 (279)
T ss_pred             cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh----C
Confidence            99976654333222222234678999999988889999999999999999999 99998654322   2221111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +..  ...       +......+.+++.+||..+|..||++.++++.|....
T Consensus       227 ~~~--~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         227 GER--LPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CCC--CCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111  000       1112346788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-37  Score=344.56  Aligned_cols=266  Identities=21%  Similarity=0.286  Sum_probs=204.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++.+..        .++.+++|.+...........++|.+|++++++++||||+++++++.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~--------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d   73 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV--------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD   73 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC--------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee
Confidence            689999999999999999987542        456677776654333333456789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCC--------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGE--------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ++..++||||++||+|.+++.....        ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.++
T Consensus        74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCC
Confidence            9999999999999999999874211        1235677889999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCC----------------CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Q 036172          298 QPQLSDFGLAIWGPTDST----------------HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~----------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~P  361 (522)
                      .++|+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            999999999976521110                0111234699999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhcccc
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGATH  436 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~~~  436 (522)
                      |.......   ... . ...        ..+.... .....+..+.+++.+||+.||.+|| +++++++.|+....
T Consensus       231 F~~~~~~k---i~~-~-~~i--------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        231 YRRKKGRK---ISY-R-DVI--------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             CCCcchhh---hhh-h-hhc--------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            96532111   100 0 000        0000000 0112345688899999999999996 67777777776543

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-37  Score=306.04  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=200.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||.|+||.||++.....     ......+++|.++...  .....++|.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   76 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP-----GKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK   76 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC-----CCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence            5689999999999999999875431     1122345666554321  12245789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          77 SRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             CCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCc
Confidence            999999999999999999997542  348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCcccc-cc--ccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          306 LAIWGPTDSTHMIRE-DV--VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       306 la~~~~~~~~~~~~~-~~--~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ++............. ..  ..+..|+|||++.+..++.++|||||||++||+++ |..||.....   .....+...  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~--  226 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ--  226 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc--
Confidence            987654332211111 11  12457999999998899999999999999999886 9999854321   122222211  


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                       .....          .+...+..+.+++.+||+.+|.+||++.+|+..|+..
T Consensus       227 -~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 -DYRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -CCcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00000          0112345678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-37  Score=302.23  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=201.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||.|+||.||++...          .+.+++|.++....    ..+++.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~----------~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~   70 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR----------GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVL   70 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec----------CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence            467899999999999999988642          34566665543221    4678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          71 QGNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             CCCCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccc
Confidence            99999999999999999999975432 258999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |.++.......     ....+..|+|||++..+.++.++||||||++++++++ |..||.....   ..+.....    .
T Consensus       147 g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~  214 (256)
T cd05039         147 GLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVE----K  214 (256)
T ss_pred             ccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----c
Confidence            99976533221     2234678999999988889999999999999999997 9999864421   12221111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +..         ...+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       215 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 GYR---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCC---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            100         01111234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.6e-37  Score=304.08  Aligned_cols=262  Identities=22%  Similarity=0.298  Sum_probs=201.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|...+.||+|+||.||++.....     ......+++|.++....  ....++|.+|++++++++||||+++++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMP-----GRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVT   76 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecC-----CCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence            35788899999999999999875421     11123455555543221  224567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+..++||||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          77 KFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCC
Confidence            9999999999999999999997532  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccc-cccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIR-EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |++............ .....+..|+|||++....++.++|||||||++|||++ |+.||.....   ........    
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~----  224 (268)
T cd05063         152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIN----  224 (268)
T ss_pred             ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHh----
Confidence            999765433221111 11223457999999988889999999999999999997 9999854332   11211111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .+...    +     .....+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       225 ~~~~~----~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DGFRL----P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCCCC----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11000    0     0112345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8e-37  Score=300.54  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=197.9

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe-
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE-  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~-  225 (522)
                      .|++.+.||.|+||.||++.+..        ..+.+++|.+..... .....+.+.+|++++++++|+|++++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT--------DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC--------CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            48999999999999999987543        234556655533221 12245678999999999999999999998764 


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +..+++||||+++++|.+++.... ...+++.+++.++.+++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEeccc
Confidence            457899999999999999997542 3358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++........  ......+++.|+|||++.+..++.++||||||+++++|++|+.||.....   ....   .... .+.
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~---~~~~-~~~  218 (257)
T cd08223         148 IARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV---YRII-EGK  218 (257)
T ss_pred             ceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHH---HHHH-hcC
Confidence            9976543222  12234688999999999988899999999999999999999999864321   1111   1111 111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..         ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       219 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11         112234567889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.4e-37  Score=303.04  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++...         ..+.+++|.+.....    ...+|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~---------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN---------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT   71 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC---------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence            468999999999999999998743         234566666543221    3467999999999999999999999875


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                       .+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          72 -QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             -cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccC
Confidence             456899999999999999987543 3358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++......... ......++..|+|||++....++.++||||||+++|++++ |+.||.....   .......    ..
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~  218 (260)
T cd05067         147 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----ER  218 (260)
T ss_pred             cceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----Hc
Confidence            999765432211 1123345778999999988889999999999999999999 9999964332   1111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +...         ..+...+..+.+++.+||+.+|++||++++|+..|+.
T Consensus       219 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 GYRM---------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1000         0111234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.8e-37  Score=305.19  Aligned_cols=257  Identities=23%  Similarity=0.313  Sum_probs=188.7

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++....      ......+++|.++...  .......|.+|+.++++++||||+++++++.+....++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~------~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           2 EIGNGWFGKVILGEVNS------GYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             cccccCCceEEEEEEcC------CCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            58999999999986321      1123345555443221  122345789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          233 SDFLPKGSLEESLHGAG--EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      |||+++|+|.+++....  ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999997542  12246777888999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCCccccccccCCCCCChhhhccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHG-------KVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      .............++..|+|||++...       .++.++||||||+++|||++ |+.||.......   .....    .
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~  223 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----V  223 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----h
Confidence            433222222234578889999998532       35789999999999999996 999996433211   11111    0


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      .+.......+.+..    .....+.+++..|+ .+|.+|||+.+|+..|+
T Consensus       224 ~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 REQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111222222221    12345777899998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.8e-37  Score=319.52  Aligned_cols=271  Identities=19%  Similarity=0.191  Sum_probs=199.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+..... .....+++.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~   92 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAI--------LERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVF   92 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECC--------CCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceee
Confidence            45789999999999999999987543        345566666543221 123456788999999999999999999987


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ..+++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~  163 (364)
T cd07875          93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC  163 (364)
T ss_pred             cccccccccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCC
Confidence            643      467999999965 78887752     37889999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH-H-
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV-K-  375 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~-~-  375 (522)
                      .+||+|||+++.......   .....+|..|+|||++.+..++.++|||||||++|+|++|+.||...........+ . 
T Consensus       164 ~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         164 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             cEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999999976543221   12346899999999999999999999999999999999999999654321110000 0 


Q ss_pred             ----------hhh----hhhcC-CCc-----ccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          376 ----------WAK----PILKN-GDT-----ETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       376 ----------~~~----~~~~~-~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                                ...    ..... ...     ........   ...........+.+++.+||+.||.+|||+.++++   
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~---  317 (364)
T cd07875         241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ---  317 (364)
T ss_pred             cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc---
Confidence                      000    00000 000     00000000   00111112356789999999999999999999997   


Q ss_pred             ccccCCccccc
Q 036172          433 GATHATDWVDR  443 (522)
Q Consensus       433 ~~~~~~~~~~~  443 (522)
                           |+|+..
T Consensus       318 -----hp~~~~  323 (364)
T cd07875         318 -----HPYINV  323 (364)
T ss_pred             -----Cccccc
Confidence                 888753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-37  Score=304.46  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=190.6

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~l  231 (522)
                      .||.|+||.||++.....      .....+++|.++..  ......+.|.+|+.+++++ +||||+++++++...+..++
T Consensus         2 ~lg~g~~g~v~~~~~~~~------~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           2 VIGEGNFGQVLKARIKKD------GLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             cCCCCCCceEEEEEEcCC------CCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            589999999999875431      11112344443321  1123456789999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          232 VSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ||||+++|+|.+++....             ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~  150 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCe
Confidence            999999999999997532             12248899999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||++........   ......+..|+|||++....++.++||||||+++|||++ |..||......   ......
T Consensus       151 ~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~  224 (270)
T cd05047         151 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL  224 (270)
T ss_pred             EEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH
Confidence            99999999853221111   111234567999999988889999999999999999997 99998543211   111111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .    .+...         ..+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       225 ~----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 P----QGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             h----CCCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1    11000         01112335688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-36  Score=302.71  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-------ccchHHHHHHHHHHHHhhCCCCCccee
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-------QFSSAWNDFSSEVDITSSLEQKSITTL  219 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-------~~~~~~~~f~~Ev~iL~~L~HpnIv~l  219 (522)
                      +|.+.++||.|+||.||++....        ..+.+++|.++....       ......+.|.+|+.++++++||||+++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   73 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT--------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQY   73 (272)
T ss_pred             ceeecceecccCceEEEEEeecC--------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceE
Confidence            58889999999999999986532        334555555432111       111234678899999999999999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ++++...+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          74 LGFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             EEEeccCCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeE
Confidence            99999999999999999999999999854   358999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +|+|||++................++..|+|||.+....  ++.++|+||||++++++++|..||.....  ...+... 
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~-  224 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKL-  224 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HHHHHHh-
Confidence            999999997654332222223456889999999987654  78999999999999999999999853221  1111110 


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         .. ......+.    .......+..+.+++.+||..+|.+||++.+|++
T Consensus       225 ---~~-~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         225 ---GN-KRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ---hc-cccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence               00 11111111    1112234567888999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.8e-37  Score=301.38  Aligned_cols=259  Identities=23%  Similarity=0.330  Sum_probs=202.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ....+++|.+....  .....+.+.+|+++++.++|+||+++++.+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP--------NNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV   70 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC--------CCcEEEEEEeccCC--cchHHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence            479999999999999999987542        23445555543222  12256789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.+++........+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~  147 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFG  147 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccc
Confidence            99999999999999999999865333458999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCc--cccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHM--IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++..........  ......|+..|+|||++... .++.++|+||||+++++|++|+.||......  ........    
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~----  221 (267)
T cd06610         148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQ----  221 (267)
T ss_pred             hHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhc----
Confidence            986655433221  22344689999999998777 7899999999999999999999998644321  11111111    


Q ss_pred             CCCcccccCCcccccc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEY-DNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      . .     .+.+.... ....+..+.+++.+||..||.+||++.+|++
T Consensus       222 ~-~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         222 N-D-----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C-C-----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1 0     00111110 1234567889999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9e-37  Score=301.70  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++..+||.|+||.||++....         ...+++|.+....    ...+.|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNG---------TTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS   71 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcC---------CceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3579999999999999999986532         1234555443211    12367899999999999999999999885


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      . +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+||
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          72 E-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             C-CCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCC
Confidence            4 56789999999999999997542 2348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++......... ......++..|+|||+..+..++.++||||||+++|+|++ |..||......   .......    .
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~  218 (260)
T cd05069         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE----R  218 (260)
T ss_pred             ccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence            999765432211 1122346778999999988889999999999999999999 99998643211   1111111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +..         ...+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       219 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 GYR---------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCC---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            100         01112245678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.1e-37  Score=306.93  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=203.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ..+.+++|.+++.........+.+.+|++++++++||||+++++++.+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG--------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD   72 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence            468999999999999999987653        345666665544332223356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||
T Consensus        73 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          73 DSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999999999999754   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++......     .....+++.|+|||.+.+...+.++||||||+++|+|++|..||.....   .......    ..+.
T Consensus       147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~  214 (290)
T cd05580         147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKI----LEGK  214 (290)
T ss_pred             CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----hcCC
Confidence            99765443     2234688999999999888889999999999999999999999865431   1111111    1111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .          ..+......+.+++.+||..+|.+||     ++.++++        ++|+..
T Consensus       215 ~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~--------~~~~~~  259 (290)
T cd05580         215 V----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN--------HPWFAG  259 (290)
T ss_pred             c----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc--------Cccccc
Confidence            1          01112245788899999999999999     7788876        777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.5e-37  Score=301.01  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=197.5

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||+|+||.||++.....     ......+++|.+......  ...++|.+|+.++++++||||+++++++.. ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~-----~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS-----GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecC-----CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence            3689999999999875421     112234566655443322  467789999999999999999999999998 89999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|.+++..... ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        73 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          73 VTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             EEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccc
Confidence            9999999999999986532 458999999999999999999999   999999999999999999999999999997765


Q ss_pred             CCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccc
Q 036172          312 TDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETL  389 (522)
Q Consensus       312 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (522)
                      ...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   .......   .....  .
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~--~  220 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGER--L  220 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCCc--C
Confidence            432221 1123457789999999988899999999999999999999 99998543211   1111111   11100  0


Q ss_pred             cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          390 LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       390 ~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      .       .+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       221 ~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 E-------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             C-------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0       11123457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-37  Score=318.37  Aligned_cols=247  Identities=21%  Similarity=0.231  Sum_probs=187.9

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHH-HHhhCCCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVD-ITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~-iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||+|+||.||++.+..        ..+.+++|.+.+...........+..|.. +++.++||||+++++++...+.++
T Consensus         1 ~~lg~G~fg~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~   72 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA--------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY   72 (325)
T ss_pred             CeeeeCCCeEEEEEEECC--------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEE
Confidence            358999999999987543        34556666554332222223344555554 567889999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        73 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          73 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999999999999999753   348889999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ......   ... ..    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~~-~~----  213 (325)
T cd05602         147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI---LNK-PL----  213 (325)
T ss_pred             ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH---HhC-Cc----
Confidence            22211  123457999999999999989999999999999999999999999643321   111111   110 00    


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                            ......+..+.+++.+||+.+|.+||++.+.+..+
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence                  01112345678899999999999999987554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.3e-37  Score=302.31  Aligned_cols=257  Identities=19%  Similarity=0.310  Sum_probs=201.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc---cchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ---FSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~---~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      +|+..+.||+|+||.||++.+..        +...+++|.+......   .....+.|.+|+.++++++|+||+++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   72 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK--------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT   72 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC--------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee
Confidence            47888999999999999876532        3456666665432211   112457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~kL~  302 (522)
                      .+.+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++ .++|+
T Consensus        73 ~~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          73 CEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             ccCCeEEEEEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEc
Confidence            9999999999999999999999753   358999999999999999999999   9999999999999998776 59999


Q ss_pred             ecCccccCCCCCCC--ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |||.+.........  .......++..|+|||.+.+..++.++||||||+++++|++|..||................  
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--  224 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--  224 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh--
Confidence            99999765443211  11223468899999999988889999999999999999999999996544332222111110  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                       ...         .....+......+.+++.+||..+|.+||++.++++
T Consensus       225 -~~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 -SAT---------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -ccC---------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             000         011223345567888999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.5e-37  Score=328.39  Aligned_cols=269  Identities=16%  Similarity=0.176  Sum_probs=193.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC------CCcce
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ------KSITT  218 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H------pnIv~  218 (522)
                      .++|++.++||+|+||.||++.+..        ..+.||+|.++...    ....++..|+.++..++|      .+|++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~--------~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRK--------RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcC--------CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            4789999999999999999987543        34566777654311    123445667777777654      45889


Q ss_pred             eeEEEEeC-CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          219 LNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       219 l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +++++..+ .++++|||++ +++|.+++...   ..+++..+..|+.||+.||.|||+.  .+||||||||+|||++.++
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSD  269 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCC
Confidence            99988765 5789999998 77999988754   3599999999999999999999972  4999999999999998765


Q ss_pred             ----------------ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Q 036172          298 ----------------QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       298 ----------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~P  361 (522)
                                      .+||+|||.+......     .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            4999999987542221     2245799999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhHHHhhh-----------------hhhc-CCCcccccCCccc-------ccccHHHHHHHHHHHHHhhhc
Q 036172          362 IGFKNLKGPESLVKWAK-----------------PILK-NGDTETLLDPKLS-------NEYDNAQMQRMLLAANLCINQ  416 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~-----------------~~~~-~~~~~~~~d~~l~-------~~~~~~~~~~l~~li~~CL~~  416 (522)
                      |...........+....                 ..+. .+......++...       ..........+.+||.+||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            97544221111111000                 0000 0000001111000       000001134577999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          417 SPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       417 dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ||.+|||+.|+++        |+|+...
T Consensus       425 dP~~R~ta~e~L~--------Hp~~~~~  444 (467)
T PTZ00284        425 DRQKRLNARQMTT--------HPYVLKY  444 (467)
T ss_pred             ChhhCCCHHHHhc--------Ccccccc
Confidence            9999999999997        9998764

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-36  Score=311.74  Aligned_cols=271  Identities=18%  Similarity=0.241  Sum_probs=196.4

Q ss_pred             eeeccccc--ccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          150 MDIPCSEG--KYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       150 ~~~~lG~G--~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      ++.+||+|  +|++||++....        +.+.+++|.++..... ....+.+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP--------TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecc--------cCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            46779999  678888877543        5667777776543221 224456788999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.++++||+.+
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchh
Confidence            9999999999999999997542 2248999999999999999999999   99999999999999999999999999875


Q ss_pred             ccCCCCCCC-----ccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          308 IWGPTDSTH-----MIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       308 ~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      .........     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  .........
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~  226 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGT  226 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCC
Confidence            432211100     01112356778999999976  458999999999999999999999996432111  000000000


Q ss_pred             hc---------------------------CCCc----ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LK---------------------------NGDT----ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~---------------------------~~~~----~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..                           .+..    ...................+.+++.+||+.||.+|||+.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00                           0000    0000000001112234567889999999999999999999997


Q ss_pred             HHhccccCCccccc
Q 036172          430 LLRGATHATDWVDR  443 (522)
Q Consensus       430 ~L~~~~~~~~~~~~  443 (522)
                              ++|++.
T Consensus       307 --------~p~f~~  312 (327)
T cd08227         307 --------HSFFKQ  312 (327)
T ss_pred             --------Chhhhh
Confidence                    888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.2e-37  Score=308.69  Aligned_cols=258  Identities=22%  Similarity=0.303  Sum_probs=202.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++.+.||.|+||.||++.+..        ..+.+++|.+..   ......+.+.+|+.+++.++|+||+++++.+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~v~ik~~~~---~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~   86 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVA--------TGQEVAIRQMNL---QQQPKKELIINEILVMRENKNPNIVNYLDSY   86 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECC--------CCcEEEEEEEec---CCcchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34689999999999999999986432        334555554432   1122456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+...++||||+++++|.+++...    .+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~d  159 (296)
T cd06654          87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTD  159 (296)
T ss_pred             EeCCEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECc
Confidence            9999999999999999999998642    38899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.........  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||......  ..+....    ..
T Consensus       160 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~----~~  231 (296)
T cd06654         160 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIA----TN  231 (296)
T ss_pred             cccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHh----cC
Confidence            9998654332211  12346889999999998888999999999999999999999999644321  1111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +. ..       ...+......+.+++.+||..+|.+||++.+|++        ++|+..
T Consensus       232 ~~-~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--------~~~~~~  275 (296)
T cd06654         232 GT-PE-------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--------HQFLKI  275 (296)
T ss_pred             CC-CC-------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh--------Chhhhc
Confidence            10 00       0112234456888999999999999999999997        777654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.1e-37  Score=305.65  Aligned_cols=259  Identities=24%  Similarity=0.308  Sum_probs=198.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.++||.|+||.||++....        ....++++.+..   ......+.|.+|+++++.++||||+++++++..
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~--------~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   73 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKE--------TGVLAAAKVIDT---KSEEELEDYMVEIDILASCDHPNIVKLLDAFYY   73 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECC--------CCeEEEEEEeCC---CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee
Confidence            347889999999999999987543        222333333321   112345779999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|..++...  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        74 ~~~~~~v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          74 ENNLWILIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccc
Confidence            99999999999999999988653  2358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ++........  ......++..|+|||++.     +..++.++|||||||++|+|++|+.||.....  ........   
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~---  221 (282)
T cd06643         149 VSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKIA---  221 (282)
T ss_pred             cccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHHh---
Confidence            9865433211  122346899999999984     34578899999999999999999999864321  11111111   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       . .......       .+...+..+.+++.+||+.+|.+||++.++++        ++|+...
T Consensus       222 -~-~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--------~~~~~~~  268 (282)
T cd06643         222 -K-SEPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ--------HPFVTVN  268 (282)
T ss_pred             -h-cCCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhc--------CCCEecc
Confidence             1 0000111       11123457889999999999999999999997        8887754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=304.80  Aligned_cols=257  Identities=22%  Similarity=0.328  Sum_probs=204.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++....        ....+++|.+....  .......+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR--------TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK   70 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC--------CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE
Confidence            478999999999999999987543        34556666554322  12345678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +..+++|+||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999999999743    58999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++........  ......++..|+|||++.+..++.++||||||+++|+|++|+.||......   .....    +..+.
T Consensus       144 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~----~~~~~  214 (274)
T cd06609         144 VSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFL----IPKNN  214 (274)
T ss_pred             cceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHH----hhhcC
Confidence            9976654321  122346888999999998888999999999999999999999999644311   11110    11111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..     .+...   ..+..+.+++.+||..+|.+||++.++++        ++|+...
T Consensus       215 ~~-----~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--------~~~~~~~  257 (274)
T cd06609         215 PP-----SLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK--------HKFIKKA  257 (274)
T ss_pred             CC-----CCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh--------ChhhcCC
Confidence            11     11111   13456888999999999999999999998        8887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.7e-37  Score=302.39  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=196.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++....         ...+++|.+.....    ..+.|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG---------NTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS   71 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC---------CceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence            3579999999999999999986432         22344444432111    2356999999999999999999999885


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      . ...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+||
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          72 E-EPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             C-CCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCc
Confidence            4 56889999999999999997542 2348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....   .......    ..
T Consensus       147 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~  218 (260)
T cd05070         147 GLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQV----ER  218 (260)
T ss_pred             eeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----Hc
Confidence            9997654332111 112235678999999988889999999999999999999 8999864321   1111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +..         ...+...+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       219 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYR---------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCC---------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            100         01112234578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.3e-37  Score=310.92  Aligned_cols=200  Identities=21%  Similarity=0.333  Sum_probs=158.2

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe--CCE
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNY  228 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~--~~~  228 (522)
                      +.+||+|+||.||++....      ....+.+++|.+....     ....+.+|+.++++++||||+++++++..  +..
T Consensus         6 g~~lG~G~~g~Vy~~~~~~------~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD------GKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRK   74 (317)
T ss_pred             ceEeccCCCeeEEEEEecC------CCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence            4579999999999987532      1234556666554311     22457889999999999999999999864  567


Q ss_pred             EEEEEecCCCCCHHHHhhcc------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec----cCCCc
Q 036172          229 LILVSDFLPKGSLEESLHGA------GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL----SSDFQ  298 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl----~~~~~  298 (522)
                      .++||||+.+ +|.+++...      .....+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  150 (317)
T cd07867          75 VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             EEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCc
Confidence            8999999965 888887532      122348899999999999999999999   999999999999999    45678


Q ss_pred             eEEeecCccccCCCCCCC-ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          299 PQLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      +||+|||+++........ .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999999999765443221 112245689999999998764 5799999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=312.93  Aligned_cols=261  Identities=18%  Similarity=0.267  Sum_probs=213.9

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      .++..+-|.+.+.||+|.|+.|.++++.-        ++..+|+|.+.+..- ..-....+.+|++.|+.++|||||++|
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVF--------TGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLY   83 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVF--------TGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLY   83 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhc--------ccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeee
Confidence            45567789999999999999988877643        566667776654222 222445688999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc-CCCce
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-SDFQP  299 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~-~~~~~  299 (522)
                      .+......+|||+|+-++|+|.+||.++..  .+.+..+.+++.||+.|+.|+|+   ..+|||||||+|+.+. .-|-+
T Consensus        84 EViDTQTKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlV  158 (864)
T KOG4717|consen   84 EVIDTQTKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLV  158 (864)
T ss_pred             ehhcccceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCce
Confidence            999999999999999999999999988744  39999999999999999999999   9999999999998775 45889


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS-DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      ||.|||++..+..+...   ...+|...|-|||++.+..|. ++.||||||||||.|++|+.||+..+..+.-..     
T Consensus       159 KLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-----  230 (864)
T KOG4717|consen  159 KLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-----  230 (864)
T ss_pred             EeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-----
Confidence            99999999766555433   345899999999999998885 789999999999999999999976543322111     


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                                ++|-  ....+...+.++.+||..||..||.+|.+.++|..        +.|++.
T Consensus       231 ----------ImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s--------~~Wlq~  275 (864)
T KOG4717|consen  231 ----------IMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS--------TSWLQA  275 (864)
T ss_pred             ----------hhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc--------cccccC
Confidence                      1221  23346678889999999999999999999999987        777654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=297.48  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=194.4

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||.|+||.||++....         .+.+++|.++.....  ...+.|.+|++++++++|+||+++++++.+....++
T Consensus         1 ~~lg~g~~g~v~~~~~~~---------~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   69 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG---------NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI   69 (251)
T ss_pred             CccccCCCceEEEEEEeC---------CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEE
Confidence            369999999999987532         345555554432221  355789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++++|.+++....  ..+++..+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++....
T Consensus        70 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          70 VMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            999999999999997542  248899999999999999999999   999999999999999999999999999997554


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ............++..|+|||.+.++.++.++||||||+++|+|++ |..||.......   ......    .+.  .  
T Consensus       145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~----~~~--~--  213 (251)
T cd05041         145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIE----SGY--R--  213 (251)
T ss_pred             CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHh----cCC--C--
Confidence            3222111112234667999999988889999999999999999999 888886443211   111111    100  0  


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                           ...+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       214 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         214 -----MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence                 01112234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-37  Score=311.64  Aligned_cols=263  Identities=23%  Similarity=0.277  Sum_probs=205.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||.|+||.||++....        ..+.+++|.+...........+.+.+|++++++++||||+++++.+.+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG--------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT   72 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC--------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec
Confidence            368999999999999999987543        345666666544322222356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +...++||||+.+++|.+++... ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          73 ETYLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             CCEEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecc
Confidence            99999999999999999998754 23458999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCc---------------------------cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          306 LAIWGPTDSTHM---------------------------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       306 la~~~~~~~~~~---------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                      ++..........                           ......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            986543221110                           11234678899999999888899999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHHHHhcc
Q 036172          359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN----MGQVLKLLRGA  434 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs----~~eVl~~L~~~  434 (522)
                      ..||......  ..+...    ... ..        ........+..+.+++.+||..+|.+||+    +.+++.     
T Consensus       229 ~~pf~~~~~~--~~~~~~----~~~-~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~-----  288 (316)
T cd05574         229 TTPFKGSNRD--ETFSNI----LKK-EV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ-----  288 (316)
T ss_pred             CCCCCCCchH--HHHHHH----hcC-Cc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc-----
Confidence            9999644321  111111    110 00        00001114578999999999999999999    777776     


Q ss_pred             ccCCccccc
Q 036172          435 THATDWVDR  443 (522)
Q Consensus       435 ~~~~~~~~~  443 (522)
                         ++|++.
T Consensus       289 ---~~~~~~  294 (316)
T cd05574         289 ---HPFFRG  294 (316)
T ss_pred             ---Cchhhc
Confidence               788764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-37  Score=309.40  Aligned_cols=268  Identities=25%  Similarity=0.366  Sum_probs=201.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.++||+|+||.||++....    ......+.+++|.++...  ......+|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP----EGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE   77 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc----CCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            457999999999999999986321    012234566666654322  12345679999999999999999999999987


Q ss_pred             C--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          226 D--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       226 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .  ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          78 DGGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             CCCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECC
Confidence            5  67899999999999999997532  248999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------ChhhH
Q 036172          304 FGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK---------GPESL  373 (522)
Q Consensus       304 FGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~---------~~~~l  373 (522)
                      ||++......... .......++..|+|||++.+..++.++||||||+++|+|++++.|.......         .....
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV  232 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence            9999765443221 1122345677899999998888999999999999999999987764321100         00001


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .. .......+...         ......+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       233 ~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         233 TR-LVRVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HH-HHHHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11 11111111110         01112456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8e-37  Score=302.45  Aligned_cols=254  Identities=23%  Similarity=0.373  Sum_probs=195.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc---chHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF---SSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~---~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      +|++.+.||.|+||.||++...         .++.+++|.++......   ....+.+.+|++++++++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~---------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   71 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN---------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC   71 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc---------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe
Confidence            4788999999999999998632         23444555443221111   12346799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          72 LDDNTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEecc
Confidence            9999999999999999999999753   248899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCC----CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          304 FGLAIWGPTDST----HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       304 FGla~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||++........    ........|+..|+|||++.+..++.++||||||+++|+|++|..||.......  ....... 
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~-  222 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYIGA-  222 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHhhh-
Confidence            999875432111    111123468999999999988889999999999999999999999996432111  1110000 


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        ..+.     .+.+    +......+.+++.+||+.+|.+||++.+++.
T Consensus       223 --~~~~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --HRGL-----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --ccCC-----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000     0111    1224456888999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.3e-37  Score=309.26  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=202.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||.|+||.||++.+..        ..+.+++|.+...........+.+.+|+++++.++||||+++++.+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE--------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET   72 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC--------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence            468999999999999999987643        445677776655443334456789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          73 KRHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCC
Confidence            99999999999999999999754   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC-------------CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          306 LAIWGPTDST-------------HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       306 la~~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      +++.......             ........++..|+|||++.+..++.++||||||+++|||++|..||......   .
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~  223 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---E  223 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence            9864211100             00111245788999999998888999999999999999999999998643211   1


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      +...   ... +...   .+..    ....+..+.+++.+||+.+|.+||++.++.+.|+     ++|+.
T Consensus       224 ~~~~---~~~-~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~-----~~~~~  277 (305)
T cd05609         224 LFGQ---VIS-DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ-----HRFFL  277 (305)
T ss_pred             HHHH---HHh-cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh-----Ccccc
Confidence            1111   111 1100   0110    0123456889999999999999999655555543     55654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-37  Score=307.78  Aligned_cols=269  Identities=26%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.+.||.|+||.||++.....    .......+++|.++.....  ...++|.+|++++++++||||+++++++..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~----~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~   77 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL----GDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEK   77 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC----CCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence            4688889999999999999874321    0223556777766543332  356789999999999999999999999987


Q ss_pred             --CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          226 --DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       226 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                        ....++||||+++++|.+++.....  .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          78 PGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcc
Confidence              5689999999999999999986432  48999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh--------hHH
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE--------SLV  374 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--------~l~  374 (522)
                      ||++.......... ......++..|+|||.+.+..++.++||||||++++||++|..|+.........        ...
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV  232 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence            99997665332211 111234566799999998888999999999999999999999997543221100        000


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ......+..+.         ....+...+..+.+++.+||+.+|.+||++.+|+++|+.+
T Consensus       233 ~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         233 TRLLELLKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00111111111         0011122346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-37  Score=305.19  Aligned_cols=256  Identities=20%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ..+.+++|.+....   ......+.+|+.++++++||||+++++++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~   75 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLH--------TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSY   75 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECC--------CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEE
Confidence            34689999999999999999987532        23445555443211   12345688999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..++..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|
T Consensus        76 ~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~d  149 (267)
T cd06646          76 LSREKLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLAD  149 (267)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECc
Confidence            9999999999999999999999743   358999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||++........  ......|+..|+|||.+.   ...++.++|||||||++|||++|..||.......  ....     
T Consensus       150 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~~~-----  220 (267)
T cd06646         150 FGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL-----  220 (267)
T ss_pred             Cccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hhee-----
Confidence            999976533221  112346889999999974   3457889999999999999999999985332111  0000     


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      +.....   ..+....  ....+..+.+++.+||..+|.+||++++|++.
T Consensus       221 ~~~~~~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         221 MSKSNF---QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             eecCCC---CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            000000   0011110  11234678899999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.1e-37  Score=305.19  Aligned_cols=267  Identities=21%  Similarity=0.248  Sum_probs=198.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++....        ..+.+++|.+.+.... ....+.+.+|++++++++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE--------TGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC--------CCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            468999999999999999987532        3566777776553322 2345678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.++....   ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeee
Confidence            99999999999999998877632   248999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh-hhHHHhhhhh---
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLVKWAKPI---  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~l~~~~~~~---  380 (522)
                      ++.........  .....++..|+|||++.+ ..++.++||||||++++||++|+.||........ ..+..+....   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07846         146 FARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR  223 (286)
T ss_pred             eeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence            98765443221  123457889999999865 4478899999999999999999999864332110 0011000000   


Q ss_pred             ----hcCCC-cccccCCcccc-----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 ----LKNGD-TETLLDPKLSN-----EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ----~~~~~-~~~~~d~~l~~-----~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                          ..... ......+....     ......+..+.+++.+||+.+|.+||++.+|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                00000 00000000000     001123567889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.4e-37  Score=302.47  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=203.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++....        ....+++|.+.+.........+.+.+|+.++++++||||+++++++.++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   72 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD--------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE   72 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc--------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC
Confidence            58999999999999999987543        4556777766554433334678899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++|+||+.+++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          73 ENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            9999999999999999999754   358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+....    ..  .
T Consensus       147 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~--~  217 (258)
T cd05578         147 ATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET--A  217 (258)
T ss_pred             ccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc--c
Confidence            876544321   12346888999999998888999999999999999999999999765443222222111    10  0


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM--GQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~--~eVl~  429 (522)
                              ....+...+..+.+++.+||+.+|.+||++  +++++
T Consensus       218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         218 --------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                    011122234678899999999999999999  77665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-36  Score=302.99  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             cccccccccccccCchhHH----------------HHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc
Q 036172          153 PCSEGKYDENTLTPSTELF----------------LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~----------------~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      .||+|+||.||++......                ..........+++|.+....   .....+|.+|+.++++++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            5999999999998632110                01111222345556554322   1234678999999999999999


Q ss_pred             ceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          217 TTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      ++++++|.++...++||||+++|+|..++...  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++..
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence            99999999999999999999999999998753  2358999999999999999999999   999999999999999764


Q ss_pred             C-------ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCC
Q 036172          297 F-------QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELL-SGRRPIGFKNL  367 (522)
Q Consensus       297 ~-------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLl-tG~~Pf~~~~~  367 (522)
                      +       .+|++|||++.......      ...++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            3       48999999875432221      2357788999998865 56899999999999999995 69999865432


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ......   ...   ...        ...    .....+.+++.+||+.+|.+||++.+|++.|.
T Consensus       228 ~~~~~~---~~~---~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEKERF---YEK---KHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHH---HHh---ccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            221111   110   000        001    11246888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=302.78  Aligned_cols=266  Identities=23%  Similarity=0.279  Sum_probs=202.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++.+..        ....+++|.++.... .....+.+.+|++++++++|+||+++++++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA--------TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC--------CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            479999999999999999987543        456778887765332 22345789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||++++.|..++..   ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeee
Confidence            9999999999998777666553   2348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh---h--
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK---P--  379 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~---~--  379 (522)
                      ++.......... .....++..|+|||++... .++.++||||||+++|+|++|+.||.......  .+.....   .  
T Consensus       146 ~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~  222 (288)
T cd07833         146 FARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLP  222 (288)
T ss_pred             cccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            997665543211 1234678899999999887 78999999999999999999999986443211  1111000   0  


Q ss_pred             ------hhcCCC-----cccccCCc-ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          380 ------ILKNGD-----TETLLDPK-LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       380 ------~~~~~~-----~~~~~d~~-l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                            ......     .....++. ....++...+..+.+++.+||..+|.+||++++|++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  000000     00000000 001122223678999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-36  Score=299.67  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.|++++...        ....+++|.+..... .....++|.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~--------~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE--------DDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC--------CCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            58999999999999998887543        344455554332211 123456789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcc
Confidence            99999999999999999997642 3358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........  ......+++.|+|||.+.+..++.++||||||+++++|++|..||......   ....   .. ..+..
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~~-~~~~~  218 (256)
T cd08221         148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV---KI-VQGNY  218 (256)
T ss_pred             eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HH-HcCCC
Confidence            976544332  122456899999999998888899999999999999999999998643221   1111   11 11111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      ...         ....+..+.+++.+||..+|.+||++.++++.
T Consensus       219 ~~~---------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 TPV---------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCC---------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            111         12234678899999999999999999999973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-36  Score=303.57  Aligned_cols=267  Identities=21%  Similarity=0.222  Sum_probs=197.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++...||+|+||.||++....        ..+.+++|.+..... .....+.|.+|+.++++++||||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE--------TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC--------CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            479999999999999999986542        345666665543221 11233568899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++||||+++++|..++...   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccc
Confidence            99999999999998888877532   248999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHHhhhhh---
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVKWAKPI---  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~~~~~~---  380 (522)
                      ++.........  .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... +.......   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07847         146 FARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR  223 (286)
T ss_pred             cceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            99765443221  123457889999999876 457899999999999999999999997543221111 11100000   


Q ss_pred             ----hcCCCc-ccccCCccccc-----ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 ----LKNGDT-ETLLDPKLSNE-----YDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ----~~~~~~-~~~~d~~l~~~-----~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                          ...... .....+.....     .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                000000 00001110000     01123467889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-36  Score=298.31  Aligned_cols=247  Identities=21%  Similarity=0.336  Sum_probs=188.4

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||.|+||.||++........ .......+++|.+....   ....+.|.+|+.+++.++||||+++++++..+...++|
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~-~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDY-GELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCcccchhheeeeecccccc-cccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            589999999999875431110 01123456666664432   23456889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc--------eEEeec
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ--------PQLSDF  304 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~--------~kL~DF  304 (522)
                      |||+++|+|.+++...+.  .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999986432  58999999999999999999999   99999999999999987765        699999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR-RPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |++......      ....++..|+|||++.+. .++.++||||||+++|+|++|. .||.......   ......   .
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~~~---~  220 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYE---D  220 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHHHH---c
Confidence            988544321      234678899999999764 5799999999999999999984 5654322111   111000   0


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ..            ..+......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       221 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 RH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00            011112356889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=298.59  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.++||.|+||.||++....        ..+.+++|.+....   ....+.+.+|+.++++++||||+++++++.+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA--------TGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLR   71 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC--------CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence            579999999999999999987543        23344554443221   2245789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +..++++|||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          72 RDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccc
Confidence            999999999999999999987542  358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG---KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++........  ......++..|+|||.+.+.   .++.++||||||+++|+|++|..||......  ........    
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~~~~----  218 (262)
T cd06613         147 VSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLISK----  218 (262)
T ss_pred             cchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh----
Confidence            9865443221  11234678899999999776   7899999999999999999999998643311  11111111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                       ....   .+.  .......+..+.+++.+||..+|.+||++.+|+.
T Consensus       219 -~~~~---~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 -SNFP---PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -ccCC---Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0000   000  1112334567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.6e-36  Score=297.54  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=194.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE-
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI-  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~-  224 (522)
                      .+|++.+.||+|+||.||++...          ...+++|.++.     ....+.|.+|+.++++++|+||+++++++. 
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~----------~~~~~~k~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR----------GNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc----------CCcEEEEEeCC-----CchHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            47899999999999999997543          23344444321     123467999999999999999999999865 


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          71 EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             CCCceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCC
Confidence            4567899999999999999997543 2348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++........     ...++..|+|||++.+..++.++|||||||++|+|++ |+.||.....   ..+....    ..
T Consensus       147 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~  214 (256)
T cd05082         147 GLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EK  214 (256)
T ss_pred             ccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hc
Confidence            99865433221     2244678999999988889999999999999999997 9999864322   1222111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +...         ......+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       215 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 GYKM---------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1110         1112234578889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-36  Score=301.61  Aligned_cols=259  Identities=21%  Similarity=0.327  Sum_probs=196.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh--hccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT--SQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t--~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .+|++.+.||+|+||.||++.+..        ..+.+++|.+....  .......+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   73 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD--------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCL   73 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC--------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEE
Confidence            578999999999999999986543        34455555443211  11122456789999999999999999999998


Q ss_pred             Ee--CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .+  +..++++|||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|
T Consensus        74 ~~~~~~~~~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          74 RDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             EcCCCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEE
Confidence            75  36789999999999999999753   248999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCC-CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||++........ ........++..|+|||++.+..++.++|||||||++|+|++|+.||.....  ......    .
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~----~  221 (266)
T cd06651         148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFK----I  221 (266)
T ss_pred             ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHH----H
Confidence            99999865432211 1111234588999999999888899999999999999999999999864321  111111    1


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      ....     ..+    ..+......+..++ +||..+|.+||++.+|++        |+|++
T Consensus       222 ~~~~-----~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~--------hp~~~  265 (266)
T cd06651         222 ATQP-----TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR--------HPFAQ  265 (266)
T ss_pred             hcCC-----CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc--------Ccccc
Confidence            1110     011    11222344566666 688899999999999997        77754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.8e-37  Score=303.80  Aligned_cols=254  Identities=21%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ..+.+++|.++...   ......+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~   76 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVN--------TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYL   76 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcC--------CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            4589999999999999999986542        34455555543211   123456889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+..++||||+++++|.+++...   ..+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          77 RRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             eCCEEEEEEeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcc
Confidence            999999999999999999998743   358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |++........  ......|+..|+|||++.   ...++.++|||||||++|+|++|..||.......  .+.....   
T Consensus       151 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~---  223 (267)
T cd06645         151 GVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTK---  223 (267)
T ss_pred             eeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhc---
Confidence            99865433211  122446899999999974   4568899999999999999999999985432111  1111000   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        ....   .+....  ....+..+.+++.+||+.+|++||++.+|++
T Consensus       224 --~~~~---~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 --SNFQ---PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --cCCC---CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              0000   000000  0112346788999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-36  Score=306.19  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++.++||.|+||.||++.+..        ..+.+++|.+..   ......+.+.+|+.+++.++|+||+++++++
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIA--------TGQEVAIKQMNL---QQQPKKELIINEILVMRENKNPNIVNYLDSY   85 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECC--------CCCEEEEEEEec---CccchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34789999999999999999987532        344566665432   1122446788999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..++..++||||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~D  158 (297)
T cd06656          86 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTD  158 (297)
T ss_pred             ecCCEEEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECc
Confidence            9999999999999999999998642    38899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.........  .....+++.|+|||.+.+..++.++|||||||++|++++|..||........  +..    ....
T Consensus       159 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~~  230 (297)
T cd06656         159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATN  230 (297)
T ss_pred             CccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----eccC
Confidence            9998654332211  1234688899999999888899999999999999999999999964332111  000    0000


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      + ...       ...+...+..+.+++.+||+.+|.+||++.+|++        ++|++..
T Consensus       231 ~-~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--------~~~~~~~  275 (297)
T cd06656         231 G-TPE-------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--------HPFLKLA  275 (297)
T ss_pred             C-CCC-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--------Cchhccc
Confidence            0 000       0112223456788999999999999999999998        8887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-36  Score=303.06  Aligned_cols=263  Identities=20%  Similarity=0.284  Sum_probs=202.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++...||.|+||.||++.......   ....+.+++|.+....  .....++|.+|++++++++|+||+++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE---EGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc---CCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            578999999999999999987543211   2234456666553321  12245789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCC------CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQ------SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ....++||||+++|+|.+++......      ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcE
Confidence            99999999999999999999865322      158999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +|+|||++........ .......++..|+|||.+.+...+.++||||||+++|+|++ |..||......   ...... 
T Consensus       157 ~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~-  231 (275)
T cd05046         157 KVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL-  231 (275)
T ss_pred             EEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH-
Confidence            9999999864432211 11223356778999999988889999999999999999999 88888533211   111111 


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                         ..+.....        .....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       232 ---~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 ---QAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---HcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence               11111100        01123457888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-36  Score=296.33  Aligned_cols=247  Identities=22%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      +||.|+||.||++...         ..+.+++|.+....  .......|.+|++++++++||||+++++++...+..++|
T Consensus         2 ~ig~g~~g~vy~~~~~---------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           2 LLGKGNFGEVFKGTLK---------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             ccCCCCCceEEEEEec---------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            6899999999998632         12344554433211  112335789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          233 SDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      |||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        71 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          71 MELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            99999999999987542  348899999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      .... ......++..|+|||++.++.++.++||||||+++|++++ |..||......   ......    ..+...    
T Consensus       146 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~~----  213 (250)
T cd05085         146 GIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQV----EKGYRM----  213 (250)
T ss_pred             cccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCCC----
Confidence            2211 1112234678999999988889999999999999999998 99998643221   111111    111100    


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                           ..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 -----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                 111123467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.9e-36  Score=298.89  Aligned_cols=257  Identities=22%  Similarity=0.313  Sum_probs=185.5

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV  232 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV  232 (522)
                      .||+|+||.||++....      ......+.+|.++..  ......+.|.+|+.+++.++||||+++++.|.+....++|
T Consensus         2 ~lg~G~~g~v~~~~~~~------~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv   73 (268)
T cd05086           2 EIGNGWFGKVLLSEIYT------DTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV   73 (268)
T ss_pred             cCCCCcCceEEEEEEEc------CCCcceEEEEEecCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence            59999999999975321      111112222222211  1122457899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHhhccCC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          233 SDFLPKGSLEESLHGAGE-QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       233 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      |||+++|+|.+++..... ...+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++....
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccC
Confidence            999999999999986422 2346777888999999999999999   999999999999999999999999999985432


Q ss_pred             CCCCCccccccccCCCCCChhhhcc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMH-------GKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ............++..|+|||++..       ..++.++||||||+++|||++ |..||.....  ...+..    .+. 
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~----~~~-  223 (268)
T cd05086         151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNH----VIK-  223 (268)
T ss_pred             cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHh-
Confidence            2211112223467889999999743       245789999999999999997 5677753321  111111    111 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      +....+.++.+...    ....+.+++..|| .+|.+||++.+|++.|.
T Consensus       224 ~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            12222333433332    3346777888999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.4e-37  Score=303.60  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=193.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .+.|++.++||.|+||.||++....        ..+.+++|.+...    .....++.+|+.+++++ +|+||+++++++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   72 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVK--------TGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAF   72 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcC--------CCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            4679999999999999999986532        3445555544321    12345788999999999 799999999999


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ..+++||||+++++|.+++.... ...+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~  148 (272)
T cd06637          73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA  148 (272)
T ss_pred             eecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCC
Confidence            853      46899999999999999998642 2358999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      .++|+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||......... 
T Consensus       149 ~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-  225 (272)
T cd06637         149 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-  225 (272)
T ss_pred             CEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-
Confidence            999999999875433221  122456899999999985     345788999999999999999999998543211111 


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                          ..  ..........        ....+..+.+++.+||..+|.+||++.+|++
T Consensus       226 ----~~--~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 ----FL--IPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ----HH--HhcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                00  0001111111        1123456889999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-36  Score=298.70  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.+|++....        ..+.+++|.+...... ....+++.+|+.++++++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE--------DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC--------CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            58999999999999999887543        3455666655432211 22456889999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence            99999999999999999997542 2247899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....|++.|+|||++.+..++.++|||||||++++|++|+.||.....   ....   ..... +..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~---~~~~~-~~~  218 (256)
T cd08218         148 ARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLV---LKIIR-GSY  218 (256)
T ss_pred             eeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHH---HHHhc-CCC
Confidence            9655432211  1234588899999999888899999999999999999999999864321   1111   11111 111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .         ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       219 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 P---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             C---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1         111223557889999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=318.14  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.++..||.|+||.||.+.+++...-.        |-|.|.   ....+.+++|+-|++||..+.||+||++++.|.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lA--------AaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy   99 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLA--------AAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYY   99 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhh--------hhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence            457999999999999999998766432211        222221   222346789999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++.++++.|||.||-++.++-..+  ..|++.++..+++|++.||.|||+   ++|||||||..|||++-+|.++|+||
T Consensus       100 ~enkLwiliEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen  100 FENKLWILIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             ccCceEEEEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecc
Confidence            9999999999999999999887654  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |.+....  ........+.||+.|||||+.+     ..+|+.++||||||+.|.||..+.+|-..-  ....-+++.++ 
T Consensus       175 GVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKiaK-  249 (1187)
T KOG0579|consen  175 GVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAK-  249 (1187)
T ss_pred             cccccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHhh-
Confidence            9984322  2223345678999999999974     467999999999999999999999995422  22222333222 


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                          ...+.++.|       ......+.+++..||.+||..||++.++++        |+|+.
T Consensus       250 ----SePPTLlqP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~--------Hpfv~  293 (1187)
T KOG0579|consen  250 ----SEPPTLLQP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK--------HPFVQ  293 (1187)
T ss_pred             ----cCCCcccCc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh--------Ccccc
Confidence                223333332       345567899999999999999999999998        77765

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.6e-38  Score=309.27  Aligned_cols=261  Identities=20%  Similarity=0.229  Sum_probs=198.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .-.|+-.+.+|.|+||.||.+...+        ....+|+|.+...+. +      =-+|+.+|+.+.|||||++.-+|.
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e--------~~~~vAIKKv~~d~r-~------knrEl~im~~l~HpNIV~L~~~f~   87 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRE--------TEEEVAIKKVLQDKR-Y------KNRELQIMRKLDHPNIVRLLYFFS   87 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcC--------CCceeEEEEecCCCC-c------CcHHHHHHHhcCCcCeeeEEEEEE
Confidence            3468889999999999999987654        245666665543222 1      125999999999999999999888


Q ss_pred             eC--C---EEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-C
Q 036172          225 ED--N---YLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-F  297 (522)
Q Consensus       225 ~~--~---~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~  297 (522)
                      ..  .   ++.|||||++. +|.++++.. ..+..++...+.-+..||++||.|||+   .+|+||||||.|+|+|.+ |
T Consensus        88 ~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg  163 (364)
T KOG0658|consen   88 SSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTG  163 (364)
T ss_pred             ecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCC
Confidence            43  2   46799999988 999999853 223458888899999999999999999   999999999999999976 8


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||||||.|+....+...   .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+  ++...
T Consensus       164 ~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eI  238 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEI  238 (364)
T ss_pred             eEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHH
Confidence            9999999999876655443   245678999999999775 59999999999999999999999998754333  22222


Q ss_pred             hhh--------------hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          377 AKP--------------ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       377 ~~~--------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ++-              ...+-....+.......-+......+..+++.++|+++|.+|.++.|++.
T Consensus       239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            211              00111111221111111233445678899999999999999999999996

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-36  Score=303.70  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        .++.+++|.+...  ......++|.+|+++++.++||||+++++++.
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~--------~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP--------TGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFL   73 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC--------CCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence            3579999999999999999987543        2344444433221  11224568999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ..+.+++||||+++++|.+++...   ..+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.++|+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          74 NENNICMCMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccC
Confidence            999999999999999999998753   3589999999999999999999962  58999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----ChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK-----GPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~-----~~~~l~~~~~~  379 (522)
                      |++.......    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......     ....+......
T Consensus       149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         149 GVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             Ccccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            9986442221    12346899999999998888999999999999999999999999754432     11112222222


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .....      .+.+.   ....+..+.+++.+||+.||.+||++.+|++
T Consensus       225 ~~~~~------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~  265 (284)
T cd06620         225 IVQEP------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCA  265 (284)
T ss_pred             Hhhcc------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            21110      01111   1124457889999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-36  Score=300.69  Aligned_cols=261  Identities=22%  Similarity=0.297  Sum_probs=199.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|.+.++||.|+||.||++.....     ......+++|.......  ....+.|.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   77 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSP-----ENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVIT   77 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecC-----CCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence            35789999999999999999864321     01223344444332211  234568999999999999999999999987


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        78 ~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          78 E-NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             C-CCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccC
Confidence            6 45789999999999999997542  248999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||.......   .....    ..
T Consensus       152 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----~~  223 (270)
T cd05056         152 GLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI----EN  223 (270)
T ss_pred             ceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----Hc
Confidence            9997654432211 112334568999999988889999999999999999986 999986443221   11111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....         .+...+..+.+++.+|+..+|.+||++.++++.|++..
T Consensus       224 ~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         224 GERLP---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             CCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11110         11123457888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=313.47  Aligned_cols=267  Identities=18%  Similarity=0.265  Sum_probs=196.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||.|+||.||++.+..        ..+.+++|.+...... ....+.+.+|+.+|++++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR--------LRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC--------CCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            35689999999999999999987542        3456666665432211 12345688999999999999999999988


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ...+++++++ +++|.+++..    ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~  155 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDC  155 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCC
Confidence            643      4579999998 7799988863    249999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+...
T Consensus       156 ~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~  228 (343)
T cd07878         156 ELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRI  228 (343)
T ss_pred             CEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHH
Confidence            99999999997654322     23468999999999876 468999999999999999999999996543211  11110


Q ss_pred             hhhhhcCC-----------CcccccC--Ccccc----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          377 AKPILKNG-----------DTETLLD--PKLSN----EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       377 ~~~~~~~~-----------~~~~~~d--~~l~~----~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      .. .....           .....+.  +....    .........+.+++.+||+.||.+|||+.++++        |+
T Consensus       229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~--------hp  299 (343)
T cd07878         229 ME-VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA--------HP  299 (343)
T ss_pred             HH-HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--------Cc
Confidence            00 00000           0000000  00000    000011235778999999999999999999997        89


Q ss_pred             cccc
Q 036172          440 WVDR  443 (522)
Q Consensus       440 ~~~~  443 (522)
                      |+..
T Consensus       300 ~~~~  303 (343)
T cd07878         300 YFSQ  303 (343)
T ss_pred             chhc
Confidence            9865

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=298.59  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||.|+||.||++....         .+.+++|.+....    ...+++.+|+.++++++|+||+++++++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~---------~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG---------TTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVC   70 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC---------CceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeee
Confidence            34689999999999999999976432         2334555443211    1346789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ......++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|
T Consensus        71 ~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d  146 (261)
T cd05034          71 SEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIAD  146 (261)
T ss_pred             ecCCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECc
Confidence            99899999999999999999997643 2358999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++......... ......++..|+|||.+.+..++.++||||||++++++++ |+.||.....   ........... 
T Consensus       147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~-  221 (261)
T cd05034         147 FGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGY-  221 (261)
T ss_pred             cccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-
Confidence            9998765432111 1112234678999999988889999999999999999998 9999854321   11111111100 


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                        .  .        ..+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       222 --~--~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 --R--M--------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --C--C--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0  0        0011124578899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-36  Score=298.15  Aligned_cols=254  Identities=22%  Similarity=0.394  Sum_probs=198.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++....         ...+++|.++..    ....+.|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK---------HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC---------CccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            4689999999999999999986422         123444444321    113467999999999999999999999988


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + ...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+||
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~  146 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADF  146 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCC
Confidence            7 77899999999999999997642 3358899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |.+......... ......++..|+|||++..+.++.++|||||||++|++++ |+.||......   .+....    ..
T Consensus       147 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~  218 (260)
T cd05073         147 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ER  218 (260)
T ss_pred             cceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hC
Confidence            999765432221 1122345678999999988889999999999999999999 99998643211   111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +...         ......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       219 ~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 GYRM---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCC---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1110         0111234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-36  Score=306.90  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=202.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||.|+||.||++.+..        ..+.+++|.+....   ....+.+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVA--------TGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFL   86 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcC--------CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence            3579999999999999999876432        34455555543221   224567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+...++|+||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          87 VGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             cCceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999998642    48999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |++.........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......  ......    .. 
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~~~----~~-  230 (296)
T cd06655         160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIA----TN-  230 (296)
T ss_pred             ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----hc-
Confidence            998654432211  123468899999999988889999999999999999999999996543211  111110    00 


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ....+       ..+...+..+.+++.+||..+|.+||++.+|++        ++|++..
T Consensus       231 ~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--------~~~~~~~  275 (296)
T cd06655         231 GTPEL-------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--------HPFLKLA  275 (296)
T ss_pred             CCccc-------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--------ChHhhhc
Confidence            00001       011123456888999999999999999999997        8888653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.1e-36  Score=300.83  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=199.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|+..++||.|+||.||++.+..        ....+++|.++..  ......+.|.+|+.+++++.||||+++++++.+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR--------TQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc--------CCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            568889999999999999987543        2344555544321  112356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++|+|.+++...    .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          74 GTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccc
Confidence            99999999999999999998642    48899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++........  ......++..|+|||++.+..++.++|+|||||++|||++|..||.......   ....    ...+ 
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~-  216 (277)
T cd06640         147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFL----IPKN-  216 (277)
T ss_pred             cceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhhh----hhcC-
Confidence            9966543321  1223467889999999988889999999999999999999999986433211   1100    0000 


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                              .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       217 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         217 --------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             --------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence                    112223345677889999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-36  Score=307.18  Aligned_cols=264  Identities=20%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|+..+.||+|+||.||++........    ....+++|.+....  ......+|.+|+.++++++||||++++++|.
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET----VKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc----ceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            46788999999999999999875421110    11234555544322  1223457899999999999999999999997


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .. ..++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+||
T Consensus        80 ~~-~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          80 SP-TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             CC-CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccc
Confidence            64 4679999999999999997542  248999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....   .....+.    ..
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~  226 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EK  226 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HC
Confidence            99976554333222223446778999999988889999999999999999997 9999864321   1222211    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +....  .       +...+..+.+++..||..+|++||++.+|++.|+.+..
T Consensus       227 ~~~~~--~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         227 GERLP--Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCC--C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11110  0       01123467889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-36  Score=299.12  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=195.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh--hccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT--SQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t--~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..|++.+.||+|+||.||++.+..        ..+.+++|.+....  .......+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   73 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD--------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCL   73 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC--------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEe
Confidence            578999999999999999987542        44566666553211  11223457899999999999999999999998


Q ss_pred             EeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .+.  ..+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|
T Consensus        74 ~~~~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          74 RDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             ccCCCceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEE
Confidence            764  5788999999999999999743   248899999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....  .......    .
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~----~  221 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFK----I  221 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHHHH----H
Confidence            999998754322111 11123458899999999988889999999999999999999999986431  1111111    1


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .....         ....+......+.+++.+|+. +|.+||++++|++
T Consensus       222 ~~~~~---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQPT---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCCC---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11100         111233445677888999985 9999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-36  Score=340.54  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=195.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||.|+||.||++.+..        ....+++|.+.... ........|..|+.+|++|+|||||+++++|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~--------tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKR--------TQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECC--------CCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            45799999999999999999987643        34455555543221 1122456799999999999999999999998


Q ss_pred             Ee--CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcC----CCCEEeccCCCCceeccC-
Q 036172          224 IE--DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVIHRDVKSSNILLSS-  295 (522)
Q Consensus       224 ~~--~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~----~~giiHrDIkp~NILl~~-  295 (522)
                      ..  ...+||||||+++|+|.++|... .....+++..++.|+.||+.||.|||+..    ..+||||||||+||||+. 
T Consensus        82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence            65  36799999999999999999753 22345999999999999999999999821    135999999999999964 


Q ss_pred             ----------------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHc
Q 036172          296 ----------------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLS  357 (522)
Q Consensus       296 ----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLlt  357 (522)
                                      .+.+||+|||++........   .....||+.|+|||++.+  ..++.++||||||||||+|++
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                            23589999999976543322   124478999999999854  458899999999999999999


Q ss_pred             CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          358 GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       358 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      |..||....  ....+...    +..+.       .+..   ...+..+.+||..||+.+|.+||++.+++.
T Consensus       239 Gk~PF~~~~--~~~qli~~----lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        239 GKTPFHKAN--NFSQLISE----LKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCCcCC--cHHHHHHH----HhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999996432  11122111    11110       0000   112456888999999999999999999994

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=315.89  Aligned_cols=267  Identities=22%  Similarity=0.369  Sum_probs=216.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...-.+.++||+|-||.|.+++-..         ...+|.|.|+.....  .+..+|.+|+++|.+|+|||||+++|+|.
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg---------~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG---------PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC---------ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            3456778999999999999997432         456666766553332  25689999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++.+++|+||+++|+|.+++..+.... +......+|+.||+.|++||.+   .+++||||.+.|+|++.++++||+||
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCc
Confidence            9999999999999999999998763222 4555667799999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS--GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+++..-...........+-..+|||||.+.-++++.++|||+||+++||+++  ...||+...   .++.+..+...+.
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~  758 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFR  758 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcC
Confidence            99987766666666666777899999999999999999999999999999875  788886432   2344444444444


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+.....      ...+..++..+.+++..||..+-.+||++++|...|+...
T Consensus       759 ~~~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  759 DQGRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CCCccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            3322221      1223345678889999999999999999999999988754

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-36  Score=303.42  Aligned_cols=258  Identities=23%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|++.++||.|+||.||++....        ....+++|.+..   ......++|.+|+.++++++||||+++++++.
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~--------~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE--------TGALAAAKVIET---KSEEELEDYMVEIEILATCNHPYIVKLLGAFY   79 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC--------CCceEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence            3679999999999999999987543        334455555432   12335678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||+++++|..++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          80 WDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             eCCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccC
Confidence            9999999999999999998886532  348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |++........  ......++..|+|||++.     ...++.++|||||||++|+|++|..||.....  .......   
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~---  227 (292)
T cd06644         155 GVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKI---  227 (292)
T ss_pred             ccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHH---
Confidence            99865332211  112346888999999984     34468899999999999999999999864331  1111111   


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                       . ........       .+...+..+.+++.+||+.+|++||++.+|++        ++|+.
T Consensus       228 -~-~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--------~~~~~  273 (292)
T cd06644         228 -A-KSEPPTLS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--------HPFVS  273 (292)
T ss_pred             -h-cCCCccCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc--------Ccccc
Confidence             1 11111110       11223456888999999999999999999997        77764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-36  Score=303.32  Aligned_cols=265  Identities=20%  Similarity=0.218  Sum_probs=193.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++....        .+..+++|.++... ........+.+|+.++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~--------~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE--------THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC--------CCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            58899999999999999987643        34456666554321 1112335678899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++|+||++ ++|.+++....  ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccch
Confidence            99999999996 48888876532  348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh-------
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK-------  378 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~-------  378 (522)
                      ++........  .....++..|+|||++.+.. ++.++|||||||++|+|++|..|+...... ...+.....       
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~  222 (284)
T cd07839         146 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTE  222 (284)
T ss_pred             hhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCCh
Confidence            9755432221  12335788999999987654 689999999999999999999886322211 111110000       


Q ss_pred             ---hhhcC-CCcc--cccCCccc-ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 ---PILKN-GDTE--TLLDPKLS-NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ---~~~~~-~~~~--~~~d~~l~-~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         +.... ....  ........ ..........+.+++.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence               00000 0000  00000000 0111223467889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-37  Score=302.63  Aligned_cols=273  Identities=22%  Similarity=0.280  Sum_probs=204.1

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCC-cceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS-ITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hpn-Iv~l~~~~~  224 (522)
                      ..|+.+.+||+|+||.||.+....        +++.+|+|.+.-...+ .-.-....+|+.+|++|+|+| ||++++++.
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~--------~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~   81 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR--------TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIH   81 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec--------CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence            458888899999999999988654        4466777766443221 012244678999999999999 999999999


Q ss_pred             eCC------EEEEEEecCCCCCHHHHhhccCCC-CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          225 EDN------YLILVSDFLPKGSLEESLHGAGEQ-SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       225 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ..+      .+++|+||++. +|..++...... ..++...+..++.||+.||+|||+   ++|+||||||.||||+++|
T Consensus        82 ~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G  157 (323)
T KOG0594|consen   82 TSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSG  157 (323)
T ss_pred             ecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCC
Confidence            877      89999999976 999999876432 347778999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+|+.+.-.....  ....+|..|.|||++.+. .|+...||||+||++.||++++..|.....  .+++...
T Consensus       158 ~lKlaDFGlAra~~ip~~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~I  233 (323)
T KOG0594|consen  158 VLKLADFGLARAFSIPMRTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRI  233 (323)
T ss_pred             cEeeeccchHHHhcCCcccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHH
Confidence            99999999998655333222  234789999999999876 699999999999999999999999876544  2222222


Q ss_pred             hhhhhcCC---C---cccccC-----Cccc--ccccHH---HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          377 AKPILKNG---D---TETLLD-----PKLS--NEYDNA---QMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       377 ~~~~~~~~---~---~~~~~d-----~~l~--~~~~~~---~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      .. .+...   .   ...+.+     +...  ......   ......+++.+||+.+|.+|.|+...+.        |++
T Consensus       234 f~-~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~--------h~y  304 (323)
T KOG0594|consen  234 FR-LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT--------HPY  304 (323)
T ss_pred             HH-HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc--------Chh
Confidence            11 11100   0   000000     0000  011111   1136788999999999999999999997        666


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      +...
T Consensus       305 f~~~  308 (323)
T KOG0594|consen  305 FSEL  308 (323)
T ss_pred             hccc
Confidence            6543

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-36  Score=298.65  Aligned_cols=255  Identities=18%  Similarity=0.268  Sum_probs=190.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE-eCCEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI-EDNYLIL  231 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~-~~~~~~l  231 (522)
                      .||+|+||.||++.....     ......+++|.+....  .....+.|.+|+.+++.++||||+++++++. .++..++
T Consensus         2 ~lg~g~~g~v~~~~~~~~-----~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDS-----DGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             cccccCCceEEEEEEecC-----CCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            589999999999874321     1223445656543211  1234578999999999999999999999876 4566899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+.+|+|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        75 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          75 VLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCcccccccc
Confidence            999999999999997542  236778889999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCC--ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCChhhHHHhhhhhhcCCCccc
Q 036172          312 TDSTH--MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG-RRPIGFKNLKGPESLVKWAKPILKNGDTET  388 (522)
Q Consensus       312 ~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (522)
                      .....  .......++..|+|||++.+..++.++||||||+++|||++| .+||....   ...+....    ..+....
T Consensus       150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~----~~~~~~~  222 (262)
T cd05058         150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL----LQGRRLL  222 (262)
T ss_pred             CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hcCCCCC
Confidence            22111  111233467789999999888899999999999999999995 55664322   11122111    1111000


Q ss_pred             ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       389 ~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                               .+...+..+.+++..||+.+|.+||++.+|++.|+...
T Consensus       223 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 ---------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                     01112456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-36  Score=295.24  Aligned_cols=256  Identities=22%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe-
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE-  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~-  225 (522)
                      +|++.+.||.|+||.||++.+..        ....+++|.+.... ......+++.+|+.++++++||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS--------DGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC--------CCCEEEEEEEeccc-CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            58899999999999999986543        33455555543211 122345678999999999999999999998864 


Q ss_pred             -CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCEEeccCCCCceeccCCCceEE
Q 036172          226 -DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSEC--SRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       226 -~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                       +...+++|||+++++|.+++... .....+++..++.++.|++.||.|||..+  ..+++|+||+|+||+++.++.+||
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence             45789999999999999999754 22346899999999999999999999211  189999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.........  .....++..|+|||.+.+..++.++||||||+++++|++|+.||....   ...+....    
T Consensus       152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~----  222 (265)
T cd08217         152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI----  222 (265)
T ss_pred             ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHH----
Confidence            999999766543321  123468999999999988889999999999999999999999997543   12222211    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+..         ...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       223 ~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         223 KEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             hcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11111         1122234567889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-36  Score=298.99  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=205.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++....        ..+.+++|.+.....  ....+++.+|++++++++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP--------TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYN   70 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC--------CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeec
Confidence            368888999999999999987542        445566665543221  2355789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++|+||+++++|.+++....  ..+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          71 NGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999998642  4589999999999999999999984  689999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      .+.........    ...++..|+|||++.+..++.++||||||+++++|++|..||....... .............. 
T Consensus       147 ~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-  220 (265)
T cd06605         147 VSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP-  220 (265)
T ss_pred             cchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC-
Confidence            98654322111    2568889999999988899999999999999999999999986442211 11122222211111 


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .     +.+...   .....+.+++.+||..+|.+||++.+++.        ++|++..
T Consensus       221 ~-----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--------~~~~~~~  263 (265)
T cd06605         221 P-----PRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE--------HPFIKKY  263 (265)
T ss_pred             C-----CCCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh--------Cchhhcc
Confidence            0     111111   14567889999999999999999999997        8888653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.4e-36  Score=294.16  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=186.9

Q ss_pred             cccccccccccccCchhHHH--HhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEE
Q 036172          153 PCSEGKYDENTLTPSTELFL--KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~--~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      .||+|+||.||++.......  .........+++|.+.....    ....|.+|+.++++++||||+++++++.. ...+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            58999999999987643210  00011122344554433221    15789999999999999999999999988 7789


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-------ceEEee
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-------QPQLSD  303 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-------~~kL~D  303 (522)
                      +||||+++|+|.+++.....  .+++..++.++.|++.||.|||+   .+++||||||+||+++.++       .+||+|
T Consensus        77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            99999999999999986432  58999999999999999999999   9999999999999999887       799999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||++......      ....++..|+|||++...  .++.++||||||+++|+|++ |..||............  .   
T Consensus       152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~--~---  220 (259)
T cd05037         152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--Q---  220 (259)
T ss_pred             CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH--h---
Confidence            9998654431      123567789999998776  78999999999999999999 57777554322111111  0   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                        ......  .+         ....+.+++.+||..+|.+||++.+|++.|+
T Consensus       221 --~~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 --DQHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --cCCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              000000  00         1157889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=303.04  Aligned_cols=259  Identities=25%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||.|+||.||++....        ....+++|.+..   ......+.|.+|++++++++||||+++++++..
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE--------TGLFAAAKIIQI---ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY   73 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC--------CCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence            579999999999999999987542        234455554432   122355789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +...++||||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          74 ENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             CCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCc
Confidence            999999999999999999987542  359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ++........  ......+++.|+|||.+.     ...++.++||||||+++|+|++|+.||......  ..+...    
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~----  220 (280)
T cd06611         149 VSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKI----  220 (280)
T ss_pred             cchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHH----
Confidence            9865433221  122346899999999975     344678999999999999999999998643211  111111    


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..+....+.       .+...+..+.+++..||+.+|.+||++.+|++        ++|+...
T Consensus       221 -~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--------~~~~~~~  268 (280)
T cd06611         221 -LKSEPPTLD-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--------HPFVSDQ  268 (280)
T ss_pred             -hcCCCCCcC-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc--------Chhhccc
Confidence             111111110       11123456788999999999999999999997        8887654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-36  Score=299.66  Aligned_cols=267  Identities=23%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|+..++||.|+||.||++....        ..+.+++|.+....  ......+|.+|++++++++||||+++++++.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   70 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN--------TGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLD   70 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC--------CCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc
Confidence            468899999999999999988643        34566666654321  22355779999999999999999999999875


Q ss_pred             C--CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          226 D--NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       226 ~--~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .  +.+++||||+++++|.+++... .....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             cCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEe
Confidence            4  4789999999999999987643 223458999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CChhhHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL--KGPESLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~--~~~~~l~~~~~~~  380 (522)
                      |||++........    ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ........+... 
T Consensus       148 dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  222 (287)
T cd06621         148 DFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-  222 (287)
T ss_pred             ecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-
Confidence            9999865433221    134578899999999888999999999999999999999999975532  111122222111 


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         .....+ .....  .....+..+.+++.+||..+|.+|||+.||++        ++|++..
T Consensus       223 ---~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--------~~~~~~~  272 (287)
T cd06621         223 ---MPNPEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--------HPWIKAQ  272 (287)
T ss_pred             ---CCchhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--------Ccccccc
Confidence               011111 00000  01123567889999999999999999999998        8887543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=305.35  Aligned_cols=272  Identities=19%  Similarity=0.256  Sum_probs=200.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++.....      ...+.+++|.+...........+.+.+|+.++++++||||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            588999999999999999886431      24667788877654322223346778899999999999999999999988


Q ss_pred             --CEEEEEEecCCCCCHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC----CCc
Q 036172          227 --NYLILVSDFLPKGSLEESLHGAG--EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS----DFQ  298 (522)
Q Consensus       227 --~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~----~~~  298 (522)
                        ..+++||||+++ +|.+++....  ....+++..++.++.|++.||.|||+   .+++||||||+||+++.    ++.
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~  150 (316)
T cd07842          75 ADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGV  150 (316)
T ss_pred             CCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccce
Confidence              889999999975 7877775432  22358999999999999999999999   99999999999999999    899


Q ss_pred             eEEeecCccccCCCCCC-CccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh------
Q 036172          299 PQLSDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP------  370 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~------  370 (522)
                      +||+|||++........ ........+++.|+|||.+.+. .++.++||||||+++++|++|+.||........      
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~  230 (316)
T cd07842         151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ  230 (316)
T ss_pred             EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence            99999999976544322 1222345678999999988664 578999999999999999999999975543320      


Q ss_pred             -hhHHHhhhhhhcC------------CCccc--------ccC-CcccccccH--HHHHHHHHHHHHhhhcCCCCCCCHHH
Q 036172          371 -ESLVKWAKPILKN------------GDTET--------LLD-PKLSNEYDN--AQMQRMLLAANLCINQSPQLRPNMGQ  426 (522)
Q Consensus       371 -~~l~~~~~~~~~~------------~~~~~--------~~d-~~l~~~~~~--~~~~~l~~li~~CL~~dP~~RPs~~e  426 (522)
                       ..+..... .+..            .....        ... ..+......  .....+.+++.+||+.||.+|||+.+
T Consensus       231 ~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         231 RDQLERIFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence             01110000 0000            00000        000 000000111  23356889999999999999999999


Q ss_pred             HHH
Q 036172          427 VLK  429 (522)
Q Consensus       427 Vl~  429 (522)
                      +++
T Consensus       310 il~  312 (316)
T cd07842         310 ALE  312 (316)
T ss_pred             Hhc
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-37  Score=304.42  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|+..+.||.|+||.||++....        ....+++|.+....  .....+.+.+|+.++++++||||+++++++..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR--------TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK   73 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC--------CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhccccc
Confidence            457888999999999999986532        23445555543221  12245689999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.+++..    ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          74 GTKLWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCceEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEcccc
Confidence            9999999999999999999863    248999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++........  ......++..|+|||++.+..++.++||||||++++||++|+.||.......   ....    ...+.
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~~  217 (277)
T cd06642         147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKNS  217 (277)
T ss_pred             ccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcCC
Confidence            9866543221  1223467889999999988889999999999999999999999986432111   1110    11110


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                           .+    ......+..+.+++.+||+.+|.+||++.+|++
T Consensus       218 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         218 -----PP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -----CC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 11    112234467889999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-36  Score=297.39  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=185.3

Q ss_pred             cccccccccccccCchhHH----HHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          153 PCSEGKYDENTLTPSTELF----LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~----~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      .||+|+||.||++......    ..........+++|.+....   ....+.|..|+.+++.++||||+++++++..+..
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            5899999999998632100    00001122234555443322   2245678899999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc-------eEE
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-------PQL  301 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~-------~kL  301 (522)
                      .++||||+++|+|..++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.       +++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            999999999999999887532  348999999999999999999999   99999999999999987654       899


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCChhhHHHhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELL-SGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~eLl-tG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      +|||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||...........      
T Consensus       154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------  221 (262)
T cd05077         154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF------  221 (262)
T ss_pred             CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH------
Confidence            999998654322      1235788999999986 456899999999999999998 58888764332211111      


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                        ..+.. ....         .....+.+++.+||+.||.+||++.+|++.|
T Consensus       222 --~~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 --YEGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HhcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              01110 0101         1235688899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.7e-36  Score=294.71  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=194.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||.|+||.||++..          ..+.+++|.++..     ...+.|.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~----------~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY----------TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILH   70 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc----------CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence            5799999999999999998753          2334555544321     133678999999999999999999999876


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++ .++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        71 ~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          71 NG-LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             CC-cEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCc
Confidence            54 799999999999999997653 2348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++........     ....+..|+|||++.++.++.++||||||+++|+|++ |+.||.......   ....    ...+
T Consensus       146 ~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~  213 (254)
T cd05083         146 LARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKEC----VEKG  213 (254)
T ss_pred             cceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----HhCC
Confidence            9865432211     2234578999999988899999999999999999998 999986543221   1111    1111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ...         ......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       214 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 YRM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            100         0111234678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.7e-36  Score=295.38  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||+|+||.||++.+..        ....+++|.+..... .....+.|.+|+.++++++||||+++++.+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA--------DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC--------CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            58999999999999999987543        344455554432211 123457899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-CceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~~kL~DFG  305 (522)
                      +..++||||+++++|.+++.... ...+++..+..++.+++.||.|||+   ++++|+||+|+||+++.+ +.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            99999999999999999997642 3348999999999999999999999   999999999999999865 468999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.........   ....++..|+|||.+.+..++.++||||||+++++|++|+.||......   ......   .. +.
T Consensus       148 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~-~~  217 (256)
T cd08220         148 ISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MS-GT  217 (256)
T ss_pred             CceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hh-cC
Confidence            99765443221   2346888999999998888999999999999999999999998654322   111111   11 11


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...+         +...+..+.+++.+||+.+|.+|||+.+++.
T Consensus       218 ~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 FAPI---------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCC---------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111         1123456889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-37  Score=292.00  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=201.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHH-Hhhccch----HHHHHHHHHHHHhhC-CCCCccee
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQ-ATSQFSS----AWNDFSSEVDITSSL-EQKSITTL  219 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~-~t~~~~~----~~~~f~~Ev~iL~~L-~HpnIv~l  219 (522)
                      +.|.--+.||.|..+.|.++...+        ++..|+.|.+.. ++..+++    ..+.-.+|+.||+++ .||||+++
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~--------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l   88 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKE--------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDL   88 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcc--------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence            345556678989888877765443        333444333221 1122222    334567899999999 89999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      .+++..+..+++|+|.|+.|.|.|+|..   ...++++...+|+.|+.+|+.|||.   ++|+||||||+|||++++.++
T Consensus        89 ~D~yes~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   89 QDVYESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             eeeccCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccce
Confidence            9999999999999999999999999984   4469999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      ||+|||++.....+...   ...+|||+|+|||.+.      ...|+...|+|++||++|-|+.|.+||-..       -
T Consensus       163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------k  232 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------K  232 (411)
T ss_pred             EEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------H
Confidence            99999999877665433   3568999999999984      235888999999999999999999998321       1


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ......++.+|++.-      ...--.+.+....++|.+||+.||.+|.|+.|+|.        |+|+..
T Consensus       233 QmlMLR~ImeGkyqF------~speWadis~~~KdLIsrlLqVdp~~Ritake~La--------Hpff~q  288 (411)
T KOG0599|consen  233 QMLMLRMIMEGKYQF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA--------HPFFIQ  288 (411)
T ss_pred             HHHHHHHHHhccccc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--------ChHHHH
Confidence            111223334444321      12222346678899999999999999999999997        888754

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-36  Score=300.08  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=196.9

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||+|+||+||++....        .++.+++|.+.+.........+.|.+|++++++++||||+++++++...+..++||
T Consensus         1 lg~g~~g~vy~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   72 (277)
T cd05577           1 LGKGGFGEVCACQVKA--------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVM   72 (277)
T ss_pred             CCCCCceeEEEEEEcC--------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEE
Confidence            6899999999886543        34556666554433333334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++++|.+++..... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus        73 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          73 TLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             ecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999999976532 358999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCc
Q 036172          314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPK  393 (522)
Q Consensus       314 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  393 (522)
                      ..   .....++..|+|||.+.++.++.++||||||+++++|++|+.||.............  ..... .         
T Consensus       149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-~---------  213 (277)
T cd05577         149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE-M---------  213 (277)
T ss_pred             Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc-c---------
Confidence            11   123457889999999988889999999999999999999999996544321111110  00000 0         


Q ss_pred             ccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          394 LSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       394 l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                       ....+......+.+++.+||+.+|.+||     ++.+++.        |+|+..
T Consensus       214 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--------h~~~~~  259 (277)
T cd05577         214 -AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE--------HPLFKD  259 (277)
T ss_pred             -cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh--------Chhhhc
Confidence             1111222355788999999999999999     6666775        888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-36  Score=296.30  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--ccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--QFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +|+..+.||.|+||.||++....        ....+++|.+.....  ...+..+.|.+|+.++++++|+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD--------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER   72 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC--------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe
Confidence            57888999999999999986532        334555554432211  11234578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+..+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          73 EEDNLYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999999754   248899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++.......   ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....  .........    ..
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~----~~  217 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIG----RS  217 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHH----hc
Confidence            9987654332   122456889999999987766 8999999999999999999999986443  111111111    10


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ....         ..+......+.+++.+||+.+|.+||++.+++.
T Consensus       218 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ccCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1111         111223456788999999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.6e-36  Score=300.38  Aligned_cols=272  Identities=22%  Similarity=0.226  Sum_probs=202.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc--cchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ--FSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~--~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +|++.+.||.|+||.||++....        ..+.+++|.++.....  .......+.+|++++++++|+||+++++++.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE--------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG   72 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC--------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee
Confidence            58889999999999999987543        3455666665443322  1223456788999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+..++||||+ +|+|.+++....  ..+++..++.++.||++||.|||+   .+++|+||||+||+++.++.++|+||
T Consensus        73 ~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          73 HKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             cCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccc
Confidence            999999999999 889999997543  259999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++..........  ....+++.|+|||.+.+ ..++.++|||||||++++|++|..||......  ..+...... ...
T Consensus       147 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~-~~~  221 (298)
T cd07841         147 GLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEA-LGT  221 (298)
T ss_pred             eeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHH-cCC
Confidence            9997654432211  12356788999999855 45789999999999999999998877543321  111111100 000


Q ss_pred             ---------CCcccccCCccc-----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          384 ---------GDTETLLDPKLS-----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       384 ---------~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                               ............     ..........+.+++.+||+.+|.+|||+.+|++        ++|+....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--------~~~~~~~~  289 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--------HPYFSNDP  289 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--------CccccCCC
Confidence                     000000000000     0111223567889999999999999999999998        88887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-36  Score=295.79  Aligned_cols=255  Identities=23%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||+|+||.||++....        ..+.+++|.++..... ....+.+.+|+.++++++|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD--------TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC--------CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            68999999999999999986432        3345555554432221 23667899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+++|+||+++++|.+++...   ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999999999999999743   348899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCcc--ccccccCCCCCChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          307 AIWGPTDSTHMI--REDVVGTFGYIAPEYLMHGK---VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       307 a~~~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +...........  .....++..|+|||++....   ++.++||||||++++++++|+.||......  .......    
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~----  219 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHV----  219 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHH----
Confidence            976544332211  12346788999999997766   889999999999999999999999643211  1111100    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+..     +.+..  .......+.+++.+||+.+|.+||++.+++.
T Consensus       220 ~~~~~-----~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         220 GAGHK-----PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             hcCCC-----CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111     11111  1112456778999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-36  Score=295.96  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=195.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.+.||.|+||.||++....         .+.+++|.++...  .  ...+|.+|++++++++||||+++++++..
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~~k~~~~~~--~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE---------KRKVAIKTIREGA--M--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE   70 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC---------CCeEEEEECCCCC--C--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc
Confidence            478899999999999999976431         2234444443211  1  23568999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          71 RSPICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCc
Confidence            999999999999999999997542  348899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++......... ......++..|+|||++.++.++.++||||||+++|||++ |..||.....   ..+....    ..+
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~  217 (256)
T cd05112         146 MTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI----NAG  217 (256)
T ss_pred             ceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH----hCC
Confidence            98755332211 1112235678999999988889999999999999999998 9999864332   1111111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                        .....+..       .+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       218 --~~~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 --FRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              01111111       2357889999999999999999999999773

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=300.75  Aligned_cols=265  Identities=21%  Similarity=0.248  Sum_probs=194.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ..+.+++|++......  .....+.+|++++++++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKL--------TGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIH   73 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcC--------CCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEe
Confidence            3689999999999999999987542        4556777776542221  12345778999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++...++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          74 TKKTLTLVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             cCCeEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECcc
Confidence            99999999999975 9999987543  258999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++........  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......  ..........+..
T Consensus       148 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~  223 (291)
T cd07844         148 GLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGT  223 (291)
T ss_pred             ccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCC
Confidence            998654322111  112346889999999865 45789999999999999999999999644311  1111100000000


Q ss_pred             C---C---------ccc----cc-CCccccccc-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 G---D---------TET----LL-DPKLSNEYD-NAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 ~---~---------~~~----~~-d~~l~~~~~-~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .   .         ...    .. ...+..... ......+.+++.+||+.+|.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0   0         000    00 000000000 001256778999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.2e-36  Score=295.57  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=189.2

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEE
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      ...||+|+||.||++....        ....+++|.+..   ......+.|.+|+.++++++|+||+++++++..++..+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~--------~~~~v~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLS--------TQVRIAIKEIPE---RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             eEEEecCCceEEEEeEecC--------CCcEEEEEEecC---CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            4569999999999987532        334455554432   12234568999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CCceEEeecCcccc
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIW  309 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~~~kL~DFGla~~  309 (522)
                      +|+||+++++|.+++.........++..+..++.|++.||.|||+   .+|+||||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999999854221112788899999999999999999   99999999999999976 67999999999865


Q ss_pred             CCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          310 GPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       310 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      .......  .....++..|+|||++....  ++.++||||||+++|+|++|+.||.......   ...+......     
T Consensus       159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----  228 (268)
T cd06624         159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-----  228 (268)
T ss_pred             cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----
Confidence            4332211  12335789999999986644  7899999999999999999999986432111   1111110000     


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                            .....+......+.+++.+||+.+|.+||++.+|+.
T Consensus       229 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                  011122234567888999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=297.61  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=196.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||.|+||.||++....        ..+.+++|.+....    ...++|.+|+.+++++ +|+||++++++
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~   71 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK--------TGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGA   71 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC--------CCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEE
Confidence            45799999999999999999987642        33445555443211    1346799999999999 79999999999


Q ss_pred             EEeCC------EEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          223 CIEDN------YLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       223 ~~~~~------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      +....      .+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~  148 (275)
T cd06608          72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTK  148 (275)
T ss_pred             EEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEcc
Confidence            97644      5899999999999999987532 23468999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      ++.++|+|||++........  ......|+..|+|||++..     ..++.++||||||+++++|++|+.||.....  .
T Consensus       149 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~  224 (275)
T cd06608         149 NAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--M  224 (275)
T ss_pred             CCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--H
Confidence            99999999999865443221  1223468999999999753     3467899999999999999999999963321  1


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+..    .. .+....+       .........+.+++.+||..||.+|||+.+|++
T Consensus       225 ~~~~~----~~-~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         225 RALFK----IP-RNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHHH----hh-ccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111    11 1111111       111224567889999999999999999999997

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-36  Score=309.31  Aligned_cols=255  Identities=21%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ...-|+++++||.||-+.||++...         .++.++++.+..... ....+.-|.+|+.+|.+| .|.+||++++|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s---------~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY  428 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS---------DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDY  428 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC---------CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence            4567999999999999999998754         344455544433222 223567899999999999 79999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      -..++.+|+||||-+. +|..+|.....  .++.-.+..+..|++.++.++|.   .||||.||||.|+|+- .|.+||+
T Consensus       429 Ev~d~~lYmvmE~Gd~-DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLI  501 (677)
T KOG0596|consen  429 EVTDGYLYMVMECGDI-DLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLI  501 (677)
T ss_pred             eccCceEEEEeecccc-cHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEee
Confidence            9999999999999855 99999987532  23323777889999999999999   9999999999999985 4689999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-----------KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      |||+|..+..+.........+||+.||+||.+...           +.+.++||||||||||+|+.|+.||...     .
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~  576 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----I  576 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----H
Confidence            99999999988888888889999999999998532           3678999999999999999999998621     1


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHH-HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQM-QRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +  .|+       ++..+.+|....+|+.... ..++++++.||..||.+||++.+||+
T Consensus       577 n--~~a-------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 N--QIA-------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H--HHH-------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1  111       1233444443333332221 23889999999999999999999997

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.3e-36  Score=297.94  Aligned_cols=266  Identities=20%  Similarity=0.252  Sum_probs=198.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++.+..        .+..+++|.++....  ....+.+.+|+.++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   70 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT--------TGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTE   70 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC--------CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC
Confidence            58999999999999999987643        345666666654322  22346678899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++ +|.+++........+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+
T Consensus        71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~  146 (284)
T cd07836          71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGL  146 (284)
T ss_pred             CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecch
Confidence            999999999975 899988765444569999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHHhhh------
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVKWAK------  378 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~~~~------  378 (522)
                      +.........  .....++..|++||++.+. .++.++||||||+++|+|++|+.||.......... +.....      
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd07836         147 ARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST  224 (284)
T ss_pred             hhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            9654332211  1223578899999998654 46899999999999999999999997554321111 000000      


Q ss_pred             -hhhcC-----CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 -PILKN-----GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 -~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                       ..+..     .......+.. ........+..+.+++.+||+.+|.+||++.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         225 WPGISQLPEYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHhcCchhcccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             00000     0000000000 01111233567889999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.7e-36  Score=299.67  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=195.0

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+...    .....++.+|+.+++++ +||||+++++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~--------~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKK--------NGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECC--------CCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            345789999999999999999987543        3445666654321    12335688999999999 7999999999


Q ss_pred             EEE-----eCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          222 VCI-----EDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       222 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ++.     .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+   .+++||||||+||+++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECC
Confidence            985     346799999999999999988643 223458999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      ++.++|+|||++........  ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||......  
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--  235 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--  235 (286)
T ss_pred             CCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--
Confidence            99999999999876543221  1223468999999999753     44788999999999999999999998643211  


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+...     .........++       ......+.+++.+||+.+|.+||++.+|++
T Consensus       236 ~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         236 RALFKI-----PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             HHHhhc-----cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            111110     11111111111       112346888999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.2e-36  Score=293.52  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      ++.+.||.|+||.||++......    ......+++|.++...  .....+.+.+|+.++.+++|+||+++++++.+.+.
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLS----GEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             cccceeccCCCcceEEEEecCCC----CCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            56788999999999998765311    0234566667664322  12256789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      .++||||+++++|.+++...... .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCce
Confidence            99999999999999999854321 28999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       309 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      ........... ...+++.|+|||.+....++.++||||||+++++|++ |+.||.....   ..+.....    .+...
T Consensus       152 ~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~  223 (258)
T smart00219      152 DLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK----KGYRL  223 (258)
T ss_pred             ecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cCCCC
Confidence            66544222111 2236789999999988889999999999999999998 8888864221   12221111    11111


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                               ......+..+.+++.+||..+|.+|||+.++++.|
T Consensus       224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                     01111456788899999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6e-36  Score=299.00  Aligned_cols=264  Identities=20%  Similarity=0.237  Sum_probs=196.7

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        ....+++|.+...... ....+.+.+|+.++++++||||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE--------TGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC--------CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            58999999999999999987543        2445555554332211 12346799999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++||||+ +++|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence            9999999999 999999987543  459999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC-
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG-  384 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-  384 (522)
                      +......... ......++..|+|||.+.+. .++.++||||||+++++|++|.+||......  ..+ ......+... 
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~-~~~~~~~~~~~  221 (286)
T cd07832         146 ARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQL-AIVFRTLGTPN  221 (286)
T ss_pred             cccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHH-HHHHHHcCCCC
Confidence            9765443221 11234688999999998654 4689999999999999999998887543321  111 1110000000 


Q ss_pred             -----------CcccccCCcc----cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 -----------DTETLLDPKL----SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 -----------~~~~~~d~~l----~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                 ....+..+..    ...........+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                       0000000000    00111123478899999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.2e-36  Score=296.68  Aligned_cols=262  Identities=19%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++.+.||+|+||.||++.....     ......+++|.++... ......+++.+|+.++++++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE-----DGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc-----CCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            67788999999999999864321     2345566776654321 12234677999999999999999999999987542


Q ss_pred             ------EEEEEEecCCCCCHHHHhhccC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          228 ------YLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       228 ------~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                            ..+++++|+.+|+|.+++....   ....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~  151 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCC
Confidence                  3578999999999998875321   22347899999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||+++...............+++.|++||.+....++.++||||||+++|+|++ |+.||.....   ..+..+.
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~  228 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL  228 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH
Confidence            99999999976543322222223345678999999988889999999999999999999 8899864322   1222111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .    .+....         .....+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       229 ~----~~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 I----KGNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             H----cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1    111000         0112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=298.70  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=208.3

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      .+..+.-|.++.+||+|+||.||.+.+.+        .+..+|+|.+...+     .++++.+|+.|+++++.|++|++|
T Consensus        28 ~K~PEEVFDi~~KLGEGSYGSV~KAIH~E--------sG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYY   94 (502)
T KOG0574|consen   28 NKPPEEVFDIVGKLGEGSYGSVHKAIHRE--------SGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYY   94 (502)
T ss_pred             cCChHHHHHHHHHhcCCcchHHHHHHHhc--------cCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhh
Confidence            34445568899999999999977766554        67777877765433     678999999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      |.+.....+++|||||..|++.++++-+  ++++++.++..++...++||+|||.   ..-||||||..|||++.+|.+|
T Consensus        95 GSYFK~sDLWIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AK  169 (502)
T KOG0574|consen   95 GSYFKHSDLWIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAK  169 (502)
T ss_pred             hhhccCCceEeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhh
Confidence            9999999999999999999999999864  4469999999999999999999999   8889999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||.|-.+...  -...+.+.||+.|||||++..-.|..++||||||+...||..|++||..-.+-.       +.-+
T Consensus       170 LADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------AIFM  240 (502)
T KOG0574|consen  170 LADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------AIFM  240 (502)
T ss_pred             hhhccccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------eeEe
Confidence            9999999544332  223456789999999999999999999999999999999999999986432111       0001


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +...       |...-..+...+..+.++++.||.++|++|-|+-++++
T Consensus       241 IPT~-------PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  241 IPTK-------PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             ccCC-------CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            1111       11111223445678999999999999999999999987

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-35  Score=288.59  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        ..+.+++|.+...... ....+.+.+|+.++++++||||+++++.+...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD--------TGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC--------CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47889999999999999987542        3445666555433221 34568899999999999999999999999988


Q ss_pred             --CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          227 --NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       227 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                        ...++|+||+++++|.+++....   .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccc
Confidence              89999999999999999998543   59999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |.+................++..|+|||.+.....+.++||||||+++++|++|..||....  ....   .........
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~~~~  220 (260)
T cd06606         146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMA---ALYKIGSSG  220 (260)
T ss_pred             ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHH---HHHhccccC
Confidence            99976655443211234568899999999988889999999999999999999999997544  1111   111111100


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .         ....+...+..+.+++.+||..+|.+||++.+++.
T Consensus       221 ~---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 E---------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             C---------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1         11122233578899999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.3e-36  Score=301.43  Aligned_cols=267  Identities=20%  Similarity=0.223  Sum_probs=197.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||.|+||.||++....        ..+.+++|.++..... ......+.+|+.++++++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK--------TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC--------CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            579999999999999999987543        3445666655432221 1223467889999999999999999999987


Q ss_pred             C--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          226 D--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       226 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .  ...++||||+++ +|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|
T Consensus        76 ~~~~~~~lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          76 SNLDKIYMVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             cCCCcEEEEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEee
Confidence            7  899999999975 9999987543  258999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHHhh----
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVKWA----  377 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~~~----  377 (522)
                      ||++.........  .....+++.|+|||.+.+.. ++.++||||||+++++|++|..||.......... +....    
T Consensus       150 ~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (293)
T cd07843         150 FGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT  227 (293)
T ss_pred             cCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9999765543211  12345788999999986544 6899999999999999999999997543211110 00000    


Q ss_pred             ---hh------hhcCCCcccccCCcccccccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          378 ---KP------ILKNGDTETLLDPKLSNEYDNA-QMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       378 ---~~------~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         ++      ..............+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               00      0000000011111111122222 3567888999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.9e-36  Score=294.82  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||.|+||.||++....        ....+++|.+.+.........+.+.+|+.++++++||||+++++++.++...++||
T Consensus         1 lg~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   72 (262)
T cd05572           1 LGVGGFGRVELVKVKS--------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM   72 (262)
T ss_pred             CCCCCceEEEEEEECC--------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEE
Confidence            6899999999987642        34566666654433322335578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++++|.+++.+.   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        73 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          73 EYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             ecCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999999999999753   348999999999999999999999   99999999999999999999999999999766543


Q ss_pred             CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCc
Q 036172          314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPK  393 (522)
Q Consensus       314 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  393 (522)
                      .   ......++..|++||.+....++.++|+||||+++|+|++|..||........ ....   .......        
T Consensus       147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~~~~--------  211 (262)
T cd05572         147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYN---DILKGNG--------  211 (262)
T ss_pred             c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHH---HHhccCC--------
Confidence            2   11234688999999999888899999999999999999999999975542111 1111   1111000        


Q ss_pred             ccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          394 LSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       394 l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                       ...++...+..+.+++.+||+.+|.+||+     +.|+++        ++|+..
T Consensus       212 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~--------~~~~~~  257 (262)
T cd05572         212 -KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK--------HKWFNG  257 (262)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc--------ChhhhC
Confidence             11112222567899999999999999999     888887        888764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.1e-36  Score=296.79  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=199.5

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-------ccchHHHHHHHHHHHHhh-CCCCCcce
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-------QFSSAWNDFSSEVDITSS-LEQKSITT  218 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-------~~~~~~~~f~~Ev~iL~~-L~HpnIv~  218 (522)
                      .|++.+.||.|+||.||++....       ...+.+++|.+.....       .......++.+|+.++.+ ++||||++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~-------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~   73 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN-------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR   73 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC-------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeee
Confidence            47889999999999999987643       1234555554432211       223356778899998876 69999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +++++.+++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCC
Confidence            999999999999999999999999988642 2234589999999999999999999952  6899999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .++|+|||++.......   ......|+..|+|||.+.++.++.++||||||+++|+|++|+.||......   ..... 
T Consensus       152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~-  224 (269)
T cd08528         152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATK-  224 (269)
T ss_pred             cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHH-
Confidence            99999999997654432   122446889999999999888999999999999999999999998643211   11111 


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                         ...+.....    .    ....+..+.+++.+||+.||.+||++.+|..+|.
T Consensus       225 ---~~~~~~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 ---IVEAVYEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---HhhccCCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               111111110    0    1123456888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-36  Score=318.36  Aligned_cols=268  Identities=20%  Similarity=0.228  Sum_probs=207.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CC-----Ccceee
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QK-----SITTLN  220 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-Hp-----nIv~l~  220 (522)
                      +|.|++.||.|+||.|.+|.+.        ++...||+|.|+....    -..+-..|+.||..|+ |.     |+|+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~--------~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH--------KTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             EEEEEEEecccccceeEEEEec--------CCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            7899999999999998888764        4788899999886444    3355667999999996 53     799999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC--Cc
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD--FQ  298 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~--~~  298 (522)
                      ++|...+++|||+|.+.. +|.++|+.+.- ..|+...+..|+.||+.||.+||+   .+|||+||||+||||.+-  ..
T Consensus       255 d~F~fr~HlciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             eccccccceeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCc
Confidence            999999999999999955 99999997743 359999999999999999999999   999999999999999754  47


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||.+.+......     ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..++-..+....
T Consensus       330 vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  330 IKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL  404 (586)
T ss_pred             eeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence            99999999976554332     3456788999999999999999999999999999999988887665433322111100


Q ss_pred             ---------------hhhcC-CCcc------c-----------------ccC---C----cccccccHHHHHHHHHHHHH
Q 036172          379 ---------------PILKN-GDTE------T-----------------LLD---P----KLSNEYDNAQMQRMLLAANL  412 (522)
Q Consensus       379 ---------------~~~~~-~~~~------~-----------------~~d---~----~l~~~~~~~~~~~l~~li~~  412 (522)
                                     ..+.. ....      .                 ..+   |    .+........-..+++++.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence                           00000 0000      0                 000   1    00011111334678999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          413 CINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       413 CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ||..||.+|+|+.+.++        |+|+...
T Consensus       485 ~L~~dP~~R~tp~qal~--------Hpfl~~~  508 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALN--------HPFLTGT  508 (586)
T ss_pred             HhccCchhcCCHHHHhc--------Ccccccc
Confidence            99999999999999998        9998743

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-35  Score=298.19  Aligned_cols=251  Identities=20%  Similarity=0.222  Sum_probs=190.4

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhh---CCCCCcceeeEEEEeCCEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSS---LEQKSITTLNGVCIEDNYL  229 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~---L~HpnIv~l~~~~~~~~~~  229 (522)
                      .||+|+||.||++....        ..+.+++|.+.+...........+.+|..+++.   ..||||+.+++++..++..
T Consensus         1 ~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD--------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL   72 (279)
T ss_pred             CcccCCCeEEEEEEECC--------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE
Confidence            38999999999987542        455666665544332222223344555544443   4799999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          230 ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       230 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        73 ~lv~e~~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          73 CFILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            9999999999999998743   349999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccc
Q 036172          310 GPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTET  388 (522)
Q Consensus       310 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (522)
                      ......    ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+.....   .      
T Consensus       147 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~------  213 (279)
T cd05633         147 FSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T------  213 (279)
T ss_pred             ccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c------
Confidence            433221    23468999999999864 457999999999999999999999997543332222111100   0      


Q ss_pred             ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       389 ~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .    ....+...+..+.+++.+||+.||.+||     ++.++++        |+|++.
T Consensus       214 -~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~--------h~~~~~  260 (279)
T cd05633         214 -V----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE--------HVFFKG  260 (279)
T ss_pred             -C----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh--------CccccC
Confidence             0    1111223456788899999999999999     6999987        778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-35  Score=292.43  Aligned_cols=260  Identities=20%  Similarity=0.318  Sum_probs=207.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +.|++.+.||.|+||.||++....        ..+.+++|.+.....  ....+.|.+|+.++++++|+||+++++++..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~--------~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP--------TGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYK   70 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC--------CCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc
Confidence            468899999999999999987643        345566655443221  1346789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++||||+++++|.+++...   ..+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          71 EGEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999999999999854   3589999999999999999999974  789999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++..........  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||................    ...
T Consensus       146 ~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~  219 (264)
T cd06623         146 ISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP  219 (264)
T ss_pred             cceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC
Confidence            997654433221  23467899999999988889999999999999999999999987554322222222222    111


Q ss_pred             cccccCCcccccccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          386 TETLLDPKLSNEYDNA-QMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~-~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..         ..+.. .+..+.+++.+||..+|.+||++.++++        ++|++.
T Consensus       220 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--------~~~~~~  261 (264)
T cd06623         220 PP---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--------HPFIKK  261 (264)
T ss_pred             CC---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--------CHHHHh
Confidence            10         11112 4567889999999999999999999998        777653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-35  Score=297.87  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=197.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++...||.|+||.||++....        ..+.+++|.+...    ......+.+|+.++.++ +||||++++++
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~--------~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKK--------DGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECC--------CCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            45789999999999999999987543        3455555554321    11235678899999999 89999999999


Q ss_pred             EEeC-----CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          223 CIED-----NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       223 ~~~~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      +...     +..++||||+++|+|.++++.. .....+++..++.++.|++.||.|||+   .+++|+||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence            9754     4689999999999999988643 123458999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-----KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      +.+||+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||.....  ..
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VK  240 (291)
T ss_pred             CCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HH
Confidence            99999999998754432211  1234688999999998543     368899999999999999999999864321  11


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .+..+     ..+....+.+       .......+.+++.+||+.+|.+||++.++++        |+|+
T Consensus       241 ~~~~~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~--------~~~~  290 (291)
T cd06639         241 TLFKI-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE--------HPFI  290 (291)
T ss_pred             HHHHH-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc--------Cccc
Confidence            11111     1111111111       1123356889999999999999999999997        7776

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-36  Score=299.47  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHH-HhhCCCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI-TSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~i-L~~L~HpnIv~l~~~~~  224 (522)
                      ++|++.+.||+|+||.||++.+..        +++.+++|.++...  ......++..|+.+ ++.++||||+++++++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~   70 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP--------TGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFYGALF   70 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC--------CCcEEEEEEEecCC--CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe
Confidence            468999999999999999987542        45667777654322  12234556667776 56669999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCceeccCCCceEEe
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .++..++||||++ |+|.+++... .....+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          71 REGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             cCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEe
Confidence            9999999999996 5998888653 233469999999999999999999998   6 99999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      |||++........   .....++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||..... ....+...  
T Consensus       147 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~--  220 (283)
T cd06617         147 DFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQLKQV--  220 (283)
T ss_pred             ecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHHHHHHH--
Confidence            9999876543221   122468889999998854    4468899999999999999999999853221 11111111  


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .. +....     +.   ....+..+.+++.+||..+|.+||++.+|++        ++|+...
T Consensus       221 --~~-~~~~~-----~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--------~~~~~~~  267 (283)
T cd06617         221 --VE-EPSPQ-----LP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--------HPFFELH  267 (283)
T ss_pred             --Hh-cCCCC-----CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc--------Cchhhhc
Confidence              11 11111     10   1123467889999999999999999999997        8887764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=318.02  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +..|.-.+.||.|+||.||.+.+..        +...||+|.+.-......+.++++.+|+..|++|+|||+|.+-|+|.
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~--------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL   96 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVR--------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL   96 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccC--------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence            4467778899999999999987643        45566666654444444558899999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+...+||||||- ||-.|++.-+.  +++-+.++..|..+.+.||+|||+   .+.||||||..|||+++.|.|||+||
T Consensus        97 re~TaWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDF  170 (948)
T KOG0577|consen   97 REHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADF  170 (948)
T ss_pred             ccchHHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccc
Confidence            9999999999995 59999887653  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |.|......      +.++|||.|||||++.   .|.|+.|+||||||++..||.-.++|+-..  ....     +...+
T Consensus       171 GSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMS-----ALYHI  237 (948)
T KOG0577|consen  171 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMS-----ALYHI  237 (948)
T ss_pred             cchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--hHHH-----HHHHH
Confidence            998654433      3568999999999984   478999999999999999999999995321  1111     12222


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+..     |.+.   .++.+..+..|+..||++-|.+|||..+++.
T Consensus       238 AQNes-----PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  238 AQNES-----PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HhcCC-----CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            22222     1122   3456678999999999999999999999886

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.2e-36  Score=302.61  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||.|+||.||++....        ..+.+++|.+...........+++.+|+++++.++||||++++++|.
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR--------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC--------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            3569999999999999999987542        34566666554333333345578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||++ |+|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeec
Confidence            9999999999997 58888776432  248999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |++.......      ...++..|+|||.+.   .+.++.++||||||+++|||++|..||......   .....    .
T Consensus       160 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~----~  226 (307)
T cd06607         160 GSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH----I  226 (307)
T ss_pred             CcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHH----H
Confidence            9986543322      346788999999874   356889999999999999999999998543211   11100    0


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .....     +.+   .....+..+.+++.+||..+|.+||++.+|+.        ++|+..
T Consensus       227 ~~~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--------~~~~~~  272 (307)
T cd06607         227 AQNDS-----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--------HRFVLR  272 (307)
T ss_pred             hcCCC-----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc--------Chhhcc
Confidence            00100     000   11224567899999999999999999999997        677654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-36  Score=299.80  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=193.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..+.|++.++||.|+||.||++....        ....+++|.+..    ......++..|+.+++++ +|+||++++++
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~a~K~~~~----~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVK--------TGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcC--------CCcEEEEEEEec----ChHHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            34789999999999999999987543        334555554322    112346788999999999 79999999999


Q ss_pred             EEe------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          223 CIE------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       223 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      +..      ...+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence            863      467899999999999999997543 2348888999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      +.++|+|||++........  ......|++.|+|||.+.     ...++.++|||||||++|+|++|..||.......  
T Consensus       158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--  233 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--  233 (282)
T ss_pred             CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--
Confidence            9999999999865432211  122346899999999975     3457889999999999999999999985432111  


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ....     .....     .+..   .....+..+.+++.+||+.||.+||++.+|++
T Consensus       234 ~~~~-----~~~~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ALFL-----IPRNP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhh-----HhhCC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1110     00000     0000   01123457899999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-36  Score=311.16  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             CCc-eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPF-QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y-~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ++| +....||+|+|-+||++.+.+..        ..+|.-+++-... ......++|..|+.+|+.|+|||||++|.++
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~g--------iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW  110 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEG--------IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW  110 (632)
T ss_pred             Cceeehhhhcccccceeeeeccccccc--------hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence            444 45678999999999998765432        2333333222111 1233568999999999999999999999999


Q ss_pred             EeCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-CceE
Q 036172          224 IEDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQ  300 (522)
Q Consensus       224 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~~k  300 (522)
                      .+..  .+.+|+|++..|+|..|+.+.+   .++...+..|+.||++||.|||+.. ++|||||||.+||||+.+ |.||
T Consensus       111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  111 VDTDNKTINFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             ecCCCceeeeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCcee
Confidence            9764  4899999999999999999654   4888999999999999999999853 799999999999999865 7999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|+|+|.........    .+.|||.|||||.+. ..|+..+||||||++++||+|+..||....  +..++.+.+...
T Consensus       187 IGDLGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SG  259 (632)
T KOG0584|consen  187 IGDLGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSG  259 (632)
T ss_pred             ecchhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcC
Confidence            9999999766554333    368999999999985 789999999999999999999999986432  222333322221


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +....+..+            ...++.+||.+||.. ...|||+.|+|+
T Consensus       260 iKP~sl~kV------------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  260 IKPAALSKV------------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHhhcc------------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111111111            124678899999999 999999999997

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.1e-36  Score=299.54  Aligned_cols=263  Identities=23%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~  224 (522)
                      .+|+....||.|+||.||++.+..        ....+++|.+.....  ......+.+|+.++.++. |+||+++++++.
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~--------~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~   73 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKP--------SGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALF   73 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECC--------CCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe
Confidence            356777889999999999877543        456677776654322  245678999999999995 999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhcc--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGA--GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .++..+++|||+.. +|.++....  .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+
T Consensus        74 ~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          74 REGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             cCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEe
Confidence            99999999999964 766654321  1224599999999999999999999972  589999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG---KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |||++.........   ....|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||....     ........
T Consensus       151 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~  222 (288)
T cd06616         151 DFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQ  222 (288)
T ss_pred             ecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhh
Confidence            99998654432211   223688999999998766   68999999999999999999999986432     11111111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ... +..     +.+........+..+.+++.+||+.+|.+||++.+|++        ++|++.
T Consensus       223 ~~~-~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--------~~~~~~  272 (288)
T cd06616         223 VVK-GDP-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--------HPFIKD  272 (288)
T ss_pred             hcC-CCC-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--------Chhhhc
Confidence            111 111     11111122234567899999999999999999999997        888765

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=296.17  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=201.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC---CCCcceeeEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE---QKSITTLNGVC  223 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~---HpnIv~l~~~~  223 (522)
                      .|++.++||.|+||.||++....        ..+.+++|.+....  .....+++.+|+.++++++   |||++++++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~--------~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~   71 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP--------TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY   71 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC--------CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee
Confidence            57888999999999999987532        34566666554321  2234567889999999996   99999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+...++||||+++++|.+++...    .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          72 LKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEcc
Confidence            9999999999999999999998642    48999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++.........  .....|+..|+|||.+.++ .++.++||||||+++|+|++|..||........   ...    ..
T Consensus       145 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~----~~  215 (277)
T cd06917         145 FGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MML----IP  215 (277)
T ss_pred             CCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhc----cc
Confidence            9999766543321  2234688999999998654 468999999999999999999999964322111   100    01


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..     ..+.+...   ..+..+.+++.+||+.+|.+||++.+++.        ++|++..
T Consensus       216 ~~-----~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~--------~~~~~~~  261 (277)
T cd06917         216 KS-----KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK--------SKWIKAH  261 (277)
T ss_pred             cC-----CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh--------ChHhhcc
Confidence            10     01111111   13457888999999999999999999997        8888654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.9e-35  Score=292.55  Aligned_cols=259  Identities=20%  Similarity=0.226  Sum_probs=192.4

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEEeC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIED  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~~~  226 (522)
                      |++.++||+|+||.||++....        ..+.+++|.+++.....  ......+|+.++.++. |+||+++++++.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~--------~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   70 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK--------TGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDR   70 (282)
T ss_pred             CceEeeccccccceEEEEEEcC--------CCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecC
Confidence            6788999999999999987542        44566777665543222  2234567999999994 99999999999987


Q ss_pred             --CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          227 --NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       227 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                        +.+++||||++ |+|.+.+....  ..+++..++.++.|++.||.|||+   .+++||||+|+||+++. +.+||+||
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          71 KTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             CCCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEec
Confidence              89999999997 58888887532  358999999999999999999999   99999999999999999 99999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh--
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL--  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--  381 (522)
                      |++.........   ....++..|+|||++.. +.++.++|||||||++|||++|..||...+...   .........  
T Consensus       144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~  217 (282)
T cd07831         144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGT  217 (282)
T ss_pred             ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCC
Confidence            999765433221   12357889999998654 557899999999999999999999996543211   111111000  


Q ss_pred             ---------cCCCcccccCCccc----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 ---------KNGDTETLLDPKLS----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ---------~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                               ..........+...    .......+..+.+++.+||+.+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                     00000000000000    0111234678999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=326.63  Aligned_cols=270  Identities=21%  Similarity=0.300  Sum_probs=219.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +..++.+.||.|.||.|+.+..+.     ..+....+|+|.||.....  .+..+|+.|+.||-++.||||++|.|+...
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~-----pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTk  701 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKL-----PGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTK  701 (996)
T ss_pred             hheEEEEEEecccccceecccccC-----CCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence            445788999999999999977432     3456678899998864432  366799999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...++||+|||++|+|+.+|+.+..  .|++.+...++++|+.|++||-+   .++|||||...|||++.+..+|++|||
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEecccc
Confidence            9999999999999999999997643  39999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          306 LAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       306 la~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      +++....+.... ....-.-..+|.|||.+...+++.++||||||+|+||.++ |..||=...  +++ .++   .+.. 
T Consensus       777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQd-VIk---aIe~-  849 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQD-VIK---AIEQ-  849 (996)
T ss_pred             ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHH-HHH---HHHh-
Confidence            999876655222 2212223578999999999999999999999999999998 999964322  111 111   1111 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                               ..+...+.+++..|.+|+..||++|-.+||.+.+|+..|.+..-....++.
T Consensus       850 ---------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  850 ---------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             ---------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                     112233456788999999999999999999999999999998755444443

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.3e-36  Score=297.82  Aligned_cols=264  Identities=20%  Similarity=0.228  Sum_probs=194.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        ....+++|.++.... .....+.+.+|++++++++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL--------TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC--------CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            48899999999999999987542        345566665543221 122345789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+. ++|..++.... ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999996 58999887543 3358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC--
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN--  383 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--  383 (522)
                      +.........  .....++..|+|||++.+.. ++.++||||||+++|+|+||+.||.....  ...+.......-..  
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~  222 (284)
T cd07860         147 ARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDE  222 (284)
T ss_pred             hhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCCh
Confidence            8655432211  11235688999999886644 58899999999999999999999864431  11111111000000  


Q ss_pred             -------------CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 -------------GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 -------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                   ..........+ ..........+.+++.+||+.||.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                         00000000000 0001123356788999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-35  Score=296.77  Aligned_cols=271  Identities=18%  Similarity=0.184  Sum_probs=197.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      ++|++.+.||+|+||.||++....        +.+.+++|.++.... .......+.+|+.+++++ +||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~--------~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN--------TGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC--------CCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            468999999999999999987542        345666666544221 112345788999999999 5699999999998


Q ss_pred             eCCE-----EEEEEecCCCCCHHHHhhccCC--CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-C
Q 036172          225 EDNY-----LILVSDFLPKGSLEESLHGAGE--QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-D  296 (522)
Q Consensus       225 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~  296 (522)
                      ....     .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+   .+++||||||+||+++. +
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~  147 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCC
Confidence            7665     8999999986 89998875422  3458999999999999999999999   99999999999999998 8


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      +.+||+|||++..........  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....  ...+..
T Consensus       148 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~  223 (295)
T cd07837         148 GLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLH  223 (295)
T ss_pred             CeEEEeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH
Confidence            899999999987543322111  12256888999998865 4578999999999999999999999865321  111111


Q ss_pred             hhhhhhcCCCcc---c-----------ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          376 WAKPILKNGDTE---T-----------LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       376 ~~~~~~~~~~~~---~-----------~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .... +......   .           ...+.............+.++|.+||+.||.+||++.+++.        ++|+
T Consensus       224 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~--------~~~~  294 (295)
T cd07837         224 IFKL-LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT--------HPYF  294 (295)
T ss_pred             HHHH-hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc--------CCCc
Confidence            1110 0000000   0           00000000111124567889999999999999999999997        7886


Q ss_pred             c
Q 036172          442 D  442 (522)
Q Consensus       442 ~  442 (522)
                      +
T Consensus       295 ~  295 (295)
T cd07837         295 D  295 (295)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2e-35  Score=298.19  Aligned_cols=259  Identities=22%  Similarity=0.304  Sum_probs=202.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||.|+||.||++....        ....+++|.+...   .....+.+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~   85 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVA--------TGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSY   85 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcC--------CCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhhee
Confidence            34789999999999999999986432        2344555544321   122456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ...+..++|+||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~d  158 (293)
T cd06647          86 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTD  158 (293)
T ss_pred             eeCCcEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEcc
Confidence            9999999999999999999999742    37899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.........  .....+++.|+|||.+..+.++.++||||||+++|++++|+.||........  +..    ....
T Consensus       159 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~----~~~~  230 (293)
T cd06647         159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATN  230 (293)
T ss_pred             Ccceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee----hhcC
Confidence            9988654432221  1234688899999999888899999999999999999999999965432111  000    0000


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +.      +  ...........+.+++.+||..+|.+||++.+++.        |+|++..
T Consensus       231 ~~------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--------h~~~~~~  275 (293)
T cd06647         231 GT------P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--------HPFLKIA  275 (293)
T ss_pred             CC------C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--------CHHHhcC
Confidence            00      0  00111223456888999999999999999999997        8887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7e-36  Score=301.43  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=199.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|....+||.|+||.||++.+..        ....+++|.+...   .....+.+.+|+.++++++|+||+++++.+..
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   90 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKH--------TGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV   90 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECC--------CCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence            345556779999999999876532        3445565554321   12345678999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.+++...    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||
T Consensus        91 ~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658          91 GDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             CCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCc
Confidence            99999999999999999988532    38999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.........  .....|+..|+|||.+.+..++.++||||||+++|||++|..||......   .........     
T Consensus       164 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~-----  233 (292)
T cd06658         164 FCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRDN-----  233 (292)
T ss_pred             chhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc-----
Confidence            98654332221  12346889999999998888999999999999999999999998643211   111111110     


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                          +.+.+..  .......+..++.+||..+|.+|||+.++++        ++|++..
T Consensus       234 ----~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--------~~~~~~~  278 (292)
T cd06658         234 ----LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQ--------HPFLKLA  278 (292)
T ss_pred             ----CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhh--------Chhhhcc
Confidence                0111111  1123456788999999999999999999997        7887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-35  Score=295.49  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=200.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      -|++.++||.|+||.||++....        ....+++|.+....  .....+.|.+|+.++++++||||+++++++..+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~--------~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   74 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR--------TQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   74 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC--------CCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence            47788899999999999986432        34456665543221  123456799999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++||||+++++|.+++...    .+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          75 TKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             CeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeeccc
Confidence            9999999999999999998632    48999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........  ......++..|+|||.+.+..++.++|||||||++|+|++|..||......   .....    +..+..
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~~~~  218 (277)
T cd06641         148 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFL----IPKNNP  218 (277)
T ss_pred             ceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHH----HhcCCC
Confidence            865543221  122346788999999998888999999999999999999999998643211   11111    111111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                           +    ......+..+.+++.+||+.+|.+||++.++++        ++|+...
T Consensus       219 -----~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--------~~~~~~~  259 (277)
T cd06641         219 -----P----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK--------HKFIVRF  259 (277)
T ss_pred             -----C----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh--------CHHHhhh
Confidence                 1    111223456888999999999999999999998        6676543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-35  Score=291.02  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=196.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        ....+++|.+...... ....+.+.+|+.++++++|+||+++++.+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS--------DSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC--------CCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            58899999999999999987643        2344555554332111 12346788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~kL~DFG  305 (522)
                      ...++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccc
Confidence            99999999999999999997542 2348999999999999999999999   9999999999999999885 57999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      .+.........  .....|++.|+|||++.+..++.++||||||+++++|++|..||......      ........ +.
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~  218 (257)
T cd08225         148 IARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GY  218 (257)
T ss_pred             cchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-cc
Confidence            98765432211  12346889999999998888999999999999999999999998643211      11111111 11


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...         .....+..+.+++.+||..+|.+||++.+|++
T Consensus       219 ~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 FAP---------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111         11123456888999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-35  Score=299.43  Aligned_cols=271  Identities=17%  Similarity=0.205  Sum_probs=192.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        +.+.+++|.+..... .......+.+|+.++++++||||+++++++
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   80 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKK--------TKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEIC   80 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECC--------CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence            45689999999999999999987543        345566665432111 111234567899999999999999999998


Q ss_pred             EeCC--------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          224 IEDN--------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       224 ~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ...+        ..++||||+.+ +|.+++....  ..+++.+++.++.|++.||.|||+   .+++|+||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~  154 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITK  154 (310)
T ss_pred             ecccccccCCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECC
Confidence            8653        45999999964 8988886532  348999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCC--ccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          296 DFQPQLSDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      ++.+||+|||++.........  .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..........
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~  234 (310)
T cd07865         155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT  234 (310)
T ss_pred             CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999765433221  1112345788999999986643 6889999999999999999999986544322111


Q ss_pred             HHHhhhhhhcCCCccc-----ccC----Cc-cccccc-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          373 LVKWAKPILKNGDTET-----LLD----PK-LSNEYD-----NAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~-----~~d----~~-l~~~~~-----~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ................     ..+    +. ......     ......+.+++.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1111110000000000     000    00 000000     001245678999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-35  Score=305.42  Aligned_cols=271  Identities=19%  Similarity=0.217  Sum_probs=201.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+.+...+ ....+++.+|+.++++++||||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV--------TGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC--------CCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            45789999999999999999987543        4556777766432221 22446788999999999999999999998


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ...++||||+.+ +|.+.+...     +++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~  155 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC  155 (353)
T ss_pred             ccCCCccccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCC
Confidence            643      357999999964 898888631     8899999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HH--
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LV--  374 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~--  374 (522)
                      .+||+|||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +.  
T Consensus       156 ~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  232 (353)
T cd07850         156 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ  232 (353)
T ss_pred             CEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999999999976543222   123467889999999999999999999999999999999999996543211000 00  


Q ss_pred             ---------Hh----hhhhhcCC------CcccccC----CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          375 ---------KW----AKPILKNG------DTETLLD----PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       375 ---------~~----~~~~~~~~------~~~~~~d----~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                               ..    ........      .....+.    +..........+..+.+++.+||+.||++|||+.++++  
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~--  310 (353)
T cd07850         233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ--  310 (353)
T ss_pred             cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc--
Confidence                     00    00000000      0000100    11111112234567889999999999999999999997  


Q ss_pred             hccccCCccccc
Q 036172          432 RGATHATDWVDR  443 (522)
Q Consensus       432 ~~~~~~~~~~~~  443 (522)
                            ++|++.
T Consensus       311 ------~~~~~~  316 (353)
T cd07850         311 ------HPYINV  316 (353)
T ss_pred             ------ChhHhh
Confidence                  888764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.3e-35  Score=285.34  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=199.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|.+.++||.|+||.||++....        ....+++|.+.....   ...+.+.+|+.++++++|+||+++++++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   69 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR--------TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKK   69 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC--------CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            47888999999999999987542        334555555543222   3557899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++++||+++++|.+++....  ..+++..+..++.|++.||.|||.   .+++||||+|+||++++++.++|+|||.
T Consensus        70 ~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          70 DELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeeccc
Confidence            99999999999999999997542  358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........   .....++..|+|||.+....++.++||||||+++++|++|+.||......  ..... ..    ....
T Consensus       145 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~----~~~~  214 (253)
T cd05122         145 SAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFK-IA----TNGP  214 (253)
T ss_pred             ccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHH-HH----hcCC
Confidence            976554332   23456889999999998888999999999999999999999998643211  11111 10    0111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .....       .......+.+++.+||+.+|.+|||+.++++
T Consensus       215 ~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 PGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111       1112467889999999999999999999997

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=310.51  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=208.4

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      ..-.+||-|.||.||.+-.+.        ..-.+|+|.||..+-    .+++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus       270 tMkhKLGGGQYGeVYeGvWKk--------yslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKK--------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             eeeeccCCCcccceeeeeeec--------cceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            344789999999999876543        334577888876443    67899999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      +|||+|||..|+|.+||+...+ ..++.-..+.++.||..|+.||..   +++|||||-..|+|+.++..+|++|||+++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999998743 347888889999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       309 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      ++..+... ......-.+.|.|||-+....++.|+|||+|||+|||+.| |..||..-+......               
T Consensus       414 lMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~---------------  477 (1157)
T KOG4278|consen  414 LMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG---------------  477 (1157)
T ss_pred             hhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH---------------
Confidence            87654322 2222344678999999999999999999999999999999 888986543221111               


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                       ++.....-+.+..++..+..|+++||+.+|.+||++.|+-+.|+...
T Consensus       478 -LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  478 -LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence             11222233334456778999999999999999999999999887754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-36  Score=310.82  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=210.3

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...+.|.+.++||.|.|+.|.++.+..        +...+|+|.+.+...+. ...+.+.+|+++|+.|+|||||+++.+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~--------t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v  123 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHIL--------TGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSV  123 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecC--------CCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            346789999999999999999987653        57788888887755444 344559999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      ......+|+||||+.+|.+++++..++.   +.+..+..++.|+++|++|||+   +.|+|||||++||||+.+.++||+
T Consensus       124 ~~t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  124 IETEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             eeecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeee
Confidence            9999999999999999999999997643   6678999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||++.++......   ...+|++.|+|||++.+.++ .+.+|+||+|+++|-|+.|..||+.........-+..     
T Consensus       198 DfgfS~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----  269 (596)
T KOG0586|consen  198 DFGFSTFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----  269 (596)
T ss_pred             ccccceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----
Confidence            99999877644332   35689999999999988876 6899999999999999999999987654433221110     


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                .+  -..+......+.++++++|..+|.+|++++++.+
T Consensus       270 ----------gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 ----------GK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----------ee--ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                      00  1112223457788999999999999999999997

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=311.16  Aligned_cols=246  Identities=23%  Similarity=0.342  Sum_probs=201.9

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      -+||.|+||+||.+++..        +....++|++....+.   ..+-+..|+.+.++|+|+|||+++|.+.+++++-|
T Consensus       581 vVLGKGTYG~VYA~RD~~--------tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kI  649 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMD--------TQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKI  649 (1226)
T ss_pred             EEeecCceeEEEeecccc--------ceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEE
Confidence            359999999999998765        5677888888764443   45678889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCC--ChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc-CCCceEEeecCccc
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVL--PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-SDFQPQLSDFGLAI  308 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~-~~~~~kL~DFGla~  308 (522)
                      .||-++||+|.++|+..  .+++  .+.++-.+..||++||.|||.   +.|||||||-+|+|++ -.|.+||+|||-++
T Consensus       650 FMEqVPGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsK  724 (1226)
T KOG4279|consen  650 FMEQVPGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSK  724 (1226)
T ss_pred             EeecCCCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccch
Confidence            99999999999999875  3345  788899999999999999999   9999999999999996 57899999999997


Q ss_pred             cCCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       309 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      ....-.  ..+..+.||.-|||||++-.++  |..++|||||||++.||.||++||-.-....   ...     ++-|.+
T Consensus       725 RLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAM-----FkVGmy  794 (1226)
T KOG4279|consen  725 RLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAM-----FKVGMY  794 (1226)
T ss_pred             hhccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhh-----hhhcce
Confidence            654332  2334678999999999997664  8999999999999999999999985322111   111     111111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                            +..+..+.+...+...+|.+|+.++|.+||++.++|.
T Consensus       795 ------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 ------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                  1234556778888999999999999999999999997

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=340.25  Aligned_cols=255  Identities=21%  Similarity=0.293  Sum_probs=205.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .-+|+.+.+||.|.||.||-+-+.+        ++...|+|+++-.-.. ....+...+|+.+|..|+|||+|+++|+-.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~--------tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD--------TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCC--------ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceee
Confidence            4489999999999999999877654        6677778887654443 556678899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+..+|.||||++|+|.+++..   ++..++.....+..|++.|+.|||+   .|||||||||.||+|+.+|.+|++||
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecc
Confidence            99999999999999999999984   3347777778889999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCC--ccccccccCCCCCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHG---KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |.|.........  .......||+.|||||++.+.   ....++||||||||++||+||+.||...+..  -.+ .   .
T Consensus      1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aI-M---y 1452 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAI-M---Y 1452 (1509)
T ss_pred             cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHH-H---h
Confidence            999776554211  122357899999999999653   3567899999999999999999999643211  011 1   1


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .+..|.         .+.++...+..=.+++.+||..||.+|.++.|+++
T Consensus      1453 ~V~~gh---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGH---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHhccC---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            111222         22334446677788999999999999999999887

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-35  Score=293.25  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=201.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~  224 (522)
                      ++|++.++||.|+||.||++....        ....+++|.+.+.........+.+.+|+.+++++. ||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   72 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE--------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ   72 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC--------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence            479999999999999999987643        44556666554433222334577899999999998 999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .++..++||||+++++|.+++...+   .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          73 DEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             CCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCC
Confidence            9999999999999999999998543   59999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCC------------------ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          305 GLAIWGPTDSTH------------------MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       305 Gla~~~~~~~~~------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      |++.........                  .......++..|+|||.+....++.++||||||++++++++|+.||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            999765443221                  12223467889999999988889999999999999999999999987543


Q ss_pred             CCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 036172          367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM----GQVLK  429 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~----~eVl~  429 (522)
                      .   ........   . .          ....+...+..+.+++.+||+.+|.+||++    .++++
T Consensus       227 ~---~~~~~~~~---~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 E---YLTFQKIL---K-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H---HHHHHHHH---h-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1   11111111   0 0          011112235678899999999999999999    88886

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-35  Score=343.90  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=206.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .+.....||+|+||.||++....        ....+++|.++....       ....|++++++++|||||+++++|.++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIK--------NGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECC--------CCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            45566789999999999987532        345666666543221       123468899999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++|+|.++++.      ++|..+..++.|++.||+|||..+..+|+||||||+||+++.++.+++. ||.
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            999999999999999999962      8999999999999999999996444899999999999999999888876 665


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      .......      ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..|+.........
T Consensus       829 ~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        829 PGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHL  901 (968)
T ss_pred             ccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccch
Confidence            5332211      12367899999999999999999999999999999999999985332 2334566666655544445


Q ss_pred             ccccCCcccc--cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          387 ETLLDPKLSN--EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       387 ~~~~d~~l~~--~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...+++.+..  ........++.+++.+||+.+|.+||+|.+|++.|+.+..
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5556665533  2344566788899999999999999999999999988753

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=290.90  Aligned_cols=265  Identities=15%  Similarity=0.146  Sum_probs=185.8

Q ss_pred             CCCCceeeecccccccccccccCchhH-------HHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTEL-------FLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~-------~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      ..++|++.+.||+|+||.||++.....       ..+........+..+......    ........+...+..+.|+||
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~----~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNN----IYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHh----hhhHHHHHHHHHhccCCCCCC
Confidence            457899999999999999999874322       011111111111111111000    011234455666778899999


Q ss_pred             ceeeEEEEeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          217 TTLNGVCIEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       217 v~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      +++++++....    ..+++++++.. ++.+.+...   ...++..+..++.|++.||.|||+   .+|+||||||+|||
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil  158 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM  158 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            99999877543    45788898844 787777643   236788899999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL  367 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~  367 (522)
                      ++.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||+++||++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999765332211     111234699999999999999999999999999999999999999975432


Q ss_pred             CCh-hhH--HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          368 KGP-ESL--VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       368 ~~~-~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      ... ...  ..+.... ..+..        .   ....+..+.+++..|+..+|.+||++.+|++.|
T Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        239 NGNLIHAAKCDFIKRL-HEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             chHHHHHhHHHHHHHh-hhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            211 110  0111111 11111        0   011246788999999999999999999999876

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-35  Score=299.30  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=193.8

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      -|....+||.|+||.||++.+..        ..+.+++|.+....   ....+.+.+|+.+++.++||||+++++++..+
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~--------~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   90 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH--------SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG   90 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC--------CCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeC
Confidence            35566689999999999886532        34456666553211   12346788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|..++..    ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~  163 (297)
T cd06659          91 EELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGF  163 (297)
T ss_pred             CeEEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechh
Confidence            999999999999999998853    248999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....|+..|+|||++.+..++.++|||||||+++||++|+.||......   ......    .....
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~  234 (297)
T cd06659         164 CAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRL----RDSPP  234 (297)
T ss_pred             Hhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hccCC
Confidence            8654432211  12356899999999998888999999999999999999999998643211   111111    11110


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...       .........+.+++.+||+.+|.+||++.+|++
T Consensus       235 ~~~-------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         235 PKL-------KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCc-------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000       001123356788999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-35  Score=294.40  Aligned_cols=264  Identities=19%  Similarity=0.176  Sum_probs=191.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ....+++|.+.....  ......+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRI--------NGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcC--------CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            689999999999999999986532        334566665543221  1233467889999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccc
Confidence            999999999996 68877775432  347888899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC-
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN-  383 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-  383 (522)
                      +++........  .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... .+.+... ...+.. 
T Consensus       149 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~-~~~~~~~  224 (291)
T cd07870         149 LARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKI-WTVLGVP  224 (291)
T ss_pred             cccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHH-HHHcCCC
Confidence            98654332211  1233578899999998654 5788999999999999999999999644321 1111110 000000 


Q ss_pred             -----------CC-cccccC---Cccccccc--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 -----------GD-TETLLD---PKLSNEYD--NAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 -----------~~-~~~~~d---~~l~~~~~--~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                 .. ......   +.......  ......+.+++.+|++.||.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                       00 000000   00000000  011356788999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=304.40  Aligned_cols=271  Identities=21%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        +...+++|.+....  ......++.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP--------TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIR   73 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC--------CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence            4689999999999999999987543        34566666654211  1224567889999999999999999999877


Q ss_pred             eC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 ED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ..     ...++|+||+.+ +|.+++..    ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~  145 (336)
T cd07849          74 PPSFESFNDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDL  145 (336)
T ss_pred             cccccccceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCE
Confidence            54     358999999965 88888863    248999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCc-cccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          300 QLSDFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      ||+|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......   .....
T Consensus       146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~  222 (336)
T cd07849         146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLI  222 (336)
T ss_pred             EECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            999999987654322111 1123468899999998755 468999999999999999999999996543211   11111


Q ss_pred             hhhhcCCC---cccc-----------cC--Cccc-ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          378 KPILKNGD---TETL-----------LD--PKLS-NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       378 ~~~~~~~~---~~~~-----------~d--~~l~-~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      ...+....   ...+           ..  +... ..........+.+++.+||+.+|.+||++.++++        ++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~--------hp~  294 (336)
T cd07849         223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA--------HPY  294 (336)
T ss_pred             HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc--------Ccc
Confidence            10000000   0000           00  0000 0001123456889999999999999999999998        888


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      +...
T Consensus       295 ~~~~  298 (336)
T cd07849         295 LEQY  298 (336)
T ss_pred             cccc
Confidence            7754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.7e-35  Score=292.45  Aligned_cols=252  Identities=20%  Similarity=0.239  Sum_probs=190.3

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHH---HHhhCCCCCcceeeEEEEeCCEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVD---ITSSLEQKSITTLNGVCIEDNYL  229 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~---iL~~L~HpnIv~l~~~~~~~~~~  229 (522)
                      .||+|+||.||++.+..        .++.+++|.+.+...........+..|..   +++...||||+++++++..++..
T Consensus         1 ~ig~g~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD--------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   72 (278)
T ss_pred             CcccCCCeEEEEEEEec--------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE
Confidence            38999999999887542        44566666554322222222223444443   44556899999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          230 ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       230 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        73 ~~v~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          73 SFILDLMNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            9999999999999998743   359999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccc
Q 036172          310 GPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTET  388 (522)
Q Consensus       310 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~  388 (522)
                      ......    ....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||...............    ..     
T Consensus       147 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~-----  213 (278)
T cd05606         147 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LT-----  213 (278)
T ss_pred             cCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh----hc-----
Confidence            433221    234689999999998754 5899999999999999999999999754332222111100    00     


Q ss_pred             ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          389 LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       389 ~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..+.    .+...+..+.+++.+||..+|.+||     ++.++++        ++|++..
T Consensus       214 -~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--------~~~~~~~  261 (278)
T cd05606         214 -MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--------HPFFRSL  261 (278)
T ss_pred             -cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh--------CccccCC
Confidence             0111    1112346788899999999999999     9999986        8887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.7e-35  Score=292.73  Aligned_cols=271  Identities=18%  Similarity=0.222  Sum_probs=199.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++..+||.|+||.||++....        ..+.+++|.+...... ....+.+.+|++++++++||||+++++++..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV--------TNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC--------CCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            579999999999999999987532        4556777776543221 2244678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CCceEEeec
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDF  304 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~~~kL~DF  304 (522)
                      +...++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+   .+++|+||+|+||+++. ++.+||+||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEccc
Confidence            999999999996 588888865432 236888899999999999999999   99999999999999985 557999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++.........  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||......  ..+..... ....
T Consensus       148 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~-~~~~  222 (294)
T PLN00009        148 GLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFR-ILGT  222 (294)
T ss_pred             ccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HhCC
Confidence            999755432211  1223578899999998664 5789999999999999999999999654321  11111100 0000


Q ss_pred             CC---------ccc------ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GD---------TET------LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~---------~~~------~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..         ...      ...+..........+..+.+++.+||+.+|.+||++.++++        ++|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--------~~~~~~  289 (294)
T PLN00009        223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--------HEYFKD  289 (294)
T ss_pred             CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--------CchHhH
Confidence            00         000      00000000011123456888999999999999999999997        788764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-35  Score=304.18  Aligned_cols=278  Identities=20%  Similarity=0.247  Sum_probs=203.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||.|+||.||++....        ....+++|.+..... .....+.+.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   74 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR--------SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILR   74 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC--------CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence            3689999999999999999987543        455677776654322 1234567889999999999999999999886


Q ss_pred             e----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          225 E----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       225 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      .    ...+++||||+. |+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          75 PPGADFKDVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             ccCCCCceEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEE
Confidence            3    357899999995 5999998743   348999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCC--ccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          301 LSDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       301 L~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      |+|||++.........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~  227 (334)
T cd07855         148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV  227 (334)
T ss_pred             ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH
Confidence            9999999655432221  11123468899999999865 45889999999999999999999999654322111100000


Q ss_pred             hh--------hhcCCCccccc---C---CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          378 KP--------ILKNGDTETLL---D---PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       378 ~~--------~~~~~~~~~~~---d---~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..        ...........   .   +..........+..+.+++.+||+.+|.+||++.+++.        ++|+..
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--------~~~~~~  299 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--------HPFLAQ  299 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--------Chhhhh
Confidence            00        00000000000   0   00001111224577899999999999999999999998        899875


Q ss_pred             ccc
Q 036172          444 HAD  446 (522)
Q Consensus       444 ~~~  446 (522)
                      ...
T Consensus       300 ~~~  302 (334)
T cd07855         300 YHD  302 (334)
T ss_pred             ccC
Confidence            543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-35  Score=290.16  Aligned_cols=255  Identities=26%  Similarity=0.345  Sum_probs=197.0

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||.|+||.||++....        ..+.+++|.+...........+.+.+|++++++++||||+++++.+..+...++||
T Consensus         1 lg~g~~~~vy~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   72 (265)
T cd05579           1 ISKGAYGRVFLAKKKS--------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVM   72 (265)
T ss_pred             CCCCCceEEEEEEECC--------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEE
Confidence            6899999999987542        34566666665443333446678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++++|.+++...+   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        73 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          73 EYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999999998543   58999999999999999999999   99999999999999999999999999998654333


Q ss_pred             CC------CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          314 ST------HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       314 ~~------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      ..      ........++..|+|||.+.....+.++||||||+++++|++|..||......   ......    ..+...
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~  219 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNI----LNGKIE  219 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hcCCcC
Confidence            21      11222346788999999998888999999999999999999999998644321   111111    111110


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .      ...  ...+..+.+++.+||+.+|.+||++..+.+.|+     ++|+.
T Consensus       220 ~------~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~-----~~~~~  261 (265)
T cd05579         220 W------PED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN-----HPFFK  261 (265)
T ss_pred             C------Ccc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc-----Ccccc
Confidence            0      000  012567889999999999999999944444332     77765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=289.46  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=189.5

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHH-hhCCCCCcceeeEEEEeCCEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDIT-SSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL-~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      +.||.|+||.||++....        ..+.+++|.+.+...........+..|..++ ..++|+||+++++++..++.++
T Consensus         2 ~~l~~g~~~~v~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   73 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS--------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY   73 (260)
T ss_pred             ccCCcCCCeeEEEEEecC--------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEE
Confidence            469999999999987543        3345666655432221122334455665554 4459999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        74 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          74 LVMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            999999999999999753   348999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCccccc
Q 036172          311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLL  390 (522)
Q Consensus       311 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~  390 (522)
                      ..      .....++..|+|||.+.+..++.++||||||+++|+|++|..||......   .....    ...+...   
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~---  211 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDN----ILSRRIN---  211 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHhcccC---
Confidence            33      12346888999999998888899999999999999999999999643321   11111    0111100   


Q ss_pred             CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          391 DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       391 d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                         .........+..+.+++.+||+.+|.+||++.++.+.|     .|+|+..
T Consensus       212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l-----~~~~~~~  256 (260)
T cd05611         212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK-----SHPFFKS  256 (260)
T ss_pred             ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH-----cChHhhc
Confidence               00111112456788999999999999999775444433     2677653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-35  Score=298.15  Aligned_cols=275  Identities=21%  Similarity=0.231  Sum_probs=198.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||.|+||.||++....        ++..+++|.++.... .......+.+|+.++++++|+||+++++++.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT--------SGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVV   76 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC--------CCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence            4689999999999999999987542        345566665432211 1112235678999999999999999999997


Q ss_pred             eC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          225 ED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      ..  +.+++||||+.+ +|.+++....  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          77 GKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             cCCCCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEC
Confidence            65  578999999965 8999887542  358999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh---
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK---  378 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~---  378 (522)
                      |||++..........  ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||................   
T Consensus       151 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         151 DFGLARTYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             ccceeeecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999997654432111  12245788999999865 457899999999999999999999997543221111111000   


Q ss_pred             -----hhhcCCCc-ccc-cCCcccccc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 -----PILKNGDT-ETL-LDPKLSNEY---DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 -----~~~~~~~~-~~~-~d~~l~~~~---~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                           +....... ... +........   .......+.+++.+||+.||++|||+.+++.        |+|++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--------h~~f~~~  296 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--------SSYFKEK  296 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--------ChhhccC
Confidence                 00000000 000 000000000   0112456788999999999999999999997        8998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-35  Score=302.43  Aligned_cols=272  Identities=18%  Similarity=0.248  Sum_probs=200.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++.+..        ..+.+++|.++.... ......++.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE--------TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC--------CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            4689999999999999999987543        455666666553221 2223456788999999999999999999887


Q ss_pred             eC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 ED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ..     ...++||||+. ++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~  147 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDL  147 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCE
Confidence            54     35899999995 6999988743   359999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      ||+|||++.........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||................
T Consensus       148 kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         148 KICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             EECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999999765443211  123457889999999865 468999999999999999999999996543211111000000


Q ss_pred             -h-------hhcCCC-------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          379 -P-------ILKNGD-------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       379 -~-------~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .       ......       .....++... ......+..+.+++.+||+.+|.+||++.++++        |+|+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~--------h~~~~~  296 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALA--------HPYLAS  296 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHc--------Ccchhh
Confidence             0       000000       0000000000 011124567889999999999999999999998        888764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=293.00  Aligned_cols=263  Identities=20%  Similarity=0.250  Sum_probs=195.2

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC-
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED-  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~-  226 (522)
                      |++.++||.|+||.||++....        ....+++|.+.... ......+.+.+|+.++++++|+||+++++++... 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~--------~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK--------TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC--------CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6788999999999999987543        24456666655432 1122346788999999999999999999999988 


Q ss_pred             -CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          227 -NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       227 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                       +..++||||+++ +|.+++....  ..+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          72 KGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             CCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEcccc
Confidence             899999999975 9999887542  358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC-
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN-  383 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-  383 (522)
                      ++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........  +.. ....... 
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~-~~~~~~~~  221 (287)
T cd07840         146 LARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEK-IFELCGSP  221 (287)
T ss_pred             ceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCC
Confidence            99765443321 1123356788999998764 4578999999999999999999999865442111  111 1000000 


Q ss_pred             --CC--------------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 --GD--------------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 --~~--------------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        ..              ........+...+....+..+.+++.+||+.+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              00              00000000011111112567899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.8e-35  Score=285.50  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.+.||.|+||.||++....        +...|++|.+..... .....+.+.+|++++++++|||++++++.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS--------DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC--------CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58899999999999999988643        345666666543211 123566789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...++|+||+++++|.+++.... ....+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCcc
Confidence            99999999999999999998642 13469999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.......  .......|++.|+|||.+.+..++.++||||||+++++|++|..||.....   ..+...   .. ...
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~---~~-~~~  219 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALK---IL-KGQ  219 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHHH---Hh-cCC
Confidence            997654433  122334688999999999888899999999999999999999999865431   111111   11 111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ...         .+......+.+++.+||..+|.+||++.++++
T Consensus       220 ~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111         11123457888999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.2e-35  Score=286.94  Aligned_cols=251  Identities=21%  Similarity=0.347  Sum_probs=200.6

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++....        ....+++|.+...... .....++.+|++++++++|+||+++++++...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS--------DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC--------CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            58899999999999999986532        3445566555432221 23456788999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeecc
Confidence            9999999999999999998763 123458999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++.......    .....++..|+|||.+.+..++.++|+||||+++++|++|+.||......   .+...    ...+.
T Consensus       149 ~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~----~~~~~  217 (256)
T cd08530         149 ISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYK----VQRGK  217 (256)
T ss_pred             chhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhcCC
Confidence            997665441    12345788999999999888999999999999999999999999654321   11111    11111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..         .........+.+++.+||+.+|.+||++.++++
T Consensus       218 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11         112234567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=289.01  Aligned_cols=254  Identities=20%  Similarity=0.278  Sum_probs=196.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHH--hhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQA--TSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~--t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .+|++.+.||+|+||.||++.+..        +.+.+++|.+...  ..........|.+|+.++++++|+||+++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~   73 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD--------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCL   73 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC--------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            579999999999999999987542        3455666654211  112233567899999999999999999999998


Q ss_pred             EeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .+.  +.+++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|
T Consensus        74 ~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          74 RDPEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             EcCCCCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEE
Confidence            764  5689999999999999999743   248899999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCC-CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||+++....... ........++..|+|||++.+..++.++|||||||++++|++|+.||....  ........    
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~----  221 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKI----  221 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHH----
Confidence            99999975432111 111123468899999999988889999999999999999999999986432  11111111    


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ....         .....+......+.+++.+||+ +|..||++.+++.
T Consensus       222 ~~~~---------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQP---------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCC---------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1110         0112233355678899999999 5799999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.3e-35  Score=292.59  Aligned_cols=259  Identities=22%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..+.|++...||.|+||.||++....        ....+++|.++....    ..+.+.+|++++++++|+||+++++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~   84 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA--------TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSY   84 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc--------CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence            34678999999999999999987542        344556655543211    456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+...++|+||+++++|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d  159 (286)
T cd06614          85 LVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLAD  159 (286)
T ss_pred             EECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECc
Confidence            99999999999999999999998643  259999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++........  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......  .......     .
T Consensus       160 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~-----~  230 (286)
T cd06614         160 FGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLIT-----T  230 (286)
T ss_pred             cchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-----h
Confidence            999854433221  112345788999999998888999999999999999999999998643211  1111111     1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .......       .....+..+.+++.+||+.+|.+||++.+|++        ++|+..
T Consensus       231 ~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--------~~~~~~  275 (286)
T cd06614         231 KGIPPLK-------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--------HPFLKK  275 (286)
T ss_pred             cCCCCCc-------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh--------ChHhhc
Confidence            1111110       01113457888999999999999999999997        666554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=280.34  Aligned_cols=260  Identities=20%  Similarity=0.261  Sum_probs=206.6

Q ss_pred             CCCceee-ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          145 ENPFQMD-IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~-~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..+|.+. ++||.|--|.|..+.++.        ++..||+|.|..        .+..++|+++.-.. .|||||.++++
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~--------T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidV  123 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKR--------TQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDV  123 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEecc--------chhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehh
Confidence            4567664 689999999988877643        778999999874        34567899986666 89999999999


Q ss_pred             EEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---
Q 036172          223 CIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---  295 (522)
Q Consensus       223 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---  295 (522)
                      +..    ...+.+|||+++||.|...++.++. ..+++.++-.|+.||+.|+.|||+   .+|.||||||+|+|...   
T Consensus       124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~  199 (400)
T KOG0604|consen  124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSP  199 (400)
T ss_pred             hhhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCC
Confidence            874    3678999999999999999998754 359999999999999999999999   99999999999999964   


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      +..+||+|||+|+.......   ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......   +..
T Consensus       200 na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---isp  273 (400)
T KOG0604|consen  200 NAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISP  273 (400)
T ss_pred             CcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CCh
Confidence            45799999999976543222   234578999999999999999999999999999999999999996543211   111


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      -.+..+..|.+..      ...--...++...++|+.+|..+|.+|.|+.++++        |+|+...
T Consensus       274 gMk~rI~~gqy~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--------hpwi~~~  328 (400)
T KOG0604|consen  274 GMKRRIRTGQYEF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--------HPWINQY  328 (400)
T ss_pred             hHHhHhhccCccC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--------Cchhccc
Confidence            1222223222211      12222356778889999999999999999999997        9997754

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=282.91  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=198.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++....        ..+.+++|.+...... ....+.+.+|++++++++|+|++++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE--------TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC--------CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            58899999999999999986532        2344555554432211 23557899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEecccc
Confidence            9999999999999999999754   358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....++..|+|||.+.+..++.++||||||+++++|++|..||....  ........    . ....
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~----~-~~~~  216 (254)
T cd06627         146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRI----V-QDDH  216 (254)
T ss_pred             ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH----h-ccCC
Confidence            9766543322  123468899999999988778999999999999999999999986432  11111110    0 0111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .         ..+...+..+.+++.+||..+|++||++.+++.
T Consensus       217 ~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 P---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             C---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1         111223467888999999999999999999996

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-34  Score=291.59  Aligned_cols=256  Identities=22%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|...++||.|+||.||++....        ..+.+++|.+..   ......+.+.+|+.++++++||||+++++++..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~   88 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS--------TGRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG   88 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC--------CCCEEEEEEEec---cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC
Confidence            45556789999999999886532        234455554321   1112345688999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++|+||+++++|.+++..    ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||+
T Consensus        89 ~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648          89 DELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             CeEEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEccccc
Confidence            999999999999999999975    248999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....|++.|+|||.+.+..++.++||||||+++++|++|+.||......   ......    .....
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~----~~~~~  232 (285)
T cd06648         162 CAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRI----RDNLP  232 (285)
T ss_pred             chhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHH----HhcCC
Confidence            8654432211  12346889999999998888999999999999999999999998643221   111111    11111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...     .  .....+..+.+++.+||+.+|.+||++.++++        ++|++..
T Consensus       233 ~~~-----~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--------~~~~~~~  275 (285)
T cd06648         233 PKL-----K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--------HPFLAKA  275 (285)
T ss_pred             CCC-----c--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc--------CcccccC
Confidence            010     0  01113457899999999999999999999997        7887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=290.54  Aligned_cols=261  Identities=22%  Similarity=0.202  Sum_probs=197.0

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++.+.||.|+||.||++....        ....+++|.++..... ......+.+|+.++++++|+||+++++++..+.
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL--------TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC--------CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            6678889999999999987532        3445566655433222 123567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            99999999975 8988887542  358999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC--
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG--  384 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--  384 (522)
                      ........  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+....  +.... ..+...  
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~-~~~~~~~~  220 (283)
T cd05118         146 RSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIF-RTLGTPDP  220 (283)
T ss_pred             EecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHcCCCch
Confidence            76654431  11224578899999998776 789999999999999999999999865432111  11100 000000  


Q ss_pred             ---------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 ---------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                     ......... ........+..+.+++.+||+.+|.+||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         221 EVWPKFTSLARNYKFSFPKKAGMP-LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HhcccchhhhhhhhhhhccccccC-HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                           000000000 01122335678999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-34  Score=289.52  Aligned_cols=265  Identities=23%  Similarity=0.283  Sum_probs=201.3

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      .|++.+.||.|+||.||++.....     ...++.+++|.++.... ......+.+.+|+.++.++ +|+||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG-----HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC-----CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence            488999999999999999864321     12456677776654332 1222456788999999999 6999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeC
Confidence            999999999999999999999753   348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||........  ..........
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~  226 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK  226 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc
Confidence            999765432211 11234688999999998653  467899999999999999999999864332211  1111111111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..           ..++......+.+++.+||+.+|.+||     ++.+++.        ++|+...
T Consensus       227 ~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~--------~~~~~~~  274 (290)
T cd05613         227 SE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK--------HPFFQKI  274 (290)
T ss_pred             cC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc--------CcccccC
Confidence            10           011122345778899999999999997     7788876        7776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-34  Score=297.41  Aligned_cols=269  Identities=21%  Similarity=0.258  Sum_probs=194.6

Q ss_pred             ccccc--ccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEE
Q 036172          153 PCSEG--KYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI  230 (522)
Q Consensus       153 ~lG~G--~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~  230 (522)
                      .||.|  +||+||++.+..        .++.+++|.+..... .....+.|.+|+.+++.++||||++++++|..++..+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~   75 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTP--------TGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW   75 (328)
T ss_pred             HhCCcccCceeEEEEEEcC--------CCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceE
Confidence            45555  889999987643        455666665543221 2234578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       231 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      +||||+.+++|.+++..... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++||+.+...
T Consensus        76 ~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          76 VISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             EEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999999999999986532 248999999999999999999999   99999999999999999999999999865322


Q ss_pred             CCCCCCc-----cccccccCCCCCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh-h--
Q 036172          311 PTDSTHM-----IREDVVGTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP-I--  380 (522)
Q Consensus       311 ~~~~~~~-----~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~-~--  380 (522)
                      .......     ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||......  ......... .  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~  229 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYS  229 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCC
Confidence            1111000     01112356679999998763  4789999999999999999999999643211  111110000 0  


Q ss_pred             --------------------h---------cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          381 --------------------L---------KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       381 --------------------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                                          .         ..+.........+...........+.+++.+||+.||.+|||+.++++  
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~--  307 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS--  307 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh--
Confidence                                0         000000111111122223345678899999999999999999999998  


Q ss_pred             hccccCCcccccc
Q 036172          432 RGATHATDWVDRH  444 (522)
Q Consensus       432 ~~~~~~~~~~~~~  444 (522)
                            ++|++..
T Consensus       308 ------~~~~~~~  314 (328)
T cd08226         308 ------HAFFKQV  314 (328)
T ss_pred             ------CHHHHHH
Confidence                  8887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-35  Score=291.31  Aligned_cols=263  Identities=20%  Similarity=0.203  Sum_probs=193.6

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++.++||.|+||.||++....        .+..+++|.+..... .....+.+.+|++++++++||||+++++++.+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~--------~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL--------TGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC--------CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6788899999999999987543        345566665543211 1123356889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          72 KLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             eEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            9999999995 699999875432 358999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC--
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG--  384 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--  384 (522)
                      .........  .....++..|+|||++.+. .++.++||||||+++|+|++|..||......  ..+...........  
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  222 (283)
T cd07835         147 RAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDED  222 (283)
T ss_pred             cccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChH
Confidence            654332211  1123568899999988654 4789999999999999999999998644321  11111110000000  


Q ss_pred             -------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 -------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                                   .......+. ........+..+.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         223 VWPGVTSLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             Hhhhhhhchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                         000000000 01111223467889999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=310.98  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=209.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +...++.++||+|.||.|+++....     ...+.-.+|+|.|+...-+  ....+|++|+.+|.+|+|+|+++|||+..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~-----psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQ-----PSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccC-----CCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            4567778999999999999998664     2334456777777653333  26789999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + ..+.+|||+++.|+|.+.|++ ..+..|.......++.||+.|+.||.+   +++|||||-..|+||...-.+||+||
T Consensus       182 ~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  182 D-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             c-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecc
Confidence            8 778999999999999999997 345568899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+.+.++...... ......-.+.|+|||.+...+++.++|||+|||+||||+| |..||......   .+         
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qI---------  324 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QI---------  324 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HH---------
Confidence            9998776655443 2233445778999999999999999999999999999999 89999654311   11         


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                          ...+|..-...-+..+++.+.+++..||..+|.+||++..|.+
T Consensus       325 ----L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  325 ----LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ----HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                1112222222234457889999999999999999999999974

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.5e-35  Score=296.46  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=194.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|...++||.|+||.||++....        ....+++|.+........+..+++.+|+.++++++|||++++++++.
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~--------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVR--------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL   95 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcC--------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3458889999999999999987533        34556666554322223345578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++...++||||+++ +|.+++...  ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+||
T Consensus        96 ~~~~~~lv~e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~df  169 (317)
T cd06635          96 REHTAWLVMEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADF  169 (317)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecC
Confidence            99999999999975 888887643  2348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |++......      ....|++.|+|||++.   .+.++.++|||||||++|+|++|..||......  .....+.    
T Consensus       170 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~----  237 (317)
T cd06635         170 GSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA----  237 (317)
T ss_pred             CCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHH----
Confidence            998654332      1346888999999974   456889999999999999999999998543211  1111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..+ ...        ......+..+.+++.+||+.+|.+||++.+|++
T Consensus       238 ~~~-~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  276 (317)
T cd06635         238 QNE-SPT--------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK  276 (317)
T ss_pred             hcc-CCC--------CCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence            111 000        001123456888999999999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=287.35  Aligned_cols=263  Identities=22%  Similarity=0.257  Sum_probs=195.3

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceeeEEEE
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLNGVCI  224 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~~~~~  224 (522)
                      |++.+.||.|+||.||++....        ....+++|.++.... .......+.+|+.+++++   +||||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~--------~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN--------TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC--------CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6788999999999999988643        345667776654332 122234577788887766   6999999999999


Q ss_pred             eCCE-----EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 EDNY-----LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ....     .+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+
T Consensus        72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~  146 (287)
T cd07838          72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQV  146 (287)
T ss_pred             eccCCCCceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCE
Confidence            8776     9999999975 89998875432 358999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      +|+|||++.........   ....++..|+|||++.+..++.++|||||||++|+|++|+.||......  +.+......
T Consensus       147 ~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~  221 (287)
T cd07838         147 KIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDV  221 (287)
T ss_pred             EEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHH
Confidence            99999999765443221   1235788999999999888999999999999999999999998654321  111111111


Q ss_pred             hhcCCCc---------ccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          380 ILKNGDT---------ETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       380 ~~~~~~~---------~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .......         ........   ...........+.+++.+||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000000         00000000   11112234567889999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-34  Score=287.38  Aligned_cols=248  Identities=19%  Similarity=0.240  Sum_probs=187.6

Q ss_pred             CCceeeecc--cccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          146 NPFQMDIPC--SEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       146 ~~y~~~~~l--G~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      +.|.+.+.+  |.|+||.||++....        ..+.+++|.+......      .  .|+.+...+ +||||++++++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKP--------TQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcC--------CCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEE
Confidence            355665555  999999999987543        3444555544332111      0  122222222 79999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceEE
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQL  301 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~kL  301 (522)
                      +..++..++||||+++++|.+++....   .+++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999997542   59999999999999999999999   9999999999999999998 9999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.......      ...++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+.... 
T Consensus       152 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-  223 (267)
T PHA03390        152 CDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-  223 (267)
T ss_pred             ecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-
Confidence            9999986554322      23588999999999888899999999999999999999999974432221 111111111 


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhccccCCcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-MGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-~~eVl~~L~~~~~~~~~~~  442 (522)
                       .. .         .......+..+.+++.+||+.+|.+||+ ++++++        |+|+.
T Consensus       224 -~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~--------h~~~~  266 (267)
T PHA03390        224 -QK-K---------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK--------HPFLK  266 (267)
T ss_pred             -cc-c---------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc--------CCccc
Confidence             00 0         0111134567889999999999999996 699997        88864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-34  Score=285.99  Aligned_cols=253  Identities=19%  Similarity=0.319  Sum_probs=192.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--ccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--QFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +|.+.++||.|+||.||++.....        ...+.++.++....  .......++.+|+.++++++||||+++++++.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA--------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL   72 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC--------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh
Confidence            689999999999999999865431        11121222221111  01113345778999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +....++||||+++++|.+++... .....+++..++.++.|++.||.|||+   .+++|+||+|+||+++. +.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecc
Confidence            999999999999999999998753 223459999999999999999999999   99999999999999975 5699999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ........ .
T Consensus       149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~  219 (260)
T cd08222         149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-E  219 (260)
T ss_pred             cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-c
Confidence            999866543222  12234678899999999888889999999999999999999999853321      11111111 1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +..         ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus       220 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 GPT---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCC---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111         1112344567889999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-35  Score=298.96  Aligned_cols=275  Identities=20%  Similarity=0.247  Sum_probs=204.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      +|++.++||.|+||.||++....        ....+++|.+..... .....+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR--------TGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC--------CCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            68999999999999999987543        355667666654321 123457899999999999999999999999877


Q ss_pred             C-----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          227 N-----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       227 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .     .+++||||++ ++|.+++...   ..+++..++.++.|++.||.|||+   .+++||||||+|||++.++.++|
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence            5     7899999997 4899988743   259999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCC-ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          302 SDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       302 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      +|||++......... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.....
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  224 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG  224 (330)
T ss_pred             cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence            999999765543210 112234678899999999877 789999999999999999999999975542211110000000


Q ss_pred             h--------hcCCCcccccC---Ccc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          380 I--------LKNGDTETLLD---PKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       380 ~--------~~~~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      .        .........+.   ...   ........+..+.+++.+||+.+|.+||++.+++.        ++|+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--------~~~~~~~~  296 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA--------HPYLAQLH  296 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh--------CccHHhhc
Confidence            0        00000000000   000   00011123567889999999999999999999997        88987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.2e-34  Score=288.85  Aligned_cols=262  Identities=23%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      .|++.+.||.|+||.||++.....     ......+++|.+++... ......+.+.+|+.++.++ +||||+++++.+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~-----~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG-----HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc-----ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence            478999999999999999764321     12344566665543322 1222456789999999999 6999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEEC
Confidence            999999999999999999998743   348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |++......... ......|+..|+|||.+.+..  .+.++||||||+++++|++|..||.........  .........
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~  226 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK  226 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc
Confidence            998765433211 112346889999999987665  788999999999999999999998643322111  111111111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .       .+.    .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       227 ~-------~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 S-------KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             c-------CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            1       011    111233567889999999999999998888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-35  Score=302.40  Aligned_cols=258  Identities=24%  Similarity=0.330  Sum_probs=205.3

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      ...+.||+|-||.||.+.-..-    .+...-.+|+|.-|+  +...+..+.|+.|..+|++++|||||+++|+|.+. .
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~----~kge~iaVAvKtCK~--d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDP----EKGERIAVAVKTCKT--DCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             cHHHhhcCCcccceeeeEeccc----ccCcceeeeeehhcc--CCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            3457899999999999753210    012223456666554  12233578899999999999999999999999874 6


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      .+||||+++-|.|..+|+.+.  ..++......++.||+.||+|||+   ..+|||||...|||+.....+||+|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence            799999999999999999753  359999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       309 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      +.......... ...-...|||||-+.-..++.++|||-|||.+||++. |..||..-...+..       ..+.+|.  
T Consensus       540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe--  609 (974)
T KOG4257|consen  540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE--  609 (974)
T ss_pred             hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC--
Confidence            88776544433 3345778999999999999999999999999999987 99999653322211       1122222  


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                             +...++.++..+..++.+||.++|.+||.+.+|...|..+.
T Consensus       610 -------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  610 -------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                   23334556778889999999999999999999998877654

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=304.19  Aligned_cols=271  Identities=21%  Similarity=0.278  Sum_probs=205.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|.....||.|+||.||++.+.+        +++.+|+|...+..  +....+...+|+++|++|+|+|||+++++-.
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnke--------tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee   81 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKE--------TGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEE   81 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccc--------cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCC
Confidence            4678889999999999999998765        67888888877644  3346788999999999999999999999876


Q ss_pred             eCC------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC--
Q 036172          225 EDN------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD--  296 (522)
Q Consensus       225 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~--  296 (522)
                      +..      ...+|||||.||||...|++-.....|++.+.+.++..++.||.|||+   ++|+||||||.||++...  
T Consensus        82 ~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Ged  158 (732)
T KOG4250|consen   82 TKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGED  158 (732)
T ss_pred             ccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCC
Confidence            543      568999999999999999987666679999999999999999999999   999999999999998432  


Q ss_pred             C--ceEEeecCccccCCCCCCCccccccccCCCCCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          297 F--QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       297 ~--~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      |  ..||+|||.|+-...+.   ....+.||..|++||.+. .+.|+..+|.|||||++|+++||..||..........-
T Consensus       159 gq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~  235 (732)
T KOG4250|consen  159 GQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE  235 (732)
T ss_pred             CceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch
Confidence            3  58999999998877765   334679999999999998 48899999999999999999999999964332211000


Q ss_pred             HHhh-hhh-----------hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHH
Q 036172          374 VKWA-KPI-----------LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP--NMGQVLKLL  431 (522)
Q Consensus       374 ~~~~-~~~-----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP--s~~eVl~~L  431 (522)
                      +.|. ...           ..+|.+..-..-............++-..+..+|..+|++|-  ...+....+
T Consensus       236 ~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~  307 (732)
T KOG4250|consen  236 IMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV  307 (732)
T ss_pred             hhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence            1111 000           011111100000012223344456677788889999999998  544444433

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.2e-34  Score=292.15  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=196.8

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|...++||.|+||.||++....        ....+++|.+...........+.+.+|+.++++++|||++++++++.+.
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~--------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSH--------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECC--------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            46777889999999999987532        3445555555433333334557789999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCC
Confidence            99999999996 58888876432  358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      +......      ....|+..|+|||++.   .+.++.++|||||||++|+|++|..||.......   .....   .. 
T Consensus       168 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~---~~-  234 (313)
T cd06633         168 ASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI---AQ-  234 (313)
T ss_pred             CcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH---Hh-
Confidence            8543221      2346889999999984   4568899999999999999999999985432111   11110   00 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .......        ....+..+.+++.+||+.+|.+||++.+++.        ++|++..
T Consensus       235 ~~~~~~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~--------~~~~~~~  279 (313)
T cd06633         235 NDSPTLQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLR--------HDFVRRD  279 (313)
T ss_pred             cCCCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc--------CcccCCC
Confidence            1111111        1112346888999999999999999999997        8887754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.1e-35  Score=299.80  Aligned_cols=276  Identities=22%  Similarity=0.242  Sum_probs=199.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||.|+||.||++....        ....+++|.+.+... .......+.+|+.+++++ +||||++++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~   75 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR--------TKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNV   75 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC--------CCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence            45789999999999999999986532        344556665533211 122345688899999999 99999999999


Q ss_pred             EEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          223 CIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       223 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      |...  ...++||||++ ++|..++...    .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          76 IKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             eccCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEE
Confidence            8753  47899999997 5999988742    58899999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCC---ccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          301 LSDFGLAIWGPTDSTH---MIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       301 L~DFGla~~~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      |+|||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............
T Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~  227 (337)
T cd07852         148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE  227 (337)
T ss_pred             EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999765443221   12224568999999998755 4578999999999999999999999864332111000000


Q ss_pred             hhh--------hhcCCCcccccC----C--cccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          377 AKP--------ILKNGDTETLLD----P--KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       377 ~~~--------~~~~~~~~~~~d----~--~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      ...        .+.......+++    .  ..........+..+.+++.+||+.+|.+|||+.++++        ++|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~--------~~~~~  299 (337)
T cd07852         228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE--------HPYVA  299 (337)
T ss_pred             HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh--------Chhhh
Confidence            000        000000000000    0  0000111113567889999999999999999999998        77776


Q ss_pred             cc
Q 036172          443 RH  444 (522)
Q Consensus       443 ~~  444 (522)
                      ..
T Consensus       300 ~~  301 (337)
T cd07852         300 QF  301 (337)
T ss_pred             hh
Confidence            53

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=290.68  Aligned_cols=253  Identities=23%  Similarity=0.262  Sum_probs=210.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...+.|++-+.||.||||.|+-++...        +++.+|.|.|.+....-..+..-.++|-.||.+++.+.||.+--.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvra--------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRA--------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEec--------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            345788899999999999999988654        677788888776666555566778899999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      |...+.++||+..|.||+|.-+|...+. ..|++..++-++.+|+.||.+||+   .+||.||+||+|||||+.|+++|+
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEee
Confidence            9999999999999999999999987764 459999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+|+|.-++......   ..+||.+|||||++.++.|+...|-|||||+||||+.|+.||.....+....-+.   ....
T Consensus       330 DLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~  403 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTL  403 (591)
T ss_pred             ccceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHh
Confidence            999998777655443   3389999999999999999999999999999999999999997544332221111   1111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN  423 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs  423 (522)
                      .          -..+++...+++...+....|++||.+|.-
T Consensus       404 ~----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 E----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             c----------chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            0          023344555677888888999999999973

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-34  Score=290.21  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=197.2

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |....+||+|+||.||++....        ....+++|.+..   ........+.+|+.++++++|+||+++++++..++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~--------~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   90 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKS--------SGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD   90 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcC--------CCeEEEEEEecc---cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC
Confidence            4445789999999999876532        344555554421   11224567999999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||+++++|.+++...    .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~  163 (292)
T cd06657          91 ELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFC  163 (292)
T ss_pred             EEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999999988532    38999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcc
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTE  387 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~  387 (522)
                      .........  .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......   ...........     
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~-----  233 (292)
T cd06657         164 AQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP-----  233 (292)
T ss_pred             eeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC-----
Confidence            655432211  12346889999999998888999999999999999999999998643211   11111111000     


Q ss_pred             cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          388 TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       388 ~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                          +.+..  ....+..+.+++.+||+.+|.+||++.+|+.        ++|+...
T Consensus       234 ----~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--------~~~~~~~  276 (292)
T cd06657         234 ----PKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK--------HPFLAKA  276 (292)
T ss_pred             ----cccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc--------ChHHhcc
Confidence                00000  0113446778999999999999999999997        8887754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-34  Score=293.43  Aligned_cols=269  Identities=18%  Similarity=0.196  Sum_probs=191.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        ....+++|.+...... ......+.+|++++++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK--------TGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC--------CCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            4789999999999999999987543        3344555554332211 112345778999999999999999999886


Q ss_pred             eC--------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          225 ED--------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       225 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      +.        ..+++||||+.+ +|...+...  ...+++..+..++.|+++||.|||+   .+++|+||||+||+++.+
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~  151 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQ  151 (311)
T ss_pred             cccccccccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence            43        357999999965 788877653  2359999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCcc---------ccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMI---------REDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~---------~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      +.++|+|||++...........         .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus       152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999975443221111         1234568889999988654 57899999999999999999999986543


Q ss_pred             CCChhhHHHhhhh--------hh---cCC---CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          367 LKGPESLVKWAKP--------IL---KNG---DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       367 ~~~~~~l~~~~~~--------~~---~~~---~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .............        ..   ...   .......+.+... .......+.+++.+||+.+|.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            3211111100000        00   000   0000000111000 0112356889999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-34  Score=291.45  Aligned_cols=265  Identities=21%  Similarity=0.268  Sum_probs=193.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        .+..+++|.++.... .......+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKD--------TGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECC--------CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            4689999999999999999987643        334555555543211 1123356788999999999999999999988


Q ss_pred             eCC----------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          225 EDN----------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       225 ~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      +..          .+++|+||+++ +|..++...  ...+++..++.++.|++.||+|||+   .+|+|+||||+||+++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~  150 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLN  150 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence            654          79999999976 787777653  2358999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +++.+||+|||++.......... .....++..|+|||.+.+. .++.++|||||||++++|++|+.||......  ..+
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~  227 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQL  227 (302)
T ss_pred             CCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHH
Confidence            99999999999997654433211 1123467889999988653 4789999999999999999999999643321  111


Q ss_pred             HHhhhhhhcCC---Ccccc--------cCC------cccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          374 VKWAKPILKNG---DTETL--------LDP------KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       374 ~~~~~~~~~~~---~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .... ......   ....+        .++      ...... ...+..+.+++.+||+.+|.+||++.+|+.
T Consensus       228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         228 ELIS-RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHH-HHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111 100000   00000        000      000000 113467889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=295.13  Aligned_cols=273  Identities=21%  Similarity=0.217  Sum_probs=197.5

Q ss_pred             CCCcee-eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc-----------chHHHHHHHHHHHHhhCC
Q 036172          145 ENPFQM-DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF-----------SSAWNDFSSEVDITSSLE  212 (522)
Q Consensus       145 ~~~y~~-~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~-----------~~~~~~f~~Ev~iL~~L~  212 (522)
                      .++|.. .+.||.|+||.||++.+..        ..+.+++|.++......           ......+.+|++++++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   78 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTL--------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK   78 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECC--------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence            467764 5779999999999987542        33445555443321110           001235789999999999


Q ss_pred             CCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          213 QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       213 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      |+||+++++++..++..++||||+. |+|.+++...   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+
T Consensus        79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nil  151 (335)
T PTZ00024         79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIF  151 (335)
T ss_pred             CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeE
Confidence            9999999999999999999999996 5999998743   348999999999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCC------------CccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCC
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDST------------HMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR  359 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~  359 (522)
                      ++.++.++|+|||++........            ........++..|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999976541110            0111123468889999998764 4689999999999999999999


Q ss_pred             CCCCCCCCCChhhHHHhhhhhhcCCC---cc------------cccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 036172          360 RPIGFKNLKGPESLVKWAKPILKNGD---TE------------TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM  424 (522)
Q Consensus       360 ~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~------------~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~  424 (522)
                      .||.......  .+. ..........   ..            ....+.. ..........+.+++.+||+.+|.+||++
T Consensus       232 ~p~~~~~~~~--~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        232 PLFPGENEID--QLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             CCCCCCCHHH--HHH-HHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            9997543221  111 1111000000   00            0000000 01111234678899999999999999999


Q ss_pred             HHHHHHHhccccCCcccccc
Q 036172          425 GQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       425 ~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+++.        ++|++..
T Consensus       308 ~~~l~--------~~~~~~~  319 (335)
T PTZ00024        308 KEALK--------HEYFKSD  319 (335)
T ss_pred             HHHhc--------CcccCCC
Confidence            99997        9998754

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-34  Score=292.30  Aligned_cols=257  Identities=26%  Similarity=0.355  Sum_probs=197.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ....|...+.||.|+||.||++....        ....+++|.+...........+++.+|+++++.++|+|++++++++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   84 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVR--------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY   84 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcC--------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            34568889999999999999987643        3344555544322222233556788999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ......++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|
T Consensus        85 ~~~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          85 LREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             EcCCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECC
Confidence            99999999999996 58888776432  348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||++......      ....++..|+|||.+.   .+.++.++|||||||++|+|++|..||......  .....+.   
T Consensus       159 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---  227 (308)
T cd06634         159 FGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA---  227 (308)
T ss_pred             cccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHh---
Confidence            9998654332      1335788999999974   356788999999999999999999997542211  1111111   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                        .+....     ..   .......+.+++.+||+.+|.+||++.+|++        ++|+..
T Consensus       228 --~~~~~~-----~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~--------~~~~~~  272 (308)
T cd06634         228 --QNESPA-----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--------HRFVLR  272 (308)
T ss_pred             --hcCCCC-----cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhh--------Cccccc
Confidence              111100     00   1124456888999999999999999999997        677554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-34  Score=285.18  Aligned_cols=264  Identities=19%  Similarity=0.201  Sum_probs=196.9

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |++.+.||+|+||.||++....        ....+++|.+..... .....+.+.+|+.++++++|+||+++++++.+.+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~--------~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK--------TGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecC--------CCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            6678889999999999987543        456677777665431 1223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||++ ++|.+++....  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcc
Confidence            9999999997 59999998642  359999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-hHHHhh-------h
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-SLVKWA-------K  378 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~l~~~~-------~  378 (522)
                      .........  .....++..|+|||.+.+. .++.++||||||++++||++|+.||......... .+....       +
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
T cd07829         146 RAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW  223 (282)
T ss_pred             cccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence            765443221  1123457789999998776 7899999999999999999999998654321110 000000       0


Q ss_pred             hhhc-----CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 PILK-----NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ~~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      +...     ........... ...........+.+++.+||..+|.+||++.+|+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         224 PGVTKLPDYKPTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HhhcccccccccccccCccc-hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000     00000000000 00111122567899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=286.13  Aligned_cols=264  Identities=19%  Similarity=0.238  Sum_probs=194.5

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEEeC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIED  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~~~  226 (522)
                      |++.+.||.|+||.||++....        ..+.+++|.+.......  ......+|+..+++++ |+||+++++++.++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~--------~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   70 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE--------TGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFREN   70 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC--------CCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcC
Confidence            6788999999999999987543        34566666665543322  2234567999999998 99999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+   .+++|+||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          71 DELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             CcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeeccc
Confidence            9999999999 779999987643 2358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHH---------
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVK---------  375 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~---------  375 (522)
                      +.........   ....++..|+|||++.. ..++.++||||||+++++|++|+.||.......... ...         
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         146 AREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             ceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence            9765433221   23457889999998754 457899999999999999999999986543221110 000         


Q ss_pred             hhhhhhcCCCcccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          376 WAKPILKNGDTETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      |.............+....   ...........+.+++.+||+.+|.+||++.||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000000000000   01111112467889999999999999999999987

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=289.20  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=206.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ...+|..+.+||.|+||.|.++..+        .+...||+|.|++...-..+.++--+.|-++|... +-|.+++++.+
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerk--------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERK--------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             eecccceEEEeccCccceeeeeccc--------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            3568899999999999998887753        35678999999998777777777788898998877 67899999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      |..-+.+|+||||+.||+|--.++..+   .+.+..+.-++..|+-||-|||+   +|||.||||.+||||+.+|++||+
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEee
Confidence            999999999999999999999998655   38889999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++..-.  ....+..++||+.|+|||++...+|+..+|-|||||+||||+.|++||+..+...   +...+.   .
T Consensus       493 DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI~---e  564 (683)
T KOG0696|consen  493 DFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAIM---E  564 (683)
T ss_pred             eccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH---H
Confidence            9999964322  2234457899999999999999999999999999999999999999998654332   221111   1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP  422 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP  422 (522)
                      .           ...++...+.+...+....|.+.|.+|.
T Consensus       565 h-----------nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 H-----------NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             c-----------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1           2234555667788889999999999995

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.2e-34  Score=288.71  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=184.1

Q ss_pred             cCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChH
Q 036172          178 RCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG  257 (522)
Q Consensus       178 ~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~  257 (522)
                      +.+.+++|.+.... ......+.+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|.+++..... ..+++.
T Consensus        24 ~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~  101 (314)
T cd08216          24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPEL  101 (314)
T ss_pred             CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc-cCCCHH
Confidence            45566666654321 1223567899999999999999999999999999999999999999999999986422 348899


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCC-----CccccccccCCCCCChh
Q 036172          258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST-----HMIREDVVGTFGYIAPE  332 (522)
Q Consensus       258 ~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE  332 (522)
                      .+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||.+........     ........++..|+|||
T Consensus       102 ~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (314)
T cd08216         102 AIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE  178 (314)
T ss_pred             HHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence            999999999999999999   9999999999999999999999999998864432211     11112345778899999


Q ss_pred             hhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh----hhcC-------CCccc----ccCCc--
Q 036172          333 YLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP----ILKN-------GDTET----LLDPK--  393 (522)
Q Consensus       333 ~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~----~~~~-------~~~~~----~~d~~--  393 (522)
                      ++..  ..++.++|||||||++|+|++|..||......  .........    .+..       .....    ..++.  
T Consensus       179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (314)
T cd08216         179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR  256 (314)
T ss_pred             HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence            9865  35789999999999999999999999743211  111111000    0000       00000    00000  


Q ss_pred             --ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          394 --LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       394 --l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                        ............+.+++.+||+.||.+|||+.++++        ++|+..
T Consensus       257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--------~p~~~~  300 (314)
T cd08216         257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--------HSFFKQ  300 (314)
T ss_pred             hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--------CchHhh
Confidence              111122334567889999999999999999999998        888763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-34  Score=298.12  Aligned_cols=272  Identities=17%  Similarity=0.233  Sum_probs=194.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ++..+++|.+....   ....+.+.+|++++++++||||+++++++.
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~--------~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~   72 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSD--------CDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLG   72 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECC--------CCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence            4789999999999999999987543        34556665543322   134567889999999999999999998766


Q ss_pred             eC--------------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          225 ED--------------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       225 ~~--------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      ..              ...++||||++ ++|.+++...    .+++..+..++.|++.||.|||+   .+++||||||+|
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~N  144 (342)
T cd07854          73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPAN  144 (342)
T ss_pred             ccccccccccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHH
Confidence            43              35799999997 5998888632    48999999999999999999999   999999999999


Q ss_pred             eeccC-CCceEEeecCccccCCCCCCC-ccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 036172          291 ILLSS-DFQPQLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNL  367 (522)
Q Consensus       291 ILl~~-~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~  367 (522)
                      |+++. ++.++|+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus       145 ili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             EEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99974 567899999999654322111 11122357889999998754 4578899999999999999999999964432


Q ss_pred             CChhhHHHhhhhhhcCCCccc------------ccCCc-ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          368 KGPESLVKWAKPILKNGDTET------------LLDPK-LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~------------~~d~~-l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...........+.........            ...+. ............+.+++.+||+.||.+||++.+|+.     
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~-----  299 (342)
T cd07854         225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM-----  299 (342)
T ss_pred             HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC-----
Confidence            111100000000000000000            00000 000011123456888999999999999999999997     


Q ss_pred             ccCCccccc
Q 036172          435 THATDWVDR  443 (522)
Q Consensus       435 ~~~~~~~~~  443 (522)
                         ++|++.
T Consensus       300 ---h~~~~~  305 (342)
T cd07854         300 ---HPYMSC  305 (342)
T ss_pred             ---CCcccc
Confidence               899864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=279.22  Aligned_cols=243  Identities=24%  Similarity=0.308  Sum_probs=193.7

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||.|+||.||++....        ....+++|.+.+...........+.+|+.++++++||||+++++.+..+...++||
T Consensus         1 lg~G~~~~v~~~~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   72 (250)
T cd05123           1 LGKGSFGKVLLVRKKD--------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVL   72 (250)
T ss_pred             CCCCCceEEEEEEECC--------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEE
Confidence            6899999999987543        34566666655544433346678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD  313 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~  313 (522)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        73 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          73 EYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999999997542   48999999999999999999999   99999999999999999999999999999765443


Q ss_pred             CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCc
Q 036172          314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPK  393 (522)
Q Consensus       314 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  393 (522)
                      ..  ......++..|+|||.+.+...+.++|+||||+++|++++|..||.....   ........   . ..        
T Consensus       147 ~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~-~~--------  209 (250)
T cd05123         147 GS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---K-DP--------  209 (250)
T ss_pred             CC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---c-CC--------
Confidence            21  12244688899999999888889999999999999999999999964432   11111111   1 10        


Q ss_pred             ccccccHHHHHHHHHHHHHhhhcCCCCCCCH---HHHHH
Q 036172          394 LSNEYDNAQMQRMLLAANLCINQSPQLRPNM---GQVLK  429 (522)
Q Consensus       394 l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~---~eVl~  429 (522)
                        ...+...+..+.+++.+||..+|.+||++   .++++
T Consensus       210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence              01111225678889999999999999999   56665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-34  Score=294.23  Aligned_cols=269  Identities=17%  Similarity=0.225  Sum_probs=198.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||.|+||.||++....        ....+++|.+++.. ......+.+.+|+.++++++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR--------TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC--------CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            35789999999999999999986542        34556666554321 1122345788999999999999999999998


Q ss_pred             EeCC------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IEDN------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ..+.      ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~  155 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDC  155 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence            7653      468999999 7799988863    248999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .++|+|||++.......     ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .....
T Consensus       156 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~  228 (343)
T cd07880         156 ELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEI  228 (343)
T ss_pred             CEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence            99999999997543322     13357889999999876 458899999999999999999999997543211  11100


Q ss_pred             hh----------hhhcCCCcccc------cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          377 AK----------PILKNGDTETL------LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       377 ~~----------~~~~~~~~~~~------~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      ..          ..+........      +.+.............+.+++.+||+.||.+|||+.+++.        ++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~--------~~~  300 (343)
T cd07880         229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA--------HPY  300 (343)
T ss_pred             HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc--------Ccc
Confidence            00          00000000000      0000000011123446889999999999999999999997        888


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      ++..
T Consensus       301 ~~~~  304 (343)
T cd07880         301 FEEF  304 (343)
T ss_pred             Hhhh
Confidence            8764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.4e-34  Score=293.40  Aligned_cols=274  Identities=21%  Similarity=0.250  Sum_probs=195.9

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~  225 (522)
                      +|++.+.||+|+||.||++.....      .....+++|.+...... ....+.+.+|+.+++++ +||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~------~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET------SEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC------CcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            588999999999999999886531      11455666665432211 12356788999999999 69999999997653


Q ss_pred             C----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          226 D----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       226 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .    ...+++++|+. ++|.+++...   ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl  146 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKI  146 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEe
Confidence            3    46789999995 5999998743   358999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCC--ccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-------
Q 036172          302 SDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-------  371 (522)
Q Consensus       302 ~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-------  371 (522)
                      +|||+++........  .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.........       
T Consensus       147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~  226 (332)
T cd07857         147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL  226 (332)
T ss_pred             CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence            999999755432211  11123468999999998765 46899999999999999999999998654321100       


Q ss_pred             ------hHHHhhhhhhcC--CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          372 ------SLVKWAKPILKN--GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       372 ------~l~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                            .+..+..+....  ..........+ ..........+.+++.+||+.+|.+||++.+++.        ++|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--------~~~~~~  297 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--------HPYLAI  297 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--------Chhhhh
Confidence                  000000000000  00000000000 0000112457889999999999999999999986        888754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=281.13  Aligned_cols=246  Identities=22%  Similarity=0.270  Sum_probs=208.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|...+.||.|.||.|-+++.+.        +++.+|+|.|++...-..+.+..-+.|-++|+..+||.+..+--.|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKa--------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKA--------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecc--------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            45789999999999999999988754        7899999999998888888888889999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ....++|+||||..||.|.-+|.+   ...+++....-+-..|+.||.|||+   ++||.||||.+|+|+|.+|++||+|
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeee
Confidence            999999999999999999999984   3459999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++..-...  .....++||+.|+|||++....|..+.|-|.+|||+|||++|+.||...+......++.     .. 
T Consensus       312 FGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~e-  383 (516)
T KOG0690|consen  312 FGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----ME-  383 (516)
T ss_pred             cccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hh-
Confidence            99996432222  22346799999999999999999999999999999999999999997655443333221     11 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP  422 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP  422 (522)
                                 ...++.....+...|+...|.+||.+|.
T Consensus       384 -----------d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 -----------DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----------hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence                       1123334455667788889999999996

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7e-34  Score=286.80  Aligned_cols=261  Identities=22%  Similarity=0.319  Sum_probs=196.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..+.|++.++||.|+||.||++....        ..+.+++|.+++..  ......++..|+.++.++ .||||++++++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKK--------TGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECC--------CCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            34689999999999999999987542        24556666554321  223456677788877777 59999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.++...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+.  .+++||||+|+||+++.++.+||+
T Consensus        83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          83 FITDSDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             eecCCeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEEC
Confidence            999999999999995 48888776532  2589999999999999999999972  589999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK----VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      |||++.........   ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... ..+.+...  
T Consensus       158 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~--  231 (296)
T cd06618         158 DFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-EFEVLTKI--  231 (296)
T ss_pred             ccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-HHHHHHHH--
Confidence            99998665433222   1235788999999986543    78899999999999999999999864211 11111111  


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                        .... ....     ..  .......+.+++.+||+.+|.+||++.+++.        ++|+..
T Consensus       232 --~~~~-~~~~-----~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--------~~~~~~  278 (296)
T cd06618         232 --LQEE-PPSL-----PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--------HPFIRR  278 (296)
T ss_pred             --hcCC-CCCC-----CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc--------Chhhhc
Confidence              1111 0000     00  0023457889999999999999999999997        777664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.8e-34  Score=275.41  Aligned_cols=211  Identities=22%  Similarity=0.304  Sum_probs=174.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++..+||+|+||.||++.....    ..+..+.||+|.++...+. ........+|+.+++.|+||||+.+..++..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~----n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNT----NDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccC----CcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            4689999999999999999843321    1122458899988764331 1223456789999999999999999999987


Q ss_pred             -CCEEEEEEecCCCCCHHHHhhcc--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC----Cc
Q 036172          226 -DNYLILVSDFLPKGSLEESLHGA--GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----FQ  298 (522)
Q Consensus       226 -~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~----~~  298 (522)
                       +..++|++||.+. +|..+++-+  .....++...+..|+.||+.|+.|||+   +=|+||||||.|||+..+    |.
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCe
Confidence             7899999999987 999999754  233569999999999999999999999   889999999999999887    89


Q ss_pred             eEEeecCccccCCCCCCCc-cccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          299 PQLSDFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      +||+|||+++.+...-... ....++-|+.|.|||.+.+. .|+.+.|||++|||+.||+|-.+.|...
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999999877654443 33456789999999999875 4899999999999999999998888644

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.8e-34  Score=291.54  Aligned_cols=271  Identities=20%  Similarity=0.241  Sum_probs=197.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||.|+||.||++.+..        ..+.+++|.+.+... .....+.+.+|+.++++++||||+++++++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   78 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQL--------TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIF   78 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECC--------CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence            45789999999999999999987542        455666665543221 122456788999999999999999999998


Q ss_pred             Ee-CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IE-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .. ....++||||+ +++|.+++...    .+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+
T Consensus        79 ~~~~~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          79 ISPLEDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             ecCCCcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeC
Confidence            76 56789999999 56999888632    37888899999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH-HHhhh--
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL-VKWAK--  378 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l-~~~~~--  378 (522)
                      |||++.......     ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .....  
T Consensus       151 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  225 (328)
T cd07856         151 DFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP  225 (328)
T ss_pred             ccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999986543221     12357889999998765 5689999999999999999999999965432111000 00000  


Q ss_pred             -----hhhcCCCcccccC------CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 -----PILKNGDTETLLD------PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 -----~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                           .....+....++.      +.............+.+++.+||+.+|.+||++.+++.        ++|+...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--------~~~~~~~  294 (328)
T cd07856         226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--------HPYLAPY  294 (328)
T ss_pred             CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--------CCccccc
Confidence                 0000000000000      00000001123467889999999999999999999987        8887643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-34  Score=292.95  Aligned_cols=269  Identities=18%  Similarity=0.232  Sum_probs=195.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        +...+++|.+++.... ....+.+.+|+.++++++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTK--------TGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcC--------CCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            34789999999999999999987542        3456666655432211 11345688999999999999999999988


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ...+++++++ +++|.+++...    .+++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence            643      3478888887 77999888632    38999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh-HHH
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES-LVK  375 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-l~~  375 (522)
                      .+||+|||++.......     ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... +..
T Consensus       158 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999986543221     23467889999999866 468899999999999999999999986433211100 000


Q ss_pred             hh-------hhhhcCCC-------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          376 WA-------KPILKNGD-------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       376 ~~-------~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      ..       ...+....       ......... ..........+.+++.+||+.+|.+||++.+++.        ++|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--------h~~f  303 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--------HAYF  303 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--------Chhh
Confidence            00       00000000       000000000 0000012456889999999999999999999997        8887


Q ss_pred             cc
Q 036172          442 DR  443 (522)
Q Consensus       442 ~~  443 (522)
                      ..
T Consensus       304 ~~  305 (345)
T cd07877         304 AQ  305 (345)
T ss_pred             hh
Confidence            75

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-34  Score=294.50  Aligned_cols=268  Identities=19%  Similarity=0.265  Sum_probs=199.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++..+||.|+||.||++....        ....+++|.+...... ....+.+.+|+.++++++||||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~--------~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK--------TGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC--------CCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            35789999999999999999987643        3455666655432111 12346688899999999999999999988


Q ss_pred             EeCCE------EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IEDNY------LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...+.      .++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~  155 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDC  155 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCC
Confidence            76554      89999999 6699999874    249999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .++|+|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......  .+...
T Consensus       156 ~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i  228 (343)
T cd07851         156 ELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRI  228 (343)
T ss_pred             CEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence            99999999997654321     23467889999999865 367899999999999999999999996443211  11110


Q ss_pred             hhhhhcC-----------CCcccc---cCCccccc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          377 AKPILKN-----------GDTETL---LDPKLSNE---YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       377 ~~~~~~~-----------~~~~~~---~d~~l~~~---~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                       ......           ......   +.......   .....+..+.+++.+||+.+|.+|||+.+|+.        ++
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~--------h~  299 (343)
T cd07851         229 -MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA--------HP  299 (343)
T ss_pred             -HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc--------CC
Confidence             000000           000000   00000000   00112567899999999999999999999997        89


Q ss_pred             ccccc
Q 036172          440 WVDRH  444 (522)
Q Consensus       440 ~~~~~  444 (522)
                      |+...
T Consensus       300 ~~~~~  304 (343)
T cd07851         300 YLAEY  304 (343)
T ss_pred             Ccccc
Confidence            98753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-33  Score=313.86  Aligned_cols=150  Identities=25%  Similarity=0.332  Sum_probs=132.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||.|+||.||++....        ..+.|++|.+++...........+.+|+.++..++||||+++++++.
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~--------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   74 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKN--------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ   74 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC--------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            3689999999999999999987643        45677877776544333445678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ....++|||||+.+++|.+++...   ..+++..++.++.||+.||.|||.   .+|+||||||+||||+.++.+||+||
T Consensus        75 ~~~~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          75 SANNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             ECCEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeC
Confidence            999999999999999999999753   248899999999999999999999   99999999999999999999999999


Q ss_pred             Cccc
Q 036172          305 GLAI  308 (522)
Q Consensus       305 Gla~  308 (522)
                      |+++
T Consensus       149 Gls~  152 (669)
T cd05610         149 GLSK  152 (669)
T ss_pred             CCCc
Confidence            9985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-34  Score=293.65  Aligned_cols=268  Identities=16%  Similarity=0.216  Sum_probs=194.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|.+...||.|+||.||++....        ....+++|.+++... .......+.+|+.++++++||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKR--------TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCC--------CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            4689999999999999999986532        345566665543221 1123456889999999999999999999987


Q ss_pred             eC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 ED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..      ...++|+||+.. +|..++.     ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~  155 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCE  155 (342)
T ss_pred             ccccCCCCceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence            54      356999999964 7877653     238999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      ++|+|||+++......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............
T Consensus       156 ~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~  230 (342)
T cd07879         156 LKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  230 (342)
T ss_pred             EEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986543221     13457889999999876 46899999999999999999999999754321110000000


Q ss_pred             h--------hhhcCCC-------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          378 K--------PILKNGD-------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       378 ~--------~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .        .......       ........+... .......+.+++.+||+.||.+||++.+++.        |+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~--------h~~f~  301 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALE--------HPYFD  301 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhc--------Ccchh
Confidence            0        0000000       000000000000 0112356889999999999999999999997        88887


Q ss_pred             cc
Q 036172          443 RH  444 (522)
Q Consensus       443 ~~  444 (522)
                      ..
T Consensus       302 ~~  303 (342)
T cd07879         302 SF  303 (342)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=272.50  Aligned_cols=268  Identities=21%  Similarity=0.229  Sum_probs=206.6

Q ss_pred             Ccee-eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          147 PFQM-DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~-~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      -|++ ...||+|+|+.|.-+....        +...+|+|.+.+..   .-...+..+|++++.+. .|+||++++++|+
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~--------t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQ--------TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeec--------cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            3444 4679999999987776543        67788888887652   22568899999999999 7999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---ceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---QPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---~~kL  301 (522)
                      ++..+|||||-|.||+|..+|+.+   ..|++.++.++...|+.||.|||.   +||.||||||+|||.....   -+||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceee
Confidence            999999999999999999999854   459999999999999999999999   9999999999999987654   3899


Q ss_pred             eecCccccCCCC--CCC---ccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--
Q 036172          302 SDFGLAIWGPTD--STH---MIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG--  369 (522)
Q Consensus       302 ~DFGla~~~~~~--~~~---~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~--  369 (522)
                      |||.+..-....  ...   ......+|+..|||||+..     ...|+.++|.||||||+|-|++|.+||......+  
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            999887332211  111   1112457889999999862     2358899999999999999999999997543322  


Q ss_pred             ------hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          370 ------PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       370 ------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                            .....+.....+++|.+..      ...-....+.+..+++...|..++.+|.++.++++        |+|++.
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeF------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln--------hPw~~~  366 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEF------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN--------HPWVQR  366 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcC------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC--------Cccccc
Confidence                  2222222233344444321      11112345677888999999999999999999997        899876


Q ss_pred             cc
Q 036172          444 HA  445 (522)
Q Consensus       444 ~~  445 (522)
                      ..
T Consensus       367 ~~  368 (463)
T KOG0607|consen  367 CA  368 (463)
T ss_pred             cc
Confidence            53

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=273.00  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~  225 (522)
                      ..+.+..||.|+-|.|+.+...        +++...|+|.+.+..  ..+..++++..++++..- ..|+||+.+|||..
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~r--------s~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFR--------STGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEc--------ccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            3455677999999999887754        355667777766533  345678889999998877 48999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +..+++.||.|. ..++.++.+.  ..++++..+-++...++.||.||...  ++|+|||+||+|||+|+.|++||||||
T Consensus       163 n~dV~IcMelMs-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  163 NTDVFICMELMS-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             CchHHHHHHHHH-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccc
Confidence            999999999994 4778887764  33599999999999999999999985  899999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++-..-....+.   ...|.+.|||||.+..   .+|..++||||||+.++||.||+.||...+.+ .+.+.+..    .
T Consensus       238 IsGrlvdSkAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvl----n  309 (391)
T KOG0983|consen  238 ISGRLVDSKAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVL----N  309 (391)
T ss_pred             ccceeecccccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHH----h
Confidence            996655444332   3479999999999843   46889999999999999999999999764322 22222211    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        .....++    ...  ..+..+.+++..||++|+.+||...++++
T Consensus       310 --~ePP~L~----~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 --EEPPLLP----GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --cCCCCCC----ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              1112222    211  14567899999999999999999999997

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-33  Score=279.81  Aligned_cols=283  Identities=24%  Similarity=0.293  Sum_probs=208.3

Q ss_pred             cccccccccceeeecCCcccccccchhhhhccCCCCCCCCCCCCCCCCCCCCCCceeeecccccccccccccCchhHHHH
Q 036172           94 YTSTVDYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQINSFSPKTENPFQMDIPCSEGKYDENTLTPSTELFLK  173 (522)
Q Consensus        94 ~~~~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~  173 (522)
                      ..+|.+.|.|+|++|+-+..                                  .++.+.||+|+||.||++....    
T Consensus       193 ~tSGSGSGlplLVQRTiarq----------------------------------I~L~e~IGkGRyGEVwrG~wrG----  234 (513)
T KOG2052|consen  193 ETSGSGSGLPLLVQRTIARQ----------------------------------IVLQEIIGKGRFGEVWRGRWRG----  234 (513)
T ss_pred             ccCCCCCCchhHhHHhhhhe----------------------------------eEEEEEecCccccceeeccccC----
Confidence            36777788888888887333                                  3566779999999999987542    


Q ss_pred             hhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC--CCCCcceeeEEEEeC----CEEEEEEecCCCCCHHHHhhc
Q 036172          174 LVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL--EQKSITTLNGVCIED----NYLILVSDFLPKGSLEESLHG  247 (522)
Q Consensus       174 ~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L--~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~  247 (522)
                            ..+|+|.+      ++.....+.+|.+|.+..  +|+||+.+++.-..+    ..++||++|.+.|||.|+|.+
T Consensus       235 ------e~VAVKiF------~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r  302 (513)
T KOG2052|consen  235 ------EDVAVKIF------SSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR  302 (513)
T ss_pred             ------CceEEEEe------cccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh
Confidence                  22333321      222446789999999886  999999999987755    369999999999999999985


Q ss_pred             cCCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCEEeccCCCCceeccCCCceEEeecCccccCCCCC--CCcccc
Q 036172          248 AGEQSVLPWGVRFEVAVAIAEALNYLHSE-----CSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS--THMIRE  320 (522)
Q Consensus       248 ~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-----~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~  320 (522)
                      .    .++.+..++++..++.||++||.+     .++.|.|||||+.|||+..++.+.|+|+|+|.......  .....+
T Consensus       303 ~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N  378 (513)
T KOG2052|consen  303 N----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPN  378 (513)
T ss_pred             c----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCC
Confidence            3    499999999999999999999973     45789999999999999999999999999996654432  233445


Q ss_pred             ccccCCCCCChhhhccCC------CCchhhHHHHHHHHHHHHcC----------CCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          321 DVVGTFGYIAPEYLMHGK------VSDKIDVYSFGVVLLELLSG----------RRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       321 ~~~gt~~Y~APE~~~~~~------~s~ksDVwSlGvvl~eLltG----------~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ..+||.+|||||++...-      --..+||||||.|+||+..+          +.||..-.+.+.. ..+ .    +.-
T Consensus       379 ~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~ee-M----rkV  452 (513)
T KOG2052|consen  379 PRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-FEE-M----RKV  452 (513)
T ss_pred             CccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-HHH-H----hcc
Confidence            678999999999984321      22469999999999999853          4455432222111 111 0    111


Q ss_pred             CcccccCCccccc-ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          385 DTETLLDPKLSNE-YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       385 ~~~~~~d~~l~~~-~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...+-+.|.+... ........|.++++.||..||.-|-|+-.|-+.|.+...
T Consensus       453 VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  453 VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            1111122222222 234567889999999999999999999999999887764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8e-33  Score=305.76  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=189.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      +.+.|+....||+||||.||+++++-        .++.||+|.|.-..  .........+|+.+|++|+|||||+++..+
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKl--------DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKL--------DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecc--------cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            56678899999999999999998753        67888888875432  223456788999999999999999998543


Q ss_pred             Ee------------------------------------------------------------------------------
Q 036172          224 IE------------------------------------------------------------------------------  225 (522)
Q Consensus       224 ~~------------------------------------------------------------------------------  225 (522)
                      .+                                                                              
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            21                                                                              


Q ss_pred             ---------------------------------C--------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHH
Q 036172          226 ---------------------------------D--------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAV  264 (522)
Q Consensus       226 ---------------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  264 (522)
                                                       +        -.+||=||||+.-+|.++++++...  -.....++++.
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFr  704 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFR  704 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHH
Confidence                                             0        1368899999997777777654211  14678899999


Q ss_pred             HHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC----------------CCCCCccccccccCCCC
Q 036172          265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP----------------TDSTHMIREDVVGTFGY  328 (522)
Q Consensus       265 qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y  328 (522)
                      +|++||.|+|+   .|+|||||||.||+|+.++.|||+|||+|....                ........+..+||.-|
T Consensus       705 eIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY  781 (1351)
T KOG1035|consen  705 EILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY  781 (1351)
T ss_pred             HHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence            99999999999   999999999999999999999999999996511                01111123456899999


Q ss_pred             CChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHH
Q 036172          329 IAPEYLMHG---KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQR  405 (522)
Q Consensus       329 ~APE~~~~~---~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  405 (522)
                      +|||++.+.   +|+.|+|+||||||++||+.   ||...    .+...  +...++.+.++..      ..+.......
T Consensus       782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~--iL~~LR~g~iP~~------~~f~~~~~~~  846 (1351)
T KOG1035|consen  782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERAS--ILTNLRKGSIPEP------ADFFDPEHPE  846 (1351)
T ss_pred             ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch----HHHHH--HHHhcccCCCCCC------cccccccchH
Confidence            999999654   59999999999999999984   45421    11111  1112334433332      1122223334


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          406 MLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       406 l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      =..+|.++++.||.+|||+.|+|+
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            466899999999999999999997

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=286.04  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=217.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+.+++..||-|+||.|.++....        ....||+|.|++...-.....+....|-.||..++.|.||++|..|.+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~--------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNS--------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecc--------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            466788899999999999876432        223699999999998888888999999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ..++|++||-|-||.|...|++++   .|+..+..-++..+++|+.|||+   ++||.|||||+|++++.+|-+||.|||
T Consensus       492 ~kyvYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  492 SKYVYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             chhhhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehh
Confidence            999999999999999999998544   59999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +|+.........   .++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-...+++-....      
T Consensus       566 FAKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------  636 (732)
T KOG0614|consen  566 FAKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------  636 (732)
T ss_pred             hHHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------
Confidence            998887765443   56999999999999999999999999999999999999999987654333332211111      


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~~  444 (522)
                               .-.++........+++++....+|.+|.-     +.+|-+        |.|+...
T Consensus       637 ---------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk--------H~Wf~gf  683 (732)
T KOG0614|consen  637 ---------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK--------HRWFEGF  683 (732)
T ss_pred             ---------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh--------hhhhhcC
Confidence                     12334455667778899999999999974     455544        8887754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=291.21  Aligned_cols=244  Identities=20%  Similarity=0.298  Sum_probs=198.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ...|.+...+|.|+|+.|..+....        +.+.++.|.+.+.+.+       -.+|+.++... +||||+++.+.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~--------t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~  385 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP--------TDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVY  385 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc--------cccchhheeccccccc-------cccccchhhhhcCCCcceeeccee
Confidence            3478888899999999988877643        5677788887765332       34578777777 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec-cCCCceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl-~~~~~~kL~  302 (522)
                      .++.+.|+|||++.|+-|.+.+....   .+. ..+..|+.+|+.|+.|||.   +||+||||||+|||+ +..++++|+
T Consensus       386 ~~~~~~~~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrlt  458 (612)
T KOG0603|consen  386 EDGKEIYLVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLT  458 (612)
T ss_pred             cCCceeeeeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEE
Confidence            99999999999999998888887432   233 7788899999999999999   999999999999999 588999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||.++.....     ....+-|..|.|||++....|+.++|+||||++||+|++|+.||......  ..+.    ..+.
T Consensus       459 yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~  527 (612)
T KOG0603|consen  459 YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQ  527 (612)
T ss_pred             EechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----Hhhc
Confidence            99999766554     12335688999999999999999999999999999999999999754433  1111    1112


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .            +.+....+....+|+.+||+.||.+||++.++..        |+|+
T Consensus       528 ~------------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--------h~w~  566 (612)
T KOG0603|consen  528 M------------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--------HPWF  566 (612)
T ss_pred             C------------CccccccCHHHHHHHHHhccCChhhCcChhhhcc--------Ccch
Confidence            1            1222445678889999999999999999999996        9998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7e-33  Score=270.79  Aligned_cols=225  Identities=19%  Similarity=0.184  Sum_probs=177.2

Q ss_pred             cccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecC
Q 036172          157 GKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFL  236 (522)
Q Consensus       157 G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~  236 (522)
                      |.||.||++.+..        +.+.+++|.+....        .+.+|...+....||||+++++++.+....++||||+
T Consensus         4 g~~~~v~~~~~~~--------~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   67 (237)
T cd05576           4 GVIDKVLLVMDTR--------TQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHA   67 (237)
T ss_pred             cccceEEEEEEcc--------CCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecC
Confidence            8999999987643        56677888775532        2345666666678999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCC
Q 036172          237 PKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH  316 (522)
Q Consensus       237 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~  316 (522)
                      ++|+|.+++...   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++|||.+.......  
T Consensus        68 ~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--  139 (237)
T cd05576          68 EGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--  139 (237)
T ss_pred             CCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--
Confidence            999999999753   248999999999999999999999   999999999999999999999999999875543321  


Q ss_pred             ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccc
Q 036172          317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSN  396 (522)
Q Consensus       317 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  396 (522)
                         ....++..|+|||.+....++.++||||+|+++|||++|+.|+.......            ..  ..       ..
T Consensus       140 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~--~~-------~~  195 (237)
T cd05576         140 ---DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT--HT-------TL  195 (237)
T ss_pred             ---ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc--cc-------cc
Confidence               12345778999999988889999999999999999999998864321100            00  00       00


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 036172          397 EYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLK  429 (522)
Q Consensus       397 ~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~  429 (522)
                      ..+......+.+++.+||+.||.+||++     .++++
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  233 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS  233 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence            1112234578889999999999999996     55554

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=303.73  Aligned_cols=265  Identities=25%  Similarity=0.378  Sum_probs=210.4

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCC
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDN  227 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~  227 (522)
                      .+.+.||+|.||.|+++.-....... ......+|+|.++.....  ...+.|..|+++|+.+ +|+||+.++|+|...+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~-~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKAL-LSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             cccceeecccccceEeEEEeeccccc-ccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            56679999999999998643222111 223567888888776554  5788999999999999 7999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccC-----CC--------CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          228 YLILVSDFLPKGSLEESLHGAG-----EQ--------SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      .+++|+||+..|+|.++|+..+     ..        ..++....+.++.||+.|++||++   .++|||||-..|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence            9999999999999999998654     00        238899999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCcccccc-ccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhh
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDV-VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES  372 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~  372 (522)
                      .+..+||+|||+|+.............. .-...|||||.+....++.|+|||||||+||||+| |..||..  ......
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--~~~~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--IPPTEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--CCcHHH
Confidence            9999999999999865554433322111 12456999999999999999999999999999999 9999864  221222


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      +..    .+..|..         ...+.....++..++..||+.+|++||++.++.+.|...
T Consensus       531 l~~----~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 LLE----FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            322    2333322         122334467888999999999999999999999999884

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=301.65  Aligned_cols=256  Identities=25%  Similarity=0.313  Sum_probs=204.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|.+.+.||.|+||.|.++..+.        +.+.||+|.|.+..---......|..|-+||..-+.+=||+++-.|.
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~--------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKS--------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeec--------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            4689999999999999999987653        67889999987733222234467889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++.++|+||||++||+|-.++.+..   .+++..+.-++..|+.||.-||+   .|+|||||||+|||||..|++||+||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence            9999999999999999999998654   59999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc----c-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM----H-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |.|.....+. .......+|||-|++||++.    + +.|...+|-||+||++|||+.|..||...      +++.-...
T Consensus       220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~K  292 (1317)
T KOG0612|consen  220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGK  292 (1317)
T ss_pred             hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHH
Confidence            9997665443 33344678999999999985    2 56899999999999999999999999644      33333333


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN---MGQVLK  429 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs---~~eVl~  429 (522)
                      ++.......+.+       ....+....+||.+.+ -+|..|..   +.++-.
T Consensus       293 Im~hk~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  293 IMNHKESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HhchhhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            333222111110       1225566777777554 47888887   888876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.1e-32  Score=257.91  Aligned_cols=276  Identities=19%  Similarity=0.260  Sum_probs=201.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHH--HhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQ--ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~--~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      .+.|+...++|+|.||.||+++..        .+.+.++++.+.-  ....|.   ..-.+|+++|..|+|+|++.++..
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~--------n~~kkvalkkvlmeneKeGfp---italreikiL~~lkHenv~nliEi   84 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSK--------NTGKKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEI   84 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhc--------CccchhHHHHHHHhccccCCc---HHHHHHHHHHHHhcchhHHHHHHH
Confidence            467889999999999987766543        3556666665432  122232   245689999999999999999998


Q ss_pred             EEe--------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          223 CIE--------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       223 ~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      |..        ...+|+|+++|+. +|..+|...  ...++..++.+++.++..||.|+|.   ..|+|||+||.|+||+
T Consensus        85 c~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt  158 (376)
T KOG0669|consen   85 CRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLIT  158 (376)
T ss_pred             HhhccCCcccccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEc
Confidence            873        2458999999987 999999753  2359999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCccc--cccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIR--EDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      .++.+||+|||+++.+.........  ...+-|..|.+||.+.+. .|+++.|||..|||+.||++|.+-+........-
T Consensus       159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql  238 (376)
T KOG0669|consen  159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL  238 (376)
T ss_pred             CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence            9999999999999766544332211  234569999999998764 6899999999999999999999998766544433


Q ss_pred             hHHHhh--------hhhhcCCCccccc--CCccccccc--HHH------HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          372 SLVKWA--------KPILKNGDTETLL--DPKLSNEYD--NAQ------MQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       372 ~l~~~~--------~~~~~~~~~~~~~--d~~l~~~~~--~~~------~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      .++...        |+...+-.+.+.+  .|.....+.  .+.      ....++++..++..||.+||.++++++    
T Consensus       239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln----  314 (376)
T KOG0669|consen  239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN----  314 (376)
T ss_pred             HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc----
Confidence            333221        1111111111111  110001000  011      135678999999999999999999997    


Q ss_pred             cccCCccccccc
Q 036172          434 ATHATDWVDRHA  445 (522)
Q Consensus       434 ~~~~~~~~~~~~  445 (522)
                          |+|+.+.+
T Consensus       315 ----h~~F~kdp  322 (376)
T KOG0669|consen  315 ----HDFFWKDP  322 (376)
T ss_pred             ----hhhhhcCC
Confidence                77766543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-32  Score=273.83  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=199.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC--CCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL--EQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L--~HpnIv~l~~  221 (522)
                      .....++...+|+|+||.||+++-..          +.||+|.+..      ...+.|++|-+|.+..  +|+||+++++
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL~~----------~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~  271 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQLDN----------RLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIG  271 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhccC----------ceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhc
Confidence            35567888999999999999987543          4555554432      1456799999988765  9999999999


Q ss_pred             EEEeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC------CCCEEeccCCCCce
Q 036172          222 VCIEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC------SRPVIHRDVKSSNI  291 (522)
Q Consensus       222 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~------~~giiHrDIkp~NI  291 (522)
                      +-....    .++||++|.+.|+|.++|..+    .++|....+|+..+++||+|||++.      +.+|+|||||++||
T Consensus       272 ~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNV  347 (534)
T KOG3653|consen  272 AEKRGTADRMEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNV  347 (534)
T ss_pred             hhccCCccccceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccce
Confidence            887654    899999999999999999854    4999999999999999999999853      56899999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCC-CC-----chhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VS-----DKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-----~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      ||..++++.|+|||+|..+............+||.+|||||++.+.. +.     .+.||||+|.|||||+++...+...
T Consensus       348 LvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~  427 (534)
T KOG3653|consen  348 LVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG  427 (534)
T ss_pred             EEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence            99999999999999997776554444444468999999999995532 22     3689999999999999876544211


Q ss_pred             CCC--------------ChhhHHHhhhhhhcCCCcccccCCccccccc-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          366 NLK--------------GPESLVKWAKPILKNGDTETLLDPKLSNEYD-NAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       366 ~~~--------------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      ...              ..+.+...+.   ..     -..|.+..... ...+.-+.+.+..||..||+-|.|+.=|-++
T Consensus       428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV---~k-----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR  499 (534)
T KOG3653|consen  428 PVPEYQLPFEAEVGNHPTLEEMQELVV---RK-----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER  499 (534)
T ss_pred             CCCcccCchhHHhcCCCCHHHHHHHHH---hh-----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence            111              1111111111   11     11122221111 1345678889999999999999999999999


Q ss_pred             Hhccc
Q 036172          431 LRGAT  435 (522)
Q Consensus       431 L~~~~  435 (522)
                      +....
T Consensus       500 ~~~l~  504 (534)
T KOG3653|consen  500 MAELM  504 (534)
T ss_pred             HHHHh
Confidence            98876

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=270.99  Aligned_cols=269  Identities=17%  Similarity=0.230  Sum_probs=205.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-C-CC----cce
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-Q-KS----ITT  218 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-H-pn----Iv~  218 (522)
                      .++|.+...+|+|+||.|-.+-+.+        ....+|+|.++....    -.+.-+-|+++|.++. + |+    +|+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~--------~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRE--------TKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecC--------CCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            6799999999999999988876654        367889998887554    3455677999999993 2 33    788


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---  295 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---  295 (522)
                      +.++|.-.++.+||+|.+ |-|+.++|..++ -.+++...+..++.|++++++|||+   .+++|-||||+|||+.+   
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccce
Confidence            889999999999999999 669999998763 4469999999999999999999999   99999999999999832   


Q ss_pred             -----------------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          296 -----------------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       296 -----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                                       +..++|+|||.|.+.....     ..++.|..|.|||++.+-.++..+||||+||||+|+.+|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                             2358999999997654433     345789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHhh--------------hhhhcCCCc-----------ccccCCc-c---cccccHHHHHHHHHH
Q 036172          359 RRPIGFKNLKGPESLVKWA--------------KPILKNGDT-----------ETLLDPK-L---SNEYDNAQMQRMLLA  409 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~--------------~~~~~~~~~-----------~~~~d~~-l---~~~~~~~~~~~l~~l  409 (522)
                      ...|......+.-.+.+.+              ......+.+           ....++. .   .-........++.+|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            9999766532211111110              001111100           0001100 0   001123345679999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          410 ANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       410 i~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +..||..||.+|+|+.|++.        |+|+..
T Consensus       386 l~~mL~fDP~~RiTl~EAL~--------HpFF~~  411 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS--------HPFFAR  411 (415)
T ss_pred             HHHHHccCccccccHHHHhc--------CHHhhc
Confidence            99999999999999999997        777764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=280.55  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=205.2

Q ss_pred             Ccee--eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          147 PFQM--DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~--~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      -|++  ++.||.|.||+||-+++.        ++++.+|+|.|.+..-.- .....+++|+.||+++.||.||.+-..|+
T Consensus       563 vYQif~devLGSGQFG~VYgg~hR--------ktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~E  633 (888)
T KOG4236|consen  563 VYQIFADEVLGSGQFGTVYGGKHR--------KTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFE  633 (888)
T ss_pred             HHHhhhHhhccCCcceeeecceec--------ccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeec
Confidence            3555  489999999999988764        477888888876643221 13467999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---CceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---FQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---~~~kL  301 (522)
                      ..+.+++|||-+.| +..+.+-.. .+..+++..-.-++.||+.||.|||-   ++|+|+||||+|||+...   -.+||
T Consensus       634 T~ervFVVMEKl~G-DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKl  708 (888)
T KOG4236|consen  634 TPERVFVVMEKLHG-DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKL  708 (888)
T ss_pred             CCceEEEEehhhcc-hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceee
Confidence            99999999999955 666655443 33459999999999999999999999   999999999999999654   37999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||||+|++++.....   ..++||+.|+|||++.++.|+..-|+||.||++|--++|..||....  +....++.+.-+ 
T Consensus       709 CDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFM-  782 (888)
T KOG4236|consen  709 CDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFM-  782 (888)
T ss_pred             ccccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccc-
Confidence            999999998776543   46799999999999999999999999999999999999999996432  111112211111 


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                              ..    .....+.....+++|...|+..-++|-+...-+.        |+|++..
T Consensus       783 --------yP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls--------h~Wlq~y  825 (888)
T KOG4236|consen  783 --------YP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS--------HPWLQDY  825 (888)
T ss_pred             --------cC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc--------chhhhcc
Confidence                    11    1222345567888999999999999999998886        7887654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-33  Score=268.25  Aligned_cols=256  Identities=22%  Similarity=0.248  Sum_probs=196.4

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIED  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~  226 (522)
                      -+-...||.|.||+|++..++.        .++..|+|.|.....  ....++|+.|.+...+- +.||||++||.+..+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~--------sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKP--------SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCc--------cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            3445679999999988766544        567777777654332  34678899999987666 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhcc--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          227 NYLILVSDFLPKGSLEESLHGA--GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +..++.||+|+- ||+.+....  -.+..+++...-+|....+.||.||-..  ..||||||||+|||++..|.+|||||
T Consensus       136 GdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  136 GDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecc
Confidence            999999999954 887765432  2344599999999999999999999986  88999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |++-.+....   ....-.|...|||||.+..  ..|..++||||||++|+|+.||..|+...+.     +...... +.
T Consensus       213 GIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~-Vv  283 (361)
T KOG1006|consen  213 GICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQ-VV  283 (361)
T ss_pred             cchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHH-HH
Confidence            9985443322   2234478899999999853  3489999999999999999999999864331     2222221 22


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .|..+.++.+.    -..+....|..+|..||.+|-..||...++++
T Consensus       284 ~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  284 IGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            33333332221    12345678999999999999999999999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.5e-31  Score=274.31  Aligned_cols=211  Identities=25%  Similarity=0.356  Sum_probs=181.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      +-|-.++.||-|+||.|-|+...+        +...+|.|.|.++..-....+...+.|-+||..-..+-||+||-.|.+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvD--------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVD--------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecc--------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            457888999999999999987654        356788999988877777778888999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+.+|+||+|++||++-.+|.+.+   .|++..+.-++..+..|+++.|.   .|+|||||||+|||||.+|++||.|||
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecc
Confidence            999999999999999999998654   69999999999999999999999   999999999999999999999999999


Q ss_pred             ccccC---------CCCCCC-------------------------------ccccccccCCCCCChhhhccCCCCchhhH
Q 036172          306 LAIWG---------PTDSTH-------------------------------MIREDVVGTFGYIAPEYLMHGKVSDKIDV  345 (522)
Q Consensus       306 la~~~---------~~~~~~-------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDV  345 (522)
                      ++.-+         ..+...                               ......+||+.|+|||++....++..+|-
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            99321         111000                               00123579999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          346 YSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       346 wSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      ||.|||||||+.|+.||-...+.+.
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcc
Confidence            9999999999999999976655443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=292.09  Aligned_cols=261  Identities=21%  Similarity=0.264  Sum_probs=213.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      ..+.+++||.|+||+||++...--    .....-++++|++...+..  ++.++|+.|+-+|.+|+|||+++++|+|...
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pe----ge~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPE----GENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecC----CceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence            456678999999999999864321    1222346777777665543  3568899999999999999999999999976


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      . +.||++|++.|+|.++++.++  ..+-.+..+.|..||++|+.|||.   +.++||||-..||||..-..+||.|||+
T Consensus       771 ~-~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  771 T-LQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             h-HHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecch
Confidence            5 889999999999999999754  358889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      ++...............-.+.|||-|.+....++.++|||||||.+||++| |..|+......+...+       ++.|.
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~ge  917 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGE  917 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhccc
Confidence            998887776665555566788999999999999999999999999999999 9999876544333332       22222


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .         -..++.....+..++.+||..|+..||+++++...+....
T Consensus       918 R---------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 R---------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             c---------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            1         2223345667888999999999999999999999887755

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1e-30  Score=252.46  Aligned_cols=240  Identities=27%  Similarity=0.331  Sum_probs=186.5

Q ss_pred             ccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCC
Q 036172          158 KYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP  237 (522)
Q Consensus       158 ~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~  237 (522)
                      +||.||++....        ....+++|.+......  ...+.|.+|++.+++++|+||+++++++......++|+||++
T Consensus         1 ~~g~v~~~~~~~--------~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   70 (244)
T smart00220        1 SFGKVYLARDKK--------TGKLVAIKVIKKEKIK--KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCD   70 (244)
T ss_pred             CceEEEEEEECC--------CCcEEEEEEecccccc--cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCC
Confidence            477888876542        3445555554432211  115789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCc
Q 036172          238 KGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM  317 (522)
Q Consensus       238 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  317 (522)
                      +++|.+++....   .+++..++.++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        71 ~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---  141 (244)
T smart00220       71 GGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---  141 (244)
T ss_pred             CCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---
Confidence            999999997543   28999999999999999999999   999999999999999999999999999997655432   


Q ss_pred             cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccccc
Q 036172          318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE  397 (522)
Q Consensus       318 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  397 (522)
                      ......++..|++||.+....++.++||||||++++++++|..||...  ...........    .+.....       .
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~----~~~~~~~-------~  208 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIG----KPKPPFP-------P  208 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHh----ccCCCCc-------c
Confidence            122346788999999998888999999999999999999999998642  11222222111    1111100       0


Q ss_pred             ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          398 YDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       398 ~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .....+..+.+++.+||..+|.+||++.++++
T Consensus       209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00003457888999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=241.84  Aligned_cols=266  Identities=21%  Similarity=0.212  Sum_probs=197.1

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|...++||+|+||+|+.+++.+        +...+++|.+.-.. +....-....+|+-+|+.|+|+|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~~--------t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE--------THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC--------ccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            46677899999999999998765        33444444432211 1111234578899999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +.+-+|+|||.. +|..+....+  ..++.+.+..++.|+++||.|+|+   ++++|||+||.|+||+.+|.+||+|||+
T Consensus        74 kkltlvfe~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   74 KKLTLVFEFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             ceeEEeHHHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccch
Confidence            999999999965 9999988653  348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++.++.......  .-+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++.|...+..++-.-+-+......+.
T Consensus       148 arafgipvrcys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  148 ARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED  225 (292)
T ss_pred             hhhcCCceEeee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence            987665432221  235689999999998765 7999999999999999987 777777665443322222221111111


Q ss_pred             ---CcccccCCccccccc---------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          385 ---DTETLLDPKLSNEYD---------NAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       385 ---~~~~~~d~~l~~~~~---------~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         .+..+.|-...+.++         +.....=.+++.+.|.-+|.+|.++++.++
T Consensus       226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               122222322222222         112233456788889999999999999886

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-31  Score=282.14  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=200.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ...|++...+|.|.||.||++++..        +.+..|+|.+..    ..+..++...|.+||+.+ .|||++.++|++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~--------~~~~aa~kI~~~----~~d~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVK--------TGQLAAIKIMDP----TEDEEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeee--------cCceeeeEeecC----CccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            4578999999999999999998765        333344443322    223446778899999999 899999999999


Q ss_pred             Ee-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IE-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..     ++.++||||||.+||..|++++.. ...+.|..+..|++.++.||.+||.   +.++|||||-.|||++.++.
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCc
Confidence            83     478999999999999999998775 5569999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +||+|||.+.....  +....+...||+.|||||++..     ..|+..+|+||||++..||.-|.+|+....+.  ..+
T Consensus       162 VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--raL  237 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--RAL  237 (953)
T ss_pred             EEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--hhh
Confidence            99999999865443  2333456789999999999853     34778999999999999999999997532211  111


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..     +     .  -+|.....-+....+++.++|..||.+|..+||++.++++
T Consensus       238 F~-----I-----p--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 FL-----I-----P--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cc-----C-----C--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            00     0     1  1122222234556789999999999999999999999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=8.8e-31  Score=286.67  Aligned_cols=271  Identities=17%  Similarity=0.186  Sum_probs=171.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE-
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV-  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~-  222 (522)
                      ..++|++.++||+|+||.||++.......    .....+++|.+....     ..+.+..|  .+....+.+++.++.. 
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~----~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS----KKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc----ccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhh
Confidence            45789999999999999999987643100    124456666443211     11112221  1222223333322222 


Q ss_pred             -----EEeCCEEEEEEecCCCCCHHHHhhccCCC-----------------CCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 036172          223 -----CIEDNYLILVSDFLPKGSLEESLHGAGEQ-----------------SVLPWGVRFEVAVAIAEALNYLHSECSRP  280 (522)
Q Consensus       223 -----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~g  280 (522)
                           +..+...+|||||+++++|.+++......                 .......+..++.|++.||.|||+   ++
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~g  275 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TG  275 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CC
Confidence                 24557899999999999999998753210                 011234466899999999999999   99


Q ss_pred             EEeccCCCCceeccC-CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC----------------------
Q 036172          281 VIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG----------------------  337 (522)
Q Consensus       281 iiHrDIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------  337 (522)
                      |+||||||+|||++. ++.+||+|||+++........ ......+++.|+|||.+...                      
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~  354 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL  354 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence            999999999999986 579999999999755433222 22345789999999976322                      


Q ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC----cccccCCccccc----c--cHHHHHHHH
Q 036172          338 KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD----TETLLDPKLSNE----Y--DNAQMQRML  407 (522)
Q Consensus       338 ~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~  407 (522)
                      .++.++|||||||++|||+++..|+...       +......+...+.    ....+.+....+    +  .........
T Consensus       355 ~~~~k~DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  427 (566)
T PLN03225        355 NLPDRFDIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW  427 (566)
T ss_pred             cCCCCcccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence            2345679999999999999987764321       1111100000000    000001100000    0  000122345


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          408 LAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       408 ~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +|+.+||+.||.+|||+.++++        |+|+...
T Consensus       428 dLi~~mL~~dP~kR~ta~e~L~--------Hpff~~~  456 (566)
T PLN03225        428 ELLKSMMRFKGRQRISAKAALA--------HPYFDRE  456 (566)
T ss_pred             HHHHHHccCCcccCCCHHHHhC--------CcCcCCC
Confidence            7999999999999999999997        9998764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-30  Score=251.10  Aligned_cols=252  Identities=20%  Similarity=0.296  Sum_probs=204.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|.+.++||+|+|+.|.++..        .++.+.+|+|.+|+..-+..+.++=.+.|-.+..+- +||.+|-++.+|
T Consensus       249 l~df~ll~vigrgsyakvl~~~~--------~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRL--------KKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccceeeeeecCcchhhhhheeh--------cccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            56899999999999999777665        447889999999999988888888788888888887 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+..+++|.||++||+|--++++.   +.++++.+.-+...|+.||.|||+   +|||.||||.+|+|+|..|.+||.|
T Consensus       321 qtesrlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  321 QTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             cccceEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecc
Confidence            9999999999999999998887743   359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-hHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-SLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~  382 (522)
                      +|+++..-...  ..+..++||+.|.|||.+.+..|....|-|+|||+++||+.|+.||+.-...+.+ +-..+..+.+.
T Consensus       395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            99996533222  2334679999999999999999999999999999999999999999744333222 12222222221


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP  422 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP  422 (522)
                      +..          ...+...+.+...+++.-|++||.+|.
T Consensus       473 ekq----------iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  473 EKQ----------IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhc----------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence            111          111222334455677788999999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-30  Score=259.68  Aligned_cols=275  Identities=21%  Similarity=0.299  Sum_probs=201.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-----CC---C
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-----QK---S  215 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-----Hp---n  215 (522)
                      ..++|-+.++||.|.|++|||+-+.+        ..+.+|+|+.|.|..-    .+.-+.||++|++++     |+   +
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq--------~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQ--------NKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeecc--------CCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            35799999999999999999988765        6678888888765542    345677999999982     43   5


Q ss_pred             cceeeEEEEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          216 ITTLNGVCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       216 Iv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      ||+|++.|..    +.++++|+|++ |-+|..+|....- +.++...+..|+.||+.||.|||..  .||||-||||+||
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENv  219 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENV  219 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCccee
Confidence            9999999984    46899999999 6699999987643 3499999999999999999999997  6899999999999


Q ss_pred             eccCC---------------------------------------------------------------------------
Q 036172          292 LLSSD---------------------------------------------------------------------------  296 (522)
Q Consensus       292 Ll~~~---------------------------------------------------------------------------  296 (522)
                      |+..+                                                                           
T Consensus       220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~  299 (590)
T KOG1290|consen  220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN  299 (590)
T ss_pred             eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence            98100                                                                           


Q ss_pred             --------------------------------------------------------------------------------
Q 036172          297 --------------------------------------------------------------------------------  296 (522)
Q Consensus       297 --------------------------------------------------------------------------------  296 (522)
                                                                                                      
T Consensus       300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~  379 (590)
T KOG1290|consen  300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL  379 (590)
T ss_pred             ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence                                                                                            


Q ss_pred             -----------CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          297 -----------FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       297 -----------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                                 .++||+|||-|.+.....+     .-..|..|.|||++.+..|+..+||||++|++|||+||...|...
T Consensus       380 v~p~~~~~~~di~vKIaDlGNACW~~khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh  454 (590)
T KOG1290|consen  380 VNPDIPLPECDIRVKIADLGNACWVHKHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH  454 (590)
T ss_pred             cCCCCCCCccceeEEEeeccchhhhhhhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence                       0123333333333222111     113466899999999999999999999999999999999999644


Q ss_pred             CCCC----hhhHHHhh-------hhhhcCCCc-ccccCC----------c-------c--cccccHHHHHHHHHHHHHhh
Q 036172          366 NLKG----PESLVKWA-------KPILKNGDT-ETLLDP----------K-------L--SNEYDNAQMQRMLLAANLCI  414 (522)
Q Consensus       366 ~~~~----~~~l~~~~-------~~~~~~~~~-~~~~d~----------~-------l--~~~~~~~~~~~l~~li~~CL  414 (522)
                      .-.+    .+.+...+       +.+...|+. ..+++.          +       |  .-.++.+...++.+++.-||
T Consensus       455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL  534 (590)
T KOG1290|consen  455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML  534 (590)
T ss_pred             CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence            3222    22222111       111222221 111111          0       0  12355677889999999999


Q ss_pred             hcCCCCCCCHHHHHHHHhccccCCccccccccc
Q 036172          415 NQSPQLRPNMGQVLKLLRGATHATDWVDRHADD  447 (522)
Q Consensus       415 ~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~~  447 (522)
                      +.+|++|||+.+.++        |+|+..-...
T Consensus       535 ef~PeKR~tA~~cl~--------hPwLn~~~~~  559 (590)
T KOG1290|consen  535 EFDPEKRPTAAQCLK--------HPWLNPVAGP  559 (590)
T ss_pred             hcCccccccHHHHhc--------CccccCCCCC
Confidence            999999999999998        9998865443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=260.44  Aligned_cols=262  Identities=21%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc----hHHHHHHHHHHHHhhCCCCCcceee
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS----SAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~----~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ..+|-+...||.|||+.||.+-+..        ..+.+|+|.-....+.-.    .-.+...+|.+|.+.|.||.||++|
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~--------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT--------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc--------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            4689999999999999988776543        344444433111111101    1345678899999999999999999


Q ss_pred             EEEE-eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---C
Q 036172          221 GVCI-EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---D  296 (522)
Q Consensus       221 ~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---~  296 (522)
                      ++|. +...+|-|+|||+|.+|+-+|..+   +.+++.++..|+.||+.||.||.+. ..+|||-||||.||||-.   -
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence            9998 456789999999999999999854   3599999999999999999999974 378999999999999954   4


Q ss_pred             CceEEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHG----KVSDKIDVYSFGVVLLELLSGRRPIGFKNL  367 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~  367 (522)
                      |.+||.|||+++.+.......     ......||.+|++||.+.-+    +.+.|+||||+|||+|..+.|+.||+....
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            689999999998876654332     23457899999999998543    478899999999999999999999975422


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                        ...+... ..++....+.....        +....+...+|++||++.-++|....++..
T Consensus       690 --QQdILqe-NTIlkAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  690 --QQDILQE-NTILKATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --HHHHHhh-hchhcceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              2222221 11122111111111        123346778999999999999988888765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.3e-29  Score=271.90  Aligned_cols=279  Identities=19%  Similarity=0.198  Sum_probs=187.2

Q ss_pred             CCCCCceeeecccccccccccccCchhH----HH----HhhcccCccchHHHHHHHhhcc-----------chHHHHHHH
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTEL----FL----KLVSSRCRQFSYEELKQATSQF-----------SSAWNDFSS  203 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~----~~----~~~~~~~~~~a~k~l~~~t~~~-----------~~~~~~f~~  203 (522)
                      ...++|++.++||+|+||.||++.....    ..    .......+.+++|.++......           ....+.+..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999998753211    00    0112234567777654321110           012234556


Q ss_pred             HHHHHhhCCCCCc-----ceeeEEEEe--------CCEEEEEEecCCCCCHHHHhhccCC--------------------
Q 036172          204 EVDITSSLEQKSI-----TTLNGVCIE--------DNYLILVSDFLPKGSLEESLHGAGE--------------------  250 (522)
Q Consensus       204 Ev~iL~~L~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------  250 (522)
                      |+.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            8888888877654     678888763        3568999999999999999975311                    


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCC
Q 036172          251 -QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI  329 (522)
Q Consensus       251 -~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~  329 (522)
                       ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence             1125677889999999999999999   99999999999999999999999999999654332211 111224578999


Q ss_pred             ChhhhccCC----------------------CCchhhHHHHHHHHHHHHcCCC-CCCCCCCCCh------hhHHHhhhhh
Q 036172          330 APEYLMHGK----------------------VSDKIDVYSFGVVLLELLSGRR-PIGFKNLKGP------ESLVKWAKPI  380 (522)
Q Consensus       330 APE~~~~~~----------------------~s~ksDVwSlGvvl~eLltG~~-Pf~~~~~~~~------~~l~~~~~~~  380 (522)
                      |||.+....                      ...+.||||+||++++|++|.. ||........      ..+..|.  .
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--M  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--h
Confidence            999975432                      1235799999999999999876 6642211100      0111111  1


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSP---QLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP---~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ......    +    -...........+++.++|..+|   .+|+|+.|+|+        |+|+..
T Consensus       456 ~~~~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~--------Hp~f~~  505 (507)
T PLN03224        456 YKGQKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS--------HRFFLP  505 (507)
T ss_pred             hcccCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC--------CCCcCC
Confidence            111111    0    00112234667889999999766   68999999997        999753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=249.12  Aligned_cols=266  Identities=21%  Similarity=0.233  Sum_probs=208.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..|++....+-+|.||.||.+...+.   ..-.+++.+-.|.++...+..  .+..|..|.-+|..+.|||+.++.+++.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eE---dt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREE---DTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhheechhhhhcCchhheeeeeeccc---CCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            34677788899999999999854421   001123444455555433332  6678999999999999999999999998


Q ss_pred             eC-CEEEEEEecCCCCCHHHHhhc-----cCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 ED-NYLILVSDFLPKGSLEESLHG-----AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~-~~~~lV~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ++ ...++++.++.-|+|..+|..     ......++..+...++.|++.|++|||+   .+|||.||...|.+|++..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhee
Confidence            65 678899999999999999983     2233457788889999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|=.+++-.-....+.....-.....||+||.+.+..|+.++|||||||++|||+| |+.|+..-++.+.....   
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl---  511 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL---  511 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH---
Confidence            99999999975544444443334456788999999999999999999999999999999 99998654433322222   


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                          .+|.         +...+.+++.++..++..||...|++||+++|++.-|.+.
T Consensus       512 ----kdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 ----KDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ----hccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                2221         1222345778899999999999999999999999988764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-31  Score=250.72  Aligned_cols=272  Identities=18%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...-+.+-+++||+|+||.||-+++-        ..++.+++|.+...-.+.. ..+++.+|+++|..++|.|++..+++
T Consensus        50 qqq~Di~PDRPIGYGAFGVVWsVTDP--------RdgrrvalkK~pnvfq~L~-s~krvFre~kmLcfFkHdNVLSaLDI  120 (449)
T KOG0664|consen   50 QQQQDIQPDRPIGYGAFGVVWSVTDP--------RSGKRVALKKMPNVFQNLA-SCKRVFREIKMLSSFRHDNVLSLLDI  120 (449)
T ss_pred             cccccCCCCCcccccceeEEEeccCC--------CCccchhHhhcchHHHHHH-HHHHHHHHHHHHHhhccccHHHHHHh
Confidence            34456677899999999999987653        3567777776654333322 45789999999999999999999988


Q ss_pred             EEeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          223 CIED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       223 ~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ..-.     ..+|+|+|++.. +|..++-.   ...++...+.-+++||++||+|||+   .+|+||||||.|+|++.+.
T Consensus       121 LQPph~dfFqEiYV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNC  193 (449)
T KOG0664|consen  121 LQPANPSFFQELYVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNC  193 (449)
T ss_pred             cCCCCchHHHHHHHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCc
Confidence            7644     347889999955 99988873   3458999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||||||+++.-..+...... .-+-|..|.|||.+++. .|+.+.||||.||++.||+.++..|...++-.+-.++.-
T Consensus       194 vLKICDFGLARvee~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd  272 (449)
T KOG0664|consen  194 ILKICDFGLARTWDQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID  272 (449)
T ss_pred             eEEecccccccccchhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence            9999999999865554433322 23568899999999876 589999999999999999999999876654433222211


Q ss_pred             ----------------hhhhhcCCCcccccCCcccc-cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          377 ----------------AKPILKNGDTETLLDPKLSN-EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       377 ----------------~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                                      ++..+..+.....--+.+.. ..+...-..-..+..+++..+|++|.+..+.+..+
T Consensus       273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                            11111111111100011110 00111223455677789999999999999888744

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=235.98  Aligned_cols=202  Identities=23%  Similarity=0.306  Sum_probs=166.6

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIED  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~  226 (522)
                      -..+..||.|+||.|.+.++..        ++...|.|.++...+  +...++.++|+++..+. ..|.+|.+||...+.
T Consensus        48 L~~i~elGrGayG~vekmrh~~--------sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQ--------SGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             hhhhhhhcCCccchhhheeecc--------CCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            3445679999999977666543        667778887766544  34667889999998777 899999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      +.+++.||.|.- ||..+-... ..+..+++..+-+|+..+++||.|||+.  ..+||||+||+|||++.+|++|+||||
T Consensus       118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccc
Confidence            999999999965 888776543 3455699999999999999999999995  789999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      ++-.+.+....   .-..|...|||||.+.    ...|+.|+||||||+.+.||.+++.||...
T Consensus       195 IsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  195 ISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             cceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99655443322   2236888999999984    346899999999999999999999998643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=268.70  Aligned_cols=242  Identities=24%  Similarity=0.304  Sum_probs=182.8

Q ss_pred             eccccccccc-ccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEE
Q 036172          152 IPCSEGKYDE-NTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYL  229 (522)
Q Consensus       152 ~~lG~G~fg~-V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~  229 (522)
                      +.+|.|+-|+ ||++.-          ..|.||+|.+......      ...+|+..|+.- +|||||++++.-.+...+
T Consensus       515 eilG~Gs~Gt~Vf~G~y----------e~R~VAVKrll~e~~~------~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~  578 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY----------EGREVAVKRLLEEFFD------FAQREIQLLQESDEHPNVIRYYCSEQDRQFL  578 (903)
T ss_pred             HHcccCCCCcEEEEEee----------CCceehHHHHhhHhHH------HHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence            5678888876 455431          4568888887764433      356899999988 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHhhccCCC-CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---C--CceEEee
Q 036172          230 ILVSDFLPKGSLEESLHGAGEQ-SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---D--FQPQLSD  303 (522)
Q Consensus       230 ~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---~--~~~kL~D  303 (522)
                      ||..|+|.. +|.+++...+.. ........+.++.|+++||++||+   .+||||||||.||||+.   +  .+++|+|
T Consensus       579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecc
Confidence            999999965 999999864111 111114457789999999999999   99999999999999976   2  4799999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG-RRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||+++....+.... ......||-+|+|||++....-+.++||||||||+|+.++| ..||+...... .+       ++
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N-------Il  726 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN-------IL  726 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh-------hh
Confidence            99998776654433 34567899999999999988888999999999999999995 99997432111 11       11


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ........+.+    .  .+.  ...+||.+|++.+|..||++.+|+.
T Consensus       727 ~~~~~L~~L~~----~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 TGNYTLVHLEP----L--PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cCccceeeecc----C--chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11111111111    1  111  6678999999999999999999996

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=8.5e-28  Score=225.73  Aligned_cols=212  Identities=31%  Similarity=0.486  Sum_probs=177.5

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||.|.||.||++....        ..+.+.+|.+.......  ..+.+.+|+.+++.++|++|+++++++......++++
T Consensus         1 l~~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~   70 (215)
T cd00180           1 LGEGGFGTVYLARDKK--------TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVM   70 (215)
T ss_pred             CCcCCceEEEEEEecC--------CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEE
Confidence            6899999999987543        23445555444322111  3567999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CCceEEeecCccccCCC
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~~~kL~DFGla~~~~~  312 (522)
                      ||+++++|.+++....  ..+++..++.++.+++.+|.+||+   .+++|+||+|.||+++. ++.++|+|||.+.....
T Consensus        71 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          71 EYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             ecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            9999899999997542  348999999999999999999999   99999999999999999 89999999999976544


Q ss_pred             CCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          313 DSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       313 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      ...  ......+...|++||.+... ..+.+.|+|++|+++++|                                    
T Consensus       146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence            331  12234678899999999777 788999999999999998                                    


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                                  ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                        457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.3e-28  Score=229.45  Aligned_cols=266  Identities=19%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~  222 (522)
                      ...+|++.+++|+|.|+.|+-+.+..        +....-+|.||...      .+.+.+|+.||..|. ||||++++++
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~--------~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~Di  101 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINIT--------NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDI  101 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccC--------CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhh
Confidence            56799999999999999988776432        22222333333221      245789999999995 9999999999


Q ss_pred             EEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ce
Q 036172          223 CIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QP  299 (522)
Q Consensus       223 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~  299 (522)
                      ..+.  ....||+||+.+.+...+..      .++...+..++.+++.||.|+|+   .||.|||+||.|++||... .+
T Consensus       102 V~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  102 VKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             hcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhcee
Confidence            9865  56889999999987777654      37888899999999999999999   9999999999999999754 69


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +|+|+|+|.+.........   .+.+..|--||.+..- .|...-|+|||||++..|+..+.|| +....+.+++++.++
T Consensus       173 rlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF-FhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVKIAK  248 (338)
T ss_pred             eeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc-cCCCCCHHHHHHHHH
Confidence            9999999988766544432   2566778899998764 4788999999999999999999998 344455666666554


Q ss_pred             hhhcC------CCcccccCCcccc----------------cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          379 PILKN------GDTETLLDPKLSN----------------EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       379 ~~~~~------~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      -+-..      .+..--+||....                +...-...+.++++.+.|..|-.+|||+.|.+.       
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~-------  321 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA-------  321 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc-------
Confidence            22100      0011112222111                001112367889999999999999999999986       


Q ss_pred             CCcccccc
Q 036172          437 ATDWVDRH  444 (522)
Q Consensus       437 ~~~~~~~~  444 (522)
                       |+|+..-
T Consensus       322 -HpyF~~~  328 (338)
T KOG0668|consen  322 -HPYFAPV  328 (338)
T ss_pred             -CchHHHH
Confidence             8887653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=253.89  Aligned_cols=201  Identities=21%  Similarity=0.295  Sum_probs=164.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchH-----HHHHHHHHHHHhhCC---CCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSA-----WNDFSSEVDITSSLE---QKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~-----~~~f~~Ev~iL~~L~---HpnI  216 (522)
                      -..|...+++|+|+||.|+++.+++        +...+-+|-|.+...-....     .-..-.|+.||+.|+   |+||
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~--------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKE--------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cccceeeeeccccccceEEEeeecc--------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            3469999999999999999998654        23333344443322211111     112335999999997   9999


Q ss_pred             ceeeEEEEeCCEEEEEEecC-CCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          217 TTLNGVCIEDNYLILVSDFL-PKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ++++++|++++++||+||-. ++-+|.+++..+   ..+++.++..|+.|++.|+++||+   .+|||||||-+|+.++.
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~  705 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDS  705 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEec
Confidence            99999999999999999975 566999999844   459999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIG  363 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~  363 (522)
                      +|-+||+|||.+.....+...    .++||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus       706 ~g~~klidfgsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  706 NGFVKLIDFGSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CCeEEEeeccchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999999776655443    4689999999999988877 567899999999999999999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=238.27  Aligned_cols=269  Identities=20%  Similarity=0.220  Sum_probs=194.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|.-.+++|.|.= .|--        +......+.+++|.+...-.+ ....++..+|..++..++|+||++++.++
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~--------a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~f   84 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVA--------AFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVF   84 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEe--------cchhhccCceehhhhcCcccc-Cccchhhhhhhhhhhhhcccceeeeeecc
Confidence            4568888888888753 2211        222334556666655444222 44567888999999999999999999999


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      .-.      ...|+||||+.. +|...+..     .++-.++..|+.|++.|++|||+   .+|+||||||+||++..+.
T Consensus        85 tP~~~l~~~~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~  155 (369)
T KOG0665|consen   85 TPQKTLEEFQEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDC  155 (369)
T ss_pred             CccccHHHHHhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchh
Confidence            843      468999999965 99999873     27778899999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh------
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE------  371 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~------  371 (522)
                      .+||.|||+|+.....   ........|..|.|||++.+..+...+||||+||++.||++|+.-|.+...-++-      
T Consensus       156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~  232 (369)
T KOG0665|consen  156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ  232 (369)
T ss_pred             heeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence            9999999999764443   2334667899999999998888999999999999999999999988643321110      


Q ss_pred             ----------hHHHhhhhhhcC------CCccccc-CCcccc--cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          372 ----------SLVKWAKPILKN------GDTETLL-DPKLSN--EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       372 ----------~l~~~~~~~~~~------~~~~~~~-d~~l~~--~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                                .+...+......      -....++ |.....  +.+.-......+++.+||..||++|.+++++|.   
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~---  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR---  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc---
Confidence                      011111111110      0111111 111111  111122345677899999999999999999997   


Q ss_pred             ccccCCcccc
Q 036172          433 GATHATDWVD  442 (522)
Q Consensus       433 ~~~~~~~~~~  442 (522)
                           |++++
T Consensus       310 -----HPY~~  314 (369)
T KOG0665|consen  310 -----HPYIK  314 (369)
T ss_pred             -----CCeee
Confidence                 88776

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=2.2e-28  Score=250.03  Aligned_cols=265  Identities=21%  Similarity=0.226  Sum_probs=204.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC------CCcce
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ------KSITT  218 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H------pnIv~  218 (522)
                      .++|.|....|.|-|++|..|.+..        .+..||+|.|.....    ..+.=+.|++||++|+.      -|+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~--------r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQA--------RGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccC--------CCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            4689999999999999988877643        444788887754222    44556789999999943      38999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-C
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-F  297 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~  297 (522)
                      |+..|...+++|||+|-+. .+|.++|...+....|....+..++.|+.-||..|-.   .+|+|.||||+|||+++. .
T Consensus       499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence            9999999999999999994 5999999998888889999999999999999999999   999999999999999875 5


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||||||.|.........    .+.-+..|.|||++.+..|+...|+||+||+||||.||+..|........-.+..-.
T Consensus       575 iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            6899999999665543322    234566799999999999999999999999999999999999766544332222211


Q ss_pred             h-----hhhcCCCc-cccc--------------------------CC------cc-----cccccHHHHHHHHHHHHHhh
Q 036172          378 K-----PILKNGDT-ETLL--------------------------DP------KL-----SNEYDNAQMQRMLLAANLCI  414 (522)
Q Consensus       378 ~-----~~~~~~~~-~~~~--------------------------d~------~l-----~~~~~~~~~~~l~~li~~CL  414 (522)
                      +     .++..+.+ .+.+                          .|      .+     ...-.......|.+|+..||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            1     11111111 1111                          11      00     11122345678999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 036172          415 NQSPQLRPNMGQVLK  429 (522)
Q Consensus       415 ~~dP~~RPs~~eVl~  429 (522)
                      ..||++|.|..+.|+
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999999996

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.5e-26  Score=221.54  Aligned_cols=201  Identities=31%  Similarity=0.426  Sum_probs=167.3

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      |.+...||.|+||.||++....        ....+++|.+......  ...+.+.+|++.+++++|+|++++++++....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~   70 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG--------TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPE   70 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC--------CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCC
Confidence            5678899999999999987543        2345555555432221  24678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++++||+++++|.+++.....  .+++..+..++.+++.+|.+||+   .+++|+||+|.||+++.++.++|+|||.+
T Consensus        71 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       71 PLYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             ceEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            99999999999999999985432  17899999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLLELLSGRRPIGF  364 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~  364 (522)
                      ......... ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       146 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            766544211 12234678899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=7.1e-28  Score=252.66  Aligned_cols=254  Identities=21%  Similarity=0.294  Sum_probs=195.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|+...++|.|+||.||+++++.        +....++|.+|-.-.   +.++-.++|+-+++..+|||||.++|.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~--------s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsy   81 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKR--------SGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSY   81 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccc--------cCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhh
Confidence            45689999999999999999988654        344455555443221   1334567899999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .....++++||||.+|+|.+.-+..   .++++.++..+.+..+.||+|||+   .+-+|||||-.|||+++.|.+|++|
T Consensus        82 lr~dklwicMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   82 LRRDKLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             hhhcCcEEEEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecc
Confidence            9999999999999999999998854   359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||.+..+...  ......+.||+.|||||+.   ..+.|..++|||++|+...|+---++|.-.  ....+.+....+..
T Consensus       156 fgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--lhpmr~l~LmTkS~  231 (829)
T KOG0576|consen  156 FGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--LHPMRALFLMTKSG  231 (829)
T ss_pred             cCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--cchHHHHHHhhccC
Confidence            9998554332  2234567899999999996   457799999999999999999887777321  11111111111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL  428 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl  428 (522)
                      .   +...+-|+       ......+.++++.||.++|++||++..+|
T Consensus       232 ~---qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  232 F---QPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             C---CCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            1   11122222       22345688899999999999999998665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=2.4e-27  Score=270.63  Aligned_cols=198  Identities=21%  Similarity=0.236  Sum_probs=140.7

Q ss_pred             HhhCCC-CCcceeeEEE-------EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 036172          208 TSSLEQ-KSITTLNGVC-------IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR  279 (522)
Q Consensus       208 L~~L~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~  279 (522)
                      .+.++| +||++++++|       .+...+++++||+ +++|.++|...  ...+++.+++.++.||+.||.|||+   +
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~   99 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHS---Q   99 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHh---C
Confidence            345566 6888888887       3335678889988 55999999743  2359999999999999999999999   9


Q ss_pred             CEEeccCCCCceeccCCC-------------------ceEEeecCccccCCCCCC--------------CccccccccCC
Q 036172          280 PVIHRDVKSSNILLSSDF-------------------QPQLSDFGLAIWGPTDST--------------HMIREDVVGTF  326 (522)
Q Consensus       280 giiHrDIkp~NILl~~~~-------------------~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~  326 (522)
                      +|+||||||+||||+..+                   .+|++|||+++.......              ........||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            999999999999996544                   455666666543211000              00011235788


Q ss_pred             CCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHH
Q 036172          327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRM  406 (522)
Q Consensus       327 ~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  406 (522)
                      .|+|||++.+..++.++|||||||+||||++|..|+....    ..+......         .+.+..     .......
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~  241 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKE  241 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence            9999999999999999999999999999999988864211    011110000         011111     0112345


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 036172          407 LLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       407 ~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..++.+||+.+|.+||++.+|++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            67888999999999999999987

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=9.1e-27  Score=234.32  Aligned_cols=274  Identities=24%  Similarity=0.312  Sum_probs=202.1

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCccee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTL  219 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l  219 (522)
                      .+...+-|.++.+||+|+|+.||.+.....     ....+.|++|.+-...     ...+..+|+++|..+ .+.||+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~-----~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~  100 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ-----DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKL  100 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh-----ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcc
Confidence            344567899999999999999999876541     3466788888776533     346799999999999 89999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-Cc
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQ  298 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~  298 (522)
                      .+++..++...+|+||++.-...+++..      ++...+..+++.++.||.++|.   +|||||||||+|+|.+.. +.
T Consensus       101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             hhhhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCC
Confidence            9999999999999999999999998873      7788999999999999999999   999999999999999854 57


Q ss_pred             eEEeecCccccCCCC------------------------------------------CCCccccccccCCCCCChhhhcc
Q 036172          299 PQLSDFGLAIWGPTD------------------------------------------STHMIREDVVGTFGYIAPEYLMH  336 (522)
Q Consensus       299 ~kL~DFGla~~~~~~------------------------------------------~~~~~~~~~~gt~~Y~APE~~~~  336 (522)
                      -.|.|||+|......                                          ......-...||++|.|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            899999999621000                                          00000113469999999999865


Q ss_pred             -CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh---------hhhcCCC--c----------------cc
Q 036172          337 -GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK---------PILKNGD--T----------------ET  388 (522)
Q Consensus       337 -~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~---------~~~~~~~--~----------------~~  388 (522)
                       ...+.++||||.|||++-+++++.||-.... +...+...+.         -....|.  +                ..
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s  330 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFET  330 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhc
Confidence             4579999999999999999999999843221 1111111100         0000011  0                00


Q ss_pred             c----cCC--c--cc-ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          389 L----LDP--K--LS-NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       389 ~----~d~--~--l~-~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      +    +.+  .  .. .......+..+.+++.+||..||.+|.|+++.|+        |+++.
T Consensus       331 ~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--------HpFF~  385 (418)
T KOG1167|consen  331 LHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--------HPFFD  385 (418)
T ss_pred             cChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--------CcCCc
Confidence            0    000  0  00 0111122347889999999999999999999998        87776

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=221.24  Aligned_cols=253  Identities=19%  Similarity=0.326  Sum_probs=181.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE-
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV-  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~-  222 (522)
                      ...|.+.+.||+|.||.+-++++..        ....+.+|.+.+..    ....+|.+|...--.| .|.||+.-|++ 
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~--------s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQ--------SKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccC--------CceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            4679999999999999999988754        22333333332211    1457899999876666 78999988765 


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--CCceE
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--DFQPQ  300 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--~~~~k  300 (522)
                      |...+.+++++||++.|+|..-+...    .+-+.-..+++.|+++||.|||+   .++||||||.+||||..  ..++|
T Consensus        91 Fqt~d~YvF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvK  163 (378)
T KOG1345|consen   91 FQTSDAYVFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVK  163 (378)
T ss_pred             hhcCceEEEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEE
Confidence            55667899999999999999988753    37888889999999999999999   99999999999999943  34899


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhcc---C--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---G--KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~--~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      |||||+.+..+..-     ....-+..|.+||....   +  ...+.+|||.||+++|.++||..||+....... ....
T Consensus       164 lcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~  237 (378)
T KOG1345|consen  164 LCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWE  237 (378)
T ss_pred             eeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHH
Confidence            99999986544322     22345677999998642   2  357789999999999999999999984443332 2222


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      |..  +..+...     .++..+. ........+.++-|..+|++|=-.-++-++
T Consensus       238 ~~~--w~~rk~~-----~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  238 WEQ--WLKRKNP-----ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHH--HhcccCc-----cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            221  2222222     1122221 234456677888999999999555555443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=5.9e-25  Score=204.41  Aligned_cols=167  Identities=23%  Similarity=0.229  Sum_probs=125.6

Q ss_pred             CCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCcc
Q 036172          239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI  318 (522)
Q Consensus       239 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  318 (522)
                      |+|.+++...  +..+++..++.++.|++.||.|||+   .+      ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence            6999999853  2359999999999999999999999   55      999999999999999  99987654322    


Q ss_pred             ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccc
Q 036172          319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY  398 (522)
Q Consensus       319 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  398 (522)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....... ...      .+.. ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~------~~~~-~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGM-PAD------DPRD-RSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHh-ccC------Cccc-ccc
Confidence               258899999999999999999999999999999999999986432211 1111111111 000      0000 011


Q ss_pred             cHHHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          399 DNAQMQ--RMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       399 ~~~~~~--~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ......  .+.+++.+||..+|.+||++.++++.+...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            122233  689999999999999999999999976544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-24  Score=223.30  Aligned_cols=264  Identities=19%  Similarity=0.214  Sum_probs=194.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC----CCcceeeEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ----KSITTLNGV  222 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H----pnIv~l~~~  222 (522)
                      +|++.++||+|+||.||++.+....       ...+++|........   ....+..|+.++..+..    +++..+++.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-------~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~   88 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-------NKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDH   88 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-------CeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEe
Confidence            8999999999999999999865421       223333332221111   11157789999999963    689999999


Q ss_pred             E-EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-----
Q 036172          223 C-IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-----  296 (522)
Q Consensus       223 ~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-----  296 (522)
                      + ..+...++||+.+ |.+|.++..... ...++..+++.|+.|++.+|.+||+   .|++||||||.|+++...     
T Consensus        89 G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~  163 (322)
T KOG1164|consen   89 GRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEV  163 (322)
T ss_pred             ccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCccc
Confidence            9 4778899999999 789999887654 4569999999999999999999999   999999999999999765     


Q ss_pred             CceEEeecCccc--cCCCCCCC---cc---ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036172          297 FQPQLSDFGLAI--WGPTDSTH---MI---REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK  368 (522)
Q Consensus       297 ~~~kL~DFGla~--~~~~~~~~---~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~  368 (522)
                      ..+.|.|||+++  .+......   ..   .....||..|+++..+.+...+.+.|+||++.++.+++.|..||......
T Consensus       164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            369999999998  32222211   11   12356999999999999999999999999999999999999999654433


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      ...............   ..         .....+..+..+...+-..+...+|....+...|+.....
T Consensus       244 ~~~~~~~~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  244 DLKSKFEKDPRKLLT---DR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             chHHHHHHHhhhhcc---cc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            222111111110000   00         1112234566666666678999999999999998776543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.8e-24  Score=208.61  Aligned_cols=265  Identities=17%  Similarity=0.155  Sum_probs=198.9

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      -+.-.|+|+++||+|.||..+++.+.-        +...+|+|-=..     .+...++..|.+..+.| ..++|..+|-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~--------nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYY   91 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLY--------NNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYY   91 (449)
T ss_pred             EecccceeccccccCcceeeecccccc--------cCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceee
Confidence            345689999999999999988887642        445555553221     11345678899999988 6789999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-----
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-----  296 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-----  296 (522)
                      +..++.+-.||+|++ |.||+|++.-+++  .|+.+++..++.|++.-++|+|+   +.+|.|||||+|+||...     
T Consensus        92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~  165 (449)
T KOG1165|consen   92 FGQEGKYNILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDA  165 (449)
T ss_pred             eccccchhhhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCC
Confidence            999999999999999 8899999987654  49999999999999999999999   999999999999999643     


Q ss_pred             CceEEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          297 FQPQLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      ..+.|+|||+|+.+....+..     ..+...||.+||+-..+.+.+.+.+.|+-|||-|+++++-|..||..-.-....
T Consensus       166 n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK  245 (449)
T KOG1165|consen  166 NVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK  245 (449)
T ss_pred             ceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence            358999999998765433221     234568999999999999999999999999999999999999999754332221


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .-.+.+...-+...         ........+.++...+.-.-..+-.+-|..+-+...+....
T Consensus       246 ~kYeKIGe~Kr~T~---------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  246 EKYEKIGETKRSTP---------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             HHHHHhccccccCC---------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            11111111001001         11122234556777777777888888998877766665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.6e-22  Score=200.76  Aligned_cols=264  Identities=27%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCC-CcceeeEEEEeC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQK-SITTLNGVCIED  226 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hp-nIv~l~~~~~~~  226 (522)
                      |.+...||.|+||.||.+...           ..+++|.+.............|.+|+.++..+.|+ +|+++++++...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-----------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   70 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-----------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE   70 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-----------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC
Confidence            778899999999999998865           44455555554444434578899999999999988 799999999888


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~kL~DFG  305 (522)
                      ...+++++++.+++|.+++........+.......++.|++.++.|+|.   .+++|||+||+||+++..+ .++++|||
T Consensus        71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccC
Confidence            8889999999999999777643211258999999999999999999999   9999999999999999988 79999999


Q ss_pred             ccccCCCCCCCc----cccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-ChhhHHHhh
Q 036172          306 LAIWGPTDSTHM----IREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK-GPESLVKWA  377 (522)
Q Consensus       306 la~~~~~~~~~~----~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~-~~~~l~~~~  377 (522)
                      .+..........    ......|+..|+|||.+..   ..++...|+||+|++++++++|..||...... .........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            997554433221    2346689999999999987   57899999999999999999999997654421 011111111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      ...... ......    ...........+.+++..|+..+|..|.+..+....
T Consensus       228 ~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         228 LELPTP-SLASPL----SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HhcCCc-cccccc----CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111100 000000    110002223567789999999999999999987764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.3e-23  Score=194.88  Aligned_cols=263  Identities=19%  Similarity=0.186  Sum_probs=196.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC-CCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H-pnIv~l~~~  222 (522)
                      ..++|+++++||.|+||.+|++....        .+..+|+|.=.. +    ....++..|.++...|+| ..|..+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~--------~ge~VAiK~Es~-~----a~hpqL~yEskvY~iL~~g~GiP~i~~y   79 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISIT--------SGEEVAIKLESS-K----AKHPQLLYESKVYRILQGGVGIPHIRHY   79 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeecc--------CCceEEEEeecc-c----CCCcchhHHHHHHHHhccCCCCchhhhh
Confidence            46899999999999999999987543        334444443111 1    123467889999999965 678888889


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---Cce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---FQP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---~~~  299 (522)
                      ..+..+-.+||+++ |.||++++.-...  .++..+++.++-|++.-++|+|.   +++|||||||+|+|..-+   ..+
T Consensus        80 ~~e~~ynvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl  153 (341)
T KOG1163|consen   80 GTEKDYNVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKL  153 (341)
T ss_pred             ccccccceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceE
Confidence            99999999999999 8899999986543  49999999999999999999999   999999999999998643   469


Q ss_pred             EEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          300 QLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      .|+|||+++.+.......     ......||..|++--.+.+...+...|+-|+|.||.++.-|..||..-......+..
T Consensus       154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            999999997664432211     223567999999999998888999999999999999999999999865544333222


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      +.+...    +....     ........+.++...+.-|-..--++-|...-+.+.++-.
T Consensus       234 EkI~Ek----K~s~~-----ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  234 EKISEK----KMSTP-----IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             HHHHHh----hcCCC-----HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            211111    11000     0111122345677788889999999999887777665543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=8.9e-24  Score=231.46  Aligned_cols=264  Identities=19%  Similarity=0.208  Sum_probs=192.2

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHH---HhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~---~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .....+|.|+||.|+.+....        ....|+.+....   .+..-......+..|+-+-..|.|+|++..+..+.+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~--------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS--------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE  392 (601)
T ss_pred             CccceeeecccCceEEEEecC--------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh
Confidence            346778999999666554321        112222222110   000000011226678888999999999888888777


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....+-+||||++ +|..++...   ..+...++..++.|++.|+.|||.   .|+.|||+|++|+++..+|.+||+|||
T Consensus       393 ~~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  393 IDGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             cccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecC
Confidence            6666666999999 999999854   348889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCC--ccccccccCCCCCChhhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      .+..+......  .......|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||............  .   ..
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~---~~  540 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--N---NY  540 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--h---cc
Confidence            99766554443  4555788999999999999888865 689999999999999999999765544332100  0   00


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                         ....-...-........+.+...++.+||+.+|.+|.|+.+|++        .+|++.
T Consensus       541 ---~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--------d~W~~~  590 (601)
T KOG0590|consen  541 ---SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--------DEWIRS  590 (601)
T ss_pred             ---ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--------ChHhhh
Confidence               00000011112223445677888999999999999999999998        888775

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.3e-22  Score=209.49  Aligned_cols=169  Identities=14%  Similarity=0.032  Sum_probs=124.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--ccchHHHHHHHHHHHHhhCCCCCcce-ee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--QFSSAWNDFSSEVDITSSLEQKSITT-LN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--~~~~~~~~f~~Ev~iL~~L~HpnIv~-l~  220 (522)
                      ..++|.+.+.||+|+||.||++....       .....+++|.+.....  ......+.|.+|+++|++|+|+||++ ++
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAG-------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcC-------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            45789999999999999999986532       0122345544321111  11224567999999999999999985 44


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccC-CCCceeccCCCce
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV-KSSNILLSSDFQP  299 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDI-kp~NILl~~~~~~  299 (522)
                      ++    +..+|||||++|++|.. +.   .   ..   ...++.+++.||.|||+   .||+|||| ||+|||++.++.+
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~-~~---~---~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHL-AR---P---HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHH-hC---c---cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCE
Confidence            32    45799999999999973 21   1   11   14678999999999999   99999999 9999999999999


Q ss_pred             EEeecCccccCCCCCCCcc------ccccccCCCCCChhhhcc
Q 036172          300 QLSDFGLAIWGPTDSTHMI------REDVVGTFGYIAPEYLMH  336 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~------~~~~~gt~~Y~APE~~~~  336 (522)
                      ||+|||+++..........      .....+++.|+|||++..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999986654332111      124678899999999854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-20  Score=179.26  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=178.2

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCE
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY  228 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~  228 (522)
                      .+.-+|.+..-|..|+++.......     .+..++.+.   +.   ....+|..|.-.|+-+.||||++++|.|....+
T Consensus       193 nl~tkl~e~hsgelwrgrwqgndiv-----akil~vr~~---t~---risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGNDIV-----AKILNVREV---TA---RISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhhhccCCCcccccccccCcchh-----hhhhhhhhc---ch---hhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            4455677777777777653211110     111111111   11   123578889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEE-eccCCCCceeccCCCceEEe--ecC
Q 036172          229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVI-HRDVKSSNILLSSDFQPQLS--DFG  305 (522)
Q Consensus       229 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~gii-HrDIkp~NILl~~~~~~kL~--DFG  305 (522)
                      +.++..||+.|+|..+|+.. ....++..++.+++.++++|++|||+-  .+++ ---|.+..+++|++.+++|.  |--
T Consensus       262 lv~isq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             ceEeeeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccce
Confidence            99999999999999999975 344578889999999999999999984  3343 34688899999999887764  321


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV---SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++         .......-.+.||+||.++..+-   -.++|+|||++++|||.|...||..-.+-+..  .+.+.    
T Consensus       339 fs---------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--mkial----  403 (448)
T KOG0195|consen  339 FS---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--MKIAL----  403 (448)
T ss_pred             ee---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--hhhhh----
Confidence            11         11112345788999999977653   35799999999999999999999654322211  11111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                               ..+....++..+..+.+++.-|++.||.+||.++.|+-.|++.
T Consensus       404 ---------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  404 ---------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                     1223344455667888999999999999999999999998864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1e-20  Score=182.69  Aligned_cols=174  Identities=10%  Similarity=0.135  Sum_probs=132.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHH------HHHHHHHHhhCCCCCcc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWND------FSSEVDITSSLEQKSIT  217 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~------f~~Ev~iL~~L~HpnIv  217 (522)
                      ..++|++.+.||.|+||.||+...          ..+.+++|.+...........+.      |.+|+..+.++.|++|.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            367999999999999999998543          13346666665444333333334      68999999999999999


Q ss_pred             eeeEEEEeC--------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          218 TLNGVCIED--------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       218 ~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      .+.+++...        +..+|||||++|.+|.++..       ++.    ....+++.+|..||.   .|++|||+||+
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~  164 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKG  164 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChH
Confidence            999986643        35899999999999988742       333    245699999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHH
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL  356 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLl  356 (522)
                      ||++++++ ++|+|||...........              ..++....+..++|+|+||+.+..+.
T Consensus       165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988 999999987544221111              11344455668999999999987764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7e-20  Score=192.96  Aligned_cols=218  Identities=23%  Similarity=0.378  Sum_probs=165.9

Q ss_pred             HhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCC
Q 036172          208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK  287 (522)
Q Consensus       208 L~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIk  287 (522)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+...  ...+++--...+++.++.||.|||+.  .-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            46789999999999999999999999999999999999863  33488888999999999999999993  333999999


Q ss_pred             CCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-------CCCchhhHHHHHHHHHHHHcCCC
Q 036172          288 SSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-------KVSDKIDVYSFGVVLLELLSGRR  360 (522)
Q Consensus       288 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwSlGvvl~eLltG~~  360 (522)
                      +.|.+++....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998665431111111122345679999998653       14778999999999999999999


Q ss_pred             CCCCCCCCCh-hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          361 PIGFKNLKGP-ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       361 Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ||........ ..++..+..     .....+.|.+....  +....+..++..||..+|.+||++.+|-..++....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9986443332 233333222     11222233332211  334478889999999999999999999998887764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=9.3e-21  Score=199.84  Aligned_cols=248  Identities=25%  Similarity=0.265  Sum_probs=196.8

Q ss_pred             cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEEEeCCEEEE
Q 036172          153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       153 ~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~l  231 (522)
                      .+|.|+||.|+++....     ....+..+++|.+++++..-.... ....|-.++..++ ||.+|++.-.+..+..+++
T Consensus         1 vlg~g~~gkvfLvrk~~-----g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAG-----GADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhc-----cccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            37999999999975432     244677889999998887665544 6777889999996 9999999999999999999


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      +++|..||.|...+...   ..+.+.....+...++-++.++|+   .+++|||+|++||+++.+|.+++.|||+++..-
T Consensus        75 ~ld~~rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             hhhhcccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhH
Confidence            99999999999888743   347777778888899999999999   999999999999999999999999999997644


Q ss_pred             CCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccC
Q 036172          312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD  391 (522)
Q Consensus       312 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  391 (522)
                      .....      +||..|||||++.  .....+|-||||++++||+||..||..          .....++.         
T Consensus       149 ~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~---------  201 (612)
T KOG0603|consen  149 KEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK---------  201 (612)
T ss_pred             hhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh---------
Confidence            33222      7999999999997  567889999999999999999999864          11111111         


Q ss_pred             CcccccccHHHHHHHHHHHHHhhhcCCCCCCCH--HHHHHHHhccc-cCCccc
Q 036172          392 PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM--GQVLKLLRGAT-HATDWV  441 (522)
Q Consensus       392 ~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~--~eVl~~L~~~~-~~~~~~  441 (522)
                        .....+.........++..++..+|.+|--.  .-+.+.++... ..++|.
T Consensus       202 --~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  202 --AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             --hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence              1223345556677778889999999999755  56666665543 345564

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=2.2e-20  Score=205.65  Aligned_cols=255  Identities=21%  Similarity=0.245  Sum_probs=181.0

Q ss_pred             CceeeecccccccccccccCchhHH--HHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELF--LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~--~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .|...+.||.++|=+|.++++.++.  .++..+.....++...+           +-..|++ ...++|||.+++.-+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~-----------qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFK-----------QRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHH-----------HHHHHHH-HHhhcCCcccchHHHHH
Confidence            5777888999999999988765543  23333333333333322           2334455 55669999999999888


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      .+...|||-+|+.+ +|.|.|.   .+..+...+...|+-|++.||..+|.   .||+|||||.+||||+.=+.+.|+||
T Consensus        92 t~kAAylvRqyvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDF  164 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDF  164 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcc
Confidence            88889999999976 9999997   45568888999999999999999999   99999999999999999999999999


Q ss_pred             CccccC--CCCCCCc---cccccccCCCCCChhhhccC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036172          305 GLAIWG--PTDSTHM---IREDVVGTFGYIAPEYLMHG----------K-VSDKIDVYSFGVVLLELLS-GRRPIGFKNL  367 (522)
Q Consensus       305 Gla~~~--~~~~~~~---~~~~~~gt~~Y~APE~~~~~----------~-~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~  367 (522)
                      ..-+..  +.+....   .......-.+|+|||.+...          . .+++.||||+|||+.||++ |++||...  
T Consensus       165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--  242 (1431)
T KOG1240|consen  165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--  242 (1431)
T ss_pred             cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence            876432  2221111   11112334579999998541          1 6789999999999999998 89998522  


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                          ++..+-...  ......++     ...   ....+..++..|++.||.+|.++++.|+.-++...
T Consensus       243 ----QL~aYr~~~--~~~~e~~L-----e~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  243 ----QLLAYRSGN--ADDPEQLL-----EKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             ----HHHhHhccC--ccCHHHHH-----HhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence                222211100  00000000     000   11257779999999999999999999998777654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=9.5e-19  Score=166.04  Aligned_cols=186  Identities=19%  Similarity=0.168  Sum_probs=133.3

Q ss_pred             eeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc-hHHHHHHHHHHHHhhC-CCCCcceeeEEEEeCC
Q 036172          150 MDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS-SAWNDFSSEVDITSSL-EQKSITTLNGVCIEDN  227 (522)
Q Consensus       150 ~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~-~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~  227 (522)
                      ++..|+.|+||+|+++...+          ..|....+....--.. -+...|.+|+++|++| +|++|++++++    +
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~----------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~   71 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGE----------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D   71 (218)
T ss_pred             cceeecCCCcceEEEeecCC----------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c
Confidence            56679999999999765422          2232222221111000 0234688999999999 55889999986    3


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccC-CCCceeccCCCceEEeecCc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV-KSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDI-kp~NILl~~~~~~kL~DFGl  306 (522)
                      ..+++|||+.|.+|...+..          ....++.|++.+|.++|+   .||+|||| ||+|||++.++.++|+|||+
T Consensus        72 ~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         72 GRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             CEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence            46999999999998754321          113577899999999999   99999999 79999999999999999999


Q ss_pred             cccCCCCCCC----c-------cccccccCCCCCChhhhccC-CCC-chhhHHHHHHHHHHHHcCCCCC
Q 036172          307 AIWGPTDSTH----M-------IREDVVGTFGYIAPEYLMHG-KVS-DKIDVYSFGVVLLELLSGRRPI  362 (522)
Q Consensus       307 a~~~~~~~~~----~-------~~~~~~gt~~Y~APE~~~~~-~~s-~ksDVwSlGvvl~eLltG~~Pf  362 (522)
                      +.........    .       .......++.|++|+...-- ..+ ...+-++.|.-+|.++||+.+.
T Consensus       139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            9755443311    0       01123468889999875322 333 5678889999999999999885

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=1.3e-19  Score=171.66  Aligned_cols=142  Identities=14%  Similarity=0.126  Sum_probs=102.1

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch-----------------------HHHHHHHHHHH
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS-----------------------AWNDFSSEVDI  207 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~-----------------------~~~~f~~Ev~i  207 (522)
                      ...||+|+||.||++...         +++.+++|.++.....+..                       ......+|+.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   72 (190)
T cd05147           2 NGCISTGKEANVYHATTA---------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRN   72 (190)
T ss_pred             CCccccccceEEEEEECC---------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHH
Confidence            457999999999998753         2344444444322111110                       01223459999


Q ss_pred             HhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH-HhcCCCCEEeccC
Q 036172          208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYL-HSECSRPVIHRDV  286 (522)
Q Consensus       208 L~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~~~giiHrDI  286 (522)
                      +.++.++++.....+....  .+|||||+++++|...+..   ...++...+..++.|++.+|.+| |+   .+|+||||
T Consensus        73 l~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDl  144 (190)
T cd05147          73 LKRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQD---CRLVHADL  144 (190)
T ss_pred             HHHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence            9999888875443332222  3899999998877655332   23588999999999999999999 68   89999999


Q ss_pred             CCCceeccCCCceEEeecCccccC
Q 036172          287 KSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       287 kp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      ||+|||++ ++.++|+|||++...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2e-18  Score=172.71  Aligned_cols=208  Identities=22%  Similarity=0.231  Sum_probs=145.8

Q ss_pred             CCCCcceeeEEEEe---------------------------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHH
Q 036172          212 EQKSITTLNGVCIE---------------------------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAV  264 (522)
Q Consensus       212 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  264 (522)
                      +|||||+++++|.+                           +..+|+||.-.+. +|.+++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            79999999998764                           2468999999976 9999997542    56677788999


Q ss_pred             HHHHHHHHHHhcCCCCEEeccCCCCceec--cCCC--ceEEeecCccccCCCCCCC----ccccccccCCCCCChhhhcc
Q 036172          265 AIAEALNYLHSECSRPVIHRDVKSSNILL--SSDF--QPQLSDFGLAIWGPTDSTH----MIREDVVGTFGYIAPEYLMH  336 (522)
Q Consensus       265 qi~~gL~yLH~~~~~giiHrDIkp~NILl--~~~~--~~kL~DFGla~~~~~~~~~----~~~~~~~gt~~Y~APE~~~~  336 (522)
                      |+++|+.|||.   +||.|||+|++|||+  ++++  .+.|+|||++.-.....-.    ...-+..|...-||||+...
T Consensus       349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999999   999999999999998  4444  4789999998432221100    01113467888999999853


Q ss_pred             --CC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHH
Q 036172          337 --GK----VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA  410 (522)
Q Consensus       337 --~~----~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li  410 (522)
                        ++    --.|+|.|+.|.+.||+++...||.......           +....+.+---|.+..    ..+..+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----------L~~r~Yqe~qLPalp~----~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----------LDTRTYQESQLPALPS----RVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-----------echhhhhhhhCCCCcc----cCChHHHHHH
Confidence              22    2358999999999999999999996522111           1111111111122222    3445677788


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHhccc-cCCcccc
Q 036172          411 NLCINQSPQLRPNMGQVLKLLRGAT-HATDWVD  442 (522)
Q Consensus       411 ~~CL~~dP~~RPs~~eVl~~L~~~~-~~~~~~~  442 (522)
                      ...|+.||.+||+..-..+.|+-.. ..++|++
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vk  523 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVK  523 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHHHHHhcCchHHH
Confidence            8999999999999877666665322 2344444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=2.3e-19  Score=178.37  Aligned_cols=237  Identities=16%  Similarity=0.197  Sum_probs=146.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC----------CCc
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ----------KSI  216 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H----------pnI  216 (522)
                      ....+..||.|+|+.||.+++.+.        ...+++|........-...++++++|.-....+.+          -.+
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t--------~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~   84 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVET--------GEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF   84 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTT--------TEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred             EEEEccccccCCceEEEEEEEccC--------CceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence            456788999999999999987653        22222222111111122256667777766655433          122


Q ss_pred             ceeeEEEE---------eC---C-----EEEEEEecCCCCCHHHHhhc---cC-CCCCCChHHHHHHHHHHHHHHHHHHh
Q 036172          217 TTLNGVCI---------ED---N-----YLILVSDFLPKGSLEESLHG---AG-EQSVLPWGVRFEVAVAIAEALNYLHS  275 (522)
Q Consensus       217 v~l~~~~~---------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qi~~gL~yLH~  275 (522)
                      +--++...         ..   .     +.+++|+-+. ++|.+++.-   .. ....+....++.+..|+++.+++||.
T Consensus        85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~  163 (288)
T PF14531_consen   85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS  163 (288)
T ss_dssp             ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence            22222222         11   1     2478888884 599888653   11 11234455667788999999999999


Q ss_pred             cCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc--------CCCCchhhHHH
Q 036172          276 ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH--------GKVSDKIDVYS  347 (522)
Q Consensus       276 ~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwS  347 (522)
                         .|++|+||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|+
T Consensus       164 ---~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  164 ---YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             ---TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             ---cceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence               99999999999999999999999999887554432211     234578999998743        24788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCC
Q 036172          348 FGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR  421 (522)
Q Consensus       348 lGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~R  421 (522)
                      ||+++|.|++|+.||...........                    .-..+. +.++.+..||..+|+.||.+|
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999999975432211110                    112233 577889999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.73  E-value=5.8e-18  Score=160.41  Aligned_cols=143  Identities=18%  Similarity=0.161  Sum_probs=102.8

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-------------c----------chHHHHHHHHHHH
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-------------F----------SSAWNDFSSEVDI  207 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-------------~----------~~~~~~f~~Ev~i  207 (522)
                      ...||+|+||.||++...         +++.+++|.+......             +          ......+.+|...
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   72 (190)
T cd05145           2 NGCISTGKEANVYHARTG---------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRN   72 (190)
T ss_pred             CceeecCCCcEEEEEEcC---------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHH
Confidence            467999999999998743         1223333332211100             0          0012345789999


Q ss_pred             HhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHH-hhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccC
Q 036172          208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES-LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV  286 (522)
Q Consensus       208 L~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDI  286 (522)
                      +.++.|++|.....+....  .+|||||++|+++... +..    ..++...+..++.|++.++.+||+.  .||+||||
T Consensus        73 l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDl  144 (190)
T cd05145          73 LKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDL  144 (190)
T ss_pred             HHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCC
Confidence            9999999875444443332  4899999998865443 332    2478889999999999999999984  79999999


Q ss_pred             CCCceeccCCCceEEeecCccccCC
Q 036172          287 KSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       287 kp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||+||+++ ++.++|+|||++....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999 7899999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=1e-17  Score=160.92  Aligned_cols=134  Identities=17%  Similarity=0.203  Sum_probs=98.3

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-----CCCCcceeeEEEEe
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-----EQKSITTLNGVCIE  225 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-----~HpnIv~l~~~~~~  225 (522)
                      ...||+|+||.||.  +.+...        . .+|.+..   ......+.+.+|+.++++|     .||||++++|++.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~--------k-~IKv~~~---~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQ--------R-CIKIVYH---RGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             cceecCCCceEEEE--CCCCcC--------e-EEEEEec---cccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            45799999999996  221111        1 1222211   1112346789999999999     57999999999998


Q ss_pred             CC---EEE-EEEec--CCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHH-HHHHhcCCCCEEeccCCCCceeccC---
Q 036172          226 DN---YLI-LVSDF--LPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEAL-NYLHSECSRPVIHRDVKSSNILLSS---  295 (522)
Q Consensus       226 ~~---~~~-lV~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~~~giiHrDIkp~NILl~~---  295 (522)
                      +.   .++ +|+||  +++|+|.+++.+.    .+++.  ..++.+++.++ .|||+   .+|+||||||+|||++.   
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~  143 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISE  143 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCC
Confidence            73   434 78999  5579999999642    25555  35678888887 99999   99999999999999974   


Q ss_pred             -CCceEEeecCcc
Q 036172          296 -DFQPQLSDFGLA  307 (522)
Q Consensus       296 -~~~~kL~DFGla  307 (522)
                       +..++|+||+.+
T Consensus       144 ~~~~~~LiDg~G~  156 (210)
T PRK10345        144 SEVIPVVCDNIGE  156 (210)
T ss_pred             CCCcEEEEECCCC
Confidence             347999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.8e-17  Score=185.92  Aligned_cols=253  Identities=18%  Similarity=0.202  Sum_probs=177.1

Q ss_pred             CCCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC---CCCc
Q 036172          140 FSPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE---QKSI  216 (522)
Q Consensus       140 ~~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~---HpnI  216 (522)
                      ........|.|.+.||+|+||+||+|....         ++.||+|.=+.....      +|.-=.+++.+|+   -+-|
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~---------~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~  756 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN---------GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSI  756 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC---------CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcch
Confidence            344456689999999999999999988653         455555543222211      1111223444444   2445


Q ss_pred             ceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-
Q 036172          217 TTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-  295 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-  295 (522)
                      ..+...+.-.+..+||+||.+.|+|.+++.   ..+.++|..+..+..|++..+..||.   .+|||+||||+|+||.. 
T Consensus       757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  757 MHISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRRE  830 (974)
T ss_pred             HHHHHHHccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecc
Confidence            566666666677899999999999999998   44569999999999999999999999   99999999999999942 


Q ss_pred             ------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          296 ------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       296 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                            ...++|+|||.+.-+..-.........++|-.+-.+|...+...+..+|.|.|+.+++-||.|+.-=       
T Consensus       831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------  903 (974)
T KOG1166|consen  831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------  903 (974)
T ss_pred             cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------
Confidence                  3458999999995433323333445668899999999999999999999999999999999997631       


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                                 ..+|.. ..++..+..-...+....   ++..+|+.+-..=|...++...|++..
T Consensus       904 -----------~~~g~~-~~~~~~~~Ry~~~~~W~~---~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  904 -----------VKNGSS-WMVKTNFPRYWKRDMWNK---FFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             -----------hcCCcc-eeccccchhhhhHHHHHH---HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence                       111111 111111222222233333   445566655555688888888887764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=4.9e-18  Score=176.26  Aligned_cols=175  Identities=27%  Similarity=0.396  Sum_probs=130.9

Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      .++||.|++|...+|.++|.+.......++.....++.|++.|+.|      ++.+|+|+||.||++..+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            3689999999999999999876555668889999999999999999      5799999999999999999999999999


Q ss_pred             cccCCCCC----CCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          307 AIWGPTDS----THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       307 a~~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ........    .........||..||+||.+.+..|+.|+||||||++|+||+. -..++..          .-+...+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhh
Confidence            86554443    1122335689999999999999999999999999999999987 2222210          0011112


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ  426 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~e  426 (522)
                      +.+.++    |....+    .+. =..|+.+++...|.+||++.+
T Consensus       473 r~g~ip----~~~~~d----~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 RDGIIP----PEFLQD----YPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hcCCCC----hHHhhc----CcH-HHHHHHHhcCCCcccCchHHH
Confidence            333222    111111    222 235788899999999994443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.3e-16  Score=174.66  Aligned_cols=144  Identities=17%  Similarity=0.166  Sum_probs=110.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|...+.||+|+||.||++..............+.+..+.+..     ....+++.+|++++++++|++|+....++.+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDE-----RLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHH-----HHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            34567889999999999996532211111111111222222211     1134678999999999999999988888888


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++||||+++++|.+++.           ....++.+++.+|.+||+   .+++||||||+|||+ .++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999999885           346789999999999999   999999999999999 67799999999


Q ss_pred             cccc
Q 036172          306 LAIW  309 (522)
Q Consensus       306 la~~  309 (522)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9854

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=1.7e-16  Score=152.19  Aligned_cols=142  Identities=20%  Similarity=0.250  Sum_probs=107.7

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||+|+||.||++........+.......+..+++...     -...++.+|+.++..+.|++|+....++......++
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDER-----IRRERTRREARIMSRARKAGVNVPAVYFVDPENFII   76 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHH-----HHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence            468999999999985321111111111112222222111     123578899999999999999887778777788899


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ||||++|++|.+++...      .. .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        77 v~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999998642      12 788999999999999999   9999999999999999 78899999998854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=1.9e-16  Score=174.88  Aligned_cols=230  Identities=25%  Similarity=0.332  Sum_probs=153.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .+++|..++.+..|+||.||++++++        +...|+. .+.+.+.        +.+-  |+.....|.+|      
T Consensus        81 ~e~df~~IklisngAygavylvrh~~--------trqrfa~-kiNkq~l--------ilRn--ilt~a~npfvv------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKE--------TRQRFAM-KINKQNL--------ILRN--ILTFAGNPFVV------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccc--------cccchhh-cccccch--------hhhc--cccccCCccee------
Confidence            35789999999999999999998764        4456666 2222110        0000  22222333333      


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                                     |+-...+...+   .++.        +++.+++|||+   .+|+|||+||+|.+|+.-|++|+.|
T Consensus       136 ---------------gDc~tllk~~g---~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTD  186 (1205)
T KOG0606|consen  136 ---------------GDCATLLKNIG---PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTD  186 (1205)
T ss_pred             ---------------chhhhhcccCC---CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccc
Confidence                           45555555332   2433        23789999999   9999999999999999999999999


Q ss_pred             cCccccCCCC-------------CCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          304 FGLAIWGPTD-------------STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       304 FGla~~~~~~-------------~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      ||+.+.....             ......+.++||+.|.|||++....|...+|-|++|+|+||++-|..||....++..
T Consensus       187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence            9998653221             111223457899999999999999999999999999999999999999976654432


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhccccCCccc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~~~~~~~~  441 (522)
                      ...+  +...+            ...+-+.....+..+++.+.|+.+|..|- +..+..-.-.+.....+|.
T Consensus       267 fg~v--isd~i------------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  267 FGQV--ISDDI------------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             Hhhh--hhhhc------------cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            2111  11100            01111233445778899999999999996 3333332233444455564

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=3.1e-16  Score=149.09  Aligned_cols=137  Identities=18%  Similarity=0.231  Sum_probs=100.5

Q ss_pred             ccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEE
Q 036172          154 CSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVS  233 (522)
Q Consensus       154 lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~  233 (522)
                      ||+|+||.||++........++......+..+++..     .-...++.+|++++..+.|+++.....++......++||
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   76 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDE-----RIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM   76 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHH-----HHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence            799999999998732211111100111111111111     113467889999999999987665555666667779999


Q ss_pred             ecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       234 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ||++|++|.+++....    .      .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++..
T Consensus        77 e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999999886321    1      788999999999999   9999999999999999 78999999999855

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.65  E-value=1e-16  Score=157.17  Aligned_cols=145  Identities=16%  Similarity=0.059  Sum_probs=105.1

Q ss_pred             CCceeeecccccccccccccC-chhHHHHhhcccCccchHHHHHHHhhcc---------------------chHHHHHHH
Q 036172          146 NPFQMDIPCSEGKYDENTLTP-STELFLKLVSSRCRQFSYEELKQATSQF---------------------SSAWNDFSS  203 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~-~~~~~~~~~~~~~~~~a~k~l~~~t~~~---------------------~~~~~~f~~  203 (522)
                      ..|++..+||.|+||.||++. +..        +++.+++|.++.....+                     ......+.+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~--------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDG--------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK   99 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCC--------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence            358899999999999999986 221        23344444332211100                     002234678


Q ss_pred             HHHHHhhCCCC--CcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-
Q 036172          204 EVDITSSLEQK--SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP-  280 (522)
Q Consensus       204 Ev~iL~~L~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g-  280 (522)
                      |+.++.++.+.  .+++++++   . ..++||||+++++|.......   ..+.......++.|++.+|.+||.   .+ 
T Consensus       100 E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~g~  169 (237)
T smart00090      100 EFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYK---EGE  169 (237)
T ss_pred             HHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHh---cCC
Confidence            99999999763  34455543   2 348999999998887765322   235666778999999999999999   89 


Q ss_pred             EEeccCCCCceeccCCCceEEeecCcccc
Q 036172          281 VIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       281 iiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ++||||||+||+++ ++.++|+|||.+..
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            99999999999999 88999999999854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.8e-17  Score=182.01  Aligned_cols=267  Identities=20%  Similarity=0.288  Sum_probs=193.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~  222 (522)
                      ....|++.+.||.|+|+.|.+.......       ...++.+.+.... ...........|..+-..+. |+|++.+++.
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~-------~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~   89 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDP-------ESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEP   89 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCC-------cceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCc
Confidence            3467889999999999998776542211       1111111111111 11112344556888888886 9999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHh-hccCCCCCCChHHHHHHHHHHHHHHHHHH-hcCCCCEEeccCCCCceeccCCC-ce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFEVAVAIAEALNYLH-SECSRPVIHRDVKSSNILLSSDF-QP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~~~giiHrDIkp~NILl~~~~-~~  299 (522)
                      ..+.+..+++++|..|+++.+.+ +..  ....+....-.++.|+..++.|+| .   .++.|+||||+|.+++..+ ..
T Consensus        90 ~~~~~~~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   90 SSSPRSYLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             cCCCcccccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcc
Confidence            99999999999999999999988 422  113667777888999999999999 7   9999999999999999999 99


Q ss_pred             EEeecCccccCCC-CCCCcccccccc-CCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          300 QLSDFGLAIWGPT-DSTHMIREDVVG-TFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       300 kL~DFGla~~~~~-~~~~~~~~~~~g-t~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      +++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......... ...|
T Consensus       165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~  243 (601)
T KOG0590|consen  165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW  243 (601)
T ss_pred             cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceee
Confidence            9999999977766 555555556778 9999999998774 4578899999999999999999999766544321 1111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ....   +.    .    .............+++.+++..+|..|.+.+++-.        .+|...
T Consensus       244 ~~~~---~~----~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~--------d~~~~~  291 (601)
T KOG0590|consen  244 KSNK---GR----F----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL--------DNWLSS  291 (601)
T ss_pred             cccc---cc----c----ccCccccCChhhhhcccccccCCchhccccccccc--------cccccc
Confidence            1100   00    0    01111123345667788889999999999998875        777665

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.56  E-value=2.1e-15  Score=143.68  Aligned_cols=140  Identities=15%  Similarity=0.047  Sum_probs=101.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHH-------------------HhhccchHHHHHHHHHHH
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQ-------------------ATSQFSSAWNDFSSEVDI  207 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~-------------------~t~~~~~~~~~f~~Ev~i  207 (522)
                      .|.+.++||.|+||.||++...         +++.+++|.+..                   ...........+.+|+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP---------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC---------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            4788899999999999987642         112222221100                   000011122357889999


Q ss_pred             HhhCCCCC--cceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEecc
Q 036172          208 TSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD  285 (522)
Q Consensus       208 L~~L~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrD  285 (522)
                      +..+.|++  +++.++.    ...++||||++|++|..+...         .....++.+++.++.++|+   .+++|||
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~D  150 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGD  150 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence            99998874  5555542    345899999999999775431         2346788999999999999   9999999


Q ss_pred             CCCCceeccCCCceEEeecCccccCC
Q 036172          286 VKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       286 Ikp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      |||+||+++.++.++|+|||++....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999985433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=2.6e-14  Score=140.42  Aligned_cols=102  Identities=20%  Similarity=0.152  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHHhhCCCCCc--ceeeEEEEeC-C---EEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHHH
Q 036172          197 AWNDFSSEVDITSSLEQKSI--TTLNGVCIED-N---YLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAEA  269 (522)
Q Consensus       197 ~~~~f~~Ev~iL~~L~HpnI--v~l~~~~~~~-~---~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~g  269 (522)
                      ...++.+|+.++.+|.|++|  ++.+++.... .   ..++|||+++| .+|.+++...    .++..    .+.+++.+
T Consensus        83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~  154 (239)
T PRK01723         83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQL  154 (239)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHH
Confidence            44678999999999998885  7777775543 2   23599999997 6999988642    24443    35789999


Q ss_pred             HHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       270 L~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      |.+||+   .||+||||||.|||++.++.++|+|||.+..
T Consensus       155 l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        155 IARFHD---AGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHH---CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            999999   9999999999999999989999999998854

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1.1e-13  Score=136.34  Aligned_cols=238  Identities=17%  Similarity=0.236  Sum_probs=154.8

Q ss_pred             HHHHhhcccCccchHHHHHHHhhc-cchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC-----CEEEEEEecCCCCCHHH
Q 036172          170 LFLKLVSSRCRQFSYEELKQATSQ-FSSAWNDFSSEVDITSSLEQKSITTLNGVCIED-----NYLILVSDFLPKGSLEE  243 (522)
Q Consensus       170 ~~~~~~~~~~~~~a~k~l~~~t~~-~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~  243 (522)
                      ++++.....+..+-..++...... +...-+....=..-|.++-|-|||+++.|+.+.     ....+++||+..|+|..
T Consensus        82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~  161 (458)
T KOG1266|consen   82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ  161 (458)
T ss_pred             HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence            444444444444444444333222 211112222223456677899999999998754     45889999999999999


Q ss_pred             Hhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc--cCCCCCCCcccc
Q 036172          244 SLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI--WGPTDSTHMIRE  320 (522)
Q Consensus       244 ~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~--~~~~~~~~~~~~  320 (522)
                      +|++. .....+....-.+|+.||+.||.|||+ |...|+|+++..+.|++..++-+|++--.-..  ............
T Consensus       162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            99875 334558888888999999999999998 56899999999999999999988876322110  000001111112


Q ss_pred             ccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CChhhHHHhhhhhhcCCCcccccCCcccccc
Q 036172          321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL--KGPESLVKWAKPILKNGDTETLLDPKLSNEY  398 (522)
Q Consensus       321 ~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  398 (522)
                      ...+.++|.+||+-..-+.+.++|||+||+..++|..+..--.....  .....+.. +...+.        ++      
T Consensus       241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-~i~~le--------n~------  305 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-VIIGLE--------NG------  305 (458)
T ss_pred             ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-heeecc--------Cc------
Confidence            34578899999987777788899999999999999887654211110  01111110 000001        00      


Q ss_pred             cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       399 ~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                            .-..++..|++..|..||+|.+++.
T Consensus       306 ------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  306 ------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             ------cccCcCcccccCCCCCCcchhhhhc
Confidence                  1123567799999999999998875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.48  E-value=4.3e-14  Score=126.24  Aligned_cols=135  Identities=18%  Similarity=0.161  Sum_probs=106.1

Q ss_pred             eeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC--CCcceeeEEEEeCC
Q 036172          150 MDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ--KSITTLNGVCIEDN  227 (522)
Q Consensus       150 ~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H--pnIv~l~~~~~~~~  227 (522)
                      +.++||.|.++.||++....          ..+.+|......   .  ...+.+|+.+++.++|  .++++++++....+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~----------~~~~iK~~~~~~---~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~   66 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD----------EDYVLKINPSRE---K--GADREREVAILQLLARKGLPVPKVLASGESDG   66 (155)
T ss_pred             cceecccccccceEEEEecC----------CeEEEEecCCCC---c--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            35679999999999987532          223333322111   0  3568899999999976  58999999998888


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..+++|||++++.+..+          +......++.+++.+|.+||.....+++|+|++|.||++++.+.+++.|||.+
T Consensus        67 ~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~  136 (155)
T cd05120          67 WSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA  136 (155)
T ss_pred             ccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence            89999999988777543          44566778899999999999843347999999999999999899999999988


Q ss_pred             cc
Q 036172          308 IW  309 (522)
Q Consensus       308 ~~  309 (522)
                      ..
T Consensus       137 ~~  138 (155)
T cd05120         137 GY  138 (155)
T ss_pred             cC
Confidence            53

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.43  E-value=1e-13  Score=130.29  Aligned_cols=139  Identities=19%  Similarity=0.153  Sum_probs=91.9

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch---------------------HHHHHHHHHHHHh
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS---------------------AWNDFSSEVDITS  209 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~---------------------~~~~f~~Ev~iL~  209 (522)
                      .+.||+|+||.||++...         ..+.+++|.+......+..                     .......|...+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~---------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~   72 (187)
T cd05119           2 GGPIGTGKEADVYLALDG---------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLK   72 (187)
T ss_pred             CcccccccceeEEEEECC---------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHH
Confidence            467999999999998643         1233333332211111100                     0112246777777


Q ss_pred             hCCCCC--cceeeEEEEeCCEEEEEEecCCCCCHHH-HhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccC
Q 036172          210 SLEQKS--ITTLNGVCIEDNYLILVSDFLPKGSLEE-SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV  286 (522)
Q Consensus       210 ~L~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDI  286 (522)
                      ++.+..  +.+.+++    ...++||||++++.+.. .+....    .. ..+..++.+++.++.++|..  .+|+|+||
T Consensus        73 ~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl  141 (187)
T cd05119          73 RLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDL  141 (187)
T ss_pred             HHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCC
Confidence            775443  5555544    23589999999854432 121110    11 56788999999999999984  78999999


Q ss_pred             CCCceeccCCCceEEeecCccccC
Q 036172          287 KSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       287 kp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      ||+||+++ ++.++|+|||.+...
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ChhhEEEE-CCcEEEEECcccccc
Confidence            99999999 889999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=5.5e-12  Score=133.69  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=177.7

Q ss_pred             CCceeeecccc--cccccccccCchhHHHHhhcccCccchHHHHHHHhhccch--HHHHHHHHHHHHhhC-CCCCcceee
Q 036172          146 NPFQMDIPCSE--GKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS--AWNDFSSEVDITSSL-EQKSITTLN  220 (522)
Q Consensus       146 ~~y~~~~~lG~--G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~--~~~~f~~Ev~iL~~L-~HpnIv~l~  220 (522)
                      ..+.+...+|.  |.+|.||.+....      ......|+.+.=+.   -++.  .-.+=.+|+...+++ .|+|.++.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~------~~s~~~~a~k~s~~---p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~  184 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN------SESPHKFAVKKSKI---PFSPPLDSKRKLREFLSHHKIDSHENPVRDS  184 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc------ccCCcccccccccC---CCCCccccccccchhhcccccCccccccccC
Confidence            45677788999  9999999877522      12223333222110   0110  111224577777777 799999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHH----HHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAE----ALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      ..+...+..++-+|++. .+|..+.+..  ...++....+.++.+...    ||.++|+   .+++|-|+||.||++..+
T Consensus       185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  185 PAWEGSGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             cccccCCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccc
Confidence            99999999999999995 6898888753  234788888889999988    9999999   999999999999999999


Q ss_pred             -CceEEeecCccccCCCCCCCcc---ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          297 -FQPQLSDFGLAIWGPTDSTHMI---REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       297 -~~~kL~DFGla~~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                       ...+++|||+...+........   .....|...|++||.. .+-++.++|||++|.++.+..++..+........   
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---  334 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS---  334 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC---
Confidence             8899999999977665442221   1233677889999987 5678999999999999999999877653221111   


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                         |  ..++.+.        +..++.......+...+.++++.+|..|++.+.+..
T Consensus       335 ---W--~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 ---W--SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ---c--ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence               1  0011111        122222223334555888899999999999988775

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=1.5e-10  Score=124.10  Aligned_cols=147  Identities=18%  Similarity=0.199  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 036172          199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECS  278 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  278 (522)
                      ....+-++-|+.|+||||+++++.+...+.+|||+|-+.  .|..++..      +....+...+.||+.||.|||..  
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d--  123 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVCLGLFQILAALSFLNDD--  123 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHHHHHHHHHHHHHHHhcc--
Confidence            445667788999999999999999999999999999983  78888874      34567777889999999999975  


Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                      .+++|++|.-+.|+|+..|..||++|.++........  ......--..|..|+.+....  -..|.|-||++++|++.|
T Consensus       124 ~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  124 CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            7899999999999999999999999998854333221  111222334466776543222  457999999999999999


Q ss_pred             C
Q 036172          359 R  359 (522)
Q Consensus       359 ~  359 (522)
                      .
T Consensus       200 ~  200 (690)
T KOG1243|consen  200 S  200 (690)
T ss_pred             c
Confidence            3

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.10  E-value=4e-11  Score=133.43  Aligned_cols=254  Identities=21%  Similarity=0.222  Sum_probs=173.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ....+.+.+.+-.|.|+.++..+...        ....++.+..+.+-.--....+....+-.++-...||-++...--+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~--------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~  873 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAG--------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF  873 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccc--------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence            34567788899999999988876432        2234444444333222222333344444455445667777666555


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ......+||++|+.+++|...|+..+   ..+.+.....+..+..+++|||.   ..+.|+|++|.|++...++..++.|
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCc
Confidence            56678999999999999999998654   35666666777888999999999   7799999999999999999999999


Q ss_pred             cCccccCCCC-----C------------------------CCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHH
Q 036172          304 FGLAIWGPTD-----S------------------------THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE  354 (522)
Q Consensus       304 FGla~~~~~~-----~------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~e  354 (522)
                      ||........     .                        .........||+.|.+||...+......+|.|++|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9844221110     0                        0011234578999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 036172          355 LLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG  425 (522)
Q Consensus       355 LltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~  425 (522)
                      .++|..||.........      .. +..+...       ....+........+++...+..+|.+|-.+.
T Consensus      1028 ~l~g~pp~na~tpq~~f------~n-i~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIF------EN-ILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhcCCCCCCCcchhhhh------hc-cccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999999755433221      11 1111111       1111222344566677788899999997765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=5e-11  Score=126.47  Aligned_cols=248  Identities=22%  Similarity=0.202  Sum_probs=173.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ..+|..+.+||.|.|+.|+.+...       ......++.+++++....+.+.+.. ..|+-+...+ .|.+++.++..+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r-------~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKR-------PEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSW  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeec-------CCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCc
Confidence            457888899999999987765421       2345566777776666555543333 3466666666 789999988888


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-CceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~~kL~  302 (522)
                      ......|+=-|||.++++...+.   ....+.+..++++..|++.++.++|+   ..++|+|+||+||++..+ +..+++
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             cccccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcc
Confidence            88888889999999999877763   23348888899999999999999999   999999999999999886 788999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCC--ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYI--APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~--APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |||....+......     ....-++.  +|.......+-.+.|+||||.-+.+.++|..--..        ...|..  
T Consensus       410 ~~~~~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~--  474 (524)
T KOG0601|consen  410 DFGCWTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLT--  474 (524)
T ss_pred             ccccccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCcc--------ccccee--
Confidence            99988542221111     12233333  55555566788999999999999999998653211        011110  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      +..+....         .+. ....+..+...++..++..||.+.++....
T Consensus       475 i~~~~~p~---------~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  475 IRSGDTPN---------LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             eecccccC---------CCc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            11111111         111 124555677778999999999998877543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.09  E-value=1.4e-10  Score=123.77  Aligned_cols=104  Identities=20%  Similarity=0.159  Sum_probs=74.8

Q ss_pred             HHHHHHHHHhhCC----CCCcceeeEEEE-eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHH-HHHHH
Q 036172          200 DFSSEVDITSSLE----QKSITTLNGVCI-EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAE-ALNYL  273 (522)
Q Consensus       200 ~f~~Ev~iL~~L~----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-gL~yL  273 (522)
                      +|.+|+..+.++.    |.+-+.+-.++. .....+|||||++|++|.++......  .+   ....++..++. .+..+
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHH
Confidence            5778888877772    333333333332 23456899999999999988753211  12   23456666666 46788


Q ss_pred             HhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          274 HSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       274 H~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      |.   .|++|+|++|.||+++.++.++|+|||++....
T Consensus       274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            98   999999999999999999999999999985543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.05  E-value=1.1e-10  Score=107.60  Aligned_cols=127  Identities=21%  Similarity=0.187  Sum_probs=87.4

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCc-ceeeEEEEeCCEE
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSI-TTLNGVCIEDNYL  229 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~  229 (522)
                      +++|+.|.++.||+++..          .+.+.+|.......    ....+.+|+.+++.+.+.++ ++++.+..  ...
T Consensus         3 ~~~l~~G~~~~vy~~~~~----------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~   66 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA----------NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETG   66 (170)
T ss_pred             eeecCCcccCceEEEEEC----------CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCC
Confidence            356888999999987632          12233333211110    12346789999999966554 45555433  335


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-----EEeccCCCCceeccCCCceEEeec
Q 036172          230 ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP-----VIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       230 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g-----iiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      ++||||++|.++....        ..   ...++.+++++|+.||.   .+     ++|+|++|.||+++ ++.++++||
T Consensus        67 ~lv~e~i~G~~l~~~~--------~~---~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf  131 (170)
T cd05151          67 VLITEFIEGSELLTED--------FS---DPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW  131 (170)
T ss_pred             eEEEEecCCCcccccc--------cc---CHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence            7999999998776430        11   12456899999999999   55     59999999999999 668999999


Q ss_pred             Cccc
Q 036172          305 GLAI  308 (522)
Q Consensus       305 Gla~  308 (522)
                      |.+.
T Consensus       132 ~~a~  135 (170)
T cd05151         132 EYAG  135 (170)
T ss_pred             cccc
Confidence            9874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.7e-09  Score=97.01  Aligned_cols=98  Identities=20%  Similarity=0.320  Sum_probs=81.2

Q ss_pred             HHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 036172          198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC  277 (522)
Q Consensus       198 ~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~  277 (522)
                      ..+-.+|+++|.+++--.|.--+=+..+.....|+|||++|..|.+.+...          ...++..+-.-+.-||.  
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~--  110 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHK--  110 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh--
Confidence            467789999999997666655555666777788999999999999898743          24567788888899999  


Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                       .||+|+||.++||++..+. +.++|||++.+
T Consensus       111 -~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         111 -AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             -cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence             9999999999999998765 99999999853

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.90  E-value=3.7e-09  Score=100.24  Aligned_cols=97  Identities=13%  Similarity=0.139  Sum_probs=74.3

Q ss_pred             HHHHHHHhhCCC--CCcceeeEEEEeCCEEEEEEecCCCCCHHH-HhhccCCCCCCChHHHHHHHHHHHHHHHHH-HhcC
Q 036172          202 SSEVDITSSLEQ--KSITTLNGVCIEDNYLILVSDFLPKGSLEE-SLHGAGEQSVLPWGVRFEVAVAIAEALNYL-HSEC  277 (522)
Q Consensus       202 ~~Ev~iL~~L~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~  277 (522)
                      .+|++.|+++..  -++++++++    ..-+|||||+.+..+.. .+..    ..++......+..+++.+|..| |.  
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~--  143 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE--  143 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh--
Confidence            389999999943  567777765    45679999997644422 2321    1255566778889999999999 88  


Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                       .+++|+||++.||+++ ++.+.|+|||.+...
T Consensus       144 -~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         144 -CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             8999999999999997 468999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.87  E-value=7.7e-10  Score=119.87  Aligned_cols=103  Identities=17%  Similarity=0.146  Sum_probs=67.5

Q ss_pred             HHHHHHHHHhhCC----CCCcceeeEEEEe-CCEEEEEEecCCCCCHHHHh--hccC-CCCCCChHHHHHHHHHHHHHHH
Q 036172          200 DFSSEVDITSSLE----QKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL--HGAG-EQSVLPWGVRFEVAVAIAEALN  271 (522)
Q Consensus       200 ~f~~Ev~iL~~L~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qi~~gL~  271 (522)
                      +|.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.|.++-  ...+ ....+....+..++.|+     
T Consensus       202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-----  276 (537)
T PRK04750        202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-----  276 (537)
T ss_pred             CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-----
Confidence            4666766666662    4444444444443 35678999999999998753  2211 01113333333334443     


Q ss_pred             HHHhcCCCCEEeccCCCCceeccCCC----ceEEeecCccccCCC
Q 036172          272 YLHSECSRPVIHRDVKSSNILLSSDF----QPQLSDFGLAIWGPT  312 (522)
Q Consensus       272 yLH~~~~~giiHrDIkp~NILl~~~~----~~kL~DFGla~~~~~  312 (522)
                        +.   .|++|+|+||.||+++.++    .++++|||++.....
T Consensus       277 --f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 --FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             --Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              34   7899999999999999888    999999999965543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.77  E-value=9.2e-09  Score=98.65  Aligned_cols=142  Identities=19%  Similarity=0.203  Sum_probs=101.2

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCC--CcceeeEEEEeC---
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQK--SITTLNGVCIED---  226 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hp--nIv~l~~~~~~~---  226 (522)
                      ++||.|.++.||++....         ++.+.+|........  ....++.+|+++++.+.+.  ++++++.+....   
T Consensus         4 ~~l~~G~~n~~~~v~~~~---------g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~   72 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG---------GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL   72 (223)
T ss_pred             eecCCCccceEEEEEecC---------CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc
Confidence            458889999999876322         123333332211110  1235688999999999664  467788877654   


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC-----------------------------  277 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----------------------------  277 (522)
                      +..++||||++|.+|.+.+..    ..++......++.+++.+|..||+..                             
T Consensus        73 ~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          73 GTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             CCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence            367899999999888776531    23677778888889999998888521                             


Q ss_pred             ------------------------CCCEEeccCCCCceeccC--CCceEEeecCccc
Q 036172          278 ------------------------SRPVIHRDVKSSNILLSS--DFQPQLSDFGLAI  308 (522)
Q Consensus       278 ------------------------~~giiHrDIkp~NILl~~--~~~~kL~DFGla~  308 (522)
                                              ...++|+|+.|.||+++.  ++.+.|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                    246799999999999998  6678999999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.75  E-value=4e-08  Score=90.59  Aligned_cols=108  Identities=25%  Similarity=0.274  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhc
Q 036172          198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSE  276 (522)
Q Consensus       198 ~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~  276 (522)
                      .++.++|+++|.++.--.|.--.=++.+...-.|+|||++| .++.+++....... ........++..+-+.+.-||. 
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~-  131 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD-  131 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh-
Confidence            46788999999999666665544566666667899999976 48888887653332 2223336788999999999999 


Q ss_pred             CCCCEEeccCCCCceeccCCC---ceEEeecCcccc
Q 036172          277 CSRPVIHRDVKSSNILLSSDF---QPQLSDFGLAIW  309 (522)
Q Consensus       277 ~~~giiHrDIkp~NILl~~~~---~~kL~DFGla~~  309 (522)
                        .+|||+||..+||+|..++   .+.++|||++..
T Consensus       132 --ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  132 --NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             --CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence              9999999999999997655   358999999843

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.71  E-value=1e-07  Score=95.07  Aligned_cols=106  Identities=16%  Similarity=0.096  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHhhCCCCC--cceeeEEEEe-----CCEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHH
Q 036172          199 NDFSSEVDITSSLEQKS--ITTLNGVCIE-----DNYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEAL  270 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~Hpn--Iv~l~~~~~~-----~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL  270 (522)
                      ..+.+|...+.+|...+  .++++++...     ....+||||++++. +|.+++.... ....+...+..++.+++..+
T Consensus        73 ~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i  151 (268)
T PRK15123         73 LGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMV  151 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHH
Confidence            34778999999884444  4455666653     23578999999886 8999986432 12356677789999999999


Q ss_pred             HHHHhcCCCCEEeccCCCCceeccC-------CCceEEeecCccc
Q 036172          271 NYLHSECSRPVIHRDVKSSNILLSS-------DFQPQLSDFGLAI  308 (522)
Q Consensus       271 ~yLH~~~~~giiHrDIkp~NILl~~-------~~~~kL~DFGla~  308 (522)
                      .-||.   .||+|+|++++|||++.       +..+.|+||+.+.
T Consensus       152 ~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        152 RDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99999   99999999999999975       4689999999874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=4.9e-09  Score=113.09  Aligned_cols=155  Identities=19%  Similarity=0.308  Sum_probs=106.6

Q ss_pred             HHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCcc-------ccccccCCCCCChh
Q 036172          260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI-------REDVVGTFGYIAPE  332 (522)
Q Consensus       260 ~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~Y~APE  332 (522)
                      +.=+.+++.|+.|+|..  .++||++|.|++|.++.++.+||+.|+.+...........       .....-...|.|||
T Consensus       102 f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE  179 (700)
T KOG2137|consen  102 FANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE  179 (700)
T ss_pred             hhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence            33345666999999996  8899999999999999999999999999855443211110       01123456799999


Q ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHH
Q 036172          333 YLMHGKVSDKIDVYSFGVVLLELLSGRRP-IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAAN  411 (522)
Q Consensus       333 ~~~~~~~s~ksDVwSlGvvl~eLltG~~P-f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~  411 (522)
                      ++.+...+.++|+||+|+++|.+..|..+ +.............             ..+..-...+....+.++.+-+.
T Consensus       180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             hhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHH
Confidence            99888889999999999999999954444 43322211111111             00111111222445667788888


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 036172          412 LCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       412 ~CL~~dP~~RPs~~eVl~  429 (522)
                      +++..++..||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            899999999998877764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.66  E-value=3.3e-07  Score=96.16  Aligned_cols=136  Identities=22%  Similarity=0.330  Sum_probs=107.8

Q ss_pred             HHHHHhhCCCCCcceeeEEEE----eCCEEEEEEecCCC-CCHHHHhhccC------------CCCCCChHHHHHHHHHH
Q 036172          204 EVDITSSLEQKSITTLNGVCI----EDNYLILVSDFLPK-GSLEESLHGAG------------EQSVLPWGVRFEVAVAI  266 (522)
Q Consensus       204 Ev~iL~~L~HpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi  266 (522)
                      -+++++++.|+|||++.+++.    .+..++|||+|.++ ++|.++-....            .+...++..+|.++.|+
T Consensus       323 lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QL  402 (655)
T KOG3741|consen  323 LVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQL  402 (655)
T ss_pred             HHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHH
Confidence            478999999999999999888    34678999999986 57877665431            12347789999999999


Q ss_pred             HHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHH
Q 036172          267 AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY  346 (522)
Q Consensus       267 ~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVw  346 (522)
                      ..||.++|+   .|+.-+-|.+.+|+++.+.+++|...|+......+...              |  +   .--.+-|.=
T Consensus       403 taaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~--------------~--l---e~~Qq~D~~  460 (655)
T KOG3741|consen  403 TAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE--------------P--L---ESQQQNDLR  460 (655)
T ss_pred             HHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCCc--------------c--h---hHHhhhhHH
Confidence            999999999   89999999999999999999999988877544433211              0  1   112467888


Q ss_pred             HHHHHHHHHHcCCCC
Q 036172          347 SFGVVLLELLSGRRP  361 (522)
Q Consensus       347 SlGvvl~eLltG~~P  361 (522)
                      .||.+++.|.||...
T Consensus       461 ~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  461 DLGLLLLALATGTEN  475 (655)
T ss_pred             HHHHHHHHHhhcccc
Confidence            999999999999664

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.64  E-value=6.5e-07  Score=91.84  Aligned_cols=202  Identities=17%  Similarity=0.160  Sum_probs=128.2

Q ss_pred             EEEEEEecCCCCC-HHHHhhc---cCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          228 YLILVSDFLPKGS-LEESLHG---AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       228 ~~~lV~E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.++|+.+++.- +..++.-   ........|.-.++++..++.+.+.||+   .|.+-+|++++|+|+.+++.+.|.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEc
Confidence            3778888887642 2222221   1223348899999999999999999999   9999999999999999999999998


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCC-----hhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSG-RRPIGFKNLKG-----PES  372 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~-----~~~  372 (522)
                      -..-....++...   ...+|...|.+||.-.     +..-+...|-|.||+++++++.| +.||..-....     .+.
T Consensus       161 sDsfqi~~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQINANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeeccCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            4433222222211   2347889999999753     34457789999999999999986 99997432111     110


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHhcccc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQS--PQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~d--P~~RPs~~eVl~~L~~~~~  436 (522)
                      -+....-... .+...-..|..........+..+..+..+|+...  +.-|||++..+..|....+
T Consensus       238 ~Ia~g~f~ya-~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         238 DIAHGRFAYA-SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hhhcceeeec-hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            1100000000 0000001111111111223345666777788653  5689999999888876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=4.4e-07  Score=87.13  Aligned_cols=105  Identities=22%  Similarity=0.203  Sum_probs=85.5

Q ss_pred             HHHHHHHHHHhhCCCC--CcceeeEEEEeC----CEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHHH
Q 036172          199 NDFSSEVDITSSLEQK--SITTLNGVCIED----NYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEALN  271 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~Hp--nIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~  271 (522)
                      .+..+|...+.+|...  .+++.+++....    ...+||+|++++. +|.+++.....   ++......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            4577888888888444  356777777753    2468999999874 79999985322   566778889999999999


Q ss_pred             HHHhcCCCCEEeccCCCCceeccCCC---ceEEeecCcccc
Q 036172          272 YLHSECSRPVIHRDVKSSNILLSSDF---QPQLSDFGLAIW  309 (522)
Q Consensus       272 yLH~~~~~giiHrDIkp~NILl~~~~---~~kL~DFGla~~  309 (522)
                      -||.   .||+|+|+++.|||++.+.   .+.|+||+-++.
T Consensus       133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999   9999999999999999887   899999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=2.3e-07  Score=87.58  Aligned_cols=98  Identities=19%  Similarity=0.181  Sum_probs=67.8

Q ss_pred             HHHHHHHHHHhhCCCC--CcceeeEEEEeCCEEEEEEecCC--CCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHH-H
Q 036172          199 NDFSSEVDITSSLEQK--SITTLNGVCIEDNYLILVSDFLP--KGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNY-L  273 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~Hp--nIv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~y-L  273 (522)
                      ....+|++.|.++..-  ++++++++.  .  -+|||||++  |..+..+....     ++......++.+++..+.. +
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~--~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~  123 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN--R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKML  123 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE--T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe--C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHH
Confidence            4577899999999766  567776552  2  369999998  65555444311     2245567788888886665 5


Q ss_pred             HhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          274 HSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       274 H~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      |.   .|++|+|+.+.||+++++ .+.|+|||.+..
T Consensus       124 ~~---~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  124 HK---AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HC---TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             Hh---cCceecCCChhhEEeecc-eEEEEecCccee
Confidence            68   999999999999999988 999999998854

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=2.7e-05  Score=73.66  Aligned_cols=104  Identities=21%  Similarity=0.233  Sum_probs=82.4

Q ss_pred             HHHHHHHhhCCC-CCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 036172          202 SSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP  280 (522)
Q Consensus       202 ~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g  280 (522)
                      ..|.-+++.+.+ +++++++|+|-+    ++|+||...+++...-.........+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999966 699999999943    568999987766432100001123799999999999999999999865556


Q ss_pred             EEeccCCCCceeccCCCceEEeecCcccc
Q 036172          281 VIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       281 iiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      +.-.|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987743

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.23  E-value=2.4e-06  Score=83.66  Aligned_cols=143  Identities=16%  Similarity=0.143  Sum_probs=92.5

Q ss_pred             eeeecccccccccccccCch---hHHHHhhcccCccchHHHHHHHhhc---------cchHHHHHHHHHHHHhhCCCC--
Q 036172          149 QMDIPCSEGKYDENTLTPST---ELFLKLVSSRCRQFSYEELKQATSQ---------FSSAWNDFSSEVDITSSLEQK--  214 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~---~~~~~~~~~~~~~~a~k~l~~~t~~---------~~~~~~~f~~Ev~iL~~L~Hp--  214 (522)
                      .++.+||.|-=+.||.+...   ++..+.+...  .-+++.++...+-         ..-......+|.++|.+|...  
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~G--rtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLG--RTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecC--chhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45667888888888887532   2222222111  2233333322221         111345667899999999665  


Q ss_pred             CcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          215 SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       215 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      .+++.+++    +...+||||++|--|...-        ++....-.++..|+.-+.-+-.   .||||+|+.+-||+++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence            77777765    5568999999885554422        1233344455555555555556   8999999999999999


Q ss_pred             CCCceEEeecCccc
Q 036172          295 SDFQPQLSDFGLAI  308 (522)
Q Consensus       295 ~~~~~kL~DFGla~  308 (522)
                      ++|.+.++||-.+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999997763

>PRK09902 hypothetical protein; Provisional

Probab=98.13  E-value=1.7e-05  Score=75.73  Aligned_cols=107  Identities=17%  Similarity=0.105  Sum_probs=83.0

Q ss_pred             HHHHHHHHHHHHhhCCCC--CcceeeEEEE-eC----CEEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHH
Q 036172          197 AWNDFSSEVDITSSLEQK--SITTLNGVCI-ED----NYLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAE  268 (522)
Q Consensus       197 ~~~~f~~Ev~iL~~L~Hp--nIv~l~~~~~-~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~  268 (522)
                      ....|.+|+..|.+|..-  .+++++ ++. ..    -..+||+|-+++ -+|.+++.... ....+...+..++.+++.
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~  139 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVAL  139 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHH
Confidence            446799999999999433  355555 333 21    347899997753 58999986542 224677888899999999


Q ss_pred             HHHHHHhcCCCCEEeccCCCCceeccCCCc--eEEeecCccc
Q 036172          269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQ--PQLSDFGLAI  308 (522)
Q Consensus       269 gL~yLH~~~~~giiHrDIkp~NILl~~~~~--~kL~DFGla~  308 (522)
                      .|.-||.   .|+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       140 ~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        140 AFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9999999   99999999999999986666  9999998764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.12  E-value=1.6e-05  Score=77.47  Aligned_cols=107  Identities=13%  Similarity=0.127  Sum_probs=64.3

Q ss_pred             HHHHHHHHHhhCCCCC--cceeeEEEEeCCEEEEEEecCCCCC-HHHHh---------------------hccCCCCCCC
Q 036172          200 DFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKGS-LEESL---------------------HGAGEQSVLP  255 (522)
Q Consensus       200 ~f~~Ev~iL~~L~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l---------------------~~~~~~~~l~  255 (522)
                      ...+|.++++.+..-.  +.++++++...+...+|||+++|.+ +...+                     +.... ....
T Consensus        38 ~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~  116 (226)
T TIGR02172        38 TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTST  116 (226)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCc
Confidence            4578999999996443  5788888888888899999998863 22111                     11100 0011


Q ss_pred             hHHHHH-HHH----------HHHH-HHHHHHh-cCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          256 WGVRFE-VAV----------AIAE-ALNYLHS-ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       256 ~~~~~~-i~~----------qi~~-gL~yLH~-~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ...... +..          .+.. ...+|.. .....++|+|+.|.||++++++ +.|+||+.+.
T Consensus       117 l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       117 FQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            111100 000          0011 1122221 1124679999999999999888 9999999873

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.97  E-value=3.9e-05  Score=73.67  Aligned_cols=67  Identities=21%  Similarity=0.286  Sum_probs=53.6

Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      ...+|||||++|..|.++..       +++    .+...+..++.-||.   .|++|+|..|.|++++++ .++++||+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~  180 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQG  180 (229)
T ss_pred             eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECcc
Confidence            45678999999988877643       332    244667788999999   999999999999999865 499999986


Q ss_pred             cc
Q 036172          307 AI  308 (522)
Q Consensus       307 a~  308 (522)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            64

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.95  E-value=9.2e-05  Score=84.75  Aligned_cols=197  Identities=18%  Similarity=0.179  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHHhhCCCCCcceeeEEEEeCCEE----EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH
Q 036172          198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYL----ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYL  273 (522)
Q Consensus       198 ~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL  273 (522)
                      .....-|+..+.++.|+|++.++.|..+....    .+..+++..-++...+...   ..++..+.+.+..++.+||.|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHH
Confidence            34455678888999999999999998866433    3455788888888888743   3588899999999999999999


Q ss_pred             HhcCCCCEEeccCCCC---ceeccCCCceEEe--ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCc--hhhHH
Q 036172          274 HSECSRPVIHRDVKSS---NILLSSDFQPQLS--DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD--KIDVY  346 (522)
Q Consensus       274 H~~~~~giiHrDIkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~--ksDVw  346 (522)
                      |+   ....|.-+..+   +-..+..+.+.++  ||+..+..+.......   ..-+..+.+||......+..  ..|+|
T Consensus       303 h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence            99   55555555544   4445566667766  8888876655433322   13455677888776555444  47999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 036172          347 SFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ  426 (522)
Q Consensus       347 SlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~e  426 (522)
                      .+|..+..+..|..+-....                  ....+++    ..    ....+.+....|+..++++|+++.+
T Consensus       377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~----~~----~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLD----VL----STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCccccccc------------------chhhhhc----cc----cchhhhhhhhhhcchhhhhccchhh
Confidence            99999999998876522110                  0000000    00    0114566778899999999999999


Q ss_pred             HHH
Q 036172          427 VLK  429 (522)
Q Consensus       427 Vl~  429 (522)
                      ++.
T Consensus       431 ll~  433 (1351)
T KOG1035|consen  431 LLT  433 (1351)
T ss_pred             hhh
Confidence            997

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.80  E-value=5.8e-06  Score=88.91  Aligned_cols=187  Identities=19%  Similarity=0.125  Sum_probs=131.2

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCC-cceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS-ITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hpn-Iv~l~~~~~~  225 (522)
                      -|....-++.|+++.+++.+....-.-.     ..            |-.......-++++|.+++||| .+..++-+..
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-----h~------------fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~  305 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-----HP------------FVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDG  305 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-----ce------------eeccchhhHHHHHHHHHccCCCCcccccccCCc
Confidence            4566777889999998876644321111     11            1111233456889999999999 7777777777


Q ss_pred             CCEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          226 DNYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       226 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +...+++++++.++ +-......  ....+..-+...+...-++++++||+   ..=+|+|    ||+..+ +..+..||
T Consensus       306 E~~~~i~~~i~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  306 EDYLWIPMRICSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             ccccchhhhhhcCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccc
Confidence            78999999999876 22111110  11123344455667777889999998   4347888    777665 68899999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG  363 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~  363 (522)
                      +....+....   ..+...+++.++|||+...+.+..+.|+|++|+-..++.-|-+|-.
T Consensus       376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            9886554433   3345679999999999999999999999999998888887877743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.61  E-value=0.00035  Score=68.47  Aligned_cols=108  Identities=17%  Similarity=0.139  Sum_probs=65.5

Q ss_pred             HHHHHHHHHhhC-CCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHh-------------------hccCC-CCCCChH-
Q 036172          200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-------------------HGAGE-QSVLPWG-  257 (522)
Q Consensus       200 ~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l-------------------~~~~~-~~~l~~~-  257 (522)
                      ++.+|+++++.+ .+--+++++++...++..++|||+++|.+|....                   +.... ...+... 
T Consensus        37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~  116 (244)
T cd05150          37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRL  116 (244)
T ss_pred             chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhH
Confidence            456788998888 3445678888887777789999999998776432                   11100 0011100 


Q ss_pred             -HHHHHHH--------------------HHHHHHHHHHh----cCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          258 -VRFEVAV--------------------AIAEALNYLHS----ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       258 -~~~~i~~--------------------qi~~gL~yLH~----~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                       .......                    .+...+..|-.    .....++|+|+.|.|||++++..+.|+||+.+
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         117 DRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             HHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence             0000000                    01111122211    01256999999999999999877889999876

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.46  E-value=0.00033  Score=68.24  Aligned_cols=98  Identities=18%  Similarity=0.152  Sum_probs=68.9

Q ss_pred             HHHHHHHhhC--CCCCcceeeEEEEeCCEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 036172          202 SSEVDITSSL--EQKSITTLNGVCIEDNYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECS  278 (522)
Q Consensus       202 ~~Ev~iL~~L--~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  278 (522)
                      .+|+.-|.++  .+=.+++-+++.    .-.|||||+... .-.-.|.    ...+...+...+..++++.+.-|-..  
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~--  185 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKE--  185 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHh--
Confidence            4678888888  344556666554    347999999553 1111111    11233336777888888888887764  


Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccccC
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG  310 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~~  310 (522)
                      .++||+||..-|||+. ++.+.|+|||.|...
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            7899999999999999 889999999988543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.42  E-value=0.00044  Score=66.34  Aligned_cols=142  Identities=18%  Similarity=0.193  Sum_probs=76.2

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCC--CcceeeEEEEe---
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQK--SITTLNGVCIE---  225 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hp--nIv~l~~~~~~---  225 (522)
                      +++|+.|..+.||+.....          +.+.+|...     .......+.+|+.+++.|...  .+++++.++..   
T Consensus         2 i~~l~~G~~n~~~~v~~~~----------~~~vlK~~~-----~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~   66 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD----------GRYVLKFYR-----PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF   66 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT----------SEEEEEEES-----SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE
T ss_pred             CccCCCCCeeeEEEEEECC----------cEEEEEEeC-----CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc
Confidence            4568889888899876432          122222100     001345677899998888433  35677775543   


Q ss_pred             CCEEEEEEecCCCCCHHH----------------Hhh---cc-CCCCCCChHH---------HHHH------------HH
Q 036172          226 DNYLILVSDFLPKGSLEE----------------SLH---GA-GEQSVLPWGV---------RFEV------------AV  264 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~  264 (522)
                      ....+++|++++|..+..                .+.   .. .....+....         ....            ..
T Consensus        67 ~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (239)
T PF01636_consen   67 NGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLE  146 (239)
T ss_dssp             TSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHH
T ss_pred             cccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhH
Confidence            356799999999988877                111   11 0111111110         0000            11


Q ss_pred             HHHH-HHHHHHh----cCCCCEEeccCCCCceecc-CCCceEEeecCcc
Q 036172          265 AIAE-ALNYLHS----ECSRPVIHRDVKSSNILLS-SDFQPQLSDFGLA  307 (522)
Q Consensus       265 qi~~-gL~yLH~----~~~~giiHrDIkp~NILl~-~~~~~kL~DFGla  307 (522)
                      .+.. .+..++.    .....++|+|+.|.||+++ .++.+.|+||+.+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  147 ELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            1222 2333332    1236799999999999999 5566689999876

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.40  E-value=0.00037  Score=75.59  Aligned_cols=105  Identities=19%  Similarity=0.183  Sum_probs=68.0

Q ss_pred             HHHHHHHHHhhC----CCCCcceeeEEEEe-CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHH-HHHH
Q 036172          200 DFSSEVDITSSL----EQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA-LNYL  273 (522)
Q Consensus       200 ~f~~Ev~iL~~L----~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~g-L~yL  273 (522)
                      +|.+|..-+.++    +...-+++=.++.+ .+.-.|+|||++|-.+.+...-..  ..++...   ++..++.+ +..+
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~  281 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQL  281 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHH
Confidence            577788777777    22223333334432 355689999999999988843221  1244222   23333332 2222


Q ss_pred             HhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCC
Q 036172          274 HSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       274 H~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~  312 (522)
                      -.   .|+.|.|..|.||+++.++++.+.|||+......
T Consensus       282 ~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             Hh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            23   6899999999999999999999999999865443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.26  E-value=0.0025  Score=60.79  Aligned_cols=100  Identities=22%  Similarity=0.233  Sum_probs=72.6

Q ss_pred             HHHHHHHHHHHHhhCC------CCCcceeeEEEEeCCEEEEEEecCCC------CCHHHHhhccCCCCCCChHHHHHHHH
Q 036172          197 AWNDFSSEVDITSSLE------QKSITTLNGVCIEDNYLILVSDFLPK------GSLEESLHGAGEQSVLPWGVRFEVAV  264 (522)
Q Consensus       197 ~~~~f~~Ev~iL~~L~------HpnIv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~  264 (522)
                      ..+++.+|+.....+.      +.+|.+++|+..++.-..+|+|.+..      .+|.+++...    .++. ...   .
T Consensus        54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~---~  125 (199)
T PF10707_consen   54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELR---Q  125 (199)
T ss_pred             hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHH---H
Confidence            4466777877777776      78899999999999889999998743      3688888532    2554 333   3


Q ss_pred             HHHHHHHHHHhcCCCCEEeccCCCCceeccCCC----ceEEee-cCcc
Q 036172          265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDF----QPQLSD-FGLA  307 (522)
Q Consensus       265 qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~----~~kL~D-FGla  307 (522)
                      .+-+-..||-.   .+|+.+|++|.||++....    .+.|+| ||..
T Consensus       126 ~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  126 ALDEFKRYLLD---HHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHHHHH---cCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            34445567777   8899999999999996432    577777 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.12  E-value=0.0017  Score=65.98  Aligned_cols=74  Identities=19%  Similarity=0.050  Sum_probs=49.7

Q ss_pred             eecccccccccccccCchh--HHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC---CCcceeeEEEEe
Q 036172          151 DIPCSEGKYDENTLTPSTE--LFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ---KSITTLNGVCIE  225 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~--~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H---pnIv~l~~~~~~  225 (522)
                      .+.||.|..+.||......  .+++...            .    . .....|.+|.+.|+.|.-   -.+++++++|..
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~------------~----~-~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~   81 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMAR------------S----F-STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH   81 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEec------------c----c-ccchHHHHHHHHHHHHccCCCCCcCcEEEEecc
Confidence            4569999999999864321  1111110            0    0 011458899999999943   368899998865


Q ss_pred             C---CEEEEEEecCCCCCH
Q 036172          226 D---NYLILVSDFLPKGSL  241 (522)
Q Consensus       226 ~---~~~~lV~E~~~~gsL  241 (522)
                      +   +..+||||+++++++
T Consensus        82 ~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         82 EQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCcCCCeEEEEeccCCEec
Confidence            3   668999999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.09  E-value=0.0018  Score=63.23  Aligned_cols=29  Identities=24%  Similarity=0.367  Sum_probs=25.5

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++|+|+.+.||+++++...-|+||+.+
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            55999999999999987766679999987

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.05  E-value=0.0025  Score=73.82  Aligned_cols=42  Identities=10%  Similarity=0.290  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHhhCC-CCCc--ceeeEEEEeC---CEEEEEEecCCCCC
Q 036172          199 NDFSSEVDITSSLE-QKSI--TTLNGVCIED---NYLILVSDFLPKGS  240 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~-HpnI--v~l~~~~~~~---~~~~lV~E~~~~gs  240 (522)
                      ..+.+|+++|+.|. |.+|  ++++.+|.+.   +..|+||||++|..
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            46789999999995 7765  8888888764   46789999998864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.87  E-value=0.0013  Score=71.35  Aligned_cols=104  Identities=16%  Similarity=0.068  Sum_probs=64.8

Q ss_pred             HHHHHHHHHhhC----CCCC------cceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHH
Q 036172          200 DFSSEVDITSSL----EQKS------ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA  269 (522)
Q Consensus       200 ~f~~Ev~iL~~L----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~g  269 (522)
                      +|.+|++-..++    .|-+      |++++-.+.  ....|+||||+|..+.|.-.-...  .++...+   +..+.++
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i---~~~l~~~  312 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR--GISPHDI---LNKLVEA  312 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc--CCCHHHH---HHHHHHH
Confidence            456666554443    5555      444443332  456899999999887765432111  2555533   3444443


Q ss_pred             HHHHHhcCCCCEEeccCCCCceeccC----CCceEEeecCccccCCC
Q 036172          270 LNYLHSECSRPVIHRDVKSSNILLSS----DFQPQLSDFGLAIWGPT  312 (522)
Q Consensus       270 L~yLH~~~~~giiHrDIkp~NILl~~----~~~~kL~DFGla~~~~~  312 (522)
                      ...+==  ..|++|+|=.|.||++..    ++.+.+.|||+......
T Consensus       313 ~~~qIf--~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  313 YLEQIF--KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHH--hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            322111  167999999999999984    66899999999865443

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=96.84  E-value=0.00028  Score=60.20  Aligned_cols=52  Identities=8%  Similarity=-0.048  Sum_probs=40.4

Q ss_pred             CCcccccccccccc---chhhhhhhhcccccccc---ccccccccccceeeecCCccc
Q 036172           62 RNSIDEEKYRNPCA---SEEACTVREGISIDQNE---EYTSTVDYGWPLLRISAPETS  113 (522)
Q Consensus        62 ~~~~~~~~~~~~c~---~~~~C~~~~~~~~~~~~---~~~~~~~~g~p~~~~~~~~~~  113 (522)
                      ....+++||++||+   +..+|..||..++..++   ..+.|+++--+.|.+|++.++
T Consensus        48 ~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~~  105 (106)
T PF01657_consen   48 GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENYP  105 (106)
T ss_dssp             -ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS-
T ss_pred             CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECCC
Confidence            45778999999999   99999999999999999   678888888899999887554

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.78  E-value=0.00026  Score=82.89  Aligned_cols=162  Identities=12%  Similarity=-0.034  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHhhCCCCCcceeeEEEE--eCCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHh
Q 036172          199 NDFSSEVDITSSLEQKSITTLNGVCI--EDNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHS  275 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~  275 (522)
                      +-...|.+.++...|+++...+.-..  +....+.+++|+.+|.+.+.|-+.- +...+...-+.....+.+.+..-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            34556666777789999887766554  2345789999999999999987652 22334444444444443666666665


Q ss_pred             cC--CCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHH
Q 036172          276 EC--SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLL  353 (522)
Q Consensus       276 ~~--~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~  353 (522)
                      ..  ..-.+|+++|+-|.+|..+..+|++++|+.+......  ...+...+++.|+.|+....-+++.++|+|..|+.+|
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            32  2447899999999999999999999999997322211  1223456788899999998888999999999999999


Q ss_pred             HHHcCCCCC
Q 036172          354 ELLSGRRPI  362 (522)
Q Consensus       354 eLltG~~Pf  362 (522)
                      +...|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            998888775

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.61  E-value=0.0062  Score=57.98  Aligned_cols=139  Identities=19%  Similarity=0.198  Sum_probs=87.1

Q ss_pred             CCCceeeeccccccc-ccccccCchh--HHHHh---hcccCccchHHHHHH-Hh--hccchHHHHHHHHHHHHhhC---C
Q 036172          145 ENPFQMDIPCSEGKY-DENTLTPSTE--LFLKL---VSSRCRQFSYEELKQ-AT--SQFSSAWNDFSSEVDITSSL---E  212 (522)
Q Consensus       145 ~~~y~~~~~lG~G~f-g~V~l~~~~~--~~~~~---~~~~~~~~a~k~l~~-~t--~~~~~~~~~f~~Ev~iL~~L---~  212 (522)
                      ..+++.++.||.|.- |.|++++-..  .++++   ..-....+..+.+.. .+  ....--...|..|.+...+|   .
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            478999999999999 9999876321  11122   000000011000110 00  01111334789999998888   4


Q ss_pred             CCCc--ceeeEEEEeC------------------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHH
Q 036172          213 QKSI--TTLNGVCIED------------------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNY  272 (522)
Q Consensus       213 HpnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~y  272 (522)
                      +.++  |+++||..-.                  ....||.||++...            .+..    .-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4566  9999998522                  12467888776532            1222    234678888899


Q ss_pred             HHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          273 LHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       273 LH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      +|.   .||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            999   99999999999987     4589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.59  E-value=0.0036  Score=58.07  Aligned_cols=128  Identities=15%  Similarity=0.152  Sum_probs=84.5

Q ss_pred             ceeeecccccccccccccCchh--HHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcc-eeeEEEE
Q 036172          148 FQMDIPCSEGKYDENTLTPSTE--LFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSIT-TLNGVCI  224 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~--~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv-~l~~~~~  224 (522)
                      -++.+.||.|++|.||++....  ++.++...                 .+-...+..|+++|..+.--++. +++.|..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~-----------------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRR-----------------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecC-----------------CcchhhHHHHHHHHHHhhhcCCCceEEEech
Confidence            3567889999999999987542  22222111                 11345688899999999877764 5555543


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCC-CCceeccCCCceEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK-SSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIk-p~NILl~~~~~~kL~D  303 (522)
                      +    ++.|||+.|-.|.+.-...      +..    -+..+++.-.-|-.   .||-|+.|. |..++|..++.+.|+|
T Consensus        87 ~----~i~me~i~G~~L~~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iID  149 (201)
T COG2112          87 D----FIRMEYIDGRPLGKLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIID  149 (201)
T ss_pred             h----hhhhhhhcCcchhhhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEE
Confidence            3    4559999998887766521      122    23455555445666   899999987 4444444455999999


Q ss_pred             cCcccc
Q 036172          304 FGLAIW  309 (522)
Q Consensus       304 FGla~~  309 (522)
                      |.-|.+
T Consensus       150 Fd~At~  155 (201)
T COG2112         150 FDSATF  155 (201)
T ss_pred             ccchhh
Confidence            998853

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.56  E-value=0.0031  Score=67.17  Aligned_cols=162  Identities=19%  Similarity=0.218  Sum_probs=90.2

Q ss_pred             HHHHHHHHhhCCCCCcceeeEEEEeC-CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 036172          201 FSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR  279 (522)
Q Consensus       201 f~~Ev~iL~~L~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~  279 (522)
                      ..-...+++.+.|+|+..++++.... ....+|||++ +.||++++..+.    +....      .+        .   +
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~----l~~~s------~~--------~---~   86 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN----LKDES------LL--------A---H   86 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc----cchhh------hc--------c---c
Confidence            44566899999999999999887733 5689999999 559999997542    11110      01        1   3


Q ss_pred             CEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCC
Q 036172          280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR  359 (522)
Q Consensus       280 giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~  359 (522)
                      ++.|-.+            .+++| .++..                  |  |     ....+|+|||++|.++.++.-|.
T Consensus        87 ~~~~~~~------------~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   87 GVLHLNI------------IYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             ccceehh------------hhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHhh
Confidence            3443222            22233 11100                  0  0     00114999999999999999987


Q ss_pred             CCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 036172          360 RPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV  427 (522)
Q Consensus       360 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eV  427 (522)
                      .-+....  ..+.+....+-....+....+..   ...+.......+.++...|+-..|..||...++
T Consensus       129 ~l~~~~~--~s~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  129 SLEAELT--ESEYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHH--HHHHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            7654221  11111111111111111110000   012233455678888999999999988855433

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.36  E-value=0.0054  Score=62.04  Aligned_cols=144  Identities=17%  Similarity=0.104  Sum_probs=87.3

Q ss_pred             ceeeecccccccccccccCch---hHHHHhhcccCccchHHHHHHHh------hccch---HHHHHHHHHHHHhhCC-CC
Q 036172          148 FQMDIPCSEGKYDENTLTPST---ELFLKLVSSRCRQFSYEELKQAT------SQFSS---AWNDFSSEVDITSSLE-QK  214 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~---~~~~~~~~~~~~~~a~k~l~~~t------~~~~~---~~~~f~~Ev~iL~~L~-Hp  214 (522)
                      +.++..||-|.=+.+|++...   ...+++..  ....++..++...      ...+-   ..-...+|+..|+.|. |.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HR--LGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHR--LGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHh--hhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            345667888877788876432   22223221  1112222222211      00000   1123457888899883 33


Q ss_pred             C-cceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          215 S-ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       215 n-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      . +++.+++    +..++|||++.|-.|...-+-      .+..+   +...+..-+.-|-.   .|+||+|..-=||++
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHH---cCceecccchheeEE
Confidence            2 5555555    456899999999877665431      22233   33444455566667   999999999999999


Q ss_pred             cCCCceEEeecCcccc
Q 036172          294 SSDFQPQLSDFGLAIW  309 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~  309 (522)
                      ++++.++++||-.+..
T Consensus       236 ~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ecCCCEEEeechHhhc
Confidence            9999999999976643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.27  E-value=0.016  Score=61.20  Aligned_cols=83  Identities=7%  Similarity=0.049  Sum_probs=47.0

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-C--CCCcceeeEEEEeCCE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-E--QKSITTLNGVCIEDNY  228 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~--HpnIv~l~~~~~~~~~  228 (522)
                      +.||.|.+..||++........+..+...++    ++.....+.-..+++..|.+.|..+ .  ..++++++.+.  ...
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~----~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~  105 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPY----VRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EEL  105 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcc----cccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCC
Confidence            4589999999998765421000000010000    1100111122446778888888887 2  34678888773  355


Q ss_pred             EEEEEecCCCCC
Q 036172          229 LILVSDFLPKGS  240 (522)
Q Consensus       229 ~~lV~E~~~~gs  240 (522)
                      .++||||+++..
T Consensus       106 ~~lVME~L~~~~  117 (401)
T PRK09550        106 AVTVMEDLSDHK  117 (401)
T ss_pred             CEEEEecCCCcc
Confidence            789999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.18  E-value=0.016  Score=57.20  Aligned_cols=29  Identities=24%  Similarity=0.330  Sum_probs=25.5

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ..++|+|+.|.||++++++ +.|+||..+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            4689999999999999876 7899999873

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.12  E-value=0.027  Score=54.58  Aligned_cols=29  Identities=24%  Similarity=0.331  Sum_probs=26.3

Q ss_pred             CCEEeccCCCCceeccC-CCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSS-DFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~-~~~~kL~DFGla  307 (522)
                      ..++|+|+.+.|||+++ ++.+.|+||..|
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            56999999999999998 578999999877

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.70  E-value=0.039  Score=56.36  Aligned_cols=105  Identities=22%  Similarity=0.282  Sum_probs=69.1

Q ss_pred             HHHHHHHHHHHhhCCC--CCcceeeEEEEeCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHH-HHHHHHHHH
Q 036172          198 WNDFSSEVDITSSLEQ--KSITTLNGVCIEDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA-VAIAEALNY  272 (522)
Q Consensus       198 ~~~f~~Ev~iL~~L~H--pnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~gL~y  272 (522)
                      ..+..+|+.+++.+.-  --+...+++|.++.  ..+.||+|++|..+.+.+...      +..  ..++ ..+++.|+-
T Consensus        65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~------~~~--~~~~~~~l~~~La~  136 (321)
T COG3173          65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE------SLG--RQFALDALADFLAE  136 (321)
T ss_pred             hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc------cch--HHHHHHHHHHHHHH
Confidence            3456678888888843  34566778888765  779999999885333322210      000  1122 244455555


Q ss_pred             HHhcC-------------------------------------------------------CCCEEeccCCCCceeccCCC
Q 036172          273 LHSEC-------------------------------------------------------SRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       273 LH~~~-------------------------------------------------------~~giiHrDIkp~NILl~~~~  297 (522)
                      ||+-.                                                       ...++|+|+.+.||+++++.
T Consensus       137 LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~  216 (321)
T COG3173         137 LHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR  216 (321)
T ss_pred             HhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC
Confidence            55411                                                       14699999999999999998


Q ss_pred             ceEEeecCccccC
Q 036172          298 QPQLSDFGLAIWG  310 (522)
Q Consensus       298 ~~kL~DFGla~~~  310 (522)
                      -+-|.||+++...
T Consensus       217 ~~gVlDwe~~~lG  229 (321)
T COG3173         217 PTGVLDWELATLG  229 (321)
T ss_pred             eeEEEeccccccC
Confidence            8999999998543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.55  E-value=0.032  Score=56.16  Aligned_cols=29  Identities=38%  Similarity=0.505  Sum_probs=26.5

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      .+++|+|+.|.||++++++.+.|+||+.+
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence            57999999999999999877889999877

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.71  E-value=0.086  Score=54.36  Aligned_cols=73  Identities=21%  Similarity=0.158  Sum_probs=59.0

Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ..+.|++|++- |++|.-.-       .-.++++..++.+.+..+.-|...  ...-|||+.-.||||+ +|++.|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence            34678888877 55554321       256889999999998888888774  7789999999999999 9999999999


Q ss_pred             cccc
Q 036172          306 LAIW  309 (522)
Q Consensus       306 la~~  309 (522)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9974

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.47  E-value=0.044  Score=55.36  Aligned_cols=41  Identities=20%  Similarity=0.244  Sum_probs=26.5

Q ss_pred             HHHHHHHHHHhhC---CCCCcceeeEEEEeCCEEEEEEecCCCC
Q 036172          199 NDFSSEVDITSSL---EQKSITTLNGVCIEDNYLILVSDFLPKG  239 (522)
Q Consensus       199 ~~f~~Ev~iL~~L---~HpnIv~l~~~~~~~~~~~lV~E~~~~g  239 (522)
                      ..|..|++-|+.|   .--.+++++++....+..+|||||++.+
T Consensus        54 ~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   54 DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4578888888888   3345889999998877789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.30  E-value=0.16  Score=51.00  Aligned_cols=30  Identities=27%  Similarity=0.428  Sum_probs=25.1

Q ss_pred             CCEEeccCCCCceeccCCCc-eEEeecCccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQ-PQLSDFGLAI  308 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~-~kL~DFGla~  308 (522)
                      ..++|+|++|.||++++++. .-|+||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            45899999999999997555 5699999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.08  E-value=0.081  Score=55.30  Aligned_cols=63  Identities=21%  Similarity=0.157  Sum_probs=46.6

Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ....||=+|.+|-++..++...+    .++....+++.-.+.||.-+---  .+++|.|+.|.||++..
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ccceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence            34567778999999999997432    55566777777777776554432  67999999999999853

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.73  E-value=0.16  Score=48.96  Aligned_cols=123  Identities=15%  Similarity=0.089  Sum_probs=79.4

Q ss_pred             HHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 036172          199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECS  278 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  278 (522)
                      .-|.++.++++++.  .|+++..=  ....+.++.|+|-..            +...    ..++..-+.+|.-.|++. 
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------------~i~~----~N~i~agi~~L~~fH~~~-  161 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------------KINF----SNFITAGIKDLMDFHSEN-  161 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------------ccch----hHHHHHhHHHHHHhhccC-
Confidence            45778888888874  46666622  334577899988431            1111    122233357788889643 


Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                      .+.+|+|..|+||+-|..|.+||.|-+....              .+..|.--|   ....+.++.+-+|=..++++...
T Consensus       162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999765410              111222211   23457778888887777777764


Q ss_pred             C
Q 036172          359 R  359 (522)
Q Consensus       359 ~  359 (522)
                      .
T Consensus       225 ~  225 (308)
T PF07387_consen  225 Q  225 (308)
T ss_pred             H
Confidence            3

The function of this family is unknown.

>PLN02236 choline kinase

Probab=93.43  E-value=0.39  Score=49.81  Aligned_cols=29  Identities=21%  Similarity=0.327  Sum_probs=25.8

Q ss_pred             CCEEeccCCCCceeccC-CCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSS-DFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~-~~~~kL~DFGla  307 (522)
                      ..++|+|+++.||++++ ++.+.|+||..+
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya  229 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYA  229 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence            57999999999999986 468999999887

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=93.34  E-value=0.24  Score=51.06  Aligned_cols=28  Identities=25%  Similarity=0.381  Sum_probs=24.9

Q ss_pred             CEEeccCCCCceeccC-CCceEEeecCcc
Q 036172          280 PVIHRDVKSSNILLSS-DFQPQLSDFGLA  307 (522)
Q Consensus       280 giiHrDIkp~NILl~~-~~~~kL~DFGla  307 (522)
                      -++|+|+.+.||++++ ++.++++||..|
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEccccc
Confidence            4899999999999975 468999999987

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.23  E-value=0.5  Score=45.95  Aligned_cols=46  Identities=24%  Similarity=0.368  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHHHhhC---CCCCcceeeEEEEeCCEEEEEEecCCCCCHH
Q 036172          197 AWNDFSSEVDITSSL---EQKSITTLNGVCIEDNYLILVSDFLPKGSLE  242 (522)
Q Consensus       197 ~~~~f~~Ev~iL~~L---~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  242 (522)
                      ....|..|+.-|..|   +.-++.+++.+.....+.|+||||++-|.+.
T Consensus        51 ~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          51 QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            445688888877777   3456889999999999999999999987665

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=92.00  E-value=0.64  Score=48.38  Aligned_cols=30  Identities=23%  Similarity=0.492  Sum_probs=25.3

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|||+.+.||+++++ .++++|+.++.+
T Consensus       192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence            678999999999999776 478999987643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=91.64  E-value=0.34  Score=48.94  Aligned_cols=30  Identities=33%  Similarity=0.382  Sum_probs=27.1

Q ss_pred             CCCEEeccCCCCceeccCC----CceEEeecCcc
Q 036172          278 SRPVIHRDVKSSNILLSSD----FQPQLSDFGLA  307 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~----~~~kL~DFGla  307 (522)
                      ...++|+|+.+.||+++++    +.+.|+||..+
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            4689999999999999985    78999999987

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.16  E-value=0.29  Score=49.70  Aligned_cols=30  Identities=37%  Similarity=0.502  Sum_probs=27.2

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..+++|+|+.+.||++++++.+.|+||+.+
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            478999999999999998887789999976

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=90.68  E-value=0.38  Score=48.98  Aligned_cols=30  Identities=37%  Similarity=0.500  Sum_probs=26.2

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||+|+.|.||+++++...-|+||+.+
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccc
Confidence            368999999999999997766689999987

>PLN02756 S-methyl-5-thioribose kinase

Probab=89.66  E-value=0.43  Score=50.49  Aligned_cols=30  Identities=20%  Similarity=0.473  Sum_probs=24.9

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ....+|||+.|.||++++++ ++++|..++.
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            36799999999999999875 8888876653

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=89.63  E-value=0.62  Score=47.07  Aligned_cols=28  Identities=32%  Similarity=0.412  Sum_probs=25.2

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      .+++|+|+.+.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            68999999999999987 67899999866

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=88.45  E-value=1.6  Score=45.95  Aligned_cols=28  Identities=29%  Similarity=0.208  Sum_probs=23.9

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ...+|.|+-+.||+.++ ..+.++||..|
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence            56899999999998754 46999999876

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=88.24  E-value=0.72  Score=46.13  Aligned_cols=50  Identities=20%  Similarity=0.146  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       258 ~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ...+.+..+-.++.-+|... .-++|+|+.|.|+++++.+.++|+||..|.
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            33445566666666666511 359999999999999999999999998873

>PRK10271 thiK thiamine kinase; Provisional

Probab=87.93  E-value=0.38  Score=45.34  Aligned_cols=29  Identities=28%  Similarity=0.295  Sum_probs=25.5

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ...+|+|+.|.||++++++ ++|+||+.+.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            4579999999999998877 8899999883

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=87.24  E-value=0.52  Score=44.95  Aligned_cols=29  Identities=34%  Similarity=0.477  Sum_probs=21.1

Q ss_pred             CCEEeccCCCCceec-cCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILL-SSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl-~~~~~~kL~DFGla  307 (522)
                      ..++|+|+.|.||++ +.++.++|+||..|
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya  172 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYA  172 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHH
Confidence            568999999999999 88899999999887

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=85.86  E-value=1.5  Score=45.30  Aligned_cols=27  Identities=33%  Similarity=0.583  Sum_probs=25.1

Q ss_pred             EEeccCCCCceeccCCCc-eEEeecCcc
Q 036172          281 VIHRDVKSSNILLSSDFQ-PQLSDFGLA  307 (522)
Q Consensus       281 iiHrDIkp~NILl~~~~~-~kL~DFGla  307 (522)
                      +||+|+.|.||+++.+.. +.++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            999999999999999874 899999977

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=85.79  E-value=1.2  Score=45.36  Aligned_cols=31  Identities=16%  Similarity=0.181  Sum_probs=27.9

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ..+++|+|+.+.||++++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3689999999999999999999999998773

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=85.47  E-value=1.6  Score=45.53  Aligned_cols=98  Identities=17%  Similarity=0.227  Sum_probs=68.0

Q ss_pred             HHHHHHHhhCCCCCcceeeEEEEeCCEEEEEEecCCCCC-HHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 036172          202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS-LEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP  280 (522)
Q Consensus       202 ~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g  280 (522)
                      ..|++-|.+|+...|.----+...  ...|||+|+.... -.-.|    +...++...+..+-.+++.-+.-|.+.  .+
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~  285 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQK--CR  285 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHH--hc
Confidence            357888888876665432222222  3468999995311 11122    223477778888889999999888876  67


Q ss_pred             EEeccCCCCceeccCCCceEEeecCccc
Q 036172          281 VIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       281 iiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      +||.||.--|+|+. +|.+.|+|-+.+.
T Consensus       286 LVHADLSEfN~Lyh-dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  286 LVHADLSEFNLLYH-DGKLYIIDVSQSV  312 (520)
T ss_pred             eeccchhhhhheEE-CCEEEEEEccccc
Confidence            99999999999986 4689999988763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	522
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
3soa_A	444	Full-Length Human Camkii Length = 444		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-04
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		7e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 89/243 (36%), Positives = 132/243 (54%), Gaps = 4/243 (1%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE-QSVLPWGVR 259
           F +EV++ S    +++  L G C+     +LV  ++  GS+   L    E Q  L W  R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A+  A  L YLH  C   +IHRDVK++NILL  +F+  + DFGLA        H + 
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VX 200
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES--LVKWA 377
             V GT G+IAPEYL  GK S+K DV+ +GV+LLEL++G+R      L   +   L+ W 
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA 437
           K +LK    E L+D  L   Y + ++++++  A LC   SP  RP M +V+++L G   A
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320
Query: 438 TDW 440
             W
Sbjct: 321 ERW 323

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 88/243 (36%), Positives = 131/243 (53%), Gaps = 4/243 (1%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE-QSVLPWGVR 259
           F +EV++ S    +++  L G C+     +LV  ++  GS+   L    E Q  L W  R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A+  A  L YLH  C   +IHRDVK++NILL  +F+  + DFGLA        H + 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VX 192
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES--LVKWA 377
             V G  G+IAPEYL  GK S+K DV+ +GV+LLEL++G+R      L   +   L+ W 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA 437
           K +LK    E L+D  L   Y + ++++++  A LC   SP  RP M +V+++L G   A
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
Query: 438 TDW 440
             W
Sbjct: 313 ERW 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 146/261 (55%), Gaps = 6/261 (2%)
Query: 170 LFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYL 229
           +F K+     R  +   LK+ T + S    +F +E++  S      + +L G C E N +
Sbjct: 51  VFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110
Query: 230 ILVSDFLPKGSLEESLHGAGEQSV-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           IL+  ++  G+L+  L+G+   ++ + W  R E+ +  A  L+YLH+   R +IHRDVKS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKS 167
Query: 289 SNILLSSDFQPQLSDFGLAIWGP-TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYS 347
            NILL  +F P+++DFG++  G   D TH+    V GT GYI PEY + G++++K DVYS
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHL-XXVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 348 FGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRML 407
           FGVVL E+L  R  I     +   +L +WA     NG  E ++DP L+++     +++  
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFG 286
Query: 408 LAANLCINQSPQLRPNMGQVL 428
             A  C+  S + RP+MG VL
Sbjct: 287 DTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 89/260 (34%), Positives = 143/260 (55%), Gaps = 4/260 (1%)
Query: 170 LFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYL 229
           +F K+     R  +   LK+ T + S    +F +E++  S      + +L G C E N +
Sbjct: 51  VFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110
Query: 230 ILVSDFLPKGSLEESLHGAGEQSV-LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           IL+  ++  G+L+  L+G+   ++ + W  R E+ +  A  L+YLH+   R +IHRDVKS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKS 167
Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            NILL  +F P+++DFG++  G       +   V GT GYI PEY + G++++K DVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 349 GVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLL 408
           GVVL E+L  R  I     +   +L +WA     NG  E ++DP L+++     +++   
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 409 AANLCINQSPQLRPNMGQVL 428
            A  C+  S + RP+MG VL
Sbjct: 288 TAVKCLALSSEDRPSMGDVL 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES 244
           EELKQ           F  E+ + +  + +++  L G   + + L LV  ++P GSL + 
Sbjct: 65  EELKQ----------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 114
Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L        L W +R ++A   A  +N+LH       IHRD+KS+NILL   F  ++SDF
Sbjct: 115 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDF 171
Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GLA      +  ++   +VGT  Y+APE L  G+++ K D+YSFGVVLLE+++G   +  
Sbjct: 172 GLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-- 228
Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
              + P+ L+   + I     T      K  N+ D+  ++ M   A+ C+++    RP++
Sbjct: 229 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 288
Query: 425 GQVLKLLRGAT 435
            +V +LL+  T
Sbjct: 289 KKVQQLLQEMT 299

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES 244
           EELKQ           F  E+ + +  + +++  L G   + + L LV  ++P GSL + 
Sbjct: 71  EELKQ----------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L        L W +R ++A   A  +N+LH       IHRD+KS+NILL   F  ++SDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDF 177
Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GLA      +  ++   +VGT  Y+APE L  G+++ K D+YSFGVVLLE+++G   +  
Sbjct: 178 GLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-- 234
Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
              + P+ L+   + I     T      K  N+ D+  ++ M   A+ C+++    RP++
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 425 GQVLKLLRGAT 435
            +V +LL+  T
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 130/251 (51%), Gaps = 16/251 (6%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES 244
           EELKQ           F  E+ + +  + +++  L G   + + L LV  ++P GSL + 
Sbjct: 71  EELKQ----------QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L        L W +R ++A   A  +N+LH       IHRD+KS+NILL   F  ++SDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDF 177
Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GLA      +  ++   +VGT  Y+APE L  G+++ K D+YSFGVVLLE+++G   +  
Sbjct: 178 GLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-- 234
Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
              + P+ L+   + I     T      K  N+ D+  ++ M   A+ C+++    RP++
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 425 GQVLKLLRGAT 435
            +V +LL+  T
Sbjct: 295 KKVQQLLQEMT 305

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 125/251 (49%), Gaps = 16/251 (6%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES 244
           EELKQ           F  E+ + +  + +++  L G   + + L LV  + P GSL + 
Sbjct: 62  EELKQ----------QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR 111
Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L        L W  R ++A   A  +N+LH       IHRD+KS+NILL   F  ++SDF
Sbjct: 112 LSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDF 168
Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GLA      +  +    +VGT  Y APE L  G+++ K D+YSFGVVLLE+++G   +  
Sbjct: 169 GLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-- 225
Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
              + P+ L+   + I     T      K  N+ D+  ++     A+ C+++    RP++
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDI 285
Query: 425 GQVLKLLRGAT 435
            +V +LL+  T
Sbjct: 286 KKVQQLLQEXT 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 18/234 (7%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           N+F  EV I   L   +I    G   +   L +V+++L +GSL   LH +G +  L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R  +A  +A+ +NYLH+  + P++HR++KS N+L+   +  ++ DFGL+      ST + 
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS--RLKASTFLS 195
Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
            +   GT  ++APE L     ++K DVYSFGV+L EL + ++P G  N   P  +V    
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVG 252
Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
              K  +    L+P+++   +             C    P  RP+   ++ LLR
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEG------------CWTNEPWKRPSFATIMDLLR 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 18/234 (7%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           N+F  EV I   L   +I    G   +   L +V+++L +GSL   LH +G +  L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R  +A  +A+ +NYLH+  + P++HRD+KS N+L+   +  ++ DFGL+      S  + 
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLS--RLKASXFLX 195
Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
            +   GT  ++APE L     ++K DVYSFGV+L EL + ++P G  N   P  +V    
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVG 252
Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
              K  +    L+P+++   +             C    P  RP+   ++ LLR
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEG------------CWTNEPWKRPSFATIMDLLR 294

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 90/178 (50%), Gaps = 18/178 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   E  + + L+  +I  L GVC+++  L LV +F   G L   L G      +P  + 
Sbjct: 52  NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDIL 107
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP--------QLSDFGLAIWGP 311
              AV IA  +NYLH E   P+IHRD+KSSNIL+    +         +++DFGLA    
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---- 163
Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
            +     +    G + ++APE +     S   DV+S+GV+L ELL+G  P  F+ + G
Sbjct: 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDG 219

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 88/161 (54%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           D   E++I  +L  ++I    G+C ED  N + L+ +FLP GSL+E L     +  L   
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-TH 316
           +++  AV I + ++YL S   R  +HRD+ + N+L+ S+ Q ++ DFGL     TD    
Sbjct: 129 LKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 183
Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            +++D      + APE LM  K     DV+SFGV L ELL+
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 88/161 (54%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           D   E++I  +L  ++I    G+C ED  N + L+ +FLP GSL+E L     +  L   
Sbjct: 57  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-TH 316
           +++  AV I + ++YL S   R  +HRD+ + N+L+ S+ Q ++ DFGL     TD    
Sbjct: 117 LKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXX 171
Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            +++D      + APE LM  K     DV+SFGV L ELL+
Sbjct: 172 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E+   S +   +I  L G C+  N + LV ++   GSL   LHGA            
Sbjct: 48  FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLSDFGLAIWGPTDSTHMIR 319
              +  ++ + YLHS   + +IHRD+K  N+LL +     ++ DFG A       THM  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTN 162
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
               G+  ++APE       S+K DV+S+G++L E+++ R+P  F  + GP   + WA  
Sbjct: 163 NK--GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA-- 216
Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            + NG    L+   L    ++   +        C ++ P  RP+M +++K++
Sbjct: 217 -VHNGTRPPLIK-NLPKPIESLMTR--------CWSKDPSQRPSMEEIVKIM 258

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E+   S +   +I  L G C+  N + LV ++   GSL   LHGA            
Sbjct: 49  FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 106
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLSDFGLAIWGPTDSTHMIR 319
              +  ++ + YLHS   + +IHRD+K  N+LL +     ++ DFG A       THM  
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTN 163
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
               G+  ++APE       S+K DV+S+G++L E+++ R+P  F  + GP   + WA  
Sbjct: 164 NK--GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA-- 217
Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            + NG    L+   L    ++   +        C ++ P  RP+M +++K++
Sbjct: 218 -VHNGTRPPLIK-NLPKPIESLMTR--------CWSKDPSQRPSMEEIVKIM 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 35/249 (14%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEV 262
           E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L  G  +++ +   +R   
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR--- 126
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I + L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G    T + R   
Sbjct: 127 --EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXF 179
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG-FKNLKGPESLVKWAKPIL 381
           VGT  ++APE +       K D++S G+  +EL  G  P      +K    + K   P L
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK---LLRGA---T 435
           +   ++ L       E+  A           C+N+ P  RP   ++LK   +LR A   +
Sbjct: 240 EGNYSKPL------KEFVEA-----------CLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 436 HATDWVDRH 444
           + T+ +DR+
Sbjct: 283 YLTELIDRY 291

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 118/248 (47%), Gaps = 33/248 (13%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEV 262
           E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L  G  +++ +   +R   
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR--- 111
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I + L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G    T + R   
Sbjct: 112 --EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXF 164
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           VGT  ++APE +       K D++S G+  +EL  G  P     L   + L      I K
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP--HSELHPMKVLFL----IPK 218
Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK---LLRGA---TH 436
           N        P L   Y     + +      C+N+ P  RP   ++LK   +LR A   ++
Sbjct: 219 NN------PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNAKKTSY 268
Query: 437 ATDWVDRH 444
            T+ +DR+
Sbjct: 269 LTELIDRY 276

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 118/248 (47%), Gaps = 33/248 (13%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEV 262
           E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L  G  +++ +   +R   
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR--- 111
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I + L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G    T + R   
Sbjct: 112 --EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTF 164
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           VGT  ++APE +       K D++S G+  +EL  G  P     L   + L      I K
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP--HSELHPMKVLFL----IPK 218
Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK---LLRGA---TH 436
           N        P L   Y     + +      C+N+ P  RP   ++LK   +LR A   ++
Sbjct: 219 NN------PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNAKKTSY 268
Query: 437 ATDWVDRH 444
            T+ +DR+
Sbjct: 269 LTELIDRY 276

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S+E+ I  SL+   +   +G   +D+++ +V +   + SL E LH   +    P   R+
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEA-RY 146
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   I + + YLH+     VIHRD+K  N+ L+ D   ++ DFGLA     D     ++
Sbjct: 147 FMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KK 200
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
           D+ GT  YIAPE L     S ++D++S G +L  LL G+ P     LK  E+ ++    I
Sbjct: 201 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK--ETYIR----I 254
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     P+  N   +A ++RML A        P LRP++ ++L
Sbjct: 255 KKNEYSV----PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S+E+ I  SL+   +   +G   +D+++ +V +   + SL E LH   +    P   R+
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEA-RY 130
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   I + + YLH+     VIHRD+K  N+ L+ D   ++ DFGLA     D     ++
Sbjct: 131 FMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KK 184
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
           D+ GT  YIAPE L     S ++D++S G +L  LL G+ P     LK  E+ ++    I
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK--ETYIR----I 238
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     P+  N   +A ++RML A        P LRP++ ++L
Sbjct: 239 KKNEYSV----PRHINPVASALIRRMLHA-------DPTLRPSVAELL 275

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 79  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 138
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 139 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 188
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R+D+ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 189 ---RDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 114 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R D+ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 164 ---RTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 118
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R+D+ G
Sbjct: 119 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCG 171
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 172 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 118 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R D+ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 168 ---RTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 53  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 113 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 162
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R D+ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 163 ---RTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 53  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 113 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 162
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R D+ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 163 ---RTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 98/175 (56%), Gaps = 11/175 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F +E ++  +L+   +  L+ V  ++  + ++++F+ KGSL + L    G +  LP  + 
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + ++     R  IHRD++++NIL+S+    +++DFGLA     D+ +  R
Sbjct: 289 F--SAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAR 342
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL 373
           E       + APE +  G  + K DV+SFG++L+E+++ GR P  +  +  PE +
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVI 395

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 98/175 (56%), Gaps = 11/175 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F +E ++  +L+   +  L+ V  ++  + ++++F+ KGSL + L    G +  LP  + 
Sbjct: 57  FLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 115
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + ++     R  IHRD++++NIL+S+    +++DFGLA     D+ +  R
Sbjct: 116 F--SAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAR 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL 373
           E       + APE +  G  + K DV+SFG++L+E+++ GR P  +  +  PE +
Sbjct: 170 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVI 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P+G + + L       EQ    
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT 117
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 118 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 168 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 33/246 (13%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEV 262
           E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L  G  +++ +   +R   
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR--- 131
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I + L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G    T + R   
Sbjct: 132 --EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTF 184
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           VGT  ++APE +       K D++S G+  +EL  G  P    +      L+    P   
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--- 241
Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK---LLRGA---TH 436
                    P L   Y     + +      C+N+ P  RP   ++LK   +LR A   ++
Sbjct: 242 ---------PTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNAKKTSY 288
Query: 437 ATDWVD 442
            T+ +D
Sbjct: 289 LTELID 294

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P+G + + L       EQ    
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT 117
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 118 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 168 ---RXXLXGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQF--SYEELKQATSQFSSAWNDFSSEV 205
           F++  P  +GK+            + L   + R+F  + + L +A  + +   +    EV
Sbjct: 7   FEIGRPLGKGKFGN----------VYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREV 56
Query: 206 DITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEV 262
           +I S L   +I  L G   +   + L+ ++ P G++   L       EQ    +      
Sbjct: 57  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  +
Sbjct: 111 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTL 163
Query: 323 VGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
            GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 164 CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S+E+ I  SL+   +   +G   +D+++ +V +   + SL E LH   +    P   R+
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEA-RY 146
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   I + + YLH+     VIHRD+K  N+ L+ D   ++ DFGLA     D     ++
Sbjct: 147 FMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KK 200
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++D++S G +L  LL G+ P     LK  E+ ++    I
Sbjct: 201 TLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK--ETYIR----I 254
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     P+  N   +A ++RML A        P LRP++ ++L
Sbjct: 255 KKNEYSV----PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 117/240 (48%), Gaps = 36/240 (15%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           D+  E++I ++ +   I  L G    D  L ++ +F P G+++  +     G  E  +  
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                 V   + EALN+LHS   + +IHRD+K+ N+L++ +   +L+DFG++       T
Sbjct: 122 ------VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKT 170
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
              R+  +GT  ++APE +M   + D     K D++S G+ L+E+     P     L   
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--HHELNPM 228
Query: 371 ESLVKWAKPILKNGDTETLLDP-KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             L+K AK      D  TLL P K S E+ +           + ++++P+ RP+  Q+L+
Sbjct: 229 RVLLKIAK-----SDPPTLLTPSKWSVEFRD--------FLKIALDKNPETRPSAAQLLE 275

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/173 (34%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 190 ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESL-- 245
           A  Q  S W     E+DI  +L  + I    G C +     L LV +++P GSL + L  
Sbjct: 72  AGPQHRSGWK---QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128
Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
           H  G   +L +      A  I E + YLH++     IHRD+ + N+LL +D   ++ DFG
Sbjct: 129 HSIGLAQLLLF------AQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 306 LAIWGP-TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           LA   P     + +RED      + APE L   K     DV+SFGV L ELL+
Sbjct: 180 LAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S+E+ I  SL+   +   +G   +D+++ +V +   + SL E LH   +    P   R+
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEA-RY 146
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   I + + YLH+     VIHRD+K  N+ L+ D   ++ DFGLA     D     ++
Sbjct: 147 FMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KK 200
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++D++S G +L  LL G+ P     LK  E+ ++    I
Sbjct: 201 XLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLK--ETYIR----I 254
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     P+  N   +A ++RML A        P LRP++ ++L
Sbjct: 255 KKNEYSV----PRHINPVASALIRRMLHA-------DPTLRPSVAELL 291

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 117/240 (48%), Gaps = 36/240 (15%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           D+  E++I ++ +   I  L G    D  L ++ +F P G+++  +     G  E  +  
Sbjct: 54  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 113
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                 V   + EALN+LHS   + +IHRD+K+ N+L++ +   +L+DFG++       T
Sbjct: 114 ------VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKT 162
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
              R+  +GT  ++APE +M   + D     K D++S G+ L+E+     P     L   
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--HHELNPM 220
Query: 371 ESLVKWAKPILKNGDTETLLDP-KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             L+K AK      D  TLL P K S E+ +           + ++++P+ RP+  Q+L+
Sbjct: 221 RVLLKIAK-----SDPPTLLTPSKWSVEFRD--------FLKIALDKNPETRPSAAQLLE 267

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 53  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 113 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 162
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R ++ GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 163 ---RTELCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  EV +   LE  ++    GV  +D  L  +++++  G+L   +     Q   PW  R 
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRV 111
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH---- 316
             A  IA  + YLHS     +IHRD+ S N L+  +    ++DFGLA     + T     
Sbjct: 112 SFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 317 --------MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
                     R  VVG   ++APE +      +K+DV+SFG+VL E++ 
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESL--HGA 248
           Q  S W     E+DI  +L  + I    G C +  +  L LV +++P GSL + L  H  
Sbjct: 58  QHRSGWK---QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSI 114
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
           G   +L +      A  I E + YLHS+     IHR++ + N+LL +D   ++ DFGLA 
Sbjct: 115 GLAQLLLF------AQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 309 WGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             P    +  +RED      + APE L   K     DV+SFGV L ELL+
Sbjct: 166 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ +FLP GSL E L    E+  +   
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHI 117
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 118 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 114/234 (48%), Gaps = 19/234 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSV 253
           + A  D   E+D+   L   ++       IEDN L +V +    G L   + H   ++ +
Sbjct: 73  AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P    ++  V +  AL ++HS   R V+HRD+K +N+ +++    +L D GL  +  + 
Sbjct: 133 IPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189
Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           +T      +VGT  Y++PE +     + K D++S G +L E+ + + P     +    +L
Sbjct: 190 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NL 243
Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
               K I      E    P L +++ + ++++++   N+CIN  P+ RP++  V
Sbjct: 244 YSLCKKI------EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDVTYV 288

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 114 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R+ + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 164 ---RDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 70  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 129
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 130 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 179
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 180 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 79  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 138
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 139 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 188
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 189 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 148 FQMDIPCSEGKYDENTLT--PSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEV 205
           F++  P  +GK+    L    +++  L L          + L +A  + +   +    EV
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILAL----------KVLFKAQLEKAGVEHQLRREV 59
Query: 206 DITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEV 262
           +I S L   +I  L G   +   + L+ ++ P G++   L       EQ    +      
Sbjct: 60  EIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ 113
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  +
Sbjct: 114 ITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAAL 166
Query: 323 VGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
            GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 167 CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 115
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 116 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 165
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 166 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 114
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 115 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 164
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 165 ---RXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ + S  +   +T   G  ++ + L ++ ++L  GS  + L         P+   F++A
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG------PFD-EFQIA 123
Query: 264 VAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             + E    L+YLHSE     IHRD+K++N+LLS     +L+DFG+A  G    T + R 
Sbjct: 124 TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRN 178
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
             VGT  ++APE +       K D++S G+  +EL  G  P    N       V +  P 
Sbjct: 179 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIP- 233
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            KN        P L  ++  +  + +    + C+N+ P  RP   ++LK
Sbjct: 234 -KNN------PPTLVGDFTKSFKEFI----DACLNKDPSFRPTAKELLK 271

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 118 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 168 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESL--HGA 248
           Q  S W     E+DI  +L  + I    G C +  +  L LV +++P GSL + L  H  
Sbjct: 58  QHRSGWK---QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSI 114
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
           G   +L +      A  I E + YLH++     IHR++ + N+LL +D   ++ DFGLA 
Sbjct: 115 GLAQLLLF------AQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 309 WGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             P    +  +RED      + APE L   K     DV+SFGV L ELL+
Sbjct: 166 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 53  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 113 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 162
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 163 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 118
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  + G
Sbjct: 119 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCG 171
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 172 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 57  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT 116
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S+ + +++DFG ++  P+   
Sbjct: 117 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR- 166
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R+ + GT  Y+ PE ++ G++ D K+D++S GV+  E L G  P 
Sbjct: 167 ---RDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 115
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 116 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 165
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 166 ---RXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 43/253 (16%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEV 262
           E+ + S  +   IT   G  ++   L ++ ++L  GS  + L  G  E++ +   +R   
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR--- 123
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I + L+YLHSE     IHRD+K++N+LLS     +L+DFG+A  G    T + R   
Sbjct: 124 --EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXF 176
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           VGT  ++APE +       K D++S G+  +EL  G  P                     
Sbjct: 177 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--------------------- 215
Query: 383 NGDTETL----LDPKLSNEYDNAQMQRMLLA-ANLCINQSPQLRPNMGQVLK------LL 431
           N D   +    L PK S      Q  +        C+N+ P+ RP   ++LK        
Sbjct: 216 NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 275
Query: 432 RGATHATDWVDRH 444
           +  +  T+ +DR+
Sbjct: 276 KKTSFLTELIDRY 288

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 115
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 116 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 165
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 166 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 111/246 (45%), Gaps = 20/246 (8%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +DN L +V+ +    SL + LH   +++        
Sbjct: 79  FRNEVAVLRKTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHV--QETKFQMFQLI 135
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L      ++ DFGLA      S     E
Sbjct: 136 DIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 321 DVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
              G+  ++APE +    +   S + DVYS+G+VL EL++G  P    N +         
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-------- 244
Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA 437
           + I   G       P LS  Y N       L A+ C+ +  + RP   Q+L  +    H+
Sbjct: 245 QIIFMVG--RGYASPDLSKLYKNCPKAMKRLVAD-CVKKVKEERPLFPQILSSIELLQHS 301
Query: 438 TDWVDR 443
              ++R
Sbjct: 302 LPKINR 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHI 117
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 118 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 115
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  + G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCG 168
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 169 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LKQ T +  +   +   E  I   L+   I  L GVC +   L+LV +    G L + L 
Sbjct: 45  LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 101
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G  E+  +P     E+   ++  + YL     +  +HRD+ + N+LL +    ++SDFGL
Sbjct: 102 GKREE--IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGL 156
Query: 307 A-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGF 364
           +   G  DS +  R        + APE +   K S + DV+S+GV + E LS G++P  +
Sbjct: 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--Y 214
Query: 365 KNLKGPESL 373
           K +KGPE +
Sbjct: 215 KKMKGPEVM 223

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 52  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 111
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 112 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 161
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 162 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 119
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  + G
Sbjct: 120 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCG 172
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 173 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 115
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  + G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCG 168
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 169 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI 207
           F++  P  +GK+    L    +    L        + + L +A  + +   +    EV+I
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFIL--------ALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAV 264
            S L   +I  L G   +   + L+ ++ P G++   L       EQ    +        
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------IT 115
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+      R  + G
Sbjct: 116 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCG 168
Query: 325 TFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
           T  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 169 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 57  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTAT 116
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S+ + +++DFG ++  P+   
Sbjct: 117 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR- 166
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G  P 
Sbjct: 167 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 114
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + ++++FG ++  P+   
Sbjct: 115 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR- 164
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 165 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 16/167 (9%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+   
Sbjct: 118 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE +      +K+D++S GV+  E L G+ P 
Sbjct: 168 ---RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 114
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 115 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 11/163 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL     
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCL 291
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL     T      +
Sbjct: 292 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQ 343
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 89/177 (50%), Gaps = 14/177 (7%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-- 253
           +A  DF  E ++ ++L+ + I    GVC+E + LI+V +++  G L + L   G  +V  
Sbjct: 57  NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 116
Query: 254 --------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                   L       +A  IA  + YL    S+  +HRD+ + N L+  +   ++ DFG
Sbjct: 117 AEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFG 173
Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           ++    +   + +    +    ++ PE +M+ K + + DV+S GVVL E+ + G++P
Sbjct: 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 117
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 118 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 62  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 119
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 120 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 176
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 177 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 61  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 118
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 119 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 175
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 176 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 11/163 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL     
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCL 119
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL     T      +
Sbjct: 120 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQ 171
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 114
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 115 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 56  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 113
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 114 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 170
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 171 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 63  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 120
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 121 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 177
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 64  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 121
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 122 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 178
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 88  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 145
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 146 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 202
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESL--HGA 248
           Q  S W     E++I  +L  + I    G C +  +  + LV +++P GSL + L  H  
Sbjct: 52  QLRSGWQ---REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV 108
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
           G   +L +      A  I E + YLH++     IHR + + N+LL +D   ++ DFGLA 
Sbjct: 109 GLAQLLLF------AQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 159
Query: 309 WGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             P    +  +RED      + APE L   K     DV+SFGV L ELL+
Sbjct: 160 AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 55  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 112
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 113 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 169
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 170 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESL--HGA 248
           Q  S W     E++I  +L  + I    G C +  +  + LV +++P GSL + L  H  
Sbjct: 53  QLRSGWQ---REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV 109
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
           G   +L +      A  I E + YLH++     IHR + + N+LL +D   ++ DFGLA 
Sbjct: 110 GLAQLLLF------AQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 160
Query: 309 WGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             P    +  +RED      + APE L   K     DV+SFGV L ELL+
Sbjct: 161 AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 114
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 115 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 86/163 (52%), Gaps = 11/163 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL     
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCL 104
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL     T      +
Sbjct: 105 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQ 156
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 115
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + ++++FG ++  P+   
Sbjct: 116 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR- 165
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 166 ---RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 58  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 115
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHR++ + NIL+ ++ + ++ DFGL    P D  + 
Sbjct: 116 KLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYY 172
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 173 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 132
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 133 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LKQ T +  +   +   E  I   L+   I  L GVC +   L+LV +    G L + L 
Sbjct: 371 LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G  E+  +P     E+   ++  + YL     +  +HR++ + N+LL +    ++SDFGL
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 307 A-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGF 364
           +   G  DS +  R        + APE +   K S + DV+S+GV + E LS G++P  +
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--Y 540
Query: 365 KNLKGPESLV 374
           K +KGPE + 
Sbjct: 541 KKMKGPEVMA 550

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 94/175 (53%), Gaps = 21/175 (12%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F +E ++  +L+   +  L+ V  ++  + ++++F+ KGSL + L    G +  LP  + 
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + ++     R  IHRD++++NIL+S+    +++DFGLA           R
Sbjct: 283 F--SAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-----------R 326
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL 373
                   + APE +  G  + K DV+SFG++L+E+++ GR P  +  +  PE +
Sbjct: 327 VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVI 379

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 18/168 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG---EQSVLP 255
           +    EV+I S L   +I  L G   +   + L+ ++ P G++   L       EQ    
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +         +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG +   P+   
Sbjct: 114 Y------ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR- 163
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
              R  + GT  Y+ PE ++ G++ D K+D++S GV+  E L G+ P 
Sbjct: 164 ---RTTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + L    E+  +   
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 132
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              +    I + + YL    ++  IHRD+ + NIL+ ++ + ++ DFGL    P D    
Sbjct: 133 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 318 -IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 89/163 (54%), Gaps = 8/163 (4%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E ++  +L+   +  L  V   +  + ++++++ KGSL + L    G + +LP  + 
Sbjct: 55  FLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 114
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + Y+     +  IHRD++++N+L+S     +++DFGLA     D+ +  R
Sbjct: 115 F--SAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAR 168
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           E       + APE +  G  + K DV+SFG++L E+++ G+ P
Sbjct: 169 EGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 209 SSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GA-GEQSVLPWGVRFEVAV 264
            SL+   I  L G+C   + L LV+ +LP GSL + +    GA G Q +L WGV+     
Sbjct: 88  GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ----- 141
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            IA+ + YL       ++HR++ + N+LL S  Q Q++DFG+A   P D   ++  +   
Sbjct: 142 -IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 197
Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
              ++A E +  GK + + DV+S+GV + EL++
Sbjct: 198 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 21/244 (8%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           ++ ++   E+   S     +I +     +  + L LV   L  GS+ + +     +    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114
Query: 256 WGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW- 309
            GV  E  +A     + E L YLH       IHRDVK+ NILL  D   Q++DFG++ + 
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 171
Query: 310 --GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI-GFK 365
             G   + + +R+  VGT  ++APE +   +  D K D++SFG+  +EL +G  P   + 
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
            +K     ++   P L+ G    + D ++  +Y  +  ++M+   +LC+ + P+ RP   
Sbjct: 232 PMKVLMLTLQNDPPSLETG----VQDKEMLKKYGKS-FRKMI---SLCLQKDPEKRPTAA 283
Query: 426 QVLK 429
           ++L+
Sbjct: 284 ELLR 287

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 209 SSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GA-GEQSVLPWGVRFEVAV 264
            SL+   I  L G+C   + L LV+ +LP GSL + +    GA G Q +L WGV+     
Sbjct: 70  GSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ----- 123
Query: 265 AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
            IA+ + YL       ++HR++ + N+LL S  Q Q++DFG+A   P D   ++  +   
Sbjct: 124 -IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
              ++A E +  GK + + DV+S+GV + EL++
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 90/163 (55%), Gaps = 8/163 (4%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E ++  +L+   +  L  V  ++  + ++++F+ KGSL + L    G + +LP  + 
Sbjct: 54  FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
           F  +  IAE + Y+     +  IHRD++++N+L+S     +++DFGLA     D+ +  R
Sbjct: 114 F--SAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAR 167
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           E       + APE +  G  + K +V+SFG++L E+++ G+ P
Sbjct: 168 EGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    E++I S L   +I  +     +   + L+ +F P+G L + L   G         
Sbjct: 60  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--------- 110
Query: 259 RFE------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           RF+          +A+AL+Y H    R VIHRD+K  N+L+    + +++DFG ++  P+
Sbjct: 111 RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 167
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
               + R  + GT  Y+ PE ++ GK  D K+D++  GV+  E L G  P 
Sbjct: 168 ----LRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    E++I S L   +I  +     +   + L+ +F P+G L + L   G         
Sbjct: 59  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--------- 109
Query: 259 RFE------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           RF+          +A+AL+Y H    R VIHRD+K  N+L+    + +++DFG ++  P+
Sbjct: 110 RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI 362
               + R  + GT  Y+ PE ++ GK  D K+D++  GV+  E L G  P 
Sbjct: 167 ----LRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 21/244 (8%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           ++ ++   E+   S     +I +     +  + L LV   L  GS+ + +     +    
Sbjct: 50  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 109
Query: 256 WGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW- 309
            GV  E  +A     + E L YLH       IHRDVK+ NILL  D   Q++DFG++ + 
Sbjct: 110 SGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 166
Query: 310 --GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPI-GFK 365
             G   + + +R+  VGT  ++APE +   +  D K D++SFG+  +EL +G  P   + 
Sbjct: 167 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 226
Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
            +K     ++   P L+ G    + D ++  +Y  +  ++M+   +LC+ + P+ RP   
Sbjct: 227 PMKVLMLTLQNDPPSLETG----VQDKEMLKKYGKS-FRKMI---SLCLQKDPEKRPTAA 278
Query: 426 QVLK 429
           ++L+
Sbjct: 279 ELLR 282

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           +  ++    + +F  EV I S+L   +I  L G+    N   +V +F+P G L   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRL--L 113
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQPQLSD 303
            +   + W V+  + + IA  + Y+ ++ + P++HRD++S NI L S         +++D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS--DKIDVYSFGVVLLELLSGRRP 361
           FGL+      S H +   ++G F ++APE +   + S  +K D YSF ++L  +L+G   
Sbjct: 173 FGLS----QQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG--- 224
Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                 +GP     + K    N   E  L P +  +       R+     LC +  P+ R
Sbjct: 225 ------EGPFDEYSYGKIKFINMIREEGLRPTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 422 PNMGQVLKLL 431
           P+   ++K L
Sbjct: 275 PHFSYIVKEL 284

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 111/233 (47%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH +  ++        
Sbjct: 55  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS--ETKFEMKKLI 111
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A  ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 112 DIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 321 DVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE +        S + DVY+FG+VL EL++G+ P  + N+   + +++  
Sbjct: 169 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIE-- 224
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
             ++  G     L P LS    N   +M+R++     C+ +    RP+  ++L
Sbjct: 225 --MVGRGS----LSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRIL 268

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 15/185 (8%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 54  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 107
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  +
Sbjct: 108 GSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 162
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  G
Sbjct: 163 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218
Query: 359 RRPIG 363
           R PIG
Sbjct: 219 RYPIG 223

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 111/233 (47%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH +  ++        
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHAS--ETKFEMKKLI 123
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A  ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 124 DIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 321 DVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE +        S + DVY+FG+VL EL++G+ P  + N+   + +++  
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIE-- 236
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
             ++  G     L P LS    N   +M+R++     C+ +    RP+  ++L
Sbjct: 237 --MVGRGS----LSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRIL 280

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV- 283
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 284 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 338
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV- 283
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 284 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 338
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV- 366
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 367 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 421
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 11/163 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL     
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCL 110
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL     T      +
Sbjct: 111 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQ 162
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE L     S K DV+SFG++L E+ S GR P
Sbjct: 163 DTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G       L +V+ +    SL   LH +  ++        
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHAS--ETKFEMKKLI 123
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A  ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 124 DIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 321 DVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE +        S + DVY+FG+VL EL++G+ P  + N+   + +++  
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIE-- 236
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
             ++  G     L P LS    N   +M+R++     C+ +    RP+  ++L
Sbjct: 237 --MVGRGS----LSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRIL 280

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V +++ KGSL + L G  G+   LP  V 
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLV- 283
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 284 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 338
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 77/147 (52%), Gaps = 27/147 (18%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH-------SECSRPV 281
           L L++ F  KGSL + L G    +++ W     VA  ++  L+YLH        E  +P 
Sbjct: 88  LWLITAFHDKGSLTDYLKG----NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 282 I-HRDVKSSNILLSSDFQPQLSDFGLAI----WGPTDSTHMIREDVVGTFGYIAPEYLMH 336
           I HRD KS N+LL SD    L+DFGLA+      P   TH      VGT  Y+APE L  
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH----GQVGTRRYMAPEVL-E 198
Query: 337 GKVSD------KIDVYSFGVVLLELLS 357
           G ++       +ID+Y+ G+VL EL+S
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 97  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 150
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  +
Sbjct: 151 GSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 205
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  G
Sbjct: 206 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261
Query: 359 RRPI 362
           R PI
Sbjct: 262 RYPI 265

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 53  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV- 110
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 111 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 165
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 166 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 51  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 108
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 109 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 163
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 49  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 106
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 107 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 161
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 162 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-- 253
           +A  DF  E ++ ++L+ + I    GVC + + LI+V +++  G L + L   G  ++  
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 254 -----------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                      L       +A  IA  + YL    S+  +HRD+ + N L+ ++   ++ 
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIG 175
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           DFG++    +   + +    +    ++ PE +M+ K + + DV+SFGV+L E+ + G++P
Sbjct: 176 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 362 -IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL 420
                N +  E + +             L  P++  +    ++  ++L    C  + PQ 
Sbjct: 236 WFQLSNTEVIECITQ----------GRVLERPRVCPK----EVYDVMLG---CWQREPQQ 278
Query: 421 RPNMGQVLKLLRGATHAT 438
           R N+ ++ K+L     AT
Sbjct: 279 RLNIKEIYKILHALGKAT 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 36/253 (14%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 38  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 91
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  +
Sbjct: 92  GSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 146
Query: 299 PQLSDFGLAIWGPTDSTHMIRE---DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
            +L DFG+       S  +I E   + VGT  Y++PE L     S + D++S G+ L+E+
Sbjct: 147 IKLCDFGV-------SGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 199
Query: 356 LSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCIN 415
             GR P      + P ++ +    I+          PKL +   + + Q  +   N C+ 
Sbjct: 200 AVGRYP------RPPMAIFELLDYIVNEP------PPKLPSAVFSLEFQDFV---NKCLI 244
Query: 416 QSPQLRPNMGQVL 428
           ++P  R ++ Q++
Sbjct: 245 KNPAERADLKQLM 257

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 58  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 114
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 115 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLV 374
            +++E     F + APE L     S   D + FGV L E+ + G+ P  +  L G + L 
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILH 229
Query: 375 K 375
           K
Sbjct: 230 K 230

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 100/191 (52%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 53  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-- 109
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 110 -----TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 161
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+ +  RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 162 DFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 219
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 220 PYPGMTNPEVI 230

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 62  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  +
Sbjct: 116 GSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 170
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  G
Sbjct: 171 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 359 RRPI 362
           R PI
Sbjct: 227 RYPI 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF  E+ I  +L    I    GV        L LV ++LP G L + L     ++ L  
Sbjct: 56  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDA 113
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-T 315
                 +  I + + YL S   R  +HRD+ + NIL+ S+   +++DFGLA   P D   
Sbjct: 114 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 170
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++RE       + APE L     S + DV+SFGVVL EL +
Sbjct: 171 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF  E+ I  +L    I    GV        L LV ++LP G L + L     ++ L  
Sbjct: 57  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDA 114
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-T 315
                 +  I + + YL S   R  +HRD+ + NIL+ S+   +++DFGLA   P D   
Sbjct: 115 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 171
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++RE       + APE L     S + DV+SFGVVL EL +
Sbjct: 172 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF  E+ I  +L    I    GV        L LV ++LP G L + L     ++ L  
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDA 126
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-T 315
                 +  I + + YL S   R  +HRD+ + NIL+ S+   +++DFGLA   P D   
Sbjct: 127 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++RE       + APE L     S + DV+SFGVVL EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 120
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 121 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++E     F + APE L     S   D + FGV L E+ + G+ P
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V +++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 120
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 121 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++E     F + APE L     S   D + FGV L E+ + G+ P
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 110
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++E     F + APE L     S   D + FGV L E+ + G+ P
Sbjct: 168 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 110
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++E     F + APE L     S   D + FGV L E+ + G+ P
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 115/250 (46%), Gaps = 30/250 (12%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           +  ++    + +F  EV I S+L   +I  L G+    N   +V +F+P G L   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRL--L 113
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQPQLSD 303
            +   + W V+  + + IA  + Y+ ++ + P++HRD++S NI L S         +++D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS--DKIDVYSFGVVLLELLSGRRP 361
           FG +      S H +   ++G F ++APE +   + S  +K D YSF ++L  +L+G   
Sbjct: 173 FGTS----QQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG--- 224
Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                 +GP     + K    N   E  L P +  +       R+     LC +  P+ R
Sbjct: 225 ------EGPFDEYSYGKIKFINMIREEGLRPTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 422 PNMGQVLKLL 431
           P+   ++K L
Sbjct: 275 PHFSYIVKEL 284

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 58  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 114
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 115 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLV 374
            +++E     F + APE L     S   D + FGV L E+ + G+ P  +  L G + L 
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILH 229
Query: 375 K 375
           K
Sbjct: 230 K 230

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 284
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGL      D+ +  R
Sbjct: 285 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRL-IEDNEYTAR 339
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 340 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 197 AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
           A +DF  EV+   SL+ +++  L GV +    + +V++  P GSL + L       +L  
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL-- 110
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
           G     AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL    P +  H
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 317 -MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLV 374
            +++E     F + APE L     S   D + FGV L E+ + G+ P  +  L G + L 
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILH 225
Query: 375 K 375
           K
Sbjct: 226 K 226

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           R+  + E+K A        N    E+ +        I    G    D  + +  + +  G
Sbjct: 36  RKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           SL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  + 
Sbjct: 90  SLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEI 144
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  GR
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 360 RPI 362
            PI
Sbjct: 201 YPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 35  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 88
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  +
Sbjct: 89  GSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 143
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  G
Sbjct: 144 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199
Query: 359 RRPI 362
           R PI
Sbjct: 200 RYPI 203

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L         P G++ 
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-------PSGIKL 112
Query: 261 ------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 113 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDN 168
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            +  RE       + APE + +G  + K DV+SFG++L E+++  R I +  +  PE +
Sbjct: 169 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVI 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           R+  + E+K A        N    E+ +        I    G    D  + +  + +  G
Sbjct: 36  RKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           SL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  + 
Sbjct: 90  SLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEI 144
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  GR
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 360 RPI 362
            PI
Sbjct: 201 YPI 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L         P G++ 
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-------PSGIKL 111
Query: 261 ------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 112 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDN 167
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            +  RE       + APE + +G  + K DV+SFG++L E+++  R I +  +  PE +
Sbjct: 168 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVI 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE 242
           + + LK+A+    SA  DF  E ++ + L+ + I    GVC E   L++V +++  G L 
Sbjct: 75  AVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 243 ESL--HG------AGEQSVLP----WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
             L  HG      AG + V P     G    VA  +A  + YL        +HRD+ + N
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 188
Query: 291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
            L+      ++ DFG++    +   + +    +    ++ PE +++ K + + DV+SFGV
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248
Query: 351 VLLELLS-GRRP 361
           VL E+ + G++P
Sbjct: 249 VLWEIFTYGKQP 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE 242
           + + LK+A+    SA  DF  E ++ + L+ + I    GVC E   L++V +++  G L 
Sbjct: 46  AVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 243 ESL--HG------AGEQSVLP----WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
             L  HG      AG + V P     G    VA  +A  + YL        +HRD+ + N
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 159
Query: 291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
            L+      ++ DFG++    +   + +    +    ++ PE +++ K + + DV+SFGV
Sbjct: 160 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 219
Query: 351 VLLELLS-GRRP 361
           VL E+ + G++P
Sbjct: 220 VLWEIFTYGKQP 231

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 78  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 134
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 135 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 192 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 249
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 250 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 291

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 38  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 95
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 96  ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 146
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           DFGLA     D+ +  RE       + APE + +G  + K DV+SFG++L E+++ GR P
Sbjct: 147 DFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 205
Query: 362 IGFKNLKGPESL 373
             +  +  PE +
Sbjct: 206 --YPGMTNPEVI 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   +  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           R+  + E+K A        N    E+ +        I    G    D  + +  + +  G
Sbjct: 36  RKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           SL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  + 
Sbjct: 90  SLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEI 144
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  GR
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 360 RPI 362
            PI
Sbjct: 201 YPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
           R+  + E+K A        N    E+ +        I    G    D  + +  + +  G
Sbjct: 36  RKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           SL++ L  AG    +P  +  +V++A+ + L YL  +    ++HRDVK SNIL++S  + 
Sbjct: 90  SLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEI 144
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +L DFG++          +    VGT  Y++PE L     S + D++S G+ L+E+  GR
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 360 RPI 362
            PI
Sbjct: 201 YPI 203

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE 242
           + + LK+A+    SA  DF  E ++ + L+ + I    GVC E   L++V +++  G L 
Sbjct: 52  AVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 243 ESL--HG------AGEQSVLP----WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
             L  HG      AG + V P     G    VA  +A  + YL        +HRD+ + N
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 165
Query: 291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
            L+      ++ DFG++    +   + +    +    ++ PE +++ K + + DV+SFGV
Sbjct: 166 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 225
Query: 351 VLLELLS-GRRP 361
           VL E+ + G++P
Sbjct: 226 VLWEIFTYGKQP 237

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+   I++ +++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 135
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 136 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 250
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 251 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 292

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 94/179 (52%), Gaps = 19/179 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L         P G++ 
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-------PSGIKL 106
Query: 261 ------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 107 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDN 162
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            +  RE       + APE + +G  + K DV+SFG++L E+++  R I +  +  PE +
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVI 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 25/234 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV++F+  G L + L    ++ +      
Sbjct: 49  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETL 106
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL   C   VIHRD+ + N L+  +   ++SDFG+  +   D  +   
Sbjct: 107 LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSS 162
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
                   + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E       
Sbjct: 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------- 213
Query: 379 PILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 214 -VVEDISTGFRLYKPRLASTHVYQIM-------NHCWRERPEDRPAFSRLLRQL 259

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 135
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 136 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 250
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 251 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 292

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD+ ++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVR 259
           F  E  I   L+   +  L  V  E+  + +V++++ KGSL + L  G G    LP  V 
Sbjct: 51  FLEEAQIMKKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLV- 108
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  +A  + Y+        IHRD++S+NIL+ +    +++DFGLA     D+    R
Sbjct: 109 -DMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTAR 163
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL++ GR P
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK 238
            R+  + E+K A        N    E+ +        I    G    D  + +  + +  
Sbjct: 45  ARKLIHLEIKPAIR------NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 98
Query: 239 GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
           GSL++ L    E   +P  +  +V++A+   L YL  +    ++HRDVK SNIL++S  +
Sbjct: 99  GSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGE 153
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L DFG++          +    VGT  Y+APE L     S + D++S G+ L+EL  G
Sbjct: 154 IKLCDFGVS----GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209
Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTE 387
           R PI   + K  E++  + +P++   + E
Sbjct: 210 RYPIPPPDAKELEAI--FGRPVVDGEEGE 236

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 115/250 (46%), Gaps = 30/250 (12%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           +  ++    + +F  EV I S+L   +I  L G+    N   +V +F+P G L   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRL--L 113
Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQPQLSD 303
            +   + W V+  + + IA  + Y+ ++ + P++HRD++S NI L S         +++D
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS--DKIDVYSFGVVLLELLSGRRP 361
           F L+      S H +   ++G F ++APE +   + S  +K D YSF ++L  +L+G   
Sbjct: 173 FSLS----QQSVHSV-SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG--- 224
Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                 +GP     + K    N   E  L P +  +       R+     LC +  P+ R
Sbjct: 225 ------EGPFDEYSYGKIKFINMIREEGLRPTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 422 PNMGQVLKLL 431
           P+   ++K L
Sbjct: 275 PHFSYIVKEL 284

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 87/167 (52%), Gaps = 17/167 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGV- 258
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 259 ---RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
              +    +A  E +NY         +HRD++++NIL+  +   +++DFGLA     D+ 
Sbjct: 116 MSAQIASGMAYVERMNY---------VHRDLRAANILVGENLVCKVADFGLARL-IEDNE 165
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +  R+       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 166 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 50  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLV- 107
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+    R
Sbjct: 108 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTAR 162
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 163 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KG L + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 71  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 127
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 128 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 185 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 242
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 243 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 284

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 112
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 113 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 227
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 228 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 269

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 112
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 113 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 227
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 228 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 269

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 49  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 106
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 107 ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 157
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 158 DFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 215
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 216 PYPGMTNPEVI 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 163
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLL 244

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 163
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLL 244

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF  E+ I  +L    I    GV        L LV ++LP G L + L     ++ L  
Sbjct: 53  RDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDA 110
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS-T 315
                 +  I + + YL S   R  +HRD+ + NIL+ S+   +++DFGLA   P D   
Sbjct: 111 SRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDX 167
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++RE       + APE L     S + DV+SFGVVL EL +
Sbjct: 168 XVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 53  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 109
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 110 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 166
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 167 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 224
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 225 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 266

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 43  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 100
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 101 ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 151
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 152 DFGLARL-IEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 209
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 210 PYPGMTNPEVI 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 163
Query: 315 THMIRED-VVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDEFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLL 244

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 163
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLL 244

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 51  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-- 107
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 108 -----TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 159
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 160 DFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 217
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 218 PYPGMTNPEVI 228

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 163
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G   Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLL 244

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 107
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 108 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 222
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 223 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 264

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G   +   L +V+ +    SL   LH    ++        
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 107
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 108 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 222
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 223 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 264

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    +
Sbjct: 68  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 126
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++
Sbjct: 127 LRQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK 179
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I
Sbjct: 180 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----I 233
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 234 KKNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 25/234 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV +F+  G L + L    ++ +      
Sbjct: 51  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETL 108
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL   C   VIHRD+ + N L+  +   ++SDFG+  +   D  +   
Sbjct: 109 LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSS 164
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
                   + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E       
Sbjct: 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------- 215
Query: 379 PILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 216 -VVEDISTGFRLYKPRLASTHVYQIM-------NHCWRERPEDRPAFSRLLRQL 261

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 43  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 100
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 101 ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 151
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 152 DFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 209
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 210 PYPGMTNPEVI 220

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 52  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 109
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 110 ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 160
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 161 DFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 218
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 219 PYPGMTNPEVI 229

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 16/142 (11%)
Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R ++VGT  ++APE +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKAY 193
Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 54  SSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK 113
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 114 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFS----NEF 163
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G   Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 164 TFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 223 ERVLRGKYRIPFYXSTDCENLL 244

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    +
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 122
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++
Sbjct: 123 LRQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK 175
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----I 229
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 230 KKNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 266

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+   I++ +++ KGSL + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+    R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 19/191 (9%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 45  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 102
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHRD++++NIL+S     +++
Sbjct: 103 ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA 153
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           DFGLA     D+    RE       + APE + +G  + K DV+SFG++L E+++  R I
Sbjct: 154 DFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-I 211
Query: 363 GFKNLKGPESL 373
            +  +  PE +
Sbjct: 212 PYPGMTNPEVI 222

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    +
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 122
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++
Sbjct: 123 LRQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK 175
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----I 229
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 230 KKNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L         P G++ 
Sbjct: 56  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-------PSGIKL 107
Query: 261 ------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 108 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDN 163
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
               RE       + APE + +G  + K DV+SFG++L E+++  R I +  +  PE +
Sbjct: 164 EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVI 221

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 86/163 (52%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V +++ KG L + L G  G+   LP  V 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV- 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  R
Sbjct: 118 -DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTAR 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L         P G++ 
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-------PSGIKL 106
Query: 261 ------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 107 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDN 162
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
               RE       + APE + +G  + K DV+SFG++L E+++  R I +  +  PE +
Sbjct: 163 EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVI 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 24/233 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F +EV +       +I    G       L +V+ +    SL   LH    ++        
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHII--ETKFEMIKLI 107
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     E
Sbjct: 108 DIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 321 DVVGTFGYIAPEYL-MHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
            + G+  ++APE + M  K   S + DVY+FG+VL EL++G+ P  + N+   + ++   
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 222
Query: 378 KPILKNGDTETLLDPKLSNEYDNA--QMQRMLLAANLCINQSPQLRPNMGQVL 428
                       L P LS    N    M+R++     C+ +    RP   Q+L
Sbjct: 223 --------GRGYLSPDLSKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQIL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 25/234 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV +F+  G L + L    ++ +      
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETL 105
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL   C   VIHRD+ + N L+  +   ++SDFG+  +   D  +   
Sbjct: 106 LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSS 161
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
                   + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E       
Sbjct: 162 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------- 212
Query: 379 PILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 213 -VVEDISTGFRLYKPRLASTHVYQIM-------NHCWKERPEDRPAFSRLLRQL 258

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           ++  Q S + + F +E ++   L+ + +  L  V  ++  + ++++++  GSL + L   
Sbjct: 39  KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT- 96
Query: 249 GEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
                 P G++       ++A  IAE + ++     R  IHR+++++NIL+S     +++
Sbjct: 97  ------PSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANILVSDTLSCKIA 147
Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           DFGLA     D+ +  RE       + APE + +G  + K DV+SFG++L E+++ GR P
Sbjct: 148 DFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206
Query: 362 IGFKNLKGPESL 373
             +  +  PE +
Sbjct: 207 --YPGMTNPEVI 216

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 25/235 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +DF  E ++   L    +  L GVC+E   + LV +F+  G L + L    ++ +     
Sbjct: 67  DDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAET 124
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              + + + E + YL   C   VIHRD+ + N L+  +   ++SDFG+  +   D  +  
Sbjct: 125 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTS 180
Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA 377
                    + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E      
Sbjct: 181 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------ 232
Query: 378 KPILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
             ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 233 --VVEDISTGFRLYKPRLASTHVYQIM-------NHCWKERPEDRPAFSRLLRQL 278

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 25/234 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV +F+  G L + L    ++ +      
Sbjct: 46  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETL 103
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL   C   VIHRD+ + N L+  +   ++SDFG+  +   D  +   
Sbjct: 104 LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSS 159
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
                   + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E       
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------- 210
Query: 379 PILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 211 -VVEDISTGFRLYKPRLASTHVYQIM-------NHCWKERPEDRPAFSRLLRQL 256

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 15/167 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH----GAGEQSVLP 255
           +F  E  I +S++   +  L GVC+    + LV+  +P G L E +H      G Q +L 
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           W       V IA+ + YL     R ++HRD+ + N+L+ S    +++DFGLA     D  
Sbjct: 122 W------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +       ++A E + + K + + DV+S+GV + EL++ G +P
Sbjct: 173 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGV 258
           DF SE  I    +  ++  L GV  +   ++++++F+  GSL+  L    G+ +V+    
Sbjct: 80  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-- 137
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL        +HRD+ + NIL++S+   ++SDFGL+ +   D++   
Sbjct: 138 -VGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 319 REDVVG---TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +G      + APE + + K +   DV+S+G+V+ E++S G RP
Sbjct: 194 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    +
Sbjct: 86  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 144
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++
Sbjct: 145 LRQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK 197
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I
Sbjct: 198 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----I 251
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 252 KKNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 288

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL---HGAGEQSVLPWGVR 259
           +E+ +  SL+  +I  L  V  +  Y  LV++F   G L E +   H   E         
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---- 150
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQLSDFGLAIWGPTDSTH 316
             +   I   + YLH      ++HRD+K  NILL   +S    ++ DFGL+ +   D  +
Sbjct: 151 --IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--Y 203
Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
            +R D +GT  YIAPE ++  K ++K DV+S GV++  LL G  P G +N
Sbjct: 204 KLR-DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    + 
Sbjct: 63  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 121
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
             + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++ 
Sbjct: 122 RQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKV 174
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I 
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----IK 228
Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 229 KNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 264

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 156 EGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSS-EVDITSSLEQK 214
           EG + +  L  STE          RQ+  +E+    S+ SS   + S  EV + ++++  
Sbjct: 34  EGSFGKAILVKSTE--------DGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKHP 83
Query: 215 SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-----EQSVLPWGVRFEVAVAIAEA 269
           +I        E+  L +V D+   G L + ++        E  +L W V+      I  A
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L ++H    R ++HRD+KS NI L+ D   QL DFG+A     +ST  +    +GT  Y+
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIA--RVLNSTVELARACIGTPYYL 192
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLEL 355
           +PE   +   ++K D+++ G VL EL
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-AGEQSVLPWGVR 259
           F  E  +   L  + +  L  V  E+  + +V++++ KGSL + L G  G+   LP  V 
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLV- 114
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            +++  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+    R
Sbjct: 115 -DMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTAR 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 170 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
            S E+ I  SL  + +   +G   +++++ +V +   + SL E LH   +    P    +
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY 146
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              + +     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D     ++
Sbjct: 147 LRQIVLG--CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KK 199
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
            + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK  E+ ++    I
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLR----I 253
Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            KN  +     PK  N    + +Q+ML          P  RP + ++L
Sbjct: 254 KKNEYS----IPKHINPVAASLIQKML-------QTDPTARPTINELL 290

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 15/167 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH----GAGEQSVLP 255
           +F  E  I +S++   +  L GVC+    + LV+  +P G L E +H      G Q +L 
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 144
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           W       V IA+ + YL     R ++HRD+ + N+L+ S    +++DFGLA     D  
Sbjct: 145 W------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +       ++A E + + K + + DV+S+GV + EL++ G +P
Sbjct: 196 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 193
Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 193
Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           SS+      EV I   L   +I  L  V   +  L LV ++   G + + L   G     
Sbjct: 47  SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK 106
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
               +F     I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG +     + 
Sbjct: 107 EARAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEF 156
Query: 315 THMIREDVV-GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           T   + D   G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK   
Sbjct: 157 TFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 215
Query: 372 SLV---KWAKPILKNGDTETLL 390
             V   K+  P   + D E LL
Sbjct: 216 ERVLRGKYRIPFYMSTDCENLL 237

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 137
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHRD+KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 194
Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV I   L   +I  L  V   +  L L+ ++   G + + L   G         +F   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-- 121
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA----IWGPTDSTHMIR 319
             I  A+ Y H    + ++HRD+K+ N+LL +D   +++DFG +    + G  D+     
Sbjct: 122 -QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----- 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV--- 374
               G   Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK     V   
Sbjct: 173 --FCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 375 KWAKPILKNGDTETLL 390
           K+  P   + D E LL
Sbjct: 230 KYRIPFYMSTDCENLL 245

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV I   L   +I  L  V   +  L L+ ++   G + + L   G         +F   
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-- 118
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA----IWGPTDSTHMIR 319
             I  A+ Y H    + ++HRD+K+ N+LL +D   +++DFG +    + G  D+     
Sbjct: 119 -QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT----- 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV--- 374
               G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK     V   
Sbjct: 170 --FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 226
Query: 375 KWAKPILKNGDTETLL 390
           K+  P   + D E LL
Sbjct: 227 KYRIPFYMSTDCENLL 242

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL--HGAG-EQSVLP 255
           ++F  E      L    +    GVC ++  + +V++++  G L   L  HG G E S L 
Sbjct: 48  DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL- 106
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   + E + +L S      IHRD+ + N L+  D   ++SDFG+       + 
Sbjct: 107 ----LEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGM-------TR 152
Query: 316 HMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
           +++ +  V + G      + APE   + K S K DV++FG+++ E+ S    +G    K 
Sbjct: 153 YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS----LG----KM 204
Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           P  L   ++ +LK      L  P L+++     M         C ++ P+ RP   Q+L
Sbjct: 205 PYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLL 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 48  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 107
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 108 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 151
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 152 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 45  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 101
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IAE +NYL     R ++HRD+ + N+L+ +   
Sbjct: 102 DYVREHKDNIGSQYLLNW------CVQIAEGMNYLED---RRLVHRDLAARNVLVKTPQH 152
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 153 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 212
Query: 358 GRRP 361
           G +P
Sbjct: 213 GSKP 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 64  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 124 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 167
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 49  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 108
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 109 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 152
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 153 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 55  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 114
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 115 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 158
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 159 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 216 ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHS 275
           I TL       +++ LV D + KG L + L    E+  L       +  ++ EA+++LH+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 276 ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL- 334
                ++HRD+K  NILL  + Q +LSDFG +     +    +RE + GT GY+APE L 
Sbjct: 219 NN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRE-LCGTPGYLAPEILK 272
Query: 335 -----MHGKVSDKIDVYSFGVVLLELLSGRRPI 362
                 H     ++D+++ GV+L  LL+G  P 
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC------SRPVI 282
           L L++ F  KGSL + L    + +V+ W     +A  +A  L YLH +        +P I
Sbjct: 97  LWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 283 -HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
            HRD+KS N+LL ++    ++DFGLA+      +       VGT  Y+APE L  G ++ 
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL-EGAINF 211
Query: 342 ------KIDVYSFGVVLLELLS 357
                 +ID+Y+ G+VL EL S
Sbjct: 212 QRDAFLRIDMYAMGLVLWELAS 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 44  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 103
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 104 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 147
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 148 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 111 FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 164
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            +          W   +   V +A  L+ +HS     +IHRDVK  N+LL      +L+D
Sbjct: 165 LMSNYDVPE--KWAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLAD 217
Query: 304 FGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLMH----GKVSDKIDVYSFGVVLLELLSG 358
           FG  +    D T M+  D  VGT  YI+PE L      G    + D +S GV L E+L G
Sbjct: 218 FGTCM--KMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275
Query: 359 RRPIGFKNLKGPESLV 374
             P    +L G  S +
Sbjct: 276 DTPFYADSLVGTYSKI 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 62/100 (62%), Gaps = 5/100 (5%)
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V  A+ +AL YLH++    VIHRD+KS +ILL+ D + +LSDFG       D     R+ 
Sbjct: 146 VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKX 200
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +     + ++D++S G++++E++ G  P
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L     S   D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 111
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+  + G T + H 
Sbjct: 112 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             +  +    + APE L + K S K DV++FGV+L E+
Sbjct: 169 GAKFPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGLA  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 118
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+  + G T + H 
Sbjct: 119 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 175
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             +  +    + APE L + K S K DV++FGV+L E+
Sbjct: 176 GAKFPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 118
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 119 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 174
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 11/160 (6%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 197 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AA 251
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 252 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKX 306
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 58  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 114
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 115 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 165
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 166 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 225
Query: 358 GRRP 361
           G +P
Sbjct: 226 GSKP 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 118
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 119 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH 174
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGT 312
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGT 315
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 49  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 108
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 109 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 152
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 153 RYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 226 DNYLI-----LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           D+YL+     +V ++L  GSL + +     ++ +  G    V     +AL +LHS     
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS---NQ 137
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGL-AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
           VIHR++KS NILL  D   +L+DFG  A   P  S    R  +VGT  ++APE +     
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 194
Query: 340 SDKIDVYSFGVVLLELLSGRRP 361
             K+D++S G++ +E++ G  P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 51  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 158
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 218
Query: 358 GRRP 361
           G +P
Sbjct: 219 GSKP 222

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 115
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 116 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXF 170
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 73  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 129
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 180
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 181 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 240
Query: 358 GRRP 361
           G +P
Sbjct: 241 GSKP 244

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 54  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 110
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 111 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 161
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 162 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 221
Query: 358 GRRP 361
           G +P
Sbjct: 222 GSKP 225

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 118 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH 173
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVL 254
           ++F  E  +  +L  + +  L GVC +   + ++++++  G L     E  H    Q +L
Sbjct: 64  DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL       S
Sbjct: 124 ------EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL-------S 167
Query: 315 THMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +++ ++   + G      +  PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 168 RYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 115
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 116 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 171
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 55  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 162
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 222
Query: 358 GRRP 361
           G +P
Sbjct: 223 GSKP 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXF 165
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 55  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 162
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 222
Query: 358 GRRP 361
           G +P
Sbjct: 223 GSKP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 118
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 119 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 174
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 50  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 106
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 157
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 158 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 217
Query: 358 GRRP 361
           G +P
Sbjct: 218 GSKP 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXF 165
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 115
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 116 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 171
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 51  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 158
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 218
Query: 358 GRRP 361
           G +P
Sbjct: 219 GSKP 222

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 51  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 158
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 218
Query: 358 GRRP 361
           G +P
Sbjct: 219 GSKP 222

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 68  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 126
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 127 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 182
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 183 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 111
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+  + G T + H 
Sbjct: 112 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHA 168
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             +  +    + APE L + K S K DV++FGV+L E+
Sbjct: 169 GAKFPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 42  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 98
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 99  DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 149
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 209
Query: 358 GRRP 361
           G +P
Sbjct: 210 GSKP 213

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGV 258
           DF SE  I    +  ++  L GV  +   ++++++F+  GSL+  L    G+ +V+    
Sbjct: 54  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ--- 110
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL        +HR + + NIL++S+   ++SDFGL+ +   D++   
Sbjct: 111 LVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
Query: 319 REDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +G      + APE + + K +   DV+S+G+V+ E++S G RP
Sbjct: 168 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGXLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGT 173
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 186 ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL---- 241
           EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L    
Sbjct: 85  ELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV 141
Query: 242 EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
            E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +    ++
Sbjct: 142 REHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKI 192
Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ G +
Sbjct: 193 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 252
Query: 361 P 361
           P
Sbjct: 253 P 253

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 113
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 114 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 168
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +++  G L    H   ++ +     RF  A  I+ ALNYLH    R +I+RD+K 
Sbjct: 96  LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKL 149
Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+LL S+   +L+D+G+   G  P D+T        GT  YIAPE L        +D +
Sbjct: 150 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGTPNYIAPEILRGEDYGFSVDWW 205
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+++GR P 
Sbjct: 206 ALGVLMFEMMAGRSPF 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  +  +     +T L       + L  V ++   G L    H + E+       RF  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-Y 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
              I  AL YLHS   R V++RD+K  N++L  D   +++DFGL   G +D   M  +  
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXF 165
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT  Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGT 172
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  AL+YLHSE  + V++RD+K  N++L  D   +++DFGL   G  D   M  +   GT
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGT 174
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y+APE L        +D +  GVV+ E++ GR P 
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 105 FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-- 156
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            ++      V     RF  A  +  AL+ +HS      IHRDVK  N+LL      +L+D
Sbjct: 157 -VNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 304 FGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSG 358
           FG  +    +   M+R D  VGT  YI+PE L      G    + D +S GV L E+L G
Sbjct: 212 FGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 359 RRPIGFKNLKGPESLV 374
             P    +L G  S +
Sbjct: 270 DTPFYADSLVGTYSKI 285

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 63/100 (63%), Gaps = 5/100 (5%)
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +++  AL+YLH++    VIHRD+KS +ILL+SD + +LSDFG       +     R+ 
Sbjct: 146 VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKX 200
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 201 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 87/161 (54%), Gaps = 13/161 (8%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA--GEQSVLPWGVRF 260
           +EV I    + +++  +    +  + L +V +FL  G+L + +      E+ +       
Sbjct: 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------ 173
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+
Sbjct: 174 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RK 228
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 229 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +++  G L    H   ++ +     RF  A  I+ ALNYLH    R +I+RD+K 
Sbjct: 128 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKL 181
Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+LL S+   +L+D+G+   G  P D+T        GT  YIAPE L        +D +
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEILRGEDYGFSVDWW 237
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+++GR P 
Sbjct: 238 ALGVLMFEMMAGRSPF 253

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 11/160 (6%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 75  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 129
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 130 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKX 184
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 185 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 207 ITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAI 266
           + S +    I  + G   +   + ++ D++  G L   L  +      P  V    A  +
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEV 115
Query: 267 AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF 326
             AL YLHS   + +I+RD+K  NILL  +   +++DFG A + P D T+ +     GT 
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYXL----CGTP 167
Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            YIAPE +     +  ID +SFG+++ E+L+G  P 
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 56  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 114
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 115 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAP 170
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGFVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 110 FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-- 161
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            ++      V     RF  A  +  AL+ +HS      IHRDVK  N+LL      +L+D
Sbjct: 162 -VNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 216
Query: 304 FGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSG 358
           FG  +    +   M+R D  VGT  YI+PE L      G    + D +S GV L E+L G
Sbjct: 217 FGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274
Query: 359 RRPIGFKNLKGPESLV 374
             P    +L G  S +
Sbjct: 275 DTPFYADSLVGTYSKI 290

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 57  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 114
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 115 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 171 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 11/160 (6%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 77  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 131
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 132 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKX 186
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 187 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 58  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 115
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 116 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 172 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 184 YEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +E +K++ S F      F  E DI +      +  L     +D YL +V +++P G L  
Sbjct: 110 FEMIKRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-- 161
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            ++      V     RF  A  +  AL+ +HS      IHRDVK  N+LL      +L+D
Sbjct: 162 -VNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 216
Query: 304 FGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSG 358
           FG  +    +   M+R D  VGT  YI+PE L      G    + D +S GV L E+L G
Sbjct: 217 FGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274
Query: 359 RRPIGFKNLKGPESLV 374
             P    +L G  S +
Sbjct: 275 DTPFYADSLVGTYSKI 290

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 135
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 136 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL   +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 113
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 114 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 35  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 91
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV--------- 262
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ F           
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEFSFNPSHNPEEQ 146
Query: 263 ---------AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA      
Sbjct: 147 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA-----R 198
Query: 314 STHMIREDVVGTFG-----YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H I      T G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 199 DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 115
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 116 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAP 171
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 85  TRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 142
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 143 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 52  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 108
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 159
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 160 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 219
Query: 358 GRRP 361
           G +P
Sbjct: 220 GSKP 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 49  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 105
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 156
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 157 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 216
Query: 358 GRRP 361
           G +P
Sbjct: 217 GSKP 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 55  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 112
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 113 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 169 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 50  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 157
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 158 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 217
Query: 358 GRRP 361
           G +P
Sbjct: 218 GSKP 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 11/160 (6%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 120
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 121 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKX 175
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 56  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 115
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 116 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 170
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 171 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 229
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 230 DVWSYGIVLWEVMSYGERP 248

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 81  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 138
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 139 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 194
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 135
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 136 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 51  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 107
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 158
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 159 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 218
Query: 358 GRRP 361
           G +P
Sbjct: 219 GSKP 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 55  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 111
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 162
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 163 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 222
Query: 358 GRRP 361
           G +P
Sbjct: 223 GSKP 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 173 KLVSSRCRQ-FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
           K+  S  RQ ++ + LK+AT +          E DI   +    I  L+     +  L L
Sbjct: 45  KISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYL 103
Query: 232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           + DFL  G L   L  + E       V+F +A  +A AL++LHS     +I+RD+K  NI
Sbjct: 104 ILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLHSLG---IIYRDLKPENI 157
Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIRE--DVVGTFGYIAPEYLMHGKVSDKIDVYSFG 349
           LL  +   +L+DFGL+     +S    ++     GT  Y+APE +     +   D +SFG
Sbjct: 158 LLDEEGHIKLTDFGLS----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 350 VVLLELLSGRRPIGFKNLKGPESLVKWAK 378
           V++ E+L+G  P   K+ K   +++  AK
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAK 242

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++ +F+  G+L + L     Q V    V 
Sbjct: 53  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVL 111
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+  + G T + H 
Sbjct: 112 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 168
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             +  +    + APE L + K S K DV++FGV+L E+
Sbjct: 169 GAKFPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++ +F+  G+L + L     Q V    V 
Sbjct: 56  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVL 114
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+  + G T + H 
Sbjct: 115 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHA 171
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             +  +    + APE L + K S K DV++FGV+L E+
Sbjct: 172 GAKFPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 135
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 136 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 191
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 11/160 (6%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           +EV I    + +++  +    +  + L +V +FL  G+L + + H    +  +       
Sbjct: 70  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 124
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           V +A+ +AL+ LH++    VIHRD+KS +ILL+ D + +LSDFG       +     R+ 
Sbjct: 125 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKX 179
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +VGT  ++APE +       ++D++S G++++E++ G  P
Sbjct: 180 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D+  E+DI +S +  +I  L      +N L ++ +F   G+++ ++    E+ +    ++
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD-AVMLELERPLTESQIQ 138
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             V     +ALNYLH      +IHRD+K+ NIL + D   +L+DFG++       T   R
Sbjct: 139 V-VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRR 192
Query: 320 EDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRP 361
           +  +GT  ++APE +M     D     K DV+S G+ L+E+     P
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++ +F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 81  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 138
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 139 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 194
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 195 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 77  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 134
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 135 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 190
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 46  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 105
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 106 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSD---MGYVHRD 160
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 161 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 219
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 220 DVWSYGIVLWEVMSYGERP 238

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 49  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGXLL 105
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 156
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFGLA     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 157 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 216
Query: 358 GRRP 361
           G +P
Sbjct: 217 GSKP 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +++  G L    H   ++ +     RF  A  I+ ALNYLH    R +I+RD+K 
Sbjct: 81  LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKL 134
Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+LL S+   +L+D+G+   G  P D+T        GT  YIAPE L        +D +
Sbjct: 135 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGTPNYIAPEILRGEDYGFSVDWW 190
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+++GR P 
Sbjct: 191 ALGVLMFEMMAGRSPF 206

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++ +F+  G+L + L     Q V    V 
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA-VVL 118
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 119 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH 174
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 135
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 136 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANA 191
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++ +F+  G+L + L     Q V    V 
Sbjct: 55  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVL 113
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D T+   
Sbjct: 114 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 29  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++++  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 89  SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSD---MGYVHRD 143
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 202
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 203 DVWSYGIVLWEVMSYGERP 221

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVL 320
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHR++ + N L+  +   +++DFGL+     D T+   
Sbjct: 321 LYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 376
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 25/234 (10%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV +F+  G L + L    ++ +      
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETL 105
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL       VIHRD+ + N L+  +   ++SDFG+  +   D  +   
Sbjct: 106 LGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSS 161
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
                   + +PE     + S K DV+SFGV++ E+ S G+ P  ++N    E       
Sbjct: 162 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSE------- 212
Query: 379 PILKNGDTE-TLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            ++++  T   L  P+L++ +    M       N C  + P+ RP   ++L+ L
Sbjct: 213 -VVEDISTGFRLYKPRLASTHVYQIM-------NHCWKERPEDRPAFSRLLRQL 258

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 83  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 140
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 141 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 196
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 197 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 62  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 119
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 120 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 175
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 176 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 71/136 (52%), Gaps = 12/136 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +++  G L    H   ++ +     RF  A  I+ ALNYLH    R +I+RD+K 
Sbjct: 85  LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKL 138
Query: 289 SNILLSSDFQPQLSDFGLAIWG--PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+LL S+   +L+D+G+   G  P D+T        GT  YIAPE L        +D +
Sbjct: 139 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF----CGTPNYIAPEILRGEDYGFSVDWW 194
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+++GR P 
Sbjct: 195 ALGVLMFEMMAGRSPF 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 25/173 (14%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGV 258
           DF  E  I       +I  L GV  +   ++++++++  G+L++ L    GE SVL    
Sbjct: 92  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-- 149
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL    +   +HRD+ + NIL++S+   ++SDFGL        + ++
Sbjct: 150 -VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGL--------SRVL 197
Query: 319 REDVVGTFG---------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +D   T+          + APE + + K +   DV+SFG+V+ E+++ G RP
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 80  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 137
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 138 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 193
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 194 FVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 6/161 (3%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E D+ S L+      L     +D  L     +   G L + +   G  S      RF 
Sbjct: 77  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY 134
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            A  I  AL YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S       
Sbjct: 135 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 190
Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            VGT  Y++PE L         D+++ G ++ +L++G  P 
Sbjct: 191 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---GEQSVLP 255
           +    E++I + L   +I  L     +   + L+ ++ P+G L + L  +    EQ    
Sbjct: 68  HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA- 126
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                 +   +A+AL Y H    + VIHRD+K  N+LL    + +++DFG ++  P+   
Sbjct: 127 -----TIMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS--- 175
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + R+ + GT  Y+ PE +     ++K+D++  GV+  ELL G  P 
Sbjct: 176 -LRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q V    V 
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA-VVL 359
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHR++ + N L+  +   +++DFGL+    T  T+   
Sbjct: 360 LYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 415
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L + K S K DV++FGV+L E+
Sbjct: 416 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 173 KLVSSRCRQ-FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
           K+  S  RQ ++ + LK+AT +          E DI   +    I  L+     +  L L
Sbjct: 46  KISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYL 104
Query: 232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           + DFL  G L   L  + E       V+F +A  +A AL++LHS     +I+RD+K  NI
Sbjct: 105 ILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLHSLG---IIYRDLKPENI 158
Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIRE--DVVGTFGYIAPEYLMHGKVSDKIDVYSFG 349
           LL  +   +L+DFGL+     +S    ++     GT  Y+APE +     +   D +SFG
Sbjct: 159 LLDEEGHIKLTDFGLS----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 214
Query: 350 VVLLELLSGRRPIGFKNLKGPESLVKWAK 378
           V++ E+L+G  P   K+ K   +++  AK
Sbjct: 215 VLMFEMLTGTLPFQGKDRKETMTMILKAK 243

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 173 KLVSSRCRQ-FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
           K+  S  RQ ++ + LK+AT +          E DI   +    I  L+     +  L L
Sbjct: 45  KISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYL 103
Query: 232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           + DFL  G L   L  + E       V+F +A  +A AL++LHS     +I+RD+K  NI
Sbjct: 104 ILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLHSLG---IIYRDLKPENI 157
Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIRE--DVVGTFGYIAPEYLMHGKVSDKIDVYSFG 349
           LL  +   +L+DFGL+     +S    ++     GT  Y+APE +     +   D +SFG
Sbjct: 158 LLDEEGHIKLTDFGLS----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 350 VVLLELLSGRRPIGFKNLKGPESLVKWAK 378
           V++ E+L+G  P   K+ K   +++  AK
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAK 242

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D+  E+DI +S +  +I  L      +N L ++ +F   G+++ ++    E+ +    ++
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD-AVMLELERPLTESQIQ 138
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI- 318
             V     +ALNYLH      +IHRD+K+ NIL + D   +L+DFG++      +T  I 
Sbjct: 139 V-VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQ 190
Query: 319 -REDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRP 361
            R+  +GT  ++APE +M     D     K DV+S G+ L+E+     P
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 229 LILVSDFLPKGSLE---ESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
           L +  +F  KG+LE   E   G     VL      E+   I + ++Y+HS   + +IHRD
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLA----LELFEQITKGVDYIHS---KKLIHRD 161
Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDV 345
           +K SNI L    Q ++ DFGL      D     R    GT  Y++PE +       ++D+
Sbjct: 162 LKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 218
Query: 346 YSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI--LKNGDTETLLDPKLSNEYDNAQM 403
           Y+ G++L ELL              ++  + +K    L++G    + D K     +   +
Sbjct: 219 YALGLILAELLH-----------VCDTAFETSKFFTDLRDGIISDIFDKK-----EKTLL 262
Query: 404 QRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA 445
           Q++L       ++ P+ RPN  ++L+ L     + +  +RH 
Sbjct: 263 QKLL-------SKKPEDRPNTSEILRTLTVWKKSPEKNERHT 297

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++ +  GSL+  L     Q  +   V   +   IA  + YL    +   +HRD
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSDMGA---VHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           D+  E+DI +S +  +I  L      +N L ++ +F   G+++ ++    E+ +    ++
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD-AVMLELERPLTESQIQ 138
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI- 318
             V     +ALNYLH      +IHRD+K+ NIL + D   +L+DFG++      +T  I 
Sbjct: 139 V-VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQ 190
Query: 319 -REDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRP 361
            R+  +GT  ++APE +M     D     K DV+S G+ L+E+     P
Sbjct: 191 RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +F  E  +   ++  ++  L GVC  +    +V++++P G+L + L     + V    V 
Sbjct: 74  EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVL 132
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+    T  T+   
Sbjct: 133 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAH 188
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
                   + APE L +   S K DV++FGV+L E+
Sbjct: 189 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 50  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 106
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 157
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 217
Query: 358 GRRP 361
           G +P
Sbjct: 218 GSKP 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 48  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 155
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 156 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
Query: 358 GRRP 361
           G +P
Sbjct: 216 GSKP 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L++  +P G L 
Sbjct: 55  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 162
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 163 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 222
Query: 358 GRRP 361
           G +P
Sbjct: 223 GSKP 226

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I   +  + + +L       + L LV   +  G L+  ++  G Q+  P       
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFY 291
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I   L  LH E    +++RD+K  NILL      ++SD GLA+  P   T   R   
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--- 345
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           VGT GY+APE + + + +   D ++ G +L E+++G+ P 
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGV 258
           +F SE  I    E  +I  L GV      ++++++F+  G+L+  L    G+ +V+    
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-- 120
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL +E S   +HRD+ + NIL++S+   ++SDFGL+ +   +S+   
Sbjct: 121 -VGMLRGIASGMRYL-AEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 319 REDVVG---TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +G      + APE +   K +   D +S+G+V+ E++S G RP
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I   +  + + +L       + L LV   +  G L+  ++  G Q+  P       
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFY 291
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A  I   L  LH E    +++RD+K  NILL      ++SD GLA+  P   T   R   
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--- 345
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           VGT GY+APE + + + +   D ++ G +L E+++G+ P 
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 114/252 (45%), Gaps = 33/252 (13%)
Query: 122 KTLLNQSTSPTPHSQINSFSPKTE-NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCR 180
           KT ++  T   P+  ++ F+ + + +  +++     G++ E          LKL   R  
Sbjct: 18  KTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGE-----VCSGRLKLPGKRDV 72
Query: 181 QFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS 240
             + + LK   ++      DF  E  I    +  ++  L GV      +++V +F+  G+
Sbjct: 73  AVAIKTLKVGYTEKQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGA 130
Query: 241 LEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           L+  L    G+ +V+       +   IA  + YL        +HRD+ + NIL++S+   
Sbjct: 131 LDAFLRKHDGQFTVIQL---VGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVC 184
Query: 300 QLSDFGL---------AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
           ++SDFGL         A++  T     +R        + APE + + K +   DV+S+G+
Sbjct: 185 KVSDFGLSRVIEDDPEAVYTTTGGKIPVR--------WTAPEAIQYRKFTSASDVWSYGI 236
Query: 351 VLLELLS-GRRP 361
           V+ E++S G RP
Sbjct: 237 VMWEVMSYGERP 248

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 24  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 80
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYSYNPSHNPEEQ 135
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 136 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 188
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 189 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV I   L   +I  L  V   +  L LV ++   G + + L   G         +F   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-- 121
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA----IWGPTDSTHMIR 319
             I  A+ Y H +    ++HRD+K+ N+LL  D   +++DFG +    +    D+     
Sbjct: 122 -QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT----- 172
Query: 320 EDVVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLK 368
               G+  Y APE L  GK  D  ++DV+S GV+L  L+SG  P   +NLK
Sbjct: 173 --FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 20  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 76
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF----------- 260
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYCYNPSHNPEEQ 131
Query: 261 -------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 132 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 184
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  EV  +S L  ++I ++  V  ED+   LV +++   +L E +   G  SV    + F
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSV-DTAINF 116
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
                I + + + H      ++HRD+K  NIL+ S+   ++ DFG+A    ++++     
Sbjct: 117 --TNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTN 170
Query: 321 DVVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRP 361
            V+GT  Y +PE    G+ +D+  D+YS G+VL E+L G  P
Sbjct: 171 HVLGTVQYFSPEQ-AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 27  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 83
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYSYNPSHNPEEQ 138
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 139 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 191
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 192 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 58  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++ +  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYL---SDMGYVHRD 172
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 231
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 35  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 91
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYSYNPSHNPEEQ 146
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 199
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 28  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 84
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYSYNPSHNPEEQ 139
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 140 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 192
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 193 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NIL+S+    ++ DFG+A     DS + + 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIA-RAIADSGNSVX 174
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGV 258
           +F SE  I    E  +I  L GV      ++++++F+  G+L+  L    G+ +V+    
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--- 117
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +   IA  + YL +E S   +HRD+ + NIL++S+   ++SDFGL+ +   +S+   
Sbjct: 118 LVGMLRGIASGMRYL-AEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 319 REDVVG---TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
               +G      + APE +   K +   D +S+G+V+ E++S G RP
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E D+  + + K ITTL+    +DN L LV D+   G L  +L    E  +     RF
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARF 179
Query: 261 EVA--VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
            +A  V   ++++ LH       +HRD+K  NIL+  +   +L+DFG  +    D T  +
Sbjct: 180 YLAEMVIAIDSVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--V 231
Query: 319 REDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           +  V VGT  YI+PE L       G+   + D +S GV + E+L G  P 
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E+   + L    I  L G   E  ++ +  + L  GSL + +    EQ  LP      
Sbjct: 133 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALY 189
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDS---THM 317
                 E L YLHS   R ++H DVK+ N+LLSSD     L DFG A+    D    + +
Sbjct: 190 YLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             + + GT  ++APE ++      K+DV+S   ++L +L+G  P
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 50  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 157
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 217
Query: 358 GRRP 361
           G +P
Sbjct: 218 GSKP 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 76  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 132
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYSYNPSHNPEEQ 187
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 188 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 240
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 35  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 91
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF----------- 260
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QARRPPGLEYCYNPSHNPEEQ 146
Query: 261 -------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 199
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAWN-----DFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +  S +E+  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 29  FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +++V++ +  GSL+  L     Q  +   V   +   IA  + YL        +HRD
Sbjct: 89  SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSD---MGYVHRD 143
Query: 286 VKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKI 343
           + + NIL++S+   ++SDFGL+  +    ++ +  R   +    + +PE + + K +   
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSAS 202
Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+S+G+VL E++S G RP
Sbjct: 203 DVWSYGIVLWEVMSYGERP 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 50  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 157
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 158 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 217
Query: 358 GRRP 361
           G +P
Sbjct: 218 GSKP 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 60/113 (53%), Gaps = 19/113 (16%)
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG------ 310
           GV   + + IAEA+ +LHS   + ++HRD+K SNI  + D   ++ DFGL          
Sbjct: 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 311 -------PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL 356
                  P  +TH  +   VGT  Y++PE +     S K+D++S G++L ELL
Sbjct: 221 QTVLTPMPAYATHXGQ---VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL- 241
           + +EL++ATS    A  +   E  + +S++   +  L G+C+    + L+   +P G L 
Sbjct: 52  AIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLL 108
Query: 242 ---EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
               E     G Q +L W       V IA+ +NYL     R ++HRD+ + N+L+ +   
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH 159
Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS- 357
            +++DFG A     +      E       ++A E ++H   + + DV+S+GV + EL++ 
Sbjct: 160 VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 219
Query: 358 GRRP 361
           G +P
Sbjct: 220 GSKP 223

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 153 PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL- 211
           P  EG + +  L  +  L  K   +R  + + + LK   ++     +D  SE+++   + 
Sbjct: 35  PLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIG 91
Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE---------- 261
           + K+I  L G C +D  L ++ ++  KG+L E L     Q+  P G+ +           
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----QAREPPGLEYSYNPSHNPEEQ 146
Query: 262 --------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                    A  +A  + YL    S+  IHRD+ + N+L++ D   +++DFGLA     D
Sbjct: 147 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RD 199
Query: 314 STHM--IREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             H+   ++   G     ++APE L     + + DV+SFGV+L E+ +
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 109/255 (42%), Gaps = 40/255 (15%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDF-LPKGSL 241
           + +++  +  Q +  W D   EV     L   +     G  + ++   LV ++ L   S 
Sbjct: 44  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD 103
Query: 242 EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
              +H    Q V       E+A     AL  L    S  +IHRDVK+ NILLS     +L
Sbjct: 104 LLEVHKKPLQEV-------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 156
Query: 302 SDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLS 357
            DFG A I  P +         VGT  ++APE ++    G+   K+DV+S G+  +E L+
Sbjct: 157 GDFGSASIMAPANX-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 208
Query: 358 GRRPIGFKNLKGPESLVKWAK---PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCI 414
            R+P  F N+    +L   A+   P L++G          S  + N          + C+
Sbjct: 209 ERKPPLF-NMNAMSALYHIAQNESPALQSG--------HWSEYFRN--------FVDSCL 251
Query: 415 NQSPQLRPNMGQVLK 429
            + PQ RP    +LK
Sbjct: 252 QKIPQDRPTSEVLLK 266

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A     DS + + 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVT 174
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 109/255 (42%), Gaps = 40/255 (15%)
Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDF-LPKGSL 241
           + +++  +  Q +  W D   EV     L   +     G  + ++   LV ++ L   S 
Sbjct: 83  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD 142
Query: 242 EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
              +H    Q V       E+A     AL  L    S  +IHRDVK+ NILLS     +L
Sbjct: 143 LLEVHKKPLQEV-------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195
Query: 302 SDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLS 357
            DFG A I  P +         VGT  ++APE ++    G+   K+DV+S G+  +E L+
Sbjct: 196 GDFGSASIMAPANX-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 247
Query: 358 GRRPIGFKNLKGPESLVKWAK---PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCI 414
            R+P  F N+    +L   A+   P L++G          S  + N          + C+
Sbjct: 248 ERKPPLF-NMNAMSALYHIAQNESPALQSG--------HWSEYFRN--------FVDSCL 290
Query: 415 NQSPQLRPNMGQVLK 429
            + PQ RP    +LK
Sbjct: 291 QKIPQDRPTSEVLLK 305

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           + E+   + L    I  L G   E  ++ +  + L  GSL + +    EQ  LP      
Sbjct: 114 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALY 170
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDSTH---M 317
                 E L YLHS   R ++H DVK+ N+LLSSD     L DFG A+    D      +
Sbjct: 171 YLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             + + GT  ++APE ++      K+DV+S   ++L +L+G  P
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A     DS + + 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVT 174
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 173 KLVSSRC--RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI 230
           K+    C  +  S  ++KQ T + S        EV +   L+  +I  L     +  Y  
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           LV +    G L + +      S +       +   +   + Y+H      ++HRD+K  N
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHK---NKIVHRDLKPEN 156
Query: 291 ILL---SSDFQPQLSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKI 343
           +LL   S D   ++ DFGL       STH       +D +GT  YIAPE ++HG   +K 
Sbjct: 157 LLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 208
Query: 344 DVYSFGVVLLELLSGRRPIGFKN 366
           DV+S GV+L  LLSG  P    N
Sbjct: 209 DVWSTGVILYILLSGCPPFNGAN 231

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL 241
           ++ + LK+AT +          E DI + +    +  L+     +  L L+ DFL  G L
Sbjct: 59  YAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL 117
Query: 242 EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
              L  + E       V+F +A  +A  L++LHS     +I+RD+K  NILL  +   +L
Sbjct: 118 FTRL--SKEVMFTEEDVKFYLA-ELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKL 171
Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +DFGL+                GT  Y+APE +     S   D +S+GV++ E+L+G  P
Sbjct: 172 TDFGLSKEAIDHEKKAY--SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229
Query: 362 IGFKNLKGPESLVKWAK 378
              K+ K   +L+  AK
Sbjct: 230 FQGKDRKETMTLILKAK 246

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A     DS + + 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVT 174
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 173 KLVSSRC--RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI 230
           K+    C  +  S  ++KQ T + S        EV +   L+  +I  L     +  Y  
Sbjct: 71  KITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFY 125
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           LV +    G L + +      S +       +   +   + Y+H      ++HRD+K  N
Sbjct: 126 LVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN---KIVHRDLKPEN 179
Query: 291 ILL---SSDFQPQLSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKI 343
           +LL   S D   ++ DFGL       STH       +D +GT  YIAPE ++HG   +K 
Sbjct: 180 LLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 231
Query: 344 DVYSFGVVLLELLSGRRPIGFKN 366
           DV+S GV+L  LLSG  P    N
Sbjct: 232 DVWSTGVILYILLSGCPPFNGAN 254

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A     DS + + 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVT 174
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 173 KLVSSRC--RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI 230
           K+    C  +  S  ++KQ T + S        EV +   L+  +I  L     +  Y  
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIXKLYEFFEDKGYFY 102
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           LV +    G L + +      S        + A  I + L+ +       ++HRD+K  N
Sbjct: 103 LVGEVYTGGELFDEIISRKRFS------EVDAARIIRQVLSGITYXHKNKIVHRDLKPEN 156
Query: 291 ILL---SSDFQPQLSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKI 343
           +LL   S D   ++ DFGL       STH       +D +GT  YIAPE ++HG   +K 
Sbjct: 157 LLLESKSKDANIRIIDFGL-------STHFEASKKXKDKIGTAYYIAPE-VLHGTYDEKC 208
Query: 344 DVYSFGVVLLELLSGRRPIGFKN 366
           DV+S GV+L  LLSG  P    N
Sbjct: 209 DVWSTGVILYILLSGCPPFNGAN 231

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 173 KLVSSRC--RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI 230
           K+    C  +  S  ++KQ T + S        EV +   L+  +I  L     +  Y  
Sbjct: 72  KITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFY 126
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           LV +    G L + +      S +       +   +   + Y+H      ++HRD+K  N
Sbjct: 127 LVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN---KIVHRDLKPEN 180
Query: 291 ILL---SSDFQPQLSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKI 343
           +LL   S D   ++ DFGL       STH       +D +GT  YIAPE ++HG   +K 
Sbjct: 181 LLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 232
Query: 344 DVYSFGVVLLELLSGRRPIGFKN 366
           DV+S GV+L  LLSG  P    N
Sbjct: 233 DVWSTGVILYILLSGCPPFNGAN 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAW-----NDFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +     E+  A     + +      DF SE  I    +  +I  L GV  +
Sbjct: 42  FGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 101
Query: 226 DNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
              ++++++++  GSL+  L    G  +V+       +   I   + YL    +   +HR
Sbjct: 102 CKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYLSDMSA---VHR 155
Query: 285 DVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           D+ + NIL++S+   ++SDFG++  +    ++ +  R   +    + APE + + K +  
Sbjct: 156 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSA 214
Query: 343 IDVYSFGVVLLELLS-GRRP 361
            DV+S+G+V+ E++S G RP
Sbjct: 215 SDVWSYGIVMWEVMSYGERP 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 173 KLVSSRC--RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLI 230
           K+    C  +  S  ++KQ T + S        EV +   L+  +I  L     +  Y  
Sbjct: 54  KITGQECAVKVISKRQVKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFY 108
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           LV +    G L + +      S +       +   +   + Y+H      ++HRD+K  N
Sbjct: 109 LVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN---KIVHRDLKPEN 162
Query: 291 ILL---SSDFQPQLSDFGLAIWGPTDSTHM----IREDVVGTFGYIAPEYLMHGKVSDKI 343
           +LL   S D   ++ DFGL       STH       +D +GT  YIAPE ++HG   +K 
Sbjct: 163 LLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 214
Query: 344 DVYSFGVVLLELLSGRRPIGFKN 366
           DV+S GV+L  LLSG  P    N
Sbjct: 215 DVWSTGVILYILLSGCPPFNGAN 237

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-----LPW 256
           SE+ I S L Q ++I  L G C     +++++++   G L   L    E  +      P 
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 257 GVR--FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
            +R     +  +A+ + +L    S+  IHRDV + N+LL++    ++ DFGLA     DS
Sbjct: 158 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 214
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +EL++AT +          EVDI   +    +I  L      + +  LV D + KG L +
Sbjct: 51  QELREATLK----------EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD 100
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            L    E+  L      ++  A+ E +  LH      ++HRD+K  NILL  D   +L+D
Sbjct: 101 YL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 154
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYL------MHGKVSDKIDVYSFGVVLLELLS 357
           FG +     D    +RE V GT  Y+APE +       H     ++D++S GV++  LL+
Sbjct: 155 FGFSC--QLDPGEKLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211
Query: 358 GRRPI 362
           G  P 
Sbjct: 212 GSPPF 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 11/103 (10%)
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIR 319
           A  I   L +LHS   + +++RD+K  NILL  D   +++DFG+    + G   +     
Sbjct: 125 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---- 177
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            +  GT  YIAPE L+  K +  +D +SFGV+L E+L G+ P 
Sbjct: 178 -EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A     DS + + 
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVT 191
Query: 320 ED--VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +EL++AT +          EVDI   +    +I  L      + +  LV D + KG L +
Sbjct: 64  QELREATLK----------EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD 113
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            L    E+  L      ++  A+ E +  LH      ++HRD+K  NILL  D   +L+D
Sbjct: 114 YL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYL------MHGKVSDKIDVYSFGVVLLELLS 357
           FG +     D    +RE V GT  Y+APE +       H     ++D++S GV++  LL+
Sbjct: 168 FGFSC--QLDPGEKLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 358 GRRPI 362
           G  P 
Sbjct: 225 GSPPF 229

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-----LPW 256
           SE+ I S L Q ++I  L G C     +++++++   G L   L    E  +      P 
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 257 GVR--FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
            +R     +  +A+ + +L    S+  IHRDV + N+LL++    ++ DFGLA     DS
Sbjct: 150 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 113/258 (43%), Gaps = 47/258 (18%)
Query: 193 QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE---ESLHGAG 249
            ++  W+ F  + + +S    +S T     C     L +  +F  KG+LE   E   G  
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTK----C-----LFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 250 EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW 309
              VL      E+   I + ++Y+HS   + +I+RD+K SNI L    Q ++ DFGL   
Sbjct: 119 LDKVLA----LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
              D     R    GT  Y++PE +       ++D+Y+ G++L ELL             
Sbjct: 172 LKNDGK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-----------V 217
Query: 370 PESLVKWAKPI--LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
            ++  + +K    L++G    + D K     +   +Q++L       ++ P+ RPN  ++
Sbjct: 218 CDTAFETSKFFTDLRDGIISDIFDKK-----EKTLLQKLL-------SKKPEDRPNTSEI 265
Query: 428 LKLLRGATHATDWVDRHA 445
           L+ L     + +  +RH 
Sbjct: 266 LRTLTVWKKSPEKNERHT 283

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           SE+ I S L Q ++I  L G C     +++++++   G L   L    +  VL     F 
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR--KSRVLETDPAFA 155
Query: 262 VAVAIAEALNYLHSE----------CSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
           +A + A   + LH             S+  IHRDV + N+LL++    ++ DFGLA    
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            DS ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAW-----NDFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +     E+  A     + +      DF SE  I    +  +I  L GV  +
Sbjct: 27  FGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 86
Query: 226 DNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
              ++++++++  GSL+  L    G  +V+       +   I   + YL S+ S   +HR
Sbjct: 87  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYL-SDMS--YVHR 140
Query: 285 DVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           D+ + NIL++S+   ++SDFG++  +    ++ +  R   +    + APE + + K +  
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSA 199
Query: 343 IDVYSFGVVLLELLS-GRRP 361
            DV+S+G+V+ E++S G RP
Sbjct: 200 SDVWSYGIVMWEVMSYGERP 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAW-----NDFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +     E+  A     + +      DF SE  I    +  +I  L GV  +
Sbjct: 21  FGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 80
Query: 226 DNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
              ++++++++  GSL+  L    G  +V+       +   I   + YL S+ S   +HR
Sbjct: 81  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYL-SDMS--YVHR 134
Query: 285 DVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           D+ + NIL++S+   ++SDFG++  +    ++ +  R   +    + APE + + K +  
Sbjct: 135 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSA 193
Query: 343 IDVYSFGVVLLELLS-GRRP 361
            DV+S+G+V+ E++S G RP
Sbjct: 194 SDVWSYGIVMWEVMSYGERP 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 56/103 (54%), Gaps = 11/103 (10%)
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIR 319
           A  I   L +LHS   + +++RD+K  NILL  D   +++DFG+    + G   +     
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF-- 178
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               GT  YIAPE L+  K +  +D +SFGV+L E+L G+ P 
Sbjct: 179 ---CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 175 VSSRC------RQFSYE--ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED 226
           V  RC      +QF+ +  ++ + TS    +  D   E  I   L+   I  L      D
Sbjct: 39  VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98
Query: 227 NYLILVSDFLPKGSL-EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
             L +V +F+    L  E +  A    V    V       I EAL Y H      +IHRD
Sbjct: 99  GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRD 155
Query: 286 VKSSNILLSS--DFQP-QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           VK  N+LL+S  +  P +L DFG+AI      + ++    VGT  ++APE +        
Sbjct: 156 VKPENVLLASKENSAPVKLGDFGVAI--QLGESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 343 IDVYSFGVVLLELLSGRRPI 362
           +DV+  GV+L  LLSG  P 
Sbjct: 214 VDVWGCGVILFILLSGCLPF 233

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 67/113 (59%), Gaps = 11/113 (9%)
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P  +  ++AV+I +AL +LHS+ S  VIHRDVK SN+L+++  Q ++ DFG++ +   D
Sbjct: 106 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
Query: 314 STHMIREDV-VGTFGYIAPEY----LMHGKVSDKIDVYSFGVVLLELLSGRRP 361
               + +D+  G   Y+APE     L     S K D++S G+ ++EL   R P
Sbjct: 164 ----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 9/96 (9%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTF 326
             L++LH+ C   ++HRD+K  NIL++S    +L+DFGLA I+    S  M  + VV T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALDPVVVTL 175
Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 171 FLKLVSSRCRQFSYEELKQATSQFSSAW-----NDFSSEVDITSSLEQKSITTLNGVCIE 225
           F ++ S R +     EL  A       +      DF  E  I    +  +I  L GV  +
Sbjct: 35  FGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTK 94
Query: 226 DNYLILVSDFLPKGSLEESLH-GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
              +++V++++  GSL+  L    G+ +V+       +   I+  + YL        +HR
Sbjct: 95  SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL---VGMLRGISAGMKYL---SDMGYVHR 148
Query: 285 DVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           D+ + NIL++S+   ++SDFGL+  +    ++ +  R   +    + APE +   K +  
Sbjct: 149 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTAPEAIAFRKFTSA 207
Query: 343 IDVYSFGVVLLELLS-GRRP 361
            DV+S+G+V+ E++S G RP
Sbjct: 208 SDVWSYGIVMWEVVSYGERP 227

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/180 (22%), Positives = 90/180 (50%), Gaps = 19/180 (10%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL---EESLHGAGEQ- 251
           S ++DF +E+ I + ++ +   T  G+    + + ++ +++   S+   +E      +  
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 252 -SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
              +P  V   +  ++  + +Y+H+E  + + HRDVK SNIL+  + + +LSDFG     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFG----- 197
Query: 311 PTDSTHMIREDVV---GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFK 365
             +S +M+ + +    GT+ ++ PE+  +    +  K+D++S G+ L  +     P   K
Sbjct: 198 --ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDN------------YLILVSDFLPKGSLEESLHGAGEQ 251
           EV   + LE   I       +E N            YL +      K +L++ ++G    
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
                 V   + + IAEA+ +LHS   + ++HRD+K SNI  + D   ++ DFGL     
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 312 TDS----------THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL 356
            D            +      VGT  Y++PE +     S K+D++S G++L ELL
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 24/170 (14%)
Query: 206 DITSSLEQKSITTLNG---------VCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           D+  ++ +K +  L G          C +  + L  V +++  G L   +   G     P
Sbjct: 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-P 442
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
             V +   +AI   L +L S   + +I+RD+K  N++L S+   +++DFG+    IW   
Sbjct: 443 HAVFYAAEIAIG--LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            +     +   GT  YIAPE + +      +D ++FGV+L E+L+G+ P 
Sbjct: 498 TT-----KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVG 324
           +   L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA I+    S  M    VV 
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVV 181
Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           T  Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTF 326
             L++LH+ C   ++HRD+K  NIL++S    +L+DFGLA I+    S  M    VV T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALAPVVVTL 175
Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            DF SE  I    +  +I  L GV       ++V++++  GSL+  L     Q  +   V
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL---------AIW 309
              +   +   + YL        +HRD+ + N+L+ S+   ++SDFGL         A +
Sbjct: 155 --GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             T     IR        + APE +     S   DV+SFGVV+ E+L+ G RP
Sbjct: 210 TTTGGKIPIR--------WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVG 324
           +   L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA I+    S  M    VV 
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVV 181
Query: 325 TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           T  Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   + L    I  L G   E  ++ +  + L  GSL + +   G    LP        
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYL 156
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDS---THMIR 319
               E L YLH+   R ++H DVK+ N+LLSSD  +  L DFG A+    D    + +  
Sbjct: 157 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           + + GT  ++APE +M      K+D++S   ++L +L+G  P   +  +GP  L
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCL 266

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   + L    I  L G   E  ++ +  + L  GSL + +   G    LP        
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYL 170
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDS---THMIR 319
               E L YLH+   R ++H DVK+ N+LLSSD  +  L DFG A+    D    + +  
Sbjct: 171 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 227
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           + + GT  ++APE +M      K+D++S   ++L +L+G  P   +  +GP  L
Sbjct: 228 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCL 280

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTF 326
             L++LH+ C   ++HRD+K  NIL++S    +L+DFGLA I+    S  M    VV T 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALTPVVVTL 183
Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEE 243
           +EL++AT +          EVDI   +    +I  L      + +  LV D + KG L +
Sbjct: 64  QELREATLK----------EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD 113
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
            L    E+  L      ++  A+ E +  LH      ++HRD+K  NILL  D   +L+D
Sbjct: 114 YL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYL------MHGKVSDKIDVYSFGVVLLELLS 357
           FG +     D    +R  V GT  Y+APE +       H     ++D++S GV++  LL+
Sbjct: 168 FGFSC--QLDPGEKLR-SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 358 GRRPI 362
           G  P 
Sbjct: 225 GSPPF 229

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 253 VLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           V+P  +  ++ +A  +ALN+L       +IHRD+K SNILL      +L DFG++     
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS-GQLV 177
Query: 313 DSTHMIREDVVGTFGYIAPEYL----MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
           DS    R+   G   Y+APE +           + DV+S G+ L EL +GR P    N  
Sbjct: 178 DSIAKTRD--AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN-- 233
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
              S+      ++K GD      P+LSN  +       +   NLC+ +    RP   ++L
Sbjct: 234 ---SVFDQLTQVVK-GDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 429 K 429
           K
Sbjct: 285 K 285

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 63/112 (56%), Gaps = 9/112 (8%)
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P  +  ++AV+I +AL +LHS+ S  VIHRDVK SN+L+++  Q ++ DFG++ +    
Sbjct: 150 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS 207
Query: 314 STHMIREDVVGTFGYIAPEY----LMHGKVSDKIDVYSFGVVLLELLSGRRP 361
               I     G   Y+APE     L     S K D++S G+ ++EL   R P
Sbjct: 208 VAKTID---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA      S  M    VV T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVT 182
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   + L    I  L G   E  ++ +  + L  GSL + +   G    LP        
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYL 172
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDS---THMIR 319
               E L YLH+   R ++H DVK+ N+LLSSD  +  L DFG A+    D    + +  
Sbjct: 173 GQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
           + + GT  ++APE +M      K+D++S   ++L +L+G  P   +  +GP  L
Sbjct: 230 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCL 282

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   ++     +RF  A  I   L ++H+   R V++RD+
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-YAAEIILGLEHMHN---RFVVYRDL 318
Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA        H      VGT GY+APE L  G   D   D 
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 346 YSFGVVLLELLSGRRPI 362
           +S G +L +LL G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   ++     +RF  A  I   L ++H+   R V++RD+
Sbjct: 266 LSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-YAAEIILGLEHMHN---RFVVYRDL 317
Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA        H      VGT GY+APE L  G   D   D 
Sbjct: 318 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADW 373
Query: 346 YSFGVVLLELLSGRRPI 362
           +S G +L +LL G  P 
Sbjct: 374 FSLGCMLFKLLRGHSPF 390

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 64/123 (52%), Gaps = 12/123 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
           Q  +P  +  ++ VAI +AL YL  +    VIHRDVK SNILL    Q +L DFG++   
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 311 PTDSTHMIREDVVGTFGYIAPEYL-----MHGKVSDKIDVYSFGVVLLELLSGRRPIGFK 365
             D     ++   G   Y+APE +            + DV+S G+ L+EL +G+ P  +K
Sbjct: 176 VDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YK 230
Query: 366 NLK 368
           N K
Sbjct: 231 NCK 233

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   ++     +RF  A  I   L ++H+   R V++RD+
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-YAAEIILGLEHMHN---RFVVYRDL 318
Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA        H      VGT GY+APE L  G   D   D 
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 346 YSFGVVLLELLSGRRPI 362
           +S G +L +LL G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 229 LILVSDFLPKGSLEESL--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDV 286
           L  + D +  G L   L  HG   ++     +RF  A  I   L ++H+   R V++RD+
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEA----DMRF-YAAEIILGLEHMHN---RFVVYRDL 318
Query: 287 KSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDV 345
           K +NILL      ++SD GLA        H      VGT GY+APE L  G   D   D 
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 346 YSFGVVLLELLSGRRPI 362
           +S G +L +LL G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           SE+ I S L Q ++I  L G C     +++++++   G L   L    +  VL     F 
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR--KSRVLETDPAFA 155
Query: 262 VAVAIAEALNYLHSE----------CSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
           +A +     + LH             S+  IHRDV + N+LL++    ++ DFGLA    
Sbjct: 156 IANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            DS ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 24/170 (14%)
Query: 206 DITSSLEQKSITTLNGV---------CIED-NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           D+  ++ +K +  L G          C +  + L  V +++  G L   +   G     P
Sbjct: 63  DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-P 121
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
             V +   +AI   L +L S   + +I+RD+K  N++L S+   +++DFG+    IW   
Sbjct: 122 HAVFYAAEIAIG--LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            +     +   GT  YIAPE + +      +D ++FGV+L E+L+G+ P 
Sbjct: 177 TT-----KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTF 326
             L++LH+ C   ++HRD+K  NIL++S    +L+DFGLA I+    S  M    VV T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALFPVVVTL 175
Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L +LH    R +I+RD+K  N+LL  D   ++SD GLA+      T    +   GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGT 352
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            G++APE L+  +    +D ++ GV L E+++ R P 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L +LH    R +I+RD+K  N+LL  D   ++SD GLA+      T    +   GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGT 352
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            G++APE L+  +    +D ++ GV L E+++ R P 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L +LH    R +I+RD+K  N+LL  D   ++SD GLA+      T    +   GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGT 352
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            G++APE L+  +    +D ++ GV L E+++ R P 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   L +LH    R +I+RD+K  N+LL  D   ++SD GLA+      T    +   GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGT 352
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            G++APE L+  +    +D ++ GV L E+++ R P 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           +   + Y+H      ++HRD+K  NILL S   D   ++ DFGL+     ++     +D 
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDR 183
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           +GT  YIAPE ++ G   +K DV+S GV+L  LLSG  P   KN
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I+ AL +LH    + +I+RD+K  NI+L+     +L+DFGL      D T  +     GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
             Y+APE LM    +  +D +S G ++ ++L+G  P   +N K
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I+ AL +LH    + +I+RD+K  NI+L+     +L+DFGL      D T  +     GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGT 184
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
             Y+APE LM    +  +D +S G ++ ++L+G  P   +N K
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +++  G L   +   G+    P  V +   ++I   L +LH    R +I+RD+K 
Sbjct: 95  LYFVMEYVNGGDLMYHIQQVGKFKE-PQAVFYAAEISIG--LFFLHK---RGIIYRDLKL 148
Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMI----REDVVGTFGYIAPEYLMHGKVSDKID 344
            N++L S+   +++DFG+         HM+      +  GT  YIAPE + +      +D
Sbjct: 149 DNVMLDSEGHIKIADFGMC------KEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVD 202
Query: 345 VYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILKN 383
            +++GV+L E+L+G+ P            I   N+  P+SL K A  I K 
Sbjct: 203 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 253

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+++  LV D +  G L E +     +            
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCI 134
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAI-WGPTDSTHMIR 319
             I E++ Y HS     ++HR++K  N+LL+S  +    +L+DFGLAI    +++ H   
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 188
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               GT GY++PE L     S  +D+++ GV+L  LL G  P 
Sbjct: 189 -GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           +   + Y+H      ++HRD+K  NILL S   D   ++ DFGL+     ++     +D 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDR 183
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           +GT  YIAPE ++ G   +K DV+S GV+L  LLSG  P   KN
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           +   + Y+H      ++HRD+K  NILL S   D   ++ DFGL+     ++     +D 
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDR 183
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           +GT  YIAPE ++ G   +K DV+S GV+L  LLSG  P   KN
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L++++
Sbjct: 45  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIT 102
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 103 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D  ++ + D      ++APE +     
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 340 SDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
           + + DV+SFGV+L E+ S G  P  +  +K  E   +     LK G          + +Y
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCR----RLKEGTRMR------APDY 266
Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR 443
              +M + +L    C +  P  RP   ++++ L     A    DR
Sbjct: 267 TTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 141 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 139 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 130 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L++++
Sbjct: 45  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIT 102
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 103 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D  ++ + D      ++APE +     
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 340 SDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
           + + DV+SFGV+L E+ S G  P  +  +K  E   +     LK G          + +Y
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCR----RLKEGTRMR------APDY 266
Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR 443
              +M + +L    C +  P  RP   ++++ L     A    DR
Sbjct: 267 TTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 325 TFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
           T  Y APE +++ K   K ID++S G +L E+LS R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG----SLEE 243
           KQ   + +   N F  E+ I   LE   +  L     ++  + +V D L  G     L++
Sbjct: 50  KQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ 108
Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
           ++H   E   L           +  AL+YL ++    +IHRD+K  NILL       ++D
Sbjct: 109 NVHFKEETVKL-------FICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITD 158
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK---VSDKIDVYSFGVVLLELLSGRR 360
           F +A   P ++       + GT  Y+APE     K    S  +D +S GV   ELL GRR
Sbjct: 159 FNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 361 P 361
           P
Sbjct: 216 P 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E D+  + + + IT L+    ++N+L LV D+   G L  +L    E  +     RF
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARF 195
Query: 261 ---EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              E+ +AI ++++ LH       +HRD+K  N+LL  +   +L+DFG  +    D T  
Sbjct: 196 YIGEMVLAI-DSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-- 246
Query: 318 IREDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           ++  V VGT  YI+PE L       GK   + D +S GV + E+L G  P 
Sbjct: 247 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E D+  + + + IT L+    ++N+L LV D+   G L  +L    E  +     RF
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARF 179
Query: 261 ---EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              E+ +AI ++++ LH       +HRD+K  N+LL  +   +L+DFG  +    D T  
Sbjct: 180 YIGEMVLAI-DSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-- 230
Query: 318 IREDV-VGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           ++  V VGT  YI+PE L       GK   + D +S GV + E+L G  P 
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E  I       +I  L GVC +   + +V + +  G     L   G +  L      
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLL 216
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
           ++    A  + YL S+C    IHRD+ + N L++     ++SDFG           M RE
Sbjct: 217 QMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFG-----------MSRE 262
Query: 321 DVVGTFG-----------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +  G +            + APE L +G+ S + DV+SFG++L E  S
Sbjct: 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL-----EESLHGAGEQSVLPWG 257
           +E+ +   ++ ++I  L  +    N+L LV   +  G L     E+  +   + S L   
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL--- 125
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWGPTD 313
           +R      + +A+ YLH      ++HRD+K  N+L  S   + +  +SDFGL+ + G  D
Sbjct: 126 IR-----QVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               +     GT GY+APE L     S  +D +S GV+   LL G  P 
Sbjct: 178 ----VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 325 TFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
           T  Y APE +++ K   K ID++S G +L E+LS R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 14/175 (8%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L ++ ++   G L E +  AG  S       F+    +   
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSG 128
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS--DFGLAIWGPTDSTHMIREDVVGTFG 327
           ++Y HS     + HRD+K  N LL     P+L   DFG   +  +   H   +  VGT  
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHSQPKSTVGTPA 182
Query: 328 YIAPEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           YIAPE L+  +   KI DV+S GV L  +L G  P  F++ + P    K  + IL
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP--FEDPEEPRDYRKTIQRIL 235

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM-IREDVVG 324
           I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA     D  H     + V 
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 325 TFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           T  Y APE +++ K  +  ID++S G +L E+LS R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I TL G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-----HGAGEQSVLPWGV 258
           E  I   L+  +I  L+    E+++  LV D +  G L E +     +   + S      
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------ 108
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAI-WGPTDS 314
                  I E++ Y HS     ++HR++K  N+LL+S  +    +L+DFGLAI    +++
Sbjct: 109 --HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            H       GT GY++PE L     S  +D+++ GV+L  LL G  P 
Sbjct: 164 WH----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+++  LV D +  G L E +     +            
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCI 111
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAI-WGPTDSTHMIR 319
             I E++ Y HS     ++HR++K  N+LL+S  +    +L+DFGLAI    +++ H   
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               GT GY++PE L     S  +D+++ GV+L  LL G  P 
Sbjct: 166 -GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+++  LV D +  G L E +     +            
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCI 110
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAI-WGPTDSTHMIR 319
             I E++ Y HS     ++HR++K  N+LL+S  +    +L+DFGLAI    +++ H   
Sbjct: 111 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 164
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
               GT GY++PE L     S  +D+++ GV+L  LL G  P 
Sbjct: 165 -GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 23/173 (13%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            DF SE  I    +  +I  L GV       ++V++++  GSL+  L     Q  +   V
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL---------AIW 309
              +   +   + YL        +HRD+ + N+L+ S+   ++SDFGL         A  
Sbjct: 155 --GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
             T     IR        + APE +     S   DV+SFGVV+ E+L+ G RP
Sbjct: 210 TTTGGKIPIR--------WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 38/285 (13%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L++++
Sbjct: 45  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIT 102
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 103 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D   + + D      ++APE +     
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 340 SDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
           + + DV+SFGV+L E+ S G  P  +  +K  E   +     LK G          + +Y
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCR----RLKEGTRMR------APDY 266
Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR 443
              +M + +L    C +  P  RP   ++++ L     A    DR
Sbjct: 267 TTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 13/163 (7%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG---VR 259
           +EV I   L+  SI  L     + NY+ LV +    G +   L    +  V P+     R
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEAR 115
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             +   I   L YLHS     ++HRD+  SN+LL+ +   +++DFGLA        H   
Sbjct: 116 HFMHQIITGML-YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ--LKMPHEKH 169
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             + GT  YI+PE         + DV+S G +   LL GR P 
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/109 (37%), Positives = 62/109 (56%), Gaps = 13/109 (11%)
Query: 261 EVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDS 314
           + AV I + L+   YLH      ++HRD+K  N+LL S   D   ++ DFGL+     ++
Sbjct: 137 DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFEN 191
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
              ++E + GT  YIAPE ++  K  +K DV+S GV+L  LL+G  P G
Sbjct: 192 QKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFG 238

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDI 177
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 235
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +++
Sbjct: 236 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 281 NLLKDDLHPS 290

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDI 180
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 238
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +++
Sbjct: 239 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 284 NLLKDDLHPS 293

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 131 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 183 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 131 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 183 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L +V ++   G L E +  AG  S       F+  ++    
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---G 126
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS--DFGLAIWGPTDSTHMIREDVVGTFG 327
           ++Y H+     V HRD+K  N LL     P+L   DFG   +  +   H   +  VGT  
Sbjct: 127 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHSQPKSTVGTPA 180
Query: 328 YIAPEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           YIAPE L+  +   K+ DV+S GV L  +L G  P  F++ + P++  K    IL
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNFRKTIHRIL 233

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E  I       +I  L GVC +   + +V + +  G     L   G +  L      
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLL 216
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW---GPTDSTHM 317
           ++    A  + YL S+C    IHRD+ + N L++     ++SDFG++     G   ++  
Sbjct: 217 QMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGG 273
Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +R+  V    + APE L +G+ S + DV+SFG++L E  S
Sbjct: 274 LRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 108
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 109 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 161 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 216

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 120
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 121 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 173 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 228

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG 327
           + L YLH       IHRD+K+ NILL+++   +L+DFG+A  G        R  V+GT  
Sbjct: 136 KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPF 190
Query: 328 YIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           ++APE +     +   D++S G+  +E+  G+ P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 128
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 129 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 181 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 236

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 110
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 111 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 163 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 218

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 115 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 167 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L +V ++   G L E +  AG  S       F+  ++    
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---G 127
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS--DFGLAIWGPTDSTHMIREDVVGTFG 327
           ++Y H+     V HRD+K  N LL     P+L   DFG   +  +   H   +  VGT  
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHSQPKSTVGTPA 181
Query: 328 YIAPEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           YIAPE L+  +   K+ DV+S GV L  +L G  P  F++ + P++  K    IL
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  LV D +  G L E +      S           
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCI 136
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPTDSTHMIRE 320
             I E++N++H      ++HRD+K  N+LL+S  +    +L+DFGLAI            
Sbjct: 137 HQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGEQQAWF 191
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 102 LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 157
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 158 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 217
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 218 HFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 115 LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 231 HFESFKRADIYAMGLVFWEI 250

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 473
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 474 -----ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 526 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 581

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 472
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 473 -----ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 525 Y-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 580

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 82  LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 137
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 138 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 197
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 198 HFESFKRADIYAMGLVFWEI 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L +V ++   G L E +  AG  S       F+  ++    
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---G 127
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           ++Y H+     V HRD+K  N LL     P+L       +  +   H   +D VGT  YI
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFG-YSKSSVLHSQPKDTVGTPAYI 183
Query: 330 APEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           APE L+  +   K+ DV+S GV L  +L G  P  F++ + P++  K    IL
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 77  LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 132
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 133 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 192
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 193 HFESFKRADIYAMGLVFWEI 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-----H---GAGE- 250
           +F  E  + + L+  ++  L GV  +D  L ++  +   G L E L     H   G+ + 
Sbjct: 75  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 251 ----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               +S L       +   IA  + YL    S  V+H+D+ + N+L+      ++SD GL
Sbjct: 135 DRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 191
Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GF 364
                    + +  + +    ++APE +M+GK S   D++S+GVVL E+ S G +P  G+
Sbjct: 192 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251
Query: 365 KN 366
            N
Sbjct: 252 SN 253

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 79  LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 134
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 135 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 194
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 195 HFESFKRADIYAMGLVFWEI 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 43/257 (16%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-----GAG- 249
           S   D  SE ++   +    +  L G C +D  L+L+ ++   GSL   L      G G 
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 250 ---------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
                          ++  L  G     A  I++ + YL       ++HRD+ + NIL++
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
              + ++SDFGL+     + +++ R        ++A E L     + + DV+SFGV+L E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 355 LLSGRRPIGFKNLKG--PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL 412
           +++    +G     G  PE L      +LK G    +  P   +E    +M R++L    
Sbjct: 245 IVT----LGGNPYPGIPPERLFN----LLKTG--HRMERPDNCSE----EMYRLMLQ--- 287
Query: 413 CINQSPQLRPNMGQVLK 429
           C  Q P  RP    + K
Sbjct: 288 CWKQEPDKRPVFADISK 304

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDI 180
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 238
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P +RP   +++
Sbjct: 239 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 284 NLLKDDLHPS 293

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 213 QKSITTLNGVCIE------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAI 266
            ++I T  G  I+      D+ L LV +F   GS+ + +      ++    + + +   I
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREI 138
Query: 267 AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF 326
              L++LH      VIHRD+K  N+LL+ + + +L DFG++     D T   R   +GT 
Sbjct: 139 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTP 193
Query: 327 GYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPI 362
            ++APE +   +  D     K D++S G+  +E+  G  P+
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L +V ++   G L E +  AG  S       F+  ++    
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---G 127
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLAIWGPTDSTHMIREDVVGTFG 327
           ++Y H+     V HRD+K  N LL     P+L  +DFG   +      H   +  VGT  
Sbjct: 128 VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFG---YSKASVLHSQPKSAVGTPA 181
Query: 328 YIAPEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           YIAPE L+  +   K+ DV+S GV L  +L G  P  F++ + P++  K    IL
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDI 180
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 238
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +++
Sbjct: 239 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 284 NLLKDDLHPS 293

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 33/151 (21%)
Query: 230 ILVSDFLPKGSLEE--SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-----PVI 282
           +LV ++ P GSL +  SLH +       W     +A ++   L YLH+E  R     P I
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTSD------WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 283 -HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR---ED-----VVGTFGYIAPEY 333
            HRD+ S N+L+ +D    +SDFGL++        ++R   ED      VGT  Y+APE 
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSM--RLTGNRLVRPGEEDNAAISEVGTIRYMAPE- 198
Query: 334 LMHGKVS--------DKIDVYSFGVVLLELL 356
           ++ G V+         ++D+Y+ G++  E+ 
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L LVSD+   GSL + L+     +V   G+  ++A++ A  L +LH E      +P I H
Sbjct: 76  LWLVSDYHEHGSLFDYLN---RYTVTVEGM-IKLALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL------M 335
           RD+KS NIL+  +    ++D GLA+     TD+  +     VGT  Y+APE L       
Sbjct: 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 191
Query: 336 HGKVSDKIDVYSFGVVLLEL 355
           H +   + D+Y+ G+V  E+
Sbjct: 192 HFESFKRADIYAMGLVFWEI 211

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFE 261
           +E+++  SL+  +I  +  V  + + + +V +    G L E +  A      L  G   E
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILL--SSDFQP-QLSDFGLAIWGPTDSTHMI 318
           +   +  AL Y HS+    V+H+D+K  NIL   +S   P ++ DFGLA    +D     
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--- 182
Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
             +  GT  Y+APE +    V+ K D++S GVV+  LL+G  P    +L+  +    + +
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241
Query: 379 PILKNGDTETL-LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           P   N   E   L P+  +      +++ML        + P+ RP+  QVL
Sbjct: 242 P---NYAVECRPLTPQAVD-----LLKQML-------TKDPERRPSAAQVL 277

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 64/113 (56%), Gaps = 11/113 (9%)
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           +P  +  ++AV+I +AL +LHS+ S  VIHRDVK SN+L+++  Q +  DFG++ +   D
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 314 STHMIREDV-VGTFGYIAPEY----LMHGKVSDKIDVYSFGVVLLELLSGRRP 361
               + +D+  G   Y APE     L     S K D++S G+  +EL   R P
Sbjct: 191 ----VAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T ST+ +    V T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTRYY 189
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ EL+ G         +G + + +W K I + G    
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGS-----VIFQGTDHIDQWNKVIEQLGTPSA 244
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 245 EFMAALQPTVRNYVEN 260

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 45  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 102
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 103 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 158
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D   + + D      ++APE +     
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 340 SDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY 398
           + + DV+SFGV+L E+ S G  P  +  +K  E   +     LK G          + +Y
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCR----RLKEGTRMR------APDY 266
Query: 399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR 443
              +M + +L    C +  P  RP   ++++ L     A    DR
Sbjct: 267 TTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
           KLV+ +C      E K+ + +         +E+ +   ++  +I  L+ +     +L L+
Sbjct: 44  KLVAIKCIAKKALEGKEGSME---------NEIAVLHKIKHPNIVALDDIYESGGHLYLI 94
Query: 233 SDFLPKGSL-----EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
              +  G L     E+  +   + S L + V         +A+ YLH      ++HRD+K
Sbjct: 95  MQLVSGGELFDRIVEKGFYTERDASRLIFQV--------LDAVKYLHD---LGIVHRDLK 143
Query: 288 SSNIL---LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
             N+L   L  D +  +SDFGL+     +    +     GT GY+APE L     S  +D
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200
Query: 345 VYSFGVVLLELLSGRRPI 362
            +S GV+   LL G  P 
Sbjct: 201 CWSIGVIAYILLCGYPPF 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDI 180
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 238
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +++
Sbjct: 239 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 284 NLLKDDLHPS 293

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 113/252 (44%), Gaps = 37/252 (14%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 65  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 124
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWG 310
                   ++A  IA+ + YL++   +  +HRD+ + N +++ DF  ++ DFG+   I+ 
Sbjct: 125 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 180
Query: 311 PTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKN 366
               T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N
Sbjct: 181 ---ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 237
Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
               E ++K+            ++D    ++ DN   +R+     +C   +P++RP   +
Sbjct: 238 ----EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLE 280
Query: 427 VLKLLRGATHAT 438
           ++ LL+   H +
Sbjct: 281 IVNLLKDDLHPS 292

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL-----H---GAGE- 250
           +F  E  + + L+  ++  L GV  +D  L ++  +   G L E L     H   G+ + 
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 251 ----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               +S L       +   IA  + YL    S  V+H+D+ + N+L+      ++SD GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GF 364
                    + +  + +    ++APE +M+GK S   D++S+GVVL E+ S G +P  G+
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 365 KN 366
            N
Sbjct: 235 SN 236

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVG 324
           I   L Y+HS     V+HRD+K SN+L+++    ++ DFGLA I  P         + V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 325 TFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
           T  Y APE +++ K   K ID++S G +L E+LS R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 54  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 112 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D  ++ + D      ++APE +     
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227
Query: 340 SDKIDVYSFGVVLLELLS 357
           + + DV+SFGV+L E+ S
Sbjct: 228 TIQSDVWSFGVLLWEIFS 245

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 63/138 (45%), Gaps = 8/138 (5%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V D++  G L    H   E+  L    RF  A  IA AL YLHS     +++RD+K 
Sbjct: 114 LYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEIASALGYLHSLN---IVYRDLKP 167
Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            NILL S     L+DFGL       ++        GT  Y+APE L        +D +  
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 349 GVVLLELLSGRRPIGFKN 366
           G VL E+L G  P   +N
Sbjct: 226 GAVLYEMLYGLPPFYSRN 243

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAIWGPTDSTHMIREDV 322
           I+ AL YLH      +IHRD+K  NI+L    Q    ++ D G A     D   +  E  
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-F 183
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           VGT  Y+APE L   K +  +D +SFG +  E ++G RP 
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 91  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 149 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 204
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D  ++ + D      ++APE +     
Sbjct: 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264
Query: 340 SDKIDVYSFGVVLLELLS 357
           + + DV+SFGV+L E+ S
Sbjct: 265 TIQSDVWSFGVLLWEIFS 282

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAIWGPTDSTHMIREDV 322
           I+ AL YLH      +IHRD+K  NI+L    Q    ++ D G A     D   +  E  
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-F 184
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           VGT  Y+APE L   K +  +D +SFG +  E ++G RP 
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLH--------------- 246
           SE+ I S L Q ++I  L G C     +++++++   G L   L                
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 247 ---GAGEQSVLPWGVR--FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
              G  ++   P  +R     +  +A+ + +L    S+  IHRDV + N+LL++    ++
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 199
Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            DFGLA     DS ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 203 SEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL---------------H 246
           SE+ I S L Q ++I  L G C     +++++++   G L   L               H
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
              EQ  L        +  +A+ + +L    S+  IHRDV + N+LL++    ++ DFGL
Sbjct: 158 NPEEQ--LSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           A     DS ++++ +      ++APE +     + + DV+S+G++L E+ S
Sbjct: 213 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 128
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 129 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 185
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 186 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 25/150 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L L++ +   GSL + L     Q++ P  +   +AV+ A  L +LH E      +P I H
Sbjct: 81  LWLITHYHEHGSLYDFLQ---RQTLEP-HLALRLAVSAACGLAHLHVEIFGTQGKPAIAH 136
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV-----VGTFGYIAPEYLMHGK 338
           RD KS N+L+ S+ Q  ++D GLA+     S ++   D+     VGT  Y+APE L    
Sbjct: 137 RDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYL---DIGNNPRVGTKRYMAPEVLDEQI 193
Query: 339 VSDKI------DVYSFGVVLLELLSGRRPI 362
            +D        D+++FG+VL E+   RR I
Sbjct: 194 RTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
           KLV+ +C      E K+ + +         +E+ +   ++  +I  L+ +     +L L+
Sbjct: 44  KLVAIKCIAKEALEGKEGSME---------NEIAVLHKIKHPNIVALDDIYESGGHLYLI 94
Query: 233 SDFLPKGSL-----EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
              +  G L     E+  +   + S L + V         +A+ YLH      ++HRD+K
Sbjct: 95  MQLVSGGELFDRIVEKGFYTERDASRLIFQV--------LDAVKYLHD---LGIVHRDLK 143
Query: 288 SSNIL---LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
             N+L   L  D +  +SDFGL+     +    +     GT GY+APE L     S  +D
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200
Query: 345 VYSFGVVLLELLSGRRPI 362
            +S GV+   LL G  P 
Sbjct: 201 CWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
           KLV+ +C      E K+ + +         +E+ +   ++  +I  L+ +     +L L+
Sbjct: 44  KLVAIKCIAKEALEGKEGSME---------NEIAVLHKIKHPNIVALDDIYESGGHLYLI 94
Query: 233 SDFLPKGSL-----EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
              +  G L     E+  +   + S L + V         +A+ YLH      ++HRD+K
Sbjct: 95  MQLVSGGELFDRIVEKGFYTERDASRLIFQV--------LDAVKYLHD---LGIVHRDLK 143
Query: 288 SSNIL---LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
             N+L   L  D +  +SDFGL+     +    +     GT GY+APE L     S  +D
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200
Query: 345 VYSFGVVLLELLSGRRPI 362
            +S GV+   LL G  P 
Sbjct: 201 CWSIGVIAYILLCGYPPF 218

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 185
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 242
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 243 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 173 KLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILV 232
           KLV+ +C      E K+ + +         +E+ +   ++  +I  L+ +     +L L+
Sbjct: 44  KLVAIKCIAKEALEGKEGSME---------NEIAVLHKIKHPNIVALDDIYESGGHLYLI 94
Query: 233 SDFLPKGSL-----EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
              +  G L     E+  +   + S L + V         +A+ YLH      ++HRD+K
Sbjct: 95  MQLVSGGELFDRIVEKGFYTERDASRLIFQV--------LDAVKYLHD---LGIVHRDLK 143
Query: 288 SSNIL---LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
             N+L   L  D +  +SDFGL+     +    +     GT GY+APE L     S  +D
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200
Query: 345 VYSFGVVLLELLSGRRPI 362
            +S GV+   LL G  P 
Sbjct: 201 CWSIGVIAYILLCGYPPF 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 RIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 131
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 132 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 188
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 189 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 43/257 (16%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-----GAG- 249
           S   D  SE ++   +    +  L G C +D  L+L+ ++   GSL   L      G G 
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 250 ---------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
                          ++  L  G     A  I++ + YL +E S  ++HRD+ + NIL++
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMS--LVHRDLAARNILVA 184
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
              + ++SDFGL+     + + + R        ++A E L     + + DV+SFGV+L E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 355 LLSGRRPIGFKNLKG--PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL 412
           +++    +G     G  PE L      +LK G    +  P   +E    +M R++L    
Sbjct: 245 IVT----LGGNPYPGIPPERLFN----LLKTG--HRMERPDNCSE----EMYRLMLQ--- 287
Query: 413 CINQSPQLRPNMGQVLK 429
           C  Q P  RP    + K
Sbjct: 288 CWKQEPDKRPVFADISK 304

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 90/179 (50%), Gaps = 19/179 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLP 255
           ++  +E ++   L+   I  + G+C  ++++ LV +    G L + L       +++++ 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  
Sbjct: 115 -----ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE- 165
Query: 316 HMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE 371
           +  +    G +   + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSE 222

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 126
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 127 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVM 183
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 184 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 54  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 112 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D   + + D      ++APE +     
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 340 SDKIDVYSFGVVLLELLS 357
           + + DV+SFGV+L E+ S
Sbjct: 228 TIQSDVWSFGVLLWEIFS 245

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I + L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 218 TLNGVCIEDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVA 265
            L  V    N + L++ F P+ SLEE         L  A    V+   +  E    +   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T
Sbjct: 135 MLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVT 188
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
             Y APE ++     + +D++S GV++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 49  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 104
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 105 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 143
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A    T S + + E     + Y+APE L   K     D
Sbjct: 144 ENLLYTSK-RPNAILKLTDFGFA--KETTSHNSLTEPCYTPY-YVAPEVLGPEKYDKSCD 199
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 200 MWSLGVIMYILLCGYPPF 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 218 TLNGVCIEDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVA 265
            L  V    N + L++ F P+ SLEE         L  A    V+   +  E    +   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T
Sbjct: 135 MLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVT 188
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
             Y APE ++     + +D++S GV++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----EESLHGAGEQSVLPWGVR 259
           E  + + +    ++ L G+C+    + LV+  +P G L     E+    G Q +L W   
Sbjct: 69  EAYVMAGVGSPYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW--- 124
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
               + IA+ ++YL       ++HRD+ + N+L+ S    +++DFGLA     D T    
Sbjct: 125 ---CMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +       ++A E ++  + + + DV+S+GV + EL++ G +P
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    +    G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L  +          
Sbjct: 71  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHRD+ + NIL+  ++  +++DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   +   DV+S+GV+L E++S
Sbjct: 188 L-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 8/138 (5%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V +F+  G L    H    +       RF  A  I  AL +LH    + +I+RD+K 
Sbjct: 99  LFFVMEFVNGGDL--MFHIQKSRRFDEARARF-YAAEIISALMFLHD---KGIIYRDLKL 152
Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            N+LL  +   +L+DFG+   G  +   +      GT  YIAPE L        +D ++ 
Sbjct: 153 DNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 349 GVVLLELLSGRRPIGFKN 366
           GV+L E+L G  P   +N
Sbjct: 211 GVLLYEMLCGHAPFEAEN 228

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L  +          
Sbjct: 61  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 120
Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHRD+ + NIL+  ++  +++DFG
Sbjct: 121 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 177
Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   +   DV+S+GV+L E++S
Sbjct: 178 L-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  LV D +  G L E +      S           
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCI 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAIWGPTDSTHMIRE 320
             I E++N+ H      ++HRD+K  N+LL+S  +    +L+DFGLAI    D       
Sbjct: 110 QQILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-- 164
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 43/257 (16%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-----GAG- 249
           S   D  SE ++   +    +  L G C +D  L+L+ ++   GSL   L      G G 
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 250 ---------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
                          ++  L  G     A  I++ + YL       ++HRD+ + NIL++
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
              + ++SDFGL+     + + + R        ++A E L     + + DV+SFGV+L E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 355 LLSGRRPIGFKNLKG--PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL 412
           +++    +G     G  PE L      +LK G    +  P   +E    +M R++L    
Sbjct: 245 IVT----LGGNPYPGIPPERLFN----LLKTG--HRMERPDNCSE----EMYRLMLQ--- 287
Query: 413 CINQSPQLRPNMGQVLK 429
           C  Q P  RP    + K
Sbjct: 288 CWKQEPDKRPVFADISK 304

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  LV D +  G L E +      S           
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCI 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPTDSTHMIRE 320
             I EA+ + H      V+HRD+K  N+LL+S  +    +L+DFGLAI    D       
Sbjct: 110 QQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF-- 164
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 165 GFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 181 QFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS 240
           + + +E+ +  S++S   ++   E+ +   L+ K+I    G   E+ ++ +  + +P GS
Sbjct: 49  RIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105
Query: 241 LEESLHGAGEQSVLPWG--------VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
           L   L          WG        + F     I E L YLH      ++HRD+K  N+L
Sbjct: 106 LSALLRSK-------WGPLKDNEQTIGFYTK-QILEGLKYLHD---NQIVHRDIKGDNVL 154
Query: 293 LSS-DFQPQLSDFG----LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDV 345
           +++     ++SDFG    LA   P   T        GT  Y+APE +  G        D+
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTET------FTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 346 YSFGVVLLELLSGRRPIGFKNLKGPES 372
           +S G  ++E+ +G+ P  F  L  P++
Sbjct: 209 WSLGCTIIEMATGKPP--FYELGEPQA 233

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 54  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+ V  E               +  +A+ + +L    SR
Sbjct: 112 EFCKFGNLSTYLRSKRNEFV-PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D   + + D      ++APE +     
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 340 SDKIDVYSFGVVLLELLS 357
           + + DV+SFGV+L E+ S
Sbjct: 228 TIQSDVWSFGVLLWEIFS 245

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 106
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 107 AQRF--FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G+ L EL S    +G     G     K+ K ++K G 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDSKFYK-MIKEGF 288
Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E+  A+M  ++     C +  P  RP   Q+++L+
Sbjct: 289 R------MLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 325

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH---GAGEQSVLPW 256
           +   E+ I   L  +++    G   E N   L  ++   G L + +    G  E    P 
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PD 105
Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
             RF     +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++  
Sbjct: 106 AQRF--FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 317 MIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRP 361
            +   + GT  Y+APE L   +  ++ +DV+S G+VL  +L+G  P
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 175 VSSRC------RQFSYE--ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED 226
           V  RC      +QF+ +  ++ + TS    +  D   E  I   L+   I  L      D
Sbjct: 41  VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 100
Query: 227 NYLILVSDFLPKGSL-EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
             L +V +F+    L  E +  A    V    V       I EAL Y H      +IHRD
Sbjct: 101 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRD 157
Query: 286 VKSSNILLSS--DFQP-QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           VK   +LL+S  +  P +L  FG+AI      + ++    VGT  ++APE +        
Sbjct: 158 VKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKP 215
Query: 343 IDVYSFGVVLLELLSGRRPI 362
           +DV+  GV+L  LLSG  P 
Sbjct: 216 VDVWGCGVILFILLSGCLPF 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 175 VSSRC------RQFSYE--ELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED 226
           V  RC      +QF+ +  ++ + TS    +  D   E  I   L+   I  L      D
Sbjct: 39  VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98
Query: 227 NYLILVSDFLPKGSL-EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
             L +V +F+    L  E +  A    V    V       I EAL Y H      +IHRD
Sbjct: 99  GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRD 155
Query: 286 VKSSNILLSS--DFQP-QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           VK   +LL+S  +  P +L  FG+AI      + ++    VGT  ++APE +        
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKP 213
Query: 343 IDVYSFGVVLLELLSGRRPI 362
           +DV+  GV+L  LLSG  P 
Sbjct: 214 VDVWGCGVILFILLSGCLPF 233

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++  +  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV---- 253
           +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L       +    
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 254 ---------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
                    + +         +A  + YL    S+  IHRD+ + N+L++ +   +++DF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 305 GLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           GLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 202 GLA--RDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 31/180 (17%)
Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           +D  SE+++   + + K+I  L G C +D  L ++  +  KG+L E L     ++  P G
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL-----RARRPPG 139
Query: 258 VRFEVAV------------------AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           + +   +                   +A  + YL    S+  IHRD+ + N+L++ +   
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVM 196
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +++DFGLA     ++    ++   G     ++APE L     + + DV+SFGV++ E+ +
Sbjct: 197 KIADFGLA--RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  LV D +  G L E +      S           
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCI 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPTDSTHMIRE 320
             I E++N+ H      ++HRD+K  N+LL+S  +    +L+DFGLAI    D       
Sbjct: 110 QQILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-- 164
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 165 GFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 9/107 (8%)
Query: 261 EVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
           EV + + E   AL +LH      +I+RD+K  NILL S+    L+DFGL+     D T  
Sbjct: 160 EVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 318 IREDVVGTFGYIAPEYLMHGKVS-DK-IDVYSFGVVLLELLSGRRPI 362
              D  GT  Y+AP+ +  G    DK +D +S GV++ ELL+G  P 
Sbjct: 217 AY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLP 237
           ++  Y  + +A  Q         SEV++   L+  +I       I+  +  L +V ++  
Sbjct: 37  KELDYGSMTEAEKQM------LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 238 KGSLEESL-HGAGEQSVLPWGVRFEVAVAIAEALNYLH--SECSRPVIHRDVKSSNILLS 294
            G L   +  G  E+  L       V   +  AL   H  S+    V+HRD+K +N+ L 
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
                +L DFGLA     D++    +  VGT  Y++PE +     ++K D++S G +L E
Sbjct: 151 GKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 355 L 355
           L
Sbjct: 209 L 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 25/150 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L L++ +   GSL + L      +V        + ++IA  L +LH E      +P I H
Sbjct: 81  LWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV-----VGTFGYIAPEYLMHGK 338
           RD+KS NIL+  + Q  ++D GLA+     +  +   DV     VGT  Y+APE L    
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETI 193
Query: 339 VSD------KIDVYSFGVVLLELLSGRRPI 362
             D      ++D+++FG+VL E+   RR +
Sbjct: 194 QVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 203 SEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ---------- 251
           SE+ + + L   ++I  L G C     + L+ ++   G L   L    E+          
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 252 ----------SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL 301
                     +VL +      A  +A+ + +L     +  +HRD+ + N+L++     ++
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 213
Query: 302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            DFGLA    +DS +++R +      ++APE L  G  + K DV+S+G++L E+ S
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 37/207 (17%)
Query: 181 QFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGS 240
           + + +E+ +  S++S   ++   E+ +   L+ K+I    G   E+ ++ +  + +P GS
Sbjct: 35  RIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 91
Query: 241 LEESLHGAGEQSVLPWG--------VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
           L   L          WG        + F     I E L YLH      ++HRD+K  N+L
Sbjct: 92  LSALLRSK-------WGPLKDNEQTIGFYTK-QILEGLKYLHD---NQIVHRDIKGDNVL 140
Query: 293 LSS-DFQPQLSDFG----LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDV 345
           +++     ++SDFG    LA   P   T        GT  Y+APE +  G        D+
Sbjct: 141 INTYSGVLKISDFGTSKRLAGINPCTET------FTGTLQYMAPEIIDKGPRGYGKAADI 194
Query: 346 YSFGVVLLELLSGRRPIGFKNLKGPES 372
           +S G  ++E+ +G+ P  F  L  P++
Sbjct: 195 WSLGCTIIEMATGKPP--FYELGEPQA 219

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 189
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 190 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 246 MWSLGVIMYILLCGYPPF 263

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 150
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 151 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 206
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 207 MWSLGVIMYILLCGYPPF 224

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 151
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 152 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 207
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 208 MWSLGVIMYILLCGYPPF 225

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 25/150 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L L++ +   GSL + L      +V        + ++IA  L +LH E      +P I H
Sbjct: 81  LWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV-----VGTFGYIAPEYLMHGK 338
           RD+KS NIL+  + Q  ++D GLA+     +  +   DV     VGT  Y+APE L    
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETI 193
Query: 339 VSD------KIDVYSFGVVLLELLSGRRPI 362
             D      ++D+++FG+VL E+   RR +
Sbjct: 194 QVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 32/182 (17%)
Query: 204 EVDITSSLE-QKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           E+ I + L   ++I  L  V   DN   + LV D++     E  LH     ++L    + 
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQ 112
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-----IWGPTDST 315
            V   + + + YLHS     ++HRD+K SNILL+++   +++DFGL+     I   T++ 
Sbjct: 113 YVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 316 HM--------------IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRR 360
            +              I  D V T  Y APE L+   K +  ID++S G +L E+L G +
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-K 228
Query: 361 PI 362
           PI
Sbjct: 229 PI 230

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEA 269
           SL   +I     V +   +L +V ++   G L E +  AG  S       F+  ++    
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---G 127
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           ++Y H+     V HRD+K  N LL     P+L       +  +   H   +  VGT  YI
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFG-YSKSSVLHSQPKSTVGTPAYI 183
Query: 330 APEYLMHGKVSDKI-DVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           APE L+  +   K+ DV+S GV L  +L G  P  F++ + P++  K    IL
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 195
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 196 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 251
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 252 MWSLGVIMYILLCGYPPF 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 170 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G+ L EL S    +G     G     K+ K ++K G 
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDSKFYK-MIKEGF 281
Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E+  A+M  ++     C +  P  RP   Q+++L+
Sbjct: 282 R------MLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 318

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 149
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 150 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 205
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 206 MWSLGVIMYILLCGYPPF 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 143
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 144 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 199
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 200 MWSLGVIMYILLCGYPPF 217

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T+ +    V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++    +  +D++S G ++ EL+      G    +G + + +W K I + G    
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVK-----GCVIFQGTDHIDQWNKVIEQLGTPSA 246
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 247 EFMAALQPTVRNYVEN 262

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 145
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 146 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 202 MWSLGVIMYILLCGYPPF 219

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLP 237
           ++  Y  + +A  Q         SEV++   L+  +I       I+  +  L +V ++  
Sbjct: 37  KELDYGSMTEAEKQM------LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 238 KGSLEESL-HGAGEQSVLPWGVRFEVAVAIAEALNYLH--SECSRPVIHRDVKSSNILLS 294
            G L   +  G  E+  L       V   +  AL   H  S+    V+HRD+K +N+ L 
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
                +L DFGLA     D++    +  VGT  Y++PE +     ++K D++S G +L E
Sbjct: 151 GKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 355 L 355
           L
Sbjct: 209 L 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 28/151 (18%)
Query: 226 DNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEALN 271
           +N + L+  F P  SLEE         L GA   +++         V+F +   I   L 
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLK 168
Query: 272 YLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAP 331
           Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y AP
Sbjct: 169 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAP 220
Query: 332 EYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
           E +   MH  ++  +D++S G ++ ELL+GR
Sbjct: 221 EIMLNWMHYNMT--VDIWSVGCIMAELLTGR 249

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 145
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 146 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 202 MWSLGVIMYILLCGYPPF 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HR++ + N +++ DF  ++ DFG+      
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMT--RDI 180
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 238
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P +RP   +++
Sbjct: 239 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 284 NLLKDDLHPS 293

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 144
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 145 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 200
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 201 MWSLGVIMYILLCGYPPF 218

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV- 258
           +F +E  +        +  L GV  +    ++V + +  G L+  L     ++    G  
Sbjct: 67  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 259 ------RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++   +  +HR++ + N +++ DF  ++ DFG+      
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMT--RDI 181
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI-GFKNLK 368
             T   R+   G     ++APE L  G  +   D++SFGVVL E+ S   +P  G  N  
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-- 239
Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             E ++K+            ++D    ++ DN   +R+     +C   +P +RP   +++
Sbjct: 240 --EQVLKF------------VMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIV 284
Query: 429 KLLRGATHAT 438
            LL+   H +
Sbjct: 285 NLLKDDLHPS 294

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS---INIAHRDVKP 159
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 160 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 215
Query: 345 VYSFGVVLLELLSGRRPI 362
           ++S GV++  LL G  P 
Sbjct: 216 MWSLGVIMYILLCGYPPF 233

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 154 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G+ L EL S    +G     G     K+ K ++K G 
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDSKFYK-MIKEGF 265
Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E+  A+M  ++     C +  P  RP   Q+++L+
Sbjct: 266 R------MLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 302

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 25/150 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L L++ +   GSL + L      +V        + ++IA  L +LH E      +P I H
Sbjct: 110 LWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIFGTQGKPAIAH 165
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV-----VGTFGYIAPEYLMHGK 338
           RD+KS NIL+  + Q  ++D GLA+     +  +   DV     VGT  Y+APE L    
Sbjct: 166 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETI 222
Query: 339 VSD------KIDVYSFGVVLLELLSGRRPI 362
             D      ++D+++FG+VL E+   RR +
Sbjct: 223 QVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 222 VCIEDNY---------LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNY 272
           VCI D Y         L+++ + +  G L   +   G+Q+        E+   I  A+ +
Sbjct: 66  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQF 124
Query: 273 LHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           LHS     + HRDVK  N+L +S   D   +L+DFG A     ++T    +    T  Y+
Sbjct: 125 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 177
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           APE L   K     D++S GV++  LL G  P 
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 172 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G+ L EL S    +G     G     K+ K ++K G 
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDSKFYK-MIKEGF 283
Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E+  A+M  ++     C +  P  RP   Q+++L+
Sbjct: 284 R------MLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 320

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    S+  IHRD+ + NILL+     ++ DFGLA     DS ++++ +    
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD 385
             ++APE + +   + + DV+S+G+ L EL S    +G     G     K+ K ++K G 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDSKFYK-MIKEGF 288
Query: 386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
                   LS E+  A+M  ++     C +  P  RP   Q+++L+
Sbjct: 289 R------MLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLI 325

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 13/183 (7%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLP 237
           ++  Y  + +A  Q         SEV++   L+  +I       I+  +  L +V ++  
Sbjct: 37  KELDYGSMTEAEKQM------LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 238 KGSLEESL-HGAGEQSVLPWGVRFEVAVAIAEALNYLH--SECSRPVIHRDVKSSNILLS 294
            G L   +  G  E+  L       V   +  AL   H  S+    V+HRD+K +N+ L 
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
                +L DFGLA     D      ++ VGT  Y++PE +     ++K D++S G +L E
Sbjct: 151 GKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 355 LLS 357
           L +
Sbjct: 209 LCA 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA---------- 248
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L  +          
Sbjct: 68  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 127
Query: 249 ---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHR++ + NIL+  ++  +++DFG
Sbjct: 128 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFG 184
Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           L     +    +  +  +G     ++A E L +   +   DV+S+GV+L E++S
Sbjct: 185 L-----SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 145
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYVATRWYRA 197
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK---GSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L   +I +L  V   +  L LV +F+ K     L+E+  G  +  +  +  + 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
              VA        H    R ++HRD+K  N+L++SD   +L+DFGLA  +G P  S TH 
Sbjct: 129 LRGVA--------HCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH- 178
Query: 318 IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
              +VV T  Y AP+ LM   K S  +D++S G +  E+++G+
Sbjct: 179 ---EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 145
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYVATRWYRA 197
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV------ 253
           DF  E  + +  +  +I  L GVC     + L+ +++  G L E L      +V      
Sbjct: 96  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 254 ---------------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
                          L    +  +A  +A  + YL     R  +HRD+ + N L+  +  
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 212
Query: 299 PQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL 356
            +++DFGL+  I+   D       D +    ++ PE + + + + + DV+++GVVL E+ 
Sbjct: 213 VKIADFGLSRNIYS-ADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 357 S 357
           S
Sbjct: 271 S 271

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 145
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYVATRWYRA 197
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 21/163 (12%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK---GSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L   +I +L  V   +  L LV +F+ K     L+E+  G  +  +  +  + 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
              VA        H    R ++HRD+K  N+L++SD   +L+DFGLA  +G P  S TH 
Sbjct: 129 LRGVA--------HCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 318 IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
                V T  Y AP+ LM   K S  +D++S G +  E+++G+
Sbjct: 180 -----VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 222 VCIEDNY---------LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNY 272
           VCI D Y         L+++ + +  G L   +   G+Q+        E+   I  A+ +
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQF 143
Query: 273 LHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           LHS     + HRDVK  N+L +S   D   +L+DFG A     ++T    +    T  Y+
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 196
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           APE L   K     D++S GV++  LL G  P 
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWG------VRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQILRGL 134
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L++ HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 56  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 113
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFE--------------VAVAIAEALNYLHSECSR 279
           +F   G+L   L     + V P+    E               +  +A+ + +L    SR
Sbjct: 114 EFCKFGNLSTYLRSKRNEFV-PYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 169
Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV 339
             IHRD+ + NILLS     ++ DFGLA     D  ++ + D      ++APE +     
Sbjct: 170 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 229
Query: 340 SDKIDVYSFGVVLLELLS 357
           + + DV+SFGV+L E+ S
Sbjct: 230 TIQSDVWSFGVLLWEIFS 247

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 218 TLNGVCIEDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVA 265
            L  V    N + L++ F P+ SLEE         L  A    V+   +  E    +   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T
Sbjct: 135 MLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVT 188
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
             Y APE ++     + +D++S G ++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 195 SSAWNDFS--SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS 252
           S A+ D S  +E+ +   ++ ++I TL  +     +  LV   +  G L +         
Sbjct: 45  SPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR-------- 96
Query: 253 VLPWGVRFE-----VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDF 304
           +L  GV  E     V   +  A+ YLH      ++HRD+K  N+L  +   + +  ++DF
Sbjct: 97  ILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           GL+        + I     GT GY+APE L     S  +D +S GV+   LL G  P 
Sbjct: 154 GLS----KMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L  +++  L  VC +     LV +F+    L++         + P G+ ++V 
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL-------ELFPNGLDYQVV 126
Query: 264 ----VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHM 317
                 I   + + HS     +IHRD+K  NIL+S     +L DFG A  +  P +    
Sbjct: 127 QKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 179
Query: 318 IREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSG 358
           + +D V T  Y APE L+   K    +DV++ G ++ E+  G
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 143
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRA 195
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 143
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRA 195
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    ++   A   + +P  +     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYL 112
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 167
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 149
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 150 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRA 201
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 176 SSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVS 233
           ++ CR  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ 
Sbjct: 55  TATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 112
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFEV-------------AVAIAEALNYLHSECSRP 280
           +F   G+L   L     + V P+    ++             +  +A+ + +L    SR 
Sbjct: 113 EFCKFGNLSTYLRSKRNEFV-PYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS 340
            IHRD+ + NILLS     ++ DFGLA     D   + + D      ++APE +     +
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 341 DKIDVYSFGVVLLELLS 357
            + DV+SFGV+L E+ S
Sbjct: 229 IQSDVWSFGVLLWEIFS 245

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 261 EVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDS 314
           + AV + + L+   YLH      ++HRD+K  N+LL S   D   ++ DFGL+       
Sbjct: 105 DAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 161
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
               R   +GT  YIAPE ++  K  +K DV+S GV+L  LL G  P G
Sbjct: 162 KMKER---LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFG 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 34/183 (18%)
Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH-- 246
           Q   ++ +AW +  + V   +++++KS             L +  ++   G+L + +H  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKST------------LFIQMEYCENGTLYDLIHSE 109
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
              +Q    W     +   I EAL+Y+HS+    +IHRD+K  NI +      ++ DFGL
Sbjct: 110 NLNQQRDEYW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 307 A--IWGPTDSTHMIREDV----------VGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLL 353
           A  +    D   +  +++          +GT  Y+A E L   G  ++KID+YS G++  
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 354 ELL 356
           E++
Sbjct: 223 EMI 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 140
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 192
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 145
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 197
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 144
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 196
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 150
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 202
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 150
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 202
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 144
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 196
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 150
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 202
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 149
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 150 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 201
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 140
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 192
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  L+ D +  G L E +      S        + +
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------EADAS 124
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAIWGPTDSTHMIRE 320
             I + L  +       V+HRD+K  N+LL+S  +    +L+DFGLAI    +       
Sbjct: 125 HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWF 182
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 183 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 143
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 195
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 137
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 138 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 189
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 113
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 114 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 168
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 169 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 111
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 166
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 148
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 149 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 200
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 144
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 196
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   S L   ++  L+    +DN ++++ +F+  G L E +  A E + +      E  
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYM 155
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS--DFGL-AIWGPTDSTHMIRE 320
             + + L ++H       +H D+K  NI+ ++    +L   DFGL A   P  S  +   
Sbjct: 156 RQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 209
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
              GT  + APE      V    D++S GV+   LLSG  P G +N
Sbjct: 210 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 140
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 192
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 112
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 167
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 111
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 166
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 110
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 165
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 143
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 195
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GXVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 116
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 117 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 171
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 172 V-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 110
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 165
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L++V + L  G L   +   G+Q+        E+  +I EA+ YLHS     + HRDVK 
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREAS-EIXKSIGEAIQYLHS---INIAHRDVKP 189
Query: 289 SNILLSSDFQP----QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
            N+L +S  +P    +L+DFG A      ++H        T  Y+APE L   K     D
Sbjct: 190 ENLLYTSK-RPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 345 VYSFGVVLLELLSGRRPI 362
            +S GV+   LL G  P 
Sbjct: 246 XWSLGVIXYILLCGYPPF 263

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 111
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 166
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 167 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 110
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 165
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 113
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 114 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 168
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 169 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 157
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 158 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 209
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 161
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 162 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 213
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 157
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 158 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 209
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 112
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 167
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 158
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 210
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 116
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 117 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 171
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 172 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 218 TLNGVCIEDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVA 265
            L  V    N + L++ F P+ SLEE         L  A    V+   +  E    +   
Sbjct: 75  VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVT 188
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
             Y APE ++     + +D++S G ++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 158
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 210
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 135
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 136 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 187
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 135
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 136 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 187
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 110
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 165
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 166 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           I EA+ YLH      ++HRD+K  N+L ++   D   +++DFGL+         ++ + V
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTV 210
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            GT GY APE L       ++D++S G++   LL G  P 
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 134
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 136
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 137 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 188
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 134
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 140
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----GYVATRWYRA 192
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE-ESLHGAGEQSVLPWGVRFEV 262
           E+ +   L   +I  L  V   +N L LV +FL   S++ +    A   + +P  +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 111
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED 321
              + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HE 166
Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           VV T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 167 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+   S L   ++  L+    +DN ++++ +F+  G L E +  A E + +      E  
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYM 261
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS--DFGL-AIWGPTDSTHMIRE 320
             + + L ++H       +H D+K  NI+ ++    +L   DFGL A   P  S  +   
Sbjct: 262 RQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 315
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
              GT  + APE      V    D++S GV+   LLSG  P G +N
Sbjct: 316 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 144
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----GYVATRWYRA 196
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE-ESLHGAGEQSVLPWGVRFEV 262
           E+ +   L   +I  L  V   +N L LV +FL   S++ +    A   + +P  +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 109
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED 321
              + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HE 164
Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           VV T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 16/104 (15%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDV- 322
           I EAL+Y+HS+    +IHRD+K  NI +      ++ DFGLA  +    D   +  +++ 
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 323 ---------VGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLLELL 356
                    +GT  Y+A E L   G  ++KID+YS G++  E++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV +FL +    +    A   + +P  +     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL--KDFMDASALTGIPLPLIKSYL 109
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 164
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 165 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E D+  + +++ IT L+    ++NYL LV ++   G L   L   GE+ +     RF
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARF 166
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +A  I  A++ +H       +HRD+K  NILL      +L+DFG  +    D T  +R 
Sbjct: 167 YLA-EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT--VRS 220
Query: 321 DV-VGTFGYIAPEYL-------MHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            V VGT  Y++PE L         G    + D ++ GV   E+  G+ P 
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 19/149 (12%)
Query: 223 CIEDNYLI-LVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVAIAEA 269
           C+    +I L++ F P+ SLEE         L  A    V+   +  E    +   +   
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG 138
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYR 192
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           APE ++     + +D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A  + +L S   R  IHRD+ + NILLS +   ++ DFGLA     +  ++ + D    
Sbjct: 208 VARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     S K DV+S+GV+L E+ S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 19/149 (12%)
Query: 223 CIEDNYLI-LVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVAIAEA 269
           C+    +I L++ F P+ SLEE         L  A    V+   +  E    +   +   
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG 138
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA---RTAGTSFMMTPYVVTRYYR 192
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           APE ++     + +D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA    TD         V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDE---MAGFVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 116/260 (44%), Gaps = 38/260 (14%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 85  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 138
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 139 NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 193
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 349 GVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLL 408
           G +L  +  G+ P  F+ +            I +      ++DP    E+ +   + +  
Sbjct: 254 GCILYYMTYGKTP--FQQI------------INQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 409 AANLCINQSPQLRPNMGQVL 428
               C+ + P+ R ++ ++L
Sbjct: 300 VLKCCLKRDPKQRISIPELL 319

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 261 EVAVAIAEALN---YLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDS 314
           + AV + + L+   YLH      ++HRD+K  N+LL S   D   ++ DFGL+       
Sbjct: 122 DAAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 178
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
               R   +GT  YIAPE ++  K  +K DV+S GV+L  LL G  P G
Sbjct: 179 KMKER---LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFG 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA    TD         V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDE---MAGFVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE-ESLHGAGEQSVLPWGVRFEV 262
           E+ +   L   +I  L  V   +N L LV +FL   S++ +    A   + +P  +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY 110
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED 321
              + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HE 165
Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           VV T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 166 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE-ESLHGAGEQSVLPWGVRFEV 262
           E+ +   L   +I  L  V   +N L LV +FL   S++ +    A   + +P  +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY 111
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRED 321
              + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HE 166
Query: 322 VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           VV T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 167 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 161
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA    TD         V T  Y A
Sbjct: 162 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDE---MXGYVATRWYRA 213
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMVPFVVTRYY 193
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            APE ++     + +D++S G ++ E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            APE ++     + +D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA      ++ M+  +VV  + Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPEVVTRY-Y 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            APE ++     + +D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            APE ++     + +D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            APE ++     + +D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTL-NGVCIEDNYLI 230
           +K++S R  +F+    ++A         +  +E++I   L    I  + N    ED Y++
Sbjct: 40  IKIISKR--KFAIGSAREADPAL-----NVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 92
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           L  + +  G L + + G          + F     +  A+ YLH      +IHRD+K  N
Sbjct: 93  L--ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAVQYLHE---NGIIHRDLKPEN 144
Query: 291 ILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKI 343
           +LLSS   D   +++DFG + I G T     +   + GT  Y+APE L+       +  +
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 344 DVYSFGVVLLELLSGRRPI 362
           D +S GV+L   LSG  P 
Sbjct: 201 DCWSLGVILFICLSGYPPF 219

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK--GSLEESLHGAGEQSVLPWGVRFE 261
           E+ +   L+ K+I  L+ V   D  L LV +F  +      +S +G  +  ++       
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----S 105
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRE 320
               + + L + HS   R V+HRD+K  N+L++ + + +L+DFGLA  +G     +    
Sbjct: 106 FLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE- 161
Query: 321 DVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
             V T  Y  P+ L   K+ S  ID++S G +  EL +  RP+
Sbjct: 162 --VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 134
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA    TD         V T  Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDE---MAGFVATRWYRA 186
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D    
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTL-NGVCIEDNYLI 230
           +K++S R  +F+    ++A         +  +E++I   L    I  + N    ED Y++
Sbjct: 39  IKIISKR--KFAIGSAREADPAL-----NVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 91
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           L  + +  G L + + G          + F     +  A+ YLH      +IHRD+K  N
Sbjct: 92  L--ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAVQYLHE---NGIIHRDLKPEN 143
Query: 291 ILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKI 343
           +LLSS   D   +++DFG + I G T     +   + GT  Y+APE L+       +  +
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 199
Query: 344 DVYSFGVVLLELLSGRRPI 362
           D +S GV+L   LSG  P 
Sbjct: 200 DCWSLGVILFICLSGYPPF 218

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D    
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTL-NGVCIEDNYLI 230
           +K++S R  +F+    ++A         +  +E++I   L    I  + N    ED Y++
Sbjct: 40  IKIISKR--KFAIGSAREADPAL-----NVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 92
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           L  + +  G L + + G          + F     +  A+ YLH      +IHRD+K  N
Sbjct: 93  L--ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAVQYLHE---NGIIHRDLKPEN 144
Query: 291 ILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKI 343
           +LLSS   D   +++DFG + I G T     +   + GT  Y+APE L+       +  +
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 344 DVYSFGVVLLELLSGRRPI 362
           D +S GV+L   LSG  P 
Sbjct: 201 DCWSLGVILFICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTL-NGVCIEDNYLI 230
           +K++S R  +F+    ++A         +  +E++I   L    I  + N    ED Y++
Sbjct: 40  IKIISKR--KFAIGSAREADPAL-----NVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 92
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           L  + +  G L + + G          + F     +  A+ YLH      +IHRD+K  N
Sbjct: 93  L--ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAVQYLHE---NGIIHRDLKPEN 144
Query: 291 ILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKI 343
           +LLSS   D   +++DFG + I G T     +   + GT  Y+APE L+       +  +
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 344 DVYSFGVVLLELLSGRRPI 362
           D +S GV+L   LSG  P 
Sbjct: 201 DCWSLGVILFICLSGYPPF 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 115/260 (44%), Gaps = 38/260 (14%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 85  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 138
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 139 NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 193
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 349 GVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLL 408
           G +L  +  G+ P              + + I +      ++DP    E+ +   + +  
Sbjct: 254 GCILYYMTYGKTP--------------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 409 AANLCINQSPQLRPNMGQVL 428
               C+ + P+ R ++ ++L
Sbjct: 300 VLKCCLKRDPKQRISIPELL 319

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 200 DFSSEVDITSSLEQKSITTL-NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +  +E++I   L    I  + N    ED Y++L  + +  G L + + G          +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL--ELMEGGELFDKVVGNKRLKEATCKL 243
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWGPTDS 314
            F     +  A+ YLH      +IHRD+K  N+LLSS   D   +++DFG + I G T  
Sbjct: 244 YF---YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 315 THMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPI 362
              +   + GT  Y+APE L+       +  +D +S GV+L   LSG  P 
Sbjct: 297 ---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ D+GLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTL-NGVCIEDNYLI 230
           +K++S R  +F+    ++A         +  +E++I   L    I  + N    ED Y++
Sbjct: 46  IKIISKR--KFAIGSAREADPAL-----NVETEIEILKKLNHPCIIKIKNFFDAEDYYIV 98
Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           L  + +  G L + + G          + F     +  A+ YLH      +IHRD+K  N
Sbjct: 99  L--ELMEGGELFDKVVGNKRLKEATCKLYF---YQMLLAVQYLHE---NGIIHRDLKPEN 150
Query: 291 ILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKI 343
           +LLSS   D   +++DFG + I G T     +   + GT  Y+APE L+       +  +
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 206
Query: 344 DVYSFGVVLLELLSGRRPI 362
           D +S GV+L   LSG  P 
Sbjct: 207 DCWSLGVILFICLSGYPPF 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 223 CI-EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVAIAEA 269
           C+   N + L++ F P+ +LEE         L  A    V+   +  E    +   +   
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG 138
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRYYR 192
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG----D 385
           APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCPE 247
Query: 386 TETLLDPKLSNEYDN 400
               L P + N  +N
Sbjct: 248 FMKKLQPTVRNYVEN 262

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/79 (40%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           HRDVK  NIL+S+D    L DFG+A    TD       + VGT  Y APE       + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 343 IDVYSFGVVLLELLSGRRP 361
            D+Y+   VL E L+G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D    
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 158
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA    TD         V T  Y A
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDE---MXGXVATRWYRA 210
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 200 DFSSEVDITSSLEQKSITTL-NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +  +E++I   L    I  + N    ED Y++L  + +  G L + + G          +
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL--ELMEGGELFDKVVGNKRLKEATCKL 257
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWGPTDS 314
            F     +  A+ YLH      +IHRD+K  N+LLSS   D   +++DFG + I G T  
Sbjct: 258 YF---YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 310
Query: 315 THMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPI 362
              +   + GT  Y+APE L+       +  +D +S GV+L   LSG  P 
Sbjct: 311 ---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D    
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 223 CI-EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVAIAEA 269
           C+   N + L++ F P+ +LEE         L  A    V+   +  E    +   +   
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG 131
Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRYYR 185
Query: 330 APEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG----D 385
           APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCPE 240
Query: 386 TETLLDPKLSNEYDN 400
               L P + N  +N
Sbjct: 241 FMKKLQPTVRNYVEN 255

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E  I   L+  +I  L+    E+ +  L+ D +  G L E +      S           
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCI 116
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPTDSTHMIRE 320
             I EA+ + H      V+HR++K  N+LL+S  +    +L+DFGLAI    +       
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWF 171
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              GT GY++PE L        +D+++ GV+L  LL G  P 
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 60  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 116
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 117 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 172
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 173 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 117
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 118 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 173
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 174 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 221

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 55  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 111
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 112 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 167
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 227 NYLILVSDFLPKGSLEE--------SLHGAGEQSVLPWGVRFE----VAVAIAEALNYLH 274
           N + L++ F P+ +LEE         L  A    V+   +  E    +   +   + +LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 275 SECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL 334
           S     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y APE +
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 335 MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG----DTETLL 390
           +     + +D++S G ++ E++  R  I F    G + + +W K I + G    +    L
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCPEFMKKL 252
Query: 391 DPKLSNEYDN 400
            P + N  +N
Sbjct: 253 QPTVRNYVEN 262

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 14/162 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L+ ++I  L  V   +N L LV +F+    L++ +      +  P G+   + 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNT-PRGLELNLV 110
Query: 264 V----AIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMI 318
                 + + L + H      ++HRD+K  N+L++   Q +L DFGLA  +G   +T   
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--F 165
Query: 319 REDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
             +VV T  Y AP+ LM  +  S  ID++S G +L E+++G+
Sbjct: 166 SSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L+  ++  L  V      L LV ++     L E       Q  +P  +   + 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSIT 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRED 321
               +A+N+ H       IHRDVK  NIL++     +L DFG A  + GP+D      +D
Sbjct: 109 WQTLQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----DD 161
Query: 322 VVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSG 358
            V T  Y +PE L+   +    +DV++ G V  ELLSG
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 229
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 284
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 285 EFMKKLQPTVRNYVEN 300

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 114
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 170
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 114
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 170
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 38  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 91
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 92  NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 146
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 349 GVVLLELLSGRRP 361
           G +L  +  G+ P
Sbjct: 207 GCILYYMTYGKTP 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 86  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 142
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 143 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 198
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 246

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 119
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+    
Sbjct: 120 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 175
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIE-DNYLILVSDFLP 237
           R  + + LK+  +   S      SE+ I   +    ++  L G C +    L+++ +F  
Sbjct: 58  RTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 238 KGSLEESLHGAGEQSVLPWGVRFE----------VAVAIAEALNYLHSECSRPVIHRDVK 287
            G+L   L     + V P+   ++           +  +A+ + +L    SR  IHRD+ 
Sbjct: 116 FGNLSTYLRSKRNEFV-PYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLA 171
Query: 288 SSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYS 347
           + NILLS     ++ DFGLA     D  ++ + D      ++APE +     + + DV+S
Sbjct: 172 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 231
Query: 348 FGVVLLELLS 357
           FGV+L E+ S
Sbjct: 232 FGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D    
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 57  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 110
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 111 NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 165
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 349 GVVLLELLSGRRP 361
           G +L  +  G+ P
Sbjct: 226 GCILYYMTYGKTP 238

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 78  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 138 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 187
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T +       + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 41  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 94
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 95  NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 149
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 150 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 209
Query: 349 GVVLLELLSGRRP 361
           G +L  +  G+ P
Sbjct: 210 GCILYYMTYGKTP 222

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 102 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 155
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T +       + GT  Y+APE ++    +  +D +
Sbjct: 156 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEYLAPEIILSKGYNKAVDWW 208
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 209 ALGVLIYEMAAGYPPF 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 246
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 247 EFMKKLQPTVRNYVEN 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 9/173 (5%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           S    F  E       +   I  L GV I +N + ++ +    G L   L     +  L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLD 489
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                  A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST
Sbjct: 490 LASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 545
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
           +           ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 77  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 137 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 186
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 246
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 247 EFMKKLQPTVRNYVEN 262

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  + E  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++  +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 229
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 284
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 285 EFMKKLQPTVRNYVEN 300

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 247
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 248 EFMKKLQPTVRNYVEN 263

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 96  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 155
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 156 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 205
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 206 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 16/168 (9%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 77  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTD 313
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA  ++    
Sbjct: 137 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEX 187
Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +   +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 188 XSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 76  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 136 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 185
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSV 253
           + F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + +
Sbjct: 68  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 127
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           + +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D
Sbjct: 128 IGFGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYD 177
Query: 314 STHMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 178 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 247
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 248 EFMKKLQPTVRNYVEN 263

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 135 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 184
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 190
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 245
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 246 EFMKKLQPTVRNYVEN 261

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 246
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 247 EFMKKLQPTVRNYVEN 262

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 78  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 138 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 187
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 246
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 247 EFMKKLQPTVRNYVEN 262

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 73  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 133 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 182
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPAFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 97  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 156
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +G++      +A+ + YL    S+  +HRD+ + N +L   F  +++DFGLA     D  
Sbjct: 157 FGLQ------VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKE 206
Query: 316 HMIREDVVGT---FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +    +  G      ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 207 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 37  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 90
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 91  NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 145
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 146 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 205
Query: 349 GVVLLELLSGRRP 361
           G +L  +  G+ P
Sbjct: 206 GCILYYMTYGKTP 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 185
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 240
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 241 EFMKKLQPTVRNYVEN 256

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D   + + D    
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++APE +     + + DV+SFGV+L E+ S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T
Sbjct: 132 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-----GYVAT 183
Query: 326 FGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
             Y APE +++    +  +D++S G ++ ELL G+
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 184
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 239
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 240 EFMKKLQPTVRNYVEN 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 109 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 162
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 163 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 216 ALGVLIYEMAAGYPPF 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 185
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG---- 384
            APE ++     + +D++S G ++ E++  R  I F    G + + +W K I + G    
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVIEQLGTPCP 240
Query: 385 DTETLLDPKLSNEYDN 400
           +    L P + N  +N
Sbjct: 241 EFMKKLQPTVRNYVEN 256

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 8/105 (7%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDV 322
           +   L Y+HS     VIHRD+K SN+L++ + + ++ DFG+A      P +  + + E  
Sbjct: 168 LLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE-Y 223
Query: 323 VGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           V T  Y APE ++   + +  ID++S G +  E+L+ R+    KN
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 268

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 79  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA   +    
Sbjct: 139 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEF 189
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 190 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 25  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 85  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 138
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 195
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 196 EADMWSIGVITYILLSGASPF 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DFGL      + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++  FGLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T
Sbjct: 140 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVAT 191
Query: 326 FGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
             Y APE +++    +  +D++S G ++ ELL G+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 175 VSSRCRQ------FSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           +  +CRQ      ++ + +K+   ++S+   +  +   EV+I   +   +I TL+ +   
Sbjct: 27  IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 86
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              ++L+ + +  G L + L    E+  L      +    I + ++YLHS   + + H D
Sbjct: 87  KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFD 140
Query: 286 VKSSNILLSSDFQP----QLSDFGLAIWGPTDSTHMIR-----EDVVGTFGYIAPEYLMH 336
           +K  NI+L     P    +L DFG+A        H I      +++ GT  ++APE + +
Sbjct: 141 LKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNIFGTPEFVAPEIVNY 192
Query: 337 GKVSDKIDVYSFGVVLLELLSGRRPI 362
             +  + D++S GV+   LLSG  P 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +   L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T
Sbjct: 140 LLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----GYVAT 191
Query: 326 FGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +++    +  +D++S G ++ ELL G+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK--GSLEESLHGAGEQSVLPWGVRFE 261
           E+ I   L+  +I  L  V      L+LV + L +    L +   G G +SV       +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +   IA    Y H    R V+HRD+K  N+L++ + + +++DFGLA            E 
Sbjct: 109 LLNGIA----YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 322 VVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSG 358
           V  T  Y AP+ LM   K S  ID++S G +  E+++G
Sbjct: 162 V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 137 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 190
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 191 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 244 ALGVLIYEMAAGYPPF 259

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 25  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 85  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 138
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 195
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 196 EADMWSIGVITYILLSGASPF 216

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 11/116 (9%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  + E  V T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMEPEVVTRYY 191
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG 384
            APE ++     + +D++S G ++ E++  +  I F    G + + +W K I + G
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK--ILF---PGRDYIDQWNKVIEQLG 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      Q++DFGLA  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLMIDQQGYIQVTDFGLAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/260 (21%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 85  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 138
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 139 NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 193
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D+T ++++  VG   Y+ PE +     S +            DV+S 
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 349 GVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLL 408
           G +L  +  G+ P              + + I +      ++DP    E+ +   + +  
Sbjct: 254 GCILYYMTYGKTP--------------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 409 AANLCINQSPQLRPNMGQVL 428
               C+ + P+ R ++ ++L
Sbjct: 300 VLKCCLKRDPKQRISIPELL 319

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 175 VSSRCRQ------FSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           +  +CRQ      ++ + +K+   ++S+   +  +   EV+I   +   +I TL+ +   
Sbjct: 20  IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              ++L+ + +  G L + L    E+  L      +    I + ++YLHS   + + H D
Sbjct: 80  KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFD 133
Query: 286 VKSSNILLSSDFQP----QLSDFGLAIWGPTDSTHMIR-----EDVVGTFGYIAPEYLMH 336
           +K  NI+L     P    +L DFG+A        H I      +++ GT  ++APE + +
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 337 GKVSDKIDVYSFGVVLLELLSGRRPI 362
             +  + D++S GV+   LLSG  P 
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK--GSLEESLHGAGEQSVLPWGVRFE 261
           E+ I   L+  +I  L  V      L+LV + L +    L +   G G +SV       +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +   IA    Y H    R V+HRD+K  N+L++ + + +++DFGLA            E 
Sbjct: 109 LLNGIA----YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 322 VVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSG 358
           V  T  Y AP+ LM   K S  ID++S G +  E+++G
Sbjct: 162 V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 8/105 (7%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDV 322
           +   L Y+HS     VIHRD+K SN+L++ + + ++ DFG+A      P +  + + E  
Sbjct: 167 LLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE-Y 222
Query: 323 VGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           V T  Y APE ++   + +  ID++S G +  E+L+ R+    KN
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 23/143 (16%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----SRPVI-H 283
           L L++D+   GSL + L    + + L      ++A +    L +LH+E      +P I H
Sbjct: 110 LYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV-----VGTFGYIAPEYL---- 334
           RD+KS NIL+  +    ++D GLA+   +D+  +   D+     VGT  Y+ PE L    
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESL 222
Query: 335 --MHGKVSDKIDVYSFGVVLLEL 355
              H +     D+YSFG++L E+
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEV 245

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK--GSLEESLHGAGEQSVLPWGVRFE 261
           E+ I   L+  +I  L  V      L+LV + L +    L +   G G +SV       +
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQ 108
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +   IA    Y H    R V+HRD+K  N+L++ + + +++DFGLA            E 
Sbjct: 109 LLNGIA----YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 322 VVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSG 358
           V  T  Y AP+ LM   K S  ID++S G +  E+++G
Sbjct: 162 V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPK--GSLEESLHGAGEQSVLPWGVRFE 261
           E+ +   L+ K+I  L+ V   D  L LV +F  +      +S +G  +  ++       
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----S 105
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIRE 320
               + + L + HS   R V+HRD+K  N+L++ + + +L++FGLA  +G     +    
Sbjct: 106 FLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE- 161
Query: 321 DVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
             V T  Y  P+ L   K+ S  ID++S G +  EL +  RP+
Sbjct: 162 --VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ DF LA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLI 114
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST     
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKAS 170
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 175 VSSRCR------QFSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           V  +CR      Q++ + +K+    +S+   +  D   EV I   ++  ++ TL+ V   
Sbjct: 26  VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              +IL+ + +  G L + L    E+  L      E    I   + YLHS     + H D
Sbjct: 86  KTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFD 139
Query: 286 VKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD 341
           +K  NI+L     P+    + DFGLA     D  +  + ++ GT  ++APE + +  +  
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK-NIFGTPEFVAPEIVNYEPLGL 196
Query: 342 KIDVYSFGVVLLELLSGRRPI 362
           + D++S GV+   LLSG  P 
Sbjct: 197 EADMWSIGVITYILLSGASPF 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 177 SRCRQFSYE--ELKQATSQFSSAWNDFSSEVDITSSLEQK-SITTLNGVCIEDNYLILVS 233
           S C++  ++   ++ A      +  D S E++I     Q  +I TL  V  +  ++ LV+
Sbjct: 41  SECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVT 100
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL- 292
           + +  G L + +     Q          V   I + + YLHS+    V+HRD+K SNIL 
Sbjct: 101 ELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILY 154
Query: 293 LSSDFQPQ---LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFG 349
           +     P+   + DFG A     ++  ++       F  +APE L      +  D++S G
Sbjct: 155 VDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDEGCDIWSLG 212
Query: 350 VVLLELLSGRRPIGFKNLKGPESLV 374
           ++L  +L+G  P        PE ++
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 177 SRCRQFSYE--ELKQATSQFSSAWNDFSSEVDITSSLEQK-SITTLNGVCIEDNYLILVS 233
           S C++  ++   ++ A      +  D S E++I     Q  +I TL  V  +  ++ LV+
Sbjct: 41  SECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVT 100
Query: 234 DFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL- 292
           + +  G L + +     Q          V   I + + YLHS+    V+HRD+K SNIL 
Sbjct: 101 ELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILY 154
Query: 293 LSSDFQPQ---LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFG 349
           +     P+   + DFG A     ++  ++       F  +APE L      +  D++S G
Sbjct: 155 VDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDEGCDIWSLG 212
Query: 350 VVLLELLSGRRPIGFKNLKGPESLV 374
           ++L  +L+G  P        PE ++
Sbjct: 213 ILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ D GLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 76  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 136 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 186
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 187 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 32/206 (15%)
Query: 175 VSSRCRQ------FSYEELKQ---ATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           +  +CRQ      ++ + +K+    +S+   +  +   EV+I   +   +I TL+ +   
Sbjct: 41  IVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 100
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              ++L+ + +  G L + L    E+  L      +    I + ++YLHS   + + H D
Sbjct: 101 KTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFD 154
Query: 286 VKSSNILLSSDFQP----QLSDFGLAIWGPTDSTHMIR-----EDVVGTFGYIAPEYLMH 336
           +K  NI+L     P    +L DFG+A        H I      +++ GT  ++APE + +
Sbjct: 155 LKPENIMLLDKNVPNPRIKLIDFGIA--------HKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 337 GKVSDKIDVYSFGVVLLELLSGRRPI 362
             +  + D++S GV+   LLSG  P 
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASPF 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 151 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 208 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 259
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 260 LVEIIK 265

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ D GLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 159 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 216 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 267
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 268 LVEIIK 273

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 214 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 265
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 266 LVEIIK 271

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 78  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 138 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 189 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 109 LYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 162
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 163 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 216 ALGVLIYEMAAGYPPF 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 11/151 (7%)
Query: 215 SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH 274
           +I  L+ V  +  +  LV + L  G L E +      S         +   +  A++++H
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSHMH 123
Query: 275 SECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAP 331
                 V+HRD+K  N+L +    + + ++ DFG A   P D+  +  +    T  Y AP
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178
Query: 332 EYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           E L      +  D++S GV+L  +LSG+ P 
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 161 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 218 VSYICSRY------YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 269
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 270 LVEIIK 275

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 79  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 139 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 189
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 190 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A         
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQ 206
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 207 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 264
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 265 QLVEIIK 271

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 78  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 138 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 188
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 189 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 83  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 142
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 143 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 193
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 194 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL----HGAGEQSVLP 255
           F +E  I       ++ +L G+C+  +   ++V  ++  G L   +    H    + ++ 
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPT 312
           +G++      +A+ + +L    S+  +HRD+ + N +L   F  +++DFGLA        
Sbjct: 197 FGLQ------VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DS H  +        ++A E L   K + K DV+SFGV+L EL++   P
Sbjct: 248 DSVHN-KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 202 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 259 VSYICSRY------YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 310
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 311 LVEIIK 316

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 16/104 (15%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDV- 322
           I EAL+Y+HS+    +IHR++K  NI +      ++ DFGLA  +    D   +  +++ 
Sbjct: 125 ILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 323 ---------VGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLLELL 356
                    +GT  Y+A E L   G  ++KID YS G++  E +
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 24/150 (16%)
Query: 225 EDNYLILVSDFLPKGSLEE--------SLHGAGEQSVLPW------GVRFEVAVAIAEAL 270
            +N + L+  F P  SLEE         L GA   +++         V+F +   I   L
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGL 138
Query: 271 NYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA 330
            Y+HS     +IHRD+K SN+ ++ D + ++ D GLA     + T       V T  Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-----GYVATRWYRA 190
Query: 331 PEYLMH-GKVSDKIDVYSFGVVLLELLSGR 359
           PE +++    +  +D++S G ++ ELL+GR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F  E       +   I  L GV I +N + ++ +    G L   L     +  L      
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLI 114
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  ++ AL YL S   +  +HRD+ + N+L+S+    +L DFGL+ +   DST+    
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKAS 170
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
                  ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-----AGEQSVL 254
           +F +E  +        +  L GV  +    +++ + + +G L+  L       A    + 
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 255 PWGV--RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           P  +    ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 178
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           S    F  E       +   I  L GV I +N + ++ +    G L   L     +  L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV--RKFSLD 489
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
                  A  ++ AL YL S   +  +HRD+ + N+L+S+    +L DFGL+ +   DST
Sbjct: 490 LASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDST 545
Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE-LLSGRRPI-GFKN 366
           +           ++APE +   + +   DV+ FGV + E L+ G +P  G KN
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLMIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 107/239 (44%), Gaps = 31/239 (12%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ----SVLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 59  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 173
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+ +   +P  ++ L  
Sbjct: 174 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN 231
Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            + L    + +++ G    LLD       DN     +L    +C   +P++RP+  +++
Sbjct: 232 EQVL----RFVMEGG----LLDKP-----DNCP-DMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 7/87 (8%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
           AL +LHS+    ++H DVK +NI L    + +L DFGL +   T     ++E   G   Y
Sbjct: 169 ALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRY 222
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLEL 355
           +APE L+ G      DV+S G+ +LE+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG-----AGEQSVL 254
           +F +E  +        +  L GV  +    +++ + + +G L+  L       A    + 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 255 PWGV--RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           P  +    ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 188
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV +   L+  +I TL+ +   +  L LV ++L K  L++ L   G  +++         
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFL 106
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             +   L Y H +    V+HRD+K  N+L++   + +L+DFGLA    +  T     +VV
Sbjct: 107 FQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVV 162
Query: 324 GTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
            T  Y  P+ L+     S +ID++  G +  E+ +GR
Sbjct: 163 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 128 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 185 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 236
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 237 LVEIIK 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 136 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 193 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 244
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 245 LVEIIK 250

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV + + +    ++   A   + +P  +     
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYL 108
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 109 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEV 163
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 164 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
           A+ Y H      ++HRD+K  N+LL  +   +++DFGL+    TD   +  +   G+  Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFL--KTSCGSPNY 173
Query: 329 IAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRP 361
            APE +++GK+    ++DV+S G+VL  +L GR P
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 196
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++  +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A         
Sbjct: 135 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQ 184
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 185 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 242
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 243 QLVEIIK 249

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 11/116 (9%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  T  +    V T  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 185
Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG 384
            APE ++     + +D++S G ++ E++  +  I F    G + + +W K I + G
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK--ILF---PGRDYIDQWNKVIEQLG 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A         
Sbjct: 131 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQ 180
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 181 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 238
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 239 QLVEIIK 245

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      +++DFGLA  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLMIDQQGYIKVTDFGLAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A         
Sbjct: 135 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQ 184
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 185 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 242
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 243 QLVEIIK 249

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 16/113 (14%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A++Y H      V+HRD+K  N+LL +    +++DFGL+          +R D  G+
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLR-DSCGS 173
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRPIG-------FKNLKG 369
             Y APE ++ G++    ++D++S GV+L  LL G  P         FK ++G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A         
Sbjct: 142 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQ 191
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 192 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 249
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 250 QLVEIIK 256

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 180 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 231
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 232 LVEIIK 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 200 DFSSEVDITSSLEQK-SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           D + E++I     Q  +I TL  V  +  Y+ +V++ +  G L + +     Q       
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSERE 117
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL-LSSDFQPQ---LSDFGLAIWGPTDS 314
              V   I + + YLH++    V+HRD+K SNIL +     P+   + DFG A     ++
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL- 373
             ++       F  +APE L         D++S GV+L  +L+G  P        PE + 
Sbjct: 175 GLLMTPCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 374 --VKWAKPILKNG------DTETLLDPKLSNEYDNAQMQRMLLAANLCI---NQSPQLRP 422
             +   K  L  G      DT   L  K+ +   + ++   L+  +  I   +Q PQ + 
Sbjct: 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292
Query: 423 NMGQVLKLLRGATHAT 438
           N      L++GA  AT
Sbjct: 293 NRQDAPHLVKGAMAAT 308

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I  ++    +T L     +++ L +V ++ P G +   L   G  S  P   RF  
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-Y 147
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRE 320
           A  I     YLHS     +I+RD+K  N+++      +++DFG A  + G T        
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------W 197
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + GT  Y+APE ++    +  +D ++ GV++ E+ +G  P 
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 24/193 (12%)
Query: 182 FSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKG 239
             Y  L++A +Q     + + +E+   + L+Q S  I  L    I D Y+ +V +    G
Sbjct: 57  IKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---G 110
Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
           +++ +     ++S+ PW  R      + EA++ +H      ++H D+K +N L+  D   
Sbjct: 111 NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 165
Query: 300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----------IDVYSF 348
           +L DFG+A     D   ++++  VGT  Y+ PE +     S +            DV+S 
Sbjct: 166 KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 349 GVVLLELLSGRRP 361
           G +L  +  G+ P
Sbjct: 226 GCILYYMTYGKTP 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG        +  
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQ 172
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 230
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 231 QLVEIIK 237

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I  ++    +T L     +++ L +V ++ P G +   L   G  S  P   RF  
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-Y 147
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRE 320
           A  I     YLHS     +I+RD+K  N+++      +++DFG A  + G T        
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------W 197
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + GT  Y+APE ++    +  +D ++ GV++ E+ +G  P 
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG        +  
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQ 172
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 230
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 231 QLVEIIK 237

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +   L   +I  L  V   +N L LV + + +    +    A   + +P  +     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDL--KKFMDASALTGIPLPLIKSYL 112
Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
             + + L + HS     V+HRD+K  N+L++++   +L+DFGLA  +G    T+    +V
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX--HEV 167
Query: 323 VGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGR 359
           V T  Y APE L+  K  S  +D++S G +  E+++ R
Sbjct: 168 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG        +  
Sbjct: 124 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQ 173
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 174 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 231
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 232 QLVEIIK 238

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG        +  
Sbjct: 127 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQ 176
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 177 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 234
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 235 QLVEIIK 241

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 137 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 190
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T +       + GT  Y+APE ++    +  +D +
Sbjct: 191 ENLLIDQQGYIQVTDFGFAKRVKGATWT-------LCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 244 ALGVLIYEMAAGYPPF 259

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 180 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 231
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 232 LVEIIK 237

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P+     + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLA---IWGPTD 313
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A   + G  +
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
            +++          Y APE +      +  IDV+S G VL ELL G +PI F    G + 
Sbjct: 180 VSYICSR------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVDQ 231
Query: 373 LVKWAK 378
           LV+  K
Sbjct: 232 LVEIIK 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 10/134 (7%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           ++LV++    G+L+  L       V    V       I + L +LH+  + P+IHRD+K 
Sbjct: 104 IVLVTELXTSGTLKTYLKRF---KVXKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKC 159
Query: 289 SNILLSS-DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYS 347
            NI ++      ++ D GLA    T       + V+GT  + APE     K  + +DVY+
Sbjct: 160 DNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYA 214
Query: 348 FGVVLLELLSGRRP 361
           FG   LE  +   P
Sbjct: 215 FGXCXLEXATSEYP 228

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ----SVLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 182
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 183 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
           YL LV D++P+     + H +  +  LP          +  +L Y+HS     + HRD+K
Sbjct: 93  YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIK 149
Query: 288 SSNILLSSDFQP-QLSDFGLAIWGPTDSTHMIRED----VVGTFGYIAPEYLMHGK-VSD 341
             N+LL  D    +L DFG        +  ++R +     + +  Y APE +      + 
Sbjct: 150 PQNLLLDPDTAVLKLCDFG-------SAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 202
Query: 342 KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
            IDV+S G VL ELL G +PI F    G + LV+  K
Sbjct: 203 SIDVWSAGCVLAELLLG-QPI-FPGDSGVDQLVEIIK 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLAGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVLEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 204 EVDITSSLEQKSITTL------NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
           E+ I   L+  +I  L      +G   ++ YL LV D++P      + H +  +  LP  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
                   +  +L Y+HS     + HRD+K  N+LL  D    +L DFG        +  
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQ 172
Query: 317 MIRED----VVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           ++R +     + +  Y APE +      +  IDV+S G VL ELL G +PI F    G +
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-FPGDSGVD 230
Query: 372 SLVKWAK 378
            LV+  K
Sbjct: 231 QLVEIIK 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLXGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 175
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 176 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS-----VL 254
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +      + 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 255 PWGV--RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           P  +    ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 179
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 180 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 117 LYMVMEYAPGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 170
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 224 ALGVLIYEMAAGYPPF 239

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + + YLH +    +IHRD+K SN+L+  D   +++DFG++       +  +  + VGT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS--NEFKGSDALLSNTVGT 200
Query: 326 FGYIAPEYLMHGK---VSDKIDVYSFGVVLLELLSGRRPI 362
             ++APE L   +       +DV++ GV L   + G+ P 
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + L Y+HS     V+HRD+K  N+ ++ D + ++ DFGLA     + T       V T
Sbjct: 153 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVT 204
Query: 326 FGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +   MH   +  +D++S G ++ E+L+G+
Sbjct: 205 RWYRAPEVILSWMH--YNQTVDIWSVGCIMAEMLTGK 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + L Y+HS     V+HRD+K  N+ ++ D + ++ DFGLA     + T       V T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVT 186
Query: 326 FGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGR 359
             Y APE +   MH   +  +D++S G ++ E+L+G+
Sbjct: 187 RWYRAPEVILSWMH--YNQTVDIWSVGCIMAEMLTGK 221

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 103 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 156
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 157 ENLLIDEQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 209
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 210 ALGVLIYEMAAGYPPF 225

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S L  ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 80  DFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 140 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 181
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+ +   +P  ++ L  
Sbjct: 182 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN 239
Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            + L    + +++ G    LLD       DN     +     +C   +P++RP+  +++
Sbjct: 240 EQVL----RFVMEGG----LLDKP-----DNCP-DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLAIW---------GPTDSTHMIREDVVGTFGYIAP 331
           VIHRD+K SN+L++S+   ++ DFGLA            PT     + E  V T  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE-YVATRWYRAP 191
Query: 332 EYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           E ++   K S  +DV+S G +L EL   RRPI
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 182
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+ +   +P  ++ L  
Sbjct: 183 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN 240
Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            + L    + +++ G    LLD       DN     +     +C   +P++RP+  +++
Sbjct: 241 EQVL----RFVMEGG----LLDKP-----DNCP-DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I  ++    +T L     +++ L +V ++ P G +   L   G         RF  
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-Y 147
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRE 320
           A  I     YLHS     +I+RD+K  N+++      +++DFG A  + G T        
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------W 197
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + GT  Y+APE ++    +  +D ++ GV++ E+ +G  P 
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   EV I   +   +I TL+ V      ++L+ + +  G L + L    ++  L     
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEA 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP----QLSDFGLAIWGPTDST 315
                 I + +NYLH+   + + H D+K  NI+L     P    +L DFGLA        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 316 HMIRE-----DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           H I +     ++ GT  ++APE + +  +  + D++S GV+   LLSG  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS-----VL 254
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +      + 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 255 PWGV--RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           P  +    ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 188
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N  ++ DF  ++ DFG+      
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMT--RDI 175
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+ +   +P  ++ L  
Sbjct: 176 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN 233
Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
            + L    + +++ G    LLD       DN     +L    +C   +P++RP+  +++
Sbjct: 234 EQVL----RFVMEGG----LLDKP-----DNCP-DMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 9/110 (8%)
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----FQPQLSDFGLAIW 309
           LP G+   +   I + ++YLH+     V+HRD+K +NIL+  +     + +++D G A  
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 310 GPTDSTHMIRED-VVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLS 357
             +    +   D VV TF Y APE L+  +   K ID+++ G +  ELL+
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F SE  I  +L+   I  L G+ IE+    ++ +  P G L   L        +   V +
Sbjct: 56  FMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 114
Query: 261 EVAVAIAEALNYLHS-ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             ++ I +A+ YL S  C    +HRD+   NIL++S    +L DFGL+ +   D  +   
Sbjct: 115 --SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKA 167
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI 362
                   +++PE +   + +   DV+ F V + E+LS G++P 
Sbjct: 168 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLAIW---------GPTDSTHMIREDVVGTFGYIAP 331
           VIHRD+K SN+L++S+   ++ DFGLA            PT     + E  V T  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE-XVATRWYRAP 191
Query: 332 EYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           E ++   K S  +DV+S G +L EL   RRPI
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS-----VL 254
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +      + 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 255 PWGV--RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
           P  +    ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 181
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 182 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F SE  I  +L+   I  L G+ IE+    ++ +  P G L   L        +   V +
Sbjct: 72  FMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 130
Query: 261 EVAVAIAEALNYLHS-ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             ++ I +A+ YL S  C    +HRD+   NIL++S    +L DFGL+ +   D  +   
Sbjct: 131 --SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKA 183
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI 362
                   +++PE +   + +   DV+ F V + E+LS G++P 
Sbjct: 184 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
           F SE  I  +L+   I  L G+ IE+    ++ +  P G L   L        +   V +
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 261 EVAVAIAEALNYLHS-ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             ++ I +A+ YL S  C    +HRD+   NIL++S    +L DFGL+ +   D  +   
Sbjct: 119 --SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKA 171
Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI 362
                   +++PE +   + +   DV+ F V + E+LS G++P 
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 12/92 (13%)
Query: 281 VIHRDVKSSNILLSSDFQPQLSDFGLAIW---------GPTDSTHMIREDVVGTFGYIAP 331
           VIHRD+K SN+L++S+   ++ DFGLA            PT     + E  V T  Y AP
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE-FVATRWYRAP 191
Query: 332 EYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           E ++   K S  +DV+S G +L EL   RRPI
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLP 255
           +F +E  +        +  L GV  +    +++ + + +G L+  L     +     VL 
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 256 ---WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL++      +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT--RDI 210
Query: 313 DSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             T   R+   G     +++PE L  G  +   DV+SFGVVL E+
Sbjct: 211 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S L  ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 94  DFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 154 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G +   P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIG-RFAEP-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 64/124 (51%), Gaps = 17/124 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A+ Y H      ++HRD+K  N+LL      +++DFGL+    TD   +  +   G+
Sbjct: 122 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFL--KTSCGS 175
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRR-------PIGFKNL-KGPESLVK 375
             Y APE ++ GK+    ++DV+S GV+L  +L  R        P+ FKN+  G  +L K
Sbjct: 176 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 234
Query: 376 WAKP 379
           +  P
Sbjct: 235 FLSP 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 16/113 (14%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A++Y H      V+HRD+K  N+LL +    +++DFGL+          +R    G+
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTS-CGS 173
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRPIG-------FKNLKG 369
             Y APE ++ G++    ++D++S GV+L  LL G  P         FK ++G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 64/124 (51%), Gaps = 17/124 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A+ Y H      ++HRD+K  N+LL      +++DFGL+    TD   +  +   G+
Sbjct: 121 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFL--KTSCGS 174
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRR-------PIGFKNL-KGPESLVK 375
             Y APE ++ GK+    ++DV+S GV+L  +L  R        P+ FKN+  G  +L K
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 233
Query: 376 WAKP 379
           +  P
Sbjct: 234 FLSP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 64/124 (51%), Gaps = 17/124 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A+ Y H      ++HRD+K  N+LL      +++DFGL+    TD   +  +   G+
Sbjct: 112 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL--KTSCGS 165
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRR-------PIGFKNL-KGPESLVK 375
             Y APE ++ GK+    ++DV+S GV+L  +L  R        P+ FKN+  G  +L K
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 224
Query: 376 WAKP 379
           +  P
Sbjct: 225 FLSP 228

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSD--FQPQLSDFGLA--IWGPTDSTHMIRED 321
           I  AL+YLH++    + HRD+K  N L S++  F+ +L DFGL+   +   +  +     
Sbjct: 177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 322 VVGTFGYIAPEYL--MHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             GT  ++APE L   +     K D +S GV+L  LL G  P 
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 35/200 (17%)
Query: 168 TELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN 227
           TE+ LK++    R +S                 F     + S L  K +    GVC+  +
Sbjct: 41  TEVLLKVLDKAHRNYS---------------ESFFEAASMMSKLSHKHLVLNYGVCVCGD 85
Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
             ILV +F+  GSL+  L        + W  + EVA  +A A+++L       +IH +V 
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT---LIHGNVC 140
Query: 288 SSNILLSSD-----FQP---QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK- 338
           + NILL  +       P   +LSD G++I      T + ++ +     ++ PE + + K 
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISI------TVLPKDILQERIPWVPPECIENPKN 194
Query: 339 VSDKIDVYSFGVVLLELLSG 358
           ++   D +SFG  L E+ SG
Sbjct: 195 LNLATDKWSFGTTLWEICSG 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 64/124 (51%), Gaps = 17/124 (13%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A+ Y H      ++HRD+K  N+LL      +++DFGL+    TD   +  +   G+
Sbjct: 116 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFL--KTSCGS 169
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRR-------PIGFKNL-KGPESLVK 375
             Y APE ++ GK+    ++DV+S GV+L  +L  R        P+ FKN+  G  +L K
Sbjct: 170 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK 228
Query: 376 WAKP 379
           +  P
Sbjct: 229 FLSP 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 269 ALNYLHSECSRPVIHRDVKSSNILLS-----SDFQPQLSDFGLA-IWGPTDSTHMIREDV 322
            L +LHS     ++HRD+K  NIL+S        +  +SDFGL         +   R  V
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 323 VGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAK 378
            GT G+IAPE L        +  +D++S G V   ++S G  P G       +SL + A 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-------KSLQRQAN 239
Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            +L     + L   K  +      +++M       I   PQ RP+   VLK
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKM-------IAMDPQKRPSAKHVLK 283

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 111 LYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 164
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 165 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 217
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 218 ALGVLIYEMAAGYPPF 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 35/178 (19%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL------EESLHGAGEQSV 253
           +   EV I   +   ++ TL+ V      ++L+ + +  G L      +ESL      S 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP----QLSDFGLAIW 309
           +           I + +NYLH+   + + H D+K  NI+L     P    +L DFGLA  
Sbjct: 121 IK---------QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-- 166
Query: 310 GPTDSTHMIRE-----DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
                 H I +     ++ GT  ++APE + +  +  + D++S GV+   LLSG  P 
Sbjct: 167 ------HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ ++ +G  P 
Sbjct: 223 ALGVLIYQMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      Q++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLIIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIISKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V ++ P G +   L   G         RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+++      +++DFG A  + G T         + GT  Y+APE ++    +  +D +
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 35/178 (19%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL------EESLHGAGEQSV 253
           +   EV I   +   ++ TL+ V      ++L+ + +  G L      +ESL      S 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP----QLSDFGLAIW 309
           +           I + +NYLH+   + + H D+K  NI+L     P    +L DFGLA  
Sbjct: 121 IK---------QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-- 166
Query: 310 GPTDSTHMIRE-----DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
                 H I +     ++ GT  ++APE + +  +  + D++S GV+   LLSG  P 
Sbjct: 167 ------HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 175 VSSRCRQ------FSYEELKQATSQFSS---AWNDFSSEVDITSSLEQKSITTLNGVCIE 225
           +  +CR+      ++ + +K+  S+ S    +  +   EV I   +   ++ TL+ V   
Sbjct: 27  IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86
Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
              ++L+ + +  G L + L    ++  L           I + +NYLH+   + + H D
Sbjct: 87  RTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFD 140
Query: 286 VKSSNILLSSDFQP----QLSDFGLAIWGPTDSTHMIRE-----DVVGTFGYIAPEYLMH 336
           +K  NI+L     P    +L DFGLA        H I +     ++ GT  ++APE + +
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLA--------HEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 337 GKVSDKIDVYSFGVVLLELLSGRRPI 362
             +  + D++S GV+   LLSG  P 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIRE 320
           A  I     YLHS     +I+RD+K  N+L+      Q++DFG A  + G T        
Sbjct: 168 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------W 217
Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + GT  Y+APE ++    +  +D ++ GV++ E+ +G  P 
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +  A+ YL     + +IHRD+K  NI+++ DF  +L DFG A +              GT
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFCGT 192
Query: 326 FGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
             Y APE LM       +++++S GV L  L+    P 
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 139 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL------EESLHGAGEQSV 253
           +   EV I   +   ++ TL+ V      ++L+ + +  G L      +ESL      S 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP----QLSDFGLAIW 309
           +           I + +NYLH+   + + H D+K  NI+L     P    +L DFGLA  
Sbjct: 121 IK---------QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-H 167
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              D      +++ GT  ++APE + +  +  + D++S GV+   LLSG  P 
Sbjct: 168 EIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 94  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 154 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 106 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 165
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 166 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 222
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 96  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 155
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 156 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 212
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   EV I   +   ++ TL+ V      ++L+ + +  G L + L    ++  L     
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEA 117
Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP----QLSDFGLAIWGPTDST 315
                 I + +NYLH+   + + H D+K  NI+L     P    +L DFGLA        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 316 HMIRE-----DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           H I +     ++ GT  ++APE + +  +  + D++S GV+   LLSG  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/95 (27%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + L Y+H+     +IHRD+K  N+ ++ D + ++ DFGLA    ++         V T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMX-----GXVVT 188
Query: 326 FGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGR 359
             Y APE +++  + +  +D++S G ++ E+++G+
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   ++Y H      V+HRD+K  N+LL +    +++DFGL+          +R    G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRXS-CGS 178
Query: 326 FGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRPI 362
             Y APE ++ G++    ++D++S GV+L  LL G  P 
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 80  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 140 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 86  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 145
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 146 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 202
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDF---QPQLSDFGLAIWGPTDSTHMIREDV 322
           I E + YLH      ++H D+K  NILLSS +     ++ DFG++          +RE +
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS--RKIGHACELRE-I 193
Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           +GT  Y+APE L +  ++   D+++ G++   LL+   P 
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 139 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 80  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 140 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR 196
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 71  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 130
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 131 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 187
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL-EESLH 246
           K+    F    + F  E++I  SL+  +I  L     ++  + LV +    G L E  +H
Sbjct: 40  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH 99
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQLSD 303
               + V        +   +  A+ Y H      V HRD+K  N L    S D   +L D
Sbjct: 100 ----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLID 152
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           FGLA         M+R   VGT  Y++P+ ++ G    + D +S GV++  LL G  P 
Sbjct: 153 FGLA--ARFKPGKMMRTK-VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL-EESLH 246
           K+    F    + F  E++I  SL+  +I  L     ++  + LV +    G L E  +H
Sbjct: 57  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH 116
Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQLSD 303
               + V        +   +  A+ Y H      V HRD+K  N L    S D   +L D
Sbjct: 117 ----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLID 169
Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
           FGLA         M+R   VGT  Y++P+ ++ G    + D +S GV++  LL G  P 
Sbjct: 170 FGLA--ARFKPGKMMRTK-VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT  Y+AP  ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPAIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 94  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 154 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
            S +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 35/200 (17%)
Query: 168 TELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN 227
           TE+ LK++    R +S                 F     + S L  K +    GVC   +
Sbjct: 41  TEVLLKVLDKAHRNYS---------------ESFFEAASMMSKLSHKHLVLNYGVCFCGD 85
Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK 287
             ILV +F+  GSL+  L        + W  + EVA  +A A+++L       +IH +V 
Sbjct: 86  ENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT---LIHGNVC 140
Query: 288 SSNILLSSD-----FQP---QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK- 338
           + NILL  +       P   +LSD G++I      T + ++ +     ++ PE + + K 
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISI------TVLPKDILQERIPWVPPECIENPKN 194
Query: 339 VSDKIDVYSFGVVLLELLSG 358
           ++   D +SFG  L E+ SG
Sbjct: 195 LNLATDKWSFGTTLWEICSG 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL-----EESLHGAGEQSVL 254
           +  +E+ + + L+  ++  L       N ++LV +++  G L     +ES +     ++L
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191
Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL-LSSDF-QPQLSDFGLAIWGPT 312
                      I E + ++H      ++H D+K  NIL ++ D  Q ++ DFGLA     
Sbjct: 192 -------FMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA----- 236
Query: 313 DSTHMIREDVVGTFG---YIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
              +  RE +   FG   ++APE + +  VS   D++S GV+   LLSG  P 
Sbjct: 237 -RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 200 DFSSEVDITSSLEQK-SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           D + E++I     Q  +I TL  V  +  Y+ +V++    G L + +     Q       
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSERE 117
Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL-LSSDFQPQ---LSDFGLAIWGPTDS 314
              V   I + + YLH++    V+HRD+K SNIL +     P+   + DFG A      +
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRA 172
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
            + +      T  ++APE L         D++S GV+L   L+G  P  F N  GP+
Sbjct: 173 ENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP--FAN--GPD 225

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+L+  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVLIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 97  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 156
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 157 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 213
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
              +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 10/165 (6%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I S    ++I    GV ++     ++ + +  G L+  L     +   P  + 
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 260 ----FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQLSDFGLAIWGPT 312
                 VA  IA    YL        IHRD+ + N LL+        ++ DFG+A     
Sbjct: 180 MLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
              +      +    ++ PE  M G  + K D +SFGV+L E+ S
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYL-----ILVSDFLPKGSLEESLHGAGEQSV- 253
           +F SE          ++  L GVCIE +       +++  F+  G L   L  +  ++  
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 254 --LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
             +P     +  V IA  + YL    +R  +HRD+ + N +L  D    ++DFGL+    
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS--KK 196
Query: 312 TDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLEL 355
             S    R+  +      +IA E L     + K DV++FGV + E+
Sbjct: 197 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 125 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 181 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 236
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 237 NYDQLVRIAKVL----GTEDLYD 255

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 125 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 181 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 236
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 237 NYDQLVRIAKVL----GTEDLYD 255

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 203 SEVDITSSLEQKSITTLNGVCIEDNY-LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           +E+ I + L    +  L+    ED Y ++L+ +FL  G L + +  A E          +
Sbjct: 97  NEISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRI--AAE----------D 143
Query: 262 VAVAIAEALNYLHSECS-------RPVIHRDVKSSNILLSSDFQP--QLSDFGLAIWGPT 312
             ++ AE +NY+   C          ++H D+K  NI+  +      ++ DFGLA     
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
           D    I +    T  + APE +    V    D+++ GV+   LLSG  P  
Sbjct: 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L +V +++  G +   L   G  S  P   RF  A  I     YLHS     +I+RD+K 
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSE-P-HARF-YAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 289 SNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVY 346
            N+L+      Q++DFG A  + G T         + GT   +APE ++    +  +D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 347 SFGVVLLELLSGRRPI 362
           + GV++ E+ +G  P 
Sbjct: 223 ALGVLIYEMAAGYPPF 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 44/197 (22%)
Query: 223 CIEDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPV 281
           C   N ++++   +L   S  + L+    Q V       E  + + +AL  +H      +
Sbjct: 88  CFRKNDHVVIAMPYLEHESFLDILNSLSFQEVR------EYMLNLFKALKRIHQ---FGI 138
Query: 282 IHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTHMI---------------------- 318
           +HRDVK SN L +   +   L DFGLA  G  D+   +                      
Sbjct: 139 VHRDVKPSNFLYNRRLKKYALVDFGLA-QGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 319 --REDVV---GTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
             R+ V    GT G+ APE L      +  ID++S GV+ L LLSGR P      K  + 
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF----YKASDD 253
Query: 373 LVKWAKPILKNGDTETL 389
           L   A+ +   G  ET+
Sbjct: 254 LTALAQIMTIRGSRETI 270

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI-WGPTDSTHMIREDVVGTF 326
           + L YLH      ++HRD+K +N+LL  +   +L+DFGLA  +G  +  +  +   V T 
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ---VVTR 176
Query: 327 GYIAPEYLMHGKVSD-KIDVYSFGVVLLELL 356
            Y APE L   ++    +D+++ G +L ELL
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 124 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 180 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 235
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 236 NYDQLVRIAKVL----GTEDLYD 254

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 131 QTLTDYDIRFYM-YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 186
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 187 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 242
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 243 NYDQLVRIAKVL----GTEDLYD 261

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q++  + +RF +   I +AL+Y HS     ++HRDVK  N+++  + +  +L D+GLA +
Sbjct: 126 QTLTDYDIRFYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  + P  F    
Sbjct: 182 YHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGHD 237
Query: 369 GPESLVKWAKPILKNGDTETLLD 391
             + LV+ AK +     TE L D
Sbjct: 238 NYDQLVRIAKVL----GTEDLYD 256

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 204 EVDITSSLEQKSITTLNGVCIED--------NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           E+ I   L+ +++  L  +C             + LV DF      E  L G     ++ 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK 121
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL--AIWGPTD 313
           + +  E+   +   LN L+      ++HRD+K++N+L++ D   +L+DFGL  A     +
Sbjct: 122 FTLS-EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
           S      + V T  Y  PE L+  +     ID++  G ++ E+ + R PI
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 58/119 (48%), Gaps = 26/119 (21%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS-------------DFQPQLSDFGLAIWGPT 312
           IA  + +LHS     +IHRD+K  NIL+S+             + +  +SDFGL      
Sbjct: 142 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC--KKL 196
Query: 313 DSTH-MIREDV---VGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLS-GRRPIG 363
           DS     R ++    GT G+ APE L      +++  ID++S G V   +LS G+ P G
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 58/119 (48%), Gaps = 26/119 (21%)
Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS-------------DFQPQLSDFGLAIWGPT 312
           IA  + +LHS     +IHRD+K  NIL+S+             + +  +SDFGL      
Sbjct: 142 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC--KKL 196
Query: 313 DSTH-MIREDV---VGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLS-GRRPIG 363
           DS     R ++    GT G+ APE L      +++  ID++S G V   +LS G+ P G
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIW 309
           Q +  + +RF +   + +AL+Y HS   + ++HRDVK  N+++    +  +L D+GLA +
Sbjct: 127 QILTDFDIRFYM-YELLKALDYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF 182
Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLK 368
                 + +R   V +  +  PE L+  ++ D  +D++S G +L  ++  R P  F    
Sbjct: 183 YHPAQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF-FHGQD 238
Query: 369 GPESLVKWAK 378
             + LV+ AK
Sbjct: 239 NYDQLVRIAK 248

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 204 EVDITSSLEQKSITTLNGVCIED--------NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           E+ I   L+ +++  L  +C             + LV DF      E  L G     ++ 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK 121
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL--AIWGPTD 313
           + +  E+   +   LN L+      ++HRD+K++N+L++ D   +L+DFGL  A     +
Sbjct: 122 FTLS-EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
           S      + V T  Y  PE L+  +     ID++  G ++ E+ + R PI
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 204 EVDITSSLEQKSITTLNGVCIED--------NYLILVSDFLPKGSLEESLHGAGEQSVLP 255
           E+ I   L+ +++  L  +C             + LV DF      E  L G     ++ 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK 120
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL--AIWGPTD 313
           + +  E+   +   LN L+      ++HRD+K++N+L++ D   +L+DFGL  A     +
Sbjct: 121 FTLS-EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 314 STHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
           S      + V T  Y  PE L+  +     ID++  G ++ E+ + R PI
Sbjct: 180 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 65/123 (52%), Gaps = 10/123 (8%)
Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTH 316
           +RF +   + +AL+Y HS   + ++HRDVK  N+++    +  +L D+GLA +      +
Sbjct: 139 IRFYM-YELLKALDYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY 194
Query: 317 MIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK 375
            +R   V +  +  PE L+  ++ D  +D++S G +L  ++  R P  F      + LV+
Sbjct: 195 NVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF-FHGQDNYDQLVR 250
Query: 376 WAK 378
            AK
Sbjct: 251 IAK 253

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDS 314
           + +R+ +   + +AL+Y HS+    ++HRDVK  N+++  + +  +L D+GLA +     
Sbjct: 146 YDIRYYI-YELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            + +R   V +  +  PE L+  +  D  +D++S G +   ++  + P  F      + L
Sbjct: 202 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQL 257
Query: 374 VKWAKPILKNGDTETL------LDPKL 394
           VK AK +  +G    L      LDP+L
Sbjct: 258 VKIAKVLGTDGLNAYLNKYRIELDPQL 284

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDS 314
           + +R+ +   + +AL+Y HS+    ++HRDVK  N+++  + +  +L D+GLA +     
Sbjct: 125 YDIRYYI-YELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            + +R   V +  +  PE L+  +  D  +D++S G +   ++  + P  F      + L
Sbjct: 181 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQL 236
Query: 374 VKWAKPILKNGDTETL------LDPKL 394
           VK AK +  +G    L      LDP+L
Sbjct: 237 VKIAKVLGTDGLNVYLNKYRIELDPQL 263

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL--AIWGPTDSTHMI 318
           E+   +   LN L+      ++HRD+K++N+L++ D   +L+DFGL  A     +S    
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 319 REDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPI 362
             + V T  Y  PE L+  +     ID++  G ++ E+ + R PI
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDS 314
           + +R+ +   + +AL+Y HS+    ++HRDVK  N+++  + +  +L D+GLA +     
Sbjct: 127 YDIRYYI-YELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            + +R   V +  +  PE L+  +  D  +D++S G +   ++  + P  F      + L
Sbjct: 183 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQL 238
Query: 374 VKWAKPILKNGDTETL------LDPKL 394
           VK AK +  +G    L      LDP+L
Sbjct: 239 VKIAKVLGTDGLNVYLNKYRIELDPQL 265

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 13/118 (11%)
Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG----LAIWGPTDSTHM 317
           + + I   L  +H+   +   HRD+K +NILL  + QP L D G      I        +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 318 IREDVVG---TFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG 369
             +D      T  Y APE      H  + ++ DV+S G VL  ++ G  P      KG
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDS 314
           + +R+ +   + +AL+Y HS+    ++HRDVK  N+++  + +  +L D+GLA +     
Sbjct: 126 YDIRYYI-YELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            + +R   V +  +  PE L+  +  D  +D++S G +   ++  + P  F      + L
Sbjct: 182 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQL 237
Query: 374 VKWAKPILKNGDTETL------LDPKL 394
           VK AK +  +G    L      LDP+L
Sbjct: 238 VKIAKVLGTDGLNVYLNKYRIELDPQL 264

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDS 314
           + +R+ +   + +AL+Y HS+    ++HRDVK  N+++  + +  +L D+GLA +     
Sbjct: 125 YDIRYYI-YELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            + +R   V +  +  PE L+  +  D  +D++S G +   ++  + P  F      + L
Sbjct: 181 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQL 236
Query: 374 VKWAKPILKNGDTETL------LDPKL 394
           VK AK +  +G    L      LDP+L
Sbjct: 237 VKIAKVLGTDGLNVYLNKYRIELDPQL 263
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	522
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-105
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-96
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-51
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-18
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-17
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  317 bits (815), Expect = e-105
 Identities = 98/308 (31%), Positives = 150/308 (48%), Gaps = 41/308 (13%)

Query: 180 RQFSYEELKQATSQFSSAWN------------------------------------DFSS 203
           ++FS  EL+ A+  FS+  N                                     F +
Sbjct: 18  KRFSLRELQVASDNFSNK-NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGE-QSVLPWGVRFEV 262
           EV++ S    +++  L G C+     +LV  ++  GS+   L    E Q  L W  R  +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           A+  A  L YLH  C   +IHRDVK++NILL  +F+  + DFGLA       TH +   V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAV 195

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES--LVKWAKPI 380
            GT G+IAPEYL  GK S+K DV+ +GV+LLEL++G+R      L   +   L+ W K +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW 440
           LK    E L+D  L   Y + ++++++  A LC   SP  RP M +V+++L G   A  W
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315

Query: 441 VDRHADDI 448
            +   +++
Sbjct: 316 EEWQKEEM 323

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  294 bits (756), Expect = 8e-97
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 51/304 (16%)

Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWND------------------------------- 200
           L++  +R   FS+ ELK  T+ F                                     
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA 64

Query: 201 ------------FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
                       F  E+ + +  + +++  L G   + + L LV  ++P GSL + L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAI 308
                L W +R ++A   A  +N+LH       IHRD+KS+NILL   F  ++SDFGLA 
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
                +  ++   +VGT  Y+APE  + G+++ K D+YSFGVVLLE+++G   +     +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238

Query: 369 GPESLVKWAKPILKNGDT-ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQV 427
            P+ L+   + I     T E  +D K+ N+ D+  ++ M   A+ C+++    RP++ +V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 428 LKLL 431
            +LL
Sbjct: 298 QQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  294 bits (755), Expect = 2e-96
 Identities = 92/299 (30%), Positives = 147/299 (49%), Gaps = 40/299 (13%)

Query: 174 LVSSRCRQFSYEELKQATSQFSSAW----------------------------------N 199
           LV     +    +L++AT+ F   +                                   
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV-LPWGV 258
           +F +E++  S      + +L G C E N +IL+  ++  G+L+  L+G+   ++ + W  
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT-DSTHM 317
           R E+ +  A  L+YLH+     +IHRDVKS NILL  +F P+++DFG++  G   D TH 
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH- 196

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
           +   V GT GYI PEY + G++++K DVYSFGVVL E+L  R  I     +   +L +WA
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH 436
                NG  E ++DP L+++     +++    A  C+  S + RP+MG VL  L  A  
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  189 bits (482), Expect = 4e-56
 Identities = 65/277 (23%), Positives = 107/277 (38%), Gaps = 33/277 (11%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY----LILVSDFLPKGSLEE 243
           K    Q   +W     EV     ++ ++I    G           L L++ F  KGSL +
Sbjct: 53  KIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111

Query: 244 SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-------PVIHRDVKSSNILLSSD 296
            L      +V+ W     +A  +A  L YLH +           + HRD+KS N+LL ++
Sbjct: 112 FLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

Query: 297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-----KVSDKIDVYSFGVV 351
               ++DFGLA+      +       VGT  Y+APE L            +ID+Y+ G+V
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 352 LLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETL--------LDPKLSNEYDNAQM 403
           L EL S             E ++ + + I ++   E +          P L + +     
Sbjct: 228 LWELASRCTAADGPV---DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284

Query: 404 QRMLLA-ANLCINQSPQLRPNMGQVLKLLRGATHATD 439
             ML      C +   + R + G V + +      T+
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  175 bits (446), Expect = 6e-51
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 22/234 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            F  E+   S +   +I  L G C+    + LV ++   GSL   LHGA           
Sbjct: 47  AFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA 104

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-PQLSDFGLAIWGPTDSTHMI 318
               +  ++ + YLHS   + +IHRD+K  N+LL +     ++ DFG A       THM 
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMT 161

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
                G+  ++APE       S+K DV+S+G++L E+++ R+P  F  + GP   + WA 
Sbjct: 162 NN--KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA- 216

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
            +           P L           M      C ++ P  RP+M +++K++ 
Sbjct: 217 -VHNG------TRPPLIKNLPKPIESLM----TRCWSKDPSQRPSMEEIVKIMT 259

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  171 bits (435), Expect = 2e-49
 Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 26/242 (10%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           +   N+F  EV I   L   +I    G   +   L +V+++L +GSL   LH +G +  L
Sbjct: 75  AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTD 313
               R  +A  +A+ +NYLH+  + P++HR++KS N+L+   +  ++ DFGL+ +   T 
Sbjct: 135 DERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            +        GT  ++APE L     ++K DVYSFGV+L EL + ++P  + NL      
Sbjct: 194 LSSK---SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP--WGNLNP---- 244

Query: 374 VKWAKPILKNGDTETL---LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
            +    +        +   L+P+++       ++        C    P  RP+   ++ L
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAA-----IIEG-------CWTNEPWKRPSFATIMDL 292

Query: 431 LR 432
           LR
Sbjct: 293 LR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  163 bits (414), Expect = 1e-46
 Identities = 72/258 (27%), Positives = 107/258 (41%), Gaps = 39/258 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
                   S    +   E  + + L+  +I  L GVC+++  L LV +F   G L   L 
Sbjct: 39  RHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS 98

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ------ 300
           G      +P  +    AV IA  +NYLH E   P+IHRD+KSSNIL+    +        
Sbjct: 99  G----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154

Query: 301 --LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             ++DFGLA  W  T           G + ++APE +     S   DV+S+GV+L ELL+
Sbjct: 155 LKITDFGLAREWHRTTKMSA-----AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209

Query: 358 GRRPIGFKNLKGPESLVKWAKPILKNGDTETL---LDPKLSNEYDNAQMQRMLLAANLCI 414
           G  P  F+ + G    +  A  +  N     +        +       M+        C 
Sbjct: 210 GEVP--FRGIDG----LAVAYGVAMNKLALPIPSTCPEPFAK-----LMED-------CW 251

Query: 415 NQSPQLRPNMGQVLKLLR 432
           N  P  RP+   +L  L 
Sbjct: 252 NPDPHSRPSFTNILDQLT 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  162 bits (413), Expect = 2e-46
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 36/254 (14%)

Query: 189 QATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA 248
           +  ++    + +F  EV I S+L   +I  L G+      +  V +F+P G L   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK 115

Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQPQLSD 303
                + W V+  + + IA  + Y+ +  + P++HRD++S NI L S         +++D
Sbjct: 116 AHP--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172

Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM--HGKVSDKIDVYSFGVVLLELLSGRRP 361
           FGL+       + +     +G F ++APE +       ++K D YSF ++L  +L+G  P
Sbjct: 173 FGLSQQSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETL---LDPKLSNEYDNAQMQRMLLAANLCINQSP 418
             F      +  +K+   I + G   T+     P+L N      ++        C +  P
Sbjct: 228 --FDEYSYGK--IKFINMIREEGLRPTIPEDCPPRLRN-----VIEL-------CWSGDP 271

Query: 419 QLRPNMGQVLKLLR 432
           + RP+   ++K L 
Sbjct: 272 KKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  156 bits (397), Expect = 3e-44
 Identities = 48/244 (19%), Positives = 91/244 (37%), Gaps = 39/244 (15%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF+ E          ++  + G C      +  L++ ++P GSL   LH  G   V+  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQ 110

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
               + A+ +A  + +LH+     +    + S ++++  D   ++S   +          
Sbjct: 111 SQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADV-------KFS 162

Query: 317 MIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
                 +    ++APE L            D++SF V+L EL++   P  F +L   E  
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--FADLSNMEIG 220

Query: 374 VKWAK-----PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
           +K A       I         + P +S       M+        C+N+ P  RP    ++
Sbjct: 221 MKVALEGLRPTIPPG------ISPHVSK-----LMKI-------CMNEDPAKRPKFDMIV 262

Query: 429 KLLR 432
            +L 
Sbjct: 263 PILE 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  149 bits (379), Expect = 2e-41
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 24/239 (10%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
             F +EV +       +I    G        I V+ +    SL   LH +  +       
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKK 121

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             ++A   A  ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S    
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178

Query: 319 REDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK 375
            E + G+  ++APE +        S + DVY+FG+VL EL++G+ P  + N+   + ++ 
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQII- 235

Query: 376 WAKPILKNGDTETLLDPKLSNEYDN--AQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
               + +       L P LS    N   +M+R++     C+ +    RP+  ++L  + 
Sbjct: 236 EM--VGRGS-----LSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRILAEIE 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  150 bits (380), Expect = 2e-41
 Identities = 55/269 (20%), Positives = 97/269 (36%), Gaps = 41/269 (15%)

Query: 199 NDFSSEVDI--TSSLEQKSITTLNGVCIEDNY-----LILVSDFLPKGSLEESLHGAGEQ 251
            +F +E +I     +E  +I                  +LV ++ P GSL + L      
Sbjct: 50  QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----L 105

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSE------CSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
               W     +A ++   L YLH+E          + HRD+ S N+L+ +D    +SDFG
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 306 LAIWGPTDSTHMIRED------VVGTFGYIAPEYLM-------HGKVSDKIDVYSFGVVL 352
           L++    +      E+       VGT  Y+APE L              ++D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 353 LELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD--------PKLSNEYDNAQMQ 404
            E+   R    F     PE  + +   +  +   E +          PK    +    + 
Sbjct: 226 WEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284

Query: 405 RMLLA--ANLCINQSPQLRPNMGQVLKLL 431
              L      C +Q  + R       + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERM 313

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  141 bits (358), Expect = 3e-38
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 17/187 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           +K+           F  EV +   LE  ++    GV  +D  L  +++++  G+L   + 
Sbjct: 40  MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK 99

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               Q   PW  R   A  IA  + YLHS     +IHRD+ S N L+  +    ++DFGL
Sbjct: 100 SMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGL 154

Query: 307 A------------IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
           A            +          R  VVG   ++APE +      +K+DV+SFG+VL E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214

Query: 355 LLSGRRP 361
           ++     
Sbjct: 215 IIGRVNA 221

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (352), Expect = 2e-37
 Identities = 47/248 (18%), Positives = 93/248 (37%), Gaps = 37/248 (14%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
             F  EV        +++    G C+   +L +++      +L   +  A     L    
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNK 131

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-----IWGPTD 313
             ++A  I + + YLH+   + ++H+D+KS N+    + +  ++DFGL      +     
Sbjct: 132 TRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKV---------SDKIDVYSFGVVLLELLSGRRPIGF 364
              +  +   G   ++APE +              S   DV++ G +  EL +   P  F
Sbjct: 188 EDKLRIQ--NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--F 243

Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
           K    P   + W   +         + P LS      ++  +LL    C     + RP  
Sbjct: 244 KTQ--PAEAIIWQ--MGTG------MKPNLSQIGMGKEISDILLF---CWAFEQEERPTF 290

Query: 425 GQVLKLLR 432
            +++ +L 
Sbjct: 291 TKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 3e-37
 Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 40/266 (15%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNY----LILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           E+  T  +  ++I       I+       L L++D+   GSL + L      + L     
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSM 136

Query: 260 FEVAVAIAEALNYLHSE-----CSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPT 312
            ++A +    L +LH+E         + HRD+KS NIL+  +    ++D GLA      T
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196

Query: 313 DSTHMIREDVVGTFGYIAPE------YLMHGKVSDKIDVYSFGVVLLELLSGRRPIG--- 363
           +   +     VGT  Y+ PE         H +     D+YSFG++L E+       G   
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 364 -----FKNLKGPE-SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---CI 414
                + +L   + S     + +         L P   N + + +  R +    L   C 
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKK-----LRPSFPNRWSSDECLRQM--GKLMTECW 309

Query: 415 NQSPQLRPNMGQVLKLLRGATHATDW 440
             +P  R    +V K L   + + D 
Sbjct: 310 AHNPASRLTALRVKKTLAKMSESQDI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  137 bits (346), Expect = 9e-37
 Identities = 60/264 (22%), Positives = 105/264 (39%), Gaps = 42/264 (15%)

Query: 199 NDFSSEVDI--TSSLEQKSITTLNGVCIEDNY----LILVSDFLPKGSLEESLHGAGEQS 252
             +  E ++  T  L  ++I       +   +    L L++ +   GSL + L      +
Sbjct: 45  KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LT 100

Query: 253 VLPWGVRFEVAVAIAEALNYLHSE-----CSRPVIHRDVKSSNILLSSDFQPQLSDFGLA 307
            L       + ++IA  L +LH E         + HRD+KS NIL+  + Q  ++D GLA
Sbjct: 101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

Query: 308 IWGPTDSTHMIRED--VVGTFGYIAPEYLMHGKVSD------KIDVYSFGVVLLELLSGR 359
           +     +  +   +   VGT  Y+APE L      D      ++D+++FG+VL E+    
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

Query: 360 RPIG--------FKNLKGPE-SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA 410
              G        F ++   + S     K +  +        P + N + +      L  A
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSL--A 273

Query: 411 NL---CINQSPQLRPNMGQVLKLL 431
            L   C  Q+P  R    ++ K L
Sbjct: 274 KLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (343), Expect = 5e-36
 Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 40/258 (15%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNY----LILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           E+  T  L  ++I        +DN     L LVSD+   GSL + L+    +  +     
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGM 141

Query: 260 FEVAVAIAEALNYLHSE-----CSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
            ++A++ A  L +LH E         + HRD+KS NIL+  +    ++D GLA+   + +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201

Query: 315 THMIRED--VVGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRPIG--- 363
             +       VGT  Y+APE L       H +   + D+Y+ G+V  E+       G   
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 364 -----FKNLKGPE-SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---CI 414
                + +L   + S+ +  K + +       L P + N + + +  R++  A +   C 
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVM--AKIMRECW 314

Query: 415 NQSPQLRPNMGQVLKLLR 432
             +   R    ++ K L 
Sbjct: 315 YANGAARLTALRIKKTLS 332

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (294), Expect = 2e-29
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 33/236 (13%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-------EQSVLP 255
            E+D+   L   ++       IEDN L +V +    G L   +           E++V  
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDST 315
           +       V +  AL ++HS   R V+HRD+K +N+ +++    +L D GL       S 
Sbjct: 141 Y------FVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG--RFFSSK 189

Query: 316 HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK-NLKGPESLV 374
                 +VGT  Y++PE +     + K D++S G +L E+ + + P  F  +     SL 
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLC 247

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
           K     ++  D   L     S E       R L+  N+CIN  P+ RP++  V  +
Sbjct: 248 K----KIEQCDYPPLPSDHYSEEL------RQLV--NMCINPDPEKRPDVTYVYDV 291

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 2e-27
 Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 31/262 (11%)

Query: 178 RCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP 237
               +  +E         S  +  S ++        K+            YL +      
Sbjct: 85  MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCR 144

Query: 238 KGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF 297
           K +L++ ++          GV   + + IAEA+ +LHS   + ++HRD+K SNI  + D 
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDD 201

Query: 298 QPQLSDFGLAIWGPTDS----------THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYS 347
             ++ DFGL      D            +      VGT  Y++PE +     S K+D++S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261

Query: 348 FGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRML 407
            G++L ELL              E +       ++N     L   K   E+        +
Sbjct: 262 LGLILFELLYSFST-------QMERVRIITD--VRNLKFPLLFTQKYPQEHM-------M 305

Query: 408 LAANLCINQSPQLRPNMGQVLK 429
           +     ++ SP  RP    +++
Sbjct: 306 V--QDMLSPSPTERPEATDIIE 325

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  110 bits (277), Expect = 7e-27
 Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 42/273 (15%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-----EQSVLPWG 257
            EV + ++++  +I        E+  L +V D+   G L + ++        E  +L W 
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW- 130

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
                 V I  AL ++H    R ++HRD+KS NI L+ D   QL DFG+A     +ST  
Sbjct: 131 -----FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIA--RVLNSTVE 180

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
           +    +GT  Y++PE   +   ++K D+++ G VL EL + +      ++K   +LV   
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVL-- 235

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA 437
              + +G       P +S  Y    ++ ++   +    ++P+ RP++  +L+        
Sbjct: 236 --KIISGSF-----PPVSLHYSY-DLRSLV---SQLFKRNPRDRPSVNSILEK------- 277

Query: 438 TDWVDRHADDILGSGIQFQEDD--DCQKFSSKP 468
             ++ +  +  L   +  +E       KF S+P
Sbjct: 278 -GFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQP 309

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  108 bits (271), Expect = 2e-26
 Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 28/235 (11%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCI----EDNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
            F  E ++   L+  +I                ++LV++ +  G+L+  L       V+ 
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMK 127

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPTDS 314
             V       I + L +LH+  + P+IHRD+K  NI ++      ++ D GLA    T  
Sbjct: 128 IKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLK 182

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
                + V+GT  ++APE     K  + +DVY+FG+ +LE+ +   P  +   +    + 
Sbjct: 183 RASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIY 239

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           +     + +G      D     E       + ++    CI Q+   R ++  +L 
Sbjct: 240 R----RVTSGVKPASFDKVAIPE------VKEII--EGCIRQNKDERYSIKDLLN 282

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  105 bits (265), Expect = 1e-25
 Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 43/249 (17%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDN------------YLILVSDFLPKGSLEESLHGAGE 250
            EV   + LE   I       +E N            YL +      K +L++ ++G   
Sbjct: 52  REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111

Query: 251 QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--- 307
                  V   + + IAEA+ +LHS   + ++HRD+K SNI  + D   ++ DFGL    
Sbjct: 112 IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168

Query: 308 -------IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR 360
                          +      VGT  Y++PE +     S K+D++S G++L ELL    
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---Y 225

Query: 361 PIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL 420
           P   +  +     +      ++N        P L  +      + +++     ++ SP  
Sbjct: 226 PFSTQMERV--RTLT----DVRNLKF-----PPLFTQKY--PCEYVMV--QDMLSPSPME 270

Query: 421 RPNMGQVLK 429
           RP    +++
Sbjct: 271 RPEAINIIE 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  105 bits (263), Expect = 1e-25
 Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 38/238 (15%)

Query: 212 EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-----EQSVLPWGVRFEVAVAI 266
                ++ N    +   L +  +F  KG+LE+ +         +   L           I
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL------FEQI 131

Query: 267 AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF 326
            + ++Y+HS   + +I+RD+K SNI L    Q ++ DFGL     +      R    GT 
Sbjct: 132 TKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGTL 185

Query: 327 GYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT 386
            Y++PE +       ++D+Y+ G++L ELL              E+   +          
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------AFETSKFFTD-------- 230

Query: 387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH 444
             L D  +S+ +D  + + +L      +++ P+ RPN  ++L+ L     + +  +RH
Sbjct: 231 --LRDGIISDIFDK-KEKTLL---QKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  104 bits (262), Expect = 3e-25
 Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 35/239 (14%)

Query: 203 SEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAG-------EQSV 253
           SEV++   L+  +I       I+  +  L +V ++   G L   +           E+ V
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113

Query: 254 LPWGVRFEVAVAIAEALNYLHS--ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
           L           +  AL   H   +    V+HRD+K +N+ L      +L DFGLA    
Sbjct: 114 LRV------MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA--RI 165

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
            +      +  VGT  Y++PE +     ++K D++S G +L EL +   P    + K   
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225

Query: 372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
             ++  K              ++   Y + ++  ++      +N     RP++ ++L+ 
Sbjct: 226 GKIREGKF------------RRIPYRYSD-ELNEII---TRMLNLKDYHRPSVEEILEN 268

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (252), Expect = 8e-24
 Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 42/246 (17%)

Query: 204 EVDITSSLEQKSITTLNGVCIED----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           E D+       +I  L   C+ +    +   L+  F  +G+L   +     + +   G  
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNF 130

Query: 260 FE------VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA----IW 309
                   + + I   L  +H+   +   HRD+K +NILL  + QP L D G      I 
Sbjct: 131 LTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187

Query: 310 GPTDSTHMIRED---VVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
                  +  +D      T  Y APE      H  + ++ DV+S G VL  ++ G  P  
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

Query: 364 FKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN 423
               KG +S+       ++N  +     P+             LL +   +   P  RP+
Sbjct: 248 MVFQKG-DSVAL----AVQNQLS----IPQSPRHSSAL---WQLLNS--MMTVDPHQRPH 293

Query: 424 MGQVLK 429
           +  +L 
Sbjct: 294 IPLLLS 299

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  101 bits (253), Expect = 1e-23
 Identities = 28/202 (13%), Positives = 56/202 (27%), Gaps = 26/202 (12%)

Query: 236 LPKGSLEESLHGAG----EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
                LE            +          +   +      L S   + ++H      N+
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNL 225

Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFG 349
            +  D +  L D        T               Y   E+L       +  ++ +  G
Sbjct: 226 FIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 350 VVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRML 407
           + +  +     P G   L  P     W +P L+   T++L     +   D  +  + R L
Sbjct: 281 LSIYRVWCLFLPFG---LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337

Query: 408 LAANLCINQSPQLRPNMGQVLK 429
                  N   + R    + ++
Sbjct: 338 -------NFDRRRRLLPLEAME 352

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  100 bits (250), Expect = 1e-23
 Identities = 41/138 (29%), Positives = 57/138 (41%), Gaps = 9/138 (6%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
            D  L +    +    L   L     Q  L       +   I  AL+  H+       HR
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHA---AGATHR 158

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLMHGKVSDKI 343
           DVK  NIL+S+D    L DFG+A    T    + +    VGT  Y+APE       + + 
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216

Query: 344 DVYSFGVVLLELLSGRRP 361
           D+Y+   VL E L+G  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 2e-23
 Identities = 34/131 (25%), Positives = 56/131 (42%), Gaps = 16/131 (12%)

Query: 231 LVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN 290
           +V +++   SL+ S         LP        + I  AL+YLHS     +++ D+K  N
Sbjct: 161 IVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPEN 212

Query: 291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
           I+L+ + Q +L D G       +S       + GT G+ APE +     +   D+Y+ G 
Sbjct: 213 IMLTEE-QLKLIDLGAV--SRINSFGY----LYGTPGFQAPEIVR-TGPTVATDIYTVGR 264

Query: 351 VLLELLSGRRP 361
            L  L      
Sbjct: 265 TLAALTLDLPT 275

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 22/164 (13%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV+I S L   +I  L G   +   + L+ ++ P G++   L             +F+  
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---------KFDEQ 109

Query: 264 VA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
                   +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG ++  P+     
Sbjct: 110 RTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            R D+ GT  Y+ PE +      +K+D++S GV+  E L G+ P
Sbjct: 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (253), Expect = 4e-23
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 42/241 (17%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               EV +   L+  +I  L     +     LV +    G L + +    + +       
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN------- 134

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWG 310
            EV  A     +   + YLH      ++HRD+K  N+LL S   D   ++ DFGL+ ++ 
Sbjct: 135 -EVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
                     + +GT  YIAPE L   K  +K DV+S GV+L  LL+G  P G +  +  
Sbjct: 191 NQKKMK----ERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVL 428
              V+  K    + +        +S     A+  +++ML           Q R +  Q L
Sbjct: 246 LRKVEKGKYTFDSPEW-----KNVSEG---AKDLIKQML-------QFDSQRRISAQQAL 290

Query: 429 K 429
           +
Sbjct: 291 E 291

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 26/195 (13%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK        A +DF  EV+   SL+ +++  L GV +     + V++  P GSL + L 
Sbjct: 54  LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR 112

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                 +L    R+  AV +AE + YL S   +  IHRD+ + N+LL++    ++ DFGL
Sbjct: 113 KHQGHFLLGTLSRY--AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL 167

Query: 307 A--IWGPTDSTHM-------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
              +    D   M                 + APE L     S   D + FGV L E+ +
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFA--------WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

Query: 358 -GRRPIGFKNLKGPE 371
            G+ P  +  L G +
Sbjct: 220 YGQEP--WIGLNGSQ 232

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 42/261 (16%)

Query: 180 RQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKG 239
            QF                 +  +E+ +  SL+  +I  L  V  +  Y  LV++F   G
Sbjct: 72  SQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG 131

Query: 240 SLEESLHGAGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLS 294
            L E +    +          E   A     I   + YLH      ++HRD+K  NILL 
Sbjct: 132 ELFEQIINRHKFD--------ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLE 180

Query: 295 S---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
           +       ++ DFGL+  +           D +GT  YIAPE L   K ++K DV+S GV
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLR----DRLGTAYYIAPEVL-KKKYNEKCDVWSCGV 235

Query: 351 VLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLL 408
           ++  LL G  P G +N +     V+  K      D        +S+E   A+  ++ ML 
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW-----KNISDE---AKELIKLML- 286

Query: 409 AANLCINQSPQLRPNMGQVLK 429
                       R    + L 
Sbjct: 287 ------TYDYNKRCTAEEALN 301

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 63/241 (26%), Positives = 110/241 (45%), Gaps = 21/241 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           ++   E+   S     +I +     +  + L LV   L  GS+ + +     +     GV
Sbjct: 58  DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117

Query: 259 RFEVAVAIA-----EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW---G 310
             E  +A       E L YLH       IHRDVK+ NILL  D   Q++DFG++ +   G
Sbjct: 118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKN-LK 368
              + + +R+  VGT  ++APE +   +  D K D++SFG+  +EL +G  P      +K
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234

Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
                ++   P L+ G  +  +  K    +      R +++  LC+ + P+ RP   ++L
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSF------RKMIS--LCLQKDPEKRPTAAELL 286

Query: 429 K 429
           +
Sbjct: 287 R 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 56/232 (24%), Positives = 84/232 (36%), Gaps = 39/232 (16%)

Query: 204 EVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG----EQSVLPWGV 258
           EV     + Q      L     E   L L ++     SL++     G    E  V  +  
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY-- 162

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHM 317
                     AL +LHS   + ++H DVK +NI L    + +L DFGL    G   +   
Sbjct: 163 ----LRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE- 214

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
                 G   Y+APE L+ G      DV+S G+ +LE+              P     W 
Sbjct: 215 ---VQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL--------PHGGEGWQ 262

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           +  L+ G         LS+E       R +L   + +   P+LR     +L 
Sbjct: 263 Q--LRQGYLPPEFTAGLSSEL------RSVLV--MMLEPDPKLRATAEALLA 304

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 42/241 (17%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               EV +   L+  +I  L     +  Y  LV +    G L + +      S       
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS------- 124

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWG 310
            EV  A     +   + Y+H      ++HRD+K  N+LL S   D   ++ DFGL+  + 
Sbjct: 125 -EVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
            +        D +GT  YIAPE L HG   +K DV+S GV+L  LLSG  P    N    
Sbjct: 181 ASKKMK----DKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVL 428
              V+  K   +          K+S     A+  +++ML          P +R +    L
Sbjct: 236 LKKVEKGKYTFELPQW-----KKVSES---AKDLIRKML-------TYVPSMRISARDAL 280

Query: 429 K 429
            
Sbjct: 281 D 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 12/178 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            ++           F  E  I       +I  L GVC +   + +V + +  G     L 
Sbjct: 147 CRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
             G +  +   ++       A  + YL S   +  IHRD+ + N L++     ++SDFG+
Sbjct: 205 TEGARLRVKTLLQM--VGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGM 259

Query: 307 AIWGPTDSTHMIREDVVGTFGY--IAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +               +        APE L +G+ S + DV+SFG++L E  S G  P
Sbjct: 260 SREEADGV--YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 45/191 (23%), Positives = 91/191 (47%), Gaps = 21/191 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L++ATS    A  +   E  + +S++   +  L G+C+     + ++  +P G L + + 
Sbjct: 52  LREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR 108

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
              +     + + +   V IA+ +NYL     R ++HRD+ + N+L+ +    +++DFGL
Sbjct: 109 EHKDNIGSQYLLNW--CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL 163

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           A     +      E      G +     A E ++H   + + DV+S+GV + EL++ G +
Sbjct: 164 AKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

Query: 361 PIGFKNLKGPE 371
           P  +  +   E
Sbjct: 219 P--YDGIPASE 227

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 22/164 (13%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E++I S L   +I  +     +   + L+ +F P+G L + L   G         RF+  
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---------RFDEQ 114

Query: 264 VA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
            +      +A+AL+Y H    R VIHRD+K  N+L+    + +++DFG ++  P+     
Sbjct: 115 RSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           +     GT  Y+ PE +      +K+D++  GV+  E L G  P
Sbjct: 172 M----CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 52/260 (20%), Positives = 95/260 (36%), Gaps = 60/260 (23%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDN-------------YLILVSDFLPKGSLEESLHGAG 249
           SEV + +SL  + +       +E                L +  ++   G+L + +H   
Sbjct: 51  SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110

Query: 250 EQSVLPWGVRFEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
                   +  +          I EAL+Y+HS   + +IHRD+K  NI +      ++ D
Sbjct: 111 --------LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159

Query: 304 FGLA------------IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD--KIDVYSFG 349
           FGLA                   +       +GT  Y+A E ++ G      KID+YS G
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLG 218

Query: 350 VVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLA 409
           ++  E++               +++K     L++   E    P   +       ++ ++ 
Sbjct: 219 IIFFEMIYP--FSTGMERV---NILK----KLRSVSIE--FPPDFDDNKMKV--EKKII- 264

Query: 410 ANLCINQSPQLRPNMGQVLK 429
             L I+  P  RP    +L 
Sbjct: 265 -RLLIDHDPNKRPGARTLLN 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.9 bits (237), Expect = 6e-22
 Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 25/168 (14%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDN---YLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +EV I   L+  SI  L     ED+   YL+L  +    G +   L    +         
Sbjct: 60  NEVKIHCQLKHPSILELYNY-FEDSNYVYLVL--EMCHNGEMNRYLKNRVK--------P 108

Query: 260 FEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
           F    A      I   + YLHS     ++HRD+  SN+LL+ +   +++DFGLA      
Sbjct: 109 FSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                   + GT  YI+PE         + DV+S G +   LL GR P
Sbjct: 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 7/137 (5%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
           ED+   LV +++   +L E +        L           I + + + H      ++HR
Sbjct: 82  EDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD---MRIVHR 135

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
           D+K  NIL+ S+   ++ DFG+A    ++++      V+GT  Y +PE        +  D
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194

Query: 345 VYSFGVVLLELLSGRRP 361
           +YS G+VL E+L G  P
Sbjct: 195 IYSIGIVLYEMLVGEPP 211

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.4 bits (243), Expect = 8e-22
 Identities = 62/241 (25%), Positives = 96/241 (39%), Gaps = 42/241 (17%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               EV++   L+  +I  L  +  + +   +V +    G L + +      S       
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------- 119

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWG 310
            E   A     +   + Y+H      ++HRD+K  NILL S   D   ++ DFGL+  + 
Sbjct: 120 -EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
                     D +GT  YIAPE L  G   +K DV+S GV+L  LLSG  P   KN    
Sbjct: 176 QNTKMK----DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVL 428
              V+  K               +S++   A+  +++ML          P LR    Q L
Sbjct: 231 LKRVETGKYAFDLPQW-----RTISDD---AKDLIRKML-------TFHPSLRITATQCL 275

Query: 429 K 429
           +
Sbjct: 276 E 276

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 4/113 (3%)

Query: 250 EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW 309
            +  +      EV     +ALN+ H      +IHRDVK +NI++S+    ++ DFG+A  
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165

Query: 310 GPTDSTHMIRED-VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                  + +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 20/169 (11%)

Query: 202 SSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
             E+   + L    I  L G   E  ++ +  + L  GSL + +           G   E
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--------QMGCLPE 149

Query: 262 VAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLA---IWGPT 312
                      E L YLH+     ++H DVK+ N+LLSSD  +  L DFG A        
Sbjct: 150 DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             + +  + + GT  ++APE +M      K+D++S   ++L +L+G  P
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 52/244 (21%), Positives = 101/244 (41%), Gaps = 39/244 (15%)

Query: 201 FSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           + +E+   + L+Q S  I  L    I D Y+ +V +      L   L    ++  +    
Sbjct: 54  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWE 109

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R      + EA++ +H      ++H D+K +N L+      +L DFG+A     D+T ++
Sbjct: 110 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVV 165

Query: 319 REDVVGTFGYIAPEYLM-----------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
           ++  VGT  Y+ PE +              K+S K DV+S G +L  +  G+ P  F+ +
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQI 223

Query: 368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMG 425
               S +      + + + E         +    Q  ++  L        + P+ R ++ 
Sbjct: 224 INQISKLH----AIIDPNHEIEFPDIPEKD---LQDVLKCCL-------KRDPKQRISIP 269

Query: 426 QVLK 429
           ++L 
Sbjct: 270 ELLA 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 36/253 (14%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ +        I    G    D  + +  + +  GSL++ L  AG    +P  +  +V+
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVS 137

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
           +A+ + L YL  +    ++HRDVK SNIL++S  + +L DFG++  G    +  +    V
Sbjct: 138 IAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 191

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN 383
           GT  Y++PE L     S + D++S G+ L+E+  GR PI   + K  E +          
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251

Query: 384 GDTETLLDPKLSNEYDNAQMQRM-----LLAA----------------------NLCINQ 416
                   P           +       LL                        N C+ +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311

Query: 417 SPQLRPNMGQVLK 429
           +P  R ++ Q++ 
Sbjct: 312 NPAERADLKQLMV 324

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 21/171 (12%), Positives = 51/171 (29%), Gaps = 33/171 (19%)

Query: 241 LEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ 300
            E  L  +     L    R ++ + +   L  LH      ++H  ++  +I+L       
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVF 246

Query: 301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----------GKVSDKIDVYSFG 349
           L+ F   +                + G+  PE                 ++   D ++ G
Sbjct: 247 LTGFEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 350 VVLLELLSGRRP--------IGFKNLKGPESLVKWAKPILKNGDTETLLDP 392
           +V+  +     P              +  +++ +  + +L+       L  
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEG-----FLRY 346

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 53/253 (20%), Positives = 102/253 (40%), Gaps = 57/253 (22%)

Query: 201 FSSEVDITSSLEQKS--ITTLNGVCIEDNYLILV--------SDFL-PKGSLEESLHGAG 249
           + +E+   + L+Q S  I  L    I D Y+ +V        + +L  K S++       
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE---- 128

Query: 250 EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW 309
                    +      + EA++ +H      ++H D+K +N L+      +L DFG+A  
Sbjct: 129 --------RKS-YWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQ 175

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLM-----------HGKVSDKIDVYSFGVVLLELLSG 358
              D+T ++++  VGT  Y+ PE +              K+S K DV+S G +L  +  G
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQ 416
           + P  F+ +    S +  A     + + E         +    Q  ++  L        +
Sbjct: 236 KTP--FQQIINQISKLH-AII---DPNHEIEFPDIPEKD---LQDVLKCCL-------KR 279

Query: 417 SPQLRPNMGQVLK 429
            P+ R ++ ++L 
Sbjct: 280 DPKQRISIPELLA 292

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.1 bits (236), Expect = 3e-21
 Identities = 18/129 (13%), Positives = 38/129 (29%), Gaps = 10/129 (7%)

Query: 239 GSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF 297
            +  E L         L    R ++ + +   L  LH      ++H  ++  +I+L    
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 248

Query: 298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL-----MHGKVSDKIDVYSFGVVL 352
              L+ F   +     S               A   L         ++   D ++ G+ +
Sbjct: 249 GVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 353 LELLSGRRP 361
             +     P
Sbjct: 308 YWIWCADLP 316

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 31/176 (17%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLS-----SDFQPQLSDFGLA-IWGPTDSTHMIR 319
               L +LHS     ++HRD+K  NIL+S        +  +SDFGL         +   R
Sbjct: 127 TTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 320 EDVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW 376
             V GT G+IAPE L        +  +D++S G V   ++S      F      ++ +  
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANIL- 241

Query: 377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---CINQSPQLRPNMGQVLK 429
               L     + L   K  +           +A  L    I   PQ RP+   VLK
Sbjct: 242 ----LGACSLDCLHPEKHEDV----------IARELIEKMIAMDPQKRPSAKHVLK 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 93.6 bits (233), Expect = 5e-21
 Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 15/166 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ I + ++ +   T  G+    + + ++ +++   S+ +                  + 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC-FIPIQ 151

Query: 264 VA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
           V       +  + +Y+H+E  + + HRDVK SNIL+  + + +LSDFG + +        
Sbjct: 152 VIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208

Query: 318 IREDVVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
                 GT+ ++ PE+  +    +  K+D++S G+ L  +     P
Sbjct: 209 ---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 95.2 bits (237), Expect = 5e-21
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 6/168 (3%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           +    +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q  +
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-V 315

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
              V   +A  I+ A+ YL     +  IHR++ + N L+  +   +++DFGL+    T  
Sbjct: 316 SAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGD 371

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           T+           + APE L + K S K DV++FGV+L E+ + G  P
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 31/180 (17%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           S + ++F  E      L    +    GVC ++  + +V++++  G L   L   G+    
Sbjct: 44  SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP 103

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
              +       + E + +L S      IHRD+ + N L+  D   ++SDFG+  +     
Sbjct: 104 SQLLEM--CYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----- 153

Query: 315 THMIREDVVGTFGYI------------APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
              + +D      Y+            APE   + K S K DV++FG+++ E+ S G+ P
Sbjct: 154 ---VLDDQ-----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 40/246 (16%), Positives = 81/246 (32%), Gaps = 23/246 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQS--VLPWGVRFE 261
            ++      Q          +  N  +LV +    G+L  +++        V+P G+   
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-----------QLSDFGLAIWG 310
            A+ +   +  +H      +IH D+K  N +L + F              L D G +I  
Sbjct: 177 FAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
                  I      T G+   E L +   + +ID +     +  +L G   +  KN  G 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGE 292

Query: 371 ESLVK-----WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
                         +        +L+    +   +  + R  L      + + ++R    
Sbjct: 293 CKPEGLFRRLPHLDMWNE-FFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351

Query: 426 QVLKLL 431
           +++ LL
Sbjct: 352 RLIVLL 357

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 31/180 (17%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           + +  DF  E ++   L    +  L GVC+E   + LV++F+  G L + L         
Sbjct: 44  AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA 103

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
              +     + + E + YL       VIHRD+ + N L+  +   ++SDFG+  +     
Sbjct: 104 ETLLGM--CLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----- 153

Query: 315 THMIREDVVGTFGYI------------APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
              + +D      Y             +PE     + S K DV+SFGV++ E+ S G+ P
Sbjct: 154 ---VLDDQ-----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 44/186 (23%), Positives = 91/186 (48%), Gaps = 11/186 (5%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L++ATS    A  +   E  + +S++   +  L G+C+     + ++  +P G L + + 
Sbjct: 52  LREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR 108

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
              +     + + +   V IA+ +NYL     R ++HRD+ + N+L+ +    +++DFGL
Sbjct: 109 EHKDNIGSQYLLNW--CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL 163

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFK 365
           A     +      E       ++A E ++H   + + DV+S+GV + EL++ G +P  + 
Sbjct: 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YD 221

Query: 366 NLKGPE 371
            +   E
Sbjct: 222 GIPASE 227

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 28/187 (14%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L +A     +    F     + S L  K +    GVC+  +  ILV +F+  GSL+  L 
Sbjct: 48  LDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK 104

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ------ 300
                  + W +  EVA  +A A+++L       +IH +V + NILL  +   +      
Sbjct: 105 KNKNCINILWKL--EVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF 159

Query: 301 --LSDFGLAIW-GPTDSTHM-IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLEL 355
             LSD G++I   P D     I         ++ PE + + K  +   D +SFG  L E+
Sbjct: 160 IKLSDPGISITVLPKDILQERIP--------WVPPECIENPKNLNLATDKWSFGTTLWEI 211

Query: 356 LS-GRRP 361
            S G +P
Sbjct: 212 CSGGDKP 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 58/183 (31%), Positives = 88/183 (48%), Gaps = 19/183 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEES 244
           LK  +    +   D   E++I  +L  ++I    G+C ED    + L+ +FLP GSL+E 
Sbjct: 58  LKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115

Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L     +  L   +++  AV I + ++YL S   R  +HRD+ + N+L+ S+ Q ++ DF
Sbjct: 116 LPKNKNKINLKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDF 170

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-G 358
           GL     TD  +      V           APE LM  K     DV+SFGV L ELL+  
Sbjct: 171 GLTKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 359 RRP 361
              
Sbjct: 227 DSD 229

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 7/168 (4%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           + +   F  E  +   L  + +  L  V  E+   I V++++ KGSL + L        L
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLK-GETGKYL 277

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+
Sbjct: 278 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDN 333

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +  R+       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 24/192 (12%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K  TS   S    F  E       +   I  L GV  E+   I + +    G L   L 
Sbjct: 51  CKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQ 107

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                  L   + +  A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL
Sbjct: 108 VRKYSLDLASLILY--AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL 162

Query: 307 AIWGPTDSTHMIREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GR 359
           + +       M                ++APE +   + +   DV+ FGV + E+L  G 
Sbjct: 163 SRY-------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215

Query: 360 RPIGFKNLKGPE 371
           +P  F+ +K  +
Sbjct: 216 KP--FQGVKNND 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 11/186 (5%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           ++  +     ++   +  +    SL+   I  L G+C   +  + V+ +LP GSL + + 
Sbjct: 50  IEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR 106

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                      + +   V IA+ + YL       ++HR++ + N+LL S  Q Q++DFG+
Sbjct: 107 QHRGALGPQLLLNW--GVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGV 161

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFK 365
           A   P D   ++  +      ++A E +  GK + + DV+S+GV + EL++ G  P  + 
Sbjct: 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YA 219

Query: 366 NLKGPE 371
            L+  E
Sbjct: 220 GLRLAE 225

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 11/174 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEES 244
           L+ +T        DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + 
Sbjct: 47  LQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103

Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L    E+      +++     I + + YL +   +  IHRD+ + NIL+ ++ + ++ DF
Sbjct: 104 LQKHKERIDHIKLLQY--TSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDF 158

Query: 305 GLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           GL    P D     ++E       + APE L   K S   DV+SFGVVL EL +
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 19/212 (8%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEES 244
           L+ +T        DF  E++I  SL+  +I    GVC       L L+ ++LP GSL + 
Sbjct: 78  LQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 134

Query: 245 LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
           L    E+      +++     I + + YL +   +  IHRD+ + NIL+ ++ + ++ DF
Sbjct: 135 LQKHKERIDHIKLLQY--TSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDF 189

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           GL    P D  +      V   G       APE L   K S   DV+SFGVVL EL +  
Sbjct: 190 GLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245

Query: 360 RPIGFKNLKGPESLVKWAKPILKNGDTETLLD 391
                   +    +    +  +       LL 
Sbjct: 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LKQ T +  +   +   E  I   L+   I  L GVC  +  ++ V +    G L + L 
Sbjct: 45  LKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLV 101

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G  E+  +           ++  + YL     +  +HRD+ + N+LL +    ++SDFGL
Sbjct: 102 GKREEIPVSNVAEL--LHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGL 156

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +     D +         + G       APE +   K S + DV+S+GV + E LS G++
Sbjct: 157 SKALGADDS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

Query: 361 PIGFKNLKGPE 371
           P  +K +KGPE
Sbjct: 213 P--YKKMKGPE 221

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 23/170 (13%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G    L    
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDC 290

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL            
Sbjct: 291 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT----------- 336

Query: 319 REDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           +E             + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 337 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 53/183 (28%), Positives = 73/183 (39%), Gaps = 19/183 (10%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
            + TS    +  D   E  I   L+   I  L      D  L +V +F+    L   +  
Sbjct: 60  AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119

Query: 248 AGEQSVLPWGVRFEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQ 298
             +      G  +  AVA      I EAL Y H      +IHRDVK   +LL+S      
Sbjct: 120 RADA-----GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAP 171

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +L  FG+AI              VGT  ++APE +        +DV+  GV+L  LLSG
Sbjct: 172 VKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

Query: 359 RRP 361
             P
Sbjct: 230 CLP 232

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 51/245 (20%), Positives = 97/245 (39%), Gaps = 41/245 (16%)

Query: 201 FSSEVDITSSLEQKS--ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           + +E+   + L+Q S  I  L    I D Y+ +V +      L   L        +    
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWE 156

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
           R      + EA++ +H      ++H D+K +N L+      +L DFG+A     D+T ++
Sbjct: 157 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVV 212

Query: 319 REDVVGTFGYIAPEYLM-----------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
           ++  VG   Y+ PE +              K+S K DV+S G +L  +  G+ P  F+ +
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQI 270

Query: 368 KGP-ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNM 424
                 L       + + + E         +    Q  ++  L        + P+ R ++
Sbjct: 271 INQISKLHA-----IIDPNHEIEFPDIPEKD---LQDVLKCCL-------KRDPKQRISI 315

Query: 425 GQVLK 429
            ++L 
Sbjct: 316 PELLA 320

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 25/172 (14%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    EV++   L+  +I  L  +  + +   +V +    G L + +      S      
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------ 119

Query: 259 RFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IW 309
             E   A     +   + Y+H      ++HRD+K  NILL S   D   ++ DFGL+  +
Sbjct: 120 --EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                      D +GT  YIAPE L  G   +K DV+S GV+L  LLSG  P
Sbjct: 175 QQNTKMK----DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 23/171 (13%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLI-LVSDFLPKGSLEESLHGAGEQSVLPWG 257
             F +E  + + L   ++  L GV +E+   + +V++++ KGSL + L  +  +SVL   
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGD 117

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
              + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL           
Sbjct: 118 CLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT---------- 164

Query: 318 IREDVVGTFG------YIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +E             + APE L   K S K DV+SFG++L E+ S GR P
Sbjct: 165 -KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 91.9 bits (228), Expect = 7e-20
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 20/191 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LKQ T +  +   +   E  I   L+   I  L GVC  +  ++ V +    G L + L 
Sbjct: 371 LKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFLV 427

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
           G  E+  +P     E+   ++  + YL     +  +HR++ + N+LL +    ++SDFGL
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +     D +         + G       APE +   K S + DV+S+GV + E LS G++
Sbjct: 483 SKALGADDS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

Query: 361 PIGFKNLKGPE 371
           P  +K +KGPE
Sbjct: 539 P--YKKMKGPE 547

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.5 bits (227), Expect = 8e-20
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 7/164 (4%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
             F  E  +   L  + +  L  V  E+   I V++++ KGSL + L        L    
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLK-GETGKYLRLPQ 364

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     D+ +  
Sbjct: 365 LVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTA 420

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           R+       + APE  ++G+ + K DV+SFG++L EL + GR P
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 66/266 (24%), Positives = 102/266 (38%), Gaps = 41/266 (15%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEESLHGAGEQSVLPW 256
            DF  E+ I  +L    I    GV        L LV ++LP G L + L     +     
Sbjct: 69  RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128

Query: 257 GVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH 316
            + +  +  I + + YL S   R  +HRD+ + NIL+ S+   +++DFGLA   P D  +
Sbjct: 129 LLLY--SSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

Query: 317 MIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGP 370
                VV   G       APE L     S + DV+SFGVVL EL +   +          
Sbjct: 184 Y----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEF 237

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQR-----------MLLAANLCINQSPQ 419
             ++   + +        LL+       +  ++             M     LC   SPQ
Sbjct: 238 LRMMGCERDVPALSRLLELLE-------EGQRLPAPPACPAEVHELMK----LCWAPSPQ 286

Query: 420 LRPNMGQVLKLLRGATHATDWVDRHA 445
            RP+   +   L      +   + HA
Sbjct: 287 DRPSFSALGPQLDMLWSGSRGCETHA 312

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 20/191 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK   +   +  ++  +E ++   L+   I  + G+C  +++++ V +    G L + L 
Sbjct: 52  LKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYLQ 109

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                  +      E+   ++  + YL  E     +HRD+ + N+LL +    ++SDFGL
Sbjct: 110 QNRH---VKDKNIIELVHQVSMGMKYL--E-ESNFVHRDLAARNVLLVTQHYAKISDFGL 163

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +     D           T G       APE + + K S K DV+SFGV++ E  S G++
Sbjct: 164 SKALRADEN----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

Query: 361 PIGFKNLKGPE 371
           P  ++ +KG E
Sbjct: 220 P--YRGMKGSE 228

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 27/195 (13%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK   +       DF SE  I    +  +I  L GV       ++V++++  GSL+  L 
Sbjct: 85  LKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               Q  +   V       +   + YL        +HRD+ + N+L+ S+   ++SDFGL
Sbjct: 143 THDGQFTIMQLVGM--LRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGL 197

Query: 307 A--IWGPTDSTHM-------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
           +  +    D+ +        IR        + APE +     S   DV+SFGVV+ E+L+
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIR--------WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

Query: 358 -GRRPIGFKNLKGPE 371
            G RP  + N+   +
Sbjct: 250 YGERP--YWNMTNRD 262

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 21/172 (12%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
               +E+++  SL+  +I  +  V  + + + +V +    G L E +  A  +       
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG----KA 120

Query: 259 RFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IW 309
             E  VA     +  AL Y HS   + V+H+D+K  NIL          ++ DFGLA ++
Sbjct: 121 LSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              + +     +  GT  Y+APE      V+ K D++S GVV+  LL+G  P
Sbjct: 178 KSDEHST----NAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 51/168 (30%), Positives = 93/168 (55%), Gaps = 7/168 (4%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           S +   F +E ++  +L+   +  L+ V  ++   I +++F+ KGSL + L  + E S  
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLK-SDEGSKQ 281

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
           P     + +  IAE + ++     R  IHRD++++NIL+S+    +++DFGLA     D+
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDN 337

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            +  RE       + APE +  G  + K DV+SFG++L+E+++ GR P
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 26/194 (13%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE---ES 244
           K+   + S        E+ +   L+ K+I    G   E+ ++ +  + +P GSL     S
Sbjct: 53  KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112

Query: 245 LHGAGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQ 298
             G  + +        E  +      I E L YLH      ++HRD+K  N+L+++    
Sbjct: 113 KWGPLKDN--------EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGV 161

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV--SDKIDVYSFGVVLLELL 356
            ++SDFG +        +   E   GT  Y+APE +  G        D++S G  ++E+ 
Sbjct: 162 LKISDFGTS--KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219

Query: 357 SGRRPIGFKNLKGP 370
           +G+ P  F  L  P
Sbjct: 220 TGKPP--FYELGEP 231

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 31/180 (17%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           S + ++F  E  +  +L  + +  L GVC +   + ++++++  G L   L     +   
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
              +       + EA+ YL S   +  +HRD+ + N L++     ++SDFGL+ +     
Sbjct: 120 QQLLEM--CKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY----- 169

Query: 315 THMIREDVVGTFGYI------------APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
              + +D      Y              PE LM+ K S K D+++FGV++ E+ S G+ P
Sbjct: 170 ---VLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 16/169 (9%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q  +   V
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVV 112

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D     
Sbjct: 113 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----- 164

Query: 319 REDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
                           APE L + K S K DV++FGV+L E+ + G  P
Sbjct: 165 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 24/196 (12%)

Query: 203 SEVDITSSLEQKSITTLNGVCIED---NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            E ++   L  K+I  L  +  E+    + +L+ +F P GSL   L        LP    
Sbjct: 56  REFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLAIWGPTDST 315
             V   +   +N+L       ++HR++K  NI+       Q    L+DFG A     D  
Sbjct: 115 LIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDE 170

Query: 316 HMIREDVVGTFGYIAPEYL--------MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
                 + GT  Y+ P+             K    +D++S GV      +G  P  F+  
Sbjct: 171 QF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPF 226

Query: 368 KGPESLVKWAKPILKN 383
           +GP    +    I+  
Sbjct: 227 EGPRRNKEVMYKIITG 242

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 26/193 (13%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K  TS   S    F  E       +   I  L GV  E+   I + +    G L   L 
Sbjct: 426 CKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQ 482

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                  L   + +  A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL
Sbjct: 483 VRKFSLDLASLILY--AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL 537

Query: 307 AIWGPTDSTHMIRED--VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-G 358
           + +        + +      + G +     APE +   + +   DV+ FGV + E+L  G
Sbjct: 538 SRY--------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589

Query: 359 RRPIGFKNLKGPE 371
            +P  F+ +K  +
Sbjct: 590 VKP--FQGVKNND 600

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 46/171 (26%), Positives = 68/171 (39%), Gaps = 23/171 (13%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           + F  E++I  SL+  +I  L     ++  + LV +    G L E +             
Sbjct: 51  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR------ 104

Query: 259 RFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWG 310
             E   A     +  A+ Y H      V HRD+K  N L  +   D   +L DFGLA   
Sbjct: 105 --ESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                       VGT  Y++P+ L  G    + D +S GV++  LL G  P
Sbjct: 160 KPGKMM---RTKVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPP 206

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 44/190 (23%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-------------LSDFGLA--IWG 310
           IA  + +LHS     +IHRD+K  NIL+S+  +               +SDFGL   +  
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLM-------HGKVSDKIDVYSFGVVLLELLS-GRRPI 362
              S      +  GT G+ APE L          +++  ID++S G V   +LS G+ P 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP- 239

Query: 363 GFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---CINQSPQ 419
            F +    ES +      L   + + L D  L  E           A +L    I+  P 
Sbjct: 240 -FGDKYSRESNIIRGIFSLD--EMKCLHDRSLIAE-----------ATDLISQMIDHDPL 285

Query: 420 LRPNMGQVLK 429
            RP   +VL+
Sbjct: 286 KRPTAMKVLR 295

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 26/193 (13%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K+  +        F SE  I  +L+   I  L G+  E+   I + +  P G L   L 
Sbjct: 48  CKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLE 104

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                  +   V +  ++ I +A+ YL S      +HRD+   NIL++S    +L DFGL
Sbjct: 105 RNKNSLKVLTLVLY--SLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGL 159

Query: 307 AIWGPTDSTHMIRED--VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-G 358
           + +        I ++     +   +     +PE +   + +   DV+ F V + E+LS G
Sbjct: 160 SRY--------IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211

Query: 359 RRPIGFKNLKGPE 371
           ++P  F  L+  +
Sbjct: 212 KQP--FFWLENKD 222

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 44/172 (25%), Positives = 86/172 (50%), Gaps = 23/172 (13%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           +AV+I +AL +LHS+    VIHRDVK SN+L+++  Q ++ DFG++  G      + ++ 
Sbjct: 114 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDD-VAKDI 168

Query: 322 VVGTFGYIAPEYLMHGKVSD----KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
             G   Y+APE +           K D++S G+ ++EL   R P  + +   P   +K  
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQ- 225

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
             +++         P+L  +  +A+        + C+ ++ + RP   ++++
Sbjct: 226 --VVEEP------SPQLPADKFSAEFVDFT---SQCLKKNSKERPTYPELMQ 266

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 17/181 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK   +       DF  E  I       +I  L GV  +   ++++++++  G+L++ L 
Sbjct: 81  LKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               +  +   V       IA  + YL +      +HRD+ + NIL++S+   ++SDFGL
Sbjct: 139 EKDGEFSVLQLVGM--LRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 193

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
           +     D           + G I     APE + + K +   DV+SFG+V+ E+++ G R
Sbjct: 194 SRVLEDDP----EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

Query: 361 P 361
           P
Sbjct: 250 P 250

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 57/187 (30%), Positives = 81/187 (43%), Gaps = 29/187 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNY--LILVSDFLPKGSLEES 244
           LK          + +  E+DI  +L  + I    G C +     L LV +++P GSL + 
Sbjct: 68  LKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125

Query: 245 L--HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
           L  H  G   +L +      A  I E + YLH+   +  IHRD+ + N+LL +D   ++ 
Sbjct: 126 LPRHSIGLAQLLLF------AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIG 176

Query: 303 DFGLAIWGPTDSTHMIRED--VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLEL 355
           DFGLA   P         +   V   G       APE L   K     DV+SFGV L EL
Sbjct: 177 DFGLAKAVPEG------HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

Query: 356 LS-GRRP 361
           L+     
Sbjct: 231 LTHCDSS 237

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 46/205 (22%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
              +EV +   L   +I  L  V  ++ Y+ LV +    G L + L+   + S     + 
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133

Query: 260 F--------------------------------EVAVA-----IAEALNYLHSECSRPVI 282
                                            E  ++     I  AL+YLH+   + + 
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGIC 190

Query: 283 HRDVKSSNILLSSD--FQPQLSDFGLAIW--GPTDSTHMIREDVVGTFGYIAPEYL--MH 336
           HRD+K  N L S++  F+ +L DFGL+       +  +       GT  ++APE L   +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP 361
                K D +S GV+L  LL G  P
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVP 275

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 87.7 bits (217), Expect = 7e-19
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 21/170 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           E+ ++      +I       I DN L +V+ F+  GS ++ L        +      E+A
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-----ELA 129

Query: 264 VA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW-----GPTD 313
           +A     + +AL+Y+H       +HR VK+S+IL+S D +  LS     +          
Sbjct: 130 IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKV--SDKIDVYSFGVVLLELLSGRRP 361
             H   +  V    +++PE L         K D+YS G+   EL +G  P
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 17/181 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK   +       DF  E  I    +  +I  L GV  +   +++V++++  GSL+  L 
Sbjct: 81  LKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               Q  +   V       IA  + YL        +HRD+ + NIL++S+   ++SDFGL
Sbjct: 139 KHDAQFTVIQLVGM--LRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193

Query: 307 AIWGPTDSTHMIREDVVGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GRR 360
                 D             G I     +PE + + K +   DV+S+G+VL E++S G R
Sbjct: 194 GRVLEDDP----EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

Query: 361 P 361
           P
Sbjct: 250 P 250

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 25/184 (13%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
           + ++S+   +  +   EV+I   +   +I TL+ +      ++L+ + +  G L + L  
Sbjct: 42  RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE 101

Query: 248 AGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-- 300
               +        E         I + ++YLHS   + + H D+K  NI+L     P   
Sbjct: 102 KESLT--------EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPR 150

Query: 301 --LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             L DFG+A      +       ++ GT  ++APE + +  +  + D++S GV+   LLS
Sbjct: 151 IKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

Query: 358 GRRP 361
           G  P
Sbjct: 207 GASP 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 21/170 (12%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E  I   L+  +I  L+    E+ +  L+ D +  G L E +      S       
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------- 108

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGP 311
            E   +     I EA+ + H      V+HR++K  N+LL+S       +L+DFGLAI   
Sbjct: 109 -EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +          GT GY++PE L        +D+++ GV+L  LL G  P
Sbjct: 165 GEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 42/248 (16%), Positives = 87/248 (35%), Gaps = 50/248 (20%)

Query: 204 EVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL-HGAGEQSVLPWGVRFE 261
           EV   + L Q   +        ED+++++ +++   GSL +++       S        +
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-------------------LS 302
           + + +   L Y+HS     ++H D+K SNI +S    P                    + 
Sbjct: 120 LLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRP 361
           D G      +           G   ++A E L        K D+++  + ++        
Sbjct: 177 DLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                   P +  +W +  ++ G     +   LS E        +L    + I+  P+ R
Sbjct: 231 --------PRNGDQWHE--IRQGRLPR-IPQVLSQE-----FTELL---KVMIHPDPERR 271

Query: 422 PNMGQVLK 429
           P+   ++K
Sbjct: 272 PSAMALVK 279

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 26/175 (14%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDN---YLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            E+ I  SL  + +   +G   EDN   +++L  +   + SL E                
Sbjct: 64  MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVL--ELCRRRSLLELHKRRK---------A 111

Query: 260 FEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                A      I     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D
Sbjct: 112 LTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
                ++ + GT  YIAPE L     S ++DV+S G ++  LL G+ P     LK
Sbjct: 169 GER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 26/168 (15%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDN---YLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            E+ I  SL  + +   +G   EDN   +++L  +   + SL E                
Sbjct: 90  MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVL--ELCRRRSLLELHKRRK---------A 137

Query: 260 FEVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                A      I     YLH      VIHRD+K  N+ L+ D + ++ DFGLA     D
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

Query: 314 STHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                ++ + GT  YIAPE L     S ++DV+S G ++  LL G+ P
Sbjct: 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 35/237 (14%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG--EQSVLP 255
             D   E+ + S  +   +T   G  ++D  L ++ ++L  GS  + L      E     
Sbjct: 64  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---- 119

Query: 256 WGVRFEVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                ++A  + E    L+YLHSE     IHRD+K++N+LLS   + +L+DFG+A  G  
Sbjct: 120 -----QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQL 169

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
             T + R   VGT  ++APE +       K D++S G+  +EL  G  P     L   + 
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP--HSELHPMKV 227

Query: 373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           L      I KN        P L   Y    ++  +     C+N+ P  RP   ++LK
Sbjct: 228 LFL----IPKNN------PPTLEGNYSKP-LKEFV---EACLNKEPSFRPTAKELLK 270

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 31/176 (17%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           + F +E ++   L+ + +  L  V  ++   I +++++  GSL + L        L    
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLK-TPSGIKLTINK 110

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA         +I
Sbjct: 111 LLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLA--------RLI 159

Query: 319 REDVVGTFGYI------------APEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
            ++      Y             APE + +G  + K DV+SFG++L E+++ GR P
Sbjct: 160 EDNE-----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 33/176 (18%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP----------KGSLEESLHGA 248
           +   +E+ +   ++ ++I TL  +     +  LV   +           +G   E     
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK---- 106

Query: 249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFG 305
            + S         V   +  A+ YLH      ++HRD+K  N+L  +   + +  ++DFG
Sbjct: 107 -DAS--------LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFG 154

Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           L+                GT GY+APE L     S  +D +S GV+   LL G  P
Sbjct: 155 LSKMEQNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 24/171 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E  I   L+  +I  L+    E+++  LV D +  G L E +      S       
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------- 103

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-IWG 310
            E   +     I E++ Y HS     ++HR++K  N+LL+S       +L+DFGLA    
Sbjct: 104 -EADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +++ H       GT GY++PE L     S  +D+++ GV+L  LL G  P
Sbjct: 160 DSEAWH----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 28/176 (15%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           + +A  +ALN+L       +IHRD+K SNILL      +L DFG++  G    + + +  
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDS-IAKTR 184

Query: 322 VVGTFGYIAPEYLMHGKVSD----KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL---- 373
             G   Y+APE +           + DV+S G+ L EL +GR P  +             
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQLTQV 242

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           VK   P L N +     + + S           +   NLC+ +    RP   ++LK
Sbjct: 243 VKGDPPQLSNSE-----EREFSPS-----FINFV---NLCLTKDESKRPKYKELLK 285

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 49/235 (20%), Positives = 85/235 (36%), Gaps = 24/235 (10%)

Query: 203 SEVDITSSLEQKSITTLNGVCIED---NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            E ++   L  K+I  L  +  E+    + +L+ +F P GSL   L        LP    
Sbjct: 56  REFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLAIWGPTDST 315
             V   +   +N+L       ++HR++K  NI+       Q    L+DFG A     D  
Sbjct: 115 LIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDE 170

Query: 316 HMIREDVVGTFGYIAPEYL--------MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL 367
                 + GT  Y+ P+             K    +D++S GV      +G  P  F+  
Sbjct: 171 QF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPF 226

Query: 368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP 422
           +GP    +    I+    +  +   + +          M ++ +L       L P
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 24/171 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E+ I +    ++I  L+        L+++ +F+    + E         +      
Sbjct: 47  LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER--------INTSAFE 98

Query: 260 F-EVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLA-IWG 310
             E  +      + EAL +LHS     + H D++  NI+  +     +   +FG A    
Sbjct: 99  LNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           P D+       +     Y APE   H  VS   D++S G ++  LLSG  P
Sbjct: 156 PGDNFR----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 28/176 (15%)

Query: 199 NDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
                EVDI   +    +I  L      + +  LV D + KG L + L      S     
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS----- 122

Query: 258 VRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGP 311
              E         + E +  LH      ++HRD+K  NILL  D   +L+DFG +    P
Sbjct: 123 ---EKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSD------KIDVYSFGVVLLELLSGRRP 361
            +       +V GT  Y+APE +      +      ++D++S GV++  LL+G  P
Sbjct: 177 GEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 11/179 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI-EDNYLILVSDFLPKGSLEESL 245
           L + T         F  E  +   L   ++  L G+ +  +    ++  ++  G L + +
Sbjct: 57  LSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                   +   + F   + +A  + YL     +  +HRD+ + N +L   F  +++DFG
Sbjct: 115 RSPQRNPTVKDLISF--GLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFG 169

Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           LA        + +++         + A E L   + + K DV+SFGV+L ELL+ G  P
Sbjct: 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.5 bits (207), Expect = 8e-18
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 22/171 (12%)

Query: 200 DFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +   E+          +I  L+ V  +  +  LV + L  G L E +      S      
Sbjct: 51  NTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS------ 104

Query: 259 RFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWG 310
             E   +     +  A++++H      V+HRD+K  N+L +    + + ++ DFG A   
Sbjct: 105 --ETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           P D+  +  +    T  Y APE L      +  D++S GV+L  +LSG+ P
Sbjct: 160 PPDNQPL--KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 26/173 (15%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
               +E+ +   L   +I  L  +      + LV + +  G L + +   G         
Sbjct: 93  KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--------- 143

Query: 259 RF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA-I 308
            +      +    I EA+ YLH      ++HRD+K  N+L ++   D   +++DFGL+ I
Sbjct: 144 YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200

Query: 309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                        V GT GY APE L       ++D++S G++   LL G  P
Sbjct: 201 VEHQVLMK----TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 33/230 (14%)

Query: 215 SITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH 274
           + +             L+   L KG L E L     +  L      ++      A+ ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 275 SECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDST-----HMIREDV--VG 324
                P+IHRD+K  N+LLS+    +L DFG A      P  S       ++ E++    
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 325 TFGYIAPE---YLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           T  Y  PE      +  + +K D+++ G +L  L   + P  F++     + ++    I+
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FED----GAKLR----IV 262

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            NG             + +  ++ ML         +P+ R ++ +V+  L
Sbjct: 263 -NGKYSIPPHDTQYTVFHSL-IRAML-------QVNPEERLSIAEVVHQL 303

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 25/184 (13%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
           +   S+   +  +   EV I   +   ++ TL+ V      ++L+ + +  G L + L  
Sbjct: 49  QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ 108

Query: 248 AGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-- 300
               S        E         I + +NYLH+   + + H D+K  NI+L     P   
Sbjct: 109 KESLS--------EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157

Query: 301 --LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             L DFGLA              ++ GT  ++APE + +  +  + D++S GV+   LLS
Sbjct: 158 IKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

Query: 358 GRRP 361
           G  P
Sbjct: 214 GASP 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 24/171 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E  I   L+  +I  L+    E+++  LV D +  G L E +      S       
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------- 126

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAI-WG 310
            E   +     I E++ Y HS     ++HR++K  N+LL+S       +L+DFGLAI   
Sbjct: 127 -EADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +++ H       GT GY++PE L     S  +D+++ GV+L  LL G  P
Sbjct: 183 DSEAWH----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           I  A+ +LHS     + HRDVK  N+L +S   D   +L+DFG A     ++        
Sbjct: 137 IGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TP 189

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             T  Y+APE L   K     D++S GV++  LL G  P
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 31/177 (17%)

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
           + VAI +AL YL  +    VIHRDVK SNILL    Q +L DFG++  G        ++ 
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDD-KAKDR 183

Query: 322 VVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPIGFKNLKGPESL--- 373
             G   Y+APE +     +      + DV+S G+ L+EL +G+ P  +KN K    +   
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVLTK 241

Query: 374 -VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            ++   P+L             S +      Q  +     C+ +  + RP   ++L+
Sbjct: 242 VLQEEPPLLPG-------HMGFSGD-----FQSFV---KDCLTKDHRKRPKYNKLLE 283

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 25/184 (13%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
           +  +S+   +  D   EV I   ++  ++ TL+ V      +IL+ + +  G L + L  
Sbjct: 48  RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE 107

Query: 248 AGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-- 300
               +        E         I   + YLHS     + H D+K  NI+L     P+  
Sbjct: 108 KESLT--------EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPR 156

Query: 301 --LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             + DFGLA      +       ++ GT  ++APE + +  +  + D++S GV+   LLS
Sbjct: 157 IKIIDFGLAHKIDFGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

Query: 358 GRRP 361
           G  P
Sbjct: 213 GASP 216

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 36/197 (18%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK  T     A  DF  E ++ ++L+ + I    GVC + + LI+V +++  G L + L 
Sbjct: 53  LKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLR 109

Query: 247 GAGEQSVLPWGVRFE-------------VAVAIAEALNYLHSECSRPVIHRDVKSSNILL 293
             G  +++    +               +A  IA  + YL S   +  +HRD+ + N L+
Sbjct: 110 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLV 166

Query: 294 SSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDV 345
            ++   ++ DFG++          +       VG    +      PE +M+ K + + DV
Sbjct: 167 GANLLVKIGDFGMS--------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 218

Query: 346 YSFGVVLLELLS-GRRP 361
           +SFGV+L E+ + G++P
Sbjct: 219 WSFGVILWEIFTYGKQP 235

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 46/184 (25%), Positives = 76/184 (41%), Gaps = 25/184 (13%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
           +   S+      +   EV I   +   +I TL+ V      ++L+ + +  G L + L  
Sbjct: 49  QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ 108

Query: 248 AGEQSVLPWGVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-- 300
               S        E         I + +NYLH+   + + H D+K  NI+L     P   
Sbjct: 109 KESLS--------EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157

Query: 301 --LSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS 357
             L DFGLA              ++ GT  ++APE + +  +  + D++S GV+   LLS
Sbjct: 158 IKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

Query: 358 GRRP 361
           G  P
Sbjct: 214 GASP 217

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 35/196 (17%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL- 245
           LK+A+     A  DF  E ++ + L+ + I    GVC E   L++V +++  G L   L 
Sbjct: 79  LKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 135

Query: 246 -----------HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
                              L  G    VA  +A  + YL        +HRD+ + N L+ 
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVG 192

Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVY 346
                ++ DFG++          I       VG    +      PE +++ K + + DV+
Sbjct: 193 QGLVVKIGDFGMS--------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244

Query: 347 SFGVVLLELLS-GRRP 361
           SFGVVL E+ + G++P
Sbjct: 245 SFGVVLWEIFTYGKQP 260

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 11/179 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL 245
           L + T       + F +E  I       ++ +L G+C+  +   ++V  ++  G L   +
Sbjct: 61  LNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                   +   + F   + +A+ + YL S   +  +HRD+ + N +L   F  +++DFG
Sbjct: 119 RNETHNPTVKDLIGF--GLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFG 173

Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           LA        + +           ++A E L   K + K DV+SFGV+L EL++ G  P
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 29/191 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           + +A S       +F +E  +        +  L GV  +    +++ + + +G L+  L 
Sbjct: 63  VNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120

Query: 247 GAGEQSVLPWGVR-------FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
                      +         ++A  IA+ + YL++      +HRD+ + N +++ DF  
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177

Query: 300 QLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVV 351
           ++ DFG+           I E      G  G +     +PE L  G  +   DV+SFGVV
Sbjct: 178 KIGDFGMT--------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229

Query: 352 LLELLS-GRRP 361
           L E+ +   +P
Sbjct: 230 LWEIATLAEQP 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 30/189 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
            + +  Q          E  I   +     I TL       +++ LV D + KG L + L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191

Query: 246 HGAGEQSVLPWGVRF------EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP 299
                                 +  ++ EA+++LH+     ++HRD+K  NILL  + Q 
Sbjct: 192 TEKV---------ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI 239

Query: 300 QLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD------KIDVYSFGVVL 352
           +LSDFG +    P +       ++ GT GY+APE L             ++D+++ GV+L
Sbjct: 240 RLSDFGFSCHLEPGEKLR----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

Query: 353 LELLSGRRP 361
             LL+G  P
Sbjct: 296 FTLLAGSPP 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 24/171 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
              +E+ I + L    +  L+    +   ++L+ +FL  G L +         +     +
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR--------IAAEDYK 145

Query: 260 F-EVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLA-IWG 310
             E  V        E L ++H      ++H D+K  NI+  +     +   DFGLA    
Sbjct: 146 MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           P +           T  + APE +    V    D+++ GV+   LLSG  P
Sbjct: 203 PDEIVK----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 11/179 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESL 245
           L + T       + F +E  I       ++ +L G+C+  +   ++V  ++  G L   +
Sbjct: 125 LNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                   +   + F   + +A+ + +L S   +  +HRD+ + N +L   F  +++DFG
Sbjct: 183 RNETHNPTVKDLIGF--GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 306 LAIWGPTDSTHMIREDVVGTF--GYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP 361
           LA          +           ++A E L   K + K DV+SFGV+L EL++ G  P
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.0 bits (205), Expect = 5e-17
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 22/170 (12%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E+   S L   ++  L+    +DN ++++ +F+  G L E +  A E + +     
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMS---- 253

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLA-IWGP 311
            E         + + L ++H       +H D+K  NI+ ++    +L   DFGL     P
Sbjct: 254 -EDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             S         GT  + APE      V    D++S GV+   LLSG  P
Sbjct: 310 KQSVK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 82.8 bits (204), Expect = 8e-17
 Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 25/174 (14%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYL------ILVSDFLPKGSLEESLHGAGEQSVLPW 256
            E+ I   L   ++ +   V      L      +L  ++   G L + L+       L  
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK- 119

Query: 257 GVRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ---LSDFGLAI 308
               E  +      I+ AL YLH      +IHRD+K  NI+L    Q     + D G A 
Sbjct: 120 ----EGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172

Query: 309 WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
                    +  + VGT  Y+APE L   K +  +D +SFG +  E ++G RP 
Sbjct: 173 ELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 36/189 (19%)

Query: 216 ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---A 269
              L     +D  L     +   G L + +   G          F+        AE   A
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSA 142

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYI 329
           L YLH    + +IHRD+K  NILL+ D   Q++DFG A     +S        VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 330 APEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLV 374
           +PE L      K S   D+++ G ++ +L++G  P            I       PE   
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 256

Query: 375 KWAKPILKN 383
             A+ +++ 
Sbjct: 257 PKARDLVEK 265

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 80.1 bits (198), Expect = 9e-17
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 22/174 (12%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
             D+  E++I ++ +   I  L G    D  L ++ +F P G+++  +            
Sbjct: 60  LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-------R 112

Query: 258 VRFEVAVAI-----AEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
              E  + +      EALN+LHS+    +IHRD+K+ N+L++ +   +L+DFG++     
Sbjct: 113 GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKN 167

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRP 361
             T   R+  +GT  ++APE +M   + D     K D++S G+ L+E+     P
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 35/197 (17%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK           +F  E  + + L+  ++  L GV  +D  L ++  +   G L E L 
Sbjct: 47  LKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 104

Query: 247 GAGEQSVLPWGVRFE-------------VAVAIAEALNYLHSECSRPVIHRDVKSSNILL 293
                S +                    +   IA  + YL S     V+H+D+ + N+L+
Sbjct: 105 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLV 161

Query: 294 SSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDV 345
                 ++SD GL           +       +     +     APE +M+GK S   D+
Sbjct: 162 YDKLNVKISDLGLF--------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 213

Query: 346 YSFGVVLLELLS-GRRP 361
           +S+GVVL E+ S G +P
Sbjct: 214 WSYGVVLWEVFSYGLQP 230

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 9/100 (9%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLAIWGPTDSTHMIRED 321
           I + + YLH+   + V+HRD+K SNIL   +        + DFG A     ++  +    
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MT 179

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              T  ++APE L         D++S GV+L  +L+G  P
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 19/169 (11%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWG 257
                +E+ +    +  +I       +  + L +V ++L  GSL + +     ++ +   
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMD-- 114

Query: 258 VRFEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
              E  +A       +AL +LHS     VIHRD+KS NILL  D   +L+DFG       
Sbjct: 115 ---EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQI 166

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                 R  +VGT  ++APE +       K+D++S G++ +E++ G  P
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           I EA+ YLHS     + HRDVK  N+L +S   +   +L+DFG A    + ++       
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TP 223

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
             T  Y+APE L   K     D++S GV++  LL G  P
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 38/200 (19%)

Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP- 237
            R  S  +    +++ +    +  +E++I   L    I  +     +     +V + +  
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEG 223

Query: 238 ---------KGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
                       L+E+                     +  A+ YLH      +IHRD+K 
Sbjct: 224 GELFDKVVGNKRLKEA-----TCK--------LYFYQMLLAVQYLHE---NGIIHRDLKP 267

Query: 289 SNILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSD 341
            N+LLSS   D   +++DFG + I G T         + GT  Y+APE L+       + 
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMR----TLCGTPTYLAPEVLVSVGTAGYNR 323

Query: 342 KIDVYSFGVVLLELLSGRRP 361
            +D +S GV+L   LSG  P
Sbjct: 324 AVDCWSLGVILFICLSGYPP 343

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 21/171 (12%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG----EQSV 253
             +   E+ I    +   +    G   ++  L +V ++   GS+ + +        E   
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-- 125

Query: 254 LPWGVRFEVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWG 310
                  E+A  +      L YLH       IHRD+K+ NILL+++   +L+DFG+A  G
Sbjct: 126 -------EIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--G 173

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
               T   R  V+GT  ++APE +     +   D++S G+  +E+  G+ P
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 49/176 (27%), Positives = 70/176 (39%), Gaps = 38/176 (21%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  + D +  G L   L   G          F  A      AE    L ++H+   R V+
Sbjct: 267 LSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHN---RFVV 314

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           +RD+K +NILL      ++SD GLA        H      VGT GY+APE L  G   D 
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDS 370

Query: 343 -IDVYSFGVVLLELLSGRRP---------------IGFKNLKGPESLVKWAKPILK 382
             D +S G +L +LL G  P                    ++ P+S     + +L+
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 24/171 (14%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +  +E+ + + L+  ++  L       N ++LV +++  G L +         ++     
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR--------IIDESYN 183

Query: 260 F-EVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLA-IWG 310
             E+        I E + ++H      ++H D+K  NIL  +    Q+   DFGLA  + 
Sbjct: 184 LTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240

Query: 311 PTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           P +          GT  ++APE + +  VS   D++S GV+   LLSG  P
Sbjct: 241 PREKLK----VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 45/148 (30%), Positives = 66/148 (44%), Gaps = 30/148 (20%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSR 279
           +  + +V D L  G L   L    +Q+V      F+       I E   AL+YL +   +
Sbjct: 87  EEDMFMVVDLLLGGDLRYHL----QQNV-----HFKEETVKLFICELVMALDYLQN---Q 134

Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---- 335
            +IHRD+K  NILL       ++DF +A   P ++       + GT  Y+APE       
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT---TMAGTKPYMAPEMFSSRKG 191

Query: 336 --HGKVSDKIDVYSFGVVLLELLSGRRP 361
             +      +D +S GV   ELL GRRP
Sbjct: 192 AGYSFA---VDWWSLGVTAYELLRGRRP 216

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 39/198 (19%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           +K+  S       DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L
Sbjct: 60  MKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117

Query: 246 HGAGEQSVLPWGVRFEV-------------AVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
             +      P                    A  +A  ++YL     +  IHRD+ + NIL
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 174

Query: 293 LSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKID 344
           +  ++  +++DFGL+           R     V  T G +     A E L +   +   D
Sbjct: 175 VGENYVAKIADFGLS-----------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223

Query: 345 VYSFGVVLLELLS-GRRP 361
           V+S+GV+L E++S G  P
Sbjct: 224 VWSYGVLLWEIVSLGGTP 241

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG 327
             L++LH      VIHRD+K  N+LL+ + + +L DFG++     D T   R   +GT  
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPY 194

Query: 328 YIAPEYLMHGKVSD-----KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK 382
           ++APE +   +  D     K D++S G+  +E+  G  P    ++    +L      I +
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--LCDMHPMRALFL----IPR 248

Query: 383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           N     L   K S ++      +  +    C+ ++   RP   Q++K
Sbjct: 249 N-PAPRLKSKKWSKKF------QSFIE--SCLVKNHSQRPATEQLMK 286

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 34/196 (17%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSL---- 241
           LK      +       SE+ I S L Q ++I  L G C     +++++++   G L    
Sbjct: 84  LKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141

Query: 242 -------EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS 294
                  E     A   S          +  +A+ + +L S   +  IHRDV + N+LL+
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198

Query: 295 SDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVY 346
           +    ++ DFGLA          I  D   +V     +     APE +     + + DV+
Sbjct: 199 NGHVAKIGDFGLA--------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250

Query: 347 SFGVVLLELLS-GRRP 361
           S+G++L E+ S G  P
Sbjct: 251 SYGILLWEIFSLGLNP 266

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 38/200 (19%)

Query: 179 CRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP- 237
            +  S  +    +++ +    +  +E++I   L    I  +     +     +V + +  
Sbjct: 40  IKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEG 98

Query: 238 ---------KGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
                       L+E+        +            +  A+ YLH      +IHRD+K 
Sbjct: 99  GELFDKVVGNKRLKEA-----TCKLY---FY-----QMLLAVQYLHE---NGIIHRDLKP 142

Query: 289 SNILLSS---DFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV---SD 341
            N+LLSS   D   +++DFG + I G T         + GT  Y+APE L+       + 
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMR----TLCGTPTYLAPEVLVSVGTAGYNR 198

Query: 342 KIDVYSFGVVLLELLSGRRP 361
            +D +S GV+L   LSG  P
Sbjct: 199 AVDCWSLGVILFICLSGYPP 218

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 39/175 (22%), Positives = 73/175 (41%), Gaps = 29/175 (16%)

Query: 200 DFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSL-----EESLHGAGEQSV 253
           +   E+ +    +    +  L+ V    + +IL+ ++   G +      E      E   
Sbjct: 74  EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-- 131

Query: 254 LPWGVRFEVAVA---IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLA 307
                  +V      I E + YLH      ++H D+K  NILLSS       ++ DFG++
Sbjct: 132 -------DVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181

Query: 308 -IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              G          +++GT  Y+APE L +  ++   D+++ G++   LL+   P
Sbjct: 182 RKIGHACELR----EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV I    +  ++  +    +    L ++ +FL  G+L + +     Q  L       V 
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVC 147

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
            A+ +AL YLH++    VIHRD+KS +ILL+ D + +LSDFG             R+ +V
Sbjct: 148 EAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLV 202

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           GT  ++APE +     + ++D++S G++++E++ G  P
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 45/193 (23%), Positives = 71/193 (36%), Gaps = 30/193 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED------NYLILVSDFLPKGS 240
           LK      SS   +F  E       +   +  L GV +           +++  F+  G 
Sbjct: 59  LKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117

Query: 241 LEE---SLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF 297
           L     +         LP        V IA  + YL S   R  IHRD+ + N +L+ D 
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM 174

Query: 298 QPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVYSFG 349
              ++DFGL+          I        G    +     A E L     +   DV++FG
Sbjct: 175 TVCVADFGLS--------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFG 226

Query: 350 VVLLELLS-GRRP 361
           V + E+++ G+ P
Sbjct: 227 VTMWEIMTRGQTP 239

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 49/191 (25%), Positives = 71/191 (37%), Gaps = 29/191 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL- 245
           L +  S       DF  E  I S    ++I    GV ++     ++ + +  G L+  L 
Sbjct: 68  LPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125

Query: 246 ---HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQP 299
                  + S L       VA  IA    YL        IHRD+ + N LL+        
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 182

Query: 300 QLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVV 351
           ++ DFG+A          I        G    +      PE  M G  + K D +SFGV+
Sbjct: 183 KIGDFGMA--------RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234

Query: 352 LLELLS-GRRP 361
           L E+ S G  P
Sbjct: 235 LWEIFSLGYMP 245

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 26/182 (14%)

Query: 196 SAWNDFSSEVDITSSLEQKSITTLNGVCIEDN-----YLILVSDFLPKGSLEE---SLHG 247
               +F SE          ++  L GVCIE +       +++  F+  G L         
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137

Query: 248 AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA 307
                 +P     +  V IA  + YL    +R  +HRD+ + N +L  D    ++DFGL+
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

Query: 308 IWGPTDSTHMIREDV--VGTFGYI-----APEYLMHGKVSDKIDVYSFGVVLLELLS-GR 359
                    +   D    G    +     A E L     + K DV++FGV + E+ + G 
Sbjct: 195 KK-------IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247

Query: 360 RP 361
            P
Sbjct: 248 TP 249

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 49/191 (25%), Positives = 72/191 (37%), Gaps = 29/191 (15%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL- 245
           L +  S+      DF  E  I S    ++I    GV ++     ++ + +  G L+  L 
Sbjct: 109 LPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 166

Query: 246 ---HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQP 299
                  + S L       VA  IA    YL        IHRD+ + N LL+        
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223

Query: 300 QLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKIDVYSFGVV 351
           ++ DFG+A          I        G    +      PE  M G  + K D +SFGV+
Sbjct: 224 KIGDFGMA--------RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275

Query: 352 LLELLS-GRRP 361
           L E+ S G  P
Sbjct: 276 LWEIFSLGYMP 286

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 36/198 (18%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK   +      +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L
Sbjct: 109 LKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166

Query: 246 -------------HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
                             +  L        A  +A  + YL S   +  IHRD+ + N+L
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223

Query: 293 LSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKID 344
           ++ D   +++DFGLA          I         T G +     APE L     + + D
Sbjct: 224 VTEDNVMKIADFGLA--------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275

Query: 345 VYSFGVVLLELLS-GRRP 361
           V+SFGV+L E+ + G  P
Sbjct: 276 VWSFGVLLWEIFTLGGSP 293

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 36/198 (18%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK   ++     +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L
Sbjct: 121 LKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178

Query: 246 -------------HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
                             +  + +         +A  + YL S   +  IHRD+ + N+L
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235

Query: 293 LSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKID 344
           ++ +   +++DFGLA          I         T G +     APE L     + + D
Sbjct: 236 VTENNVMKIADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287

Query: 345 VYSFGVVLLELLS-GRRP 361
           V+SFGV++ E+ + G  P
Sbjct: 288 VWSFGVLMWEIFTLGGSP 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 36/198 (18%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK   +      +D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L
Sbjct: 75  LKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132

Query: 246 -------------HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL 292
                             +  + +         +A  + YL S   +  IHRD+ + N+L
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189

Query: 293 LSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKID 344
           ++ +   +++DFGLA          I         T G +     APE L     + + D
Sbjct: 190 VTENNVMKIADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241

Query: 345 VYSFGVVLLELLS-GRRP 361
           V+SFGV++ E+ + G  P
Sbjct: 242 VWSFGVLMWEIFTLGGSP 259

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 23/137 (16%), Positives = 41/137 (29%), Gaps = 37/137 (27%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHR 284
                ++V++++  GSL+E    +      P G       ++A A +  H      V   
Sbjct: 102 TRAGGLVVAEWIRGGSLQEVADTS----PSPVGAI-RAMQSLAAAADAAHR---AGVALS 153

Query: 285 DVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKID 344
               S + +S D        G                V+     +          + + D
Sbjct: 154 IDHPSRVRVSID--------GDV--------------VLAYPATMPD-------ANPQDD 184

Query: 345 VYSFGVVLLELLSGRRP 361
           +   G  L  LL  R P
Sbjct: 185 IRGIGASLYALLVNRWP 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 32/176 (18%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L LV   +  G +   ++   E +       F+   A    A+    L +LH    R +I
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNP-----GFQEPRAIFYTAQIVSGLEHLHQ---RNII 311

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           +RD+K  N+LL  D   ++SD GLA+      T    +   GT G++APE L+  +    
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFS 369

Query: 343 IDVYSFGVVLLELLSGRRP----------------IGFKNLKGPESLVKWAKPILK 382
           +D ++ GV L E+++ R P                +  + +  P+     +K   +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA      ++ M+   VV T  Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVV-TRYY 192

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++ G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 30/181 (16%)

Query: 200 DFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG-----EQSV 253
               EV++    +  +++  L     E++   LV + +  GS+   +H        E SV
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAI-- 308
           +   V+      +A AL++LH+   + + HRD+K  NIL     Q    ++ DF L    
Sbjct: 116 V---VQ-----DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

Query: 309 ---WGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-----IDVYSFGVVLLELLSGRR 360
                 +  +        G+  Y+APE +              D++S GV+L  LLSG  
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

Query: 361 P 361
           P
Sbjct: 225 P 225

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 12/169 (7%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L LV   +  G L+  ++  G+         F  A  I   L  LH      +++RD+K 
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHR---ERIVYRDLKP 314

Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSF 348
            NILL      ++SD GLA+  P   T   R   VGT GY+APE + + + +   D ++ 
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDWWAL 371

Query: 349 GVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE 397
           G +L E+++G+ P  F+  K      +  + + +          + S +
Sbjct: 372 GCLLYEMIAGQSP--FQQRKKKIKREEVERLVKEV---PEEYSERFSPQ 415

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 38/200 (19%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK +     +      SE+ + S L    +I  L G C      ++++++   G L   L
Sbjct: 61  LKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 246 HGAGEQSVLPWGVRFEV---------------AVAIAEALNYLHSECSRPVIHRDVKSSN 290
               +  +        +               +  +A+ + +L S   +  IHRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175

Query: 291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDK 342
           ILL+     ++ DFGLA          I+ D   VV     +     APE + +   + +
Sbjct: 176 ILLTHGRITKICDFGLA--------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227

Query: 343 IDVYSFGVVLLELLS-GRRP 361
            DV+S+G+ L EL S G  P
Sbjct: 228 SDVWSYGIFLWELFSLGSSP 247

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 42/146 (28%), Positives = 61/146 (41%), Gaps = 19/146 (13%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
           +NYL LV ++   G L   L   GE+       RF +A  I  A++ +H       +HRD
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVHR---LGYVHRD 187

Query: 286 VKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK 342
           +K  NILL      +L+DFG         T  + +     VGT  Y++PE L        
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDYLSPEILQAVGGGPG 243

Query: 343 IDVY-------SFGVVLLELLSGRRP 361
              Y       + GV   E+  G+ P
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTP 269

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 45/205 (21%), Positives = 78/205 (38%), Gaps = 43/205 (20%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK+  S       DF  E  + +  +  +I  L GVC     + L+ +++  G L E L 
Sbjct: 85  LKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142

Query: 247 GAGEQSVLPWGVRFE---------------------VAVAIAEALNYLHSECSRPVIHRD 285
                +V                             +A  +A  + YL     R  +HRD
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199

Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHG 337
           + + N L+  +   +++DFGL+          I             I      PE + + 
Sbjct: 200 LATRNCLVGENMVVKIADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYN 251

Query: 338 KVSDKIDVYSFGVVLLELLS-GRRP 361
           + + + DV+++GVVL E+ S G +P
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQP 276

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 44/178 (24%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V +F+  G L   +  +          RF+ A A    AE   AL +LH    + +I
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHD---KGII 146

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N+LL  +   +L+DFG+    I     +T        GT  YIAPE L    +
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGIC-NGVTTATF----CGTPDYIAPEILQEMLY 201

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           G     +D ++ GV+L E+L G  P            I    +  P  L + A  ILK
Sbjct: 202 GPA---VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 43/205 (20%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSL----- 241
           LK+  S   S   D  SE ++   +    +  L G C +D  L+L+ ++   GSL     
Sbjct: 61  LKENAS--PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118

Query: 242 ----------------EESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
                             S     ++  L  G     A  I++ + YL       ++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175

Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHG 337
           + + NIL++   + ++SDFGL+          + E+   V  + G I     A E L   
Sbjct: 176 LAARNILVAEGRKMKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227

Query: 338 KVSDKIDVYSFGVVLLELLS-GRRP 361
             + + DV+SFGV+L E+++ G  P
Sbjct: 228 IYTTQSDVWSFGVLLWEIVTLGGNP 252

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 63/248 (25%), Positives = 92/248 (37%), Gaps = 56/248 (22%)

Query: 198 WNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFL----------PKGSLEESLHG 247
           W D   EV     L   +     G  + ++   LV ++            K  L+E    
Sbjct: 98  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV--- 154

Query: 248 AGEQSVLPWGVRFEVAVAIAE---ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF 304
                        E+A         L YLHS     +IHRDVK+ NILLS     +L DF
Sbjct: 155 -------------EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 198

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD---KIDVYSFGVVLLELLSGRRP 361
           G A      S        VGT  ++APE ++         K+DV+S G+  +EL   + P
Sbjct: 199 GSA------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
               N+    +L      I +N  +  L     S  +      R  +    C+ + PQ R
Sbjct: 253 --LFNMNAMSALYH----IAQNE-SPALQSGHWSEYF------RNFVD--SCLQKIPQDR 297

Query: 422 PNMGQVLK 429
           P    +LK
Sbjct: 298 PTSEVLLK 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 37/199 (18%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVC-IEDNYLILVSDFLPKGSLEES 244
           LK+  +   S      SE+ I   +    ++  L G C      L+++ +F   G+L   
Sbjct: 65  LKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122

Query: 245 LHGAGEQSVLPWGVRFEV-------------AVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           L     + V       ++             +  +A+ + +L S   R  IHRD+ + NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 179

Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIRED---VVGTFGYI-----APEYLMHGKVSDKI 343
           LLS     ++ DFGLA          I +D   V      +     APE +     + + 
Sbjct: 180 LLSEKNVVKICDFGLA--------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231

Query: 344 DVYSFGVVLLELLS-GRRP 361
           DV+SFGV+L E+ S G  P
Sbjct: 232 DVWSFGVLLWEIFSLGASP 250

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 45/204 (22%)

Query: 203 SEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEV 262
           +E  I  ++    +  L     +++ L +V +++  G +   L   G         RF  
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---------RFSE 140

Query: 263 AVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS 314
             A      I     YLHS     +I+RD+K  N+L+      Q++DFG A  + G T +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197

Query: 315 THMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP---------- 361
                  + GT   +APE ++   + K    +D ++ GV++ E+ +G  P          
Sbjct: 198 -------LCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQIY 247

Query: 362 --IGFKNLKGPESLVKWAKPILKN 383
             I    ++ P       K +L+N
Sbjct: 248 EKIVSGKVRFPSHFSSDLKDLLRN 271

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 51/185 (27%)

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPV 281
           +LIL  D++  G L   L             RF        + E   AL +LH      +
Sbjct: 135 HLIL--DYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHK---LGI 180

Query: 282 IHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM--- 335
           I+RD+K  NILL S+    L+DFGL+   +   T+  +       GT  Y+AP+ +    
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF----CGTIEYMAPDIVRGGD 236

Query: 336 --HGKVSDKIDVYSFGVVLLELLSGRRP----------------IGFKNLKGPESLVKWA 377
             H K    +D +S GV++ ELL+G  P                I       P+ +   A
Sbjct: 237 SGHDKA---VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293

Query: 378 KPILK 382
           K +++
Sbjct: 294 KDLIQ 298

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 44/178 (24%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V +++  G L   +   G         RF+   A    AE    L +L S   + +I
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQS---KGII 143

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N++L S+   +++DFG+    IW    +T        GT  YIAPE +    +
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKTF----CGTPDYIAPEIIAYQPY 198

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           GK    +D ++FGV+L E+L+G+ P            I   N+  P+S+ K A  I K
Sbjct: 199 GKS---VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 24/107 (22%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV--- 322
           + + + YLH    + +IHRD+K SN+L+  D   +++DFG+       S      D    
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGV-------SNEFKGSDALLS 195

Query: 323 --VGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRP 361
             VGT  ++APE L        GK    +DV++ GV L   + G+ P
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQCP 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 33/173 (19%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS 288
           L  V ++   G L    H + E+       RF  A  I  AL+YLHSE  + V++RD+K 
Sbjct: 223 LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKL 277

Query: 289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF----GYIAPEYLM---HGKVSD 341
            N++L  D   +++DFGL          +     + TF     Y+APE L    +G+   
Sbjct: 278 ENLMLDKDGHIKITDFGLC------KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-- 329

Query: 342 KIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
            +D +  GVV+ E++ GR P            I  + ++ P +L   AK +L 
Sbjct: 330 -VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 23/175 (13%)

Query: 204 EVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFE 261
           E+ +   L+  ++ +L  V +   D  + L+ D+     L   +            V+  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP 126

Query: 262 VAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSDFGLA--IW 309
             +       I + ++YLH+     V+HRD+K +NIL+  +   +    ++D G A    
Sbjct: 127 RGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

Query: 310 GPTDS-THMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
            P      +    VV TF Y APE L+  +  +  ID+++ G +  ELL+   PI
Sbjct: 184 SPLKPLADLDPV-VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 46/179 (25%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V ++L  G L   +             +F+++ A    AE    L +LHS   + ++
Sbjct: 93  LFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHS---KGIV 140

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF-G---YIAPEYLM--- 335
           +RD+K  NILL  D   +++DFG+         +M+ +    TF G   YIAPE L+   
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMC------KENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 336 HGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           +      +D +SFGV+L E+L G+ P            I   N   P  L K AK +L 
Sbjct: 195 YNHS---VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 44/178 (24%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA------IAEALNYLHSECSRPVI 282
           L  V +++  G L   +   G         RF+   A      IA  L +L S   + +I
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQS---KGII 464

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N++L S+   +++DFG+    IW    +T        GT  YIAPE +    +
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKTF----CGTPDYIAPEIIAYQPY 519

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           GK    +D ++FGV+L E+L+G+ P            I   N+  P+S+ K A  I K
Sbjct: 520 GKS---VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 70.2 bits (173), Expect = 1e-13
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 21/166 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L+ K+I  L+ V   D  L LV +F     K   +        + V  +    
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---- 106

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
                + + L + HS   R V+HRD+K  N+L++ + + +L++FGLA  +G P    +  
Sbjct: 107 --LFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA- 160

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
              +VV T  Y  P+ L   K+ S  ID++S G +  EL +  RP+
Sbjct: 161 ---EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 54/179 (30%), Positives = 77/179 (43%), Gaps = 46/179 (25%)

Query: 228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPV 281
           YLIL  DFL  G L   L              F        +AE   AL++LHS     +
Sbjct: 102 YLIL--DFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHS---LGI 147

Query: 282 IHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM--- 335
           I+RD+K  NILL  +   +L+DFGL+   I       +       GT  Y+APE +    
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSF----CGTVEYMAPEVVNRRG 202

Query: 336 HGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           H +     D +SFGV++ E+L+G  P            I    L  P+ L   A+ +L+
Sbjct: 203 HTQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 44/144 (30%), Positives = 64/144 (44%), Gaps = 17/144 (11%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRD 285
           DN L LV D+   G L   L    ++       RF +A  +  A++ +H       +HRD
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVHQ---LHYVHRD 200

Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM--------HG 337
           +K  NIL+  +   +L+DFG  +    D T       VGT  YI+PE L         +G
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYG 259

Query: 338 KVSDKIDVYSFGVVLLELLSGRRP 361
                 D +S GV + E+L G  P
Sbjct: 260 PE---CDWWSLGVCMYEMLYGETP 280

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + +LHS     +IHRD+K SNI++ SD   ++ DFGLA      ++ M+   VV T  Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVV-TRYY 229

Query: 329 IAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     + +D++S G ++ E++  +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 25/98 (25%), Positives = 46/98 (46%), Gaps = 5/98 (5%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           + + L YLHS   + ++H+D+K  N+LL++    ++S  G+A      +         G+
Sbjct: 118 LIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174

Query: 326 FGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
             +  PE           K+D++S GV L  + +G  P
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 52/178 (29%), Positives = 77/178 (43%), Gaps = 44/178 (24%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L L+ ++L  G L   L   G          F    A   +AE   AL +LH    + +I
Sbjct: 96  LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQ---KGII 143

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  NI+L+     +L+DFGL    I      TH       GT  Y+APE LM   H
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTF----CGTIEYMAPEILMRSGH 198

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
            +    +D +S G ++ ++L+G  P            I    L  P  L + A+ +LK
Sbjct: 199 NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLK 253

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 45/191 (23%)

Query: 216 ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---A 269
           I  + G   +   + ++ D++  G L   L  +          RF   VA    AE   A
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLA 118

Query: 270 LNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTFG 327
           L YLHS   + +I+RD+K  NILL  +   +++DFG A  +   T +       + GT  
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGTPD 168

Query: 328 YIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPES 372
           YIAPE +    + K    ID +SFG+++ E+L+G  P            I    L+ P  
Sbjct: 169 YIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 225

Query: 373 LVKWAKPILKN 383
             +  K +L  
Sbjct: 226 FNEDVKDLLSR 236

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 17/102 (16%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A+ Y H +    ++HRD+K+ N+LL +D   +++DFG        S        +  
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDA 172

Query: 326 F----GYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
           F     Y APE L  GK  D  ++DV+S GV+L  L+SG  P
Sbjct: 173 FCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 51/178 (28%), Positives = 75/178 (42%), Gaps = 44/178 (24%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V ++   G L    H       L     F    A    AE   AL YLHS   R V+
Sbjct: 80  LCFVMEYANGGEL--FFH-------LSRERVFTEERARFYGAEIVSALEYLHS---RDVV 127

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N++L  D   +++DFGL    I     +         GT  Y+APE L    +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF----CGTPEYLAPEVLEDNDY 182

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           G+    +D +  GVV+ E++ GR P            I  + ++ P +L   AK +L 
Sbjct: 183 GRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 16/163 (9%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L+ ++I  L  V   +N L LV +F+    K  ++    G   + +    V+ 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK- 111

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
                + + L + H      ++HRD+K  N+L++   Q +L DFGLA  +G P ++ +  
Sbjct: 112 YFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS- 167

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
              +VV T  Y AP+ LM  +  S  ID++S G +L E+++G+
Sbjct: 168 ---EVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 45/152 (29%), Positives = 61/152 (40%), Gaps = 36/152 (23%)

Query: 226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSR 279
           D YL +V +++P G L   ++                  A    AE   AL+ +HS    
Sbjct: 141 DRYLYMVMEYMPGGDL---VNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---M 187

Query: 280 PVIHRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM- 335
             IHRDVK  N+LL      +L+DFG                    VGT  YI+PE L  
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYISPEVLKS 243

Query: 336 ------HGKVSDKIDVYSFGVVLLELLSGRRP 361
                 +G+     D +S GV L E+L G  P
Sbjct: 244 QGGDGYYGRE---CDWWSVGVFLYEMLVGDTP 272

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 50/179 (27%), Positives = 71/179 (39%), Gaps = 46/179 (25%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V D++  G L   L              F    A    AE   AL YLHS     ++
Sbjct: 114 LYFVLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHS---LNIV 161

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTF-G---YIAPEYLM--- 335
           +RD+K  NILL S     L+DFGL         ++       TF G   Y+APE L    
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLC------KENIEHNSTTSTFCGTPEYLAPEVLHKQP 215

Query: 336 HGKVSDKIDVYSFGVVLLELLSGRRP------------IGFKNLKGPESLVKWAKPILK 382
           + +    +D +  G VL E+L G  P            I  K L+   ++   A+ +L+
Sbjct: 216 YDRT---VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 41/204 (20%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK+     SS      SE+ + + L   ++I  L G C     + L+ ++   G L   L
Sbjct: 83  LKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140

Query: 246 HGAGEQSVLPWGVRFE--------------------VAVAIAEALNYLHSECSRPVIHRD 285
               E+                               A  +A+ + +L     +  +HRD
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197

Query: 286 VKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED--VVGTFGYI-----APEYLMHGK 338
           + + N+L++     ++ DFGLA         ++ +   VV     +     APE L  G 
Sbjct: 198 LAARNVLVTHGKVVKICDFGLA-------RDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250

Query: 339 VSDKIDVYSFGVVLLELLS-GRRP 361
            + K DV+S+G++L E+ S G  P
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNP 274

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 32/145 (22%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V +++  G L   +             +     A    AE   ALNYLH    R +I
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHE---RGII 132

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N+LL S+   +L+D+G+    +  P D+T        GT  YIAPE L    +
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTF----CGTPNYIAPEILRGEDY 187

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP 361
           G     +D ++ GV++ E+++GR P
Sbjct: 188 GFS---VDWWALGVLMFEMMAGRSP 209

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 15/101 (14%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP-QLSDFGLAIWGPTDSTHMIREDVVG 324
           +  A+ + HS   R V+HRD+K  NIL+       +L DFG               D  G
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPY--TDFDG 200

Query: 325 TFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSGRRP 361
           T  Y  PE++     H        V+S G++L +++ G  P
Sbjct: 201 TRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP 238

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 11/97 (11%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDSTHMIREDVVGT 325
             L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA I+      T      VV T
Sbjct: 131 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS----VVV-T 182

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 11/97 (11%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDSTHMIREDVVGT 325
             L++LH+     ++HRD+K  NIL++S    +L+DFGLA I+      T +    VV T
Sbjct: 131 RGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV----VV-T 182

Query: 326 FGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI 362
             Y APE L+    +  +D++S G +  E+   R+P+
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 9/92 (9%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L Y+HS     V+HRD+K  N+ ++ D + ++ DFGLA     + T       V T  Y
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWY 189

Query: 329 IAPEYLM-HGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     +  +D++S G ++ E+L+G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 15/101 (14%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLAIWGPTDSTHMIREDVVG 324
           + EA+ + H+     V+HRD+K  NIL+  +  + +L DFG       D+ +    D  G
Sbjct: 158 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVY---TDFDG 210

Query: 325 TFGYIAPEYLM----HGKVSDKIDVYSFGVVLLELLSGRRP 361
           T  Y  PE++     HG+      V+S G++L +++ G  P
Sbjct: 211 TRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP 248

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 9/92 (9%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L Y+H+     +IHRD+K  N+ ++ D + ++ DFGLA    ++ T       V T  Y
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWY 191

Query: 329 IAPEYLM-HGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++   + +  +D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIR--EDVVG 324
             L Y+H      ++HRD+K++N+L++ D   +L+DFGLA  +    ++   R    VV 
Sbjct: 135 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 325 TFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
           T  Y  PE L+  +     ID++  G ++ E+ + R PI
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + YLH      + HRD+K  N+LL      ++SDFGLA     ++   +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 329 IAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
           +APE L   +      +DV+S G+VL  +L+G  P
Sbjct: 174 VAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 38/94 (40%), Positives = 54/94 (57%), Gaps = 7/94 (7%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTHMIREDVVGTF 326
            L Y+HS     V+HRD+K SN+LL++    ++ DFGLA       D T  + E V  T 
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TR 195

Query: 327 GYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
            Y APE +++ K   K ID++S G +L E+LS R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 11/105 (10%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +  A+ YL     + +IHRD+K  NI+++ DF  +L DFG A +        +     GT
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGT 192

Query: 326 FGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLK 368
             Y APE LM G      +++++S GV L  L+    P  F  L+
Sbjct: 193 IEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP--FCELE 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 46/163 (28%), Positives = 67/163 (41%), Gaps = 21/163 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L+  ++  L  V      L LV ++        L+    G  E  V       
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI---- 107

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS-THM 317
                  +A+N+ H       IHRDVK  NIL++     +L DFG A  + GP+D     
Sbjct: 108 --TWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
                V T  Y +PE L+        +DV++ G V  ELLSG 
Sbjct: 163 -----VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 7/92 (7%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L+ LH      V+HRD+   NILL+ +    + DF LA      +       V     Y
Sbjct: 146 GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA--REDTADANKTHYVT-HRWY 199

Query: 329 IAPEYLM-HGKVSDKIDVYSFGVVLLELLSGR 359
            APE +M     +  +D++S G V+ E+ + +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 27/96 (28%), Positives = 51/96 (53%), Gaps = 8/96 (8%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFG 327
           AL+Y HS     ++HRDVK  N+++     + +L D+GLA +      + +R   V +  
Sbjct: 142 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRY 195

Query: 328 YIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPI 362
           +  PE L+  ++ D  +D++S G +L  ++  + P 
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 32/145 (22%)

Query: 229 LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVA---IAE---ALNYLHSECSRPVI 282
           L  V +++  G L   +             +     A    AE   ALNYLH    R +I
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHE---RGII 175

Query: 283 HRDVKSSNILLSSDFQPQLSDFGLA---IWGPTDSTHMIREDVVGTFGYIAPEYLM---H 336
           +RD+K  N+LL S+   +L+D+G+    +  P D+T        GT  YIAPE L    +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTF----CGTPNYIAPEILRGEDY 230

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP 361
           G     +D ++ GV++ E+++GR P
Sbjct: 231 GFS---VDWWALGVLMFEMMAGRSP 252

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 40/121 (33%), Positives = 56/121 (46%), Gaps = 13/121 (10%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL--SDFGLAIWGPTDSTHMIREDVV 323
           +   ++Y HS     + HRD+K  N LL     P+L   DFG +      S     +  V
Sbjct: 125 LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTV 178

Query: 324 GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
           GT  YIAPE L+  +  D    DV+S GV L  +L G  P  F++ + P    K  + IL
Sbjct: 179 GTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYP--FEDPEEPRDYRKTIQRIL 235

Query: 382 K 382
            
Sbjct: 236 S 236

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 9/92 (9%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            L Y+HS     +IHRD+K SN+ ++ D + ++ DFGLA     + T       V T  Y
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----GYVATRWY 195

Query: 329 IAPEYLM-HGKVSDKIDVYSFGVVLLELLSGR 359
            APE ++     +  +D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY 328
            + YLH      + HRD+K  N+LL      ++SDFGLA     ++   +   + GT  Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 329 IAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
           +APE L   +      +DV+S G+VL  +L+G  P
Sbjct: 174 VAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.0 bits (162), Expect = 4e-12
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 21/163 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ I   L+  +I  L  V      L+LV + L    K  L+    G    +   +    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF---- 105

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
              + +   + Y H    R V+HRD+K  N+L++ + + +++DFGLA  +G P    TH 
Sbjct: 106 --LLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH- 159

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
              ++V T  Y AP+ LM  K  S  ID++S G +  E+++G 
Sbjct: 160 ---EIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.0 bits (162), Expect = 4e-12
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 21/163 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L   +I +L  V   +  L LV +F+    K  L+E+  G  +  +  +    
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY---- 124

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PTDS-THM 317
                +   + + H      ++HRD+K  N+L++SD   +L+DFGLA  +G P  S TH 
Sbjct: 125 --LYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH- 178

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
              +VV T  Y AP+ LM  K  S  +D++S G +  E+++G+
Sbjct: 179 ---EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 65.7 bits (161), Expect = 6e-12
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 33/169 (19%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           EV +   L+  +I TL+ +   +  L LV ++L    K  L++             G   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC------------GNII 97

Query: 261 EVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PT 312
            +         +   L Y H    + V+HRD+K  N+L++   + +L+DFGLA     PT
Sbjct: 98  NMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154

Query: 313 DS-THMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
            +  +     VV T  Y  P+ L+     S +ID++  G +  E+ +GR
Sbjct: 155 KTYDNE----VV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 65.3 bits (160), Expect = 9e-12
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 34/172 (19%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L   +I  L       + + LV DF+    +  ++++             +  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN------------SLVL 109

Query: 261 EVAVA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWG-PT 312
             +          + L YLH      ++HRD+K +N+LL  +   +L+DFGLA  +G P 
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

Query: 313 DS-THMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPI 362
            + TH     VV T  Y APE L   ++    +D+++ G +L ELL  R P 
Sbjct: 167 RAYTHQ----VV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)

Query: 263 AVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV 322
           +  +A+ + +L    SR  IHRD+ + NILLS     ++ DFGLA     D  ++ + D 
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL 381
                ++APE +     + + DV+SFGV+L E+ S G  P  +  +K  E   +     L
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRR----L 309

Query: 382 KNGDTETLLDPKLSNE--YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT 438
           K G    +  P  +    Y    M         C +  P  RP   ++++ L     A 
Sbjct: 310 KEG--TRMRAPDYTTPEMYQ--TMLD-------CWHGEPSQRPTFSELVEHLGNLLQAN 357

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 21/163 (12%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLP---KGSLEESLHGAGEQSVLPWGVRF 260
           E+ +   L  +++  L  VC +     LV +F+       LE   +G   Q V  +    
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY---- 129

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDS-THM 317
                I   + + HS     +IHRD+K  NIL+S     +L DFG A  +  P +     
Sbjct: 130 --LFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184

Query: 318 IREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
                V T  Y APE L+        +DV++ G ++ E+  G 
Sbjct: 185 -----VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 40/104 (38%), Positives = 54/104 (51%), Gaps = 15/104 (14%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA---------IWGPTDSTHMIR 319
           A+  LH      VIHRD+K SN+L++S+   ++ DFGLA            PT     + 
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 320 EDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
           E V  T  Y APE ++   K S  +DV+S G +L EL   RRPI
Sbjct: 181 EFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPI 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTF 326
            L Y+HS     V+HRD+K +N+ + + D   ++ DFGLA I  P  S      + + T 
Sbjct: 132 GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 327 GYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGR 359
            Y +P  L+      K ID+++ G +  E+L+G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 17/102 (16%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I  A++Y H      V+HRD+K  N+LL +    +++DFGL       S  M   + + T
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGEFLRT 169

Query: 326 F----GYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
                 Y APE ++ G++    ++D++S GV+L  LL G  P
Sbjct: 170 SCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 33/171 (19%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
           EV +   L+ ++I  L  V   ++ L L+ ++      E  L        +       + 
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKK-----YMDKNPDVSMR 132

Query: 264 VA------IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-----LSDFGLA-IWG- 310
           V       +   +N+ HS   R  +HRD+K  N+LLS     +     + DFGLA  +G 
Sbjct: 133 VIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189

Query: 311 PTDS-THMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGR 359
           P    TH    +++ T  Y  PE L+  +  S  +D++S   +  E+L   
Sbjct: 190 PIRQFTH----EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 19/103 (18%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV-- 323
           I  A+ Y H      ++HRD+K  N+LL  +   +++DFGL+        +++ +     
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLS--------NIMTDGNFLK 165

Query: 324 ---GTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
              G+  Y APE +++GK+    ++DV+S G+VL  +L GR P
Sbjct: 166 TSCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 24/98 (24%), Positives = 42/98 (42%), Gaps = 13/98 (13%)

Query: 268 EALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ------LSDFGLAIWGPTDSTHMIRED 321
             L+Y+H  C   +IH D+K  N+L+     P+      ++D G A W            
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----DEHYTNS 195

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
           +     Y +PE L+        D++S   ++ EL++G 
Sbjct: 196 IQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 23/148 (15%)

Query: 225 EDNYLILVSDFLPKGSLEESLH------GAGEQSVLPWGVRFEVAVAIAEALNYLHSECS 278
            D YL +V +++P     ++LH         + +  P  ++      +  ++  LH   S
Sbjct: 97  RDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLHLP-S 149

Query: 279 RPVIHRDVKSSNILL-SSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMH 336
             V HRD+K  N+L+  +D   +L DFG A    P++    +    + +  Y APE L+ 
Sbjct: 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAY--ICSRYYRAPE-LIF 204

Query: 337 G--KVSDKIDVYSFGVVLLELLSGRRPI 362
           G    +  +D++S G +  E++ G  PI
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 27/108 (25%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILL-SSDFQPQLSDFGLAIWGPTDSTHMIREDVVG 324
           +  A+ ++HS     + HRD+K  N+L+ S D   +L DFG A           ++ +  
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSA-----------KKLIPS 195

Query: 325 TF--GYI------APEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPI 362
                YI      APE LM G  + +  ID++S G V  EL+   +P+
Sbjct: 196 EPSVAYICSRFYRAPE-LMLGATEYTPSIDLWSIGCVFGELI-LGKPL 241

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 17/102 (16%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I   ++Y H      V+HRD+K  N+LL +    +++DFGL       S  M   + + T
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGL-------SNMMSDGEFLRT 174

Query: 326 F----GYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRP 361
                 Y APE ++ G++    ++D++S GV+L  LL G  P
Sbjct: 175 SCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 39/108 (36%), Positives = 52/108 (48%), Gaps = 27/108 (25%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLAIWGPTDSTHMIREDVVG 324
           +  +L Y+HS     + HRD+K  N+LL  D    +L DFG A           ++ V G
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRG 210

Query: 325 TF--GYI------APEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPI 362
                YI      APE L+ G    +  IDV+S G VL ELL G +PI
Sbjct: 211 EPNVSYICSRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 26/115 (22%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--------------------I 308
            + YLHS     ++HRD+K SNILL+++   +++DFGL+                     
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 309 WGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
               D   ++ + V  T  Y APE L+   K +  ID++S G +L E+L   +PI
Sbjct: 178 ENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 30/99 (30%), Positives = 41/99 (41%), Gaps = 30/99 (30%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDSTHMIREDV 322
           I EA+ YLHS     + HRDVK  N+L +S   +   +L+DFG                 
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166

Query: 323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
                  A E     K     D++S GV++  LL G  P
Sbjct: 167 -------AKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 26/115 (22%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--------------------- 307
             N++H      +IHRD+K +N LL+ D   ++ DFGLA                     
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 308 IWGPTDSTHMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRP 361
                +    +   VV T  Y APE ++     +  ID++S G +  ELL+  + 
Sbjct: 198 GPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLA-IWGPTDSTHMIREDVV 323
           +  +L Y+HS     + HRD+K  N+LL       +L DFG A I    +    +    +
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSY--I 202

Query: 324 GTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGR 359
            +  Y APE L+ G    +  ID++S G V+ EL+ G+
Sbjct: 203 CSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 28/145 (19%), Positives = 48/145 (33%), Gaps = 56/145 (38%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILL-------------------------------- 293
           + + L+YLH++C   +IH D+K  NILL                                
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 294 -----------------SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH 336
                            +   + +++D G A W     T  I+     T  Y + E L+ 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIG 267

Query: 337 GKVSDKIDVYSFGVVLLELLSGRRP 361
              +   D++S   +  EL +G   
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYL 292

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 10/96 (10%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHMIREDVV 323
           I + L+ LH      +IH D+K  NILL    +    + DFG +          +   + 
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ 261

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             F Y APE ++  +    ID++S G +L ELL+G 
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 8/96 (8%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHMIREDVV 323
           +  AL +L +     +IH D+K  NILL +  +    + DFG +          I + + 
Sbjct: 166 MCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQ 220

Query: 324 GTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR 359
             F Y +PE L+       ID++S G +L+E+ +G 
Sbjct: 221 SRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 27/127 (21%), Positives = 49/127 (38%), Gaps = 29/127 (22%)

Query: 269 ALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHMIREDVVGTFG 327
            + Y+HS     ++HRD+K +N L++ D   ++ DFGLA      ++ +           
Sbjct: 168 GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 328 ------------------------YIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPI 362
                                   Y APE ++  +   + IDV+S G +  ELL+  +  
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 363 GFKNLKG 369
              +   
Sbjct: 285 VAYHADR 291

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 24/166 (14%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAG-----EQSVLPWGVRFEVAVAIAEALNYLHSECSR 279
           +D Y  LV   L + SL+ +L  +      E+SVL      +VA  + +AL +LH     
Sbjct: 129 QDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVL------QVACRLLDALEFLHE---N 178

Query: 280 PVIHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHM-IREDV----VGTFGYIAPE 332
             +H +V + NI +  + Q Q  L+ +G A        H+   E       G   +I+ +
Sbjct: 179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238

Query: 333 YLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
                  S + D+ S G  +L+ L G  P  + N       +   K
Sbjct: 239 LHKGCGPSRRSDLQSLGYCMLKWLYGFLP--WTNCLPNTEDIMKQK 282

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 26/168 (15%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQ----SVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           E  + +LV D L   SLE+ L   G +    +V         A  +   +  +H    + 
Sbjct: 77  EGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVA------MAAKQMLARVQSIHE---KS 126

Query: 281 VIHRDVKSSNILLSSDFQPQ-----LSDFGLAI--WGPTDSTHM-IRED--VVGTFGYIA 330
           +++RD+K  N L+            + DFG+      P    H+  RE   + GT  Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186

Query: 331 PEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
               +  + S + D+ + G V +  L G  P  ++ LK   +  K+ +
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAATNKQKYER 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 34/165 (20%), Positives = 68/165 (41%), Gaps = 23/165 (13%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAG----EQSVLPWGVRFEVAVAIAEALNYLHSECSRP 280
             +Y  ++ D      L++           ++VL      ++++ I + L Y+H      
Sbjct: 123 GKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVL------QLSLRILDILEYIHE---HE 172

Query: 281 VIHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHM-IRED----VVGTFGYIAPEY 333
            +H D+K+SN+LL+     Q  L D+GLA     +  H     D      GT  + + + 
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232

Query: 334 LMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
                 S + D+   G  +++ L+G  P  +++       V+ +K
Sbjct: 233 HNGVAPSRRGDLEILGYCMIQWLTGHLP--WEDNLKDPKYVRDSK 275

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 26/168 (15%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQ----SVLPWGVRFEVAVAIAEALNYLHSECSRP 280
              Y  +V + L   SLE+            +VL       +A+ +   + Y+HS   + 
Sbjct: 76  CGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVL------MIAIQLISRMEYVHS---KN 125

Query: 281 VIHRDVKSSNILLSSDFQPQ-----LSDFGLAI--WGPTDSTHM-IRED--VVGTFGYIA 330
           +I+RDVK  N L+            + DF LA     P    H+  RE   + GT  Y++
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185

Query: 331 PEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
               +  + S + D+ + G + +  L G  P  ++ LK      ++ K
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLP--WQGLKADTLKERYQK 231

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 33/147 (22%), Positives = 64/147 (43%), Gaps = 20/147 (13%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPV 281
             +Y  +V + L    L++     G   + +VL      ++ + + + L Y+H       
Sbjct: 123 GRSYRFMVMERLGI-DLQKISGQNGTFKKSTVL------QLGIRMLDVLEYIHE---NEY 172

Query: 282 IHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHM-IREDV----VGTFGYIAPEYL 334
           +H D+K++N+LL      Q  L+D+GL+     +  H   +E+      GT  + + +  
Sbjct: 173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232

Query: 335 MHGKVSDKIDVYSFGVVLLELLSGRRP 361
               +S + DV   G  +L  L G+ P
Sbjct: 233 KGVALSRRSDVEILGYCMLRWLCGKLP 259

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 25/110 (22%), Positives = 39/110 (35%), Gaps = 23/110 (20%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           +  AL +LH      + H D+K  NIL  +     L +   +    +     IR   V  
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR---VAD 185

Query: 326 FG-----------YI------APEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           FG            +       PE ++    +   DV+S G +L E   G
Sbjct: 186 FGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 1e-04
 Identities = 68/546 (12%), Positives = 134/546 (24%), Gaps = 179/546 (32%)

Query: 25  EFDCTKTDSTDSSLERDNEFSTRQIIHGTEDASTDGGRNSIDEEKYRNPCASEEACTVRE 84
            FDC           +D +   + I+   E          ID     +  A      +  
Sbjct: 32  NFDC-----------KDVQDMPKSILSKEE----------IDH-IIMSKDAVSGTLRLFW 69

Query: 85  GISIDQNEEYTSTV------DYGWPLLRISAPETSDSLRDCEDKTLLNQSTSPTPHSQIN 138
            +   Q E     V      +Y + +  I   E     R     T +        ++   
Sbjct: 70  TLLSKQEEMVQKFVEEVLRINYKFLMSPIKT-EQ----RQPSMMTRMYIEQRDRLYNDNQ 124

Query: 139 SFSPKTENPFQMDIPCSEGKYDE-----NTLTPSTELFL-------K--LVSSRCRQFSY 184
            F+         ++   +  Y +       L P+  + +       K  +    C  +  
Sbjct: 125 VFAK-------YNVSRLQ-PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176

Query: 185 EELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC--IEDNYLILVSDFLPKGSLE 242
               Q    F   W +  +     + LE      L  +   I+ N+    SD      L 
Sbjct: 177 ----QCKMDFKIFWLNLKNCNSPETVLEM-----LQKLLYQIDPNWTSR-SDHSSNIKL- 225

Query: 243 ESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP---VIHRDVKSSNILLSSDFQP 299
                           R     +I   L  L          ++  +V+++    + +   
Sbjct: 226 ----------------RIH---SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266

Query: 300 QL----SDFGLA-IWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
           ++        +        +TH+  +    T      E                   +  
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDE-------------------VKS 305

Query: 355 LLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLD-PKLSNEYDNAQMQRMLLAANLC 413
           LL   + +  +    P  ++    P   +   E++ D     + + +    ++       
Sbjct: 306 LLL--KYLDCRPQDLPREVLT-TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362

Query: 414 INQSPQLRPN------------------MGQVLKLLRGATHATDWVDRHADDILGSGIQF 455
           +N    L P                      +L L+        W D    D+       
Sbjct: 363 LN---VLEPAEYRKMFDRLSVFPPSAHIPTILLSLI--------WFDVIKSDV------M 405

Query: 456 QEDDDCQKFS-----SKPHLDFPILDIDLEATSPSSIYTKSFSGTGEKPTSLIGTERTQH 510
              +   K+S      K      I  I LE                         E   H
Sbjct: 406 VVVNKLHKYSLVEKQPKEST-ISIPSIYLELKVKLE------------------NEYALH 446

Query: 511 RKLKDY 516
           R + D+
Sbjct: 447 RSIVDH 452

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 24/166 (14%)

Query: 225 EDNYLILVSDFLPKGSLEESLHGAGEQ----SVLPWGVRFEVAVAIAEALNYLHSECSRP 280
           E +Y ++V + L   SLE+  +    +    +VL       +A  +   + Y+HS   + 
Sbjct: 76  EGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVL------LLADQMISRIEYIHS---KN 125

Query: 281 VIHRDVKSSNILLSSDFQPQ---LSDFGLAI--WGPTDSTHM-IRED--VVGTFGYIAPE 332
            IHRDVK  N L+    +     + DFGLA          H+  RE+  + GT  Y +  
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 333 YLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
             +  + S + D+ S G VL+    G  P  ++ LK      K+ +
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYER 229

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/110 (24%), Positives = 43/110 (39%), Gaps = 23/110 (20%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGT 325
           I +++N+LHS     + H D+K  NIL       +  +  +     T     I+   V  
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK---VVD 180

Query: 326 FG-----------YI------APEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           FG            +      APE ++    S   DV+S G +L+E   G
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 28/113 (24%), Positives = 42/113 (37%), Gaps = 23/113 (20%)

Query: 266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDV--- 322
           I +ALNYL       + H D+K  NILL   +  +       +           +     
Sbjct: 146 ILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 323 VGTFG-----------YI------APEYLMHGKVSDKIDVYSFGVVLLELLSG 358
           +  FG            I      APE +++       D++SFG VL EL +G
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	522
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.8
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.09
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.94
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.45
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.44
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.18
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.13
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.99
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	96.92
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	96.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.15
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	91.86
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	86.63
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	85.97
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.87
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	82.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	80.65

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-54  Score=434.60  Aligned_cols=267  Identities=21%  Similarity=0.292  Sum_probs=218.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++++.||+|+||.||++.+..        +.+.||+|.+.+.........+.+.+|+++|++|+|||||++++++
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~--------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  101 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELA--------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF  101 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECC--------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34679999999999999999998654        5778888887654433334568899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+|||||||+||+|.+++...+   .+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|
T Consensus       102 ~~~~~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~D  175 (311)
T 4aw0_A          102 QDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITD  175 (311)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEE
Confidence            99999999999999999999998543   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+|+..............+||+.|||||++.+..|+.++|||||||++|||++|+.||...+   ...+...   +.. 
T Consensus       176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~---i~~-  248 (311)
T 4aw0_A          176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAK---IIK-  248 (311)
T ss_dssp             CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHH-
T ss_pred             cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---HHc-
Confidence            999987765544444556789999999999999999999999999999999999999996543   2222211   111 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +..          .++...+..+.+|+.+||+.||.+|||+.|++..-.  ...|+|++.
T Consensus       249 ~~~----------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~--i~~Hp~F~~  296 (311)
T 4aw0_A          249 LEY----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP--LKAHPFFES  296 (311)
T ss_dssp             TCC----------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH--HHTSGGGTT
T ss_pred             CCC----------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH--HHCCCCcCC
Confidence            111          111123456889999999999999999998753210  123888764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3e-54  Score=435.74  Aligned_cols=268  Identities=23%  Similarity=0.380  Sum_probs=213.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|.+.++||+|+||.||++......   ...+...+|+|.++..   .....++|.+|+++|++|+|||||+++|+|.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~---~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLC---PEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC-------CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcc---cCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            357999999999999999998643210   1224566777776532   2335678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG----------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      +++.++||||||++|+|.++|+..+          ....++|..++.|+.||+.||.|||+   ++||||||||+||||+
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~  162 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVG  162 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEEC
Confidence            9999999999999999999997642          23469999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhH
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL  373 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l  373 (522)
                      .++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....   ..+
T Consensus       163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~  239 (299)
T 4asz_A          163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV  239 (299)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH
T ss_pred             CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            999999999999976554433333345579999999999999999999999999999999999 9999975431   222


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      ....    ..+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       240 ~~~i----~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          240 IECI----TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHH----HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            2221    1222111         1223456788999999999999999999999999887643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-53  Score=435.69  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=207.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|+++++||+|+||.||++.+..        +++.||+|.+.+... .....++|.+|+.+|++|+|||||++++++.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~--------~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   93 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTE--------DGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFE   93 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETT--------TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECC--------CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence            4689999999999999999998653        567788887754322 2235678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|||||||+||+|.++|...+ ...+++..++.|+.||+.||.|||+   ++||||||||+||||+.++.+||+||
T Consensus        94 ~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           94 ENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECST
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEccc
Confidence            9999999999999999999997543 3358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+......  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.   ..+.   ..+.. +
T Consensus       170 Gla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~---~~i~~-~  240 (350)
T 4b9d_A          170 GIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV---LKIIS-G  240 (350)
T ss_dssp             TEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHH-T
T ss_pred             ccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH---HHHHc-C
Confidence            9997654321  122346799999999999999999999999999999999999999975431   1221   11111 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      ....     +    +...+..+.+|+.+||+.||.+|||+.|+++        |+|+....
T Consensus       241 ~~~~-----~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--------hp~~~~~~  284 (350)
T 4b9d_A          241 SFPP-----V----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE--------KGFIAKRI  284 (350)
T ss_dssp             CCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SHHHHTTG
T ss_pred             CCCC-----C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHHhhcCC
Confidence            1111     1    1223457889999999999999999999997        88876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-53  Score=433.37  Aligned_cols=269  Identities=24%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..++.+.++||+|+||.||++.....   ....+.+.||+|.++..   .....++|.+|+++|++|+|||||+++|+|.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~---~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNL---LPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSS---CC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCc---ccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            35688899999999999999864311   01224567787776532   2345688999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCC------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGE------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      +++.++||||||++|+|.++|+....            ...++|.+++.|+.||+.||.|||+   ++||||||||+|||
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCL  190 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEE
Confidence            99999999999999999999986432            2359999999999999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChh
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPE  371 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~  371 (522)
                      |+.++.+||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.....   .
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~  267 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---T  267 (329)
T ss_dssp             EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---H
T ss_pred             ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---H
Confidence            99999999999999987655444434445679999999999999999999999999999999999 9999965431   1


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      .+...+    ..+...         ..+...+..+.+|+.+||+.||.+|||+.||++.|+.+....
T Consensus       268 ~~~~~i----~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          268 EAIDCI----TQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHHHHH----HHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHH----HcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            222211    111111         112223467889999999999999999999999999876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=425.17  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+++++.++||+|+||.||++....           .+|+|.++.. ....+..++|.+|+.+|++|+|||||+++|+|.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-----------~vAvK~~~~~-~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~  102 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG-----------DVAVKILKVV-DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT  102 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS-----------EEEEEECCCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC-----------cEEEEEEEec-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4678899999999999999986432           2444444321 122345678999999999999999999999986


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +.++||||||++|+|.++|+...  ..+++..++.|+.||+.||.|||+   ++||||||||+||||+.++.+||+||
T Consensus       103 ~-~~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          103 K-DNLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             S-SSCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             C-CeEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeec
Confidence            5 56899999999999999997542  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |+|+...............||+.|||||++.+   +.|+.++|||||||++|||+||+.||.....  ...+.....   
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~---  251 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVG---  251 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH---
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHh---
Confidence            99987654433333445689999999999964   4689999999999999999999999964332  222222111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                       .+..    .|.+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       252 -~~~~----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          252 -RGYA----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             -TTCC----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             -cCCC----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence             1111    1111 1112234567889999999999999999999999998765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-53  Score=430.69  Aligned_cols=267  Identities=21%  Similarity=0.285  Sum_probs=212.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..+.+++.++||+|+||.||++.....   ......+.||+|.++...  .....++|.+|+.++++|+|||||+++|+|
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~---~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGP---APGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC----------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCC---ccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            345788999999999999999874321   112345677888775432  223467899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      .+++.++||||||++|+|.++|.....             ...+++..++.|+.||+.||.|||+   ++||||||||+|
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~N  175 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRN  175 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccc
Confidence            999999999999999999999975421             2359999999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~  369 (522)
                      |||++++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||....   
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---  252 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---  252 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999986544433333445679999999999999999999999999999999998 899996543   


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...+...+    ..+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       253 ~~~~~~~i----~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQDVVEMI----RNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHH----HcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22222222    2222211         1223456788999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-52  Score=430.12  Aligned_cols=257  Identities=21%  Similarity=0.318  Sum_probs=211.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.++||+|+||.||++.+..        +++.||+|.+......   ..+.|.+|+.+|++|+|||||++++++.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~--------tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  142 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS--------SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLV  142 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC--------CCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            569999999999999999998653        5677888877543322   34568899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+|||||||+||+|.+++...    .+++..+..++.||+.||.|||+   ++||||||||+||||+.++.+||+|||
T Consensus       143 ~~~~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          143 GDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             TTEEEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCc
Confidence            99999999999999999999742    39999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +|+........  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.   ........    .+.
T Consensus       216 la~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~----~~~  286 (346)
T 4fih_A          216 FCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR----DNL  286 (346)
T ss_dssp             TCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSS
T ss_pred             CceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH----cCC
Confidence            99876543322  2356899999999999999999999999999999999999999965421   11211111    111


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .     +.+  ......+..+.+|+.+||+.||.+|||+.|+++        |+|+...
T Consensus       287 ~-----~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--------Hp~~~~~  330 (346)
T 4fih_A          287 P-----PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--------HPFLAKA  330 (346)
T ss_dssp             C-----CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CGGGGGC
T ss_pred             C-----CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------CHhhcCC
Confidence            1     111  111224467889999999999999999999997        9998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-52  Score=418.80  Aligned_cols=258  Identities=20%  Similarity=0.271  Sum_probs=196.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +++.||+|.+.+.........++|.+|+.+|++++|||||++++++
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   82 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTT--------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI   82 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTT--------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            45799999999999999999997653        5677888876543333334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+|+||||+ +|+|.+++...+   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~D  155 (275)
T 3hyh_A           83 KSKDEIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIAD  155 (275)
T ss_dssp             ECSSEEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECC
T ss_pred             EECCEEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEee
Confidence            9999999999999 679999998543   59999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+|+.......   .....||+.|||||++.+..+ +.++|||||||++|+|++|+.||...+   ...+.....    
T Consensus       156 FGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~----  225 (275)
T 3hyh_A          156 FGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNIS----  225 (275)
T ss_dssp             SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----
T ss_pred             cCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----
Confidence            999976544322   234689999999999988776 579999999999999999999996532   222222111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+..          .++...+..+.+++.+||+.||.+|||+.|+++        |+|++..
T Consensus       226 ~~~~----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~--------hpw~k~~  269 (275)
T 3hyh_A          226 NGVY----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--------DDWFKVD  269 (275)
T ss_dssp             HTCC----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--------CHHHHTT
T ss_pred             cCCC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc--------CcccccC
Confidence            1111          011123456888999999999999999999998        9998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-52  Score=417.85  Aligned_cols=257  Identities=23%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             CCc-eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPF-QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y-~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ++| ++.++||+|+||.||++.+..        +.+.||+|.+..... .....++|.+|+++|++|+|||||+++++|.
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTE--------TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECC--------CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            455 788899999999999987653        456677666543221 2235678999999999999999999999997


Q ss_pred             e----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceeccC-CC
Q 036172          225 E----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLSS-DF  297 (522)
Q Consensus       225 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~~-~~  297 (522)
                      +    ++.+|||||||+||+|.+++...   ..+++..+..++.||+.||.|||+   ++  ||||||||+||||+. ++
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g  169 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTS
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCC
Confidence            5    35689999999999999999854   359999999999999999999999   77  999999999999984 78


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||+|+.....    .....+||+.|||||++. ++|+.++|||||||++|||+||+.||....  ....+... 
T Consensus       170 ~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~-  241 (290)
T 3fpq_A          170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRR-  241 (290)
T ss_dssp             CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHH-
T ss_pred             CEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHH-
Confidence            9999999999764332    223568999999999885 569999999999999999999999996432  22222221 


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         +..+....        ..+...+..+.+|+.+||+.||.+|||+.|+++        |+|++++
T Consensus       242 ---i~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--------Hp~~~~~  289 (290)
T 3fpq_A          242 ---VTSGVKPA--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--------HAFFQEE  289 (290)
T ss_dssp             ---HTTTCCCG--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGC--
T ss_pred             ---HHcCCCCC--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CccccCC
Confidence               11111111        111122346888999999999999999999997        9998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.8e-52  Score=422.64  Aligned_cols=263  Identities=22%  Similarity=0.258  Sum_probs=209.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|++.++||+|+||.||++.+..        +++.||+|.++...        .+.+|+.+|++|+|||||++++++.
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~--------~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~  120 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQ--------TGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVR  120 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECC--------CCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4578999999999999999998653        56778888765321        1347999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~kL~D  303 (522)
                      +++.+|||||||+||+|.++|...+   .+++..+..++.||+.||.|||+   ++||||||||+||||+.++ .+||+|
T Consensus       121 ~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~D  194 (336)
T 4g3f_A          121 EGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCD  194 (336)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECC
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEee
Confidence            9999999999999999999998643   59999999999999999999999   9999999999999999987 699999


Q ss_pred             cCccccCCCCCC---CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDST---HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||+|+.......   .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.     
T Consensus       195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-----  269 (336)
T 4g3f_A          195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-----  269 (336)
T ss_dssp             CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-----
T ss_pred             CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----
Confidence            999987654321   112234679999999999999999999999999999999999999997654333221111     


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc-----cCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT-----HATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~-----~~~~~~~~  443 (522)
                       .....        ....+...+..+.+++.+||+.||.+|||+.||++.|....     -.|+|+..
T Consensus       270 -~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          270 -SEPPP--------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             -HSCCG--------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             -cCCCC--------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence             11000        01122334567889999999999999999999998876643     24677653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=431.77  Aligned_cols=258  Identities=21%  Similarity=0.296  Sum_probs=211.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.++||+|+||.||++.+..        +++.||+|.+.....   ...+.|.+|+.+|++|+|||||+++++|.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~--------tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  218 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRS--------SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYL  218 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECC--------CCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEE
Confidence            3579999999999999999998653        567788887653322   23456899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|||||||+||+|.+++...    .+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+||
T Consensus       219 ~~~~~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          219 VGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecC
Confidence            999999999999999999999743    39999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+........  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....   ........   . +
T Consensus       292 Gla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~---~-~  362 (423)
T 4fie_A          292 GFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR---D-N  362 (423)
T ss_dssp             TTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH---H-S
T ss_pred             ccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH---c-C
Confidence            999876543322  2356899999999999999999999999999999999999999965331   11111111   1 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ....+     .  .....+..+.+|+.+||+.||.+|||+.|+++        |+|+...
T Consensus       363 ~~~~~-----~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--------Hp~~~~~  407 (423)
T 4fie_A          363 LPPRL-----K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--------HPFLAKA  407 (423)
T ss_dssp             CCCCC-----S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CGGGGGC
T ss_pred             CCCCC-----c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------CHHhcCC
Confidence            11111     0  11123457889999999999999999999997        9998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.9e-52  Score=417.80  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=202.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++++.||+|+||.||++....     .....+.||+|.+++...... ...+|.+|+++|++|+|||||++++++.
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKIS-----GSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECS-----STTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEcc-----CCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            3679999999999999999986532     123456788887755332211 2346889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|||||||+||+|.+++...+   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DF  170 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF  170 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESS
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccc
Confidence            9999999999999999999998643   49999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+........  ....+||+.|||||++.+..++.++|||||||++|||++|+.||...+.   ..+...   ... +
T Consensus       171 Gla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~---i~~-~  241 (304)
T 3ubd_A          171 GLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTM---ILK-A  241 (304)
T ss_dssp             EEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---HHH-C
T ss_pred             ccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHH---HHc-C
Confidence            999765433221  2346899999999999999999999999999999999999999975432   122111   111 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..          .++...+..+.+|+.+||+.||.+|||+     +|+++        |+|++.
T Consensus       242 ~~----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--------Hp~f~~  287 (304)
T 3ubd_A          242 KL----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--------HSFFST  287 (304)
T ss_dssp             CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--------SGGGTT
T ss_pred             CC----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--------CccccC
Confidence            11          1112234578899999999999999984     67775        999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-51  Score=426.34  Aligned_cols=268  Identities=24%  Similarity=0.372  Sum_probs=213.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC-CCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H-pnIv~l~~~~  223 (522)
                      .++|++.++||+|+||.||++......   .....+.+|+|.++...  .....++|.+|+.+|++++| ||||+++|+|
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~---~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGID---KTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSS---STTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCC---cccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            468999999999999999998744211   11234567777664322  23356789999999999965 8999999999


Q ss_pred             EeC-CEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          224 IED-NYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       224 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      .+. +.++||||||++|+|.++|+....             ...+++..++.++.||+.||.|||+   ++||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcc
Confidence            765 578999999999999999975421             3458999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987766555555556789999999999999999999999999999999998 99999754322


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        ..+...    +..+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       295 --~~~~~~----i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          295 --EEFCRR----LKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             --HHHHHH----HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHH----HHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              122221    12221111         11223457889999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.8e-49  Score=397.27  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++++.||+|+||.||++.+..        +.+.||+|.++..  +.....++|.+|+.+|++|+|||||++++++.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~--------~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   74 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV--------DDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLE   74 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT--------TCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC--------CCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            468999999999999999987643        5667888776432  223356789999999999999999999999975


Q ss_pred             CC------------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          226 DN------------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       226 ~~------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      .+            .+|+|||||++|+|.+++.........++..++.++.||+.||+|||+   ++|+||||||+||||
T Consensus        75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl  151 (299)
T 4g31_A           75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFF  151 (299)
T ss_dssp             EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred             cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEE
Confidence            44            479999999999999999876544446677889999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCc----------cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHM----------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG  363 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~  363 (522)
                      +.++.+||+|||+|+.........          .....+||+.|||||++.+..|+.++|||||||++|||++   ||.
T Consensus       152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            999999999999997664432211          1234579999999999999999999999999999999996   764


Q ss_pred             CCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          364 FKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       364 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..     ......... .......         .........+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       229 ~~-----~~~~~~~~~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--------h~~~~~  285 (299)
T 4g31_A          229 TQ-----MERVRTLTD-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--------NAVFED  285 (299)
T ss_dssp             SH-----HHHHHHHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SGGGCC
T ss_pred             Cc-----cHHHHHHHH-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--------CHhhCC
Confidence            21     111111111 1111111         112233445678999999999999999999997        888764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-49  Score=399.58  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=197.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|.+.++||+|+||.||++...          ++.||+|.+....    .....+..|+..+.+++|||||+++++|.+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~----------g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~   68 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR----------GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET----------TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC----------CEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            46889999999999999998642          3457777653211    111223456666678999999999999987


Q ss_pred             CC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC-----CCCEEeccCCCCceeccCC
Q 036172          226 DN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC-----SRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       226 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~giiHrDIkp~NILl~~~  296 (522)
                      ++    .++||||||++|+|.++|+..    .+++..+++++.|++.||+|||+.+     ..+||||||||+||||+.+
T Consensus        69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~  144 (303)
T 3hmm_A           69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  144 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             cCCCceEEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence            54    689999999999999999853    3899999999999999999999721     2399999999999999999


Q ss_pred             CceEEeecCccccCCCCCCC--ccccccccCCCCCChhhhccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036172          297 FQPQLSDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHG------KVSDKIDVYSFGVVLLELLSGRRPIGFKNLK  368 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~  368 (522)
                      +.+||+|||+++........  .......||+.|||||++.+.      .++.++|||||||++|||+||..||......
T Consensus       145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~  224 (303)
T 3hmm_A          145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence            99999999999765443322  122345799999999999654      3678999999999999999998887543221


Q ss_pred             Chh--------hHHHhhhhhhcCCCcccccCCcccccc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          369 GPE--------SLVKWAKPILKNGDTETLLDPKLSNEY-DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       369 ~~~--------~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...        ............    ..++|.+.... ....+..+.+++.+||+.||.+|||+.||++.|+.+.+
T Consensus       225 ~~p~~~~~~~~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          225 QLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhcccccchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            110        000111111111    12223332222 23456788999999999999999999999999988653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=404.11  Aligned_cols=273  Identities=19%  Similarity=0.273  Sum_probs=207.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|+++++||+|+||.||++.+..        +++.||+|.+++... .....+++.+|+.+|++|+|||||++++++.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~--------t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRL--------TGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECC--------CCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            4689999999999999999998653        567888888764332 2334578999999999999999999999986


Q ss_pred             e------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 E------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      .      .+.+|||||||+ |+|.+++...   ..+++..+..++.||+.||.|||+   ++||||||||+|||++.++.
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~  196 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCE  196 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCC
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCC
Confidence            4      367999999995 6899999743   459999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCC--CCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          299 PQLSDFGLAIWGPTDS--THMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      +||+|||+|+.+....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+ 
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I-  275 (398)
T 4b99_A          197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI-  275 (398)
T ss_dssp             EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH-
T ss_pred             EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence            9999999998654332  12223456899999999998775 4699999999999999999999999754422211111 


Q ss_pred             hhhhhhcCCCccc--------------ccCCccc---ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          376 WAKPILKNGDTET--------------LLDPKLS---NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       376 ~~~~~~~~~~~~~--------------~~d~~l~---~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                       .. .........              .+.+...   .......+..+.+|+.+||+.||.+|||+.|+++        |
T Consensus       276 -~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--------H  345 (398)
T 4b99_A          276 -MM-VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--------H  345 (398)
T ss_dssp             -HH-HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--------S
T ss_pred             -HH-hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--------C
Confidence             10 000000000              0000000   0011122457889999999999999999999997        9


Q ss_pred             cccccc
Q 036172          439 DWVDRH  444 (522)
Q Consensus       439 ~~~~~~  444 (522)
                      +|++..
T Consensus       346 p~f~~~  351 (398)
T 4b99_A          346 PFLAKY  351 (398)
T ss_dssp             GGGTTT
T ss_pred             HhhCcC
Confidence            999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.2e-47  Score=391.78  Aligned_cols=273  Identities=22%  Similarity=0.262  Sum_probs=201.9

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ...++|++.++||+|+||.||+|.+..     .....+.||+|.+.+.     ....++.+|+++|+.+ +|||||++++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQL-----QVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEB-----TTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcc-----cCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEE
Confidence            345789999999999999999987531     1234566777765432     1345688999999999 7999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-CceE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQ  300 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-~~~k  300 (522)
                      ++.+++++||||||+++|+|.+++.      .+++.++..++.||+.||+|||+   +||+||||||+|||++.+ +.+|
T Consensus        88 ~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           88 CFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEE
Confidence            9999999999999999999999985      28999999999999999999999   999999999999999876 7999


Q ss_pred             EeecCccccCCCCCCC--------------------------ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHH
Q 036172          301 LSDFGLAIWGPTDSTH--------------------------MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLL  353 (522)
Q Consensus       301 L~DFGla~~~~~~~~~--------------------------~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~  353 (522)
                      |+|||+|+........                          ......+||+.|+|||++.+. .++.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999755432211                          011235799999999999775 4899999999999999


Q ss_pred             HHHcCCCCCCCCCCCChhhHHHhhh------------hh----hcCCCcc--------------cccCCccc--------
Q 036172          354 ELLSGRRPIGFKNLKGPESLVKWAK------------PI----LKNGDTE--------------TLLDPKLS--------  395 (522)
Q Consensus       354 eLltG~~Pf~~~~~~~~~~l~~~~~------------~~----~~~~~~~--------------~~~d~~l~--------  395 (522)
                      ||++|+.||..... ....+.....            ..    .......              ....|...        
T Consensus       239 ell~G~~Pf~~~~~-~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  317 (361)
T 4f9c_A          239 SLLSGRYPFYKASD-DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT  317 (361)
T ss_dssp             HHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred             HHHHCCCCCCCCCC-HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence            99999999953321 1111111100            00    0000000              00000000        


Q ss_pred             -ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          396 -NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       396 -~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .......+..+.+|+.+||+.||.+|||+.|+++        |+|++.
T Consensus       318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--------Hp~f~~  358 (361)
T 4f9c_A          318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--------HPFFKD  358 (361)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--------SGGGTT
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--------CcccCC
Confidence             0001123456789999999999999999999997        999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.2e-47  Score=415.49  Aligned_cols=261  Identities=21%  Similarity=0.239  Sum_probs=210.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHH---HHHHHHHHHHhhCCCCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAW---NDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~---~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ..++|++++.||+|+||.||++.+..        +++.||+|.|.+.........   .....++.+++.++|||||+++
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~--------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKAD--------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECC--------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            45789999999999999999998653        677888888755432222222   3334457778888999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +++.+.+.+|||||||+||+|.++|...+   .+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+|
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vK  332 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVR  332 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEE
Confidence            99999999999999999999999998643   49999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |+|||+|+.......    ...+||+.|||||++.. ..|+.++|||||||++|||++|+.||..........+..... 
T Consensus       333 L~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-  407 (689)
T 3v5w_A          333 ISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-  407 (689)
T ss_dssp             ECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-
T ss_pred             ecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-
Confidence            999999987654332    24589999999999975 479999999999999999999999997655444333222211 


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .. .          ..++...+..+.+||.+||+.||.+|++     +.||++        |+|++.-
T Consensus       408 --~~-~----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--------HpfF~~i  456 (689)
T 3v5w_A          408 --TM-A----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--------SPFFRSL  456 (689)
T ss_dssp             --HC-C----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--------SGGGTTC
T ss_pred             --CC-C----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--------CccccCC
Confidence              11 0          1112223457889999999999999998     688876        9998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-46  Score=406.46  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=210.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        +++.||+|.+.+.   .....+.+.+|+.+|++|+|||||++++++.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~--------tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  224 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA--------TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFE  224 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC--------CCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4689999999999999999987653        5667777765431   2234567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC--CceEEe
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD--FQPQLS  302 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~--~~~kL~  302 (522)
                      +++.+|||||||+||+|.++|...  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+
T Consensus       225 ~~~~~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          225 DDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             CSSEEEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             ECCEEEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEe
Confidence            999999999999999999999743  2359999999999999999999999   999999999999999854  799999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+|+.......   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......   ......    .
T Consensus       300 DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i----~  369 (573)
T 3uto_A          300 DFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNV----K  369 (573)
T ss_dssp             CCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH----H
T ss_pred             eccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH----H
Confidence            9999987654322   23457999999999999999999999999999999999999999654321   111111    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+..      .+........+..+.+||.+||+.||.+|||+.|+++        |+|++..
T Consensus       370 ~~~~------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--------Hpw~~~~  417 (573)
T 3uto_A          370 SCDW------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--------HPWLTPG  417 (573)
T ss_dssp             TTCC------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------STTTSCC
T ss_pred             hCCC------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CcCcCCC
Confidence            1111      0011111223457889999999999999999999998        8998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.2e-45  Score=368.80  Aligned_cols=280  Identities=31%  Similarity=0.547  Sum_probs=237.6

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ....++|++.+.||+|+||.||++...         ..+.+++|.+..   ......++|.+|+.++++++||||+++++
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  102 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR---------DGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPHLVSLIG  102 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT---------TCCEEEEEECCS---CCSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC---------CCCEEEEEEecc---cChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            345679999999999999999998742         234556554322   22335678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      ++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEE
T ss_pred             EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999997643 22359999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||++................||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............|....
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999997654433333333456899999999999999999999999999999999999999877666666667776666


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...+.....+++.+........+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            66777778888888777888899999999999999999999999999999998753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-44  Score=367.15  Aligned_cols=286  Identities=33%  Similarity=0.577  Sum_probs=234.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++...         ..+.+++|.+......  .....|.+|+.++++++||||+++++++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA---------DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS---------SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             HhhccccceeEecCCCcEEEEEEec---------CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3578999999999999999998632         2456666655432211  1223689999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998653 33459999999999999999999999211299999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCChhhHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN--LKGPESLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~--~~~~~~l~~~~~~~  380 (522)
                      |||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....  .........|....
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999876543332 2234569999999999998899999999999999999999999996321  22233456667777


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      ..........+..+...+....+..+.+++.+||+.||.+|||+.+|++.|++..-...|.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  316 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE  316 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence            7777788888888888888899999999999999999999999999999999877655553

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-43  Score=356.56  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=208.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|.+....   ....+.+.+|+.++++++||||+++++++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVA--------TGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSY   86 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTT--------TCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECC--------CCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEE
Confidence            35689999999999999999987543        45566666543222   22356789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..++..++||||+++|+|.+++...    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EECCEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999753    38999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.........  .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||......  .......    ..
T Consensus       160 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~----~~  231 (297)
T 3fxz_A          160 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIA----TN  231 (297)
T ss_dssp             CTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH----HH
T ss_pred             CCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----hC
Confidence            9999765543322  23457999999999999999999999999999999999999999643211  1111111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +.. ..       ..+...+..+.+++.+||+.||.+|||+.++++        ++|++..
T Consensus       232 ~~~-~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--------h~~~~~~  276 (297)
T 3fxz_A          232 GTP-EL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--------HQFLKIA  276 (297)
T ss_dssp             CSC-CC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CGGGGGC
T ss_pred             CCC-CC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh--------Chhhccc
Confidence            110 00       111223456889999999999999999999997        8898753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-43  Score=368.54  Aligned_cols=270  Identities=22%  Similarity=0.352  Sum_probs=212.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++++.||+|+||.||++...... .........+++|.++..  ......++|.+|+.+++++ +||||++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCS-TTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEeccc-CcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3568999999999999999998753210 001223445676666432  1223567899999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      |.+.+.+++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~  232 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAAR  232 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchh
Confidence            9999999999999999999999986531             2348999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999986654433333334567889999999999999999999999999999999 99999754322


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                         .+....    ..+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       313 ---~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          313 ---ELFKLL----KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ---GHHHHH----HTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHH----hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               222111    111111         111223457889999999999999999999999998875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-43  Score=363.13  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=209.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +++.+++|.+.+... .....+++.+|+.++++++||||+++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   83 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL--------TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVI   83 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35789999999999999999987643        456677776543221 223567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ...+.+++||||+++|+|.+++...+   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           84 ETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EECCEEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEee
Confidence            99999999999999999999997543   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS-DKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++........   .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||......   .+....   ..
T Consensus       158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i---~~  228 (328)
T 3fe3_A          158 FGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERV---LR  228 (328)
T ss_dssp             TTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH
T ss_pred             ccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---Hh
Confidence            999976544322   2345799999999999888765 8999999999999999999999754321   111111   11


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       +...          .+...+..+.+++.+||+.||.+|||+.++++        |+|+...
T Consensus       229 -~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~--------h~~~~~~  271 (328)
T 3fe3_A          229 -GKYR----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK--------DRWINAG  271 (328)
T ss_dssp             -CCCC----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--------CTTTTTT
T ss_pred             -CCCC----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc--------CHhhcCC
Confidence             1110          11123456788999999999999999999997        9998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=356.05  Aligned_cols=258  Identities=23%  Similarity=0.335  Sum_probs=206.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        ..+.+++|.+..   ......+.|.+|+.++++++||||+++++++.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   77 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE--------TGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY   77 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT--------TCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECC--------CCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence            4689999999999999999987643        345566554421   22345678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df  152 (310)
T 3s95_A           78 KDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADF  152 (310)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCC
T ss_pred             cCCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeec
Confidence            9999999999999999999998642  349999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCc------------cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          305 GLAIWGPTDSTHM------------IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       305 Gla~~~~~~~~~~------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      |++..........            ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~  232 (310)
T 3s95_A          153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF  232 (310)
T ss_dssp             TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred             ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence            9997654432211            1114579999999999999999999999999999999999999986443222110


Q ss_pred             ---HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          373 ---LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       373 ---l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                         .......                 ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       233 ~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          233 GLNVRGFLDR-----------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             SBCHHHHHHH-----------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhhhccccc-----------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               1110000                 011122346888999999999999999999999998875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=365.68  Aligned_cols=262  Identities=21%  Similarity=0.326  Sum_probs=212.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +.+.|++|.+.+.........+.+.+|+.+|++++|||||++++++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~--------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKND--------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45789999999999999999987643        4567777766543333334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||+.+|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~D  158 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITD  158 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEec
Confidence            9999999999999999999999853   359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||++........   .....||+.|+|||++..   ..++.++|||||||++|+|++|+.||..........+.......
T Consensus       159 FG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~  235 (384)
T 4fr4_A          159 FNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT  235 (384)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC
T ss_pred             cceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc
Confidence            999986654322   234579999999999864   45899999999999999999999999765544443333322211


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .              ..++...+..+.+++.+||+.||.+||+ +.+|++        |+|+..-
T Consensus       236 ~--------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~--------hp~f~~~  278 (384)
T 4fr4_A          236 V--------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN--------FPYMNDI  278 (384)
T ss_dssp             C--------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT--------SGGGTTC
T ss_pred             c--------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc--------ChhhhcC
Confidence            0              1112223467889999999999999998 777765        7777653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.2e-43  Score=358.51  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=205.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        ..+.+++|.+....  .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   75 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV--------TEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRR   75 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC--------CCcEEEEEEEEccc--ccchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4789999999999999999986543        34556665542111  1123466889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Df  149 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDF  149 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEe
Confidence            999999999999999999999743   359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+...    
T Consensus       150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~----  224 (323)
T 3tki_A          150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----  224 (323)
T ss_dssp             TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT----
T ss_pred             eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc----
Confidence            99976543333333335679999999999987775 78999999999999999999999755433221 1111111    


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...   ..+      ....+..+.+++.+||+.||.+|||+.|+++        ++|+...
T Consensus       225 ~~~---~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--------h~~~~~~  268 (323)
T 3tki_A          225 KTY---LNP------WKKIDSAPLALLHKILVENPSARITIPDIKK--------DRWYNKP  268 (323)
T ss_dssp             CTT---STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CTTTTCC
T ss_pred             ccc---CCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhh--------Chhhccc
Confidence            000   000      1123456788999999999999999999997        8998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-43  Score=359.35  Aligned_cols=258  Identities=22%  Similarity=0.306  Sum_probs=210.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        +++.+++|.+++.........+.+.+|+.+|++++||||+++++++.
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~   75 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKA--------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence            4689999999999999999987643        56677877765543323335678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+.+++||||+++|+|.+++...+   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           76 THDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999998543   48999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+....   ... 
T Consensus       150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i---~~~-  220 (337)
T 1o6l_A          150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI---LME-  220 (337)
T ss_dssp             TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHC-
T ss_pred             cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHH---HcC-
Confidence            99975433221  1234579999999999999999999999999999999999999996432   11121111   111 


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..          .++...+..+.+++.+||+.||.+||     ++.+|++        |+|+..
T Consensus       221 ~~----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~--------h~~f~~  266 (337)
T 1o6l_A          221 EI----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--------HRFFLS  266 (337)
T ss_dssp             CC----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--------SGGGTT
T ss_pred             CC----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc--------CCCcCC
Confidence            10          01112345788899999999999999     8999997        888764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.5e-43  Score=352.26  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=207.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+...........++|.+|+.++++++||||+++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~   80 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTI--------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD   80 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETT--------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECC--------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence            45789999999999999999987543        3455666655333333344567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..++||||+++++|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           81 EEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eeCCeEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999999998543   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......   ..   .......
T Consensus       155 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~---~~~~~~~  227 (294)
T 4eqm_A          155 FGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---SI---AIKHIQD  227 (294)
T ss_dssp             CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HH---HHHHHSS
T ss_pred             CCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HH---HHHHhhc
Confidence            9999765433221 223457999999999999999999999999999999999999999654311   11   1111111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~~~  436 (522)
                      . .     +..........+..+.+++.+||+.||.+|| +++++.+.|+....
T Consensus       228 ~-~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          228 S-V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             C-C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             c-C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            1 0     1111112223456788999999999999999 99999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-43  Score=364.09  Aligned_cols=262  Identities=20%  Similarity=0.271  Sum_probs=208.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc---hHHHHHHHHHHHHhhCCCCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS---SAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~---~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ..++|++.+.||+|+||.||++....        +++.+++|.+++......   ...+.+.+|+.+|++++||||++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~--------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKS--------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECC--------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            45689999999999999999987643        455666666543222111   1357799999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---  297 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---  297 (522)
                      +++.+.+.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSS
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCc
Confidence            9999999999999999999999999743   359999999999999999999999   9999999999999998877   


Q ss_pred             -ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 -QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                       .+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ......
T Consensus       156 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~  229 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLAN  229 (361)
T ss_dssp             CCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHH
T ss_pred             cCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence             799999999977654322   2245799999999999988999999999999999999999999965321   111111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .    ..+...      .........+..+.+++.+||..||.+|||+.++++        |+|+..
T Consensus       230 i----~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~~~~  278 (361)
T 2yab_A          230 I----TAVSYD------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR--------HPWITP  278 (361)
T ss_dssp             H----HTTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--------STTTSC
T ss_pred             H----HhcCCC------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc--------CcCcCC
Confidence            1    111100      011111223457889999999999999999999997        899874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3e-43  Score=358.10  Aligned_cols=267  Identities=23%  Similarity=0.277  Sum_probs=205.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++...          .+.+++|.++..    ......+.+|+.++++++|||||++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL----------NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET----------TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC----------CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhccee
Confidence            3568999999999999999998653          245666654321    12344567799999999999999999999


Q ss_pred             EeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC----------CEEeccCCCC
Q 036172          224 IEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR----------PVIHRDVKSS  289 (522)
Q Consensus       224 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~----------giiHrDIkp~  289 (522)
                      .+..    .+++||||+++|+|.+++...    .+++..++.++.|++.||.|||+   .          +|+||||||+
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~  160 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSK  160 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGG
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChH
Confidence            9743    579999999999999999753    38999999999999999999999   7          9999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-----KVSDKIDVYSFGVVLLELLSGRRPIGF  364 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwSlGvvl~eLltG~~Pf~~  364 (522)
                      |||++.++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||..
T Consensus       161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999766554433333446799999999999763     456789999999999999999999976


Q ss_pred             CCCCChhhHH----------HhhhhhhcCCCcccccCCccccc-ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          365 KNLKGPESLV----------KWAKPILKNGDTETLLDPKLSNE-YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       365 ~~~~~~~~l~----------~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      ..........          .+... ......    .+.+... .....+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          241 PVDEYMLPFEEEIGQHPSLEDMQEV-VVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHH-HTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcchhccchhhhhccCCchhhhhhh-hhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            5432211111          11111 111111    1111111 122355679999999999999999999999999988


Q ss_pred             ccc
Q 036172          434 ATH  436 (522)
Q Consensus       434 ~~~  436 (522)
                      +..
T Consensus       316 l~~  318 (322)
T 3soc_A          316 MQR  318 (322)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=364.93  Aligned_cols=261  Identities=22%  Similarity=0.284  Sum_probs=205.6

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceee
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLN  220 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~  220 (522)
                      ....++|++.+.||+|+||.||++....        +.+.||+|.+++.........+.+.+|..+++.+ +||||++++
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~   90 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKE--------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF   90 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcC--------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence            3456799999999999999999987643        4567777776554333333567789999999998 799999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +++.+.+.+++||||+++|+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+|
T Consensus        91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ik  164 (353)
T 3txo_A           91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCK  164 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999998543   49999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+...   +
T Consensus       165 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~---i  236 (353)
T 3txo_A          165 LADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEA---I  236 (353)
T ss_dssp             ECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH---H
T ss_pred             EccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHH---H
Confidence            999999975333221  22345799999999999988899999999999999999999999965432   111111   1


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM------GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~------~eVl~~L~~~~~~~~~~~~  443 (522)
                      .. +..          .++...+..+.+++.+||+.||.+||++      .+|++        |+|++.
T Consensus       237 ~~-~~~----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--------hp~f~~  286 (353)
T 3txo_A          237 LN-DEV----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--------HPFFKE  286 (353)
T ss_dssp             HH-CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--------SGGGTT
T ss_pred             Hc-CCC----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--------CCcccC
Confidence            11 111          1111234568889999999999999998      77876        888765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-42  Score=350.34  Aligned_cols=275  Identities=19%  Similarity=0.188  Sum_probs=206.3

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.++||+|+||.||++.+.         ..+.+++|.+..... .....+.+.+|+.++++++||||++++++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   87 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS---------QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDV   87 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET---------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC---------CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            34689999999999999999998753         245666666543221 12245778999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+++.+++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~  161 (311)
T 3niz_A           88 IHSERCLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLA  161 (311)
T ss_dssp             ECCSSCEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EccCCEEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEc
Confidence            9999999999999975 8888887542  349999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||+++........  .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...................
T Consensus       162 Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  239 (311)
T 3niz_A          162 DFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP  239 (311)
T ss_dssp             CCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred             cCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence            99999765433222  223468999999999876 568999999999999999999999997654433222111100000


Q ss_pred             cCCC-------------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          382 KNGD-------------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~-------------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ....             ....................+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~f~~  306 (311)
T 3niz_A          240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--------HPYFKD  306 (311)
T ss_dssp             CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--------SGGGTT
T ss_pred             ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--------Cccccc
Confidence            0000             00001111111111223457889999999999999999999997        999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=356.21  Aligned_cols=261  Identities=16%  Similarity=0.206  Sum_probs=207.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.++.    .....+.+.+|+.++++++||||+++++++
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~~a~K~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   70 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETS--------SKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHESF   70 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECC----CTHHHHHHHHHHHHHHHSCCTTBCCEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECC--------CCcEEEEEEEec----CcccHHHHHHHHHHHHhCCCCCCCeEeEEE
Confidence            45789999999999999999987543        334455544321    122446788999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--CCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--DFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--~~~~kL  301 (522)
                      .+.+.+++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.  ++.+||
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           71 ESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EETTEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             ecCCEEEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEE
Confidence            9999999999999999999999753  2359999999999999999999999   99999999999999987  789999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .......   .
T Consensus       146 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i---~  216 (321)
T 1tki_A          146 IEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENI---M  216 (321)
T ss_dssp             CCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH---H
T ss_pred             EECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHH---H
Confidence            99999977654322   2345799999999999888899999999999999999999999965331   1111111   1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      .. ...      .........+..+.+++.+||..||.+|||+.|+++        |+|++...
T Consensus       217 ~~-~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--------hp~~~~~~  265 (321)
T 1tki_A          217 NA-EYT------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--------HPWLKQKI  265 (321)
T ss_dssp             HT-CCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------SHHHHSCG
T ss_pred             cC-CCC------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------ChhhccCc
Confidence            11 100      001111123467889999999999999999999998        89987653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=352.23  Aligned_cols=257  Identities=24%  Similarity=0.320  Sum_probs=209.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +++.+++|.+++.........+.+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRH--------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            34689999999999999999987643        4567777776554332233567789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~D  149 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITD  149 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEee
Confidence            9999999999999999999999854   349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ....   ......
T Consensus       150 fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~---~~i~~~  218 (318)
T 1fot_A          150 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTY---EKILNA  218 (318)
T ss_dssp             CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH---HHHHHC
T ss_pred             cCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhC
Confidence            9999765432     1245799999999999999999999999999999999999999964321   1111   111111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..          .++...+..+.+++.+||+.||.+||     ++.+|++        |+|++.-
T Consensus       219 -~~----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--------hp~f~~~  265 (318)
T 1fot_A          219 -EL----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--------HPWFKEV  265 (318)
T ss_dssp             -CC----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--------SGGGSSC
T ss_pred             -CC----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--------CccccCC
Confidence             10          01112345788899999999999999     8999987        8998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=347.70  Aligned_cols=277  Identities=17%  Similarity=0.192  Sum_probs=213.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.++...  .....+.+.+|++++++++||||+++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKK--------TGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIE   76 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECC--------CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            35689999999999999999987643        45667777665322  223467789999999999999999999999


Q ss_pred             EeCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec----cCCC
Q 036172          224 IEDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL----SSDF  297 (522)
Q Consensus       224 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl----~~~~  297 (522)
                      ....  ..++||||+++|+|.+++........+++..++.++.|++.||.|||+   .+|+||||||+|||+    +.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCE
T ss_pred             ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCc
Confidence            8765  789999999999999999876444459999999999999999999999   999999999999999    7788


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM--------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      .+||+|||+++........   ....||+.|+|||++.        +..++.++|||||||++|||++|+.||.......
T Consensus       154 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          154 VYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             EEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             eEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            8999999999776544322   2346999999999986        5778999999999999999999999996433221


Q ss_pred             h-hhHHHhhhhhhcCCCcccc---------c--CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          370 P-ESLVKWAKPILKNGDTETL---------L--DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       370 ~-~~l~~~~~~~~~~~~~~~~---------~--d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      . ...................         .  ...............+.+++.+||+.||.+|||+.|+++.......
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1 1111111110000000000         0  0111224456778889999999999999999999999998876653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-43  Score=354.91  Aligned_cols=262  Identities=26%  Similarity=0.387  Sum_probs=198.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++...          ...+++|.+... .......++|.+|+.++++++||||+++++++
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~----------~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH----------GSDVAVKILMEQ-DFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET----------TEEEEEEEECCC-CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC----------CCcEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3568999999999999999998642          233444443221 11123457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceeccCCCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~~~~~~kL  301 (522)
                      .+.+..++||||+++|+|.+++........+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEE
Confidence            9999999999999999999999865433349999999999999999999999   88  999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   .........  
T Consensus       181 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~--  253 (309)
T 3p86_A          181 CDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGF--  253 (309)
T ss_dssp             CCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHH--
T ss_pred             CCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh--
Confidence            99999975433221  12345799999999999999999999999999999999999999965432   111111110  


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       ....         ...+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       254 -~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          254 -KCKR---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -SCCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -cCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             1100         01112234568899999999999999999999999987753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-43  Score=361.10  Aligned_cols=259  Identities=18%  Similarity=0.267  Sum_probs=208.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++.+..        +.+.+++|.+.+.........+.+.+|+.+++.++||||++++++
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   77 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYK--------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV   77 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456899999999999999999988643        456677776544332222344679999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+..++||||+ +|+|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           78 ITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             EECSSEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEEC
T ss_pred             EEeCCEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEE
Confidence            99999999999999 679999987543   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||++........   .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...........       +
T Consensus       151 DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i  220 (336)
T 3h4j_B          151 DFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------V  220 (336)
T ss_dssp             CSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------C
T ss_pred             EeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------H
Confidence            9999976544322   224579999999999987775 7899999999999999999999975432221100       0


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..+          ....+...+..+.+++.+||+.||.+|||+.||++        ++|++..
T Consensus       221 ~~~----------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--------hp~~~~~  265 (336)
T 3h4j_B          221 NSC----------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--------DPWFNVN  265 (336)
T ss_dssp             CSS----------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--------CHHHHTT
T ss_pred             HcC----------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--------ChhhccC
Confidence            000          00111223456888999999999999999999997        8998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=354.76  Aligned_cols=262  Identities=20%  Similarity=0.279  Sum_probs=207.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc---chHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF---SSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~---~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      .++|++.+.||+|+||.||++....        +.+.+++|.+++.....   ....+.|.+|+.+|++++||||+++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKS--------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETT--------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECC--------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            4579999999999999999987643        44556666554322111   113577999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC----
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF----  297 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~----  297 (522)
                      ++.+....++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++    
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSC
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCC
Confidence            999999999999999999999999743   359999999999999999999999   9999999999999999887    


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .......
T Consensus       156 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~  229 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANV  229 (326)
T ss_dssp             CEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH
T ss_pred             CEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHH
Confidence            7999999999776543221   245799999999999988999999999999999999999999964321   1111111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..    ...      ..........+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       230 ~~----~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--------hp~~~~~  278 (326)
T 2y0a_A          230 SA----VNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--------HPWIKPK  278 (326)
T ss_dssp             HH----TCC------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--------STTTSCC
T ss_pred             Hh----cCC------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--------CCCccCC
Confidence            10    000      0011111123457889999999999999999999998        8998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-42  Score=351.48  Aligned_cols=267  Identities=16%  Similarity=0.135  Sum_probs=209.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+....     ..+.|.+|+.++++| +||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~   73 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLY--------TNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYF   73 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETT--------TTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECC--------CCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEE
Confidence            35789999999999999999987543        34566666543211     224688999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc----
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ----  298 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~----  298 (522)
                      +..++..++||||+ +++|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.    
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           74 GPCGKYNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTT
T ss_pred             EecCCccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCc
Confidence            99999999999999 89999999864  2359999999999999999999999   99999999999999998887    


Q ss_pred             -eEEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          299 -PQLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       299 -~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                       +||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~  227 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE  227 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence             9999999997654432211     1235679999999999999999999999999999999999999998765444333


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      .............         ........+ .+.+++..||+.+|.+||++.+|++.|+.......
T Consensus       228 ~~~~i~~~~~~~~---------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          228 RYQKIGDTKRATP---------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHHHHHHHHSC---------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhhhccCC---------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            3222211100000         000001123 78999999999999999999999999987764433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.3e-43  Score=353.45  Aligned_cols=277  Identities=20%  Similarity=0.257  Sum_probs=195.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++......     .....+++|.++.... .....++|.+|+.++++++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQED-----GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC------------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccC-----CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3568999999999999999998755321     1122456665543221 233567899999999999999999999999


Q ss_pred             EeCCEE------EEEEecCCCCCHHHHhhccC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          224 IEDNYL------ILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       224 ~~~~~~------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      ......      ++||||+++|+|.+++....   ....+++..++.++.|++.||.|||+   .+|+||||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEc
Confidence            977655      99999999999999997542   12258999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhH
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL  373 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l  373 (522)
                      .++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.......   +
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~  248 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I  248 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H
Confidence            999999999999976654433333334467889999999999999999999999999999999 999997543222   1


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHAD  446 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~  446 (522)
                      ....   .. +...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+.. ++|+.....
T Consensus       249 ~~~~---~~-~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~-~~~~~~~~~  307 (323)
T 3qup_A          249 YNYL---IG-GNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG-HLSVLSTSQ  307 (323)
T ss_dssp             HHHH---HT-TCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH-C--------
T ss_pred             HHHH---hc-CCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH-HhhhcCCCC
Confidence            1111   11 1100         1111234578899999999999999999999999999875 667665433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-42  Score=358.71  Aligned_cols=265  Identities=25%  Similarity=0.304  Sum_probs=208.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh--hccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT--SQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t--~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      .++|++.+.||+|+||.||++.+..        +.+.|++|.+....  .......+.|.+|+.++++++||||++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRE--------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECC--------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            4689999999999999999987643        45677777654322  1111235789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc---
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---  298 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~---  298 (522)
                      +.+++.+++||||+++|+|.+++... .....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.   
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCC
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCc
Confidence            99999999999999999999888654 223358999999999999999999999   99999999999999986654   


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....    ..+.... 
T Consensus       172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i-  244 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGI-  244 (351)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHH-
T ss_pred             EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHH-
Confidence            99999999976654322  1234579999999999999899999999999999999999999996531    1111111 


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .. +...  ..+    ......+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       245 --~~-~~~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--------hp~~~~~  293 (351)
T 3c0i_A          245 --IK-GKYK--MNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALN--------HPWLKER  293 (351)
T ss_dssp             --HH-TCCC--CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHTH
T ss_pred             --Hc-CCCC--CCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--------ChhhcCC
Confidence              11 1110  000    001123467889999999999999999999997        8887653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8e-43  Score=355.70  Aligned_cols=265  Identities=20%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++........    ....+++|.+.....  ....++|.+|+.++++++||||++++++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEK----VKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC--------CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCce----EEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            356899999999999999999875432111    122345555543222  23457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .++. .++|+||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEcc
Confidence            9765 788999999999999998643  359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........   ..    
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~----  233 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LE----  233 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HH----
T ss_pred             CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---HH----
Confidence            999987655444433444567889999999999999999999999999999999 9999975443222111   11    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+....
T Consensus       234 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          234 KGERL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTCCC---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             cCCCC---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11100         0111234568889999999999999999999999988764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=352.51  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++.+..        +.+.+++|.++...  .....+.|.+|+.+|++++||||+++++++.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   75 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV--------DDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLE   75 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT--------TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC--------CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            579999999999999999987643        45667777654221  22356789999999999999999999999876


Q ss_pred             CC---------------------------------------------------------EEEEEEecCCCCCHHHHhhcc
Q 036172          226 DN---------------------------------------------------------YLILVSDFLPKGSLEESLHGA  248 (522)
Q Consensus       226 ~~---------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~  248 (522)
                      ..                                                         ..++||||+++|+|.+++...
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  155 (332)
T 3qd2_B           76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR  155 (332)
T ss_dssp             CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred             eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence            43                                                         389999999999999999876


Q ss_pred             CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCC----------cc
Q 036172          249 GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTH----------MI  318 (522)
Q Consensus       249 ~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~  318 (522)
                      ......++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........          ..
T Consensus       156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          156 CSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             CSGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred             cCccchhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence            555567778899999999999999999   99999999999999999999999999999766543211          11


Q ss_pred             ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccc
Q 036172          319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY  398 (522)
Q Consensus       319 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  398 (522)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|..|+.        ........ ......         ...
T Consensus       233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~-~~~~~~---------~~~  294 (332)
T 3qd2_B          233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITD-VRNLKF---------PLL  294 (332)
T ss_dssp             CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHH-HHTTCC---------CHH
T ss_pred             ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHH-hhccCC---------Ccc
Confidence            234579999999999999999999999999999999999877642        11111111 111111         111


Q ss_pred             cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          399 DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       399 ~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .......+.+++.+||+.||.+|||+.++++        ++|++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--------~~~f~  330 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE--------NAIFE  330 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH--------STTCC
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhh--------chhhh
Confidence            2334466788999999999999999999998        88875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.9e-42  Score=357.08  Aligned_cols=262  Identities=20%  Similarity=0.264  Sum_probs=196.9

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ....++|++.++||+|+||.||++.+..        +.+.+++|.+.+...    ..+.+.+|+.++++++||||+++++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~   83 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKL--------TKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKE   83 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETT--------TCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECC--------CCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3446799999999999999999987643        456677776543211    2356889999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc--e
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ--P  299 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~--~  299 (522)
                      ++.+.+.+++||||+++|+|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.  +
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~  157 (361)
T 3uc3_A           84 VILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRL  157 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCE
T ss_pred             EEeeCCEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceE
Confidence            9999999999999999999999997543   49999999999999999999999   99999999999999987765  9


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCCh-hhHHHhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLVKWA  377 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~k-sDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~l~~~~  377 (522)
                      ||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ .....  
T Consensus       158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--  232 (361)
T 3uc3_A          158 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--  232 (361)
T ss_dssp             EECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH--
T ss_pred             EEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH--
Confidence            9999999964332221   224579999999999988887655 8999999999999999999975443221 11111  


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..... .....  .      ....+..+.+++.+||+.||.+|||+.++++        |+|+...
T Consensus       233 -~~~~~-~~~~~--~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--------hp~f~~~  281 (361)
T 3uc3_A          233 -RILSV-KYSIP--D------DIRISPECCHLISRIFVADPATRISIPEIKT--------HSWFLKN  281 (361)
T ss_dssp             -HHHTT-CCCCC--T------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--------SHHHHTT
T ss_pred             -HHhcC-CCCCC--C------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh--------CcchhcC
Confidence             11111 00000  0      0012356888999999999999999999997        8887554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-42  Score=350.62  Aligned_cols=269  Identities=23%  Similarity=0.330  Sum_probs=213.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++......   .....+.+++|.++..  ......+++.+|+.++++++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLK---GRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGG---GCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccC---cccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            3578999999999999999998753211   1223456666665432  1233567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC---------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE---------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVI  282 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~gii  282 (522)
                      .+++..++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+   .+|+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCc
Confidence            999999999999999999999986532                     2348999999999999999999999   9999


Q ss_pred             eccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCC
Q 036172          283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP  361 (522)
Q Consensus       283 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~P  361 (522)
                      ||||||+|||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976655443333334567889999999999899999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      |.......   +....    ..+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       253 ~~~~~~~~---~~~~~----~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          253 YPGIPPER---LFNLL----KTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             STTCCGGG---HHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHH---HHHHh----hcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            97544322   21111    111111         1112234578899999999999999999999999988653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.8e-42  Score=341.83  Aligned_cols=267  Identities=16%  Similarity=0.132  Sum_probs=211.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+..     ....+.+.+|+.+++++ +|+||++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~-----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~   74 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLL--------NNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCTGIPNVYYF   74 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT--------TTEEEEEEEEEC-----CTTSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECC--------CCcEEEEEEecc-----CCccHHHHHHHHHHHHHhcCCCCCeEEee
Confidence            45789999999999999999987532        345666665422     11234688999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc----
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ----  298 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~----  298 (522)
                      +.++...++||||+ +++|.+++...+  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.    
T Consensus        75 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           75 GQEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTT
T ss_pred             cCCCceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCC
Confidence            99999999999999 899999998643  249999999999999999999999   99999999999999987765    


Q ss_pred             -eEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          299 -PQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       299 -~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                       +||+|||++.........     .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence             999999999766543221     12235579999999999999999999999999999999999999998655444333


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      ..............         .......+..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       229 ~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          229 KYERIGEKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhhccCccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            32222111110000         1111123467889999999999999999999999999876533

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.8e-43  Score=359.38  Aligned_cols=269  Identities=23%  Similarity=0.360  Sum_probs=211.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.++||+|+||.||++.....   .....++.+++|.++..  ......+.|.+|+++++++ +||||++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGI---DKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS---SSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceeeceeecCCCCceEEEEEeccc---cccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            357899999999999999999863211   01234567777766432  2233567899999999999 89999999999


Q ss_pred             EEeCC-EEEEEEecCCCCCHHHHhhccCC---------------------------------------------------
Q 036172          223 CIEDN-YLILVSDFLPKGSLEESLHGAGE---------------------------------------------------  250 (522)
Q Consensus       223 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------  250 (522)
                      +.+.+ .+++||||+++|+|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            98764 58999999999999999986532                                                   


Q ss_pred             ------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCcc
Q 036172          251 ------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI  318 (522)
Q Consensus       251 ------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  318 (522)
                                  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...........
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                        1228999999999999999999999   9999999999999999999999999999987655544444


Q ss_pred             ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccccc
Q 036172          319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE  397 (522)
Q Consensus       319 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  397 (522)
                      .....||+.|+|||++.+..++.++||||||+++|||++ |..||.......  .+.....    .+....         
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~~~---------  316 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGTRMR---------  316 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH----HTCCCC---------
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHH----cCCCCC---------
Confidence            455678999999999999999999999999999999998 999997544322  1111111    111110         


Q ss_pred             ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          398 YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       398 ~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            11123456888999999999999999999999998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-42  Score=356.07  Aligned_cols=256  Identities=18%  Similarity=0.237  Sum_probs=209.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +++.+++|.+.+.........+.+.+|+.+|++++||||+++++++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKE--------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECC--------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45789999999999999999987643        4567777766543332233567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||+++|+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~D  184 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcc
Confidence            99999999999999999999998643   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+..   .+.. 
T Consensus       185 Fg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~-  252 (350)
T 1rdq_E          185 FGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIVS-  252 (350)
T ss_dssp             CTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH-
T ss_pred             cccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHH---HHHc-
Confidence            99997654322     245799999999999999999999999999999999999999964321   11111   1111 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +..          .++...+..+.+++.+||+.||.+||+     +.+|++        |+|+..
T Consensus       253 ~~~----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--------h~~f~~  299 (350)
T 1rdq_E          253 GKV----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--------HKWFAT  299 (350)
T ss_dssp             CCC----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--------SGGGTT
T ss_pred             CCC----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--------CcCcCC
Confidence            111          011123457889999999999999998     888886        888764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=356.67  Aligned_cols=265  Identities=21%  Similarity=0.292  Sum_probs=207.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.....     ......+++|.++...  .....++|.+|+.++++++||||+++++++
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  119 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVP-----GQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVV  119 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCT-----TSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecC-----CCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            457899999999999999999875421     1123346666554321  223557899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECC
Confidence            99999999999999999999997542  359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....   ..+.....   
T Consensus       195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~---  268 (325)
T 3kul_A          195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVE---  268 (325)
T ss_dssp             CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH---
T ss_pred             CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH---
Confidence            99998765433221 2223456788999999998999999999999999999999 9999864321   11211111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       .+..         ...+...+..+.+++..||+.||.+||++.+|++.|+.+..
T Consensus       269 -~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          269 -EGYR---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             -TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCC---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             1100         01112234578899999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.4e-42  Score=362.15  Aligned_cols=266  Identities=20%  Similarity=0.282  Sum_probs=207.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.++||+|+||.||++....        +.+.+|+|.+++.........+.+.+|..++.++ +|||||+++++
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~--------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKK--------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            35689999999999999999987643        4566777776655444444556788999999887 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+.+++||||+++|+|..++...+   .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~  195 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLT  195 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEe
Confidence            999999999999999999999998543   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh--hHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE--SLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--~l~~~~~~~  380 (522)
                      |||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........
T Consensus       196 DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~  273 (396)
T 4dc2_A          196 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  273 (396)
T ss_dssp             CCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred             ecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence            9999975332221  223568999999999999999999999999999999999999999643221110  001111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM------GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~------~eVl~~L~~~~~~~~~~~~  443 (522)
                      +.....          .++...+..+.+++.+||+.||.+||++      .+|++        |+|++.
T Consensus       274 i~~~~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~--------Hpff~~  324 (396)
T 4dc2_A          274 ILEKQI----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--------HPFFRN  324 (396)
T ss_dssp             HHHCCC----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH--------STTTTT
T ss_pred             Hhcccc----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc--------CccccC
Confidence            111111          1112234578899999999999999985      67776        888764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=362.34  Aligned_cols=271  Identities=25%  Similarity=0.361  Sum_probs=213.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.++||+|+||.||++...... +........+++|.++..  ......+++.+|+++++++ +|||||+++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSS-TTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEcccc-ccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            4578999999999999999998753210 001123345666655432  1233567899999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +.+++..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcc
Confidence            9999999999999999999999986532             2359999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||....  
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--  298 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--  298 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence            99999999999999999986655433333334567889999999999999999999999999999999 999986543  


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       ...+.....    .+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       299 -~~~~~~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          299 -VEELFKLLK----EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -HHHHHHHHH----TTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHH----cCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             122222211    111111         111234578899999999999999999999999998864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-42  Score=344.40  Aligned_cols=271  Identities=21%  Similarity=0.225  Sum_probs=203.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++.+..        +.+.+++|.+.... ......+.+.+|+.++++++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE--------THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC--------CCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            579999999999999999997643        35566666554322 122345778999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++ +|.+.+...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999976 666666543  2359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++.........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||-...  ................
T Consensus       147 ~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          147 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             TCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCC
T ss_pred             cceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCC
Confidence            99765433221  22447899999999997766 7999999999999999999888853221  1111111111111100


Q ss_pred             Ccc------cc---------cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          385 DTE------TL---------LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~------~~---------~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ...      ..         .............+..+.+++.+||+.||.+|||+.|+++        |+|+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~f~~  288 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--------HPYFSD  288 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGTT
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--------Cccccc
Confidence            000      00         0000011111234567889999999999999999999997        999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.9e-43  Score=358.72  Aligned_cols=260  Identities=22%  Similarity=0.278  Sum_probs=208.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ...++|++.+.||+|+||.||++....        +.+.||+|.+++.........+.+.+|..++..+ +||||+++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~   85 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKK--------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC   85 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence            346799999999999999999988643        4567777776554332333567788999999987 9999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+.+.+++||||+++|+|.+++...+   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           86 TFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEE
Confidence            9999999999999999999999998543   49999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.....   
T Consensus       160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~---  231 (345)
T 1xjd_A          160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIR---  231 (345)
T ss_dssp             CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---
T ss_pred             eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH---
Confidence            99999975433221  12356799999999999999999999999999999999999999965432   12211111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG-QVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~-eVl~~L~~~~~~~~~~~~  443 (522)
                      . +.      +.    ++...+..+.+++.+||+.||.+||++. +|++        |+|++.
T Consensus       232 ~-~~------~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~--------hp~f~~  275 (345)
T 1xjd_A          232 M-DN------PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--------HPLFRE  275 (345)
T ss_dssp             H-CC------CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--------SGGGTT
T ss_pred             h-CC------CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc--------CccccC
Confidence            1 11      01    1112345788899999999999999997 5554        888765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-42  Score=356.67  Aligned_cols=279  Identities=18%  Similarity=0.229  Sum_probs=209.3

Q ss_pred             CCCCCceeeeccccc--ccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          143 KTENPFQMDIPCSEG--KYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G--~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ...++|++.++||+|  +||.||++....        +.+.+++|.++.... .....+.+.+|+.++++++|||||+++
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~   92 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKP--------TGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYR   92 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETT--------TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcC--------CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEe
Confidence            356799999999999  999999998653        456677776643221 223567889999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +++.+++.+++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B           93 ATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999998652 2349999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCC-----CCccccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          301 LSDFGLAIWGPTDS-----THMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       301 L~DFGla~~~~~~~-----~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      |+|||.+.......     .........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--  246 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--  246 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--
Confidence            99999885432211     1111223478999999999987  57899999999999999999999999754332221  


Q ss_pred             HHhhhhhhc----CCC------------------ccccc---------CCcccccccHHHHHHHHHHHHHhhhcCCCCCC
Q 036172          374 VKWAKPILK----NGD------------------TETLL---------DPKLSNEYDNAQMQRMLLAANLCINQSPQLRP  422 (522)
Q Consensus       374 ~~~~~~~~~----~~~------------------~~~~~---------d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP  422 (522)
                      .........    ...                  ....+         ............+..+.+|+.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            111000000    000                  00000         00000112223456789999999999999999


Q ss_pred             CHHHHHHHHhccccCCcccccc
Q 036172          423 NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       423 s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      |+.++++        |+|++..
T Consensus       327 ta~ell~--------hp~f~~~  340 (389)
T 3gni_B          327 SASTLLN--------HSFFKQI  340 (389)
T ss_dssp             CHHHHTT--------SGGGGGC
T ss_pred             CHHHHhc--------CHHHHHH
Confidence            9999997        8998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-42  Score=343.76  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=205.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ....+++|.+.+.........+.+.+|+.++++++||||+++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQ--------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   78 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEcc--------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence            45789999999999999999987543        3445666654333222222456799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++|+|.+++....   .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECS
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEe
Confidence            99999999999999999999998543   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++........    ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   ........    
T Consensus       153 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~----  221 (279)
T 3fdn_A          153 FGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISR----  221 (279)
T ss_dssp             CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH----
T ss_pred             ccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHHh----
Confidence            999855433221    2457899999999999889999999999999999999999999643311   11111111    


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      ..          ...+...+..+.+++.+||+.||.+||++.+|++        |+|+....
T Consensus       222 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--------h~~~~~~~  265 (279)
T 3fdn_A          222 VE----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--------HPWITANS  265 (279)
T ss_dssp             TC----------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--------CHHHHHHC
T ss_pred             CC----------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--------CccccCCc
Confidence            00          0111123456788999999999999999999998        89987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.8e-42  Score=352.30  Aligned_cols=266  Identities=20%  Similarity=0.283  Sum_probs=209.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.+++.........+.+.+|+.+++++ +||||++++++
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKK--------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECC--------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            35689999999999999999987643        4567777777655444445667899999999998 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+.+++||||+++|+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEE
Confidence            999999999999999999999998543   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh--hHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE--SLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--~l~~~~~~~  380 (522)
                      |||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .........
T Consensus       153 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          153 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             CGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             eccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence            9999975432221  123457999999999999999999999999999999999999999643221110  001111111


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM------GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~------~eVl~~L~~~~~~~~~~~~  443 (522)
                      +.....          .++...+..+.+++.+||+.||.+||++      .++++        |+|++.
T Consensus       231 i~~~~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--------hp~f~~  281 (345)
T 3a8x_A          231 ILEKQI----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--------HPFFRN  281 (345)
T ss_dssp             HHHCCC----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--------SGGGTT
T ss_pred             HHcCCC----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--------CCccCC
Confidence            111111          1112234578889999999999999996      66665        888764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-43  Score=366.66  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=206.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        ..+.+++|.++...  .....++|.+|+.++++++||||+++++++.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA--------DNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec--------CCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            4689999999999999999987642        34566666554221  1234567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...+  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcC
Confidence            9999999999999999999998542  348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..||.....   ......    +..
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~----~~~  330 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREF----VEK  330 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHH----HHT
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHc
Confidence            99976443221111122345778999999998999999999999999999998 9999865432   111111    111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       331 ~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 GGRL---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            1111         0111234578889999999999999999999999988753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.3e-42  Score=340.79  Aligned_cols=259  Identities=23%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch----HHHHHHHHHHHHhhCCCCCcce
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS----AWNDFSSEVDITSSLEQKSITT  218 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~----~~~~f~~Ev~iL~~L~HpnIv~  218 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+.........    ..++|.+|+.++++++||||++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   87 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVK--------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK   87 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETT--------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhhccceehhccccCCceeEEEEEEcC--------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence            446799999999999999999987643        3455666654322211111    1268999999999999999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceeccCC
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLSSD  296 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~~~  296 (522)
                      +++++.+..  ++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+  |+||||||+|||++.+
T Consensus        88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             EEEEETTTT--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCC
T ss_pred             hheeecCCC--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEecc
Confidence            999997665  6999999999999988754  2359999999999999999999999   88  9999999999999887


Q ss_pred             Cc-----eEEeecCccccCCCCCCCccccccccCCCCCChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          297 FQ-----PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM--HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       297 ~~-----~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      +.     +||+|||+++.....     .....||+.|+|||.+.  ...++.++||||||+++|+|++|+.||.......
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            76     999999999643332     23457999999999983  4557899999999999999999999997554332


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ........    ..+..     +    ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       236 ~~~~~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 IKFINMIR----EEGLR-----P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHH----HSCCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHHh----ccCCC-----C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            22111111    11110     1    11122345788999999999999999999999999763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-42  Score=343.77  Aligned_cols=272  Identities=28%  Similarity=0.444  Sum_probs=211.7

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .|..+++||+|+||.||++...          .+.+++|.+..... ......+.|.+|+.++++++||||+++++++.+
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  101 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVN----------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD  101 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESS----------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccCCccccCCCeEEEEEEEC----------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec
Confidence            3556688999999999998642          23444444332111 112356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++|+|.+++........+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg  178 (307)
T 2nru_A          102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG  178 (307)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            99999999999999999999865444569999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh-cCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL-KNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~-~~~  384 (522)
                      ++................||+.|+|||.+. +.++.++||||||+++|+|++|..||..........  .+..... ...
T Consensus       179 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~  255 (307)
T 2nru_A          179 LARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--DIKEEIEDEEK  255 (307)
T ss_dssp             TCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--HHHHHHHTTSC
T ss_pred             cccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--HHHHHhhhhhh
Confidence            997665544333334567999999999885 458999999999999999999999997544332111  1111111 111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+...+++.+ .......+..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       256 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          256 TIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             CHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            2223333333 2345667788999999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=354.61  Aligned_cols=269  Identities=20%  Similarity=0.343  Sum_probs=210.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++......   .....+.+++|.++...  .....+.|.+|+.++++++||||+++++++
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLL---PYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSS---TTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcC---CCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            4578999999999999999998764210   01233566666654321  223567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC---------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE---------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVI  282 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~gii  282 (522)
                      .+++..++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+   .+|+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            999999999999999999999986421                     1469999999999999999999999   9999


Q ss_pred             eccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCC
Q 036172          283 HRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRP  361 (522)
Q Consensus       283 HrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~P  361 (522)
                      ||||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999976543322222334568899999999999999999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      |.....   ..+...    +..+....         .+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       277 ~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          277 YYGMAH---EEVIYY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTSCH---HHHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCh---HHHHHH----HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            864321   122111    11222111         111234578899999999999999999999999998763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-42  Score=357.08  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=205.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        ..+.|++|.+..... .....+.+.+|+.++++|+||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT--------TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC--------CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4579999999999999999987543        455666665543211 1234578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---ceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---QPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---~~kL  301 (522)
                      +++..++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEE
Confidence            999999999999999999999743   359999999999999999999999   9999999999999998654   5999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||....   ...+.....   
T Consensus       173 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~---  243 (362)
T 2bdw_A          173 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIK---  243 (362)
T ss_dssp             CCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---
T ss_pred             eecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH---
Confidence            99999976654322   124579999999999998899999999999999999999999996432   112221111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                       .+....      ........+..+.+++.+||+.||.+||++.++++        |+|+..
T Consensus       244 -~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~~~~  290 (362)
T 2bdw_A          244 -AGAYDY------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--------VPWICN  290 (362)
T ss_dssp             -HTCCCC------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT--------SHHHHT
T ss_pred             -hCCCCC------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc--------CcccCC
Confidence             111100      00001123457889999999999999999999997        788754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=346.19  Aligned_cols=274  Identities=19%  Similarity=0.226  Sum_probs=200.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc--cchHHHHHHHHHHHHhhC---CCCCcce
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ--FSSAWNDFSSEVDITSSL---EQKSITT  218 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~--~~~~~~~f~~Ev~iL~~L---~HpnIv~  218 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|.+......  .......+.+|+.+++++   +||||++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~   78 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPH--------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVR   78 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTT--------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECC--------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEE
Confidence            35799999999999999999987543        4556676665321110  011124566777777776   4999999


Q ss_pred             eeEEEEeCC-----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec
Q 036172          219 LNGVCIEDN-----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       219 l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl  293 (522)
                      +++++....     .+++||||+. |+|.+++..... ..+++..++.++.|++.||.|||+   .+|+||||||+|||+
T Consensus        79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           79 LMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILV  153 (308)
T ss_dssp             EEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEE
T ss_pred             eeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEE
Confidence            999998765     6899999996 599999986532 349999999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +.++.+||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .+
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~  228 (308)
T 3g33_A          154 TSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QL  228 (308)
T ss_dssp             CTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HH
T ss_pred             cCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence            99999999999999765443322   34578999999999999999999999999999999999999996543221  11


Q ss_pred             HHhhhhhhcC---CCccc-------ccC---CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          374 VKWAKPILKN---GDTET-------LLD---PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       374 ~~~~~~~~~~---~~~~~-------~~d---~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      ..... ....   .....       .+.   +..........+..+.+++.+||+.||.+|||+.|+++        |+|
T Consensus       229 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------h~~  299 (308)
T 3g33_A          229 GKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--------HSY  299 (308)
T ss_dssp             HHHHH-HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--------STT
T ss_pred             HHHHH-HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--------Ccc
Confidence            11111 1100   00000       000   00001111223467889999999999999999999997        999


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      +...
T Consensus       300 ~~~~  303 (308)
T 3g33_A          300 LHKD  303 (308)
T ss_dssp             C---
T ss_pred             ccCC
Confidence            8764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=362.18  Aligned_cols=270  Identities=21%  Similarity=0.263  Sum_probs=208.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.....   ......+.+++|.++..  .......+|.+|+.++++++|||||++++++
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGM---PNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC--------CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccC---CCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            457899999999999999999874321   01234556777765421  1233556799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC--
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF--  297 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~--  297 (522)
                      .+....++||||+++|+|.+++.....    ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++  
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  220 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPG  220 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTT
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCC
Confidence            999999999999999999999986531    2358999999999999999999999   9999999999999999554  


Q ss_pred             -ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHH
Q 036172          298 -QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       298 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~  375 (522)
                       .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....   ..+..
T Consensus       221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~  297 (367)
T 3l9p_A          221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE  297 (367)
T ss_dssp             CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH
T ss_pred             ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence             599999999965432222222234568999999999999999999999999999999998 9999965431   22222


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      ...    .+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+.....
T Consensus       298 ~i~----~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVT----SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHH----cCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            111    11110         01112345688899999999999999999999999887643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-43  Score=353.72  Aligned_cols=272  Identities=24%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....    ......+.+++|.+..   ......+.|.+|+.++++++||||+++++++
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   80 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDP----LQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVC   80 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECT----TCSSCCEEEEEEEESC---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEec----ccCCCCcEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45789999999999999999986321    1123456677776542   2234567899999999999999999999999


Q ss_pred             EeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ...  ..+++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl  155 (295)
T 3ugc_A           81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI  155 (295)
T ss_dssp             CHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEE
T ss_pred             ecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEE
Confidence            653  56899999999999999998642  349999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CChh
Q 036172          302 SDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL---------KGPE  371 (522)
Q Consensus       302 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~---------~~~~  371 (522)
                      +|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....         ....
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T 3ugc_A          156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  235 (295)
T ss_dssp             CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred             ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence            999999766543322 122234577889999999999999999999999999999999999853210         0001


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .........+..+..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       236 ~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          236 MIVFHLIELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            111111111111111         11122344678899999999999999999999999988753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-42  Score=365.88  Aligned_cols=252  Identities=17%  Similarity=0.249  Sum_probs=204.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +++.+++|.+.+......+..+.+.+|+.+++.++||||+++++++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHEL--------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETT--------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            46799999999999999999987643        4566777766443322223467899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||+++|+|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~D  159 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIAD  159 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEe
Confidence            9999999999999999999999743   359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......   .+....    .
T Consensus       160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i----~  229 (476)
T 2y94_A          160 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKI----C  229 (476)
T ss_dssp             CSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHH----H
T ss_pred             ccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHH----h
Confidence            999977654322   224579999999999988765 78999999999999999999999754321   111111    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .+...          .+...+..+.+++.+||+.||.+|||+.+|++
T Consensus       230 ~~~~~----------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          230 DGIFY----------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TTCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcC----------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            11110          01112356888999999999999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-42  Score=362.97  Aligned_cols=263  Identities=22%  Similarity=0.255  Sum_probs=206.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        +.+.+|+|.+++.........+.+.+|+.+++.++|||||++++++.
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~--------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKS--------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECC--------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4689999999999999999987653        45667777664432221223345889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||++||+|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence            999999999999999999999753    38999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK----VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+++....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......   .........
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~  288 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNH  288 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTH
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhc
Confidence            99976544321 1223567999999999997655    789999999999999999999999754321   111111100


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...-..     |.     ....+..+.+++.+||+.+|.+  ||++.+|++        |+|++..
T Consensus       289 ~~~~~~-----p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--------Hp~f~~~  336 (410)
T 3v8s_A          289 KNSLTF-----PD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--------HLFFKND  336 (410)
T ss_dssp             HHHCCC-----CT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--------SGGGCCS
T ss_pred             cccccC-----CC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhc--------CccccCC
Confidence            000000     00     0113457888999999999988  999999997        8888754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=343.85  Aligned_cols=274  Identities=21%  Similarity=0.211  Sum_probs=201.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++.+..        +++.+++|.+... .......+.+.+|+.++++++||||+++++++.+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD--------TGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR   73 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECCC-CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC--------CCcEEEEEEeecc-ccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence            689999999999999999987643        3455665544221 1112245678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           74 KRRLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCeEEEEEEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999999988743   359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh------
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK------  378 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~------  378 (522)
                      ++.........  .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................      
T Consensus       148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (311)
T 4agu_A          148 FARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR  225 (311)
T ss_dssp             TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             CchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence            99765533221  124478999999999976 568999999999999999999999996543222111111000      


Q ss_pred             --hhhcCCC---cccccCCcccc---cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 --PILKNGD---TETLLDPKLSN---EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 --~~~~~~~---~~~~~d~~l~~---~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .......   .....++....   ......+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~f~~~  291 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--------HPYFENI  291 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--------SGGGTTC
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--------ChHHHhc
Confidence              0000000   00000110000   001123456889999999999999999999997        9998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=348.28  Aligned_cols=259  Identities=20%  Similarity=0.286  Sum_probs=194.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh-----------------------hccchHHHH
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT-----------------------SQFSSAWND  200 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t-----------------------~~~~~~~~~  200 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+.+..                       .......++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNEN--------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETT--------TTEEEEEEEEECC-------------------------------CH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECC--------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            35789999999999999999986542        23334443321110                       001123467


Q ss_pred             HHHHHHHHhhCCCCCcceeeEEEEe--CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 036172          201 FSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECS  278 (522)
Q Consensus       201 f~~Ev~iL~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~  278 (522)
                      |.+|+.++++++||||+++++++.+  .+.+++||||+++++|.+++.    ...+++..++.++.|++.||.|||+   
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---  155 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---  155 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence            9999999999999999999999997  578999999999999988764    2359999999999999999999999   


Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCC---CCchhhHHHHHHHHHHH
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK---VSDKIDVYSFGVVLLEL  355 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~eL  355 (522)
                      .+|+||||||+|||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++|||||||++|+|
T Consensus       156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l  233 (298)
T 2zv2_A          156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF  233 (298)
T ss_dssp             TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred             CCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence            9999999999999999999999999999976544322  123457999999999987655   47899999999999999


Q ss_pred             HcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          356 LSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       356 ltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ++|+.||.....   ..+....    .........    .    ...+..+.+++.+||+.||.+||++.+|++      
T Consensus       234 ~~g~~pf~~~~~---~~~~~~~----~~~~~~~~~----~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~------  292 (298)
T 2zv2_A          234 VFGQCPFMDERI---MCLHSKI----KSQALEFPD----Q----PDIAEDLKDLITRMLDKNPESRIVVPEIKL------  292 (298)
T ss_dssp             HHSSCSSCCSSH---HHHHHHH----HHCCCCCCS----S----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT------
T ss_pred             HHCCCCCCCccH---HHHHHHH----hcccCCCCC----c----cccCHHHHHHHHHHhhcChhhCCCHHHHhc------
Confidence            999999964321   1111111    111110000    0    113356888999999999999999999997      


Q ss_pred             cCCcccc
Q 036172          436 HATDWVD  442 (522)
Q Consensus       436 ~~~~~~~  442 (522)
                        |+|+.
T Consensus       293 --hp~~~  297 (298)
T 2zv2_A          293 --HPWVT  297 (298)
T ss_dssp             --CHHHH
T ss_pred             --Ccccc
Confidence              88864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-42  Score=349.67  Aligned_cols=269  Identities=22%  Similarity=0.322  Sum_probs=213.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.....   ......+.+++|.++..  ......+.|.+|+.+++++ +||||++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGL---IKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS---SSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeec---cccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            357899999999999999999864211   01234456666655422  1223457899999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC---------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE---------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK  287 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIk  287 (522)
                      +.+++..++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||+   .+|+|||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCc
Confidence            9999999999999999999999986532               1248999999999999999999999   999999999


Q ss_pred             CCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 036172          288 SSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKN  366 (522)
Q Consensus       288 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~  366 (522)
                      |+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999987766554444445567889999999999999999999999999999999 999987543


Q ss_pred             CCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       367 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ...  ...........         +    ..+...+..+.+++.+||+.||.+|||+.+|++.|++..
T Consensus       253 ~~~--~~~~~~~~~~~---------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          253 VDS--KFYKMIKEGFR---------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             SSH--HHHHHHHHTCC---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chh--HHHHHhccCCC---------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            221  11111111100         0    001123457889999999999999999999999998765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=355.50  Aligned_cols=269  Identities=22%  Similarity=0.325  Sum_probs=209.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.+.||+|+||.||++.....   ........+++|.++...  .....+.|.+|+.+++++ +||||+++++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGI---SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESC---SSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeecc---ccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            46899999999999999999875210   001234456666554221  122457899999999999 999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCC--------------------CCCChHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQ--------------------SVLPWGVRFEVAVAIAEALNYLHSECSRPVIH  283 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiH  283 (522)
                      ...+..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+   .+|+|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence            9999999999999999999999865321                    248999999999999999999999   99999


Q ss_pred             ccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 036172          284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI  362 (522)
Q Consensus       284 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf  362 (522)
                      |||||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999976655444444445678899999999999999999999999999999998 99999


Q ss_pred             CCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          363 GFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .......  .+....    ..+..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       276 ~~~~~~~--~~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          276 PGIPVDA--NFYKLI----QNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TTCCCSH--HHHHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ccCCcHH--HHHHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            6543221  121111    11110         01111234578889999999999999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.5e-42  Score=353.68  Aligned_cols=259  Identities=20%  Similarity=0.286  Sum_probs=208.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....        +.+.||+|.+++.........+.+.+|..++..+ +||||++++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   89 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG--------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC   89 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT--------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence            45789999999999999999987643        4566777776554333334567889999999998 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+.+|+||||++||+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           90 FQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEE
Confidence            999999999999999999999998543   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...   +..
T Consensus       164 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~---i~~  235 (353)
T 2i0e_A          164 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQS---IME  235 (353)
T ss_dssp             CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HHH
T ss_pred             eCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHH---HHh
Confidence            9999975332221  2235679999999999999999999999999999999999999996532   1122111   111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                      . ..          .++...+..+.+++.+||+.||.+||+     +.+|++        |+|++.
T Consensus       236 ~-~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~--------h~~f~~  282 (353)
T 2i0e_A          236 H-NV----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--------HAFFRY  282 (353)
T ss_dssp             C-CC----------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT--------SGGGTT
T ss_pred             C-CC----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc--------CccccC
Confidence            1 11          111223457888999999999999995     577775        777764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.4e-42  Score=366.70  Aligned_cols=265  Identities=23%  Similarity=0.245  Sum_probs=206.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        ..+.||+|.+++.........+.+.+|+.++..++||||++++++|.
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKN--------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcC--------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            4689999999999999999987653        35567777654432222223345889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.++|||||+++|+|.+++...  ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999999853  2359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |+++........ ......||+.|+|||++.     .+.++.++|||||||++|||++|+.||......   ........
T Consensus       220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~  295 (437)
T 4aw2_A          220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMN  295 (437)
T ss_dssp             TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred             hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhh
Confidence            999765443322 223457999999999987     466899999999999999999999999754321   11111110


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQL--RPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~--RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .......     |....    ..+..+.+++.+||..+|.+  ||++.+|++        |+|++.
T Consensus       296 ~~~~~~~-----p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--------Hpff~~  344 (437)
T 4aw2_A          296 HKERFQF-----PTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKK--------HPFFSG  344 (437)
T ss_dssp             HHHHCCC-----CSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--------SGGGTT
T ss_pred             ccccccC-----Ccccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhC--------CCccCC
Confidence            0000001     11101    13456888999999888888  999999997        888864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.9e-42  Score=347.80  Aligned_cols=273  Identities=21%  Similarity=0.257  Sum_probs=191.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        +.+.+++|.++...  .....+.+.+|+.++++++||||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   73 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT--------TGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIH   73 (317)
T ss_dssp             ---------------CEEEEEECSS--------SCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC--------CCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence            4689999999999999999986542        45566666554222  1123467889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG---EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      +++.+++||||++ |+|.+++....   ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl  149 (317)
T 2pmi_A           74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKL  149 (317)
T ss_dssp             CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEE
Confidence            9999999999997 59999987541   22358999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||++.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   .......
T Consensus       150 ~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~  224 (317)
T 2pmi_A          150 GDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDI  224 (317)
T ss_dssp             CCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH
T ss_pred             CcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence            999999765433221  123478999999999976 4689999999999999999999999975432211   1111110


Q ss_pred             hcCC------------CcccccCCc--------ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          381 LKNG------------DTETLLDPK--------LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       381 ~~~~------------~~~~~~d~~--------l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      ....            .....+...        +........+..+.+++.+||+.||.+|||+.++++        ++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--------hp~  296 (317)
T 2pmi_A          225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--------HPW  296 (317)
T ss_dssp             HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--------SGG
T ss_pred             hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC--------Chh
Confidence            0000            000000000        000011123457889999999999999999999997        999


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      +...
T Consensus       297 f~~~  300 (317)
T 2pmi_A          297 FAEY  300 (317)
T ss_dssp             GGGG
T ss_pred             hhcc
Confidence            8764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.7e-42  Score=340.47  Aligned_cols=258  Identities=21%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....         ...+++|.++...    ...+++.+|+.++++++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG---------QYDVAVKMIKEGS----MSEDEFFQEAQTMMKLSHPKLVKFYGVC   72 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT---------TEEEEEEEECBTT----BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecC---------ceeEEEEEeccCC----CcHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35689999999999999999986432         2335555543211    1346799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..++||||+++++|.+++...+  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~D  147 (268)
T 3sxs_A           73 SKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSD  147 (268)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECC
T ss_pred             ccCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEcc
Confidence            99999999999999999999998642  349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......   ......    .
T Consensus       148 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~  219 (268)
T 3sxs_A          148 FGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKV----S  219 (268)
T ss_dssp             TTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH----H
T ss_pred             Cccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHH----H
Confidence            9999765543322 1223456778999999998889999999999999999999 99998644321   111111    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+.  ....+       ...+..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       220 ~~~--~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          220 QGH--RLYRP-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TTC--CCCCC-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cCC--CCCCC-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            111  01111       1123568889999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-42  Score=352.62  Aligned_cols=265  Identities=21%  Similarity=0.315  Sum_probs=202.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.......    .....+++|.+...  ......+++.+|+.++++++||||+++++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~kv~~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGE----SIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTC----SCCEEEEEEEECCT--TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCc----eEEEEEEEEecccc--ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            35789999999999999999987532110    00111333332111  1112335678899999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+ +..++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        85 ~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           85 PG-SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             CB-SSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECS
T ss_pred             cC-CccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECC
Confidence            64 5688999999999999999754  2359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||.............       
T Consensus       159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------  231 (325)
T 3kex_A          159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------  231 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------
T ss_pred             CCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------
Confidence            999988766554444455678889999999999999999999999999999999 999997654332222211       


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+....  .       +...+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus       232 ~~~~~~--~-------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          232 KGERLA--Q-------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTCBCC--C-------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             cCCCCC--C-------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111000  0       01122356779999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-42  Score=341.74  Aligned_cols=257  Identities=22%  Similarity=0.369  Sum_probs=204.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....         .+.+++|.+....    ...++|.+|+.++++++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   75 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN---------KDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCL   75 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC---------CCeEEEEEecccc----cCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4689999999999999999987532         2345555544221    12367999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           76 EQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             cCCceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccc
Confidence            9999999999999999999997542  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ........    .
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~----~  222 (269)
T 4hcu_A          151 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS----T  222 (269)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----T
T ss_pred             ccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHh----c
Confidence            99976543221 11123456788999999999999999999999999999999 9999965332   12211111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +.  ....       +...+..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus       223 ~~--~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          223 GF--RLYK-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TC--CCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Cc--cCCC-------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            10  0011       11124568889999999999999999999999988753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.9e-42  Score=363.17  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=203.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        .++.+++|.+..... .....+.+.+|+.++++++|||||++++++.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~--------~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVL--------AGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETT--------TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECC--------CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            4689999999999999999987543        334444443322110 1124567899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc---CCCceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~---~~~~~kL  301 (522)
                      +++..++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL  154 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKL  154 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEE
Confidence            999999999999999999999854   349999999999999999999999   9999999999999998   4678999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....   ...+.....   
T Consensus       155 ~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~---  226 (444)
T 3soa_A          155 ADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIK---  226 (444)
T ss_dssp             CCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH---
T ss_pred             ccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHH---
Confidence            999999766543322  224579999999999998899999999999999999999999996432   112221111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .+... ...+     .....+..+.+++.+||+.||.+|||+.++++        |+|+...
T Consensus       227 -~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--------hp~~~~~  274 (444)
T 3soa_A          227 -AGAYD-FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK--------HPWISHR  274 (444)
T ss_dssp             -HTCCC-CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SCTTHHH
T ss_pred             -hCCCC-CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--------CccccCC
Confidence             11110 0000     01123457889999999999999999999998        8998653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-42  Score=358.50  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....     .......+++|.++...  .....++|.+|+.++++++||||+++++++.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKL-----PSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBC-----TTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEec-----CCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4689999999999999999987541     12345566776654321  2235678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcC
Confidence            9999999999999999999998542  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+.....    
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~----  264 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVD----  264 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHH----
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----
Confidence            9997665432211 1222345788999999999999999999999999999998 9999864321   12222111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+.         ....+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       265 ~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          265 EGY---------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             TTE---------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            110         001111234678899999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-42  Score=343.32  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=199.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ....+++|.+.....  ....+.+.+|++++++++||||+++++++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   89 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERS--------SGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVF   89 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEcc--------CCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence            45789999999999999999987543        344555554433221  22457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCce
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQP  299 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~  299 (522)
                      .+.+..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+   .+|+||||||+||++   +.++.+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCE
T ss_pred             ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCE
Confidence            9999999999999999999998643 123459999999999999999999999   999999999999999   456789


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||+|||++........   .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||......   ........
T Consensus       167 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~~  239 (285)
T 3is5_A          167 KIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKATY  239 (285)
T ss_dssp             EECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             EEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhcc
Confidence            9999999976544322   22457899999999885 57899999999999999999999999654321   11111110


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                        ........     ..    ..+..+.+++.+||+.||.+|||+.||++        ++|++.
T Consensus       240 --~~~~~~~~-----~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~--------hp~f~~  284 (285)
T 3is5_A          240 --KEPNYAVE-----CR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH--------HEWFKQ  284 (285)
T ss_dssp             --CCCCCCC-------C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT--------SGGGGC
T ss_pred             --CCcccccc-----cC----cCCHHHHHHHHHHccCChhhCcCHHHHhc--------CHHhhc
Confidence              11000000     00    12356788999999999999999999997        888764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-41  Score=337.27  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=206.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ..+.+++|.+..... .....+.+.+|+.++++++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKT--------TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSI   74 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcC--------CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            45789999999999999999987543        345556555432221 223457799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc---eE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ---PQ  300 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~---~k  300 (522)
                      .+++..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +|
T Consensus        75 ~~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~k  148 (284)
T 3kk8_A           75 QEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVK  148 (284)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEE
T ss_pred             EcCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEE
Confidence            9999999999999999999988754   349999999999999999999999   99999999999999986655   99


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||++.........   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ........  
T Consensus       149 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~--  220 (284)
T 3kk8_A          149 LADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIK--  220 (284)
T ss_dssp             ECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH--
T ss_pred             EeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHH--
Confidence            9999999765443221   235789999999999999999999999999999999999999964321   11111111  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .+... ...+     .....+..+.+++.+||+.||.+|||+.++++        ++|+...
T Consensus       221 --~~~~~-~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--------h~~~~~~  268 (284)
T 3kk8_A          221 --AGAYD-YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK--------VPWICNR  268 (284)
T ss_dssp             --HTCCC-CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------SHHHHSC
T ss_pred             --hcccc-CCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc--------CccccCC
Confidence              11110 0000     01123456888999999999999999999997        8898754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=339.55  Aligned_cols=261  Identities=21%  Similarity=0.301  Sum_probs=187.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+...........+++.+|+.++++++||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIH--------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF   80 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEcc--------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence            34689999999999999999987542        3456666655433222223457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~d  155 (278)
T 3cok_A           81 EDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIAD  155 (278)
T ss_dssp             ECSSEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEe
Confidence            9999999999999999999999853  2359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.........  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........  .    .. .
T Consensus       156 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~----~~-~  226 (278)
T 3cok_A          156 FGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--K----VV-L  226 (278)
T ss_dssp             CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-S
T ss_pred             ecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--H----Hh-h
Confidence            9999765432221  123468999999999988889999999999999999999999997544322110  0    00 0


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .      +..    .+...+..+.+++.+||+.||.+||++.+|++        ++|+...
T Consensus       227 ~------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--------h~~~~~~  269 (278)
T 3cok_A          227 A------DYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--------HPFMSRN  269 (278)
T ss_dssp             S------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--------STTTC--
T ss_pred             c------ccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc--------CccccCC
Confidence            0      001    11123457888999999999999999999997        8897754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=362.34  Aligned_cols=265  Identities=21%  Similarity=0.247  Sum_probs=206.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        +++.||+|.+++.........+.+.+|..++.+++||||+++++++.
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~--------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQ--------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4689999999999999999987643        56677877765432222223456889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+.+||||||+++|+|.+++...+  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999998643  249999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      |+++........ ......||+.|+|||++.       ...++.++|||||||++|||++|+.||......   ......
T Consensus       207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i  282 (412)
T 2vd5_A          207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKI  282 (412)
T ss_dssp             TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH
T ss_pred             hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            999765543221 122457999999999987       356899999999999999999999999654321   111111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR---PNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~R---Ps~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .........     |.    .....+..+.+++.+||. +|.+|   |++.+|++        |+|++.-
T Consensus       283 ~~~~~~~~~-----p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--------Hpff~~i  334 (412)
T 2vd5_A          283 VHYKEHLSL-----PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--------HPFFFGL  334 (412)
T ss_dssp             HTHHHHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--------SGGGTTC
T ss_pred             HhcccCcCC-----Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--------CCCcCCC
Confidence            100000000     11    111234578889999999 99998   69999986        8888653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.8e-42  Score=351.37  Aligned_cols=268  Identities=20%  Similarity=0.260  Sum_probs=203.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-----CCCccee
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-----QKSITTL  219 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-----HpnIv~l  219 (522)
                      .++|++.++||+|+||.||++....        ..+.+++|.++.    .....+.+..|+.+++.+.     ||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHID--------NKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECC--------CCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            5799999999999999999987643        456677776532    1224567888999999996     9999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC----
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS----  295 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~----  295 (522)
                      ++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.    
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            99999999999999999 8899999986532 349999999999999999999999   99999999999999975    


Q ss_pred             ---------------------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHH
Q 036172          296 ---------------------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE  354 (522)
Q Consensus       296 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~e  354 (522)
                                           ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 7889999999997644332     24578999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCCCChhhHHHhhhh-----------------hhcCCCcccccCCccc------------ccccHHHHHH
Q 036172          355 LLSGRRPIGFKNLKGPESLVKWAKP-----------------ILKNGDTETLLDPKLS------------NEYDNAQMQR  405 (522)
Q Consensus       355 LltG~~Pf~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~d~~l~------------~~~~~~~~~~  405 (522)
                      |++|+.||.................                 ................            ..+.......
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999975432111111100000                 0000000000000000            0000111256


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          406 MLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       406 l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      +.+++.+||+.||.+|||+.|+++        |+|++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~--------hp~f~  360 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK--------HKFLE  360 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT--------SGGGC
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc--------CcccC
Confidence            789999999999999999999997        88864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.6e-41  Score=338.45  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhh--CCCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSS--LEQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~--L~HpnIv~l~~  221 (522)
                      ..++|++.+.||+|+||.||++...          .+.+++|.+..      ...+.+.+|.+++..  ++||||+++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~h~niv~~~~   69 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ----------GENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGFIA   69 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET----------TEEEEEEEECG------GGHHHHHHHHHHHHHTCCCCTTBCCEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC----------CEEEEEEEecc------ccchhhHHHHHHHHHhhccCcCeeeEEE
Confidence            4578999999999999999998642          34566665432      133556777777777  79999999999


Q ss_pred             EEEeC----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHH--------hcCCCCEEeccCCCC
Q 036172          222 VCIED----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH--------SECSRPVIHRDVKSS  289 (522)
Q Consensus       222 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~giiHrDIkp~  289 (522)
                      ++...    ..+++||||+++|+|.++++..    .+++..++.++.|++.||.|||        +   .+|+||||||+
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~  142 (301)
T 3q4u_A           70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSK  142 (301)
T ss_dssp             EEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGG
T ss_pred             eeccccCCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChH
Confidence            97753    5689999999999999999632    4999999999999999999999        7   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCc--cccccccCCCCCChhhhccC------CCCchhhHHHHHHHHHHHHcC---
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHM--IREDVVGTFGYIAPEYLMHG------KVSDKIDVYSFGVVLLELLSG---  358 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwSlGvvl~eLltG---  358 (522)
                      |||++.++.+||+|||+++.........  ......||+.|+|||.+.+.      .++.++|||||||++|||++|   
T Consensus       143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~  222 (301)
T 3q4u_A          143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS  222 (301)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence            9999999999999999997654433221  12234799999999999776      455799999999999999999   


Q ss_pred             -------CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          359 -------RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       359 -------~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                             ..||.......... ................    .........+..+.+++.+||+.||.+|||+.+|++.|
T Consensus       223 ~~~~~~~~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          223 NGIVEDYKPPFYDVVPNDPSF-EDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCH-HHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCcch-hhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence                   77775433222111 1111111111111111    11122345678899999999999999999999999999


Q ss_pred             hcc
Q 036172          432 RGA  434 (522)
Q Consensus       432 ~~~  434 (522)
                      +++
T Consensus       298 ~~i  300 (301)
T 3q4u_A          298 TKI  300 (301)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-41  Score=345.30  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=205.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|...++||+|+||.||++....        .++.+++|.+....   ....+.|.+|+.++++++||||+++++++...
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~--------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKH--------SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG  114 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             hhhccEEeccCCCeEEEEEEECC--------CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence            47888899999999999987542        45566666553221   23457799999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCc
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL  306 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGl  306 (522)
                      +..++||||+++|+|.+++...    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  187 (321)
T 2c30_A          115 EELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGF  187 (321)
T ss_dssp             TEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeee
Confidence            9999999999999999998642    49999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       307 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +.........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ........    ....
T Consensus       188 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~----~~~~  258 (321)
T 2c30_A          188 CAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLR----DSPP  258 (321)
T ss_dssp             CEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSSC
T ss_pred             eeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCCC
Confidence            9765443221  2345799999999999999999999999999999999999999964321   11111111    1111


Q ss_pred             ccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          387 ETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       387 ~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..     +.  .....+..+.+++.+||+.||.+|||+.+|++        ++|+...
T Consensus       259 ~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--------hp~~~~~  301 (321)
T 2c30_A          259 PK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD--------HPFLLQT  301 (321)
T ss_dssp             CC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGGGC
T ss_pred             CC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc--------ChhhccC
Confidence            11     00  01123456888999999999999999999997        8898653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-42  Score=342.44  Aligned_cols=263  Identities=20%  Similarity=0.272  Sum_probs=194.6

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++.....     ......+++|.++...  .....+.|.+|+.++++++||||++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSP-----ENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC-------CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecC-----CCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence            3457899999999999999999875321     1123345555443221  22356789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +. ++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           85 IT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             EC-SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             Ec-cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEEC
Confidence            84 567899999999999999998542  348999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....    
T Consensus       159 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----  230 (281)
T 1mp8_A          159 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----  230 (281)
T ss_dssp             C--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----
T ss_pred             ccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----
Confidence            99999765443221 1223456789999999998999999999999999999997 999997543221   11111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       231 ~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          231 ENGERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111110         11223457888999999999999999999999998865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=347.02  Aligned_cols=254  Identities=23%  Similarity=0.258  Sum_probs=195.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.++||+|+||+||++....        ..+.+|+|.+...... .....++..|+..+.++ +||||++++++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~  126 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKE--------DGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAW  126 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT--------TSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECC--------CCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            3689999999999999999987643        3556666643321111 12334556666666666 999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+++||||+ +++|.+++...+  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          127 EEGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECC
T ss_pred             EeCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999 669999988653  359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++........   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+...     ....     .+..
T Consensus       201 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~-----~~~~  266 (311)
T 3p1a_A          201 FGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQ-----QLRQ  266 (311)
T ss_dssp             CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHH-----HHTT
T ss_pred             ceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHH-----HHhc
Confidence            999976544322   223469999999998865 7999999999999999999997665321     1111     1111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +..        ...+....+..+.+++.+||+.||.+|||+.+|++        ++|++.
T Consensus       267 ~~~--------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--------hp~~~~  310 (311)
T 3p1a_A          267 GYL--------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA--------LPVLRQ  310 (311)
T ss_dssp             TCC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGSC
T ss_pred             cCC--------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--------CccccC
Confidence            111        11122234567899999999999999999999997        899764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-41  Score=340.70  Aligned_cols=269  Identities=26%  Similarity=0.368  Sum_probs=206.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++....    ......+.+++|.++....  ....+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDP----EGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT----TSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcc----ccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            4579999999999999999986211    1133566777776654322  224578999999999999999999999999


Q ss_pred             eC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          225 ED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       225 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.  ..+++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEEC
Confidence            76  67899999999999999996543  349999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------CCChhh
Q 036172          303 DFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN---------LKGPES  372 (522)
Q Consensus       303 DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~---------~~~~~~  372 (522)
                      |||++......... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+....         ......
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT  248 (302)
T ss_dssp             CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred             cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence            99999776554322 22234568889999999999999999999999999999999999864221         001111


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ... ....+..+..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       249 ~~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          249 VTR-LVNTLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-HHHHHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            111 1111111111         111223446788999999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.5e-42  Score=347.94  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=185.9

Q ss_pred             Cceee---ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEE
Q 036172          147 PFQMD---IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGV  222 (522)
Q Consensus       147 ~y~~~---~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~  222 (522)
                      +|++.   ++||+|+||.||++.+..        ..+.+++|.+.+      .....+.+|+.+++++. ||||++++++
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~------~~~~~~~~e~~~l~~l~~h~niv~~~~~   74 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKK--------SNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVKLHEV   74 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETT--------TCCEEEEEEEEG------GGHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECC--------CCCEEEEEEECh------hhhhhHHHHHHHHHHhcCCCCeeEEEEE
Confidence            46664   789999999999987643        456677776532      13467889999999996 9999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---ce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---QP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---~~  299 (522)
                      +.++...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++   .+
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~  148 (325)
T 3kn6_A           75 FHDQLHTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEI  148 (325)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEE
T ss_pred             EEcCCEEEEEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccE
Confidence            99999999999999999999999854   359999999999999999999999   9999999999999997765   89


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-hHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-SLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~l~~~~~  378 (522)
                      ||+|||+++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .......
T Consensus       149 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  226 (325)
T 3kn6_A          149 KIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK  226 (325)
T ss_dssp             EECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred             EEeccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence            99999999765443222  22456899999999999999999999999999999999999999754332111 1111111


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .+..+...      .........+..+.+++.+||+.||.+|||+.+|++        |+|++..
T Consensus       227 -~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--------h~w~~~~  277 (325)
T 3kn6_A          227 -KIKKGDFS------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--------NEWLQDG  277 (325)
T ss_dssp             -HHTTTCCC------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--------CGGGCTT
T ss_pred             -HHHcCCCC------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--------ChhhccC
Confidence             11222111      111111234567889999999999999999999986        9998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.1e-42  Score=366.54  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+|+|.+++...........+.+|+.++++++||||+++++++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKA--------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcC--------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            35689999999999999999987643        4667787776654433344567789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||+++|+|.+++....   .+++..+..++.||+.||.|||+.  .+|+||||||+||||+.++.+||+|
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEcc
Confidence            99999999999999999999997543   599999999999999999999963  7899999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+....   ...
T Consensus       293 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i---~~~  364 (446)
T 4ejn_A          293 FGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LME  364 (446)
T ss_dssp             CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHC
T ss_pred             CCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHH---HhC
Confidence            999975433222  12346799999999999999999999999999999999999999965432   1121111   111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..          .++...+..+.+++.+||+.||.+||     ++.++++        |+|+..-
T Consensus       365 -~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--------hp~f~~~  411 (446)
T 4ejn_A          365 -EI----------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--------HRFFAGI  411 (446)
T ss_dssp             -CC----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--------SGGGTTC
T ss_pred             -CC----------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--------CccccCC
Confidence             00          01112345788899999999999999     9999997        8998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-41  Score=370.70  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=213.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +++.||+|.+.+...........+.+|+.+|++++|||||++++++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~--------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRA--------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            45789999999999999999987643        4667777776544332233457789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+.+++||||++||+|.+++...+ ...+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEe
Confidence            99999999999999999999998653 2349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh-hhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP-ESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~  382 (522)
                      ||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+......   
T Consensus       330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---  403 (576)
T 2acx_A          330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---  403 (576)
T ss_dssp             CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---
T ss_pred             cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---
Confidence            999977654332   2235799999999999988899999999999999999999999976543322 122211111   


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                       ..          ..++...+..+.+++.+||+.||.+||     ++.+|++        |+|++.
T Consensus       404 -~~----------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--------HpfF~~  450 (576)
T 2acx_A          404 -VP----------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--------HPLFKK  450 (576)
T ss_dssp             -CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--------SGGGTT
T ss_pred             -cc----------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--------Chhhcc
Confidence             00          111122345788999999999999999     7899987        888765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.5e-42  Score=349.12  Aligned_cols=271  Identities=22%  Similarity=0.357  Sum_probs=210.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++...... .........+++|.++..  ......+++.+|+.+++++ +||||++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCS-TTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEecccc-ccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3578999999999999999998753210 011223455666665432  1223567899999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +.+.+..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccc
Confidence            9999999999999999999999986432             1248999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..... 
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence            99999999999999999976655433223334467889999999988889999999999999999999 9999865431 


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                        ..+.....    .+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       266 --~~~~~~~~----~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 --EELFKLLK----EGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHH----HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHh----cCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              22222111    11110         0111234578889999999999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.3e-42  Score=342.23  Aligned_cols=269  Identities=20%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++...         ..+.+++|.+..... .....+.+.+|+.++++++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN---------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET---------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC---------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            57999999999999999998752         244556555432111 11234678899999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      .+..++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECc
Confidence            9999999999975 9999997542  348999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++.........  .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||......  ..+..... .....
T Consensus       146 ~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~~  220 (288)
T 1ob3_A          146 LARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFR-ILGTP  220 (288)
T ss_dssp             HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHCCC
T ss_pred             cccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HHCCC
Confidence            99765432211  1234689999999999764 5899999999999999999999999654311  11111111 00000


Q ss_pred             C---c-----ccccC-------CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          385 D---T-----ETLLD-------PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~---~-----~~~~d-------~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .   .     ....+       +..........+..+.+++.+||+.||.+|||+.++++        |+|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--------hp~f~~  286 (288)
T 1ob3_A          221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--------HAYFKE  286 (288)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SGGGGC
T ss_pred             ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--------Ccchhh
Confidence            0   0     00000       00011111224567889999999999999999999997        899864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-42  Score=349.75  Aligned_cols=268  Identities=21%  Similarity=0.243  Sum_probs=201.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--ccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--QFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      .++|++.+.||+|+||.||++....        ..+.+++|.+.+...  ......+.|.+|+.++++++||||++++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   96 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQ--------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV   96 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECC--------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence            5689999999999999999987543        445566665433211  123356789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccC-------------------------------------CCCCCChHHHHHHHHH
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAG-------------------------------------EQSVLPWGVRFEVAVA  265 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~q  265 (522)
                      +.+.+..++||||+++|+|.+++....                                     ....+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            999999999999999999999996310                                     0112467788999999


Q ss_pred             HHHHHHHHHhcCCCCEEeccCCCCceeccCCC--ceEEeecCccccCCCCCC--CccccccccCCCCCChhhhcc--CCC
Q 036172          266 IAEALNYLHSECSRPVIHRDVKSSNILLSSDF--QPQLSDFGLAIWGPTDST--HMIREDVVGTFGYIAPEYLMH--GKV  339 (522)
Q Consensus       266 i~~gL~yLH~~~~~giiHrDIkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~~~~--~~~  339 (522)
                      |+.||.|||+   .+|+||||||+|||++.++  .+||+|||++........  ........||+.|+|||.+.+  ..+
T Consensus       177 i~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            9999999999   9999999999999998776  899999999975433211  112234579999999999965  678


Q ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCC
Q 036172          340 SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQ  419 (522)
Q Consensus       340 s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~  419 (522)
                      +.++||||||+++|+|++|+.||......  .....    .......  .     ........+..+.+++.+||+.||.
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~----~~~~~~~--~-----~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQ----VLNKKLC--F-----ENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCCCC--T-----TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHH----HHhcccc--c-----CCcccccCCHHHHHHHHHHcCCChh
Confidence            99999999999999999999999644311  11111    1111100  0     0011112345788999999999999


Q ss_pred             CCCCHHHHHHHHhccccCCcccccc
Q 036172          420 LRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       420 ~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +||++.++++        ++|++..
T Consensus       321 ~Rps~~~~l~--------hp~~~~~  337 (345)
T 3hko_A          321 ERFDAMRALQ--------HPWISQF  337 (345)
T ss_dssp             TSCCHHHHHH--------SHHHHTT
T ss_pred             HCCCHHHHhc--------ChhhccC
Confidence            9999999998        8898754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5e-42  Score=338.82  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=190.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-cchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-FSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .++|++.+.||+|+||.||++...          ...+++|.++..... .....+.|.+|++++++++||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC   75 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            468999999999999999998743          234555544332221 123457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC---EEeccCCCCceeccC-----
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP---VIHRDVKSSNILLSS-----  295 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g---iiHrDIkp~NILl~~-----  295 (522)
                      .+++..++||||+++++|.+++..    ..+++..++.++.|++.||.|||+   .+   |+||||||+|||++.     
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~  148 (271)
T 3dtc_A           76 LKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENG  148 (271)
T ss_dssp             CCC--CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred             ecCCceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccc
Confidence            999999999999999999999963    249999999999999999999999   77   999999999999986     


Q ss_pred             ---CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          296 ---DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       296 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                         ++.+||+|||++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......   .
T Consensus       149 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~  221 (271)
T 3dtc_A          149 DLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---A  221 (271)
T ss_dssp             CCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---H
T ss_pred             cccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence               67899999999975543322    2346899999999999999999999999999999999999999643211   1


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...   ..... ..        ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       222 ~~~---~~~~~-~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 VAY---GVAMN-KL--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHH---HHHTS-CC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHH---hhhcC-CC--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111   11111 11        0111122345788999999999999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-41  Score=335.37  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=206.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.+....  .....+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV--------TEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECC--------CCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            579999999999999999987542        34556666543221  12355789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+++++|.+++..   ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCC
Confidence            9999999999999999999974   3359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++................|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ....+...    .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----~  225 (276)
T 2yex_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----K  225 (276)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT----C
T ss_pred             CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc----c
Confidence            9976543322222334578999999999987665 7899999999999999999999976543322 11111110    0


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..   ..+      ....+..+.+++.+||+.||.+|||+.+|++        ++|++..
T Consensus       226 ~~---~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--------~~~~~~~  268 (276)
T 2yex_A          226 TY---LNP------WKKIDSAPLALLHKILVENPSARITIPDIKK--------DRWYNKP  268 (276)
T ss_dssp             TT---STT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CTTTTCC
T ss_pred             cc---cCc------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc--------CccccCh
Confidence            00   000      1123456788999999999999999999997        8887754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-41  Score=338.89  Aligned_cols=259  Identities=23%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+...........+.+.+|+.++++++||||+++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQ--------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcC--------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            45789999999999999999987543        3445555554332222222456799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++|+|.+++...+   .+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~D  157 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIAD  157 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEec
Confidence            99999999999999999999998543   48999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.......    .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......   ....   ... .
T Consensus       158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~~~-~  226 (284)
T 2vgo_A          158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHR---RIV-N  226 (284)
T ss_dssp             CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHH-T
T ss_pred             ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHH---HHh-c
Confidence            99986544322    22457899999999999989999999999999999999999999653311   1111   111 1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      ...      .    ++...+..+.+++.+||+.||.+||++.++++        |+|++...
T Consensus       227 ~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--------h~~~~~~~  270 (284)
T 2vgo_A          227 VDL------K----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME--------HPWVKANS  270 (284)
T ss_dssp             TCC------C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--------CHHHHHHC
T ss_pred             ccc------C----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--------CHHHHhhc
Confidence            110      0    11123456888999999999999999999997        89987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.9e-42  Score=341.30  Aligned_cols=263  Identities=23%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....           .+++|.++.. .......+.|.+|+.++++++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----------~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG-----------DVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS-----------EEEEEEESCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC-----------ceEEEEEecc-CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            46789999999999999999986432           1333332211 11223557899999999999999999999965


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                       .....++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECC
T ss_pred             -cCCccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEcc
Confidence             456689999999999999999754  2359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||++................||+.|+|||.+.   ...++.++||||||+++|+|++|+.||....  ....+...... 
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~-  240 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGR-  240 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHHHHHHHHH-
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcc-
Confidence            99997654433333334557999999999986   5678999999999999999999999996533  22222222211 


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                         +.....+     .......+..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       241 ---~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          241 ---GSLSPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---TSCCCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---cccCcch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence               1111110     1111223467899999999999999999999999998875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.4e-42  Score=341.67  Aligned_cols=257  Identities=19%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....         .+.+++|.++....    ..++|.+|++++++++||||+++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~   88 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRG---------QYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVC   88 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETT---------TEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcC---------CCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            45689999999999999999986432         23455555432211    236799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~D  163 (283)
T 3gen_A           89 TKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD  163 (283)
T ss_dssp             CSSSSEEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECS
T ss_pred             ecCCCeEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcc
Confidence            9999999999999999999999853  2349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .......    
T Consensus       164 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----  235 (283)
T 3gen_A          164 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA----  235 (283)
T ss_dssp             TTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----
T ss_pred             ccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHh----
Confidence            9999765432111 1123356788999999999999999999999999999998 99999654321   1111111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+..  ...       +...+..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       236 ~~~~--~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          236 QGLR--LYR-------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             TTCC--CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccC--CCC-------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            1100  000       1112356888999999999999999999999998765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=352.84  Aligned_cols=262  Identities=20%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC--CCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ--KSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H--pnIv~l~~  221 (522)
                      ..++|++.+.||+|+||.||++...         ..+.+++|.+.... ......+.|.+|+.+|++++|  |||+++++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE---------KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT---------TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC---------CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            3568999999999999999998642         24456666543211 122355789999999999976  99999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+++.+++|||+ .+|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||
T Consensus        77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           77 YEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEE
T ss_pred             eEeeCCEEEEEEeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEE
Confidence            99999999999995 578999999864   359999999999999999999999   9999999999999997 578999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      +|||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....  .
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~  226 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q  226 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--H
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--H
Confidence            99999987655444333445679999999999865           6789999999999999999999999964221  1


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                        . .........         .....++...+..+.+++.+||+.||.+|||+.++++        |+|++...
T Consensus       227 --~-~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--------hp~~~~~~  281 (343)
T 3dbq_A          227 --I-SKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--------HPYVQIQT  281 (343)
T ss_dssp             --H-HHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHSCC
T ss_pred             --H-HHHHHHhcC---------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--------CccccccC
Confidence              1 111111111         1111111122356888999999999999999999997        88887543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=348.85  Aligned_cols=265  Identities=19%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.......    .....+++|.+...  ......++|.+|+.++++++||||+++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTC----SCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCc----eEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            35789999999999999999987532110    00112233333211  1223557899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+. .++|++|+.+|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~-~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~D  160 (327)
T 3lzb_A           87 LTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             ESSS-EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             ecCC-ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEcc
Confidence            8765 788999999999999998643  349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...........   .    .
T Consensus       161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~----~  233 (327)
T 3lzb_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L----E  233 (327)
T ss_dssp             TTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----H
T ss_pred             CcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---H----H
Confidence            999987655444333334567889999999999999999999999999999999 9999975443222111   1    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus       234 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          234 KGERL---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             cCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11100         0111234468889999999999999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=350.00  Aligned_cols=253  Identities=20%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc-----chHHHHHHHHHHHHhhCCCCCcce
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF-----SSAWNDFSSEVDITSSLEQKSITT  218 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~-----~~~~~~f~~Ev~iL~~L~HpnIv~  218 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|.++......     ....+.|.+|+.++++++||||++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~   93 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKE--------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK   93 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETT--------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECC--------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence            34689999999999999999987543        34556655544322110     113346788999999999999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          219 LNGVCIEDNYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +++++.+.+..++||||+.+| +|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             EEEEEECSSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTS
T ss_pred             EEEEEeeCCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCC
Confidence            999999999999999999777 999999853   359999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||++.........   ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....     .    
T Consensus       168 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~----  235 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-----E----  235 (335)
T ss_dssp             CEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-----G----
T ss_pred             cEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-----H----
Confidence            9999999999776544322   23579999999999988876 889999999999999999999985311     0    


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         ....     ...+      +...+..+.+++.+||+.||.+|||+.+|++        ++|++..
T Consensus       236 ---~~~~-----~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--------hp~~~~~  281 (335)
T 3dls_A          236 ---TVEA-----AIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVT--------DPWVTQP  281 (335)
T ss_dssp             ---GTTT-----CCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--------CTTTTCC
T ss_pred             ---HHhh-----ccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhc--------CccccCC
Confidence               0000     0000      1113456889999999999999999999998        8998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-41  Score=345.04  Aligned_cols=262  Identities=19%  Similarity=0.274  Sum_probs=207.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc---hHHHHHHHHHHHHhhCCCCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS---SAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~---~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.++.......   ...++|.+|+.++++++||||++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKS--------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH   81 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECC--------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence            34689999999999999999987543        345566665443222111   1357899999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC---
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF---  297 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~---  297 (522)
                      +++.+.+..++||||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++   
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSS
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCc
Confidence            9999999999999999999999999843   358999999999999999999999   9999999999999999887   


Q ss_pred             -ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 -QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                       .+||+|||++.........   ....||+.|+|||.+.+..++.++||||||+++|+|++|..||.....   ......
T Consensus       156 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~  229 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLAN  229 (321)
T ss_dssp             CCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHH
T ss_pred             CCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHH
Confidence             7999999999766543221   244689999999999989999999999999999999999999964321   111111


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..    ....      ..........+..+.+++.+||+.||.+|||+.++++        |+|+..
T Consensus       230 i~----~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--------hp~~~~  278 (321)
T 2a2a_A          230 IT----SVSY------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR--------HPWITP  278 (321)
T ss_dssp             HH----TTCC------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--------STTTSC
T ss_pred             HH----hccc------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc--------CccccC
Confidence            11    1100      0011111123457889999999999999999999998        888764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-41  Score=350.97  Aligned_cols=261  Identities=18%  Similarity=0.242  Sum_probs=205.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.+..   ........+.+|+.+|++++||||+++++++
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~--------~~~~~a~K~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~  117 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKA--------TGRVFVAKFINT---PYPLDKYTVKNEISIMNQLHHPKLINLHDAF  117 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEC---CSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECC--------CCCEEEEEEecc---cchhhHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            35689999999999999999987543        344555554321   1122345789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--CCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--DFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--~~~~kL  301 (522)
                      .+...+++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.  ++.+||
T Consensus       118 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL  192 (387)
T 1kob_A          118 EDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI  192 (387)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEE
Confidence            99999999999999999999997532  348999999999999999999999   99999999999999974  468999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ........   
T Consensus       193 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~---  263 (387)
T 1kob_A          193 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVK---  263 (387)
T ss_dssp             CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH---
T ss_pred             EecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHH---
Confidence            99999977654322   2234799999999999999999999999999999999999999965321   11111111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      . ....  +++..    ....+..+.+++.+||+.||.+|||+.++++        ++|+...
T Consensus       264 ~-~~~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~~~~~  311 (387)
T 1kob_A          264 R-CDWE--FDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--------HPWLKGD  311 (387)
T ss_dssp             H-CCCC--CCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--------STTTSSC
T ss_pred             h-CCCC--CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh--------CccccCC
Confidence            1 1000  11111    1123457889999999999999999999997        8898754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.2e-42  Score=339.08  Aligned_cols=259  Identities=21%  Similarity=0.275  Sum_probs=203.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ....+++|.+....   ....+.|.+|+.++++++||||+++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKG--------TRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETF   75 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCC--------CCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35689999999999999999987543        33445555443222   22457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCceE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQ  300 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~k  300 (522)
                      .+++..++||||+++++|.+++....   .+++..++.++.|++.||.|||+   .+|+||||||+||++   +.++.+|
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           76 EDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             ecCCeEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEE
Confidence            99999999999999999999997543   48999999999999999999999   999999999999999   7888999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||++.........   ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....   .......   
T Consensus       150 l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~---  219 (277)
T 3f3z_A          150 LIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKI---  219 (277)
T ss_dssp             ECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---
T ss_pred             EEecccceeccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHH---
Confidence            9999999765543322   24479999999999854 499999999999999999999999965331   1111111   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ..+...      .........+..+.+++.+||+.||.+||++.++++        |+|++..
T Consensus       220 -~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--------h~~~~~~  268 (277)
T 3f3z_A          220 -REGTFT------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--------HEWFEKQ  268 (277)
T ss_dssp             -HHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--------SHHHHHH
T ss_pred             -HhCCCC------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--------CHHHhcc
Confidence             111100      000000123467889999999999999999999997        8898764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=352.40  Aligned_cols=259  Identities=20%  Similarity=0.224  Sum_probs=198.0

Q ss_pred             CCcee--eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQM--DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~--~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      +.|.+  .+.||+|+||.||++....        .++.+++|.++..   .....++|.+|+.++++++||||+++++++
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~--------~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  155 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETA--------TGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAF  155 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETT--------TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcC--------CCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45555  5689999999999987543        3455665554321   112456899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec--cCCCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL--SSDFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl--~~~~~~kL  301 (522)
                      .+.+.++|||||+++|+|.+++...  ...+++..++.++.||+.||.|||+   .+|+||||||+|||+  +.++.+||
T Consensus       156 ~~~~~~~lv~E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl  230 (373)
T 2x4f_A          156 ESKNDIVLVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKI  230 (373)
T ss_dssp             ECSSEEEEEEECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEE
Confidence            9999999999999999999998753  2359999999999999999999999   999999999999999  56789999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..+.......+
T Consensus       231 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~  305 (373)
T 2x4f_A          231 IDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRW  305 (373)
T ss_dssp             CCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCC
T ss_pred             EeCCCceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccC
Confidence            999999776543322   2346999999999998888999999999999999999999999654311  11111111100


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         ..        ........+..+.+++.+||+.||.+||++.++++        |+|+...
T Consensus       306 ---~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--------hp~~~~~  349 (373)
T 2x4f_A          306 ---DL--------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK--------HPWLSDH  349 (373)
T ss_dssp             ---CS--------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------SHHHHCH
T ss_pred             ---CC--------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--------CcCcCCC
Confidence               00        01111123467889999999999999999999998        8887754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-41  Score=343.78  Aligned_cols=267  Identities=20%  Similarity=0.231  Sum_probs=200.9

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+...........+.|.+|+.++++++||||++++++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~  102 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTV--------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF  102 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcC--------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            346799999999999999999987543        345677776655444444456889999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +..++..++||||+++++|.+++....   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          103 GEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             EEETTEEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EeeCCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEe
Confidence            999999999999999999999998543   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||++......... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   .+..    .+.
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~~~  248 (309)
T 2h34_A          177 DFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGA----HIN  248 (309)
T ss_dssp             SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHH----HHH
T ss_pred             cCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHH----Hhc
Confidence            99999765443211 122456899999999999889999999999999999999999999643211   1111    111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhccccCC
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGATHAT  438 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~~~~~  438 (522)
                      .....       ........+..+.+++.+||+.||.+|| ++.++++.|+......
T Consensus       249 ~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          249 QAIPR-------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             SCCCC-------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCCC-------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            11100       0111122345688899999999999999 9999999999876443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-42  Score=349.78  Aligned_cols=274  Identities=18%  Similarity=0.205  Sum_probs=196.2

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.++||+|+||.||++.+..        ..+.+++|.++... ......+.+.+|+.++++++||||++++++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTV--------TNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSV  101 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECC--------CCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence            346789999999999999999986543        34556666553211 112234678899999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec-----cCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL-----SSDF  297 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl-----~~~~  297 (522)
                      +.+++.+++||||+++ +|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||+     +.++
T Consensus       102 ~~~~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          102 IHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CC
T ss_pred             EecCCEEEEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccc
Confidence            9999999999999975 9999998543   49999999999999999999999   999999999999999     4555


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......  ..+...
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~  250 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKI  250 (329)
T ss_dssp             EEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             eEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHH
Confidence            6999999999765432221  1234689999999999775 4899999999999999999999999654321  111111


Q ss_pred             hhhhh--cCC-------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          377 AKPIL--KNG-------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       377 ~~~~~--~~~-------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .....  ...             .........+...........+.+++.+||+.||.+|||+.|+++        |+|+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~f  322 (329)
T 3gbz_A          251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE--------HPYF  322 (329)
T ss_dssp             HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SGGG
T ss_pred             HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--------Cccc
Confidence            11000  000             000000111111111123467889999999999999999999997        9998


Q ss_pred             ccc
Q 036172          442 DRH  444 (522)
Q Consensus       442 ~~~  444 (522)
                      +..
T Consensus       323 ~~~  325 (329)
T 3gbz_A          323 SHN  325 (329)
T ss_dssp             SSS
T ss_pred             CCC
Confidence            754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-41  Score=347.12  Aligned_cols=275  Identities=20%  Similarity=0.266  Sum_probs=204.5

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+... .......+.+.+|+.++++++||||++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKD--------TGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENLVNLLEV   92 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETT--------TCCEEEEEEEESC-SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECC--------CCceEEEEEEecC-CCchHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            346799999999999999999987643        3455666654221 1122245678899999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+..++||||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A           93 CKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEETTEEEEEEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eecCCEEEEEEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEE
Confidence            99999999999999999998887643   349999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh---
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK---  378 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~---  378 (522)
                      |||++.........  .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......  .+.....   
T Consensus       167 Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~  242 (331)
T 4aaa_A          167 DFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLG  242 (331)
T ss_dssp             CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             eCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhC
Confidence            99999765432221  2244689999999999775 68999999999999999999999996543211  1111100   


Q ss_pred             -------------hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 -------------PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 -------------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                                   +.......................+..+.+++.+||+.||.+|||+.||++        |+|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--------hp~f~~~  313 (331)
T 4aaa_A          243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--------HDFFQMD  313 (331)
T ss_dssp             SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--------SHHHHGG
T ss_pred             CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--------CchhccC
Confidence                         001111111111111111111234567899999999999999999999997        8898754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.4e-41  Score=347.24  Aligned_cols=282  Identities=16%  Similarity=0.166  Sum_probs=202.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc--------hHHHHHHHHHHHHhhCCCCC
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS--------SAWNDFSSEVDITSSLEQKS  215 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~--------~~~~~f~~Ev~iL~~L~Hpn  215 (522)
                      ..++|++.++||+|+||.||++......   .....+.+++|.+......+.        .....+..|+..++.++|||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSE---SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSS---CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCcc---ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            3568999999999999999999643210   000122333332211100000        01235667888899999999


Q ss_pred             cceeeEEEEeC----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          216 ITTLNGVCIED----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       216 Iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      |+++++++...    ...+|||||+ +++|.+++...  ...+++..++.++.||+.||.|||+   .+|+||||||+||
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Ni  183 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNL  183 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHE
Confidence            99999999865    5689999999 99999999864  2359999999999999999999999   9999999999999


Q ss_pred             ecc--CCCceEEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 036172          292 LLS--SDFQPQLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF  364 (522)
Q Consensus       292 Ll~--~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~  364 (522)
                      |++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999  88999999999997654322111     11234599999999999999999999999999999999999999975


Q ss_pred             CCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      .....  ........... .....++++.+..   ...+..+.+++..||+.+|.+||++.+|++.|+........
T Consensus       264 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          264 NLKDP--KYVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             GTTCH--HHHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccCH--HHHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            33221  11111111111 0111111111110   11245788999999999999999999999999987654433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.3e-41  Score=340.06  Aligned_cols=266  Identities=23%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        .++.+++|.++..........++|.+|+.++++++||||+++++++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLL--------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETT--------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcC--------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45689999999999999999987543        3456666655432222334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+++..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEE
Confidence            9999999999999999999999753 123458999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||++.........  .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+...    +.
T Consensus       179 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~  251 (310)
T 2wqm_A          179 DLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK----IE  251 (310)
T ss_dssp             CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHH----HH
T ss_pred             eccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHH----hh
Confidence            99999765433221  22346899999999999999999999999999999999999998644322 1111111    11


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ........        ....+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       252 ~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          252 QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             TTCSCCCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCCCCc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111111        1123457888999999999999999999999998875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-41  Score=337.68  Aligned_cols=260  Identities=21%  Similarity=0.322  Sum_probs=209.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ....+++|.++.    .....+.|.+|+.++++++||||+++++++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKK--------YSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGG--------GTEEEEEEEECS----CSTHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecC--------CCEEEEEEecCc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45689999999999999999987653        234555554432    223567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEcc
Confidence            99999999999999999999998653 3459999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ......... 
T Consensus       155 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~~~-  229 (288)
T 3kfa_A          155 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDY-  229 (288)
T ss_dssp             CCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTC-
T ss_pred             CccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhccC-
Confidence            999976654332 22234567889999999999999999999999999999999 999987543222   111111110 


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                                  ....+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       230 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 ------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                        001112234578899999999999999999999999988653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=350.55  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=191.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        ..+.+++|.++...     ..+.+.+|+.++++++||||+++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKG--------TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECC--------CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            4679999999999999999987643        34566666554321     3457889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---CCceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---~~~~kL  301 (522)
                      +.+..++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+||
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl  192 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKI  192 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEE
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEE
Confidence            999999999999999999999743   359999999999999999999999   99999999999999975   889999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..+....    
T Consensus       193 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i----  263 (349)
T 2w4o_A          193 ADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRI----  263 (349)
T ss_dssp             CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHH----
T ss_pred             ccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHH----
Confidence            99999976543221   22457899999999999989999999999999999999999998643221  1111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...... ...     ......+..+.+++.+||+.||.+|||+.++++        ++|+...
T Consensus       264 ~~~~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--------hp~~~~~  312 (349)
T 2w4o_A          264 LNCEYY-FIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--------HPWVTGK  312 (349)
T ss_dssp             HTTCCC-CCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------STTTTST
T ss_pred             HhCCCc-cCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--------CcccCCC
Confidence            111110 000     111123457889999999999999999999998        8998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-41  Score=347.65  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=209.1

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ....++|++.+.||+|+||.||++.+..        ..+.+++|.+.+.........+.|.+|+.++++++||||+++++
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  108 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDAD--------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG  108 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456789999999999999999987643        34455555544332222345678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+.+..++||||+++++|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl  182 (335)
T 2owb_A          109 FFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKI  182 (335)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEE
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEE
Confidence            999999999999999999999998754   349999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.........  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......   ......   .
T Consensus       183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~---~  254 (335)
T 2owb_A          183 GDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRI---K  254 (335)
T ss_dssp             CCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---H
T ss_pred             eeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHH---h
Confidence            999999765433221  23457899999999999889999999999999999999999999654311   111111   1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      . +..      .+    +......+.+++.+||+.||.+||++.++++        ++|+...
T Consensus       255 ~-~~~------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--------~~~~~~~  298 (335)
T 2owb_A          255 K-NEY------SI----PKHINPVAASLIQKMLQTDPTARPTINELLN--------DEFFTSG  298 (335)
T ss_dssp             H-TCC------CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--------SHHHHTS
T ss_pred             c-CCC------CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CccccCC
Confidence            1 110      01    1122346788999999999999999999997        8887653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-41  Score=352.89  Aligned_cols=264  Identities=20%  Similarity=0.232  Sum_probs=198.0

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHH-HhhCCCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI-TSSLEQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~i-L~~L~HpnIv~l~~  221 (522)
                      ...++|++.+.||+|+||.||++....        +.+.+++|.+++...........+.+|..+ ++.++||||+++++
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~  106 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKA--------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF  106 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETT--------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcC--------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEE
Confidence            345789999999999999999987643        456677777655443333455677888887 56789999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+.+.+|+||||++||+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          107 SFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999998543   48999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.   ..+..   .+.
T Consensus       181 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~  252 (373)
T 2r5t_A          181 TDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---NIL  252 (373)
T ss_dssp             CCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHH---HHH
T ss_pred             eeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHH---HHH
Confidence            99999975332211  12345799999999999999999999999999999999999999964321   11111   111


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .. ..          .++...+..+.+++.+||+.||.+||++.+.++.+.    .|+|++.
T Consensus       253 ~~-~~----------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~----~h~~f~~  299 (373)
T 2r5t_A          253 NK-PL----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK----SHVFFSL  299 (373)
T ss_dssp             HS-CC----------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH----TSGGGTT
T ss_pred             hc-cc----------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh----CCccccC
Confidence            11 10          011123456888999999999999999864333332    2677654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-41  Score=365.92  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=208.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++....        ....+++|.++...    ...++|.+|+.+|++++|||||+++++|.
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKK--------YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGG--------GTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcC--------CCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4578999999999999999987643        34556666554321    23578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+.++|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeec
Confidence            9999999999999999999998653 2358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||.......   +.....    .
T Consensus       363 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~  434 (495)
T 1opk_A          363 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----K  434 (495)
T ss_dssp             TCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----T
T ss_pred             ccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence            99986543321 11223456789999999999999999999999999999999 999997543221   221111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +.         ....+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       435 ~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 DY---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CC---------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            11         011122234678899999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-41  Score=339.04  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=208.9

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      +...++|++.+.||+|+||.||++....        ..+.+++|.+.+.........+.+.+|+.++++++||||+++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDAD--------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG   82 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECC--------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            3456789999999999999999987643        34455555543332222345678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+++..++||||+++++|.+++....   .+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl  156 (294)
T 2rku_A           83 FFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKI  156 (294)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEE
Confidence            9999999999999999999999987542   49999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.........  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....     +
T Consensus       157 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~-----~  227 (294)
T 2rku_A          157 GDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLR-----I  227 (294)
T ss_dssp             CCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-----H
T ss_pred             EeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----H
Confidence            999999765433221  224578999999999998889999999999999999999999996543211  1111     1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..+..      .    .+......+.+++.+||+.||.+|||+.++++        ++|+...
T Consensus       228 ~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--------~~~~~~~  272 (294)
T 2rku_A          228 KKNEY------S----IPKHINPVAASLIQKMLQTDPTARPTINELLN--------DEFFTSG  272 (294)
T ss_dssp             HTTCC------C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--------SHHHHTS
T ss_pred             hhccC------C----CccccCHHHHHHHHHHcccChhhCcCHHHHhh--------ChheecC
Confidence            11110      0    11122356888999999999999999999997        8887654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-41  Score=354.85  Aligned_cols=272  Identities=22%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~  223 (522)
                      .++|++.++||+|+||.||++.+..        +.+.+++|.+.+... .....+++.+|+.+++++. ||||+++++++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRR--------TGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETT--------TCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECC--------CCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            4689999999999999999987543        456677776533211 1235577889999999996 99999999999


Q ss_pred             EeCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IEDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ...+  .+|+||||++ |+|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl  150 (388)
T 3oz6_A           79 RADNDRDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKV  150 (388)
T ss_dssp             ECTTSSCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             ecCCCCEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEe
Confidence            8654  7999999997 5999999753    48999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCC-------------------CccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCC
Q 036172          302 SDFGLAIWGPTDST-------------------HMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       302 ~DFGla~~~~~~~~-------------------~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~P  361 (522)
                      +|||+++.......                   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence            99999976533110                   111234579999999999976 6789999999999999999999999


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcc---ccc------------------CCccccccc------------HHHHHHHHH
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTE---TLL------------------DPKLSNEYD------------NAQMQRMLL  408 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~---~~~------------------d~~l~~~~~------------~~~~~~l~~  408 (522)
                      |.......  .+.... ..+......   .+.                  .......++            ...+..+.+
T Consensus       231 f~~~~~~~--~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  307 (388)
T 3oz6_A          231 FPGSSTMN--QLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD  307 (388)
T ss_dssp             CCCSSHHH--HHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred             CCCCCHHH--HHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence            97543211  111111 000000000   000                  000000000            012356889


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          409 AANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       409 li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      |+.+||+.||.+|||+.|+++        |+|+...
T Consensus       308 ll~~~L~~dP~~R~t~~e~l~--------Hp~~~~~  335 (388)
T 3oz6_A          308 LLDKLLQFNPNKRISANDALK--------HPFVSIF  335 (388)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTT--------STTTTTT
T ss_pred             HHHHhhccCcccCCCHHHHhC--------CHHHHHh
Confidence            999999999999999999997        9998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.6e-42  Score=348.40  Aligned_cols=262  Identities=23%  Similarity=0.291  Sum_probs=197.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....     ....++.+++|.+++... ........+.+|+.+|++++||||++++++
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVT-----GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECS-----STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEec-----cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            45789999999999999999986531     123456667666543211 111234668899999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+++.+++||||+++|+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEE
Confidence            999999999999999999999998543   48999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......   ...
T Consensus       164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~---i~~  235 (327)
T 3a62_A          164 DFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDK---ILK  235 (327)
T ss_dssp             CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH---HHH
T ss_pred             eCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHh
Confidence            9999865432221  12345799999999999988999999999999999999999999965431   111111   111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      . ..          ..+...+..+.+++.+||+.||.+||     ++.++++        |+|++.
T Consensus       236 ~-~~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--------hp~f~~  282 (327)
T 3a62_A          236 C-KL----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--------HPFFRH  282 (327)
T ss_dssp             T-CC----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--------SGGGSS
T ss_pred             C-CC----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--------CCcccC
Confidence            1 00          01112345788899999999999999     7889987        899874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-41  Score=363.74  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=213.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        +++.|++|.+.+.........+.+.+|+.+|++++||||+++++++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~--------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKA--------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECC--------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            45789999999999999999987643        4667777776554433334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+...+|+||||++||+|.+++.... ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEe
Confidence            99999999999999999999997653 23459999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-hhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG-PESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~  381 (522)
                      |||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+...   ..
T Consensus       332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~  406 (543)
T 3c4z_A          332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VL  406 (543)
T ss_dssp             CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HH
T ss_pred             ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hh
Confidence            99999765543322  224579999999999999999999999999999999999999997654322 1122211   11


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~~L~~~~~~~~~~~~  443 (522)
                      .. .          ..++...+..+.+++.+||+.||.+||++     .+|++        |+|++.
T Consensus       407 ~~-~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~--------Hpff~~  454 (543)
T 3c4z_A          407 EQ-A----------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT--------HPLFRD  454 (543)
T ss_dssp             HC-C----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT--------SGGGTT
T ss_pred             hc-c----------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc--------CccccC
Confidence            11 0          01112234578889999999999999965     67775        888875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.9e-41  Score=337.52  Aligned_cols=272  Identities=20%  Similarity=0.219  Sum_probs=202.2

Q ss_pred             CCCCCCCceee-ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcce
Q 036172          141 SPKTENPFQMD-IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITT  218 (522)
Q Consensus       141 ~~~~~~~y~~~-~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~  218 (522)
                      .....++|++. +.||+|+||.||++.+..        ..+.+++|.+...   .....+.+.+|+.++.++ +||||++
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~i~~   75 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI--------TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLE   75 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSS--------SCCEEEEEEEECC---SSCCHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcC--------CCcEEEEEEEeeC---cchhHHHHHHHHHHHHHhcCCCCeee
Confidence            44556789995 789999999999987542        4566777665432   223457899999999995 8999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      +++++.+++.+++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~  149 (316)
T 2ac3_A           76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQ  149 (316)
T ss_dssp             EEEEEEETTEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSS
T ss_pred             EEEEEeeCCEEEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCC
Confidence            999999999999999999999999999854   348999999999999999999999   99999999999999998775


Q ss_pred             ---eEEeecCccccCCCCCC-----CccccccccCCCCCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          299 ---PQLSDFGLAIWGPTDST-----HMIREDVVGTFGYIAPEYLMH-----GKVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       299 ---~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                         +||+|||++........     ........||+.|+|||++..     ..++.++|||||||++|+|++|+.||...
T Consensus       150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence               99999999875532211     111123469999999999865     55889999999999999999999999765


Q ss_pred             CCCChh--------hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          366 NLKGPE--------SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       366 ~~~~~~--------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      ......        .........+..+...      .........+..+.+++.+||+.||.+|||+.++++        
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--------  295 (316)
T 2ac3_A          230 CGSDCGWDRGEACPACQNMLFESIQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--------  295 (316)
T ss_dssp             CCSCSCC----CCHHHHHHHHHHHHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------
T ss_pred             ccccccccccccchhHHHHHHHHHhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--------
Confidence            432210        0000001111111110      000000123457889999999999999999999998        


Q ss_pred             Cccccc
Q 036172          438 TDWVDR  443 (522)
Q Consensus       438 ~~~~~~  443 (522)
                      |+|++.
T Consensus       296 hp~~~~  301 (316)
T 2ac3_A          296 HPWVQG  301 (316)
T ss_dssp             STTCC-
T ss_pred             ChhhcC
Confidence            999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-41  Score=365.20  Aligned_cols=264  Identities=25%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh----------ccchHHHHHHHHHHHHhhCC
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS----------QFSSAWNDFSSEVDITSSLE  212 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~----------~~~~~~~~f~~Ev~iL~~L~  212 (522)
                      ...++|++.++||+|+||.||++....        ..+.+++|.+++...          ......+.+.+|+.+|++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKN--------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETT--------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             CcccceEEEeEecccCCeEEEEEEECC--------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            346789999999999999999987643        334455554432111          11134578999999999999


Q ss_pred             CCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          213 QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       213 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      ||||+++++++.+...+++||||+++|+|.+++....   .+++..++.++.||+.||.|||+   .+|+||||||+|||
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL  178 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEE
Confidence            9999999999999999999999999999999997543   49999999999999999999999   99999999999999


Q ss_pred             ccCCC---ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          293 LSSDF---QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       293 l~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      ++.++   .+||+|||++........   .....||+.|+|||++. +.++.++|||||||++|+|++|..||.....  
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--  252 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--  252 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred             EecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence            98776   699999999977654322   22457999999999986 5699999999999999999999999975432  


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                       ..+.....    .+....      ........+..+.+++.+||+.||.+|||+.++++        |+|++...
T Consensus       253 -~~~~~~i~----~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--------h~~~~~~~  309 (504)
T 3q5i_A          253 -QDIIKKVE----KGKYYF------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--------SRWIKKYA  309 (504)
T ss_dssp             -HHHHHHHH----HCCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHHTC
T ss_pred             -HHHHHHHH----cCCCCC------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--------CHhhhhch
Confidence             12221111    111100      00001123467889999999999999999999997        88887654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-42  Score=349.07  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.++..........+.|.+|+.++++++||||+++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLR--------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECC--------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            45789999999999999999988643        4556777766544333444667899999999999999999999998


Q ss_pred             EeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          224 IEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       224 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ....    ..++||||+++|+|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCE
Confidence            8653    4599999999999999998543   49999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      ||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......   ..   ..
T Consensus       156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~---~~  229 (311)
T 3ork_A          156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SV---AY  229 (311)
T ss_dssp             EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HH
T ss_pred             EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HH---HH
Confidence            99999999765443222 2223456899999999999999999999999999999999999999653311   11   11


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      .........       ........+..+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          230 QHVREDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHCCCCC-------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHhcCCCCC-------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            111111110       01111123457889999999999999998877775

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.9e-42  Score=351.25  Aligned_cols=269  Identities=21%  Similarity=0.322  Sum_probs=209.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.......   ....+.+++|.++...  .....+.|.+|+.+++++ +||||++++++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGK---EDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSS---SCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCc---ccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            45789999999999999999987543110   1122345555543211  223567899999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-----------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-----------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      +.+++..++||||+++|+|.+++.....           ...+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceE
Confidence            9999999999999999999999975421           2358999999999999999999999   9999999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGP  370 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~  370 (522)
                      |++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... 
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            999999999999999976554444333445567889999999999999999999999999999998 999986543221 


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                       ...........    .         ..+...+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       275 -~~~~~~~~~~~----~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          275 -KFYKLVKDGYQ----M---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHHHHTCC----C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHhcCCC----C---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             11111111100    0         001112457888999999999999999999999998765

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7e-41  Score=357.03  Aligned_cols=276  Identities=17%  Similarity=0.189  Sum_probs=190.5

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.++||+|+||.||++.+..        +.+.||+|.+.+.. ......+++.+|+.+|++++|||||+++++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  120 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKL--------EKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDI  120 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC----------CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECC--------CCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            345799999999999999999987543        35566666553321 122345789999999999999999999999


Q ss_pred             EEeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          223 CIED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       223 ~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +...     ..+|+||||+ +|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+||||+.++
T Consensus       121 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~  193 (458)
T 3rp9_A          121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDC  193 (458)
T ss_dssp             CCCSCTTTCCCEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTC
T ss_pred             EecCCcccCceEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCC
Confidence            9543     5799999998 56999999743   359999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCC-------------------------ccccccccCCCCCChhhh-ccCCCCchhhHHHHHHH
Q 036172          298 QPQLSDFGLAIWGPTDSTH-------------------------MIREDVVGTFGYIAPEYL-MHGKVSDKIDVYSFGVV  351 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvv  351 (522)
                      .+||+|||+++........                         .......||+.|+|||++ ....++.++|||||||+
T Consensus       194 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~i  273 (458)
T 3rp9_A          194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI  273 (458)
T ss_dssp             CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred             CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHH
Confidence            9999999999765432211                         112345789999999986 45669999999999999


Q ss_pred             HHHHHc-----------CCCCCCCCCCCC------------------hhhHHHhhhhhhcCCC-----------------
Q 036172          352 LLELLS-----------GRRPIGFKNLKG------------------PESLVKWAKPILKNGD-----------------  385 (522)
Q Consensus       352 l~eLlt-----------G~~Pf~~~~~~~------------------~~~l~~~~~~~~~~~~-----------------  385 (522)
                      +|||++           |+++|.......                  ...+.. ....+....                 
T Consensus       274 l~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-i~~~~g~p~~~~~~~~~~~~~~~~~~  352 (458)
T 3rp9_A          274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV-IFNILGTPSEEDIEALEKEDAKRYIR  352 (458)
T ss_dssp             HHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHH-HHHHHCCCCHHHHHTSSCHHHHHHHT
T ss_pred             HHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHH-HHHHcCCCCHHHHhhcCCHHHHHHHH
Confidence            999999           556654332100                  000000 000000000                 


Q ss_pred             -cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          386 -TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       386 -~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       ........+ ..........+.+|+.+||+.||.+|||+.|+++        |+|++..
T Consensus       353 ~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--------Hp~f~~~  403 (458)
T 3rp9_A          353 IFPKREGTDL-AERFPASSADAIHLLKRMLVFNPNKRITINECLA--------HPFFKEV  403 (458)
T ss_dssp             TSCCCCCCCG-GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SGGGTTT
T ss_pred             hcCCCCCCCH-HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--------CHhhhhc
Confidence             000000000 0111123567889999999999999999999998        9998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.8e-41  Score=333.52  Aligned_cols=266  Identities=18%  Similarity=0.212  Sum_probs=201.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+..     ....+++.+|+.++++++|++++..+.++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~-----~~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA--------AGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGVGIPTIRWC   73 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETT--------TTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcC--------CCceEEEEeecc-----cccchHHHHHHHHHHHhcCCCCCCeeeee
Confidence            45789999999999999999987543        344556553211     11234588999999999988877766665


Q ss_pred             -EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCce
Q 036172          224 -IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQP  299 (522)
Q Consensus       224 -~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~  299 (522)
                       ..+...++||||+ +++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||+   +.++.+
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~  147 (296)
T 4hgt_A           74 GAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCE
T ss_pred             cCCCCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeE
Confidence             5778899999999 889999998542  249999999999999999999999   999999999999999   788999


Q ss_pred             EEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          300 QLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      ||+|||+++........     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus       148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  227 (296)
T 4hgt_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  227 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred             EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence            99999999765543321     1223457999999999999999999999999999999999999999765443332222


Q ss_pred             Hhh-hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          375 KWA-KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       375 ~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      ... ...... .         ........+..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       228 ~~~~~~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          228 ERISEKKMST-P---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHHHHS-C---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhhhcccccc-h---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            211 111110 0         00001112457889999999999999999999999999876433

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-41  Score=363.80  Aligned_cols=262  Identities=22%  Similarity=0.315  Sum_probs=206.7

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.++||+|+||.||++.+..        +.+.+++|.+.+.... ....+.+.+|+.+|++++||||++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~   89 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRI--------TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEI   89 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETT--------TCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECC--------CCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            345789999999999999999987643        4567777776543322 1245789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc---CCCce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~---~~~~~  299 (522)
                      +.+.+.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  163 (486)
T 3mwu_A           90 LEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDI  163 (486)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCE
T ss_pred             EEcCCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCE
Confidence            99999999999999999999998754   349999999999999999999999   9999999999999995   45679


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....   ..+....  
T Consensus       164 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i--  234 (486)
T 3mwu_A          164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRV--  234 (486)
T ss_dssp             EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH--
T ss_pred             EEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--
Confidence            9999999976544322   224579999999999864 699999999999999999999999965431   1111111  


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        ..+.....      .......+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       235 --~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--------hp~~~~~  283 (486)
T 3mwu_A          235 --ETGKYAFD------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--------HPWIQKY  283 (486)
T ss_dssp             --HHTCCCSC------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--------CHHHHHT
T ss_pred             --HhCCCCCC------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--------CHhhccC
Confidence              11111100      0011123457889999999999999999999998        8887654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.8e-41  Score=340.09  Aligned_cols=268  Identities=20%  Similarity=0.267  Sum_probs=199.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.....     ......+++|.++.... .....+.|.+|+.++++++||||+++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE-----DGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT-----TSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc-----CCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            356899999999999999999864321     12344667776654321 233567899999999999999999999999


Q ss_pred             EeCC-----EEEEEEecCCCCCHHHHhhcc---CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          224 IEDN-----YLILVSDFLPKGSLEESLHGA---GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       224 ~~~~-----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      .+..     ..++||||+++|+|.+++...   .....+++..++.++.|++.||.|||+   .+|+||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence            8754     359999999999999999532   233469999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLV  374 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~  374 (522)
                      ++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ..
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~  259 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY  259 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH
Confidence            99999999999976654433223334567889999999999999999999999999999999 999986543221   11


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ....    .+...         ..+...+..+.+++.+||..||.+||++.+|++.|+.+..
T Consensus       260 ~~~~----~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          260 DYLL----HGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHH----TTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH----cCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111    11110         1112234578899999999999999999999999988753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-41  Score=344.04  Aligned_cols=269  Identities=17%  Similarity=0.296  Sum_probs=209.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.....   ......+.+++|.+....  ......+|.+|+.++++++||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGV---VKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEE---ETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCc---cCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            356899999999999999999865421   001234456665543221  223456799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC-------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG-------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      .+++..++||||+++|+|.+++....       ....+++..++.++.|++.||.|||+   .+|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            99999999999999999999997532       12357999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHH
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~  375 (522)
                      +.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....   .....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLR  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHH
Confidence            9999999999975544332223334467889999999999999999999999999999999 8999865321   12211


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ..    ..+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       252 ~~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FV----MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH----HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            11    1111111         111234568889999999999999999999999998763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.2e-41  Score=343.78  Aligned_cols=274  Identities=17%  Similarity=0.182  Sum_probs=194.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHH-------hhcc-chHHHHHHHHHHHHhhCCCCC
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQA-------TSQF-SSAWNDFSSEVDITSSLEQKS  215 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~-------t~~~-~~~~~~f~~Ev~iL~~L~Hpn  215 (522)
                      ..++|++.+.||+|+||.||++.....     ......+++|.+...       .... .-....+.+|+.+++.++|||
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNK-----PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSS-----CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCC-----CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            457899999999999999999975420     001112222211100       0000 002246888999999999999


Q ss_pred             cceeeEEEEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          216 ITTLNGVCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       216 Iv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      |+++++++..    ....++||||+ +++|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI  182 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANL  182 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHE
Confidence            9999999998    78899999999 999999998543   59999999999999999999999   9999999999999


Q ss_pred             eccCCC--ceEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 036172          292 LLSSDF--QPQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF  364 (522)
Q Consensus       292 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~  364 (522)
                      |++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998877  9999999999765432211     112345799999999999999999999999999999999999999964


Q ss_pred             CCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       365 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ...... ...........  .....+.....   ....+..+.+++..||+.||.+||++.+|++.|+...
T Consensus       263 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          263 NLKDPV-AVQTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             GTTCHH-HHHHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccccH-HHHHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            322211 11111111100  00000000000   0023457899999999999999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=351.51  Aligned_cols=276  Identities=17%  Similarity=0.177  Sum_probs=212.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        +.+.+++|.++...  .....+.+.+|++++++++||||+++++++.
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK--------TGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC--------CCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            4689999999999999999987643        45677777665322  2234677899999999999999999999999


Q ss_pred             eCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec----cCCCc
Q 036172          225 EDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL----SSDFQ  298 (522)
Q Consensus       225 ~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl----~~~~~  298 (522)
                      ..+  ..++||||+++|+|.+++........+++..++.++.|++.||.|||+   .+|+||||||+|||+    +.++.
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~  154 (396)
T 4eut_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSV  154 (396)
T ss_dssp             CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEE
T ss_pred             cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCcee
Confidence            765  789999999999999999865444459999999999999999999999   999999999999999    77788


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH--------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG-  369 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-  369 (522)
                      +||+|||+++.......   .....||+.|+|||++..        ..++.++|||||||++|||++|+.||....... 
T Consensus       155 ~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             EEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             EEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            99999999976544322   123579999999999865        567889999999999999999999996433221 


Q ss_pred             hhhHHHhhhhhhcCCCccc-----------ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          370 PESLVKWAKPILKNGDTET-----------LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~-----------~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...................           .-+..............+.+++.+||+.||.+||++.++++.++.+..
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            1111111111000000000           000111223446678889999999999999999999999999988764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.7e-41  Score=357.50  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++...          .+.+++|.++..     ...+.|.+|+.+|++++|||||++++++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR----------GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET----------TEEEEEEEESSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec----------CCeEEEEEeCCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            3568999999999999999998643          235666655431     1457899999999999999999999999


Q ss_pred             EeCC-EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IEDN-YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+.. .+++||||+++|+|.+++...+ ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~  331 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVS  331 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEEC
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEe
Confidence            8765 7999999999999999998653 2347999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||+++......     ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...........       +
T Consensus       332 DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i  399 (450)
T 1k9a_A          332 DFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------V  399 (450)
T ss_dssp             CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------H
T ss_pred             eCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------H
Confidence            999997543321     12357889999999999999999999999999999998 9999976543322111       1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ..+..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       400 ~~~~~---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          400 EKGYK---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            11111         01112234678899999999999999999999999988653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.4e-42  Score=347.14  Aligned_cols=272  Identities=22%  Similarity=0.261  Sum_probs=205.0

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      .....++|++.+.||+|+||.||++......   .....+.+++|.+...  .......+|.+|+.++++++||||++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMP---NDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC-----------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCC---CCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence            3345679999999999999999998743210   1234556777765421  1223556899999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCC----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGE----QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-  295 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-  295 (522)
                      +++.+....++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+   .+|+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCS
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecC
Confidence            999999999999999999999999986532    1348999999999999999999999   99999999999999984 


Q ss_pred             --CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhh
Q 036172          296 --DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPES  372 (522)
Q Consensus       296 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~  372 (522)
                        +..+||+|||++................|++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  253 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QE  253 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HH
Confidence              44699999999965433322222234568899999999999999999999999999999998 9999865421   12


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +.....    .+....         .+...+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus       254 ~~~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          254 VLEFVT----SGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHHH----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHh----cCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            222111    111110         111234578889999999999999999999999987754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-41  Score=341.27  Aligned_cols=270  Identities=23%  Similarity=0.360  Sum_probs=211.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.....   .....++.+++|.++..  ......+.|.+|+.+++++ +||||++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGI---DKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS---SSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecC---CccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            357899999999999999999864210   01234556777665432  1223557899999999999 79999999999


Q ss_pred             EEeCC-EEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          223 CIEDN-YLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       223 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                      +...+ .+++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+   .+|+||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCcc
Confidence            98754 58999999999999999986532             1238899999999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNL  367 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~  367 (522)
                      +||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            999999999999999999987655544444445678999999999999999999999999999999998 9999965432


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ..  .+.....    .+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       257 ~~--~~~~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          257 DE--EFCRRLK----EGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             SH--HHHHHHH----HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hH--HHHHHhc----cCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            21  1111111    111100         111134568889999999999999999999999988753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-41  Score=333.72  Aligned_cols=259  Identities=18%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+...........+.+.+|+.++++++||||+++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL--------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC--------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            35789999999999999999987542        3456666655433222223467899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++++|.+++....   .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           81 STPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECC
T ss_pred             ecCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEee
Confidence            99999999999999999999998543   48999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++........   .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....   ...+.....    
T Consensus       155 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~----  224 (276)
T 2h6d_A          155 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIR----  224 (276)
T ss_dssp             CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----
T ss_pred             cccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhh----
Confidence            999976544322   123468999999999987765 689999999999999999999996432   112211111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+..      .    .+...+..+.+++.+||+.||.+|||+.+|++        ++|++..
T Consensus       225 ~~~~------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--------h~~~~~~  268 (276)
T 2h6d_A          225 GGVF------Y----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--------HEWFKQD  268 (276)
T ss_dssp             HCCC------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--------SHHHHTT
T ss_pred             cCcc------c----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh--------ChhhccC
Confidence            1110      0    01112356888999999999999999999998        8887654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-41  Score=349.92  Aligned_cols=255  Identities=26%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.+.||+|+||.||++.+..        ..+.+++|.+...........++|.+|++++++++||||+++++++.+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  125 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR--------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR  125 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc--------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            469999999999999999987543        345566665432222223356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+. |+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       126 ~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          126 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             CCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeecc
Confidence            999999999997 58988886532  359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++......      ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.....  ...+.    ....
T Consensus       200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~----~~~~  267 (348)
T 1u5q_A          200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALY----HIAQ  267 (348)
T ss_dssp             TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHH
T ss_pred             CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHH----HHHh
Confidence            99765432      2347999999999985   56789999999999999999999999864321  11111    1111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .. .....        ....+..+.+++.+||+.||.+|||+.+|++        ++|+..
T Consensus       268 ~~-~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--------h~~~~~  311 (348)
T 1u5q_A          268 NE-SPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--------HRFVLR  311 (348)
T ss_dssp             SC-CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--------CHHHHS
T ss_pred             cC-CCCCC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhh--------Chhhhc
Confidence            11 11111        1112456888999999999999999999997        777654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=348.04  Aligned_cols=277  Identities=17%  Similarity=0.175  Sum_probs=207.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcce-----
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITT-----  218 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~-----  218 (522)
                      ..++|++.+.||+|+||.||++..............+.+++|.+...        +.+.+|++++++++||||++     
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence            35799999999999999999998654322222223566777665321        46889999999999999988     


Q ss_pred             ----------eeEEEEe-CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCC
Q 036172          219 ----------LNGVCIE-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK  287 (522)
Q Consensus       219 ----------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIk  287 (522)
                                +++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+   .+|+|||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik  186 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT  186 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence                      6788887 78999999999 999999998642 2459999999999999999999999   999999999


Q ss_pred             CCceeccCCC--ceEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Q 036172          288 SSNILLSSDF--QPQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR  360 (522)
Q Consensus       288 p~NILl~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~  360 (522)
                      |+|||++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  8999999999765432211     11123479999999999999899999999999999999999999


Q ss_pred             CCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          361 PIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       361 Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      ||....... ..+.........  ....+..+...   ....+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       267 pf~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          267 PWTNCLPNT-EDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TTGGGTTCH-HHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CcccCCcCH-HHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            997554222 222222111111  11111111100   01124578899999999999999999999999998865443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-41  Score=355.61  Aligned_cols=260  Identities=20%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC--CCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE--QKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~--HpnIv~l~~~  222 (522)
                      ..+|++.+.||+|+||.||++...         ..+.+++|.+..... .....+.|.+|+.+|++|+  ||||++++++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE---------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT---------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC---------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            346999999999999999998643         244566665432211 2235678999999999996  5999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +..++.+++||| +.+++|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEEC
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEE
Confidence            999999999999 55789999998643   58999999999999999999999   9999999999999995 5799999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      |||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||..... ...
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~  275 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QIS  275 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHH
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-HHH
Confidence            9999987654443333345679999999999865           4689999999999999999999999964321 111


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+    ...+....         ...++...+..+.+++.+||+.||.+||++.+|++        ++|++..
T Consensus       276 ~~----~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--------hp~~~~~  327 (390)
T 2zmd_A          276 KL----HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--------HPYVQIQ  327 (390)
T ss_dssp             HH----HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHSC
T ss_pred             HH----HHHhCccc---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh--------CcCcccc
Confidence            11    11111110         11111112356888999999999999999999997        8887654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.3e-41  Score=336.01  Aligned_cols=257  Identities=22%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.+.||+|+||.||++....        ....+++|.+..... .....+.|.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTE--------TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecC--------CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            4568999999999999999987543        344455444432211 1235678999999999999999999999987


Q ss_pred             e----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceecc-CCC
Q 036172          225 E----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLS-SDF  297 (522)
Q Consensus       225 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~-~~~  297 (522)
                      .    ...+++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+  |+||||||+|||++ .++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTS
T ss_pred             cccCCCceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCC
Confidence            5    46789999999999999999854   348999999999999999999999   88  99999999999998 788


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||++.......    .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||....  .........
T Consensus       170 ~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~  242 (290)
T 1t4h_A          170 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRV  242 (290)
T ss_dssp             CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHH
T ss_pred             CEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC--cHHHHHHHH
Confidence            99999999996544332    22456899999999875 569999999999999999999999996432  111221111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                          ..+....        ..+...+..+.+++.+||+.||.+|||+.+|++        |+|++.
T Consensus       243 ----~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--------h~~f~~  288 (290)
T 1t4h_A          243 ----TSGVKPA--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--------HAFFQE  288 (290)
T ss_dssp             ----TTTCCCG--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGC-
T ss_pred             ----hccCCcc--------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--------Cccccc
Confidence                1111111        111122346889999999999999999999997        899865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.1e-41  Score=353.56  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=194.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-----cchHHHHHHHHHHHHhhCCCCCccee
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-----FSSAWNDFSSEVDITSSLEQKSITTL  219 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-----~~~~~~~f~~Ev~iL~~L~HpnIv~l  219 (522)
                      .++|++.+.||+|+||.||++....        +++.+|+|.+.+....     .......|.+|+.+|++++||||+++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERK--------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECC--------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            5789999999999999999987543        4456666655432211     11123458899999999999999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC--
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF--  297 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~--  297 (522)
                      ++++. .+..++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++  
T Consensus       206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          206 KNFFD-AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             CEEEE-SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSS
T ss_pred             EEEEe-cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCc
Confidence            99975 45689999999999999998743   359999999999999999999999   9999999999999997544  


Q ss_pred             -ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          298 -QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       298 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                       .+||+|||+++.......   .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........  +
T Consensus       279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~  353 (419)
T 3i6u_A          279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L  353 (419)
T ss_dssp             CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H
T ss_pred             ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H
Confidence             599999999977654322   234579999999999853   5688999999999999999999999975432211  1


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ....    ..+....      ........+..+.+++.+||+.||.+||++.++++        |+|++.
T Consensus       354 ~~~i----~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--------hp~~~~  405 (419)
T 3i6u_A          354 KDQI----TSGKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--------HPWLQD  405 (419)
T ss_dssp             HHHH----HTTCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SGGGCC
T ss_pred             HHHH----hcCCCCC------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--------CcccCC
Confidence            1111    1111100      01111123467889999999999999999999998        999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-41  Score=337.51  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=203.0

Q ss_pred             CCCceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          145 ENPFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .++|++.. .||+|+||.||++....      ....+.+++|.++... ......++|.+|+.++++++||||+++++++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQM------KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEEC------SSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecC------CCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            46899988 99999999999984321      2234556666554332 1233467899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                       ..+..++||||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECC
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEcc
Confidence             567789999999999999999854   349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+....    
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----  233 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAML----  233 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----
Confidence            99997665443221 1122346788999999988889999999999999999999 9999965432   1222111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus       234 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          234 EKGERM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111111         111223467889999999999999999999999998864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-41  Score=365.57  Aligned_cols=263  Identities=21%  Similarity=0.311  Sum_probs=209.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        +.+.+++|.+.+.........+.+.+|+.++++++||||+++++++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   95 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKI--------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF   95 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECC--------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34689999999999999999987643        4566777766443333334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCceE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQ  300 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~k  300 (522)
                      .+.+..++||||+.+|+|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||+   +.++.+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEE
Confidence            9999999999999999999999743   359999999999999999999999   999999999999999   5678999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....   ..+....   
T Consensus       170 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i---  239 (484)
T 3nyv_A          170 IIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKV---  239 (484)
T ss_dssp             ECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---
T ss_pred             EEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---
Confidence            999999976654332   234579999999999865 799999999999999999999999975431   1121111   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                       ..+....      ........+..+.+++.+||+.||.+|||+.++++        |+|++...
T Consensus       240 -~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--------h~~~~~~~  289 (484)
T 3nyv_A          240 -EKGKYTF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD--------HEWIQTYT  289 (484)
T ss_dssp             -HHCCCCC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SHHHHHHT
T ss_pred             -HcCCCCC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--------Chhhcccc
Confidence             1111110      00011123467889999999999999999999997        88887543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-41  Score=347.74  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=203.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|++.+.||+|+||.||++.+..        +.+.|++|.+++...       .+.+|++++.++ +||||+++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKA--------TNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECC--------CCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEE
Confidence            4679999999999999999987643        456677776644322       345788999888 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC----Cce
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD----FQP  299 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~----~~~  299 (522)
                      .+++.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||+.++    +.+
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~  159 (342)
T 2qr7_A           86 DDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESI  159 (342)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGE
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeE
Confidence            9999999999999999999999853   359999999999999999999999   999999999999998543    359


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........+..... 
T Consensus       160 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-  236 (342)
T 2qr7_A          160 RICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-  236 (342)
T ss_dssp             EECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-
T ss_pred             EEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-
Confidence            99999999765443221  224578999999999988889999999999999999999999997544333333332221 


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                         .+...      +........+..+.+++.+||+.||.+||++.++++        |+|+..
T Consensus       237 ---~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--------hp~~~~  283 (342)
T 2qr7_A          237 ---SGKFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--------HPWIVH  283 (342)
T ss_dssp             ---HCCCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--------SHHHHT
T ss_pred             ---cCCcc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--------CCeecC
Confidence               11111      011111224467889999999999999999999997        888854

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-40  Score=356.46  Aligned_cols=268  Identities=19%  Similarity=0.206  Sum_probs=198.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        +.+.+++|.+.+.. ......+++.+|+.+|+.++|||||++++++.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV--------LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFT  131 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT--------TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC--------CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence            5789999999999999999987543        34566666654321 12235678999999999999999999999997


Q ss_pred             eC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 ED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..      ..++|||||+++ +|.+.+..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~  202 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT  202 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSC
T ss_pred             cCCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCC
Confidence            54      468999999976 67777752     28999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....  +.....
T Consensus       203 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~  277 (464)
T 3ttj_A          203 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIE  277 (464)
T ss_dssp             EEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred             EEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            99999999976544322   2345799999999999999999999999999999999999999975432111  111100


Q ss_pred             ------------------hhhcCC------CcccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          379 ------------------PILKNG------DTETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       379 ------------------~~~~~~------~~~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                                        ......      .....+...+   ...........+.+|+.+||+.||.+|||+.|+++  
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--
Confidence                              000000      0000000000   01111223567899999999999999999999997  


Q ss_pred             hccccCCccccc
Q 036172          432 RGATHATDWVDR  443 (522)
Q Consensus       432 ~~~~~~~~~~~~  443 (522)
                            |+|+..
T Consensus       356 ------Hp~~~~  361 (464)
T 3ttj_A          356 ------HPYINV  361 (464)
T ss_dssp             ------STTTGG
T ss_pred             ------Chhhhh
Confidence                  899874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.4e-41  Score=336.96  Aligned_cols=265  Identities=18%  Similarity=0.265  Sum_probs=200.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++.++||+|+||.||++......     .....+++|.++.  .......+.|.+|+.++++++||||+++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~~avk~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDND-----GKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC----------CEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cceehhhcceeeecCCceEEEEEEecCC-----CceeEEEEEeccc--CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            3467999999999999999998743211     1122334443332  11223567899999999999999999999997


Q ss_pred             Ee-CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IE-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+ ++..++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A           96 LRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             CCSSSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EcCCCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEEC
Confidence            64 56789999999999999999753  2358999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCC--CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhh
Q 036172          303 DFGLAIWGPTDST--HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       303 DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |||++........  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.............    
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----  246 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----  246 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----
Confidence            9999976543321  112234467889999999999999999999999999999999 666665443332211111    


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                         .+..  ...       +...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       247 ---~~~~--~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          247 ---QGRR--LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---TTCC--CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCCC--CCC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1110  000       11123568889999999999999999999999998753

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-41  Score=337.35  Aligned_cols=266  Identities=25%  Similarity=0.350  Sum_probs=200.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.....     ......+++|.++..........++|.+|+.++++++||||+++++++
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAP-----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECT-----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccC-----CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            356899999999999999999864310     122335677777654444445678999999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..+. .++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECC
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcc
Confidence            8765 889999999999999998642  348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+....   .
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~---~  238 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKI---D  238 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH---H
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHH---H
Confidence            99997765443322 2234467889999999988889999999999999999999 9999965431   1121111   1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ......         ..+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus       239 ~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          239 KEGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             TSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ccCCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            111110         011123467889999999999999999999999998765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-41  Score=344.12  Aligned_cols=270  Identities=24%  Similarity=0.331  Sum_probs=206.4

Q ss_pred             CCCCc-eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          144 TENPF-QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y-~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ..++| ++.++||+|+||.||++...    +......+.+++|.++..  ......+.|.+|++++++++||||++++++
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~----~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYD----PTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEC----SCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEc----cCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence            34566 99999999999999775321    111235667777766532  122356789999999999999999999999


Q ss_pred             EEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          223 CIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       223 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +.+.  ..+++||||+++|+|.+++...    .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEE
Confidence            9984  6899999999999999999753    38999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------Chh
Q 036172          301 LSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK--------GPE  371 (522)
Q Consensus       301 L~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~--------~~~  371 (522)
                      |+|||++......... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.||......        ...
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            9999999876554322 1223456788899999999989999999999999999999999998642110        000


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .........+..+.         ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       255 ~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          255 MTVLRLTELLERGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            00001111111111         11112234467899999999999999999999999998865

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=346.62  Aligned_cols=271  Identities=20%  Similarity=0.239  Sum_probs=197.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||.||++....        +.+.+++|.++....  ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL--------TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHT   71 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC--------CCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence            579999999999999999987543        345566665432111  1112245679999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||++ |+|.+++...+  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           72 EKSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             CCEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCc
Confidence            999999999997 59999988643  359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      ++.........  .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......   ............
T Consensus       146 ~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~  220 (324)
T 3mtl_A          146 LARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTP  220 (324)
T ss_dssp             EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             ccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence            99754432221  223468999999999876 568999999999999999999999997543221   111111111110


Q ss_pred             ---CcccccC---------Ccc----cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          385 ---DTETLLD---------PKL----SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       385 ---~~~~~~d---------~~l----~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                         .......         +..    ...........+.+++.+||+.||.+|||+.|+++        |+|+....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~f~~~~  289 (324)
T 3mtl_A          221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--------HPFFLSLG  289 (324)
T ss_dssp             CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--------SGGGGGGC
T ss_pred             ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--------Chhhhhcc
Confidence               0000000         000    00111123457889999999999999999999997        99987643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-41  Score=335.99  Aligned_cols=262  Identities=22%  Similarity=0.309  Sum_probs=204.4

Q ss_pred             CCCceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          145 ENPFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .++|.+.. .||+|+||.||++....      ......+++|.++..  ......++|.+|+.++++++||||+++++++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~------~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRM------RKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---------CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEecc------CCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            35677776 99999999999986432      123445666655432  1233567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                       ..+..++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           80 -QAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECC
T ss_pred             -cCCCcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECc
Confidence             556789999999999999999753  2359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .+....    
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i----  226 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----  226 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH----
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----
Confidence            99997665433221 1223456889999999988889999999999999999998 99999654321   122111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ..+...         ..+...+..+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus       227 ~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          227 EQGKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCcC---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111111         1112234678899999999999999999999999988753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-41  Score=334.77  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=201.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.....     ......+++|.++...  .....++|.+|+.++++++||||+++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNH-----KGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECT-----TCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCC-----CCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            457899999999999999999864321     1122345555443221  123457899999999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .++ ..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        83 ~~~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D  156 (281)
T 3cc6_A           83 EEE-PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGD  156 (281)
T ss_dssp             CSS-SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECC
T ss_pred             cCC-CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCc
Confidence            754 5689999999999999997643  348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........   .....    
T Consensus       157 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~----  228 (281)
T 3cc6_A          157 FGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLE----  228 (281)
T ss_dssp             CCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHH----
T ss_pred             cCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHh----
Confidence            9999765443221 1223457889999999998999999999999999999998 9999965432221   11111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+....         .+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       229 ~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          229 KGDRLP---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            111000         01113456888999999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-41  Score=336.36  Aligned_cols=260  Identities=20%  Similarity=0.301  Sum_probs=201.6

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc---chHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF---SSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~---~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ++|++.+.||+|+||.||++....        ..+.+++|.++......   ....+.|.+|+.++++++||||++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG--------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC--------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            579999999999999999987543        34455555443221111   1135789999999999999999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC----c
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF----Q  298 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~----~  298 (522)
                      +.+....++||||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++    .
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCC
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCc
Confidence            99999999999999999999999753   349999999999999999999999   9999999999999998877    8


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||++.........   ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ....... 
T Consensus       151 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~-  223 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNI-  223 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH-
T ss_pred             eEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHh-
Confidence            999999999765443221   234689999999999988999999999999999999999999965331   1111111 


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                         .....      ..........+..+.+++.+||+.||.+||++.++++        ++|++.
T Consensus       224 ---~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--------h~~~~~  271 (283)
T 3bhy_A          224 ---SAVNY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE--------HSWIKA  271 (283)
T ss_dssp             ---HTTCC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH--------CHHHHH
T ss_pred             ---Hhccc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh--------CHHHHH
Confidence               11100      0011111223457889999999999999999999998        777664

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-40  Score=330.35  Aligned_cols=265  Identities=18%  Similarity=0.211  Sum_probs=204.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+...     ...+++.+|+.++++++|++++..+.++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA--------AGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGVGIPTIRWC   73 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT--------TTEEEEEEEEESC-----SSCCHHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcC--------CCcEEEEEEecCC-----cchhHHHHHHHHHHHhhcCCCCCccccc
Confidence            45789999999999999999987542        3455666643221     1234688999999999988876666655


Q ss_pred             -EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCce
Q 036172          224 -IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQP  299 (522)
Q Consensus       224 -~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~  299 (522)
                       ..++..++||||+ +++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||+   +.++.+
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~  147 (296)
T 3uzp_A           74 GAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCE
T ss_pred             cCCCCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeE
Confidence             5678899999999 889999997542  349999999999999999999999   999999999999999   478899


Q ss_pred             EEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          300 QLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      ||+|||++..........     ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus       148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  227 (296)
T 3uzp_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  227 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred             EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence            999999997655433211     123457999999999999999999999999999999999999999765433322222


Q ss_pred             Hhhh-hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          375 KWAK-PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       375 ~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      .... ..... .         ........+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       228 ~~~~~~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          228 ERISEKKMST-P---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHHHHHS-C---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccCC-c---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            1111 11110 0         0001112345788999999999999999999999999987543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-41  Score=360.39  Aligned_cols=258  Identities=22%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....         ...+++|.++...    ...++|.+|+.+|++++|||||++++++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNK---------HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT---------TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECC---------ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            35689999999999999999987531         3346666554322    2467899999999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      . .+.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       253 ~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          253 T-KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECS
T ss_pred             e-CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEee
Confidence            6 567899999999999999998542 2248899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++....... .......+++.|+|||++..+.++.++|||||||++|||++ |+.||.....   ..+.....    
T Consensus       328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~----  399 (454)
T 1qcf_A          328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE----  399 (454)
T ss_dssp             TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH----
T ss_pred             CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----
Confidence            999976543211 11123346788999999999999999999999999999999 9999964321   12222111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       400 ~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          400 RGYRM---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             HTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            11100         0112234678899999999999999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-40  Score=342.81  Aligned_cols=278  Identities=17%  Similarity=0.193  Sum_probs=202.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        +.+.+++|.+..... .......+.+|+.++++++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   85 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRK--------TGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEIC   85 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETT--------TCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeEEEEEecCCCcEEEEEEECC--------CCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhhee
Confidence            45799999999999999999987643        445666665432211 112345688999999999999999999999


Q ss_pred             Ee--------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          224 IE--------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       224 ~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ..        .+.+++||||+++ +|.+.+....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.
T Consensus        86 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~  159 (351)
T 3mi9_A           86 RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITR  159 (351)
T ss_dssp             EEC--------CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred             eccccccccCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcC
Confidence            87        4578999999975 8888887542  349999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCC--CccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          296 DFQPQLSDFGLAIWGPTDST--HMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      ++.+||+|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus       160 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  239 (351)
T 3mi9_A          160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  239 (351)
T ss_dssp             TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999976543221  112234578999999999876 457999999999999999999999997543222111


Q ss_pred             HHHhhhhhhcCCCcccc--------cC--CcccccccHH-----HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          373 LVKWAKPILKNGDTETL--------LD--PKLSNEYDNA-----QMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~--------~d--~~l~~~~~~~-----~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      .+...............        +.  ..........     ....+.+++.+||+.||.+|||+.|+++        
T Consensus       240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------  311 (351)
T 3mi9_A          240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--------  311 (351)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------
T ss_pred             HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--------
Confidence            11111000000000000        00  0000000000     1345889999999999999999999998        


Q ss_pred             Ccccccc
Q 036172          438 TDWVDRH  444 (522)
Q Consensus       438 ~~~~~~~  444 (522)
                      |+|+...
T Consensus       312 hp~f~~~  318 (351)
T 3mi9_A          312 HDFFWSD  318 (351)
T ss_dssp             SGGGGSS
T ss_pred             CCCcCCC
Confidence            9998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=333.94  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=202.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-ccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-QFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.++.... ......+.|.+|+.++++++||||++++++
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSE--------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTT--------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECC--------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            34789999999999999999987643        345566655543221 123356789999999999999999999999


Q ss_pred             EE--eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          223 CI--EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       223 ~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +.  +.+..++||||++++ |.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEE
Confidence            95  446789999999875 888877543 3459999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      |+|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.....   ....... 
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i-  225 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENI-  225 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH-
T ss_pred             eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHH-
Confidence            99999997765433333334557999999999997644  47899999999999999999999975321   1111111 


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         ..+..      .+..    ..+..+.+++.+||+.||.+|||+.++++        ++|++..
T Consensus       226 ---~~~~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------~~~~~~~  270 (305)
T 2wtk_C          226 ---GKGSY------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--------HSWFRKK  270 (305)
T ss_dssp             ---HHCCC------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH--------SHHHHSC
T ss_pred             ---hcCCC------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhc--------CcccccC
Confidence               11111      0111    23456788999999999999999999998        8887654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-40  Score=334.35  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=198.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC--CCCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL--EQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L--~HpnIv~l~~~  222 (522)
                      .++|++.++||+|+||.||++...          .+.+++|.+..      .....+.+|.+++..+  +||||++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~   99 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR----------GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAA   99 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET----------TEEEEEEEEEG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC----------CceEEEEEEec------cccchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence            468999999999999999998653          34566655421      1234556677776665  99999999999


Q ss_pred             EEeC----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC--------CEEeccCCCCc
Q 036172          223 CIED----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR--------PVIHRDVKSSN  290 (522)
Q Consensus       223 ~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~--------giiHrDIkp~N  290 (522)
                      +...    ...++||||+++|+|.+++...    .+++..++.++.|++.||.|||+   .        +|+||||||+|
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A          100 DIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGG
T ss_pred             EccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHH
Confidence            9987    7899999999999999999753    38999999999999999999998   6        99999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCc--cccccccCCCCCChhhhccCCCCch------hhHHHHHHHHHHHHcC----
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHM--IREDVVGTFGYIAPEYLMHGKVSDK------IDVYSFGVVLLELLSG----  358 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~k------sDVwSlGvvl~eLltG----  358 (522)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+.....+      +|||||||++|||++|    
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            999999999999999997654433221  1224579999999999987766554      9999999999999999    


Q ss_pred             ------CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccccc-ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          359 ------RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE-YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       359 ------~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                            ..||..........  ...........    ..+..... .....+..+.+++.+||+.||.+|||+.+|++.|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSY--EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cccccccccHhhhcCCCCch--hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                  56654332221111  00111111111    11111111 1235678899999999999999999999999999


Q ss_pred             hccccC
Q 036172          432 RGATHA  437 (522)
Q Consensus       432 ~~~~~~  437 (522)
                      +.+...
T Consensus       327 ~~l~~~  332 (337)
T 3mdy_A          327 AKMSES  332 (337)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            987653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-41  Score=337.68  Aligned_cols=273  Identities=21%  Similarity=0.323  Sum_probs=187.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+....  .....+++.+|+.++++++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAP--------KKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC------------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECC--------CCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            45789999999999999999987543        33455665543221  122456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhcc-----CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGA-----GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ...+..++||||+++++|.+++...     .....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCC
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCC
Confidence            9999999999999999999999742     123459999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCC---CccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          299 PQLSDFGLAIWGPTDST---HMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~---~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      +||+|||++........   ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........  ..
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~  237 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM  237 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH
Confidence            99999999976543321   111234578999999999865 5689999999999999999999999975432211  11


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..... ..........++....    ..+..+.+++.+||+.||.+||++.+|++        ++|+...
T Consensus       238 ~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~--------h~~~~~~  294 (303)
T 2vwi_A          238 LTLQN-DPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR--------HKFFQKA  294 (303)
T ss_dssp             HHHTS-SCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--------STTC---
T ss_pred             HHhcc-CCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh--------ChhhhcC
Confidence            10000 0000000011111111    23356888999999999999999999997        8887653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=336.54  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=196.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++...          .+.+++|.+..     ....+.|.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR----------AKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACL   71 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET----------TEEEEEEECSS-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC----------CeeEEEEEecC-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            468999999999999999998643          23455554421     234578999999999999999999999887


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc-eEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-PQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~-~kL~D  303 (522)
                      +  ..++||||+++|+|.+++........+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|
T Consensus        72 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           72 N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             T--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             C--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence            4  47899999999999999986544445889999999999999999999854468999999999999998886 79999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++.......     ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........  ..+.   ...
T Consensus       150 fg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~---~~~  219 (307)
T 2eva_A          150 FGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHN  219 (307)
T ss_dssp             CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH---HHT
T ss_pred             ccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH---Hhc
Confidence            99996543321     2346899999999999989999999999999999999999999644322111  1111   111


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....     ..    ...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       220 ~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          220 GTRPP-----LI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             TCCCC-----CB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             CCCCC-----cc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            11111     11    123456888999999999999999999999998875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-41  Score=334.73  Aligned_cols=264  Identities=18%  Similarity=0.232  Sum_probs=201.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.++||+|+||.||++.....     ......+++|.+..  .......+.|.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~aiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   92 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQ-----AQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLNHPNVLALIGIML   92 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECS-----SSCEEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred             ceEEccCceeccCCCceEEEEEEecC-----CCceeeeeeeeccc--cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            34678889999999999999864321     11222455554432  112235678999999999999999999999998


Q ss_pred             eCCEE-EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 EDNYL-ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~~-~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +.+.. ++||||+.+|+|.+++...  ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~D  167 (298)
T 3pls_A           93 PPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVAD  167 (298)
T ss_dssp             CSSSCCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCc
Confidence            76554 9999999999999999863  3358999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCC--CCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDS--THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP-IGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~--~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~P-f~~~~~~~~~~l~~~~~~~  380 (522)
                      ||+++......  .........+++.|+|||.+.+..++.++||||||+++|+|++|..| |......   .+.....  
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~--  242 (298)
T 3pls_A          168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLA--  242 (298)
T ss_dssp             TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHH--
T ss_pred             CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhh--
Confidence            99997554322  11122345678999999999999999999999999999999995555 4332221   1221111  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                        .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       243 --~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          243 --QGRRL---------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             --TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCC---------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              11100         0111234578899999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8e-41  Score=336.13  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ....|++.++||+|+||.||++....        ..+.+++|.+....  .....+.|.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   89 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNR--------TQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSY   89 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECC--------CCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            34679999999999999999986532        34556666543221  123567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..++||||+++++|.+++..    ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~D  162 (303)
T 3a7i_A           90 LKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLAD  162 (303)
T ss_dssp             EETTEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             ecCCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEee
Confidence            999999999999999999999963    249999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||++........  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ........    .
T Consensus       163 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~  233 (303)
T 3a7i_A          163 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIP----K  233 (303)
T ss_dssp             CTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----H
T ss_pred             cccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhh----c
Confidence            999976543321  12345789999999999999999999999999999999999999864321   11111111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +..     +.+..    ..+..+.+++.+||+.||.+|||+.+|++        ++|+...
T Consensus       234 ~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------~~~~~~~  277 (303)
T 3a7i_A          234 NNP-----PTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLK--------HKFILRN  277 (303)
T ss_dssp             SCC-----CCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTT--------CHHHHHH
T ss_pred             CCC-----CCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhh--------ChhhhcC
Confidence            111     11111    22356888999999999999999999997        6776543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.7e-41  Score=351.23  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=195.5

Q ss_pred             CCCceee-ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhh-CCCCCcceeeEE
Q 036172          145 ENPFQMD-IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSS-LEQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~-~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~-L~HpnIv~l~~~  222 (522)
                      .++|.+. +.||.|+||.||++.+..        +.+.|++|.++.        ...+.+|+.++.+ ++||||++++++
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~--------~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~  123 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKR--------TQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDV  123 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECC--------CCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEE
Confidence            4578776 789999999999987643        456677776531        2457789998755 499999999999


Q ss_pred             EEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---
Q 036172          223 CIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---  295 (522)
Q Consensus       223 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---  295 (522)
                      +..    ...++|||||+++|+|.+++.... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.   
T Consensus       124 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~  199 (400)
T 1nxk_A          124 YENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRP  199 (400)
T ss_dssp             EEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSST
T ss_pred             EeecccCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCC
Confidence            876    567999999999999999998643 2359999999999999999999999   99999999999999997   


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh-hHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE-SLV  374 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~l~  374 (522)
                      ++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...
T Consensus       200 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  276 (400)
T 1nxk_A          200 NAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK  276 (400)
T ss_dssp             TCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred             CccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence            78999999999976543322   22457899999999999899999999999999999999999999754432211 111


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...    ..+... ...+     .....+..+.+++.+||+.||.+|||+.+|++        |+|+...
T Consensus       277 ~~i----~~~~~~-~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--------hp~~~~~  328 (400)
T 1nxk_A          277 TRI----RMGQYE-FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--------HPWIMQS  328 (400)
T ss_dssp             HHH----HHTCCC-CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------SHHHHTT
T ss_pred             HHH----HcCccc-CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--------CccccCC
Confidence            111    111110 0000     01123457889999999999999999999998        8887653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.7e-41  Score=360.89  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=199.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++.+..        ....+++|.+++.... ......+.+|+.++++++|||||++++++.
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  106 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKV--------THVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFE  106 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETT--------TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECC--------CCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3479999999999999999987643        3455566554332211 113467899999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---CceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---FQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---~~~kL  301 (522)
                      +.+.+++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++..   +.+||
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl  180 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI  180 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEE
Confidence            999999999999999999998754   349999999999999999999999   999999999999999764   45999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++........   .....||+.|+|||++. +.++.++|||||||++|+|++|..||.....   ..+.....   
T Consensus       181 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~---  250 (494)
T 3lij_A          181 VDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVE---  250 (494)
T ss_dssp             CCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---
T ss_pred             EECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---
Confidence            99999976554322   22457999999999985 5799999999999999999999999975432   11211111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .+... . ..    ......+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       251 -~~~~~-~-~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--------hp~~~~~  298 (494)
T 3lij_A          251 -KGKYT-F-DS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE--------HPWIKEM  298 (494)
T ss_dssp             -HTCCC-C-CS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------CHHHHHH
T ss_pred             -hCCCC-C-Cc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc--------CcccccC
Confidence             11110 0 00    001123457889999999999999999999997        8887653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.6e-41  Score=342.05  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++.......      ...+++|.++..  ......++|.+|+.+++++ +||||++++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGL------RMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTE------EEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCc------ccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            35789999999999999999987543110      001133322211  1112446789999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAG-------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      +.+.+..++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~  171 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAAR  171 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccc
Confidence            999999999999999999999997542             12359999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||+++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... 
T Consensus       172 NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-  247 (327)
T 1fvr_A          172 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  247 (327)
T ss_dssp             GEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             eEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence            99999999999999999864332211   123357889999999988889999999999999999998 9999965431 


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                        ..+....    ..+..     .    ..+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       248 --~~~~~~~----~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          248 --AELYEKL----PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             --HHHHHHG----GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHh----hcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              1111111    11100     0    1111234578899999999999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=340.42  Aligned_cols=268  Identities=20%  Similarity=0.273  Sum_probs=201.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++......    ......+++|.++...  ......+|.+|+.++++++||||+++++++
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSS----GKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC-------CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCC----CCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4578999999999999999998754211    1112335555543211  123456799999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECC
Confidence            99999999999999999999998642  359999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          304 FGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       304 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      ||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+....    
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~----  263 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAI----  263 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----
T ss_pred             CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----
Confidence            99997654432211 1223356788999999998999999999999999999999 9999864321   1222111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      ..+...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus       264 ~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          264 NDGFRL---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             HTTCCC---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HCCCcC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            111100         011123457888999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=340.96  Aligned_cols=275  Identities=20%  Similarity=0.182  Sum_probs=201.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc--hHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS--SAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~--~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.++.......  ...+.+.+|+.++++++||||+++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   79 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKN--------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD   79 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSS--------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECC--------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEE
Confidence            45789999999999999999987543        455677776654322111  12346889999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+.+..++||||+++ +|.+++...  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        80 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl  153 (346)
T 1ua2_A           80 AFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKL  153 (346)
T ss_dssp             EECCTTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEeeCCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEE
Confidence            99999999999999976 899988754  2358999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||+++........  .....||+.|+|||.+.+. .++.++|||||||++|+|++|..||.....  ...+...... 
T Consensus       154 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~-  228 (346)
T 1ua2_A          154 ADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFET-  228 (346)
T ss_dssp             CCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH-
T ss_pred             EecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHH-
Confidence            999999765433221  2245789999999999764 489999999999999999999999865431  1111111111 


Q ss_pred             hcCCC---------cccccCCccc-----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          381 LKNGD---------TETLLDPKLS-----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       381 ~~~~~---------~~~~~d~~l~-----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      .....         ....+.....     .......+..+.+++.+||+.||.+|||+.|+++        ++|+....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------h~~f~~~~  299 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--------MKYFSNRP  299 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--------SGGGTSSS
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--------ChhhhcCC
Confidence            00000         0000000000     0011223467899999999999999999999998        99987653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-41  Score=336.86  Aligned_cols=260  Identities=21%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....... ........+++|.+....   ....+.|.+|+.++++++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGD-YGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECG-GGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccc-cccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45789999999999999999987543110 011122345555543322   23457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc-----
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-----  298 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~-----  298 (522)
                      .+++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.     
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccc
Confidence            99999999999999999999998642  348999999999999999999999   99999999999999998876     


Q ss_pred             ---eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCChhhH
Q 036172          299 ---PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRR-PIGFKNLKGPESL  373 (522)
Q Consensus       299 ---~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~-Pf~~~~~~~~~~l  373 (522)
                         +||+|||++.....      .....||+.|+|||.+.+ ..++.++||||||+++|+|++|.. ||....   ....
T Consensus       157 ~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~  227 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD---SQRK  227 (289)
T ss_dssp             CCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHH
T ss_pred             cceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---hHHH
Confidence               99999999854422      123468999999999987 678999999999999999999554 443221   1111


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .....   .......            ..+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       228 ~~~~~---~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          228 LQFYE---DRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHH---TTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHHhh---ccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111   1111111            112357789999999999999999999999998864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-40  Score=333.28  Aligned_cols=264  Identities=21%  Similarity=0.310  Sum_probs=205.1

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh------ccchHHHHHHHHHHHHhhCC-CCC
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS------QFSSAWNDFSSEVDITSSLE-QKS  215 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~------~~~~~~~~f~~Ev~iL~~L~-Hpn  215 (522)
                      ...++|++.+.||+|+||.||++.+..        .++.+++|.+.....      ......+.+.+|+.+++++. |||
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~   85 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKP--------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   85 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             chhhccceeeeecCCCceEEEEEEEcC--------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            346799999999999999999987643        334455554322110      01124567899999999995 999


Q ss_pred             cceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          216 ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       216 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      |+++++++..++..++||||+++++|.+++...   ..+++..++.++.|++.||.|||+   .+++||||||+||+++.
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDD  159 (298)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECT
T ss_pred             EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcC
Confidence            999999999999999999999999999999854   349999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      ++.+||+|||++.........   ....|++.|+|||.+.      ...++.++||||||+++|+|++|+.||.....  
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--  234 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--  234 (298)
T ss_dssp             TCCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred             CCcEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--
Confidence            999999999999765543222   2457899999999985      45688999999999999999999999864321  


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .......    ..+... ...+     .....+..+.+++.+||+.||.+|||+.++++        |+|++..
T Consensus       235 -~~~~~~~----~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------h~~~~~~  290 (298)
T 1phk_A          235 -MLMLRMI----MSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--------HPFFQQY  290 (298)
T ss_dssp             -HHHHHHH----HHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--------SGGGCTT
T ss_pred             -HHHHHHH----hcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh--------ChHhhhc
Confidence             1111111    111110 0000     11123457889999999999999999999997        8998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-41  Score=333.51  Aligned_cols=256  Identities=15%  Similarity=0.195  Sum_probs=199.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....        +.+.+++|.++.... ......++.+|+.++.++ +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRL--------DGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcC--------CCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            34689999999999999999987543        455666665543211 122456789999999999 99999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-----
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-----  296 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-----  296 (522)
                      +.+++..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.+     
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~  156 (289)
T 1x8b_A           80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNA  156 (289)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-------
T ss_pred             eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcc
Confidence            999999999999999999999998642 12458999999999999999999999   999999999999999844     


Q ss_pred             --------------CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCC
Q 036172          297 --------------FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       297 --------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~P  361 (522)
                                    ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                          479999999997665432      23589999999999766 567899999999999999999887


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      +...     .....     +..+....     +..    ..+..+.+++.+||+.||.+|||+.++++        |+|+
T Consensus       231 ~~~~-----~~~~~-----~~~~~~~~-----~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~--------h~~~  283 (289)
T 1x8b_A          231 PRNG-----DQWHE-----IRQGRLPR-----IPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK--------HSVL  283 (289)
T ss_dssp             CSSS-----HHHHH-----HHTTCCCC-----CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT--------CTTC
T ss_pred             Ccch-----hHHHH-----HHcCCCCC-----CCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh--------ChHh
Confidence            6422     11111     11111111     111    23457888999999999999999999997        8887


Q ss_pred             ccc
Q 036172          442 DRH  444 (522)
Q Consensus       442 ~~~  444 (522)
                      ...
T Consensus       284 ~~~  286 (289)
T 1x8b_A          284 LSA  286 (289)
T ss_dssp             ---
T ss_pred             hhh
Confidence            753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-41  Score=349.46  Aligned_cols=273  Identities=22%  Similarity=0.294  Sum_probs=204.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....        ..+.+++|.+...  ......+.+.+|+.++++++||||+++++++
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKP--------SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECC--------CCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            35689999999999999999987643        3455555544321  1223457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCceeccCCCceEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+++..++||||+++|+|.+++...+   .+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~  174 (360)
T 3eqc_A          101 YSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLC  174 (360)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EECCEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEE
Confidence            99999999999999999999998543   48999999999999999999998   6 89999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh---
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP---  379 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~---  379 (522)
                      |||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.................   
T Consensus       175 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (360)
T 3eqc_A          175 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA  250 (360)
T ss_dssp             CCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred             ECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence            999985432211    1234789999999999999999999999999999999999999975432111110000000   


Q ss_pred             ------hhcCC--------------Ccccc----cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          380 ------ILKNG--------------DTETL----LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       380 ------~~~~~--------------~~~~~----~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                            ....+              .....    .............+..+.+++.+||+.||.+|||+.++++      
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------  324 (360)
T 3eqc_A          251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV------  324 (360)
T ss_dssp             -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT------
T ss_pred             CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh------
Confidence                  00000              00000    0000000001113457889999999999999999999997      


Q ss_pred             cCCcccccc
Q 036172          436 HATDWVDRH  444 (522)
Q Consensus       436 ~~~~~~~~~  444 (522)
                        |+|++..
T Consensus       325 --hp~~~~~  331 (360)
T 3eqc_A          325 --HAFIKRS  331 (360)
T ss_dssp             --SHHHHHH
T ss_pred             --ChHhhcc
Confidence              8998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=348.88  Aligned_cols=264  Identities=18%  Similarity=0.270  Sum_probs=195.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ...|++.+.||+|+||.||++.....     ......+++|.++..  ......++|.+|+.++++++||||+++++++.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDN-----DGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEET-----TTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECC-----CCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            34688999999999999999875321     111233444444321  12235678999999999999999999999976


Q ss_pred             e-CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 E-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      + ++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       161 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~D  235 (373)
T 3c1x_A          161 RSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD  235 (373)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             cCCCCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEee
Confidence            4 467899999999999999997542  348899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCC--ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhh
Q 036172          304 FGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       304 FGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      ||+++........  .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||............      
T Consensus       236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------  309 (373)
T 3c1x_A          236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------  309 (373)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------
T ss_pred             ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------
Confidence            9999765433211  11223467889999999999999999999999999999999 78888655433322111      


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       ..+..  ...       +...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       310 -~~~~~--~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          310 -LQGRR--LLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -HTTCC--CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HcCCC--CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             11111  011       11234568889999999999999999999999998763

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-41  Score=331.93  Aligned_cols=257  Identities=22%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....         .+.+++|.++....    ..+++.+|+.++++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~   73 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN---------KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCL   73 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---------TEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC---------CCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            4689999999999999999987532         23455555433211    2367999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           74 EQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             cCCCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccc
Confidence            9999999999999999999998642  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .......    ..
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i----~~  220 (267)
T 3t9t_A          149 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI----ST  220 (267)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HT
T ss_pred             ccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHH----hc
Confidence            99976543211 11123457788999999998999999999999999999999 8999865321   1121111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +..  ...       +...+..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus       221 ~~~--~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 GFR--LYK-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TCC--CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCc--CCC-------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            110  001       11124568889999999999999999999999988753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-41  Score=345.07  Aligned_cols=271  Identities=26%  Similarity=0.326  Sum_probs=208.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....    ......+.+++|.+..   ......+.|.+|+.++++++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDP----LGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECT----TSSSCSEEEEEEEESS---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEecc----CCCCcceEEEEEEecc---CCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            35789999999999999999986311    1123456666665542   2233557799999999999999999999998


Q ss_pred             E--eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 I--EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .  +....++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEE
Confidence            7  4577999999999999999998642  249999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------Chh
Q 036172          302 SDFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK---------GPE  371 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~---------~~~  371 (522)
                      +|||++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......         ...
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  248 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP  248 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence            9999998765443221 223346888899999999988999999999999999999999998532110         000


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .... .......+.         ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       249 ~~~~-~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          249 ALSR-LLELLEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHH-HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             cHHH-HHHHhhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0000 111111111         111122345678899999999999999999999999998753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-40  Score=344.98  Aligned_cols=269  Identities=19%  Similarity=0.268  Sum_probs=200.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        +.+.||+|.+....       ..+.+|+.+++.++|||||++++++
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~--------~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIE--------SGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETT--------TCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECC--------CCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhhee
Confidence            35789999999999999999987643        45667777553221       2234799999999999999999999


Q ss_pred             Ee--------------------------------------CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHH
Q 036172          224 IE--------------------------------------DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAV  264 (522)
Q Consensus       224 ~~--------------------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~  264 (522)
                      ..                                      ...+++||||++ |+|.+.+... .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            54                                      345899999997 4888887642 2334699999999999


Q ss_pred             HHHHHHHHHHhcCCCCEEeccCCCCceecc-CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCch
Q 036172          265 AIAEALNYLHSECSRPVIHRDVKSSNILLS-SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDK  342 (522)
Q Consensus       265 qi~~gL~yLH~~~~~giiHrDIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~k  342 (522)
                      ||+.||.|||+   .+|+||||||+|||++ .++.+||+|||+++........   ....||+.|+|||.+.+. .++.+
T Consensus       149 qi~~aL~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          149 QLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcc
Confidence            99999999999   9999999999999997 6889999999999765443322   234689999999998765 48999


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh--------------hhcCCCcccccCCcccccccHHHHHHHHH
Q 036172          343 IDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP--------------ILKNGDTETLLDPKLSNEYDNAQMQRMLL  408 (522)
Q Consensus       343 sDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~--------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  408 (522)
                      +|||||||++|+|++|+.||......  ..+......              ..................++...+..+.+
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            99999999999999999999754321  111111110              00011111111111112222334567899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          409 AANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       409 li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ++.+||+.||.+|||+.|+++        |+|++..
T Consensus       301 li~~~L~~dP~~R~t~~e~l~--------hp~f~~~  328 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMA--------HPFFDHL  328 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT--------SGGGHHH
T ss_pred             HHHHHccCChhhCCCHHHHhc--------CHHHHHH
Confidence            999999999999999999997        9998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.2e-41  Score=356.45  Aligned_cols=258  Identities=22%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....         ...+++|.++...    ...++|.+|+.+|++++||||+++++++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG---------TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT---------TEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC---------CceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35689999999999999999987542         2346666554322    1246799999999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+ +..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~D  323 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD  323 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECC
Confidence            76 67899999999999999997532 2348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.....   ..+....    .
T Consensus       324 fG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i----~  395 (452)
T 1fmk_A          324 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----E  395 (452)
T ss_dssp             CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----H
T ss_pred             CccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----H
Confidence            9999765432211 1223457889999999999999999999999999999999 9999864321   1121111    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       396 ~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          396 RGYRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            11110         1112244678899999999999999999999999988753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.2e-40  Score=343.13  Aligned_cols=268  Identities=18%  Similarity=0.238  Sum_probs=204.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC--------CCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE--------QKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~--------HpnI  216 (522)
                      .++|++.++||+|+||.||++.+..        ..+.+++|.++..    ....+.+.+|+.++++++        |+||
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ--------GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC--------CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            5789999999999999999987543        3456677665421    224577899999999995        7889


Q ss_pred             ceeeEEEE----eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCce
Q 036172          217 TTLNGVCI----EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNI  291 (522)
Q Consensus       217 v~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NI  291 (522)
                      +++++++.    ....+++||||+ +++|.+.+.... ...+++..++.++.||+.||.|||+   + +|+||||||+||
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NI  178 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENI  178 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHe
Confidence            99999998    456899999999 557777766542 2359999999999999999999999   8 999999999999


Q ss_pred             eccCCC-------------------------------------------------ceEEeecCccccCCCCCCCcccccc
Q 036172          292 LLSSDF-------------------------------------------------QPQLSDFGLAIWGPTDSTHMIREDV  322 (522)
Q Consensus       292 Ll~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~  322 (522)
                      |++.++                                                 .+||+|||++.......     ...
T Consensus       179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~  253 (397)
T 1wak_A          179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TED  253 (397)
T ss_dssp             EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSC
T ss_pred             eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccC
Confidence            998775                                                 79999999997654332     234


Q ss_pred             ccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh---HHHhhhhhhc-----------------
Q 036172          323 VGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES---LVKWAKPILK-----------------  382 (522)
Q Consensus       323 ~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~---l~~~~~~~~~-----------------  382 (522)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||..........   ..........                 
T Consensus       254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            68999999999999999999999999999999999999997654333211   1111100000                 


Q ss_pred             --CCCcccccCCcc---------cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          383 --NGDTETLLDPKL---------SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       383 --~~~~~~~~d~~l---------~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                        .+....+.+...         ....+......+.+|+.+||+.||.+|||+.||++        |+|++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--------hp~~~  396 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR--------HPWLN  396 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT--------SGGGG
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh--------Ccccc
Confidence              000000000000         01234566788999999999999999999999997        88875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.6e-40  Score=334.34  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=202.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~  223 (522)
                      .++|++.++||+|+||.||++.+..        ..+.+++|.++.      ...+.+.+|+.++++++ ||||+++++++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~  100 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINIT--------NNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIV  100 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECC--------CCcEEEEEEecc------cchHHHHHHHHHHHHcCCCCCEEEeeeee
Confidence            5689999999999999999987543        355666665532      23467999999999996 99999999999


Q ss_pred             Ee--CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ceE
Q 036172          224 IE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQ  300 (522)
Q Consensus       224 ~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~k  300 (522)
                      .+  ....++||||+++++|.+++..      +++..+..++.|++.||.|||+   .+|+||||||+|||++.++ .+|
T Consensus       101 ~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          101 KDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             ECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEE
T ss_pred             ccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEE
Confidence            98  6789999999999999999862      8899999999999999999999   9999999999999999776 899


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      |+|||+++........   ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ....+......
T Consensus       172 l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~l~~~~~~  247 (330)
T 3nsz_A          172 LIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVRIAKV  247 (330)
T ss_dssp             ECCCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-HHHHHHHHHHH
T ss_pred             EEeCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc-hHHHHHHHHHh
Confidence            9999999765543322   23478999999999977 6689999999999999999999999853321 11111111100


Q ss_pred             --------hhcCCC--------------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          380 --------ILKNGD--------------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       380 --------~~~~~~--------------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                              .+....              .................+..+.+++.+||+.||.+|||+.++++        
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--------  319 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--------  319 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--------
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--------
Confidence                    000000              00000000111111223567899999999999999999999997        


Q ss_pred             Ccccccc
Q 036172          438 TDWVDRH  444 (522)
Q Consensus       438 ~~~~~~~  444 (522)
                      |+|++.-
T Consensus       320 hp~f~~~  326 (330)
T 3nsz_A          320 HPYFYTV  326 (330)
T ss_dssp             SGGGTTC
T ss_pred             CccHhhh
Confidence            9998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-40  Score=369.80  Aligned_cols=259  Identities=20%  Similarity=0.286  Sum_probs=210.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....        +.+.||+|.+++.........+.+..|..+|..+ +||||++++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~  410 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKG--------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC  410 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESS--------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECC--------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            35689999999999999999987643        5567888877654333334567889999999998 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+.+.+||||||+++|+|.+++...+   .+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+
T Consensus       411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          411 FQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             CBCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEEC
T ss_pred             EEeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEe
Confidence            999999999999999999999998643   49999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+..   .+..
T Consensus       485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~  556 (674)
T 3pfq_A          485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIME  556 (674)
T ss_dssp             CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHS
T ss_pred             ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHH---HHHh
Confidence            9999975433222  23356899999999999999999999999999999999999999975432   11211   1111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHhccccCCccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM-----GQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~-----~eVl~~L~~~~~~~~~~~~  443 (522)
                       ...          .++...+..+.+|+.+||+.||.+||++     .+|++        |+|++.
T Consensus       557 -~~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~--------h~ff~~  603 (674)
T 3pfq_A          557 -HNV----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--------HAFFRY  603 (674)
T ss_dssp             -SCC----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS--------SGGGSS
T ss_pred             -CCC----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc--------CccccC
Confidence             111          1122344678899999999999999998     67765        788764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=344.59  Aligned_cols=267  Identities=17%  Similarity=0.221  Sum_probs=198.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        +++.+++|.+..... .....+++.+|+.+|++++||||+++++++
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   93 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGR--------TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVF   93 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT--------TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECC--------CCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence            35789999999999999999987543        455666665533211 122457899999999999999999999999


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ..+++||||+ +++|.+++...    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A           94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTC
T ss_pred             ecCCccccCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCC
Confidence            865      3469999999 78999999752    48999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++......     ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........  +...
T Consensus       166 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i  238 (367)
T 1cm8_A          166 ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEI  238 (367)
T ss_dssp             CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred             CEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence            99999999997654322     23478999999999877 6799999999999999999999999975432111  1111


Q ss_pred             hhhhhcCC------------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          377 AKPILKNG------------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       377 ~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      .. .....                  ......... ........+..+.+++.+||+.||.+|||+.++++        |
T Consensus       239 ~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~--------h  308 (367)
T 1cm8_A          239 MK-VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--------H  308 (367)
T ss_dssp             HH-HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--------S
T ss_pred             HH-hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc--------C
Confidence            00 00000                  000000000 01111223467889999999999999999999998        9


Q ss_pred             cccccc
Q 036172          439 DWVDRH  444 (522)
Q Consensus       439 ~~~~~~  444 (522)
                      +|+...
T Consensus       309 p~f~~~  314 (367)
T 1cm8_A          309 PYFESL  314 (367)
T ss_dssp             GGGTTT
T ss_pred             hHHHhh
Confidence            998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.4e-41  Score=329.48  Aligned_cols=255  Identities=17%  Similarity=0.255  Sum_probs=199.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++...          ...+++|.++.. .......++|.+|+.++++++||||+++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~avK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ----------GNDIVVKVLKVR-DWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET----------TEEEEEEEECCT-TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC----------CeeEEEEEeccc-ccCHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            4578999999999999999998753          233444443321 11123457799999999999999999999999


Q ss_pred             EeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceeccCCCce
Q 036172          224 IED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       224 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~~~~~~  299 (522)
                      .+.  +..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+  ++||||||+||+++.++.+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCE
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcce
Confidence            987  78899999999999999998643 2358999999999999999999999   88  9999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD---KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~---ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      +|+|||++.....       ....||+.|+|||.+.+..++.   ++||||||+++|+|++|+.||......   ..   
T Consensus       153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---  219 (271)
T 3kmu_A          153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EI---  219 (271)
T ss_dssp             EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HH---
T ss_pred             eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HH---
Confidence            9999988754222       2346899999999998765444   899999999999999999999643211   11   


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .......+..     +    ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       220 ~~~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          220 GMKVALEGLR-----P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHSCCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111111111     1    111223457889999999999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=334.91  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=200.2

Q ss_pred             CCCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceee
Q 036172          141 SPKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLN  220 (522)
Q Consensus       141 ~~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~  220 (522)
                      ......+|++.+.||+|+||.||++....        .++.+++|.+...     ...+++.+|+.++++++||||++++
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~   90 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKE--------TGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYY   90 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETT--------TCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECC--------CCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence            34456789999999999999999987543        3456666654321     2346789999999999999999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceE
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~k  300 (522)
                      +++..++..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~k  165 (314)
T 3com_A           91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAK  165 (314)
T ss_dssp             EEEEETTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEeCCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEE
Confidence            99999999999999999999999997432  349999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||++........  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......   ......   
T Consensus       166 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---  237 (314)
T 3com_A          166 LADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMI---  237 (314)
T ss_dssp             ECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---
T ss_pred             Eeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH---
Confidence            999999976543321  122457899999999999889999999999999999999999999643211   111100   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .. .......       .+...+..+.+++.+||+.||.+|||+.++++        ++|++..
T Consensus       238 ~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--------~~~~~~~  285 (314)
T 3com_A          238 PT-NPPPTFR-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--------HPFVRSA  285 (314)
T ss_dssp             HH-SCCCCCS-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--------SHHHHTC
T ss_pred             hc-CCCcccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh--------CHHHhcC
Confidence            01 1111110       11123457889999999999999999999997        7777653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.9e-41  Score=332.55  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=199.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+..... .....+.|.+|+.++++++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKS--------DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRI   74 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECC--------CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            45789999999999999999987643        345555555432111 123457899999999999999999999988


Q ss_pred             Ee--CCEEEEEEecCCCCCHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-----EEeccCCCCceeccC
Q 036172          224 IE--DNYLILVSDFLPKGSLEESLHGAG-EQSVLPWGVRFEVAVAIAEALNYLHSECSRP-----VIHRDVKSSNILLSS  295 (522)
Q Consensus       224 ~~--~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g-----iiHrDIkp~NILl~~  295 (522)
                      .+  +...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+   .+     |+||||||+||+++.
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECS
T ss_pred             ecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcC
Confidence            65  578999999999999999997542 23459999999999999999999999   77     999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      ++.+||+|||++........  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....   ...+..
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~  226 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG  226 (279)
T ss_dssp             SSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred             CCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHH
Confidence            99999999999976543321  1224578999999999998899999999999999999999999987543   112221


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK  429 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~  429 (522)
                      ..    ..+....         .+...+..+.+++.+||+.||.+||++.+|++
T Consensus       227 ~i----~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (279)
T 2w5a_A          227 KI----REGKFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  267 (279)
T ss_dssp             HH----HHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH----hhccccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11    1121111         11123457889999999999999999999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.4e-41  Score=337.51  Aligned_cols=264  Identities=20%  Similarity=0.271  Sum_probs=200.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        ..+.+++|.+..   ......+.+.+|+.++++++||||+++++++.
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   96 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH--------DGHFYALKRILC---HEQQDREEAQREADMHRLFNHPNILRLVAYCL   96 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT--------TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC--------CCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence            5689999999999999999987643        455666665422   12235678999999999999999999999997


Q ss_pred             e----CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 E----DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~----~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      .    ....++||||+++|+|.+++... .....+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A           97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCE
T ss_pred             eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCE
Confidence            3    34789999999999999999863 223469999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCc-------cccccccCCCCCChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          300 QLSDFGLAIWGPTDSTHM-------IREDVVGTFGYIAPEYLMHGK---VSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      ||+|||++..........       ......||+.|+|||.+....   ++.++||||||+++|+|++|+.||.......
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            999999986543221110       011245799999999986544   6899999999999999999999985321111


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      . .+....    ... ..        .......+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       254 ~-~~~~~~----~~~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          254 D-SVALAV----QNQ-LS--------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             S-CHHHHH----HCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             c-hhhHHh----hcc-CC--------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            0 011100    100 00        00011234578899999999999999999999999988753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-40  Score=342.05  Aligned_cols=272  Identities=21%  Similarity=0.251  Sum_probs=204.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +.+.+++|.+..  .......+.+.+|+.++++++||||+++++++
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   94 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNL--------NKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDII   94 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECC--TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECC--------CCeEEEEEEecc--ccCcHHHHHHHHHHHHHHhcCCCCCccceeEE
Confidence            35699999999999999999987543        345566665432  11223457899999999999999999999999


Q ss_pred             EeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ...     ...++||||+. |+|.+++...    .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        95 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~  166 (364)
T 3qyz_A           95 RAPTIEQMKDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCD  166 (364)
T ss_dssp             CCSSTTTCCCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCC
T ss_pred             ecCCccccceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCC
Confidence            765     47899999997 5999999753    39999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCc-cccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          299 PQLSDFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      +||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. 
T Consensus       167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-  245 (364)
T 3qyz_A          167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-  245 (364)
T ss_dssp             EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH-
T ss_pred             EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-
Confidence            9999999997654432211 1234579999999998755 458999999999999999999999997554322211110 


Q ss_pred             hhhhhcCCCc---------------ccccCC--cccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          377 AKPILKNGDT---------------ETLLDP--KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       377 ~~~~~~~~~~---------------~~~~d~--~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                        ........               .....+  ..........+..+.+++.+||+.||.+|||+.++++        |+
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp  315 (364)
T 3qyz_A          246 --GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--------HP  315 (364)
T ss_dssp             --HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SG
T ss_pred             --HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--------Cc
Confidence              00000000               000000  0000111123457889999999999999999999997        99


Q ss_pred             ccccc
Q 036172          440 WVDRH  444 (522)
Q Consensus       440 ~~~~~  444 (522)
                      |++..
T Consensus       316 ~~~~~  320 (364)
T 3qyz_A          316 YLEQY  320 (364)
T ss_dssp             GGTTT
T ss_pred             chhhc
Confidence            98765

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-40  Score=343.69  Aligned_cols=259  Identities=21%  Similarity=0.327  Sum_probs=201.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-----cchHHHHHHHHHHHHhhC-CCCCccee
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-----FSSAWNDFSSEVDITSSL-EQKSITTL  219 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-----~~~~~~~f~~Ev~iL~~L-~HpnIv~l  219 (522)
                      ++|++.++||.|+||.||++....        +++.+++|.+......     .....+.+.+|+.+++++ +||||+++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRA--------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hhcccceEEecCCCEEEEEEEECC--------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            579999999999999999987542        3445555543221111     112356789999999999 89999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ++++...+..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+   .||+||||||+|||++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999999854   349999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      ||+|||++.........   ....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||....   ....
T Consensus       240 kl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILM  313 (365)
T ss_dssp             EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHH
T ss_pred             EEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHH
Confidence            99999999766543322   24579999999999863      358899999999999999999999996432   1111


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .....    .+....      ........+..+.+++.+||+.||.+||++.++++        ++|++
T Consensus       314 ~~~i~----~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--------hp~f~  364 (365)
T 2y7j_A          314 LRMIM----EGQYQF------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ--------HPFFE  364 (365)
T ss_dssp             HHHHH----HTCCCC------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SGGGC
T ss_pred             HHHHH----hCCCCC------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------CcccC
Confidence            11111    111100      00000112356889999999999999999999998        88875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.7e-41  Score=340.30  Aligned_cols=263  Identities=19%  Similarity=0.252  Sum_probs=203.0

Q ss_pred             CCCceee-ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          145 ENPFQMD-IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~-~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      .++|.+. +.||+|+||.||++....        ..+.+++|.+++... .......+.+|+.++.++ +||||++++++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKS--------TGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECC--------CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4578887 899999999999987543        455666665543221 122457899999999999 56999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---CCce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---~~~~  299 (522)
                      +.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999998654 23459999999999999999999999   99999999999999987   7899


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      ||+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   ........
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~  247 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQ  247 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHh
Confidence            9999999976644322   12357999999999999999999999999999999999999999653321   11111111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .  ....        ........+..+.+++.+||+.||.+|||+.++++        ++|++..
T Consensus       248 ~--~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--------h~~~~~~  294 (327)
T 3lm5_A          248 V--NVDY--------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--------HSWLQQW  294 (327)
T ss_dssp             T--CCCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--------CGGGCCC
T ss_pred             c--cccc--------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--------CHhhccc
Confidence            0  0000        11111123456888999999999999999999997        8998754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-40  Score=326.52  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=199.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        ..+.+++|.++..       .+.+.+|++++++++||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRI--------DGKTYVIKRVKYN-------NEKAEREVKALAKLDHVNIVHYNGCWD   74 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETT--------TCCEEEEEEEECC-------SGGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceeeeeccCCceEEEEEEEcC--------CCeEEEEEEeccc-------cHHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence            4579999999999999999987642        3456666654321       135778999999999999999999986


Q ss_pred             e----------------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          225 E----------------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       225 ~----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                      .                ...+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp  150 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKP  150 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCH
Confidence            4                456899999999999999997542 2359999999999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK  368 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~  368 (522)
                      +||+++.++.+||+|||++.........   ....|++.|+|||.+.+..++.++||||||+++|+|++|..|+...   
T Consensus       151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---  224 (284)
T 2a19_B          151 SNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---  224 (284)
T ss_dssp             GGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred             HHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence            9999999999999999999766543322   2346899999999999999999999999999999999999886311   


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                           .... ..+..+...        .    ..+..+.+++.+||+.||.+||++.++++.|+....
T Consensus       225 -----~~~~-~~~~~~~~~--------~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          225 -----SKFF-TDLRDGIIS--------D----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -----HHHH-HHHHTTCCC--------T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -----HHHH-HHhhccccc--------c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                 1111 111111111        1    123457889999999999999999999999987653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9e-40  Score=346.37  Aligned_cols=204  Identities=21%  Similarity=0.274  Sum_probs=165.8

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGV  222 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~  222 (522)
                      ...++|++.+.||+|+||.||++.+..        +.+.+|+|.+++... .....+++.+|+.+|++++||||++++++
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKN--------TEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETT--------TTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECC--------CCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            356799999999999999999997643        455666666543211 22345789999999999999999999999


Q ss_pred             EEeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          223 CIED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       223 ~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      +...     ..+|+||||+. |+|.+++...   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~  166 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDC  166 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTC
T ss_pred             EecCCCCcCCeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCC
Confidence            9876     57999999996 5999999843   359999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCC--------------------ccccccccCCCCCChhhh-ccCCCCchhhHHHHHHHHHHHH
Q 036172          298 QPQLSDFGLAIWGPTDSTH--------------------MIREDVVGTFGYIAPEYL-MHGKVSDKIDVYSFGVVLLELL  356 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~--------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwSlGvvl~eLl  356 (522)
                      .+||+|||+++........                    .......||+.|+|||++ ....++.++|||||||++|||+
T Consensus       167 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            9999999999866443211                    112356799999999986 4566999999999999999999


Q ss_pred             cCCCCC
Q 036172          357 SGRRPI  362 (522)
Q Consensus       357 tG~~Pf  362 (522)
                      +|..||
T Consensus       247 ~g~~p~  252 (432)
T 3n9x_A          247 NMLQSH  252 (432)
T ss_dssp             TTCTTT
T ss_pred             hccccc
Confidence            865554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-40  Score=334.86  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=203.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        .++.+++|.++...   ....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRL--------TGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYE   76 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECC--------CCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence            4689999999999999999987643        34566666554211   113356889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~kL  301 (522)
                      +.+..++||||+++++|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+||++   +.++.+||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl  150 (304)
T 2jam_A           77 STTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMI  150 (304)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred             cCCEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEE
Confidence            9999999999999999999997543   48999999999999999999999   999999999999999   77889999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ..+....    
T Consensus       151 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i----  219 (304)
T 2jam_A          151 TDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKI----  219 (304)
T ss_dssp             CSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----
T ss_pred             ccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----
Confidence            9999986543321    2234689999999999988999999999999999999999999965321   1111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..+... .     ........+..+.+++.+||+.||.+||++.++++        ++|+...
T Consensus       220 ~~~~~~-~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--------h~~~~~~  268 (304)
T 2jam_A          220 KEGYYE-F-----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS--------HPWIDGN  268 (304)
T ss_dssp             HHCCCC-C-----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--------SHHHHSS
T ss_pred             HcCCCC-C-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------CccccCC
Confidence            111110 0     01111223457889999999999999999999997        8887653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-41  Score=352.84  Aligned_cols=253  Identities=12%  Similarity=0.104  Sum_probs=193.9

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHH---HHHhhCCCCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEV---DITSSLEQKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev---~iL~~L~HpnIv~l~  220 (522)
                      ..++|++.++||+|+||.||++....        +.+.+++|.+...........+.|.+|+   .+|++++|||||+++
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQE--------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-C--------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CCceEEEcceeecCCCEEEEEEEECC--------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            35689999999999999999987632        4567777776533233334668899999   555666899999998


Q ss_pred             -------EEEEeCC-----------------EEEEEEecCCCCCHHHHhhccCC----CCCCChHHHHHHHHHHHHHHHH
Q 036172          221 -------GVCIEDN-----------------YLILVSDFLPKGSLEESLHGAGE----QSVLPWGVRFEVAVAIAEALNY  272 (522)
Q Consensus       221 -------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~gL~y  272 (522)
                             +++.+.+                 ..++||||+ +|+|.+++...+.    ...+++..++.|+.||+.||.|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   7776553                 289999999 6799999986421    1224458889999999999999


Q ss_pred             HHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-----------CCCc
Q 036172          273 LHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-----------KVSD  341 (522)
Q Consensus       273 LH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~s~  341 (522)
                      ||+   .+|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.
T Consensus       222 LH~---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          222 LHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             HHH---TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             HHh---CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence            999   9999999999999999999999999999975332     2234467 999999999877           8999


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCC
Q 036172          342 KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR  421 (522)
Q Consensus       342 ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~R  421 (522)
                      ++|||||||++|||++|+.||...........               +...  ..    ..+..+.+++.+||+.||.+|
T Consensus       293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~---------------~~~~--~~----~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCADLPITKDAALGGSEW---------------IFRS--CK----NIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC------CCSGG---------------GGSS--CC----CCCHHHHHHHHHHTCSSGGGC
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcccccccchhh---------------hhhh--cc----CCCHHHHHHHHHHcCCCchhC
Confidence            99999999999999999999964432211100               0000  01    123568889999999999999


Q ss_pred             CCHHHHHHHHhccccCCccccc
Q 036172          422 PNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       422 Ps~~eVl~~L~~~~~~~~~~~~  443 (522)
                      |++.++++        ++|++.
T Consensus       352 pt~~e~l~--------hp~f~~  365 (377)
T 3byv_A          352 LLPLQAME--------TPEYEQ  365 (377)
T ss_dssp             CCHHHHHT--------SHHHHH
T ss_pred             CCHHHHhh--------ChHHHH
Confidence            99999997        777654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=338.31  Aligned_cols=259  Identities=16%  Similarity=0.163  Sum_probs=202.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC---CCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE---QKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~---HpnIv~l~  220 (522)
                      ..++|++.+.||+|+||.||++.....   ......+.+++|.++.      ....+|.+|+.++.+++   |+||++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~~~vavK~~~~------~~~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDL---NDAKNKQKFVLKVQKP------ANPWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC----------CCCCEEEEEESS------CCHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCC---cccccCcEEEEEEeCC------CChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            457899999999999999999953221   1123567778777643      13457888999999886   99999999


Q ss_pred             EEEEeCCEEEEEEecCCCCCHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC---
Q 036172          221 GVCIEDNYLILVSDFLPKGSLEESLHGAG--EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---  295 (522)
Q Consensus       221 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~---  295 (522)
                      +++..++..+|||||+++|+|.+++....  ....+++..++.++.||+.||.|||+   .+|+||||||+||||+.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEeccccc
Confidence            99999999999999999999999997531  23459999999999999999999999   99999999999999998   


Q ss_pred             --------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 036172          296 --------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNL  367 (522)
Q Consensus       296 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~  367 (522)
                              ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999654433333333456799999999999999999999999999999999999999853221


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHhccc
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR-PNMGQVLKLLRGAT  435 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~R-Ps~~eVl~~L~~~~  435 (522)
                      ...              .....+    ...   .....+.+++..||+.+|.+| |++.++.+.|+...
T Consensus       291 ~~~--------------~~~~~~----~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          291 GEC--------------KPEGLF----RRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             TEE--------------EECSCC----TTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             Cce--------------eechhc----ccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            100              000000    110   123466778999999999999 57888888887654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-41  Score=344.90  Aligned_cols=267  Identities=23%  Similarity=0.289  Sum_probs=206.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-cchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-FSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ..++|++.++||+|+||.||++....     .....+.+++|.+++.... .....+.+.+|+.+|+++ +||||+++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKIS-----GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECS-----STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcc-----cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            34689999999999999999987531     1235667777766543211 112345678899999999 7999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++..++.+++||||+++|+|.+++....   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEE
Confidence            9999999999999999999999998543   49999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP  379 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~  379 (522)
                      +|||+++........ ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..........  .....
T Consensus       201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~  277 (355)
T 1vzo_A          201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR  277 (355)
T ss_dssp             SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHH
T ss_pred             eeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHH
Confidence            999999765432221 12245799999999999753  47899999999999999999999997544332211  11111


Q ss_pred             hhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       380 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .....       +    .++...+..+.+++.+||+.||.+||     ++.++++        ++|+..
T Consensus       278 ~~~~~-------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~--------h~~f~~  327 (355)
T 1vzo_A          278 ILKSE-------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--------HLFFQK  327 (355)
T ss_dssp             HHHCC-------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--------SGGGTT
T ss_pred             HhccC-------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc--------Ccchhc
Confidence            11110       1    11122345688899999999999999     9999997        788764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=340.61  Aligned_cols=258  Identities=19%  Similarity=0.225  Sum_probs=185.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~~  223 (522)
                      ..+|++.++||+|+||.||++.+..        ..+.|++|.+..   ......+.+.+|+.+++++. ||||+++++++
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVG--------SGREYALKRLLS---NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETT--------TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CceEEEEEEEccCCceEEEEEEECC--------CCcEEEEEEecC---CchHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            4589999999999999999987643        455666665421   22335577999999999995 99999999999


Q ss_pred             E--------eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceec
Q 036172          224 I--------EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILL  293 (522)
Q Consensus       224 ~--------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl  293 (522)
                      .        ....+++||||+. |+|.+++........+++..++.++.||+.||.|||+   .+  |+||||||+|||+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~  171 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLL  171 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEE
T ss_pred             cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEE
Confidence            5        3346899999996 6999999764344469999999999999999999999   88  9999999999999


Q ss_pred             cCCCceEEeecCccccCCCCCCCc----------cccccccCCCCCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCC
Q 036172          294 SSDFQPQLSDFGLAIWGPTDSTHM----------IREDVVGTFGYIAPEYL---MHGKVSDKIDVYSFGVVLLELLSGRR  360 (522)
Q Consensus       294 ~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwSlGvvl~eLltG~~  360 (522)
                      +.++.+||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  251 (337)
T 3ll6_A          172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH  251 (337)
T ss_dssp             CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence            999999999999997665432211          11134589999999998   56678999999999999999999999


Q ss_pred             CCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          361 PIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       361 Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ||.......   ..        .+......        .......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       252 p~~~~~~~~---~~--------~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          252 PFEDGAKLR---IV--------NGKYSIPP--------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             CC-----------------------CCCCT--------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcchhHHH---hh--------cCcccCCc--------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            996432111   00        00000000        01112347789999999999999999999999988764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=327.40  Aligned_cols=260  Identities=20%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED  226 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~  226 (522)
                      .|.....||+|+||.||++.+..        ..+.+++|.+...   .....+.|.+|+.++++++||||+++++++.+.
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   91 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS--------NQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN   91 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT--------TCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CCCCcEEEeecCcEEEEEEEECC--------CCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence            34445589999999999987543        3455665554321   223457899999999999999999999999999


Q ss_pred             CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CCceEEeecC
Q 036172          227 NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFG  305 (522)
Q Consensus       227 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~~~kL~DFG  305 (522)
                      +..++||||+++++|.+++........+++..+..++.|++.||.|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecc
Confidence            9999999999999999999876444457899999999999999999999   99999999999999987 8999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK--VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ++........  ......|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||........ ....  ..... 
T Consensus       169 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~--~~~~~-  242 (295)
T 2clq_A          169 TSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFK--VGMFK-  242 (295)
T ss_dssp             TCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHH--HHHHC-
T ss_pred             cccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHh--hcccc-
Confidence            9976543221  122457899999999997654  78999999999999999999999864321111 1111  00000 


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                            ..+.    .+...+..+.+++.+||+.||.+||++.++++        ++|++..
T Consensus       243 ------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--------~~~~~~~  285 (295)
T 2clq_A          243 ------VHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLV--------DEFLKVS  285 (295)
T ss_dssp             ------CCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--------SGGGCC-
T ss_pred             ------cccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc--------Chhhhhc
Confidence                  0111    11223457888999999999999999999997        8887643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.5e-41  Score=332.62  Aligned_cols=263  Identities=19%  Similarity=0.278  Sum_probs=190.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.+++|.++.... .....+.+..+..+++.++||||+++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP--------SGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC--------CCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            35789999999999999999987643        455666665543211 112334455556668888999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCceeccCCCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NILl~~~~~~kL  301 (522)
                      .+++..++||||+++ +|.+++... .....+++..++.++.|++.||.|||+   . +|+||||||+||+++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           76 FREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             ECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEB
T ss_pred             eccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999974 998887642 233469999999999999999999999   7 9999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhh----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL----MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +|||++.........   ....||+.|+|||.+    .+..++.++||||||+++|+|++|+.||...... ...+..  
T Consensus       152 ~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~--  225 (290)
T 3fme_A          152 CDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQ--  225 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHH--
T ss_pred             eecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHH--
Confidence            999999765443222   234689999999996    4567899999999999999999999999643211 111111  


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        ....... ...        ....+..+.+++.+||+.||.+|||+.++++        |+|+...
T Consensus       226 --~~~~~~~-~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--------hp~f~~~  273 (290)
T 3fme_A          226 --VVEEPSP-QLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--------HPFFTLH  273 (290)
T ss_dssp             --HHHSCCC-CCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--------SHHHHHH
T ss_pred             --HhccCCC-Ccc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh--------CcccccC
Confidence              1111111 000        1123456889999999999999999999997        8888754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-40  Score=336.90  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=197.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHh-----hccchHHHHHHHHHHHHhhCCCCCccee
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQAT-----SQFSSAWNDFSSEVDITSSLEQKSITTL  219 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t-----~~~~~~~~~f~~Ev~iL~~L~HpnIv~l  219 (522)
                      .++|++.+.||+|+||.||++.+..        .++.+++|.+....     .........|.+|+.++++++||||+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK--------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC--------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            4689999999999999999987543        33455555432211     1111234568899999999999999999


Q ss_pred             eEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc-
Q 036172          220 NGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ-  298 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~-  298 (522)
                      ++++..+. .++||||+++|+|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++. 
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSS
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCC
Confidence            99997665 89999999999999999743   359999999999999999999999   99999999999999987654 


Q ss_pred             --eEEeecCccccCCCCCCCccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          299 --PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       299 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                        +||+|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  +
T Consensus       154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~  228 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L  228 (322)
T ss_dssp             CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H
T ss_pred             CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H
Confidence              9999999997654321   122457899999999974   46689999999999999999999999975433211  1


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .....    .+....      ........+..+.+++.+||+.||.+||++.++++        |+|+..
T Consensus       229 ~~~~~----~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~--------h~~~~~  280 (322)
T 2ycf_A          229 KDQIT----SGKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--------HPWLQD  280 (322)
T ss_dssp             HHHHH----HTCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGCC
T ss_pred             HHHHH----hCcccc------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh--------CcCcCC
Confidence            11111    111100      01111123467889999999999999999999997        888765

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.4e-41  Score=347.09  Aligned_cols=265  Identities=12%  Similarity=0.066  Sum_probs=187.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC--CCCCcceee--
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL--EQKSITTLN--  220 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L--~HpnIv~l~--  220 (522)
                      ...|++.++||+|+||.||++.+..        +.+.+++|.++..........+.+.+|+.+++.|  +||||++++  
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~  132 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVE--------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR  132 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECC--------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence            3469999999999999999998643        3456666665543322233566788885555554  699988755  


Q ss_pred             -----EEEEeC-----------------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHH------HHHHHHHHHHHHH
Q 036172          221 -----GVCIED-----------------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR------FEVAVAIAEALNY  272 (522)
Q Consensus       221 -----~~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~gL~y  272 (522)
                           +++...                 ..++|||||++ |+|.+++...+.  .+++..+      +.++.||+.||.|
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence                 555543                 34899999998 799999986422  3566666      7888999999999


Q ss_pred             HHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc--CCCCchhhHHHHHH
Q 036172          273 LHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGV  350 (522)
Q Consensus       273 LH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGv  350 (522)
                      ||+   .+|+||||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||
T Consensus       210 LH~---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHH---TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHH---CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            999   999999999999999999999999999997654321     13457799999999987  67999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 036172          351 VLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL  430 (522)
Q Consensus       351 vl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~  430 (522)
                      ++|||++|+.||............        ....................+..+.+++.+||+.||.+|||+.++++ 
T Consensus       282 il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME-  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT-
T ss_pred             HHHHHHhCCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc-
Confidence            999999999999765432211100        00000000001111111123567889999999999999999999997 


Q ss_pred             HhccccCCcccccc
Q 036172          431 LRGATHATDWVDRH  444 (522)
Q Consensus       431 L~~~~~~~~~~~~~  444 (522)
                             |+|++..
T Consensus       353 -------hp~f~~~  359 (371)
T 3q60_A          353 -------TPEFLQL  359 (371)
T ss_dssp             -------SHHHHHH
T ss_pred             -------CHHHHHH
Confidence                   8887653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-40  Score=330.31  Aligned_cols=256  Identities=22%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....         ...+++|.++...    ...+.|.+|++++++++||||+++++++.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNG---------HTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---------TEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcC---------CcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            4689999999999999999986431         2345555443211    13467999999999999999999999987


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        79 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             C-CCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCC
Confidence            4 55899999999999999997532 1248999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |++........ .......++..|+|||.+.++.++.++||||||+++|+|++ |+.||.....   ..+.....    .
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~  225 (279)
T 1qpc_A          154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLE----R  225 (279)
T ss_dssp             TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH----T
T ss_pred             cccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHh----c
Confidence            99976654321 11223457889999999988899999999999999999999 9999864321   12221111    1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +..     +    ..+...+..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       226 ~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          226 GYR-----M----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             TCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccC-----C----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            100     0    011123457889999999999999999999999998865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=333.21  Aligned_cols=274  Identities=18%  Similarity=0.254  Sum_probs=196.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHH--HhhCCCCCcceeeE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDI--TSSLEQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~i--L~~L~HpnIv~l~~  221 (522)
                      ..++|++.+.||+|+||.||++..          ..+.+++|.+...      ..+.+..|.++  +..++||||+++++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~----------~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~   74 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL----------DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIV   74 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE----------TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE----------CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhhee
Confidence            457999999999999999999854          2345666654321      22445555555  44589999999998


Q ss_pred             EEEe-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC---------CEEeccCC
Q 036172          222 VCIE-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR---------PVIHRDVK  287 (522)
Q Consensus       222 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~---------giiHrDIk  287 (522)
                      .+..     ...+++||||+++|+|.+++....    +++..++.++.||+.||.|||+   .         +|+|||||
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dik  147 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLN  147 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCS
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccc
Confidence            7653     236799999999999999997542    5899999999999999999999   7         99999999


Q ss_pred             CCceeccCCCceEEeecCccccCCCCCC------CccccccccCCCCCChhhhcc-------CCCCchhhHHHHHHHHHH
Q 036172          288 SSNILLSSDFQPQLSDFGLAIWGPTDST------HMIREDVVGTFGYIAPEYLMH-------GKVSDKIDVYSFGVVLLE  354 (522)
Q Consensus       288 p~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~e  354 (522)
                      |+|||++.++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++||
T Consensus       148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e  227 (336)
T 3g2f_A          148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE  227 (336)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence            9999999999999999999976543221      111224469999999999976       356779999999999999


Q ss_pred             HHcCCCCCCCCCC-CChhhHHH----------hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC
Q 036172          355 LLSGRRPIGFKNL-KGPESLVK----------WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN  423 (522)
Q Consensus       355 LltG~~Pf~~~~~-~~~~~l~~----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs  423 (522)
                      |++|..||..... ........          ..............+.....  .....+..+.+++.+||+.||.+|||
T Consensus       228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps  305 (336)
T 3g2f_A          228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLT  305 (336)
T ss_dssp             HHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcc
Confidence            9999777632221 11110000          00000111111111111111  12235678999999999999999999


Q ss_pred             HHHHHHHHhccccCCcccccc
Q 036172          424 MGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       424 ~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +.+|++.|+.+.  +.|.+..
T Consensus       306 ~~e~l~~L~~ll--~~~~~~~  324 (336)
T 3g2f_A          306 AQXAEERMAELM--MIWERNK  324 (336)
T ss_dssp             HHHHHHHHHHHH--HCCCC--
T ss_pred             hHHHHHHHHHHH--HHHHhcc
Confidence            999999999987  4565443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=364.63  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             Cceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          147 PFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       147 ~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++.+.. +||+|+||.||++....      ......+++|.++...  .....++|.+|+.+|++++|||||+++++|..
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~------~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRM------RKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEEC------SSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeEcCcEEecCCCcEEEEEEEec------CCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            344444 79999999999986432      1233456666665432  22356789999999999999999999999976


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                       +.+++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence             5689999999999999999754  3359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          306 LAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       306 la~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      +++......... ......+++.|+|||++.++.++.++|||||||++|||++ |+.||......   .+...    +..
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~  554 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQ  554 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHT
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHc
Confidence            998764432211 1122346789999999999999999999999999999998 99999754322   12221    112


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +...         ..+...+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       555 ~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          555 GKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2111         112234467889999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=343.50  Aligned_cols=271  Identities=24%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....    ......+.+++|.+..   ......+.|.+|+.++++++||||+++++++
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDP----LQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECT----TSSSCCEEEEEEEESS---CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeeccCCCeEEEEEEecc----ccCCCceEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            35689999999999999999986211    1123456667666543   2334667899999999999999999999998


Q ss_pred             EeCC--EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          224 IEDN--YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       224 ~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ...+  .+++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEE
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEE
Confidence            7653  7899999999999999998643  348999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------CCChh
Q 036172          302 SDFGLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN---------LKGPE  371 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~---------~~~~~  371 (522)
                      +|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....         .....
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            9999998765443221 1223457788999999998889999999999999999999999975321         00001


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .........+..+...         ..+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       267 ~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111111111110         111223467889999999999999999999999998865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-39  Score=338.78  Aligned_cols=268  Identities=19%  Similarity=0.203  Sum_probs=194.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        ..+.+++|.+.... ......+++.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI--------LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC--------CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            4789999999999999999987543        34556666543211 11234577899999999999999999999998


Q ss_pred             eCC------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 EDN------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..+      ..++||||+++ +|.+++..     .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~  165 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT  165 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSC
T ss_pred             cccccccccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCC
Confidence            664      78999999975 89888862     38999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .+.....
T Consensus       166 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~  240 (371)
T 2xrw_A          166 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIE  240 (371)
T ss_dssp             EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC
T ss_pred             EEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            9999999997654322   1224578999999999999899999999999999999999999997543211  1110000


Q ss_pred             ------------------hhhcC-CC-----cccccCCcc---cccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          379 ------------------PILKN-GD-----TETLLDPKL---SNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       379 ------------------~~~~~-~~-----~~~~~d~~l---~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                                        ..... ..     ....+....   ...........+.+++.+||+.||.+|||+.++++  
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--  318 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--  318 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--
Confidence                              00000 00     000000000   01112234678999999999999999999999998  


Q ss_pred             hccccCCccccc
Q 036172          432 RGATHATDWVDR  443 (522)
Q Consensus       432 ~~~~~~~~~~~~  443 (522)
                            |+|+..
T Consensus       319 ------hp~~~~  324 (371)
T 2xrw_A          319 ------HPYINV  324 (371)
T ss_dssp             ------SHHHHT
T ss_pred             ------Ccchhh
Confidence                  999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.5e-40  Score=347.27  Aligned_cols=269  Identities=19%  Similarity=0.257  Sum_probs=202.5

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC------CCCCcc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL------EQKSIT  217 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L------~HpnIv  217 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+|+|.++.    .....+.+.+|+.+++.+      +|+||+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~--------~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv  162 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHK--------VHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVI  162 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETT--------TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECC--------CCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEE
Confidence            45789999999999999999987543        345666665532    122346678888888887      677999


Q ss_pred             eeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          218 TLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       218 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ++++++...+.+++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+   .+|+||||||+||||+.++
T Consensus       163 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          163 HMLENFTFRNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQG  237 (429)
T ss_dssp             CEEEEEEETTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTT
T ss_pred             EEEeecccCCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCC
Confidence            99999999999999999996 599999986532 349999999999999999999999   9999999999999999988


Q ss_pred             c--eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          298 Q--PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       298 ~--~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      .  +||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+..
T Consensus       238 ~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~l~~  310 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD--QLAC  310 (429)
T ss_dssp             SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred             CcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            7  9999999996644322     23478999999999999999999999999999999999999997543211  1111


Q ss_pred             hhh-----------------hhhcCCCccc------c-----------------cCCccccc----ccHHHHHHHHHHHH
Q 036172          376 WAK-----------------PILKNGDTET------L-----------------LDPKLSNE----YDNAQMQRMLLAAN  411 (522)
Q Consensus       376 ~~~-----------------~~~~~~~~~~------~-----------------~d~~l~~~----~~~~~~~~l~~li~  411 (522)
                      ...                 ..+.......      .                 ..+.....    ........+.+|+.
T Consensus       311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~  390 (429)
T 3kvw_A          311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK  390 (429)
T ss_dssp             HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred             HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence            110                 0000000000      0                 00000000    00112456889999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          412 LCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       412 ~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +||+.||.+|||+.|+++        |+|++..
T Consensus       391 ~~L~~dP~~Rpta~e~L~--------Hpw~~~~  415 (429)
T 3kvw_A          391 QCLEWDPAVRMTPGQALR--------HPWLRRR  415 (429)
T ss_dssp             HHTCSSTTTSCCHHHHHT--------STTTC--
T ss_pred             HHCCCChhhCCCHHHHhC--------ChhhccC
Confidence            999999999999999997        9998865

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-40  Score=344.52  Aligned_cols=269  Identities=19%  Similarity=0.236  Sum_probs=194.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++.+.||+|+||.||++.....         ..+++|.+....       ....+|+.+++.++||||+++++++
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~---------~~~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~  101 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVES---------DEVAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFF  101 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTT---------EEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCC---------CeEEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEE
Confidence            346899999999999999999975431         113333221111       1123699999999999999999999


Q ss_pred             EeCC------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc-CC
Q 036172          224 IEDN------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-SD  296 (522)
Q Consensus       224 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~-~~  296 (522)
                      ...+      .+++||||++++.+............+++..+..++.||+.||.|||+   .+|+||||||+|||++ .+
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~  178 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPS  178 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTT
T ss_pred             EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCC
Confidence            7543      388999999874443333222234469999999999999999999999   9999999999999999 78


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      +.+||+|||+++........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+..
T Consensus       179 ~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~  253 (394)
T 4e7w_A          179 GVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVE  253 (394)
T ss_dssp             TEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred             CcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            99999999999765443322   234789999999998765 5899999999999999999999999754321  11111


Q ss_pred             hhh--------------hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          376 WAK--------------PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       376 ~~~--------------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      ...              +..............+...+....+..+.+++.+||+.||.+|||+.++++        |+|+
T Consensus       254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--------hp~f  325 (394)
T 4e7w_A          254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC--------HPFF  325 (394)
T ss_dssp             HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--------SGGG
T ss_pred             HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc--------Chhh
Confidence            111              001111111111111111122234567899999999999999999999997        8998


Q ss_pred             ccc
Q 036172          442 DRH  444 (522)
Q Consensus       442 ~~~  444 (522)
                      +.-
T Consensus       326 ~~~  328 (394)
T 4e7w_A          326 DEL  328 (394)
T ss_dssp             STT
T ss_pred             hhh
Confidence            753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-39  Score=331.21  Aligned_cols=271  Identities=18%  Similarity=0.235  Sum_probs=204.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCC------cc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS------IT  217 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hpn------Iv  217 (522)
                      ..++|++.++||+|+||.||++.+..       ...+.+++|.++.    .....+.+.+|+.+++.++|+|      |+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~   80 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHK-------AGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCV   80 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT-------TTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecC-------CCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence            35799999999999999999986521       1345566665432    1224567889999999997664      99


Q ss_pred             eeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--
Q 036172          218 TLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--  295 (522)
Q Consensus       218 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--  295 (522)
                      ++++++.+.+..++||||+ +++|.+++...+ ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.  
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~  155 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSD  155 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCC
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccc
Confidence            9999999999999999999 889999998653 2358999999999999999999999   99999999999999987  


Q ss_pred             -----------------CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          296 -----------------DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       296 -----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                                       ++.+||+|||++.......     ....||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                             6689999999997644322     234789999999999998999999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHhhhh-----hhcCCCcccc---------------------cCCc-ccccccHHHHHHHHHHHH
Q 036172          359 RRPIGFKNLKGPESLVKWAKP-----ILKNGDTETL---------------------LDPK-LSNEYDNAQMQRMLLAAN  411 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~~-----~~~~~~~~~~---------------------~d~~-l~~~~~~~~~~~l~~li~  411 (522)
                      ..||.................     .+........                     ..+. .........+..+.+++.
T Consensus       231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            999975432211111110000     0000000000                     0000 000112245678999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          412 LCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       412 ~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +||+.||.+|||+.||++        |+|++.
T Consensus       311 ~~L~~dP~~Rpt~~ell~--------hp~f~~  334 (339)
T 1z57_A          311 KMLEYDPAKRITLREALK--------HPFFDL  334 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTT--------SGGGGG
T ss_pred             HHhCcCcccccCHHHHhc--------CHHHHH
Confidence            999999999999999997        899864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-40  Score=333.57  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=199.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+....   ....++|.+|+.++++++||||+++++++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE--------TGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAY   85 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT--------TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcC--------CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeee
Confidence            35689999999999999999987643        34455555543321   22467899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ..++..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        86 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           86 YHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             ECC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEE
Confidence            99999999999999999999987542  349999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      ||++.......  .......||+.|+|||++.     ...++.++||||||+++|+|++|..||......  .....   
T Consensus       161 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~---  233 (302)
T 2j7t_A          161 FGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK---  233 (302)
T ss_dssp             CHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH---
T ss_pred             CCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH---
Confidence            99874321110  0112346899999999983     567899999999999999999999998654311  11111   


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .... ......       .+...+..+.+++.+||+.||.+|||+.+|++        |+|+...
T Consensus       234 -~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------h~~~~~~  282 (302)
T 2j7t_A          234 -IAKS-DPPTLL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--------HPFVSSI  282 (302)
T ss_dssp             -HHHS-CCCCCS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--------STTTTTC
T ss_pred             -Hhcc-CCcccC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc--------ChHHhhh
Confidence             1111 111111       11123457889999999999999999999997        8887753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-39  Score=332.52  Aligned_cols=272  Identities=19%  Similarity=0.207  Sum_probs=202.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        .++.+++|.+..  ........++.+|+.++++++||||+++++++
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   78 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKP--------TGEIVAIKKIEP--FDKPLFALRTLREIKILKHFKHENIITIFNIQ   78 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECC--CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECC--------CCcEEEEEeecc--cccchHHHHHHHHHHHHHhCcCCCcCCeeeee
Confidence            45799999999999999999987643        345566665432  11223456788999999999999999999998


Q ss_pred             EeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ...     ...++||||+. |+|.+++...    .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~  150 (353)
T 2b9h_A           79 RPDSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCD  150 (353)
T ss_dssp             CCSCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCC
T ss_pred             cccccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCc
Confidence            764     67999999997 5999999752    49999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCc--------cccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036172          299 PQLSDFGLAIWGPTDSTHM--------IREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG  369 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~--------~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~  369 (522)
                      +||+|||++..........        ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.......
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999997654322111        1123468999999998765 678999999999999999999999997543211


Q ss_pred             hhhHHHhhhhhhcCCC----ccccc--------------CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          370 PESLVKWAKPILKNGD----TETLL--------------DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~----~~~~~--------------d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      .  +.. .........    .....              ............+..+.+++.+||+.||.+|||+.++++  
T Consensus       231 ~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--  305 (353)
T 2b9h_A          231 Q--LLL-IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--  305 (353)
T ss_dssp             H--HHH-HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--
T ss_pred             H--HHH-HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--
Confidence            1  111 000000000    00000              000000111123467889999999999999999999997  


Q ss_pred             hccccCCcccccc
Q 036172          432 RGATHATDWVDRH  444 (522)
Q Consensus       432 ~~~~~~~~~~~~~  444 (522)
                            |+|++..
T Consensus       306 ------hp~~~~~  312 (353)
T 2b9h_A          306 ------HPYLQTY  312 (353)
T ss_dssp             ------SGGGTTT
T ss_pred             ------Ccccccc
Confidence                  9998754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.8e-40  Score=327.16  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=195.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++...          .+.+++|.++.     ....+.|.+|+.++++++||||+++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR----------GNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET----------TEEEEEEECCC-----CC--HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc----------CCEEEEEEecc-----hhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4578999999999999999998643          23455554431     12457899999999999999999999997


Q ss_pred             EeC-CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          224 IED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       224 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      .+. +..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEe
Confidence            655 47899999999999999997542 2238999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |||++.......     ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .+....    
T Consensus       160 Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~----  227 (278)
T 1byg_A          160 DFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----  227 (278)
T ss_dssp             CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----
T ss_pred             eccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----
Confidence            999986544322     12357889999999999999999999999999999998 99999754322   111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..+..     +    ..+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       228 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          228 EKGYK-----M----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             TTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCC-----C----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            11110     1    111223457889999999999999999999999998875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-40  Score=335.75  Aligned_cols=270  Identities=20%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc--------------hHHHHHHHHHHHHh
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS--------------SAWNDFSSEVDITS  209 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~--------------~~~~~f~~Ev~iL~  209 (522)
                      ..++|++.+.||+|+||.||++..          ..+.+++|.+........              ...+.|.+|+.+++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            357999999999999999999875          245566665544332211              12378999999999


Q ss_pred             hCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHH------hhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 036172          210 SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEES------LHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIH  283 (522)
Q Consensus       210 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiH  283 (522)
                      +++||||+++++++.+.+..++||||+++|+|.++      +... ....+++..++.++.|++.||.|||+.  .+|+|
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H  175 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICH  175 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhcc--CCEee
Confidence            99999999999999999999999999999999998      5432 134699999999999999999999973  78999


Q ss_pred             ccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCc-hhhHHHHHHHHHHHHcCCCC
Q 036172          284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSD-KIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       284 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~-ksDVwSlGvvl~eLltG~~P  361 (522)
                      |||||+||+++.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|+|++|+.|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999765433    22345789999999999877 5666 99999999999999999999


Q ss_pred             CCCCCCCChhhHHHhhhhhhcCCCcccc------cC---CcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          362 IGFKNLKGPESLVKWAKPILKNGDTETL------LD---PKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       362 f~~~~~~~~~~l~~~~~~~~~~~~~~~~------~d---~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      |......  ..+.....    .+.....      ..   +..........+..+.+++.+||+.||.+||++.++++   
T Consensus       252 f~~~~~~--~~~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~---  322 (348)
T 2pml_X          252 FSLKISL--VELFNNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK---  322 (348)
T ss_dssp             SCCSSCS--HHHHHHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT---
T ss_pred             CCCCCcH--HHHHHHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc---
Confidence            9754331  11221111    1111000      00   00000111234567889999999999999999999997   


Q ss_pred             ccccCCcccccc
Q 036172          433 GATHATDWVDRH  444 (522)
Q Consensus       433 ~~~~~~~~~~~~  444 (522)
                           |+|+...
T Consensus       323 -----hp~f~~~  329 (348)
T 2pml_X          323 -----HEWLADT  329 (348)
T ss_dssp             -----SGGGTTC
T ss_pred             -----CccccCC
Confidence                 8888753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-39  Score=347.49  Aligned_cols=265  Identities=21%  Similarity=0.234  Sum_probs=206.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC-CCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H-pnIv~l~~~  222 (522)
                      ..++|++.++||+|+||.||++.+..        ..+.|++|.+....     ..+++.+|+++++.|+| ++|+.+..+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~   71 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWF   71 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETT--------TCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECC--------CCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            46789999999999999999987542        34566666432211     22458899999999976 566677777


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---cCCCce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---SSDFQP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---~~~~~~  299 (522)
                      +.+....+|||||+ +++|.+++....  ..+++..++.|+.||+.||.|||+   .+|+||||||+||||   +.++.+
T Consensus        72 ~~~~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~v  145 (483)
T 3sv0_A           72 GVEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQV  145 (483)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCE
T ss_pred             EeeCCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeE
Confidence            78889999999999 889999998543  349999999999999999999999   999999999999999   588899


Q ss_pred             EEeecCccccCCCCCCCc-----cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          300 QLSDFGLAIWGPTDSTHM-----IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      ||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (483)
T 3sv0_A          146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY  225 (483)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred             EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence            999999997665433221     122567999999999999999999999999999999999999999865544433333


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .............         ......+..+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus       226 ~~i~~~~~~~~~~---------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          226 EKISEKKVATSIE---------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHHHHHHSCHH---------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHhhccccccHH---------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            2221111100000         1111234678999999999999999999999999988743

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-40  Score=341.12  Aligned_cols=272  Identities=18%  Similarity=0.232  Sum_probs=189.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        .++.+++|.+...    .....++.+|+..++.++||||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKS--------TGMSVAIKKVIQD----PRFRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHTTEEEC----------CEEEEETT--------TCCEEEEEEEECC----TTCCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEEecC----ccccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            45789999999999999999987643        3456666654221    11234577888999999999999999999


Q ss_pred             EeCC-------EEEEEEecCCCCCHHHHhhc-cCCCCCCChHHHHHHHHHHHHHHHHHH--hcCCCCEEeccCCCCceec
Q 036172          224 IEDN-------YLILVSDFLPKGSLEESLHG-AGEQSVLPWGVRFEVAVAIAEALNYLH--SECSRPVIHRDVKSSNILL  293 (522)
Q Consensus       224 ~~~~-------~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~~~giiHrDIkp~NILl  293 (522)
                      ...+       .+++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +   .+|+||||||+|||+
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll  164 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLV  164 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEE
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEE
Confidence            7643       38999999976 66555443 234456899999999999999999999  7   999999999999999


Q ss_pred             cC-CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          294 SS-DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       294 ~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      +. ++.+||+|||++.........   ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......  
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--  239 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--  239 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             eCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--
Confidence            97 899999999999766543322   2346899999999986654 8999999999999999999999997543211  


Q ss_pred             hHHHhhhhh----------hcC-CCcccccCC------cccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          372 SLVKWAKPI----------LKN-GDTETLLDP------KLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       372 ~l~~~~~~~----------~~~-~~~~~~~d~------~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .+.......          +.. .......+.      ..........+..+.+++.+||+.||.+|||+.|+++     
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-----  314 (360)
T 3e3p_A          240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC-----  314 (360)
T ss_dssp             HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT-----
T ss_pred             HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc-----
Confidence            111111100          000 000000000      0001111124567999999999999999999999997     


Q ss_pred             ccCCcccccc
Q 036172          435 THATDWVDRH  444 (522)
Q Consensus       435 ~~~~~~~~~~  444 (522)
                         |+|++..
T Consensus       315 ---hp~f~~~  321 (360)
T 3e3p_A          315 ---HPYFDEL  321 (360)
T ss_dssp             ---SGGGGGG
T ss_pred             ---Ccccccc
Confidence               9998864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=332.66  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=197.9

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+...    ....+.+.+|+.+++++ +||||+++++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK--------TGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECC----SSTTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC--------CCCeEEEEEEecC----cccHHHHHHHHHHHHhccCCCCeeeeee
Confidence            346799999999999999999987643        3455666654321    12346789999999999 8999999999


Q ss_pred             EEEe------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          222 VCIE------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       222 ~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      ++..      .+.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECT
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcC
Confidence            9987      568999999999999999998642 2358999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      ++.+||+|||++........  ......|++.|+|||.+.     +..++.++|||||||++|+|++|+.||......  
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--  240 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--  240 (326)
T ss_dssp             TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred             CCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--
Confidence            99999999999876543221  122447899999999986     567899999999999999999999998643211  


Q ss_pred             hhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      ..+..    ... ........        ...+..+.+++.+||..||.+||++.+|++        ++|++...
T Consensus       241 ~~~~~----~~~-~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------hp~~~~~~  294 (326)
T 2x7f_A          241 RALFL----IPR-NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK--------HPFIRDQP  294 (326)
T ss_dssp             HHHHH----HHH-SCCCCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--------SHHHHCCT
T ss_pred             HHHHH----hhc-CccccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh--------ChHHhhCc
Confidence            11111    111 11111111        112357888999999999999999999997        78876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.5e-39  Score=330.29  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhh--CCCCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSS--LEQKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~--L~HpnIv~l~~~  222 (522)
                      .++|++.+.||+|+||.||++...          .+.+++|.+..      ...+.+.+|++++..  ++||||++++++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR----------GEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET----------TEEEEEEEECG------GGHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc----------CccEEEEEeCc------hhHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            468999999999999999998652          34566665432      134678889999988  799999999999


Q ss_pred             EEeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHH--------hcCCCCEEeccCCCCc
Q 036172          223 CIEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH--------SECSRPVIHRDVKSSN  290 (522)
Q Consensus       223 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--------~~~~~giiHrDIkp~N  290 (522)
                      +....    ..++||||+++|+|.+++...    .+++..++.++.|++.||.|||        +   .+|+||||||+|
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~N  177 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKN  177 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGG
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHH
Confidence            99875    899999999999999999753    3899999999999999999999        7   899999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCc--cccccccCCCCCChhhhccCC------CCchhhHHHHHHHHHHHHcC----
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHM--IREDVVGTFGYIAPEYLMHGK------VSDKIDVYSFGVVLLELLSG----  358 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwSlGvvl~eLltG----  358 (522)
                      ||++.++.+||+|||++..........  ......||+.|+|||.+.+..      ++.++||||||+++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999997654433211  123457999999999997652      34789999999999999999    


Q ss_pred             ------CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCccccc-ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          359 ------RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNE-YDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       359 ------~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                            ..||......... ...+... +....    ..+.+... .....+..+.+++.+||+.||.+|||+.+|++.|
T Consensus       258 ~~~~~~~~p~~~~~~~~~~-~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS-VEEMRKV-VCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-HHHHHHH-HTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             CcccccccCccccCcCccc-HHHHHHH-HHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence                  7787544322211 1111111 11111    11222211 1235677899999999999999999999999999


Q ss_pred             hcccc
Q 036172          432 RGATH  436 (522)
Q Consensus       432 ~~~~~  436 (522)
                      +.+..
T Consensus       332 ~~i~~  336 (342)
T 1b6c_B          332 SQLSQ  336 (342)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.3e-40  Score=348.50  Aligned_cols=268  Identities=21%  Similarity=0.246  Sum_probs=197.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||++....        ..+.|++|.+....       ..+.+|+++|++|+|||||++++++.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~  117 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCD--------SGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFY  117 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECC--------CCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEe
Confidence            4579999999999999999987643        35566666543211       22347999999999999999999986


Q ss_pred             eC------CEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC-
Q 036172          225 ED------NYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-  296 (522)
Q Consensus       225 ~~------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~-  296 (522)
                      ..      ..+++||||+++ +|.+++... .....+++..++.++.||+.||.|||+   .+|+||||||+||||+.+ 
T Consensus       118 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~  193 (420)
T 1j1b_A          118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDT  193 (420)
T ss_dssp             EEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTT
T ss_pred             ccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCC
Confidence            42      247899999976 777766532 223459999999999999999999999   999999999999999965 


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      +.+||+|||+++........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  ...+..
T Consensus       194 ~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~  268 (420)
T 1j1b_A          194 AVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVE  268 (420)
T ss_dssp             TEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred             CeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            57899999999865443222   235789999999998765 689999999999999999999999975431  222222


Q ss_pred             hhhhh-------h--cCCCcccccCCccc-----ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          376 WAKPI-------L--KNGDTETLLDPKLS-----NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       376 ~~~~~-------~--~~~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      .....       +  ..........+.+.     ..+....+..+.+|+.+||+.||.+||++.|+++        |+|+
T Consensus       269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~--------hp~f  340 (420)
T 1j1b_A          269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--------HSFF  340 (420)
T ss_dssp             HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGG
T ss_pred             HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC--------CHhh
Confidence            21110       0  00011111111111     1112223467899999999999999999999997        8888


Q ss_pred             ccc
Q 036172          442 DRH  444 (522)
Q Consensus       442 ~~~  444 (522)
                      +..
T Consensus       341 ~~~  343 (420)
T 1j1b_A          341 DEL  343 (420)
T ss_dssp             GGG
T ss_pred             ccc
Confidence            653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=341.56  Aligned_cols=276  Identities=18%  Similarity=0.261  Sum_probs=187.8

Q ss_pred             CCcee-eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPFQM-DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~-~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      +.|++ +++||+|+||.||++....      ....+.|++|.+....     ....+.+|+.+|++|+|||||++++++.
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~------~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKD------GKDDKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFL   88 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESS------SSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEcc------CCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            45776 5689999999999997542      2345667777664211     2246889999999999999999999997


Q ss_pred             e--CCEEEEEEecCCCCCHHHHhhccC------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec---
Q 036172          225 E--DNYLILVSDFLPKGSLEESLHGAG------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL---  293 (522)
Q Consensus       225 ~--~~~~~lV~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl---  293 (522)
                      .  +..+++||||+.+ +|.+++....      ....+++..++.++.||+.||.|||+   .+|+||||||+||||   
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~  164 (405)
T 3rgf_A           89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGE  164 (405)
T ss_dssp             ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCS
T ss_pred             cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecC
Confidence            5  6789999999965 8888886321      12249999999999999999999999   999999999999999   


Q ss_pred             -cCCCceEEeecCccccCCCCCCC-ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-
Q 036172          294 -SSDFQPQLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKG-  369 (522)
Q Consensus       294 -~~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-  369 (522)
                       +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... 
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  244 (405)
T 3rgf_A          165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  244 (405)
T ss_dssp             STTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             CCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence             67789999999999766443211 222346789999999999774 58999999999999999999999996543211 


Q ss_pred             ------hhhHHHhhhhhhcCCC---ccccc------------CCccccccc---------HHHHHHHHHHHHHhhhcCCC
Q 036172          370 ------PESLVKWAKPILKNGD---TETLL------------DPKLSNEYD---------NAQMQRMLLAANLCINQSPQ  419 (522)
Q Consensus       370 ------~~~l~~~~~~~~~~~~---~~~~~------------d~~l~~~~~---------~~~~~~l~~li~~CL~~dP~  419 (522)
                            ...+..... .+....   ...+.            .........         ......+.+|+.+||+.||.
T Consensus       245 ~~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~  323 (405)
T 3rgf_A          245 TSNPYHHDQLDRIFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI  323 (405)
T ss_dssp             --CCCCHHHHHHHHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred             ccccchHHHHHHHHH-hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence                  111111111 000000   00000            000000000         00134678899999999999


Q ss_pred             CCCCHHHHHHHHhccccCCccccccc
Q 036172          420 LRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       420 ~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      +|||+.|+++        |+|+....
T Consensus       324 ~R~ta~e~L~--------hp~f~~~~  341 (405)
T 3rgf_A          324 KRITSEQAMQ--------DPYFLEDP  341 (405)
T ss_dssp             GSCCHHHHHT--------SGGGTSSS
T ss_pred             cCCCHHHHhc--------ChhhccCC
Confidence            9999999997        99987643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=331.77  Aligned_cols=272  Identities=16%  Similarity=0.196  Sum_probs=194.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.+..   ......+++.+|+.++++++||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   77 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDND--------CDKRVAIKKIVL---TDPQSVKHALREIKIIRRLDHDNIVKVFEIL   77 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETT--------TTEEEEEEEEEC---CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECC--------CCeEEEEEEEec---CChHHHHHHHHHHHHHHhcCCCCeeEEEEec
Confidence            35789999999999999999987643        345566554421   1223567899999999999999999999987


Q ss_pred             E--------------eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          224 I--------------EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       224 ~--------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      .              +....++||||++ |+|.+++..    ..+++..++.++.|++.||.|||+   .+|+||||||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~  149 (320)
T 2i6l_A           78 GPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPA  149 (320)
T ss_dssp             CTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGG
T ss_pred             cccccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHH
Confidence            3              4478999999997 599999963    248999999999999999999999   99999999999


Q ss_pred             ceecc-CCCceEEeecCccccCCCCCC-CccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          290 NILLS-SDFQPQLSDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       290 NILl~-~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      |||++ .++.+||+|||++........ ........+|..|+|||.+.. ..++.++||||||+++|+|++|+.||....
T Consensus       150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            99997 567999999999976543211 111223467999999999865 678999999999999999999999997543


Q ss_pred             CCChhhHHHhhhhh--hcC-------CCccc-----ccCCc-ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 036172          367 LKGPESLVKWAKPI--LKN-------GDTET-----LLDPK-LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL  431 (522)
Q Consensus       367 ~~~~~~l~~~~~~~--~~~-------~~~~~-----~~d~~-l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L  431 (522)
                      ...  .+.......  ...       .....     ...+. .........+..+.+++.+||+.||.+|||+.++++  
T Consensus       230 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--  305 (320)
T 2i6l_A          230 ELE--QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--  305 (320)
T ss_dssp             HHH--HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--
T ss_pred             HHH--HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--
Confidence            211  111110000  000       00000     00000 000111223567899999999999999999999997  


Q ss_pred             hccccCCcccccc
Q 036172          432 RGATHATDWVDRH  444 (522)
Q Consensus       432 ~~~~~~~~~~~~~  444 (522)
                            |+|+...
T Consensus       306 ------hp~~~~~  312 (320)
T 2i6l_A          306 ------HPYMSIY  312 (320)
T ss_dssp             ------SHHHHTT
T ss_pred             ------Ccccccc
Confidence                  8888753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.7e-40  Score=364.70  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||+|+||.||++....      ....+.+|+|.++... ......++|.+|+.+|++|+|||||++++++.. +..++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~------~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQM------KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEEC------SSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcC------CCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            479999999999974321      2234567777665432 222346789999999999999999999999965 45889


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       447 v~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             EEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            99999999999999753   359999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccc
Q 036172          312 TDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETL  389 (522)
Q Consensus       312 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (522)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   .+...    +..+...  
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~~~~--  591 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKGERM--  591 (635)
T ss_dssp             C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCCC--
T ss_pred             cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--
Confidence            43322 12223456889999999999999999999999999999998 99999654321   11111    1111111  


Q ss_pred             cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          390 LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       390 ~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                             ..+...+..+.+++..||+.||.+||++.+|++.|+..
T Consensus       592 -------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   11122446788999999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-40  Score=342.04  Aligned_cols=268  Identities=19%  Similarity=0.220  Sum_probs=185.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        .++.+++|.+.... ......+++.+|+.+|++++||||+++++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTK--------TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETT--------TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECC--------CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35799999999999999999987543        34556666553211 1122457889999999999999999999999


Q ss_pred             EeC------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IED------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...      ...++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~  169 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC  169 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTC
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCC
Confidence            754      5689999999 6799999864    249999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .+...
T Consensus       170 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i  242 (367)
T 2fst_X          170 ELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLI  242 (367)
T ss_dssp             CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH
T ss_pred             CEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence            9999999999764432     124578999999999876 678999999999999999999999997543211  11111


Q ss_pred             hhhhhcCCCc---cc-----------cc---CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          377 AKPILKNGDT---ET-----------LL---DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       377 ~~~~~~~~~~---~~-----------~~---d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      . ..+.....   ..           .+   .+.............+.+|+.+||+.||.+|||+.++++        |+
T Consensus       243 ~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~--------hp  313 (367)
T 2fst_X          243 L-RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--------HA  313 (367)
T ss_dssp             H-HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SG
T ss_pred             H-HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc--------Ch
Confidence            1 10000000   00           00   000000001112456889999999999999999999997        99


Q ss_pred             ccccc
Q 036172          440 WVDRH  444 (522)
Q Consensus       440 ~~~~~  444 (522)
                      |+...
T Consensus       314 ~~~~~  318 (367)
T 2fst_X          314 YFAQY  318 (367)
T ss_dssp             GGTTT
T ss_pred             hhhhc
Confidence            98754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-39  Score=324.29  Aligned_cols=260  Identities=22%  Similarity=0.375  Sum_probs=194.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        ..+.+++|.+..    .....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNAL--------DSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWL   72 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccchhhheeccCCcEEEEEEEEcC--------CCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHH
Confidence            3579999999999999999987543        345666665521    2235678999999999999999999999987


Q ss_pred             e-------------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          225 E-------------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       225 ~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      +             .+..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Ni  147 (303)
T 1zy4_A           73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNI  147 (303)
T ss_dssp             ECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             hhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhE
Confidence            5             357899999999999999998642  347889999999999999999999   9999999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCC------------CccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcC
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDST------------HMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG  358 (522)
                      |++.++.+||+|||++........            ........||+.|+|||.+.+. .++.++||||||+++|+|++ 
T Consensus       148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence            999999999999999976543211            1112245689999999999754 68999999999999999998 


Q ss_pred             CCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                        ||...     ......... +....      ......+....+..+.+++.+||+.||.+|||+.++++        +
T Consensus       227 --p~~~~-----~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--------h  284 (303)
T 1zy4_A          227 --PFSTG-----MERVNILKK-LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN--------S  284 (303)
T ss_dssp             --CCSSH-----HHHHHHHHH-HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH--------S
T ss_pred             --ccCCc-----hhHHHHHHh-ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC--------C
Confidence              44311     111111111 11111      11112223334556888999999999999999999998        8


Q ss_pred             cccccc
Q 036172          439 DWVDRH  444 (522)
Q Consensus       439 ~~~~~~  444 (522)
                      +|+...
T Consensus       285 ~~~~~~  290 (303)
T 1zy4_A          285 GWLPVK  290 (303)
T ss_dssp             SCSCCC
T ss_pred             CCcCCC
Confidence            998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5e-40  Score=338.85  Aligned_cols=271  Identities=18%  Similarity=0.228  Sum_probs=194.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh--------ccchHHHHHHHHHHHHhhCCCCCc
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS--------QFSSAWNDFSSEVDITSSLEQKSI  216 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~--------~~~~~~~~f~~Ev~iL~~L~HpnI  216 (522)
                      .++|++.+.||+|+||.||++.+..         ++.+++|.+.....        ......+.|.+|+.++++++||||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE---------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT---------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC---------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            4789999999999999999986532         34455554422111        111235789999999999999999


Q ss_pred             ceeeEEEEeC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          217 TTLNGVCIED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       217 v~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      +++++++...     ..+++||||++ |+|.+++...  ...+++..++.++.||+.||.|||+   .+|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence            9999999643     47899999997 5899888753  3359999999999999999999999   9999999999999


Q ss_pred             eccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCh
Q 036172          292 LLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP  370 (522)
Q Consensus       292 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~  370 (522)
                      |++.++.+||+|||++........   .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... 
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-  241 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-  241 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999999999999999975433322   224578999999999876 678999999999999999999999997543211 


Q ss_pred             hhHHHhhhhhhcCCC------------------cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          371 ESLVKWAKPILKNGD------------------TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       371 ~~l~~~~~~~~~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                        .............                  ....................+.+++.+||+.||.+|||+.++++   
T Consensus       242 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---  316 (362)
T 3pg1_A          242 --QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR---  316 (362)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT---
T ss_pred             --HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc---
Confidence              1111100000000                  00000001111111223456889999999999999999999997   


Q ss_pred             ccccCCcccccc
Q 036172          433 GATHATDWVDRH  444 (522)
Q Consensus       433 ~~~~~~~~~~~~  444 (522)
                           |+|++..
T Consensus       317 -----hp~f~~~  323 (362)
T 3pg1_A          317 -----HPYFESL  323 (362)
T ss_dssp             -----SGGGTTT
T ss_pred             -----Cchhhhc
Confidence                 9998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-39  Score=325.80  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=203.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        ..+.+++|.+...... ....+.|.+|+.++++++||||+++++++.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~--------~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRI--------TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcC--------CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            4689999999999999999987642        4556666665433222 224678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC---CceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD---FQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~---~~~kL  301 (522)
                      +.+..++||||+++++|.+++....   .+++..++.++.|++.||.|||+   .+++||||||+||+++.+   +.+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL  165 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI  165 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEE
Confidence            9999999999999999999987543   48999999999999999999999   999999999999999764   46999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||++.........   ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ..+....    
T Consensus       166 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----  234 (287)
T 2wei_A          166 IDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRV----  234 (287)
T ss_dssp             CSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----
T ss_pred             eccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHH----
Confidence            999999765443322   23468999999999864 589999999999999999999999965421   1111111    


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..+......      ......+..+.+++.+||+.||.+|||+.++++        ++|++..
T Consensus       235 ~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--------hp~~~~~  283 (287)
T 2wei_A          235 ETGKYAFDL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--------HPWIQKY  283 (287)
T ss_dssp             HHCCCCCCS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--------SHHHHHH
T ss_pred             HcCCCCCCc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--------CHHHhcc
Confidence            111111000      001123457889999999999999999999998        7887653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-40  Score=358.49  Aligned_cols=258  Identities=22%  Similarity=0.346  Sum_probs=203.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++....         ...+++|.++...    ...++|.+|+.+|++|+|||||++++++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG---------TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---------TEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC---------CceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            35679999999999999999987542         2346666554322    1246799999999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+ +.++|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~D  406 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD  406 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcc
Confidence            76 67899999999999999997532 2348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++...... ........++..|+|||.+..+.++.++|||||||++|||++ |+.||.....   ..+....    .
T Consensus       407 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i----~  478 (535)
T 2h8h_A          407 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----E  478 (535)
T ss_dssp             TTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHH----H
T ss_pred             cccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----H
Confidence            99997654321 111123356788999999999999999999999999999999 9999864321   1122111    1


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       479 ~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          479 RGYRM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            11110         1112234578899999999999999999999999988753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-38  Score=329.05  Aligned_cols=270  Identities=15%  Similarity=0.233  Sum_probs=202.6

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-----------
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-----------  212 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-----------  212 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+..    .....+.+.+|+.++++++           
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~   84 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMV--------NNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMG   84 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecC--------CCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccc
Confidence            35789999999999999999987543        345666665432    1123467889999999986           


Q ss_pred             CCCcceeeEEEEeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCC
Q 036172          213 QKSITTLNGVCIEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVK  287 (522)
Q Consensus       213 HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIk  287 (522)
                      ||||+++++++...+    .+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+   + +|+|||||
T Consensus        85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dik  159 (373)
T 1q8y_A           85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIK  159 (373)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCS
T ss_pred             cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCC
Confidence            899999999998654    799999999 8899999986532 349999999999999999999999   8 99999999


Q ss_pred             CCceecc------CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Q 036172          288 SSNILLS------SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP  361 (522)
Q Consensus       288 p~NILl~------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~P  361 (522)
                      |+|||++      ..+.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             hHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            9999994      44589999999997654332     234689999999999999999999999999999999999999


Q ss_pred             CCCCCCCCh----hhHHHhhhhhhc------------------CC-CcccccCCc---------ccccccHHHHHHHHHH
Q 036172          362 IGFKNLKGP----ESLVKWAKPILK------------------NG-DTETLLDPK---------LSNEYDNAQMQRMLLA  409 (522)
Q Consensus       362 f~~~~~~~~----~~l~~~~~~~~~------------------~~-~~~~~~d~~---------l~~~~~~~~~~~l~~l  409 (522)
                      |........    ..+.... ..+.                  .. ....+....         ....++...+..+.++
T Consensus       235 f~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
T 1q8y_A          235 FEPDEGHSYTKDDDHIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  313 (373)
T ss_dssp             C---------CHHHHHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCcccccCChHHHHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence            975442211    1111111 0000                  00 000000000         0112345677889999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          410 ANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       410 i~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +.+||+.||.+|||+.+|++        |+|++..
T Consensus       314 i~~~L~~dP~~Rpt~~ell~--------hp~f~~~  340 (373)
T 1q8y_A          314 LSPMLQLDPRKRADAGGLVN--------HPWLKDT  340 (373)
T ss_dssp             HGGGGCSSTTTCBCHHHHHT--------CGGGTTC
T ss_pred             HHHHhccCccccCCHHHHhh--------Chhhhcc
Confidence            99999999999999999997        9998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-38  Score=331.21  Aligned_cols=271  Identities=18%  Similarity=0.203  Sum_probs=202.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCC-----cc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKS-----IT  217 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-Hpn-----Iv  217 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+|+|.++.    .....+++.+|+.+++.++ |+|     |+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRV--------EQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT--------TTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcC--------CCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            35799999999999999999987543        345666666542    1123567888999999884 553     99


Q ss_pred             eeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc--C
Q 036172          218 TLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS--S  295 (522)
Q Consensus       218 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~--~  295 (522)
                      ++++++...+..++||||++ |+|.+++..... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTT
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCC
Confidence            99999999999999999996 599999986532 3499999999999999999999941 17899999999999995  4


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||........  +..
T Consensus       197 ~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~  269 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ--MNK  269 (382)
T ss_dssp             SCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH
T ss_pred             CCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence            7789999999997764332     234789999999999999999999999999999999999999975432111  111


Q ss_pred             hhhhh-----------------hc---CCCc--------ccccC-Ccc--------------------cccccHHHHHHH
Q 036172          376 WAKPI-----------------LK---NGDT--------ETLLD-PKL--------------------SNEYDNAQMQRM  406 (522)
Q Consensus       376 ~~~~~-----------------~~---~~~~--------~~~~d-~~l--------------------~~~~~~~~~~~l  406 (522)
                      .....                 +.   .+..        ..... +..                    ...........+
T Consensus       270 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (382)
T 2vx3_A          270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF  349 (382)
T ss_dssp             HHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred             HHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence            10000                 00   0000        00000 000                    001112334578


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          407 LLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       407 ~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+|+.+||+.||.+|||+.|+++        |+|++..
T Consensus       350 ~dli~~mL~~dP~~Rpta~e~L~--------hp~f~~~  379 (382)
T 2vx3_A          350 KDLILRMLDYDPKTRIQPYYALQ--------HSFFKKT  379 (382)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTT--------SGGGCC-
T ss_pred             HHHHHHhcCCChhhCCCHHHHhc--------CcccccC
Confidence            99999999999999999999997        9998754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.1e-39  Score=332.05  Aligned_cols=266  Identities=18%  Similarity=0.219  Sum_probs=197.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        .++.+++|.+.... ......+++.+|+.++++++||||+++++++.
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR--------SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC--------CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            4789999999999999999987543        34556666553211 11224578999999999999999999999998


Q ss_pred             eCCEE------EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 EDNYL------ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..+..      ++||||+. ++|.+++..     .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~  182 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE  182 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCC
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCC
Confidence            77654      99999997 599888742     39999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||+++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  ..+....
T Consensus       183 ~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~  255 (371)
T 4exu_A          183 LKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQIL  255 (371)
T ss_dssp             EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred             EEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence            9999999997554322     23468999999999977 67899999999999999999999999754311  1111111


Q ss_pred             hhhhcCCC--ccc------------ccCCccc---ccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcc
Q 036172          378 KPILKNGD--TET------------LLDPKLS---NEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDW  440 (522)
Q Consensus       378 ~~~~~~~~--~~~------------~~d~~l~---~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~  440 (522)
                      . ......  ...            .+.....   .......+..+.+++.+||+.||.+|||+.++++        |+|
T Consensus       256 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~  326 (371)
T 4exu_A          256 K-VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--------HPF  326 (371)
T ss_dssp             H-HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--------SGG
T ss_pred             H-HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc--------Ccc
Confidence            0 000000  000            0000000   0111123567899999999999999999999997        999


Q ss_pred             cccc
Q 036172          441 VDRH  444 (522)
Q Consensus       441 ~~~~  444 (522)
                      ++..
T Consensus       327 f~~~  330 (371)
T 4exu_A          327 FEPF  330 (371)
T ss_dssp             GTTT
T ss_pred             cccC
Confidence            8754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-40  Score=330.62  Aligned_cols=260  Identities=20%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC--CCCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE--QKSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~--HpnIv~l~~~  222 (522)
                      .++|++.+.||+|+||.||++....         .+.+++|.+.... ......+.|.+|+.++++++  ||||++++++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEK---------KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT---------CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCC---------CcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            4679999999999999999986531         3445555442211 11235678999999999996  5999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+++..++||| +.+++|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 4578999999854   358999999999999999999999   99999999999999965 899999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-----------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      |||++................|++.|+|||.+.+           ..++.++||||||+++|+|++|+.||...... ..
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~  247 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-IS  247 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HH
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HH
Confidence            9999976654433333345579999999999865           46889999999999999999999999643211 11


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .+    ........         ...++...+..+.+++.+||+.||.+||++.+|++        ++|+...
T Consensus       248 ~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--------h~~~~~~  299 (313)
T 3cek_A          248 KL----HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--------HPYVQIQ  299 (313)
T ss_dssp             HH----HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHCC
T ss_pred             HH----HHHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--------CccccCC
Confidence            11    11111111         11111112356888999999999999999999997        8887754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-39  Score=328.73  Aligned_cols=274  Identities=21%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceee
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLN  220 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~  220 (522)
                      ..++|++.+.||+|+||.||++....       ...+.+++|.++..... ......+.+|+.+++.+   +||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLK-------NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT-------TTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecC-------CCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            35789999999999999999987531       12344555544321111 11123466777777766   899999999


Q ss_pred             EEEE-----eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC
Q 036172          221 GVCI-----EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS  295 (522)
Q Consensus       221 ~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~  295 (522)
                      +++.     .....++||||++ |+|.+++..... ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~  155 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTS  155 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcC
Confidence            9998     4578999999997 599999986532 348999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          296 DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       296 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      ++.+||+|||++.......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......  ..+..
T Consensus       156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~  230 (326)
T 1blx_A          156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGK  230 (326)
T ss_dssp             TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred             CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH
Confidence            9999999999997654321   223457899999999999999999999999999999999999999754321  11111


Q ss_pred             hhhhhhcCC---Ccc-------ccc---CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          376 WAKPILKNG---DTE-------TLL---DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       376 ~~~~~~~~~---~~~-------~~~---d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      ... .....   ...       ..+   ............+..+.+++.+||+.||.+||++.++++        |+|++
T Consensus       231 i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--------hp~~~  301 (326)
T 1blx_A          231 ILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--------HPYFQ  301 (326)
T ss_dssp             HHH-HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGT
T ss_pred             HHH-HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--------Ccccc
Confidence            111 00000   000       000   000011122234567889999999999999999999997        88986


Q ss_pred             cc
Q 036172          443 RH  444 (522)
Q Consensus       443 ~~  444 (522)
                      ..
T Consensus       302 ~~  303 (326)
T 1blx_A          302 DL  303 (326)
T ss_dssp             TC
T ss_pred             cc
Confidence            43

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.2e-38  Score=324.04  Aligned_cols=272  Identities=16%  Similarity=0.215  Sum_probs=202.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCC------cc
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS------IT  217 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hpn------Iv  217 (522)
                      ..++|++.+.||+|+||.||++.....       ..+.+++|.++.    .....+.+.+|+.++++++|++      ++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-------GKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-------TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-------CceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            357999999999999999999875431       123556655432    1224567889999999997766      99


Q ss_pred             eeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceec----
Q 036172          218 TLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL----  293 (522)
Q Consensus       218 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl----  293 (522)
                      .+++++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+   .+|+||||||+|||+    
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSE  160 (355)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCC
T ss_pred             EeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccc
Confidence            9999999999999999999 667877776543 2359999999999999999999999   999999999999999    


Q ss_pred             ---------------cCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 036172          294 ---------------SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG  358 (522)
Q Consensus       294 ---------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG  358 (522)
                                     +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                           567899999999997644332     234789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHhhh-h----hhcCCCcccc-------cCC---------------cccccccHHHHHHHHHHHH
Q 036172          359 RRPIGFKNLKGPESLVKWAK-P----ILKNGDTETL-------LDP---------------KLSNEYDNAQMQRMLLAAN  411 (522)
Q Consensus       359 ~~Pf~~~~~~~~~~l~~~~~-~----~~~~~~~~~~-------~d~---------------~l~~~~~~~~~~~l~~li~  411 (522)
                      +.||................ +    .+........       .+.               .............+.+++.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            99997543211111110000 0    0000000000       000               0000111234567899999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          412 LCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       412 ~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +||+.||.+|||+.++++        |+|+...
T Consensus       316 ~~L~~dP~~Rpt~~e~l~--------hp~f~~~  340 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALL--------HPFFAGL  340 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTT--------SGGGGGC
T ss_pred             HHhcCChhhCcCHHHHhc--------ChhhcCC
Confidence            999999999999999997        9998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.4e-40  Score=333.24  Aligned_cols=254  Identities=16%  Similarity=0.237  Sum_probs=201.2

Q ss_pred             CCCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc---hHHHHHHHHHHHHhhCC--CCCc
Q 036172          142 PKTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS---SAWNDFSSEVDITSSLE--QKSI  216 (522)
Q Consensus       142 ~~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~---~~~~~f~~Ev~iL~~L~--HpnI  216 (522)
                      ....++|++.+.||+|+||.||++....        ..+.+++|.++.......   ...+.+.+|+.++++++  ||||
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS--------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT--------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC--------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            3356789999999999999999986542        345666666543322110   12245778999999996  5999


Q ss_pred             ceeeEEEEeCCEEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc-
Q 036172          217 TTLNGVCIEDNYLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS-  294 (522)
Q Consensus       217 v~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~-  294 (522)
                      +++++++..++..++|||++.+ ++|.+++...   ..+++..++.++.|++.||.|||+   .+|+||||||+|||++ 
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDL  184 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEET
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeC
Confidence            9999999999999999999976 8999999854   348999999999999999999999   9999999999999999 


Q ss_pred             CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....     ..
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~  255 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI  255 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh
Confidence            78899999999997655432    123468999999999987776 688999999999999999999985321     11


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      .       .. ..  ..    ..    ..+..+.+++.+||+.||.+||++.+|++        ++|+...
T Consensus       256 ~-------~~-~~--~~----~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~--------hp~~~~~  300 (320)
T 3a99_A          256 I-------RG-QV--FF----RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN--------HPWMQDV  300 (320)
T ss_dssp             H-------HC-CC--CC----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SGGGSSC
T ss_pred             h-------cc-cc--cc----cc----cCCHHHHHHHHHHccCChhhCcCHHHHhc--------CHhhcCc
Confidence            1       00 00  00    11    12356888999999999999999999997        8887754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-39  Score=331.39  Aligned_cols=262  Identities=20%  Similarity=0.246  Sum_probs=176.1

Q ss_pred             CCCCCceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          143 KTENPFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      ...++|++.+ .||+|+||.||++.+..        +.+.+++|.+...       ..........++.++||||+++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~--------~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRR--------TGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECC--------CCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHH
Confidence            3467999965 59999999999987653        4566777765321       111222233456779999999999


Q ss_pred             EEEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--
Q 036172          222 VCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--  295 (522)
Q Consensus       222 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--  295 (522)
                      ++..    ...+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.  
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~  165 (336)
T 3fhr_A           90 VYENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKE  165 (336)
T ss_dssp             EEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSS
T ss_pred             HHhhccCCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecC
Confidence            9986    456899999999999999998653 2359999999999999999999999   99999999999999976  


Q ss_pred             -CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          296 -DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       296 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                       ++.+||+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus       166 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  241 (336)
T 3fhr_A          166 KDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM  241 (336)
T ss_dssp             TTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             CCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH
Confidence             45599999999976543221    2346899999999998888999999999999999999999999654322211000


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                         ......+..      ..........+..+.+++.+||+.||.+|||+.++++        ++|+...
T Consensus       242 ---~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--------hp~~~~~  294 (336)
T 3fhr_A          242 ---KRRIRLGQY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--------HPWINQS  294 (336)
T ss_dssp             ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--------SHHHHTG
T ss_pred             ---HHhhhcccc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--------Ccccccc
Confidence               000000000      0000111123457889999999999999999999998        8888754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=326.63  Aligned_cols=260  Identities=17%  Similarity=0.250  Sum_probs=194.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++....           .+++|.++... ......+.|.+|+.++++++||||+++++++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----------~~avk~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   98 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG-----------EVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGAC   98 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS-----------SEEEEECCCCS-CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC-----------eEEEEEeecCC-CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            45789999999999999999986532           13333332211 1112335678899999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+.+..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+   .+++||||||+|||++ ++.+||+|
T Consensus        99 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B           99 MSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             ECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECC
T ss_pred             ecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEee
Confidence            99999999999999999999997542  358999999999999999999999   9999999999999998 67999999


Q ss_pred             cCccccCCCCC---CCccccccccCCCCCChhhhcc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChh
Q 036172          304 FGLAIWGPTDS---THMIREDVVGTFGYIAPEYLMH---------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE  371 (522)
Q Consensus       304 FGla~~~~~~~---~~~~~~~~~gt~~Y~APE~~~~---------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~  371 (522)
                      ||++.......   .........|++.|+|||.+..         ..++.++||||||+++|+|++|+.||.....   .
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~  249 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---E  249 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---H
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H
Confidence            99986543211   1112223468999999999864         4578999999999999999999999965331   1


Q ss_pred             hHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       372 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      .....    ...+........        ..+..+.+++.+||..||.+|||+.+|++.|+.+..
T Consensus       250 ~~~~~----~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          250 AIIWQ----MGTGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HHHHH----HHTTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             HHHHH----hccCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11111    111111111111        123457889999999999999999999999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=328.66  Aligned_cols=254  Identities=20%  Similarity=0.269  Sum_probs=191.6

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc---chHHHHHHHHHHHHhhC----CCCC
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF---SSAWNDFSSEVDITSSL----EQKS  215 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~---~~~~~~f~~Ev~iL~~L----~Hpn  215 (522)
                      ...++|++.+.||+|+||.||++....        ..+.+++|.+.......   ......+.+|+.++.++    +|||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLT--------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTT--------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEcc--------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            346789999999999999999986543        34455555543211100   01234567899999999    8999


Q ss_pred             cceeeEEEEeCCEEEEEEec-CCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc
Q 036172          216 ITTLNGVCIEDNYLILVSDF-LPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS  294 (522)
Q Consensus       216 Iv~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~  294 (522)
                      |+++++++...+..++|||| +.+++|.+++....   .+++..++.++.|++.||.|||+   .+|+||||||+||+++
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILID  173 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEE
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEe
Confidence            99999999999999999999 78999999998643   49999999999999999999999   9999999999999999


Q ss_pred             -CCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          295 -SDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVS-DKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       295 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                       .++.+||+|||++........    ....|+..|+|||++.+..+. .++||||||+++|+|++|+.||...     ..
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~  244 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QE  244 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH
T ss_pred             CCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HH
Confidence             889999999999976654322    245689999999999877764 5999999999999999999998532     11


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      ...       . ..          .++...+..+.+++.+||+.||.+||++.++++        ++|++...
T Consensus       245 ~~~-------~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--------~~~~~~~~  291 (312)
T 2iwi_A          245 ILE-------A-EL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--------DPWMQTPA  291 (312)
T ss_dssp             HHH-------T-CC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--------STTTCC--
T ss_pred             Hhh-------h-cc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc--------ChhhcCch
Confidence            110       0 00          011123456888999999999999999999998        88987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.6e-39  Score=358.00  Aligned_cols=262  Identities=20%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.....     ......+++|.++...  .....+.|.+|+.++++++||||+++++++
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSP-----ENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCS-----SSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecC-----CCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            346899999999999999999864321     1123344555433211  123457899999999999999999999998


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      . ++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEe
Confidence            5 456899999999999999998542  348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.....   ........    
T Consensus       535 FG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~----  606 (656)
T 2j0j_A          535 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIE----  606 (656)
T ss_dssp             CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----
T ss_pred             cCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH----
Confidence            9999766443221 1223457789999999998999999999999999999997 9999865331   11211111    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+....         .+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       607 ~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          607 NGERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111110         11223457889999999999999999999999998865

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9e-39  Score=328.80  Aligned_cols=265  Identities=17%  Similarity=0.216  Sum_probs=197.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|.+.+.||+|+||.||++.+..        .++.+++|.+.... ......+++.+|+.++++++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR--------SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC--------CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            4689999999999999999987543        34556666553211 11224578999999999999999999999998


Q ss_pred             eCCE------EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          225 EDNY------LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       225 ~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ..+.      .++||||+. ++|.+++..     .+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~  164 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE  164 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCC
T ss_pred             cccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCc
Confidence            7653      599999997 588887742     38999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||++......     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......  .+....
T Consensus       165 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~  237 (353)
T 3coi_A          165 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL  237 (353)
T ss_dssp             EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHH
T ss_pred             EEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence            999999999764432     123478999999999876 678999999999999999999999997543211  111110


Q ss_pred             hhhhcCC------------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          378 KPILKNG------------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       378 ~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      . .....                  .......+.+ .......+..+.+++.+||+.||.+|||+.++++        |+
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--------hp  307 (353)
T 3coi_A          238 K-VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--------HP  307 (353)
T ss_dssp             H-HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--------SG
T ss_pred             H-HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc--------Cc
Confidence            0 00000                  0000000000 1111234567889999999999999999999997        99


Q ss_pred             ccccc
Q 036172          440 WVDRH  444 (522)
Q Consensus       440 ~~~~~  444 (522)
                      |+...
T Consensus       308 ~f~~~  312 (353)
T 3coi_A          308 FFEPF  312 (353)
T ss_dssp             GGTTT
T ss_pred             chhhc
Confidence            98754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.8e-39  Score=326.28  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=181.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHH-HHhhCCCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVD-ITSSLEQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~-iL~~L~HpnIv~l~~~  222 (522)
                      ..++|++.+.||+|+||.||++....        ..+.+++|.++..  .......++.+|+. +++.++||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKP--------SGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETT--------TTEEEEEEEEECC--CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcC--------CCCEEEEEEeecc--cCchHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            45789999999999999999987643        3455666655321  11224456667776 6777899999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhcc--CCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCceeccCCCce
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGA--GEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NILl~~~~~~  299 (522)
                      +.+++..++||||+++ +|.+++...  .....+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~  165 (327)
T 3aln_A           90 LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNI  165 (327)
T ss_dssp             EECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEE
T ss_pred             EEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCE
Confidence            9999999999999975 888887632  123459999999999999999999999   7 99999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhh----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL----MHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK  375 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~  375 (522)
                      ||+|||++.........   ....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......     .
T Consensus       166 kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~  237 (327)
T 3aln_A          166 KLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----D  237 (327)
T ss_dssp             EECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred             EEccCCCceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----H
Confidence            99999999765443221   233689999999998    45678999999999999999999999996432110     0


Q ss_pred             hhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          376 WAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       376 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...... .+..     +.+........+..+.+++.+||+.||.+||++.+|++        ++|+...
T Consensus       238 ~~~~~~-~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--------hp~~~~~  292 (327)
T 3aln_A          238 QLTQVV-KGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK--------HPFILMY  292 (327)
T ss_dssp             --CCCC-CSCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT--------SHHHHHH
T ss_pred             HHHHHh-cCCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh--------ChHHHHh
Confidence            011111 1111     11111111123457889999999999999999999997        7887654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.3e-38  Score=331.98  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=190.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..+.|.+.+.||+|+||+||.+..         ..++.+|+|.+..      +..+.+.+|+.+|+++ +|||||+++++
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~---------~~g~~vAvK~~~~------~~~~~~~~E~~~l~~l~~HpnIv~~~~~   77 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGS---------FQGRPVAVKRMLI------DFCDIALMEIKLLTESDDHPNVIRYYCS   77 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEE---------SSSSEEEEEEEEG------GGHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEEE---------ECCeEEEEEEEcH------HHHHHHHHHHHHHHhccCCCCcCeEEEE
Confidence            456777889999999999976421         2456777775532      1235678999999986 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCC----CCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC--
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQS----VLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD--  296 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~--  296 (522)
                      +.+++.+++||||+. |+|.+++.......    ..++..++.++.||+.||.|||+   .+|+||||||+|||++.+  
T Consensus        78 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~  153 (434)
T 2rio_A           78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR  153 (434)
T ss_dssp             EECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHH
T ss_pred             EecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcc
Confidence            999999999999995 69999998653211    12344567899999999999999   999999999999999754  


Q ss_pred             -----------CceEEeecCccccCCCCCCCc--cccccccCCCCCChhhhcc-------CCCCchhhHHHHHHHHHHHH
Q 036172          297 -----------FQPQLSDFGLAIWGPTDSTHM--IREDVVGTFGYIAPEYLMH-------GKVSDKIDVYSFGVVLLELL  356 (522)
Q Consensus       297 -----------~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwSlGvvl~eLl  356 (522)
                                 +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell  233 (434)
T 2rio_A          154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL  233 (434)
T ss_dssp             HHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence                       489999999998765433221  1234579999999999965       56899999999999999999


Q ss_pred             c-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          357 S-GRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       357 t-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      + |+.||.......    .........   .     +..........+..+.+++.+||+.||.+|||+.+|++      
T Consensus       234 t~g~~Pf~~~~~~~----~~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------  295 (434)
T 2rio_A          234 SKGKHPFGDKYSRE----SNIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR------  295 (434)
T ss_dssp             TTSCCTTCSTTTHH----HHHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT------
T ss_pred             hCCCCCCCCchhhH----HHHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh------
Confidence            9 999996432211    111111111   0     01111123456678999999999999999999999996      


Q ss_pred             cCCccccc
Q 036172          436 HATDWVDR  443 (522)
Q Consensus       436 ~~~~~~~~  443 (522)
                        |+|+..
T Consensus       296 --hp~f~~  301 (434)
T 2rio_A          296 --HPLFWP  301 (434)
T ss_dssp             --SGGGSC
T ss_pred             --CCccCC
Confidence              888753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-38  Score=350.56  Aligned_cols=264  Identities=22%  Similarity=0.266  Sum_probs=197.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||.|+||.||++.+..        .++.+++|.++..  ......++|.+|+.++++++||||+++++++
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~--------tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~   81 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQD--------TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVP   81 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTT--------TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECC--------CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeee
Confidence            45799999999999999999988643        3556666655321  1233567899999999999999999999997


Q ss_pred             Ee------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IE------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ..      ++..++||||+++|+|.+++........+++..++.++.|++.||.|||+   .+|+||||||+||+++.++
T Consensus        82 ~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g  158 (676)
T 3qa8_A           82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGP  158 (676)
T ss_dssp             TTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCS
T ss_pred             cccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCC
Confidence            65      67789999999999999999876554569999999999999999999999   9999999999999999766


Q ss_pred             c---eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          298 Q---PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       298 ~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                      .   +||+|||++.........   ....||+.|+|||.+.+..++.++||||||+++|+|++|..||....     ...
T Consensus       159 ~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~  230 (676)
T 3qa8_A          159 QRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPV  230 (676)
T ss_dssp             SSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHH
T ss_pred             CceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chh
Confidence            4   999999999776543322   24579999999999999999999999999999999999999996431     111


Q ss_pred             Hhhhhhhc------------CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 036172          375 KWAKPILK------------NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL  428 (522)
Q Consensus       375 ~~~~~~~~------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl  428 (522)
                      .|......            .+.....-............+..+.+++..||..||.+|||+.+++
T Consensus       231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            11111000            0000000000111223344677899999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=314.68  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=181.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++....        ..+.+++|.+..... .....+.+..+..+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK--------TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT--------TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEec--------CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            4689999999999999999987643        345666665533211 1112334455556788889999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CEEeccCCCCceeccCCCceEEee
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSR-PVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~-giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      +++..++||||+ ++.+..+....  ...+++..++.++.|++.||.|||+   . +++||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred             cCCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEE
Confidence            999999999999 55666666543  2358999999999999999999998   6 999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      ||++........   .....||+.|+|||.+.     ...++.++||||||+++|+|++|+.||.....  ......   
T Consensus       169 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~---  240 (318)
T 2dyl_A          169 FGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLT---  240 (318)
T ss_dssp             CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHH---
T ss_pred             CCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHH---
Confidence            999966544322   12346899999999984     45688999999999999999999999964321  111111   


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...... ....     ..  ....+..+.+++.+||+.||.+||++.+|++        ++|++..
T Consensus       241 ~~~~~~-~~~~-----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--------h~~~~~~  290 (318)
T 2dyl_A          241 KVLQEE-PPLL-----PG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--------HSFIKRY  290 (318)
T ss_dssp             HHHHSC-CCCC-----CS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--------SHHHHHH
T ss_pred             HHhccC-CCCC-----Cc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh--------CHHHHhc
Confidence            111111 1100     00  0112356888999999999999999999997        7776643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-37  Score=311.52  Aligned_cols=237  Identities=15%  Similarity=0.092  Sum_probs=186.1

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        ..+.+++|.+...........++|.+|+.++++++||||+++++++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTA--------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETT--------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecC--------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            35789999999999999999987643        4566777776544333344668899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++..|+||||++|++|.+++...     ....++..++.|++.||.|||+   .||+||||||+|||++.++.+||++
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECS
T ss_pred             EECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEe
Confidence            9999999999999999999999531     3556788999999999999999   9999999999999999999999985


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      +|                      |++       .++.++|||||||++|||++|+.||...........   +......
T Consensus       173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~  220 (286)
T 3uqc_A          173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAG  220 (286)
T ss_dssp             CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTS
T ss_pred             cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhcc
Confidence            43                      333       368999999999999999999999975443211000   0000000


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                       .      +..........+..+.+++.+||+.||.+| |+.++++.|+....
T Consensus       221 -~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          221 -Q------PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             -C------BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             -C------CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence             0      000111122345678899999999999999 99999999998764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=333.14  Aligned_cols=256  Identities=21%  Similarity=0.248  Sum_probs=187.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      ..+|++.+.||+|+||+|+...         ....+.+|+|.+....      ...+.+|+.+|+++ +|||||++++++
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~---------~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRG---------MFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEE---------ESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEE---------EeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence            3469999999999999975422         1245667777653311      12356899999999 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-----CCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQ  298 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-----~~~  298 (522)
                      .+....+|||||+. |+|.+++....  ..+.+..++.++.||+.||.|||+   .+|+||||||+|||++.     ...
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~  161 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIK  161 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCcee
Confidence            99999999999996 59999998643  235566778999999999999999   99999999999999953     336


Q ss_pred             eEEeecCccccCCCCCCC-ccccccccCCCCCChhhhc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhH
Q 036172          299 PQLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESL  373 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l  373 (522)
                      +||+|||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    
T Consensus       162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----  237 (432)
T 3p23_A          162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----  237 (432)
T ss_dssp             EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----
T ss_pred             EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----
Confidence            889999999766543221 2223457999999999997   4567889999999999999999 999985432111    


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..   ........ ....+      .......+.+++.+||+.||.+|||+.+|++        |+|+..
T Consensus       238 ~~---~~~~~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~--------hp~f~~  289 (432)
T 3p23_A          238 AN---ILLGACSL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK--------HPFFWS  289 (432)
T ss_dssp             HH---HHTTCCCC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT--------STTTCC
T ss_pred             HH---HHhccCCc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh--------CccccC
Confidence            11   01111111 11111      1234456788999999999999999999997        888754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-36  Score=306.07  Aligned_cols=241  Identities=20%  Similarity=0.285  Sum_probs=183.4

Q ss_pred             CCCCCceee-ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHH-hhCCCCCcceee
Q 036172          143 KTENPFQMD-IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDIT-SSLEQKSITTLN  220 (522)
Q Consensus       143 ~~~~~y~~~-~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL-~~L~HpnIv~l~  220 (522)
                      ...++|.+. +.||+|+||.||++.+..        +.+.|++|.++.        ...+.+|+.++ +.++||||++++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~   77 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKR--------TQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV   77 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcC--------CCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHH
Confidence            345788887 779999999999987643        456677776531        24577899998 556999999999


Q ss_pred             EEEEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-
Q 036172          221 GVCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-  295 (522)
Q Consensus       221 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-  295 (522)
                      +++..    ...+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++. 
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~  153 (299)
T 3m2w_A           78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK  153 (299)
T ss_dssp             EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSS
T ss_pred             hhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecC
Confidence            99987    678999999999999999998653 2359999999999999999999999   99999999999999998 


Q ss_pred             --CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          296 --DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       296 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                        ++.+||+|||++....                        +..++.++|||||||++|+|++|+.||.........  
T Consensus       154 ~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--  207 (299)
T 3m2w_A          154 RPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--  207 (299)
T ss_dssp             STTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------
T ss_pred             CCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--
Confidence              7889999999985322                        234678999999999999999999999643321100  


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       .........+.      ...........+..+.+++.+||+.||.+|||+.++++        |+|+...
T Consensus       208 -~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--------hp~~~~~  263 (299)
T 3m2w_A          208 -PGMKTRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--------HPWIMQS  263 (299)
T ss_dssp             -CCSCCSSCTTC------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SHHHHTG
T ss_pred             -HHHHHHHhhcc------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--------Chhhccc
Confidence             00000000000      00010001123567899999999999999999999997        8887654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-36  Score=339.93  Aligned_cols=243  Identities=20%  Similarity=0.207  Sum_probs=190.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||++.+...       ..+.+++|.+..  .......+.|.+|+.++++++|||||++++++
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-------~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  148 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNV-------NGRPVVLKGLVH--SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFV  148 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGG-------TTEEEEEEESCS--SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCC-------CCcEEEEEEeCc--cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence            357999999999999999999976431       345566665532  12234567899999999999999999999999


Q ss_pred             EeCCE-----EEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          224 IEDNY-----LILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       224 ~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      ...+.     .||||||+++++|.+++..     .+++..++.++.||+.||.|||+   .+|+||||||+|||++.+ .
T Consensus       149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~  219 (681)
T 2pzi_A          149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-Q  219 (681)
T ss_dssp             EEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-C
T ss_pred             eecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-c
Confidence            97654     7999999999999988753     49999999999999999999999   999999999999999986 8


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +||+|||+++.....      ....||+.|+|||++.++ ++.++|||||||++|+|++|..||.......         
T Consensus       220 ~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------  283 (681)
T 2pzi_A          220 LKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------  283 (681)
T ss_dssp             EEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------
T ss_pred             EEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------
Confidence            999999999765443      234799999999998765 4899999999999999999998875321110         


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhcc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-MGQVLKLLRGA  434 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-~~eVl~~L~~~  434 (522)
                             ..       ...........+.+++.+||+.||.+||+ ++++...|.+.
T Consensus       284 -------~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -------LP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -------CC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------cc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                   00       00111223467889999999999999995 56666666554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-37  Score=315.88  Aligned_cols=251  Identities=16%  Similarity=0.128  Sum_probs=188.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhh-----ccchHHHHHHHHHHHHhhCC-------
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATS-----QFSSAWNDFSSEVDITSSLE-------  212 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~-----~~~~~~~~f~~Ev~iL~~L~-------  212 (522)
                      .++|++.++||+|+||.||++...          .+.+|+|.++....     ......+.+.+|+.+++.++       
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~   88 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD----------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC   88 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET----------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred             cccchheeeecccCceEEEEEEeC----------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence            468999999999999999998752          35667776654321     12234578899999999886       


Q ss_pred             --CCCcceeeEEEE------------------------------eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHH
Q 036172          213 --QKSITTLNGVCI------------------------------EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF  260 (522)
Q Consensus       213 --HpnIv~l~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~  260 (522)
                        |||||++.+++.                              ..+.++|||||+++|+|.+.+.+    ..+++..++
T Consensus        89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~  164 (336)
T 2vuw_A           89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAK  164 (336)
T ss_dssp             SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHH
T ss_pred             ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHH
Confidence              777777777653                              26789999999999977776643    348999999


Q ss_pred             HHHHHHHHHHHHHH-hcCCCCEEeccCCCCceeccCCC--------------------ceEEeecCccccCCCCCCCccc
Q 036172          261 EVAVAIAEALNYLH-SECSRPVIHRDVKSSNILLSSDF--------------------QPQLSDFGLAIWGPTDSTHMIR  319 (522)
Q Consensus       261 ~i~~qi~~gL~yLH-~~~~~giiHrDIkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~  319 (522)
                      .++.||+.||.||| +   .+|+||||||+||||+.++                    .+||+|||+++.....      
T Consensus       165 ~i~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 8   9999999999999999887                    8999999999765432      


Q ss_pred             cccccCCCCCChhhhccCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccc
Q 036172          320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVV-LLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEY  398 (522)
Q Consensus       320 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvv-l~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  398 (522)
                       ...||+.|+|||++.+.. +.++||||||++ .+++++|..||...     .................    .......
T Consensus       236 -~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~  304 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK----TKCNTPA  304 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS----SCCCSHH
T ss_pred             -cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC----cccchhh
Confidence             347999999999997655 899999998776 77788899997320     00000011111111111    1112223


Q ss_pred             cHHHHHHHHHHHHHhhhcCCCCCCCHHHHH-HHHhccccCCcccc
Q 036172          399 DNAQMQRMLLAANLCINQSPQLRPNMGQVL-KLLRGATHATDWVD  442 (522)
Q Consensus       399 ~~~~~~~l~~li~~CL~~dP~~RPs~~eVl-~~L~~~~~~~~~~~  442 (522)
                      ....+..+.+|+.+||+.|     |+.|++ +        |+|++
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~--------Hp~f~  336 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQ--------HSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHH--------CGGGC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhc--------CCCcC
Confidence            4567788999999999976     999999 7        88864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-36  Score=319.06  Aligned_cols=245  Identities=13%  Similarity=0.086  Sum_probs=179.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC-CCcce------
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ-KSITT------  218 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H-pnIv~------  218 (522)
                      ..|.+.+.||+|+||.||++.+..        +++.||+|.++..........+.|.+|+.+++.++| +|...      
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~  149 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQE--------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  149 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred             eeEEEecccccCCCEEEEEEEecC--------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence            458899999999999999998653        455677775542222222346789999999999987 32211      


Q ss_pred             ---------------eeEEEEe-----CCEEEEEEecCCCCCHHHHhhcc----CCCCCCChHHHHHHHHHHHHHHHHHH
Q 036172          219 ---------------LNGVCIE-----DNYLILVSDFLPKGSLEESLHGA----GEQSVLPWGVRFEVAVAIAEALNYLH  274 (522)
Q Consensus       219 ---------------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH  274 (522)
                                     ++.++..     ...++++|+++ +++|.+++...    .....+++..++.++.||+.||.|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  228 (413)
T 3dzo_A          150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  228 (413)
T ss_dssp             BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                           1111111     23467888877 67999998521    12345888999999999999999999


Q ss_pred             hcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhh----------ccCCCCchhh
Q 036172          275 SECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYL----------MHGKVSDKID  344 (522)
Q Consensus       275 ~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~s~ksD  344 (522)
                      +   .+|+||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|
T Consensus       229 ~---~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          229 H---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             H---TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             h---CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            9   99999999999999999999999999998764433     224467 999999999          4456888999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 036172          345 VYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM  424 (522)
Q Consensus       345 VwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~  424 (522)
                      ||||||++|||++|+.||........      ..         ..+..  ..    ..+..+.+++.+||+.||.+||++
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~~------~~---------~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALGG------SE---------WIFRS--CK----NIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGSC------SG---------GGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhhh------HH---------HHHhh--cc----cCCHHHHHHHHHHccCChhhCcCH
Confidence            99999999999999999964432111      00         01110  01    123578899999999999999999


Q ss_pred             HHHHH
Q 036172          425 GQVLK  429 (522)
Q Consensus       425 ~eVl~  429 (522)
                      .++++
T Consensus       359 ~~~l~  363 (413)
T 3dzo_A          359 LQAME  363 (413)
T ss_dssp             HHHTT
T ss_pred             HHHHh
Confidence            99986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.6e-28  Score=268.80  Aligned_cols=153  Identities=17%  Similarity=0.147  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHhhC-CCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 036172          197 AWNDFSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHS  275 (522)
Q Consensus       197 ~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~  275 (522)
                      ..++|.+|+++|+++ .|+||+++++++.+++.+||||||++|++|.++|...+   .++..   +|+.||+.||+|||+
T Consensus       284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~  357 (569)
T 4azs_A          284 NKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEK  357 (569)
T ss_dssp             HHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHH
Confidence            457899999999999 89999999999999999999999999999999998543   46654   578999999999999


Q ss_pred             cCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHH
Q 036172          276 ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLEL  355 (522)
Q Consensus       276 ~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eL  355 (522)
                         +|||||||||+||||+.++.+||+|||+|+........  ....+||+.|+|||++.+ .+..++|+||+|++++++
T Consensus       358 ---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          358 ---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             ---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHHHHHHHHHHHHHHC------------------CCC
T ss_pred             ---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhh
Confidence               99999999999999999999999999999866544322  234689999999999854 577889999999998887


Q ss_pred             HcCCCC
Q 036172          356 LSGRRP  361 (522)
Q Consensus       356 ltG~~P  361 (522)
                      .++..+
T Consensus       432 ~~~~~~  437 (569)
T 4azs_A          432 PQPWSN  437 (569)
T ss_dssp             CTTHHH
T ss_pred             ccccch
Confidence            665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.5e-26  Score=251.63  Aligned_cols=192  Identities=14%  Similarity=0.164  Sum_probs=140.9

Q ss_pred             eeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEE
Q 036172          150 MDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYL  229 (522)
Q Consensus       150 ~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~  229 (522)
                      ..+.||+|+||.||++..............+.+..+.+..     ....++|.+|++++++++||||+++..++...+..
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDE-----NIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHH-----HHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhh-----HHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            3568999999999977422111111111112222122211     11356799999999999999999777777777888


Q ss_pred             EEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          230 ILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       230 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      +|||||+++++|.+++..           +..++.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+++.
T Consensus       415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            999999999999999974           46899999999999999   99999999999999998  999999999987


Q ss_pred             CCCCCCCc-----cccccccCCCCCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 036172          310 GPTDSTHM-----IREDVVGTFGYIAPEYLMH--GKVSDKIDVYSFGVVLLELLSGRRPI  362 (522)
Q Consensus       310 ~~~~~~~~-----~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwSlGvvl~eLltG~~Pf  362 (522)
                      ........     ......||+.|+|||++..  ..|+..+|+|+..+-.++-+.++.+|
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            65432211     1235689999999999976  56888899999999999988877765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=9e-23  Score=203.87  Aligned_cols=148  Identities=18%  Similarity=0.089  Sum_probs=113.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc---------------hHHHHHHHHHHHHhh
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS---------------SAWNDFSSEVDITSS  210 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~---------------~~~~~f~~Ev~iL~~  210 (522)
                      ..|++++.||.|+||.||++.. .        .++.+++|.++.....+.               .....|.+|+.++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~--------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-E--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-T--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEecCEeccCCCceEEEEEe-C--------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            3567779999999999999875 2        234455554432221111               245679999999999


Q ss_pred             CCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          211 LEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       211 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      ++  | +++++++.. +..++||||++||+|.+ +.       .  .....++.|++.||.|||+   .+|+||||||+|
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N  223 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN  223 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence            99  5 666665544 45699999999999988 42       1  2345799999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhc
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLM  335 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~  335 (522)
                      ||++ ++.+||+|||+++               .+..|.|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence            9999 9999999999983               455688999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=1.2e-18  Score=171.39  Aligned_cols=140  Identities=16%  Similarity=0.098  Sum_probs=101.4

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCcc--chHHHHHHHhhcc---------------------chHHHHHHH
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQ--FSYEELKQATSQF---------------------SSAWNDFSS  203 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~--~a~k~l~~~t~~~---------------------~~~~~~f~~  203 (522)
                      -|++...||.|+||.||++....        .++.  +++|.++.....+                     ......+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~--------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVF--------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEE--------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcC--------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            47889999999999999987521        1222  3443211100000                     012346889


Q ss_pred             HHHHHhhCCCCCc--ceeeEEEEeCCEEEEEEecCCC-C----CHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHH-h
Q 036172          204 EVDITSSLEQKSI--TTLNGVCIEDNYLILVSDFLPK-G----SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLH-S  275 (522)
Q Consensus       204 Ev~iL~~L~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~  275 (522)
                      |+.+|.+|.|++|  +.++++    ...+|||||+.+ |    +|.++...      .++..+..++.|++.||.||| +
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH
Confidence            9999999988864  444443    245899999942 3    77776542      335677899999999999999 8


Q ss_pred             cCCCCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          276 ECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       276 ~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                         .+|+||||||+|||++.  .++|+|||+|..
T Consensus       190 ---~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          190 ---AELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             ---SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             ---CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence               99999999999999998  999999999954

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=1.7e-15  Score=156.84  Aligned_cols=140  Identities=11%  Similarity=0.120  Sum_probs=96.0

Q ss_pred             CceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch-------------------HHHHHHHHHHH
Q 036172          147 PFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS-------------------AWNDFSSEVDI  207 (522)
Q Consensus       147 ~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~-------------------~~~~f~~Ev~i  207 (522)
                      -|+++.+||.|+||.||++.+.         .++.+|+|.++.....|..                   ..-...+|...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~---------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE---------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT---------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC---------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            3899999999999999998643         2344454443322221111                   01112457778


Q ss_pred             HhhCCCCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCC
Q 036172          208 TSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVK  287 (522)
Q Consensus       208 L~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIk  287 (522)
                      |.+|.+.++.-..-+....  .+|||||++|++|.++..         ......++.|++.+|.+||+   .||||||||
T Consensus       167 L~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~---~gIVHrDLK  232 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAK---HGLIHGDFN  232 (397)
T ss_dssp             HHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred             HHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCC
Confidence            8888555543222222222  269999999988866432         12345788999999999999   999999999


Q ss_pred             CCceeccCCC----------ceEEeecCcccc
Q 036172          288 SSNILLSSDF----------QPQLSDFGLAIW  309 (522)
Q Consensus       288 p~NILl~~~~----------~~kL~DFGla~~  309 (522)
                      |.|||+++++          .+.|+||+.+..
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999998776          389999998743

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.06  E-value=1.3e-10  Score=113.34  Aligned_cols=141  Identities=13%  Similarity=0.030  Sum_probs=103.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~~  224 (522)
                      ..|++...+|.|+++.||++...          .+.+.+|......   .....++.+|+.+++.| .+..++++++++.
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~----------~~~~vlK~~~~~~---~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~   80 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE----------NENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS----------SCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC----------CCcEEEEeCCccc---CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence            46888888998888889987522          1222222211100   01123588899999999 4678889999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC---------------------------  277 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---------------------------  277 (522)
                      +.+..++||||++|.+|.+.+.        +......++.+++.+|..||+-.                           
T Consensus        81 ~~~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T 3tm0_A           81 HDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             cCCceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence            9999999999999999987642        12234577899999999999810                           


Q ss_pred             -----------------------------CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 -----------------------------SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 -----------------------------~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                                                   ...++|+|++|.||+++++..+.|+||+.+
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                         145999999999999987656679999876

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.80  E-value=3.2e-09  Score=102.61  Aligned_cols=136  Identities=17%  Similarity=0.063  Sum_probs=91.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCC--cceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKS--ITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hpn--Iv~l~~~~  223 (522)
                      ..|.+....+.|..+.||++....         ++.+.+|....   .   ....+.+|+.+++.+.+.+  +++++++.
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~---------g~~~vlK~~~~---~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~   84 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQG---------RPVLFVKTDLS---G---ALNELQDEAARLSWLATTGVPCAAVLDVV   84 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTT---------SCCEEEEEECS---C---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCC---------CCeEEEEeCCc---c---cchhhhHHHHHHHHHHhCCCCCCeEEEec
Confidence            456665544456668888875321         11122221100   0   1134778999999995544  56699988


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC--------------------------  277 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------  277 (522)
                      ..++..++||||++|.+|.  ...      ..   ...++.+++..|..||+..                          
T Consensus        85 ~~~~~~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (264)
T 1nd4_A           85 TEAGRDWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV  153 (264)
T ss_dssp             ECSSCEEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred             cCCCCCEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence            8888899999999998884  211      11   2356778888888888721                          


Q ss_pred             -----------------------------CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 -----------------------------SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 -----------------------------~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                                                   ...++|+|++|.||+++++..+.|+||+.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                         012999999999999987766779999987

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.73  E-value=1.1e-08  Score=104.64  Aligned_cols=142  Identities=9%  Similarity=0.163  Sum_probs=98.6

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHH--HHhhccchHHHHHHHHHHHHhhCC--CCCcceeeEEEEeC
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELK--QATSQFSSAWNDFSSEVDITSSLE--QKSITTLNGVCIED  226 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~--~~t~~~~~~~~~f~~Ev~iL~~L~--HpnIv~l~~~~~~~  226 (522)
                      .++|+.|.++.||+......          .+.+|...  ...  .......+.+|+.+++.|.  +..+++++.++.+.
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~----------~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQ----------TYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSC----------EEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             EEEcCCcccceEEEEEECCc----------eEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            55688899999998753210          11111100  000  0012246788999999996  45688999998876


Q ss_pred             ---CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC--------------------------
Q 036172          227 ---NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC--------------------------  277 (522)
Q Consensus       227 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--------------------------  277 (522)
                         +..++||||++|..|.+...     ..++...+..++.+++..|..||+..                          
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence               45899999999987754221     13778888999999999999999721                          


Q ss_pred             -----------------------------CCCEEeccCCCCceeccCCCc--eEEeecCcccc
Q 036172          278 -----------------------------SRPVIHRDVKSSNILLSSDFQ--PQLSDFGLAIW  309 (522)
Q Consensus       278 -----------------------------~~giiHrDIkp~NILl~~~~~--~kL~DFGla~~  309 (522)
                                                   ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                         257999999999999997753  68999998854

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.71  E-value=3.3e-09  Score=106.02  Aligned_cols=182  Identities=19%  Similarity=0.159  Sum_probs=116.7

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCC--cceeeEEEEeCC-
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKS--ITTLNGVCIEDN-  227 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~Hpn--Iv~l~~~~~~~~-  227 (522)
                      ..++.|....||+.... ..++..    +.             ......+.+|+.+|+.+ .+..  +.+++......+ 
T Consensus        26 ~~~~~G~~n~v~~v~~~-~vlR~~----~~-------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~   87 (304)
T 3sg8_A           26 EISGEGNDCIAYEINRD-FIFKFP----KH-------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET   87 (304)
T ss_dssp             CEEEECSSEEEEESTTS-EEEEEE----SS-------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS
T ss_pred             EecCCCCcceEEEECCE-EEEEec----CC-------------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC
Confidence            34788988888886521 111110    00             01345788999999988 3333  445555544333 


Q ss_pred             --EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 036172          228 --YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC----------------------------  277 (522)
Q Consensus       228 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~----------------------------  277 (522)
                        ..|+||++++|.+|.+....     .++..++..++.+++..|..||+..                            
T Consensus        88 ~~~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (304)
T 3sg8_A           88 YQMSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS  162 (304)
T ss_dssp             CSCSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence              35889999999888754331     2777888888999999999998611                            


Q ss_pred             ---------------------------CCCEEeccCCCCceeccC--CCceEEeecCccccCCCCCCCccccccccCCCC
Q 036172          278 ---------------------------SRPVIHRDVKSSNILLSS--DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGY  328 (522)
Q Consensus       278 ---------------------------~~giiHrDIkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y  328 (522)
                                                 ...++|+|++|.||++++  ...+.|+||+.+.......      +......+
T Consensus       163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~  236 (304)
T 3sg8_A          163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMED  236 (304)
T ss_dssp             TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCT
T ss_pred             ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhh
Confidence                                       135899999999999998  4568899999885532210      00111111


Q ss_pred             ---CChhhhcc-----CCC---------CchhhHHHHHHHHHHHHcCCCCC
Q 036172          329 ---IAPEYLMH-----GKV---------SDKIDVYSFGVVLLELLSGRRPI  362 (522)
Q Consensus       329 ---~APE~~~~-----~~~---------s~ksDVwSlGvvl~eLltG~~Pf  362 (522)
                         ..|+....     +..         ....+.|++|.+++.+.+|..+|
T Consensus       237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          237 DEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               23332210     111         22368999999999999998875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.09  E-value=9.8e-06  Score=78.79  Aligned_cols=102  Identities=20%  Similarity=0.132  Sum_probs=79.4

Q ss_pred             HHHHHHHHHHhhCC-CCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 036172          199 NDFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC  277 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~  277 (522)
                      .++.+|..+|+.|. +--+.++++++.+++..++|||+++|.++.+....       .......+..+++..|..||...
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~  136 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIP  136 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSC
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCC
Confidence            46788999999883 33478899999999999999999999888876642       12334456777788888888521


Q ss_pred             -------------------------------------------------------CCCEEeccCCCCceeccCCCceEEe
Q 036172          278 -------------------------------------------------------SRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       278 -------------------------------------------------------~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                                                                             ...++|+|+.+.||++++++.+-|+
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi  216 (272)
T 4gkh_A          137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI  216 (272)
T ss_dssp             GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred             cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence                                                                   0138999999999999988777899


Q ss_pred             ecCcc
Q 036172          303 DFGLA  307 (522)
Q Consensus       303 DFGla  307 (522)
                      ||+.+
T Consensus       217 Dwe~a  221 (272)
T 4gkh_A          217 DVGRV  221 (272)
T ss_dssp             CCTTC
T ss_pred             ECccc
Confidence            99987

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.94  E-value=3.1e-05  Score=77.31  Aligned_cols=107  Identities=21%  Similarity=0.198  Sum_probs=76.4

Q ss_pred             HHHHHHHHHHHhhCCCC---CcceeeEEEE-eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH
Q 036172          198 WNDFSSEVDITSSLEQK---SITTLNGVCI-EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYL  273 (522)
Q Consensus       198 ~~~f~~Ev~iL~~L~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yL  273 (522)
                      ...+.+|+.+|+.|.+.   .+.+++.++. ..+..++||||++|.+|.+....     .++......++.++...|..|
T Consensus        53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~L  127 (306)
T 3tdw_A           53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNEL  127 (306)
T ss_dssp             HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHH
Confidence            45788999999999653   3667777775 34567899999999888764221     145555556666666666666


Q ss_pred             Hhc---------------------------------------------------------CCCCEEeccCCCCceeccC-
Q 036172          274 HSE---------------------------------------------------------CSRPVIHRDVKSSNILLSS-  295 (522)
Q Consensus       274 H~~---------------------------------------------------------~~~giiHrDIkp~NILl~~-  295 (522)
                      |+.                                                         ....++|+|++|.||+++. 
T Consensus       128 H~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~  207 (306)
T 3tdw_A          128 SAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLN  207 (306)
T ss_dssp             HHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTT
T ss_pred             hcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecC
Confidence            641                                                         1235799999999999987 


Q ss_pred             --CCc-eEEeecCcccc
Q 036172          296 --DFQ-PQLSDFGLAIW  309 (522)
Q Consensus       296 --~~~-~kL~DFGla~~  309 (522)
                        ++. +.|+||+.+..
T Consensus       208 ~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          208 SRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CSSCCEEEECCCTTCEE
T ss_pred             CCCCceEEEEehhhcCC
Confidence              355 58999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.45  E-value=0.00013  Score=73.97  Aligned_cols=43  Identities=2%  Similarity=0.064  Sum_probs=32.3

Q ss_pred             HHHHHHHHHhhCC-C--CCcceeeEEEEeC---CEEEEEEecCCCCCHH
Q 036172          200 DFSSEVDITSSLE-Q--KSITTLNGVCIED---NYLILVSDFLPKGSLE  242 (522)
Q Consensus       200 ~f~~Ev~iL~~L~-H--pnIv~l~~~~~~~---~~~~lV~E~~~~gsL~  242 (522)
                      .+.+|+.+++.|. +  -.+.+++.++.+.   +..++||||++|..|.
T Consensus        73 ~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           73 RLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            4677888888883 3  3577888887765   3568999999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.18  E-value=0.0016  Score=61.30  Aligned_cols=101  Identities=18%  Similarity=0.099  Sum_probs=66.2

Q ss_pred             CHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccc
Q 036172          240 SLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR  319 (522)
Q Consensus       240 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  319 (522)
                      ||.++|...+  .+++++++|.++.|.+.+|.-+-..  ..-..+=+.|..|+|..+|.+.+.+ +.+.           
T Consensus        34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            8999998754  4699999999999999998776221  1111333456889999999888764 1110           


Q ss_pred             cccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Q 036172          320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRR  360 (522)
Q Consensus       320 ~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~  360 (522)
                         .....+.|||... ...+.+.=|||||+++|..+--..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1233466888753 345788999999999999886333

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.13  E-value=0.00011  Score=75.72  Aligned_cols=30  Identities=23%  Similarity=0.464  Sum_probs=26.1

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|||+.+.||+++.+ .++|+||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            689999999999999876 489999987754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.99  E-value=0.0012  Score=65.91  Aligned_cols=30  Identities=27%  Similarity=0.292  Sum_probs=27.4

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ...++|+|+++.||+++.++.+.|+||+.+
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            378999999999999988888999999976

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=96.92  E-value=0.00018  Score=60.51  Aligned_cols=51  Identities=14%  Similarity=0.042  Sum_probs=44.8

Q ss_pred             Ccccccccccccc---chhhhhhhhcccccccc---ccccccccccceeeecCCccc
Q 036172           63 NSIDEEKYRNPCA---SEEACTVREGISIDQNE---EYTSTVDYGWPLLRISAPETS  113 (522)
Q Consensus        63 ~~~~~~~~~~~c~---~~~~C~~~~~~~~~~~~---~~~~~~~~g~p~~~~~~~~~~  113 (522)
                      ...|++||++||+   +..+|..||..++..++   ..+.|+++-.+.|.+|++.++
T Consensus        51 ~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~  107 (108)
T 3a2e_A           51 GGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRS  107 (108)
T ss_dssp             TTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSC
T ss_pred             CCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCc
Confidence            4568999999999   89999999999999998   678888998899999887554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.23  E-value=0.011  Score=59.03  Aligned_cols=138  Identities=16%  Similarity=0.159  Sum_probs=82.8

Q ss_pred             eecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC---CCCcceeeEEEEeCC
Q 036172          151 DIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE---QKSITTLNGVCIEDN  227 (522)
Q Consensus       151 ~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~---HpnIv~l~~~~~~~~  227 (522)
                      ..+|+.|.+..+|+.....          +.+-+|.-.      ......|..|+..|+.|.   ...+++++.++...+
T Consensus        41 ~~~l~gG~~n~~y~v~~~~----------~~~vlK~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEV----------QTVFVKINE------RSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             EEEECCSSSSEEEEEESSS----------CEEEEEEEE------GGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             eEEeCCccceeeeEEEECC----------CeEEEEeCC------cccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            4567888888888765211          111111100      012356888999999883   356889999998888


Q ss_pred             EEEEEEecCCCCCHH--------H---HhhccCC--CC-----------------CCChHHHH---HHH-----------
Q 036172          228 YLILVSDFLPKGSLE--------E---SLHGAGE--QS-----------------VLPWGVRF---EVA-----------  263 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~--------~---~l~~~~~--~~-----------------~l~~~~~~---~i~-----------  263 (522)
                      ..++||||+++..+.        .   .|+....  ..                 .-+|...+   ++.           
T Consensus       105 ~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~  184 (312)
T 3jr1_A          105 HSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGL  184 (312)
T ss_dssp             EEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTC
T ss_pred             ceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            999999999987642        1   2232211  00                 01343322   111           


Q ss_pred             -----HHHHHHH-HHHHh-cCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          264 -----VAIAEAL-NYLHS-ECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       264 -----~qi~~gL-~yLH~-~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                           ..++..+ ..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus       185 ~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          185 IFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                 1122222 23421 1236799999999999999887 8899974

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.15  E-value=0.012  Score=58.77  Aligned_cols=31  Identities=26%  Similarity=0.332  Sum_probs=27.3

Q ss_pred             CCEEeccCCCCceeccCC----CceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSD----FQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~----~~~kL~DFGla~~  309 (522)
                      ..++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            679999999999999874    6799999998854

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.16  E-value=0.03  Score=54.99  Aligned_cols=30  Identities=17%  Similarity=0.117  Sum_probs=25.4

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5667789999988743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.96  E-value=0.019  Score=59.94  Aligned_cols=38  Identities=18%  Similarity=0.305  Sum_probs=24.9

Q ss_pred             HHHHHHHHHhhCCCCC-cceeeEEEEeCCEEEEEEecCCCCCH
Q 036172          200 DFSSEVDITSSLEQKS-ITTLNGVCIEDNYLILVSDFLPKGSL  241 (522)
Q Consensus       200 ~f~~Ev~iL~~L~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL  241 (522)
                      .+.+|+.+++.|...+ .+++++.+.  +  .+|+||++|.+|
T Consensus       121 ~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l  159 (429)
T 1nw1_A          121 HLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence            3456888888884333 467777653  2  289999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.88  E-value=0.022  Score=58.50  Aligned_cols=105  Identities=22%  Similarity=0.272  Sum_probs=63.9

Q ss_pred             HHHHHHHHHHhhCC-CCCcceeeEEEEeCCEEEEEEecCCCCCHHH--------------H---hhccCC--CCCC--Ch
Q 036172          199 NDFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEE--------------S---LHGAGE--QSVL--PW  256 (522)
Q Consensus       199 ~~f~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~--------------~---l~~~~~--~~~l--~~  256 (522)
                      ..+.+|..+++.|. +.-..++++++.+    .+||||++|.+|..              .   |+....  ....  -+
T Consensus        98 ~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~  173 (379)
T 3feg_A           98 DSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLF  173 (379)
T ss_dssp             HHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHH
Confidence            44568999998883 3334677766543    28999999865431              1   111110  1112  23


Q ss_pred             HHHHHHHHHHHH-------------------HHHHHHh-----cCCCCEEeccCCCCceeccCC----CceEEeecCcc
Q 036172          257 GVRFEVAVAIAE-------------------ALNYLHS-----ECSRPVIHRDVKSSNILLSSD----FQPQLSDFGLA  307 (522)
Q Consensus       257 ~~~~~i~~qi~~-------------------gL~yLH~-----~~~~giiHrDIkp~NILl~~~----~~~kL~DFGla  307 (522)
                      .++.++..++..                   .+..|..     .....++|+|+.+.||+++.+    +.+.|+||..+
T Consensus       174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            455555544322                   2333322     123579999999999999876    68999999877

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.50  E-value=0.024  Score=55.27  Aligned_cols=75  Identities=12%  Similarity=0.036  Sum_probs=44.1

Q ss_pred             ceeeecccccccccccccCch---hHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCC---CcceeeE
Q 036172          148 FQMDIPCSEGKYDENTLTPST---ELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQK---SITTLNG  221 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~---~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~Hp---nIv~l~~  221 (522)
                      ..-...+|.|..+.||+....   .+++|......               ......|..|+..|+.|.-.   -++++++
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~---------------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~   81 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA---------------PALDGLFRAEALGLDWLGRSFGSPVPQVAG   81 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC---------------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC---------------cchhhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence            344667899999999987532   12222211110               01123478899999988422   3556665


Q ss_pred             EEEeCCEEEEEEecCCCCCH
Q 036172          222 VCIEDNYLILVSDFLPKGSL  241 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL  241 (522)
                      +.  .  -++||||++++..
T Consensus        82 ~~--~--~~lv~e~l~~~~~   97 (288)
T 3f7w_A           82 WD--D--RTLAMEWVDERPP   97 (288)
T ss_dssp             EE--T--TEEEEECCCCCCC
T ss_pred             cc--C--ceEEEEeecccCC
Confidence            42  2  3689999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=91.86  E-value=0.11  Score=53.47  Aligned_cols=78  Identities=14%  Similarity=0.133  Sum_probs=45.7

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC---CCCchhhHHHHHHHHHHH
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG---KVSDKIDVYSFGVVLLEL  355 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwSlGvvl~eL  355 (522)
                      ..++|+|++|.|||++.++ ++|+||+.+............ ...-...|++|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            7899999999999998876 999999988543221100000 00001235555554311   112234555777777777


Q ss_pred             HcC
Q 036172          356 LSG  358 (522)
Q Consensus       356 ltG  358 (522)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.71  E-value=0.57  Score=43.79  Aligned_cols=116  Identities=8%  Similarity=0.084  Sum_probs=81.8

Q ss_pred             CCCCCcceeeEEEEeCCEEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          211 LEQKSITTLNGVCIEDNYLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       211 L~HpnIv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      ..||++++. .+-.+++.+.+.++.-+. -++.. ++      .++...+++++.+|+....+++.     -+|--|.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            378999877 566777777777776542 23333 32      27889999999999998876665     578899999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG  363 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~  363 (522)
                      ||+++.++.+++.-.|+-..                   ++|.     ..+...=.-.+=+++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987776421                   1121     11111222357788999999988874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=86.63  E-value=0.2  Score=49.16  Aligned_cols=42  Identities=31%  Similarity=0.445  Sum_probs=31.1

Q ss_pred             HHHHHHHHHhc----CCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          266 IAEALNYLHSE----CSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       266 i~~gL~yLH~~----~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      +...+.+|+..    ...+++|+|+.+.||+++++..+.|+||+.+
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence            34445555531    1357999999999999998766689999876

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.97  E-value=1.4  Score=41.23  Aligned_cols=113  Identities=11%  Similarity=0.148  Sum_probs=78.3

Q ss_pred             CCCCcceeeEEEEeCCEEEEEEecCCCC-CHHHHhhccCCCCCCChHHHHHHHHHHHHHHH-HHHhcCCCCEEeccCCCC
Q 036172          212 EQKSITTLNGVCIEDNYLILVSDFLPKG-SLEESLHGAGEQSVLPWGVRFEVAVAIAEALN-YLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       212 ~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~~~giiHrDIkp~  289 (522)
                      .||++  -..+-.+++.+.+.++.-+++ ++. .++      .++...+++++.+|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67888  344456778888888876443 444 343      2788999999999888777 6655     688899999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhH-HHHHHHHHHHHcCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDV-YSFGVVLLELLSGRRPIG  363 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDV-wSlGvvl~eLltG~~Pf~  363 (522)
                      ||+++.++.++|.-.|+-.                   -++|.-     .+ ..|. -.+=+++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETT-------------------TBSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998777642                   122221     11 1222 256788888888887763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=85.97  E-value=0.52  Score=46.30  Aligned_cols=29  Identities=31%  Similarity=0.343  Sum_probs=25.2

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            5689999999999999 4 899999987743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.87  E-value=0.76  Score=48.11  Aligned_cols=36  Identities=22%  Similarity=0.238  Sum_probs=25.2

Q ss_pred             HHHHHHHhhCCCCCc-ceeeEEEEeCCEEEEEEecCCCCCH
Q 036172          202 SSEVDITSSLEQKSI-TTLNGVCIEDNYLILVSDFLPKGSL  241 (522)
Q Consensus       202 ~~Ev~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL  241 (522)
                      .+|+.+++.|...++ +++++++.  +  .+||||++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            478899998865554 57777762  3  259999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=82.76  E-value=0.69  Score=46.12  Aligned_cols=31  Identities=16%  Similarity=0.326  Sum_probs=27.5

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            6799999999999999888899999987743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=80.65  E-value=0.7  Score=46.43  Aligned_cols=28  Identities=25%  Similarity=0.398  Sum_probs=24.0

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++|+|+.+.|||++++. +.|+||..+
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a  239 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYS  239 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTC
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCC
Confidence            5699999999999998654 899999876

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	522
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-39
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-27
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 20/236 (8%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            F +EV +       +I    G       L +V+ +    SL   LH    +        
Sbjct: 50  AFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKL 106

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A   A+ ++YLH+   + +IHRD+KS+NI L  D   ++ DFGLA      S     
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163

Query: 320 EDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW 376
           E + G+  ++APE +        S + DVY+FG+VL EL++G+ P  + N+   + ++  
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFM 221

Query: 377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
                        L P LS    N   + M      C+ +    RP   Q+L  + 
Sbjct: 222 VG--------RGYLSPDLSKVRSNC-PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-45
 Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 26/254 (10%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPW 256
             +E+  T  L  ++I        +DN     L LVSD+   GSL + L+       +  
Sbjct: 44  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTV 99

Query: 257 GVRFEVAVAIAEALNYLHSEC-----SRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW-- 309
               ++A++ A  L +LH E         + HRD+KS NIL+  +    ++D GLA+   
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYL------MHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
             TD+  +     VGT  Y+APE L       H +   + D+Y+ G+V  E+       G
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219

Query: 364 FKNLKGP----ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLA-ANLCINQSP 418
                            +   ++    E  L P + N + + +  R++      C   + 
Sbjct: 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279

Query: 419 QLRPNMGQVLKLLR 432
             R    ++ K L 
Sbjct: 280 AARLTALRIKKTLS 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 7e-44
 Identities = 59/258 (22%), Positives = 103/258 (39%), Gaps = 36/258 (13%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           N    E+ +        I    G    D  + +  + +  GSL++ L  AG    +P  +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQI 105

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             +V++A+ + L YL  +    ++HRDVK SNIL++S  + +L DFG++        +  
Sbjct: 106 LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-- 161

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK---------- 368
               VGT  Y++PE L     S + D++S G+ L+E+  GR PI   + K          
Sbjct: 162 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

Query: 369 -------------GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA----N 411
                            L  +            LLD  ++            L      N
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

Query: 412 LCINQSPQLRPNMGQVLK 429
            C+ ++P  R ++ Q++ 
Sbjct: 280 KCLIKNPAERADLKQLMV 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 8e-44
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 27/243 (11%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L +A  + +   +    EV+I S L   +I  L G   +   + L+ ++ P G++   L 
Sbjct: 39  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
              +               +A AL+Y HS   + VIHRD+K  N+LL S  + +++DFG 
Sbjct: 99  KLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGW 152

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           ++  P+         + GT  Y+ PE +      +K+D++S GV+  E L G+ P     
Sbjct: 153 SVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
            +     +   +    +  TE   D               L++    +  +P  RP + +
Sbjct: 209 YQETYKRISRVEFTFPDFVTEGARD---------------LISR--LLKHNPSQRPMLRE 251

Query: 427 VLK 429
           VL+
Sbjct: 252 VLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-42
 Identities = 50/235 (21%), Positives = 95/235 (40%), Gaps = 28/235 (11%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
            F  E ++   L+  +I                ++LV++ +  G+L+  L       V+ 
Sbjct: 54  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMK 110

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDFGLAIWGPTDS 314
             V       I + L +LH+    P+IHRD+K  NI ++      ++ D GLA       
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
                  V+GT  ++APE     K  + +DVY+FG+ +LE+ +   P  +   +    + 
Sbjct: 170 AKA----VIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIY 222

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           +     + +G      D     E     ++ ++     CI Q+   R ++  +L 
Sbjct: 223 R----RVTSGVKPASFDKVAIPE-----VKEIIEG---CIRQNKDERYSIKDLLN 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-42
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 21/233 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E ++   L    +  L GVC+E   + LV +F+  G L +  +   ++ +      
Sbjct: 46  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETL 103

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
             + + + E + YL       VIHRD+ + N L+  +   ++SDFG+  +   D      
Sbjct: 104 LGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-S 159

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
                   + +PE     + S K DV+SFGV++ E+ S  +       +    +V+    
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDIST 217

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
             +      L  P+L++         +    N C  + P+ RP   ++L+ L 
Sbjct: 218 GFR------LYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-41
 Identities = 55/237 (23%), Positives = 109/237 (45%), Gaps = 21/237 (8%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           S + + F +E ++   L+ + +  L  V  ++   I +++++  GSL + L        L
Sbjct: 49  SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIK-L 106

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 ++A  IAE + ++     R  IHRD++++NIL+S     +++DFGLA     D+
Sbjct: 107 TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DN 162

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
            +  RE       + APE + +G  + K DV+SFG++L E+++  R   +  +  PE + 
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQ 221

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
              +          +       E     + +++    LC  + P+ RP    +  +L
Sbjct: 222 NLER------GYRMVRPDNCPEE-----LYQLMR---LCWKERPEDRPTFDYLRSVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 23/235 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAG-EQSVLPW 256
              SEV++   L+  +I       I+  +  L +V ++   G L   +     E+  L  
Sbjct: 49  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108

Query: 257 GVRFEVAVAIAEALNYLH--SECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                V   +  AL   H  S+    V+HRD+K +N+ L      +L DFGLA     D+
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
           +    +  VGT  Y++PE +     ++K D++S G +L EL +   P  F      E   
Sbjct: 169 SFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAG 224

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           K  +   +       +  + S+E     +  ++      +N     RP++ ++L+
Sbjct: 225 KIREGKFRR------IPYRYSDE-----LNEIITR---MLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 26/248 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K   ++      D+  E+DI +S +  +I  L      +N L ++ +F   G+++  + 
Sbjct: 42  AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                  L       V     +ALNYLH      +IHRD+K+ NIL + D   +L+DFG+
Sbjct: 102 ELERP--LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGV 156

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRP 361
           +            +  +GT  ++APE +M           K DV+S G+ L+E+     P
Sbjct: 157 SAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                L     L+K    I K+         + S+ + +  +++ L        ++   R
Sbjct: 215 --HHELNPMRVLLK----IAKSEPPTLAQPSRWSSNFKDF-LKKCL-------EKNVDAR 260

Query: 422 PNMGQVLK 429
               Q+L+
Sbjct: 261 WTTSQLLQ 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (373), Expect = 4e-41
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 30/246 (12%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           +  +  Q +  W D   EV     L   +     G  + ++   LV ++    + +    
Sbjct: 48  MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 107

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               +  L       V     + L YLHS     +IHRDVK+ NILLS     +L DFG 
Sbjct: 108 ---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS 161

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLM---HGKVSDKIDVYSFGVVLLELLSGRRPIG 363
           A      ++       VGT  ++APE ++    G+   K+DV+S G+  +EL   + P  
Sbjct: 162 ASIMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-- 213

Query: 364 FKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN 423
             N+    +L      I +N        P L + + +   +  + +   C+ + PQ RP 
Sbjct: 214 LFNMNAMSALYH----IAQNE------SPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260

Query: 424 MGQVLK 429
              +LK
Sbjct: 261 SEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-41
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 24/235 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   E  I   L+   I  L GVC +   L+LV +    G L + L G  E+  +P    
Sbjct: 55  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNV 111

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIW-GPTDSTHMI 318
            E+   ++  + YL     +  +HRD+ + N+LL +    ++SDFGL+   G  DS +  
Sbjct: 112 AELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWA 377
           R        + APE +   K S + DV+S+GV + E LS G++P  +K +KGPE +    
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAF-- 224

Query: 378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
             I +    E    P+   E     +  ++     C     + RP+   V + +R
Sbjct: 225 --IEQGKRME--CPPECPPE-----LYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 25/234 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            F +E  + + L   ++  L GV +E+   L +V++++ KGSL + L   G +SVL    
Sbjct: 46  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDC 104

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
             + ++ + EA+ YL        +HRD+ + N+L+S D   ++SDFGL     +      
Sbjct: 105 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 161

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
                    + APE L   K S K DV+SFG++L E+ S  R         P   +K   
Sbjct: 162 -----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------YPRIPLKDVV 210

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
           P ++ G           +    A  + M      C +    +RP+  Q+ + L 
Sbjct: 211 PRVEKG-----YKMDAPDGCPPAVYEVMK----NCWHLDAAMRPSFLQLREQLE 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-40
 Identities = 51/258 (19%), Positives = 100/258 (38%), Gaps = 38/258 (14%)

Query: 195 SSAWNDFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ-- 251
           SS      SE+ + + L   ++I  L G C     + L+ ++   G L   L    E+  
Sbjct: 81  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140

Query: 252 ------------------SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILL 293
                             +VL +      A  +A+ + +L     +  +HRD+ + N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 197

Query: 294 SSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLL 353
           +     ++ DFGLA    +DS +++R +      ++APE L  G  + K DV+S+G++L 
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

Query: 354 ELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLC 413
           E+ S      +  +    +  K             L+      +      + + +    C
Sbjct: 258 EIFSLGVNP-YPGIPVDANFYK-------------LIQNGFKMDQPFYATEEIYIIMQSC 303

Query: 414 INQSPQLRPNMGQVLKLL 431
                + RP+   +   L
Sbjct: 304 WAFDSRKRPSFPNLTSFL 321

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 9e-40
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 21/231 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   E+ I   L  +++    G   E N   L  ++   G L + +        +P    
Sbjct: 49  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDA 105

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
                 +   + YLH      + HRD+K  N+LL      ++SDFGLA     ++   + 
Sbjct: 106 QRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162

Query: 320 EDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
             + GT  Y+APE L   +     +DV+S G+VL  +L+G  P    +    +S  +++ 
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----DSCQEYS- 217

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
              K   T      K+ +      + ++L        ++P  R  +  + K
Sbjct: 218 -DWKEKKTYLNPWKKIDSAPLAL-LHKIL-------VENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-39
 Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 33/250 (13%)

Query: 200 DFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAG--------- 249
              SE+ + S L    +I  L G C      ++++++   G L   L             
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 250 ------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD 303
                 ++  L        +  +A+ + +L S   +  IHRD+ + NILL+     ++ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICD 188

Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
           FGLA     DS ++++ +      ++APE + +   + + DV+S+G+ L EL S      
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 247

Query: 364 FKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN 423
           +  +       K  K               LS E+  A+M  ++     C +  P  RP 
Sbjct: 248 YPGMPVDSKFYKMIKEGF----------RMLSPEHAPAEMYDIMK---TCWDADPLKRPT 294

Query: 424 MGQVLKLLRG 433
             Q+++L+  
Sbjct: 295 FKQIVQLIEK 304

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 5e-39
 Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 21/238 (8%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           S + ++F  E  +  +L  + +  L GVC +   + ++++++  G L   L     +   
Sbjct: 40  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRF 97

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                 E+   + EA+ YL S   +  +HRD+ + N L++     ++SDFGL+ +   D 
Sbjct: 98  QTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
                        +  PE LM+ K S K D+++FGV++ E+ S  +   ++     E+  
Sbjct: 155 YTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAE 212

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
             A+          L  P L++E       ++      C ++    RP    +L  + 
Sbjct: 213 HIAQG-------LRLYRPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-39
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 23/243 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           ++Q   Q         +E+ +    +  +I       +  + L +V ++L  GSL + + 
Sbjct: 50  IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                     G    V     +AL +LHS     VIHRD+KS NILL  D   +L+DFG 
Sbjct: 110 ETCM----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 162

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
                 + +      +VGT  ++APE +       K+D++S G++ +E++ G  P  + N
Sbjct: 163 CAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLN 218

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
                +L      I  NG  E     KLS  + +  + R L       +   + R +  +
Sbjct: 219 ENPLRALYL----IATNGTPELQNPEKLSAIFRDF-LNRCL-------DMDVEKRGSAKE 266

Query: 427 VLK 429
           +L+
Sbjct: 267 LLQ 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (350), Expect = 6e-38
 Identities = 46/254 (18%), Positives = 95/254 (37%), Gaps = 39/254 (15%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV------ 253
           DF  E  + +  +  +I  L GVC     + L+ +++  G L E L      +V      
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 254 ---------------LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ 298
                          L    +  +A  +A  + YL     R  +HRD+ + N L+  +  
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV 178

Query: 299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG 358
            +++DFGL+    +   +    +      ++ PE + + + + + DV+++GVVL E+ S 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 359 RRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSP 418
                +  +   E +       +                        +     LC ++ P
Sbjct: 239 GLQP-YYGMAHEEVIYYVRDGNIL--------------ACPENCPLELYNLMRLCWSKLP 283

Query: 419 QLRPNMGQVLKLLR 432
             RP+   + ++L+
Sbjct: 284 ADRPSFCSIHRILQ 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 6e-38
 Identities = 49/235 (20%), Positives = 98/235 (41%), Gaps = 23/235 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE-DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
            F +E  I       ++ +L G+C+  +   ++V  ++  G L   +        +   +
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IWGPTDSTH 316
            F + VA       +    S+  +HRD+ + N +L   F  +++DFGLA  ++     + 
Sbjct: 134 GFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188

Query: 317 MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW 376
             +        ++A E L   K + K DV+SFGV+L EL++   P          +    
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDI 243

Query: 377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
              +L+      LL P    EY    +  ++L    C +   ++RP+  +++  +
Sbjct: 244 TVYLLQG---RRLLQP----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (347), Expect = 1e-37
 Identities = 51/252 (20%), Positives = 102/252 (40%), Gaps = 23/252 (9%)

Query: 195 SSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
           +    +F  E  +   ++  ++  L GVC  +    ++++F+  G+L + L     Q  +
Sbjct: 54  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-V 112

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
              V   +A  I+ A+ YL     +  IHRD+ + N L+  +   +++DFGL+     D+
Sbjct: 113 SAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
                        + APE L + K S K DV++FGV+L E+ +               + 
Sbjct: 170 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY 226

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA 434
           +             LL+     E      +++      C   +P  RP+  ++ +     
Sbjct: 227 E-------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

Query: 435 ---THATDWVDR 443
              +  +D V++
Sbjct: 274 FQESSISDEVEK 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-37
 Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 25/236 (10%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           ++  +E ++   L+   I  + G+C  +++++ V +    G L + L        +    
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYLQQNRH---VKDKN 108

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM- 317
             E+   ++  + YL        +HRD+ + N+LL +    ++SDFGL+     D  +  
Sbjct: 109 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKW 376
            +        + APE + + K S K DV+SFGV++ E  S G++P  ++ +KG E     
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTAM- 222

Query: 377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
               L+ G+           E     M  ++    LC     + RP    V   LR
Sbjct: 223 ----LEKGERMG-CPAGCPRE-----MYDLMN---LCWTYDVENRPGFAAVELRLR 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 3e-37
 Identities = 54/303 (17%), Positives = 108/303 (35%), Gaps = 73/303 (24%)

Query: 182 FSYEELKQATSQFSS--------------------------------------------- 196
           F++E+  +A  +F+                                              
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 197 ---AWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSV 253
                 DF SE  I    +  ++  L GV  +   ++++++F+  GSL+           
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTD 313
                   +   IA  + YL        +HRD+ + NIL++S+   ++SDFGL+ +   D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 314 STHMIREDVVG---TFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKG 369
           ++       +G      + APE + + K +   DV+S+G+V+ E++S G RP  + ++  
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTN 239

Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
            + +                ++              +      C  +    RP  GQ++ 
Sbjct: 240 QDVINA--------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 430 LLR 432
            L 
Sbjct: 286 TLD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 6e-37
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 21/232 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            F  E  +   L  + +  L  V  E+   I V++++ KGSL + L G   + +      
Sbjct: 58  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYL-RLPQL 115

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++A  IA  + Y+        +HRD++++NIL+  +   +++DFGLA     +     R
Sbjct: 116 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-R 171

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
           +       + APE  ++G+ + K DV+SFG++L EL +  R            ++     
Sbjct: 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQ--- 226

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
           + +         P+      +            C  + P+ RP    +   L
Sbjct: 227 VERGYRMP--CPPECPESLHD--------LMCQCWRKEPEERPTFEYLQAFL 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 7e-36
 Identities = 49/248 (19%), Positives = 95/248 (38%), Gaps = 21/248 (8%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           DF  E  I       +I  L GV  +   ++++++++  G+L++      +         
Sbjct: 55  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQL 112

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI- 318
             +   IA  + YL +      +HRD+ + NIL++S+   ++SDFGL+     D      
Sbjct: 113 VGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
                    + APE + + K +   DV+SFG+V+ E+++      ++             
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------------- 216

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT 438
             L N +    ++              +      C  Q    RP    ++ +L     A 
Sbjct: 217 --LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

Query: 439 DWVDRHAD 446
           D +   AD
Sbjct: 275 DSLKTLAD 282

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 21/262 (8%)

Query: 172 LKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL 231
               S +    + + LK        A +DF  EV+   SL+ +++  L GV      + +
Sbjct: 29  WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKM 87

Query: 232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI 291
           V++  P GSL +       Q     G     AV +AE + YL S   +  IHRD+ + N+
Sbjct: 88  VTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNL 142

Query: 292 LLSSDFQPQLSDFGLAIWGPTDSTHMIRED-VVGTFGYIAPEYLMHGKVSDKIDVYSFGV 350
           LL++    ++ DFGL    P +  H + ++     F + APE L     S   D + FGV
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202

Query: 351 VLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA 410
            L E+ +  +   +  L G + L K     +               +     +  +++  
Sbjct: 203 TLWEMFTYGQEP-WIGLNGSQILHK-----IDKEGERLPRPEDCPQD-----IYNVMV-- 249

Query: 411 NLCINQSPQLRPNMGQVLKLLR 432
             C    P+ RP    +   L 
Sbjct: 250 -QCWAHKPEDRPTFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 52/247 (21%), Positives = 97/247 (39%), Gaps = 35/247 (14%)

Query: 200 DFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG----------- 247
           DF+ E+++   L    +I  L G C    YL L  ++ P G+L + L             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 248 --AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                 S L        A  +A  ++YL     +  IHRD+ + NIL+  ++  +++DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172

Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK 365
           L+          +         ++A E L +   +   DV+S+GV+L E++S      + 
Sbjct: 173 LSRGQEVYVKKTM---GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YC 228

Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
                 +  +  + + +    E        +E     +  ++     C  + P  RP+  
Sbjct: 229 G----MTCAELYEKLPQGYRLE--KPLNCDDE-----VYDLMR---QCWREKPYERPSFA 274

Query: 426 QVLKLLR 432
           Q+L  L 
Sbjct: 275 QILVSLN 281

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 23/250 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L++      +     + E D+ S L+      L     +D  L     +   G L + + 
Sbjct: 41  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
             G                 AE ++ L     + +IHRD+K  NILL+ D   Q++DFG 
Sbjct: 101 KIG---SFDET---CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 154

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKN 366
           A     +S        VGT  Y++PE L         D+++ G ++ +L++G  P  F+ 
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRA 212

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQ 426
                   K    I+K    E     K   +  +  ++++L             R    +
Sbjct: 213 GNEYLIFQK----IIKL---EYDFPEKFFPKARDL-VEKLL-------VLDATKRLGCEE 257

Query: 427 VLKLLRGATH 436
           +        H
Sbjct: 258 MEGYGPLKAH 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 40/232 (17%), Positives = 88/232 (37%), Gaps = 21/232 (9%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
           +   E  + +S++   +  L G+C+     ++    +P G L + +    +         
Sbjct: 57  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI--GSQYL 113

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
               V IA+ +NYL     R ++HRD+ + N+L+ +    +++DFGLA     +      
Sbjct: 114 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
           E       ++A E ++H   + + DV+S+GV + EL++                      
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYD 215

Query: 380 ILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLL 431
            +   +  ++L+              + +    C       RP   +++   
Sbjct: 216 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 42/244 (17%), Positives = 95/244 (38%), Gaps = 25/244 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQ-------S 252
           +F +E  +        +  L GV  +    +++ + + +G L+  L             +
Sbjct: 69  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 253 VLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPT 312
                   ++A  IA+ + YL    +   +HRD+ + N +++ DF  ++ DFG+      
Sbjct: 129 PPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES 372
              +      +    +++PE L  G  +   DV+SFGVVL E+ +      ++ L   + 
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQV 244

Query: 373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
           L    +  L               +  +     +     +C   +P++RP+  +++  ++
Sbjct: 245 LRFVMEGGLL--------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 433 GATH 436
               
Sbjct: 291 EEME 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 50/245 (20%), Positives = 94/245 (38%), Gaps = 23/245 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K   +   S       E+   S L   ++  L+    +DN ++++ +F+  G L E + 
Sbjct: 56  AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 115

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF--QPQLSDF 304
              E + +      E    + + L ++H       +H D+K  NI+ ++    + +L DF
Sbjct: 116 D--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 170

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GL        +        GT  + APE      V    D++S GV+   LLSG  P  F
Sbjct: 171 GLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--F 225

Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
                 E+L         + + +      +S +  +  ++++L          P  R  +
Sbjct: 226 GGENDDETLRNVKS---CDWNMDDSAFSGISEDGKDF-IRKLL-------LADPNTRMTI 274

Query: 425 GQVLK 429
            Q L+
Sbjct: 275 HQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  127 bits (321), Expect = 2e-33
 Identities = 45/245 (18%), Positives = 88/245 (35%), Gaps = 23/245 (9%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
            K   + +        +E+ I + L    +  L+    +   ++L+ +FL  G L + + 
Sbjct: 59  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ--LSDF 304
               +  +             E L ++H      ++H D+K  NI+  +       + DF
Sbjct: 119 AEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 173

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGF 364
           GLA     D           T  + APE +    V    D+++ GV+   LLSG  P   
Sbjct: 174 GLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--- 227

Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
               G + L         + + +      +S E  +  ++ +L        + P+ R  +
Sbjct: 228 --FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF-IKNLL-------QKEPRKRLTV 277

Query: 425 GQVLK 429
              L+
Sbjct: 278 HDALE 282

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 3e-33
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 31/231 (13%)

Query: 216 ITTLNGVCIED-NYLILVSDFLPKGSLEESLHGAGEQSV-------------LPWGVRFE 261
           +  L G C +    L+++ +F   G+L   L     + V             L       
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 262 VAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRED 321
            +  +A+ + +L S   R  IHRD+ + NILLS     ++ DFGLA     D  ++ + D
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 322 VVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL 381
                 ++APE +     + + DV+SFGV+L E+ S               + +     L
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-----VKIDEEFCRRL 250

Query: 382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
           K G      D      Y   +M + +L    C +  P  RP   ++++ L 
Sbjct: 251 KEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 32/246 (13%)

Query: 200 DFSSEVDITSSLEQ-KSITTLNGVCIEDNYLILVSDFLPKGSLEESLH------------ 246
           D  SE+++   + + K+I  L G C +D  L ++ ++  KG+L E L             
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123

Query: 247 -GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
                +  L        A  +A  + YL S   +  IHRD+ + N+L++ D   +++DFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180

Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK 365
           LA        +    +      ++APE L     + + DV+SFGV+L E+ +        
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--- 237

Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
               P   V+    +LK G          +NE     +  M+     C +  P  RP   
Sbjct: 238 ---YPGVPVEELFKLLKEGHRMD-KPSNCTNE-----LYMMMRD---CWHAVPSQRPTFK 285

Query: 426 QVLKLL 431
           Q+++ L
Sbjct: 286 QLVEDL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  121 bits (305), Expect = 7e-32
 Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 29/236 (12%)

Query: 201 FSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
              EVDI   +    +I  L      + +  LV D + KG L + L    E+  L     
Sbjct: 56  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKET 112

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
            ++  A+ E +  LH      ++HRD+K  NILL  D   +L+DFG +            
Sbjct: 113 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-- 167

Query: 320 EDVVGTFGYIAPEYLM------HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL 373
            +V GT  Y+APE +       H     ++D++S GV++  LL+G  P  F + K    L
Sbjct: 168 -EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLML 224

Query: 374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
                   + G  E       S+   +  + R L          PQ R    + L 
Sbjct: 225 RMIMSGNYQFGSPE---WDDYSDTVKDL-VSRFL-------VVQPQKRYTAEEALA 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 24/234 (10%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
            F  E       +   I  L GV   +N + ++ +    G L         +  L     
Sbjct: 54  KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASL 110

Query: 260 FEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIR 319
              A  ++ AL YL S   +  +HRD+ + N+L+SS+   +L DFGL+ +   DST+   
Sbjct: 111 ILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKA 166

Query: 320 EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELL-SGRRPIGFKNLKGPESLVKWAK 378
                   ++APE +   + +   DV+ FGV + E+L  G +P            ++  +
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR 432
            +         + P          +  ++     C    P  RP   ++   L 
Sbjct: 227 RL--------PMPPNCPPT-----LYSLMTK---CWAYDPSRRPRFTELKAQLS 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 55/253 (21%), Positives = 104/253 (41%), Gaps = 26/253 (10%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDN----YLILVSDFLPKGSLE 242
           L+   ++  S +  F  E    ++L   +I  +      +        +V +++   +L 
Sbjct: 40  LRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99

Query: 243 ESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
           + +H  G    +      EV     +ALN+        +IHRDVK +NI++S+    ++ 
Sbjct: 100 DIVHTEGP---MTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVM 153

Query: 303 DFGLAIWGPTDSTHMIR-EDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           DFG+A         + +   V+GT  Y++PE      V  + DVYS G VL E+L+G  P
Sbjct: 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213

Query: 362 IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
             F          +    + ++    +     LS + D   + + L        ++P+ R
Sbjct: 214 --FTGDSPVSVAYQH---VREDPIPPSARHEGLSADLDAV-VLKAL-------AKNPENR 260

Query: 422 PNMGQVLK--LLR 432
                 ++  L+R
Sbjct: 261 YQTAAEMRADLVR 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 2e-30
 Identities = 43/231 (18%), Positives = 85/231 (36%), Gaps = 23/231 (9%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
              E+ I +    ++I  L+        L+++ +F+    + E ++ +  +  L      
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIV 105

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ--LSDFGLAIWGPTDSTHMI 318
                + EAL +LHS     + H D++  NI+  +       + +FG A          +
Sbjct: 106 SYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK 378
              +     Y APE   H  VS   D++S G ++  LLSG  P  F      + +     
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMN 217

Query: 379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
                   +     ++S E  +  + R+L        +  + R    + L+
Sbjct: 218 ---AEYTFDEEAFKEISIEAMDF-VDRLL-------VKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 21/230 (9%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
             +E+ +   ++  +I  L+ +     +L L+   +  G L + +    E+         
Sbjct: 54  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDAS 110

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
            +   + +A+ YLH         +        L  D +  +SDFGL+      S      
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LS 167

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
              GT GY+APE L     S  +D +S GV+   LL G  P  F +    E+  K  + I
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYD----ENDAKLFEQI 221

Query: 381 LK-NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
           LK   + ++     +S+   +  ++ ++        + P+ R    Q L+
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDF-IRHLM-------EKDPEKRFTCEQALQ 263

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 47/242 (19%), Positives = 81/242 (33%), Gaps = 24/242 (9%)

Query: 200 DFSSEVDITSSLEQKS-ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
               E  I   ++    I T+     E +Y ++V + L     +     + +        
Sbjct: 48  QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKT 104

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS---DFQPQLSDFGLAIWGPTDST 315
              +A  +   + Y+HS   +  IHRDVK  N L+          + DFGLA       T
Sbjct: 105 VLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161

Query: 316 H-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGP 370
           H        +++ GT  Y +    +  + S + D+ S G VL+    G  P         
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

Query: 371 ESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKL 430
               +       +   E  L     +E         L   N C +     +P+   + +L
Sbjct: 222 RQKYERISEKKMSTPIEV-LCKGYPSE-----FATYL---NFCRSLRFDDKPDYSYLRQL 272

Query: 431 LR 432
            R
Sbjct: 273 FR 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-28
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 30/250 (12%)

Query: 200 DFSSEVDITSSLEQKS---ITTLNGVCI-----EDNYLILVSDFLPKGSLEESLHGAGEQ 251
               EV +   LE      +  L  VC       +  L LV + + +            +
Sbjct: 53  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPE 110

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP 311
             +P     ++   +   L++LHS     V+HRD+K  NIL++S  Q +L+DFGLA    
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--- 164

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
             S  M    VV T  Y APE L+    +  +D++S G +  E+   +    F+     +
Sbjct: 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVD 222

Query: 372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRML---------LAANL---CINQSPQ 419
            L K    I   G+ +   D  L  +  +++  + +         L  +L   C+  +P 
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282

Query: 420 LRPNMGQVLK 429
            R +    L 
Sbjct: 283 KRISAYSALS 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 8e-28
 Identities = 61/313 (19%), Positives = 111/313 (35%), Gaps = 35/313 (11%)

Query: 187 LKQATSQFSSAWNDFSSEVDITS-SLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESL 245
           LK+              E  + S + E   +T +         L  V ++L  G L   +
Sbjct: 35  LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG 305
               +            A  I   L +L    S+ +++RD+K  NILL  D   +++DFG
Sbjct: 95  QSCHK---FDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFG 148

Query: 306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK 365
           +                 GT  YIAPE L+  K +  +D +SFGV+L E+L G+ P   +
Sbjct: 149 MCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206

Query: 366 NLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
           + +     ++   P       +   D           + ++         + P+ R  + 
Sbjct: 207 DEEELFHSIRMDNPFYPRWLEKEAKD----------LLVKLF-------VREPEKRLGVR 249

Query: 426 QVLK---LLRGATHATDWVDRHADDILGSGI-QFQEDDDCQKFSSKPHLDFPILDIDLEA 481
             ++   L R      +W +    +I      + +   DC  F  +   + P L    + 
Sbjct: 250 GDIRQHPLFRE----INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFA-DR 304

Query: 482 TSPSSIYTKSFSG 494
              +S+    F  
Sbjct: 305 ALINSMDQNMFRN 317

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 47/177 (26%), Positives = 72/177 (40%), Gaps = 11/177 (6%)

Query: 204 EVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVA 263
            + + S+ +   I  ++      + L  + D +  G L   L    +  V         A
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYA 113

Query: 264 VAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVV 323
             I   L ++H+   R V++RD+K +NILL      ++SD GLA        H      V
Sbjct: 114 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166

Query: 324 GTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKP 379
           GT GY+APE L  G   D   D +S G +L +LL G  P      K    + +    
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 55/247 (22%), Positives = 89/247 (36%), Gaps = 19/247 (7%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
                E+ I      ++I  +N +        +   +L    +   L+   +   L    
Sbjct: 51  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDH 110

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA-IWGPTDSTHM 317
                  I   L Y+HS     V+HRD+K SN+LL++    ++ DFGLA +  P      
Sbjct: 111 ICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167

Query: 318 IREDVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKN---------- 366
              + V T  Y APE +++ K     ID++S G +L E+LS R     K+          
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227

Query: 367 LKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA----NLCINQSPQLRP 422
           + G  S       I        L  P  +    N         A    +  +  +P  R 
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

Query: 423 NMGQVLK 429
            + Q L 
Sbjct: 288 EVEQALA 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (272), Expect = 6e-27
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 11/175 (6%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           LK+            + E  + S +    I  + G   +   + ++ D++  G L   L 
Sbjct: 37  LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
            +                  AE    L    S+ +I+RD+K  NILL  +   +++DFG 
Sbjct: 97  KSQRFP------NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
           A + P  +  +      GT  YIAPE +     +  ID +SFG+++ E+L+G  P
Sbjct: 151 AKYVPDVTYTL-----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (268), Expect = 9e-27
 Identities = 34/244 (13%), Positives = 73/244 (29%), Gaps = 26/244 (10%)

Query: 200 DFSSEVDITSSLEQKS-ITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
               E      L   + I  +     E  + +LV D L     +                
Sbjct: 46  QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKT 102

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ-----LSDFGLAIWGPTD 313
               A  +   +  +H    + +++RD+K  N L+            + DFG+  +    
Sbjct: 103 VAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159

Query: 314 STH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
            T        ++++ GT  Y++    +  + S + D+ + G V +  L G  P       
Sbjct: 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219

Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVL 428
             +   +      ++     L       E       + +   +   N +    P+   + 
Sbjct: 220 TNKQKYERIGEKKQSTPLRELC-AGFPEE-----FYKYM---HYARNLAFDATPDYDYLQ 270

Query: 429 KLLR 432
            L  
Sbjct: 271 GLFS 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 54/246 (21%), Positives = 97/246 (39%), Gaps = 26/246 (10%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHG 247
           +  +S+   +  D   EV I   ++  ++ TL+ V      +IL+ + +  G L + L  
Sbjct: 47  RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA- 105

Query: 248 AGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQ----LSD 303
             E+  L      E    I   +   +   S  + H D+K  NI+L     P+    + D
Sbjct: 106 --EKESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160

Query: 304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIG 363
           FGLA      +      ++ GT  ++APE + +  +  + D++S GV+   LLSG  P  
Sbjct: 161 FGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-- 215

Query: 364 FKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN 423
                G       A     N + E       S    +  ++R+L        + P+ R  
Sbjct: 216 ---FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF-IRRLL-------VKDPKKRMT 264

Query: 424 MGQVLK 429
           +   L+
Sbjct: 265 IQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 28/240 (11%)

Query: 200 DFSSEVDITSSLEQ-KSITTLNGVC----IEDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
               EV++     Q   I  +  V          L++V + L  G L   +   G+Q+  
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-F 108

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP---QLSDFGLAIWGP 311
                 E+  +I EA+ YLHS     + HRDVK  N+L +S       +L+DFG A    
Sbjct: 109 TEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

Query: 312 TDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
           + ++         T  Y+APE L   K     D++S GV++  LL G  P  F +  G  
Sbjct: 166 SHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLA 220

Query: 372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQ--MQRMLLAANLCINQSPQLRPNMGQVLK 429
                   I          +P+ S   +  +  ++ +L          P  R  + + + 
Sbjct: 221 ISPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLL-------KTEPTQRMTITEFMN 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 1e-25
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 36/233 (15%)

Query: 201 FSSEVDITSSLEQ--KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
              EV +   +      +  L       +  +L+ +               E+  L   +
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEEL 111

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLAIWGPTDSTHM 317
                  + EA+ +     +  V+HRD+K  NIL+  +  + +L DFG            
Sbjct: 112 ARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT- 167

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDK-IDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW 376
              D  GT  Y  PE++ + +   +   V+S G++L +++ G  P      +  E +++ 
Sbjct: 168 ---DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219

Query: 377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK 429
                     +     ++S+E  +  ++  L          P  RP   ++  
Sbjct: 220 ----------QVFFRQRVSSECQHL-IRWCL-------ALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 44/256 (17%), Positives = 93/256 (36%), Gaps = 32/256 (12%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE--------DNYLILVSDFLPKGSLEESLHGAGEQ 251
               E+ I   L+ +++  L  +C             + LV DF          +   + 
Sbjct: 55  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 114

Query: 252 SVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA--IW 309
           ++       E+   +   LN L+      ++HRD+K++N+L++ D   +L+DFGLA    
Sbjct: 115 TLS------EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168

Query: 310 GPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLK 368
              +S      + V T  Y  PE L+  +     ID++  G ++ E+ +    +     +
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228

Query: 369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---------------C 413
              +L+      +       + + +L  + +  + Q+  +   L                
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288

Query: 414 INQSPQLRPNMGQVLK 429
           +   P  R +    L 
Sbjct: 289 LVLDPAQRIDSDDALN 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 49/244 (20%), Positives = 94/244 (38%), Gaps = 20/244 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    E+ +   L   +I  L  V   +N L LV +FL +   +     A   + +P  +
Sbjct: 46  STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPL 103

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
                  + + L + HS     V+HRD+K  N+L++++   +L+DFGLA           
Sbjct: 104 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160

Query: 319 REDVVGTFGYIAPE-YLMHGKVSDKIDVYSFGVVLLELLSGRRP--------IGFKNLKG 369
               V T  Y APE  L     S  +D++S G +  E+++ R            F+  + 
Sbjct: 161 --HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218

Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAA----NLCINQSPQLRPNMG 425
             +  +   P + +        PK + +  +  +  +        +  ++  P  R +  
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

Query: 426 QVLK 429
             L 
Sbjct: 279 AALA 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 51/241 (21%), Positives = 84/241 (34%), Gaps = 20/241 (8%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
              E+ +   L   +I  L       + + LV DF+           +    VL      
Sbjct: 47  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIK 103

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
              +   + L YLH      ++HRD+K +N+LL  +   +L+DFGLA      S +    
Sbjct: 104 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYT 158

Query: 321 DVVGTFGYIAPEYLMHGKVSD-KIDVYSFGVVLLELLSGRRPIGFKN----------LKG 369
             V T  Y APE L   ++    +D+++ G +L ELL     +   +            G
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218

Query: 370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLA-ANLCINQSPQLRPNMGQVL 428
             +  +W               P +   +  +     LL         +P  R    Q L
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

Query: 429 K 429
           K
Sbjct: 279 K 279

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-25
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 30/252 (11%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIE------DNYLILVSDFLPKGSLEESLHGAGEQSV 253
             + E+ I   L+  +I  L            + YL LV D++P+     + H +  +  
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 254 LPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD-FQPQLSDFGLAIWGPT 312
           LP          +  +L Y+H   S  + HRD+K  N+LL  D    +L DFG A     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 313 DSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPE 371
              ++     + +  Y APE +      +  IDV+S G VL ELL G+    F    G +
Sbjct: 176 GEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVD 230

Query: 372 SLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLL-----------AANL---CINQS 417
            LV+  K +      +         E+   Q++               A  L    +  +
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290

Query: 418 PQLRPNMGQVLK 429
           P  R    +   
Sbjct: 291 PTARLTPLEACA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-24
 Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 8/175 (4%)

Query: 187 LKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           L++             +E  +  +     +T L       + L  V ++   G L   L 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
               + V             AE ++ L    SR V++RD+K  N++L  D   +++DFGL
Sbjct: 98  ---RERVFTEE---RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
              G +D   M      GT  Y+APE L        +D +  GVV+ E++ GR P
Sbjct: 152 CKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =   99 bits (248), Expect = 5e-24
 Identities = 50/244 (20%), Positives = 91/244 (37%), Gaps = 21/244 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    E+ I   L+  +I  L  V      L+LV + L +   +      G    L    
Sbjct: 45  STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVT 101

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
                + +   + Y H    R V+HRD+K  N+L++ + + +++DFGLA           
Sbjct: 102 AKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158

Query: 319 REDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPIGFKN----------L 367
               + T  Y AP+ LM   K S  ID++S G +  E+++G       +          +
Sbjct: 159 --HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

Query: 368 KGPESLVKWAK--PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG 425
            G  +   W     + K     T+ +P     +     +  +   +  +   P  R    
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

Query: 426 QVLK 429
           Q L+
Sbjct: 277 QALE 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.9 bits (235), Expect = 7e-22
 Identities = 55/297 (18%), Positives = 107/297 (36%), Gaps = 38/297 (12%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRF 260
             +E  I  ++    +  L     +++ L +V +++  G +   L   G           
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHAR 144

Query: 261 EVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIRE 320
             A  I     YLHS     +I+RD+K  N+L+      Q++DFG A      +  +   
Sbjct: 145 FYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-- 199

Query: 321 DVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI 380
              GT   +APE ++    +  +D ++ GV++ E+ +G  P            +   K  
Sbjct: 200 ---GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256

Query: 381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLK--LLRGATHAT 438
                         S++  +  + R LL  +L   +   L+  +  +            T
Sbjct: 257 ---------FPSHFSSDLKD--LLRNLLQVDLT-KRFGNLKNGVNDIKNHKWFAT----T 300

Query: 439 DWVDRHADDILGSGI-QFQEDDDCQKFSSKPHLDFPILDIDLEATSPSSIYTKSFSG 494
           DW+  +   +    I +F+   D   F      D+   +I +   S +    K F+ 
Sbjct: 301 DWIAIYQRKVEAPFIPKFKGPGDTSNFD-----DYEEEEIRV---SINEKCGKEFTE 349

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 2e-21
 Identities = 51/245 (20%), Positives = 90/245 (36%), Gaps = 22/245 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGV 258
           +    E+ +   L+ K+I  L+ V   D  L LV +F  +   +      G         
Sbjct: 46  SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------DLD 99

Query: 259 RFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMI 318
              V   + + L  L    SR V+HRD+K  N+L++ + + +L++FGLA           
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

Query: 319 REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPI-----------GFKNL 367
            E VV  +             S  ID++S G +  EL +  RP+               L
Sbjct: 160 AE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

Query: 368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANL---CINQSPQLRPNM 424
            G  +  +W   + K  D +       +    N   +      +L    +  +P  R + 
Sbjct: 219 LGTPTEEQWPS-MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

Query: 425 GQVLK 429
            + L+
Sbjct: 278 EEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 6e-21
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 23/242 (9%)

Query: 188 KQATSQFSSAWNDFSSEVDITSSLEQKS-ITTLNGVCIEDNYLILVSDFLPKGSLEESLH 246
           K    Q +       +E  +   + Q   + TL+     +  L L+ D++  G L   L 
Sbjct: 62  KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 121

Query: 247 GAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGL 306
                +     +         E +  L       +I+RD+K  NILL S+    L+DFGL
Sbjct: 122 QRERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175

Query: 307 AIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSD--KIDVYSFGVVLLELLSGRRPIGF 364
           +     D T    +   GT  Y+AP+ +  G       +D +S GV++ ELL+G  P  F
Sbjct: 176 SKEFVADETERAYDF-CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--F 232

Query: 365 KNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNM 424
                  S  + ++ ILK+   E     ++S    +  +QR+L        + P+ R   
Sbjct: 233 TVDGEKNSQAEISRRILKS---EPPYPQEMSALAKDL-IQRLL-------MKDPKKRLGC 281

Query: 425 GQ 426
           G 
Sbjct: 282 GP 283

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (213), Expect = 4e-19
 Identities = 44/246 (17%), Positives = 89/246 (36%), Gaps = 22/246 (8%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGA-GEQSVLPWG 257
                E+ +   +  +++  L  V   D  L   +DF        +  G   +   L   
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121

Query: 258 VRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHM 317
               +   + + L Y+H+     +IHRD+K  N+ ++ D + ++ DFGLA    ++ T  
Sbjct: 122 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 178

Query: 318 IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA 377
               VV  +       L   + +  +D++S G ++ E+++G+      +       +   
Sbjct: 179 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 378 KPILKNGDTETLLDPKLSN------EYDNAQMQRML-----LAANL---CINQSPQLRPN 423
                    + L   +  N      E +      +L     LA NL    +    + R  
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294

Query: 424 MGQVLK 429
            G+ L 
Sbjct: 295 AGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 80.7 bits (198), Expect = 3e-17
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 17/169 (10%)

Query: 199 NDFSSEVDITSSLEQ-KSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLP 255
                E+ I  +L    +I TL  +  +       LV + +     ++      +  +  
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF 133

Query: 256 WGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QPQLSDFGLAIWGPTDS 314
           +         I +AL+Y HS     ++HRDVK  N+++  +  + +L D+GLA +     
Sbjct: 134 Y------MYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184

Query: 315 THMIREDVVGTFGYIAPEYLM-HGKVSDKIDVYSFGVVLLELLSGRRPI 362
            + +R   V +  +  PE L+ +      +D++S G +L  ++  + P 
Sbjct: 185 EYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.1 bits (196), Expect = 6e-17
 Identities = 33/177 (18%), Positives = 63/177 (35%), Gaps = 16/177 (9%)

Query: 199 NDFSSEVDITSSLEQKSITTLNGVCIE-------------DNYLILVSDFLPKGSLEESL 245
                E+ +   +     T  + +                 N + +V  F   G    +L
Sbjct: 54  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113

Query: 246 HGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DFQPQLSDF 304
               E   +P     +++  +   L+Y+H  C   +IH D+K  N+L+   D    L   
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQI 171

Query: 305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP 361
            +A  G          + + T  Y +PE L+        D++S   ++ EL++G   
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 3e-16
 Identities = 50/262 (19%), Positives = 93/262 (35%), Gaps = 47/262 (17%)

Query: 201 FSSEVDITSSLEQKSITTLNGVCI------EDNYLILVSDFLPKGSLEESLHGAGEQSVL 254
              E+ +   +  K+I +L  V        E   + LV + +     +        + + 
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 122

Query: 255 PWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
                  +   +   + +LHS     +IHRD+K SNI++ SD   ++ DFGLA    T  
Sbjct: 123 ------YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRP------------- 361
                   V T  Y APE ++     + +D++S G ++ E++  +               
Sbjct: 174 MMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

Query: 362 --------------IGFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRML 407
                         +        E+  K+A         ++L      +    A   R L
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290

Query: 408 LAANLCINQSPQLRPNMGQVLK 429
           L+  L I+  P  R ++   L+
Sbjct: 291 LSKMLVID--PAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.7 bits (185), Expect = 1e-15
 Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 16/227 (7%)

Query: 200 DFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVR 259
               E+ +   ++ +++  L  V      L   +D      L   L GA   +++     
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKL 118

Query: 260 FEVAVA-----IAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGPTDS 314
            +  V      I   L Y+HS       HRD+K SN+ ++ D + ++ DFGLA     + 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 315 THMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV 374
           T  +       +       L     +  +D++S G ++ ELL+GR      +      L+
Sbjct: 176 TGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

Query: 375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLR 421
                       + +      N   +      +  AN+ I  +P   
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 57.5 bits (138), Expect = 3e-10
 Identities = 29/173 (16%), Positives = 60/173 (34%), Gaps = 17/173 (9%)

Query: 183 SYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLILVSDFLPKGSLE 242
            +   K+   +       FS     ++  E +++  L G+ +   Y           ++ 
Sbjct: 35  GHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE------GNAVL 88

Query: 243 ESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS 302
             L  A E   +      EV   I E +   +      ++H D+   N+L+ S+    + 
Sbjct: 89  MELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWII 144

Query: 303 DFGLAIW-GPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLE 354
           DF  ++  G      ++  DV     Y +  Y        + D+ S    +L+
Sbjct: 145 DFPQSVEVGEEGWREILERDVRNIITYFSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	522
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.23
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.58
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	81.27

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=415.32  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=207.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.+.||+|+||.||++.+..        +++.||+|.+...  ...+..++|.+|+.+|++++|||||++++++.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~--------~~~~vAiK~i~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV--------TEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEEehh--hcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            579999999999999999998653        4566777765322  122345679999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+||||||+++|+|.+++..   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CceeEEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccch
Confidence            9999999999999999999974   3359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +|+...............||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ....    ...
T Consensus       149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~----~~~  223 (271)
T d1nvra_         149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK----EKK  223 (271)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHH----TTC
T ss_pred             hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHh----cCC
Confidence            9987654433333445689999999999988776 578999999999999999999997554332211 1111    110


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ...         ......+..+.+++.+||+.||.+|||+.||++        |+|+++.
T Consensus       224 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--------hpwf~~~  266 (271)
T d1nvra_         224 TYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK--------DRWYNKP  266 (271)
T ss_dssp             TTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------CTTTTCC
T ss_pred             CCC---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--------CHhhCcC
Confidence            000         001123456788999999999999999999987        9998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=412.98  Aligned_cols=258  Identities=23%  Similarity=0.402  Sum_probs=213.4

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ...+|++++.||+|+||.||++.+..        +.+.||+|.+.+.........+.+.+|+.++++++|||||++++++
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   75 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQ--------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   75 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECC--------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            34689999999999999999998643        5677888876554433334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+++||||+++|+|.+++...+   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~D  149 (263)
T d2j4za1          76 HDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIAD  149 (263)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EECCEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecc
Confidence            99999999999999999999998543   49999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+++.......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+....    ..
T Consensus       150 FG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i----~~  218 (263)
T d2j4za1         150 FGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRI----SR  218 (263)
T ss_dssp             CCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH----HT
T ss_pred             cceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHH----Hc
Confidence            999976554332    245799999999999999999999999999999999999999965431   1222111    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      +..          .++...+..+.+++.+||+.||.+|||+.||++        |+|+..+
T Consensus       219 ~~~----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~--------hp~~~~~  261 (263)
T d2j4za1         219 VEF----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--------HPWITAN  261 (263)
T ss_dssp             TCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--------CHHHHHH
T ss_pred             CCC----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc--------CcCcCCc
Confidence            111          111223457888999999999999999999997        8898653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=407.94  Aligned_cols=257  Identities=22%  Similarity=0.316  Sum_probs=209.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.++||+|+||.||++.+..        +++.||+|.++...   ....+.|.+|+.+|++++|||||++++++.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~--------~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   87 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVA--------TGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYL   87 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTT--------TCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECC--------CCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence            3589999999999999999997643        46678887765322   224578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+||||||++||+|.+++...    .+++..+..++.||+.||.|||+   +||+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          88 VGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccc
Confidence            999999999999999999988743    49999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......  ..+..    ....+
T Consensus       161 G~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~----~~~~~  232 (293)
T d1yhwa1         161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL----IATNG  232 (293)
T ss_dssp             TTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHHC
T ss_pred             hhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHH----HHhCC
Confidence            999876543322  23457999999999999999999999999999999999999999643311  11111    11111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .. .+       ..+...+..+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       233 ~~-~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--------Hp~~~~  275 (293)
T d1yhwa1         233 TP-EL-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--------HQFLKI  275 (293)
T ss_dssp             SC-CC-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--------CGGGGG
T ss_pred             CC-CC-------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHhhCC
Confidence            11 01       111223467889999999999999999999986        999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=411.33  Aligned_cols=266  Identities=20%  Similarity=0.290  Sum_probs=211.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++++.||+|+||.||++.+..        +++.||+|.+.+.........+.|.+|+++|++++|||||++++++.
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELA--------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            3579999999999999999998643        46678888765543333345678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|+||||+++|+|.+++...+   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEeccc
Confidence            9999999999999999999988543   49999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+   ...+...   .. .+
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~---i~-~~  225 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQK---II-KL  225 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH---HH-TT
T ss_pred             ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHH---HH-cC
Confidence            99987765544444445689999999999999999999999999999999999999997542   1122111   11 11


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..          .++...+..+.+|+.+||+.||.+|||++|+++...  ...|+|++.
T Consensus       226 ~~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~--i~~Hpff~~  272 (288)
T d1uu3a_         226 EY----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP--LKAHPFFES  272 (288)
T ss_dssp             CC----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH--HHTSGGGTT
T ss_pred             CC----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH--HHcCCccCC
Confidence            11          111123456889999999999999999999765321  123777754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=405.57  Aligned_cols=263  Identities=23%  Similarity=0.328  Sum_probs=201.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....           .+|+|.++.. .......++|.+|+.+|++++|||||++++++.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------~vAvK~~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~   74 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-----------DVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST   74 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-----------EEEEEECCCS-SCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-----------EEEEEEEEcc-cCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence            4689999999999999999986432           2555554322 122346788999999999999999999999876


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +.++|||||+++|+|.+++....  ..+++..++.++.||+.||+|||+   ++||||||||+||||+.++.+||+||
T Consensus        75 ~-~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          75 A-PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             S-SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             c-cEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccc
Confidence            5 56899999999999999997543  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      |+|+...............||+.|+|||++.+   +.++.++|||||||++|||+||+.||.....  ...+......  
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~--  224 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGR--  224 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHH--
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhc--
Confidence            99987655444444456689999999999864   3589999999999999999999999965332  2222222211  


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                        +...    |. ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       225 --~~~~----p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 --GYLS----PD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             --TSCC----CC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCC----Cc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              1111    11 111222345678899999999999999999999999987653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-51  Score=405.89  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=209.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++....        +.+.||+|.+++.    ....++|.+|+.+|++++|||||+++++|.
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK--------YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT   83 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG--------GTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC--------CCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence            4689999999999999999997643        4556777766432    224578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+||
T Consensus        84 ~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          84 REPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eCCeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccc
Confidence            9999999999999999999997653 3459999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++........ ......|++.|+|||++.++.++.++|||||||++|||++|..||....  ....+....    ..+
T Consensus       160 G~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i----~~~  232 (287)
T d1opja_         160 GLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELL----EKD  232 (287)
T ss_dssp             CCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHH----HTT
T ss_pred             cceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHH----hcC
Confidence            999876544322 2234568999999999999999999999999999999999777653221  122222221    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..         ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       233 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 YR---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11         1112234467889999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=405.32  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=196.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++.+.||+|+||.||++.+..        +++.||+|.+..... .....+.|.+|+++|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS--------DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC--------CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            579999999999999999997653        456777777644322 22346789999999999999999999999975


Q ss_pred             --CCEEEEEEecCCCCCHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCEEeccCCCCceeccCCCceE
Q 036172          226 --DNYLILVSDFLPKGSLEESLHGA-GEQSVLPWGVRFEVAVAIAEALNYLHSEC--SRPVIHRDVKSSNILLSSDFQPQ  300 (522)
Q Consensus       226 --~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--~~giiHrDIkp~NILl~~~~~~k  300 (522)
                        ++.+|+|||||++|+|.+++... .....+++..++.++.||+.||.|||+..  ..+|+||||||+||||+.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              46689999999999999999753 22346999999999999999999999821  12499999999999999999999


Q ss_pred             EeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          301 LSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       301 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+|||+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+   ...+...    
T Consensus       155 l~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~----  225 (269)
T d2java1         155 LGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGK----  225 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH----
T ss_pred             EeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHH----
Confidence            9999999876543222  234689999999999999999999999999999999999999996432   2222211    


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWV  441 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~  441 (522)
                      +..+....+         +...+..+.+++.+||+.||.+|||+.||++        |+|+
T Consensus       226 i~~~~~~~~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~--------hp~i  269 (269)
T d2java1         226 IREGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE--------NPLI  269 (269)
T ss_dssp             HHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--------STTC
T ss_pred             HHcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh--------CCcC
Confidence            112222111         1123457889999999999999999999997        8874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=396.06  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=200.0

Q ss_pred             CCc-eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPF-QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y-~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ++| ++.++||+|+||.||++.+..        +.+.+|+|.+..... .....++|.+|+++|++++|||||++++++.
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~--------~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTE--------TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECC--------CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            455 788899999999999997643        345566665543221 2234678999999999999999999999997


Q ss_pred             e----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--EEeccCCCCceecc-CCC
Q 036172          225 E----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRP--VIHRDVKSSNILLS-SDF  297 (522)
Q Consensus       225 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~g--iiHrDIkp~NILl~-~~~  297 (522)
                      +    +..+++||||+++|+|.+++....   .+++..++.++.||+.||.|||+   ++  |+||||||+|||++ +++
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~  152 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTG  152 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTS
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCC
Confidence            5    356899999999999999998543   59999999999999999999999   77  99999999999996 578


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||+++......    .....||+.|+|||++. ++++.++|||||||++|||++|+.||....  ....+....
T Consensus       153 ~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i  225 (270)
T d1t4ha_         153 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRV  225 (270)
T ss_dssp             CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHH
T ss_pred             CEEEeecCcceeccCCc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHH
Confidence            99999999997643322    23567999999999885 469999999999999999999999996432  222222211


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                          ..+....        .++...+..+.+++.+||+.||++|||+.|+++        |+|++
T Consensus       226 ----~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~--------Hp~fk  270 (270)
T d1t4ha_         226 ----TSGVKPA--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--------HAFFQ  270 (270)
T ss_dssp             ----TTTCCCG--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGC
T ss_pred             ----HcCCCCc--------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC--------CcccC
Confidence                1111111        111123346888999999999999999999997        88874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=412.40  Aligned_cols=270  Identities=23%  Similarity=0.313  Sum_probs=207.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||+||++.+..        +++.||+|.++..  ......+++.+|+.+|++++|||||+++++|.
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~--------~~~~vAiK~i~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKP--------SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETT--------TTEEEEEEEEECC--CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECC--------CCcEEEEEEEChh--hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4689999999999999999998643        4567777766432  12334578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.++|||||+++|+|.+++.+.+   .+++..+..++.|++.||.|||+.  ++|+||||||+||||+.++.+||+||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeC
Confidence            9999999999999999999998543   499999999999999999999971  48999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh-hhhh--
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA-KPIL--  381 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~-~~~~--  381 (522)
                      |+|+......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........... ....  
T Consensus       150 Gla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  225 (322)
T d1s9ja_         150 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  225 (322)
T ss_dssp             CCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred             CCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence            9997543221    22458999999999999999999999999999999999999999754432211100000 0000  


Q ss_pred             ------cCCC--cccc-------------------cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          382 ------KNGD--TETL-------------------LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       382 ------~~~~--~~~~-------------------~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                            ..+.  ....                   ..+.+.   ....+..+.+++.+||+.||.+|||+.|+++     
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~-----  297 (322)
T d1s9ja_         226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV-----  297 (322)
T ss_dssp             --------------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT-----
T ss_pred             CCcccccccccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhh-----
Confidence                  0000  0000                   000000   0112356888999999999999999999997     


Q ss_pred             ccCCcccccc
Q 036172          435 THATDWVDRH  444 (522)
Q Consensus       435 ~~~~~~~~~~  444 (522)
                         |+|++..
T Consensus       298 ---Hpf~~~~  304 (322)
T d1s9ja_         298 ---HAFIKRS  304 (322)
T ss_dssp             ---SHHHHHH
T ss_pred             ---CHhhCcC
Confidence               8888753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=403.96  Aligned_cols=259  Identities=24%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++.++||+|+||.||++.+..        +++.+|+|.+++.   .....++|.+|+++|++++|||||++++++.+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   80 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE--------TSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYY   80 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC--------CCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            579999999999999999997643        4566777765432   23356789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.++|||||+++|+|.+++....  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          81 ENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEech
Confidence            999999999999999999987542  359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLM-----HGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|+......  .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......  .+....   
T Consensus       156 ~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i~---  228 (288)
T d2jfla1         156 VSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKIA---  228 (288)
T ss_dssp             TCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHH---
T ss_pred             hhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHHH---
Confidence            996543211  1123457999999999984     4558999999999999999999999997543221  111111   


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       . +....+       ..+...+..+.+++.+||+.||.+|||+.|+++        |+|+...
T Consensus       229 -~-~~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--------hp~~~~~  275 (288)
T d2jfla1         229 -K-SEPPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--------HPFVTVD  275 (288)
T ss_dssp             -H-SCCCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--------SGGGCCC
T ss_pred             -c-CCCCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CcccCCC
Confidence             1 111111       111223467889999999999999999999987        8998653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-50  Score=405.79  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=196.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||+||++......     .....+++|.+...  ......++|.+|+.+|++|+|||||+++|+|.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPG-----KREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC--------CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            367999999999999999998754211     11123344433211  12235578999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...  ...+++.+++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+||
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCc
Confidence            999999999999999999998854  2359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCcc---ccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhh
Q 036172          305 GLAIWGPTDSTHMI---REDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       305 Gla~~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |+++..........   .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....   ..+.....  
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~--  247 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE--  247 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH--
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHH--
Confidence            99987654332221   123457899999999999999999999999999999998 8999865432   22222221  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                        .+..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       248 --~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         248 --QDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             --TTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --cCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence              1111         11122345678899999999999999999999999987653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=396.20  Aligned_cols=256  Identities=22%  Similarity=0.378  Sum_probs=195.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++...         +...+|+|.+++.    ....++|.+|++++++++|||||+++|+|.
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~---------~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL---------NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL   70 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET---------TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC---------CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceec
Confidence            357999999999999999998743         2335677665431    223468999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        71 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          71 EQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred             cCCceEEEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEeccc
Confidence            999999999999999999998754  3358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG-RRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++......... .....||+.|+|||++.+..++.++|||||||++|||+|+ .+||....   ...+......    
T Consensus       146 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~----  217 (263)
T d1sm2a_         146 GMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIST----  217 (263)
T ss_dssp             C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHH----
T ss_pred             chheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHh----
Confidence            9997665433222 2245789999999999999999999999999999999995 55554322   2222222211    


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +..  ...|       ...+..+.+++.+||+.||.+|||+++|++.|+++.
T Consensus       218 ~~~--~~~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         218 GFR--LYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TCC--CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC--CCCc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            110  1111       122457889999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-50  Score=405.11  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=193.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.+.||+|+||.||++.+..        +.+.||+|.+.+...  ....+.|.+|+.+|++++|||||++++++.
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKR--------TQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETT--------TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECC--------CCCEEEEEEEchHHh--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4679999999999999999987643        456777777643221  123467889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc---CCCceEE
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQPQL  301 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~---~~~~~kL  301 (522)
                      +++.+|||||||+||+|.+++...   ..+++..+..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             ECCEEEEEEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEE
Confidence            999999999999999999999843   359999999999999999999999   9999999999999994   5789999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+....   .
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i---~  222 (307)
T d1a06a_         152 SDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQI---L  222 (307)
T ss_dssp             CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH---H
T ss_pred             eccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHH---h
Confidence            99999976544332   2245799999999999999999999999999999999999999964321   1111111   1


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      . +...      .........+..+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       223 ~-~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--------hp~~~~  269 (307)
T d1a06a_         223 K-AEYE------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--------HPWIAG  269 (307)
T ss_dssp             T-TCCC------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--------STTTTS
T ss_pred             c-cCCC------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--------CHhhCC
Confidence            1 1110      011111223457889999999999999999999998        899864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-50  Score=408.35  Aligned_cols=256  Identities=24%  Similarity=0.326  Sum_probs=205.9

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|+..++||+|+||.||+|.+..        +.+.+|+|.+...........++|.+|+.+|++|+|||||++++++.+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVR--------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECC--------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            359999999999999999987643        456677776654333333466789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+++|||||++|+|..++...   ..+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             CCEEEEEEEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecc
Confidence            99999999999999998776643   359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMH---GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ++......      ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||.....  ...+.    ....
T Consensus       161 ~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~~----~i~~  228 (309)
T d1u5ra_         161 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALY----HIAQ  228 (309)
T ss_dssp             TCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHH
T ss_pred             cccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHh
Confidence            99765432      23579999999999854   4689999999999999999999999964321  11111    1111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                       +.......        ...+..+.+|+.+||+.||.+|||++|+++        |+|+...
T Consensus       229 -~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--------Hp~~~~~  273 (309)
T d1u5ra_         229 -NESPALQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--------HRFVLRE  273 (309)
T ss_dssp             -SCCCCCSC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--------CHHHHSC
T ss_pred             -CCCCCCCC--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh--------CHHhcCC
Confidence             11111111        123457889999999999999999999987        8887653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=396.04  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             ecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeCCEEEE
Q 036172          152 IPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIEDNYLIL  231 (522)
Q Consensus       152 ~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~l  231 (522)
                      ++||+|+||.||++....      ....+.+|+|.++.... .....++|.+|+++|++++|||||+++|+|..+ ..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~------~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM------KKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC------SSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred             CCcccCCCeEEEEEEEcc------CCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEE
Confidence            579999999999986432      22446677777654332 234567899999999999999999999999654 5789


Q ss_pred             EEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCccccCC
Q 036172          232 VSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLAIWGP  311 (522)
Q Consensus       232 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla~~~~  311 (522)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 vmE~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            99999999999999854   349999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCCCcccc
Q 036172          312 TDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNGDTETL  389 (522)
Q Consensus       312 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~~  389 (522)
                      ...... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....   ..+...    +..+...  
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~----i~~~~~~--  229 (277)
T d1xbba_         159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAM----LEKGERM--  229 (277)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH----HHTTCCC--
T ss_pred             ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHH----HHcCCCC--
Confidence            443322 2234578999999999999999999999999999999998 8999975431   222221    2222211  


Q ss_pred             cCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          390 LDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       390 ~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                             ..+...+..+.+++.+||+.||.+|||+++|++.|+..
T Consensus       230 -------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                   11122346788999999999999999999999988653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=397.51  Aligned_cols=261  Identities=20%  Similarity=0.279  Sum_probs=210.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhcc---chHHHHHHHHHHHHhhCCCCCcceeeE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQF---SSAWNDFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~---~~~~~~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      .++|++++.||+|+||.||++.+..        +++.||+|.+++.....   ....+.|.+|+.+|++|+|||||++++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~--------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~   80 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKS--------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   80 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECC--------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            4679999999999999999987643        56677877765432211   124678999999999999999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC----
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF----  297 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~----  297 (522)
                      ++.+++.++||||||++|+|.+++...+   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++    
T Consensus        81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          81 VYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSC
T ss_pred             EEEECCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCccc
Confidence            9999999999999999999999998543   59999999999999999999999   9999999999999998776    


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+   ........
T Consensus       155 ~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i  228 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANV  228 (293)
T ss_dssp             CEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred             ceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHH
Confidence            5999999999776543322   24578999999999999999999999999999999999999997532   11111111


Q ss_pred             hhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          378 KPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       378 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                          ..+..      ..........+..+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       229 ----~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--------hp~~~~  276 (293)
T d1jksa_         229 ----SAVNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--------HPWIKP  276 (293)
T ss_dssp             ----HTTCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------STTTCC
T ss_pred             ----HhcCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CcccCC
Confidence                11111      0111112223467889999999999999999999998        999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=407.07  Aligned_cols=265  Identities=22%  Similarity=0.330  Sum_probs=206.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|+++++||+|+||.||++.......   ......+++|.+....  .......|.+|+.+|+++ +|||||++++++
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISK---TGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSS---SSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCc---ccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            3579999999999999999987542100   0112234544432211  122446799999999998 899999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCC--------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGE--------------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIH  283 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiH  283 (522)
                      .+.+.+++|||||++|+|.++|+....                    ...+++..++.++.||+.||.|||+   ++|+|
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence            999999999999999999999976421                    1358999999999999999999999   99999


Q ss_pred             ccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 036172          284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPI  362 (522)
Q Consensus       284 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf  362 (522)
                      |||||+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999987665555444456678999999999999999999999999999999998 89999


Q ss_pred             CCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 036172          363 GFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLR  432 (522)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~  432 (522)
                      ......  ..+....    ..+..         ...+...+..+.+|+.+||+.||.+|||++||++.|.
T Consensus       268 ~~~~~~--~~~~~~~----~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVD--ANFYKLI----QNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCS--HHHHHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHH--HHHHHHH----hcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            754332  1222211    11111         1112223467889999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.5e-49  Score=402.55  Aligned_cols=261  Identities=19%  Similarity=0.271  Sum_probs=210.3

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +++.||+|.+.+   ......+.|.+|+.+|++|+|||||++++++
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~--------~g~~vAvK~i~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   92 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERA--------TGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAF   92 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TTEEEEEEEECC---CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEEcc---cchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35689999999999999999998653        456677776542   1223457899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--CCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--DFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--~~~~kL  301 (522)
                      .+++.++||||||+||+|.+++...  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.  ++.+||
T Consensus        93 ~~~~~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL  167 (350)
T d1koaa2          93 EDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKL  167 (350)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEE
T ss_pred             EECCEEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEE
Confidence            9999999999999999999999643  2359999999999999999999999   99999999999999964  578999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+   .........   
T Consensus       168 ~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~---  238 (350)
T d1koaa2         168 IDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVK---  238 (350)
T ss_dssp             CCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---
T ss_pred             eecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHH---
Confidence            999999876544332   34579999999999999999999999999999999999999996442   112221111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      . +..      ..........+..+.+|+.+||+.||.+|||+.|+++        |+|+...
T Consensus       239 ~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--------hp~~~~~  286 (350)
T d1koaa2         239 S-CDW------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--------HPWLTPG  286 (350)
T ss_dssp             H-TCC------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--------STTTSCT
T ss_pred             h-CCC------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CcccCCC
Confidence            1 110      0011111223457889999999999999999999998        8998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=394.40  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=204.6

Q ss_pred             CCceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          146 NPFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ++|.+.. +||+|+||.||++....      ......+|+|.++...  .....++|.+|+++|++++|||||+++|+|.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRM------RKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEec------CCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            4567776 59999999999986432      2233456777664322  2335678999999999999999999999997


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +.++|||||+++|+|.+++...  +..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccc
Confidence            5 4579999999999999998653  2359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+++........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......   .+...    +.
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~  226 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IE  226 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HH
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HH
Confidence            999876554322 22234568999999999999999999999999999999998 99999754321   22221    12


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .+....         .+...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       227 ~~~~~~---------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         227 QGKRME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCC---------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            222111         1222446788999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-48  Score=401.88  Aligned_cols=261  Identities=18%  Similarity=0.240  Sum_probs=210.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.++||+|+||.||+|.+..        +++.||+|.+.+   ......+.+.+|+.+|++|+|||||++++++
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~--------~~~~vAiK~i~~---~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   95 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKA--------TGRVFVAKFINT---PYPLDKYTVKNEISIMNQLHHPKLINLHDAF   95 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEC---CSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEECC---cchhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34679999999999999999987643        466777776543   2223456789999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc--CCCceEE
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS--SDFQPQL  301 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~--~~~~~kL  301 (522)
                      .+++.+|||||||+||+|.+++...  ...+++.+++.|+.||+.||.|||+   .||+||||||+||||+  .++.+||
T Consensus        96 ~~~~~~~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL  170 (352)
T d1koba_          96 EDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI  170 (352)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EECCEEEEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEE
Confidence            9999999999999999999988653  2349999999999999999999999   9999999999999998  5789999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPIL  381 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~  381 (522)
                      +|||+|........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+.....   
T Consensus       171 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~---  241 (352)
T d1koba_         171 IDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVK---  241 (352)
T ss_dssp             CCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH---
T ss_pred             eecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---
Confidence            99999987655432   23457999999999999999999999999999999999999999643321   1111111   


Q ss_pred             cCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          382 KNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       382 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      . +...      .........+..+.+|+.+||+.||.+|||+.|+++        |+|++..
T Consensus       242 ~-~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--------Hp~~~~~  289 (352)
T d1koba_         242 R-CDWE------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--------HPWLKGD  289 (352)
T ss_dssp             H-CCCC------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--------STTTSSC
T ss_pred             h-CCCC------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHhhCCC
Confidence            1 1110      011111223457889999999999999999999997        8998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-49  Score=396.42  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=211.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++++.||+|+||.||++.+..        +++.||+|.+++.........+.|.+|+.+|++++|||||++++++.
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~--------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRH--------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECC--------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            3579999999999999999998643        56778888775543333345678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|+||||++||+|..++...   ..+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+||
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCeeeeEeeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecC
Confidence            999999999999999999999854   348899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+..   .... +
T Consensus       149 G~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~---~i~~-~  216 (316)
T d1fota_         149 GFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYE---KILN-A  216 (316)
T ss_dssp             SSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHHH-C
T ss_pred             ccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHH---HHHc-C
Confidence            9998765432     245799999999999999999999999999999999999999965431   11111   1111 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..          .++...+..+.+++.+||+.||.+||     |++++++        |+|++.-
T Consensus       217 ~~----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--------Hp~f~~i  263 (316)
T d1fota_         217 EL----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--------HPWFKEV  263 (316)
T ss_dssp             CC----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--------SGGGSSC
T ss_pred             CC----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--------CcccccC
Confidence            11          11112345688899999999999996     8999987        8998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=399.32  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=213.2

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++++.||+|+||.||++.+..        +++.||+|.+++.........+.+.+|+.+|++++|||||++++++
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~--------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKA--------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            34689999999999999999988643        5778888887654333334567899999999999999999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      .+++.+|+||||++||+|.+++...+   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~D  148 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEee
Confidence            99999999999999999999998643   48999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      ||+|+.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+....   . .
T Consensus       149 FG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i---~-~  219 (337)
T d1o6la_         149 FGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI---L-M  219 (337)
T ss_dssp             CTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---H-H
T ss_pred             cccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHH---h-c
Confidence            999986544322  22356899999999999999999999999999999999999999975432   2222111   1 1


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                      +..          .++...+..+.+||.+||++||.+||+     +.++++        |+|++.
T Consensus       220 ~~~----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~--------Hp~f~~  266 (337)
T d1o6la_         220 EEI----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME--------HRFFLS  266 (337)
T ss_dssp             CCC----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--------SGGGTT
T ss_pred             CCC----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc--------Cccccc
Confidence            111          111223456788999999999999995     888886        888764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=392.51  Aligned_cols=256  Identities=22%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++...         ..+.||+|.++..    ....++|.+|+.++++++|||||+++|++.
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN---------GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET---------TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC---------CCCEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            468999999999999999998743         2345677766432    123567999999999999999999999886


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +.+++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+   ++|+||||||+||||+.++.+||+||
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccc
Confidence            5 55789999999999999886542 2249999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||..|+....  ....+....    ..+
T Consensus       154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i----~~~  226 (272)
T d1qpca_         154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNL----ERG  226 (272)
T ss_dssp             TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHH----HTT
T ss_pred             cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHH----Hhc
Confidence            99987654322 22234578999999999999999999999999999999999655543221  122222222    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      ...     .    .+...+..+.+++.+||+.||.+|||+++|++.|+..
T Consensus       227 ~~~-----~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 YRM-----V----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----C----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            111     1    1112345788999999999999999999999999764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-48  Score=400.20  Aligned_cols=259  Identities=20%  Similarity=0.244  Sum_probs=206.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHH---HHHHHHHHHhhCCCCCcceeeE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWN---DFSSEVDITSSLEQKSITTLNG  221 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~---~f~~Ev~iL~~L~HpnIv~l~~  221 (522)
                      .++|++.+.||+|+||.||++.+..        +++.||+|.+.+..........   +..+|+.+++.++|||||++++
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~--------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKAD--------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECC--------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            4689999999999999999998653        5667887766433222222223   3344577888889999999999


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEE
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQL  301 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL  301 (522)
                      ++.+++.+|+||||++||+|.+++....   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEE
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEE
Confidence            9999999999999999999999998543   48999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          302 SDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       302 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      +|||+|+.......    ....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.....  
T Consensus       149 ~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--  222 (364)
T d1omwa3         149 SDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--  222 (364)
T ss_dssp             CCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--
T ss_pred             eeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--
Confidence            99999986654332    24579999999999975 468999999999999999999999997665444333222111  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPN-----MGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs-----~~eVl~~L~~~~~~~~~~~~  443 (522)
                        ...          ...+...+..+.++|.+||+.||.+|||     ++++++        |+|++.
T Consensus       223 --~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--------Hp~f~~  270 (364)
T d1omwa3         223 --TMA----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--------SPFFRS  270 (364)
T ss_dssp             --SCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--------SGGGTT
T ss_pred             --cCC----------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--------CccccC
Confidence              000          0111123456889999999999999999     688887        899875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=390.67  Aligned_cols=267  Identities=19%  Similarity=0.253  Sum_probs=200.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|+..+.||+|+||.||++......    ......+|+|.+...  ......++|.+|+.+|++++|||||+++|++.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~----~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSS----GKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-------CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCC----CEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            356899999999999999998744211    112235666655321  12234567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +.+..++||||+.+|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||||+.++.+||+||
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEccc
Confidence            9999999999999999999887542  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCC-ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++........ .......||+.|+|||++.++.++.++|||||||++|||++|..|+....  ....+....    ..
T Consensus       155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i----~~  228 (283)
T d1mqba_         155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAI----ND  228 (283)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHH----HT
T ss_pred             chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHH----hc
Confidence            999876543322 22234568999999999999999999999999999999999766653321  122222222    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                      +..         ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       229 ~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         229 GFR---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TCC---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             cCC---------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            111         111222346788999999999999999999999999887643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=386.06  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=206.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .+.|++.++||+|+||.||++...         +.+.||+|.+++..    ...++|++|+.++++++|||||+++|+|.
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~---------~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~   69 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR---------GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCT   69 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET---------TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC---------CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            368999999999999999998853         24456776655322    13467999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+++||||+++|+|.+++....  ..+++..+++++.|+++||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        70 ~~~~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~Df  144 (258)
T d1k2pa_          70 KQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDF  144 (258)
T ss_dssp             CSSSEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCC
T ss_pred             eCCceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcc
Confidence            9999999999999999999987542  348999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....   ..+....    ..
T Consensus       145 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i----~~  216 (258)
T d1k2pa_         145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHI----AQ  216 (258)
T ss_dssp             SSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHH----HT
T ss_pred             hhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHH----Hh
Confidence            999765543322 2224578999999999999999999999999999999998 8999975432   2222211    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRG  433 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~  433 (522)
                      +..  ...|       ...+..+.+++.+||+.||.+|||+++|++.|..
T Consensus       217 ~~~--~~~p-------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 GLR--LYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TCC--CCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCC--CCCc-------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            111  1111       1233578899999999999999999999999865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-48  Score=395.56  Aligned_cols=256  Identities=18%  Similarity=0.240  Sum_probs=211.0

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|+++++||+|+||.||++.+..        +++.||+|.+.+.........+.+.+|+.+|++++|||||++++++.
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~--------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKE--------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECC--------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            4689999999999999999988643        56678888765433223345678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +...+++||||+.+|+|.+++...+   .+++..++.++.||+.||.|||+   ++||||||||+||||+.++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeec
Confidence            9999999999999999999998643   49999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+|+......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+   ...+....   .. +
T Consensus       186 G~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i---~~-~  253 (350)
T d1rdqe_         186 GFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKI---VS-G  253 (350)
T ss_dssp             TTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HH-C
T ss_pred             eeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHH---hc-C
Confidence            9998764332     24579999999999999999999999999999999999999996532   11211111   11 1


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCcccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ..          ..+...+..+.+++.+||+.||.+|+     |+++|++        |+|++.-
T Consensus       254 ~~----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--------Hp~f~~~  300 (350)
T d1rdqe_         254 KV----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--------HKWFATT  300 (350)
T ss_dssp             CC----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--------SGGGTTC
T ss_pred             CC----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--------CccccCC
Confidence            11          01112345788999999999999994     8999986        8998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-48  Score=384.44  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc------cchHHHHHHHHHHHHhhCC-CCCcce
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ------FSSAWNDFSSEVDITSSLE-QKSITT  218 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~------~~~~~~~f~~Ev~iL~~L~-HpnIv~  218 (522)
                      .+|++.+.||+|+||+||++.+..        +++.+|+|.+.+....      .....+++.+|+.++++|+ |||||+
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~--------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~   74 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP--------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   74 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             ccCEEceEEecCcCeEEEEEEECC--------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            589999999999999999997643        3456666655432211      1124467999999999996 999999


Q ss_pred             eeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCc
Q 036172          219 LNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQ  298 (522)
Q Consensus       219 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~  298 (522)
                      +++++.+++.+||||||+++|+|.++|...+   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCC
T ss_pred             EEeecccCcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCC
Confidence            9999999999999999999999999998543   59999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH------GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES  372 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~  372 (522)
                      +||+|||+++........   ....||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.....   ..
T Consensus       149 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~  222 (277)
T d1phka_         149 IKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---ML  222 (277)
T ss_dssp             EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred             eEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HH
Confidence            999999999876553322   34579999999999853      3478899999999999999999999975432   11


Q ss_pred             HHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          373 LVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       373 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                      ....   .. .+... .     ........+..+.+++.+||+.||.+|||+.||++        |+|+++.
T Consensus       223 ~~~~---i~-~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--------h~~~~~~  276 (277)
T d1phka_         223 MLRM---IM-SGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--------HPFFQQY  276 (277)
T ss_dssp             HHHH---HH-HTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--------SGGGCTT
T ss_pred             HHHH---HH-hCCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--------CHHHHHh
Confidence            1111   11 11111 0     11111224467889999999999999999999987        9998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-48  Score=385.21  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=204.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|++.+.||+|+||.||++.+..        +.+.||+|.+++.........++|.+|+.++++++|||||++++++
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLR--------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECC--------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            35789999999999999999998653        5677888887655444555678899999999999999999999999


Q ss_pred             EeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          224 IEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       224 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ...+    .+||||||++||+|.+++...+   .+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++..
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~  150 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAV  150 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccc
Confidence            8653    4899999999999999998543   49999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCC-CccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDST-HMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      +|+|||.+........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||.....   .   ....
T Consensus       151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~  224 (277)
T d1o6ya_         151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---V---SVAY  224 (277)
T ss_dssp             EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHHH
T ss_pred             eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---H---HHHH
Confidence            9999999865543322 2233456799999999999999999999999999999999999999964321   1   1111


Q ss_pred             hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhcc
Q 036172          379 PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-NMGQVLKLLRGA  434 (522)
Q Consensus       379 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-s~~eVl~~L~~~  434 (522)
                      ..+......       ........+..+.+++.+||+.||.+|| |++++++.|..+
T Consensus       225 ~~~~~~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         225 QHVREDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHHHCCCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhcCCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            222222111       1111122346788999999999999999 899999877654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=385.61  Aligned_cols=261  Identities=20%  Similarity=0.277  Sum_probs=195.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++++.||+|+||.||++.....     ......+++|.++...  .....+.|.+|+.+|++++|||||++++++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~-----~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP-----ENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-------CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC-----CceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            35899999999999999999865321     1123345555543322  2235678999999999999999999999996


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                       ++.+++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+||
T Consensus        79 -~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          79 -ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             -cCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccc
Confidence             467899999999999999887542  358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKN  383 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~  383 (522)
                      |+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |.+||.......   +....    ..
T Consensus       153 G~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~  224 (273)
T d1mp8a_         153 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----EN  224 (273)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HT
T ss_pred             hhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----Hc
Confidence            999765443222 2234568999999999999999999999999999999998 899987554322   22211    11


Q ss_pred             CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          384 GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       384 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      +....         .+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       225 ~~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         225 GERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            21111         12223467889999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=385.92  Aligned_cols=264  Identities=26%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|++.+.||+|+||.||++.....     ......+|+|.+++.........++|.+|+.+|++++|||||+++|+|.
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~-----~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAP-----SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECT-----TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECC-----CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            35799999999999999999864321     2234467888887766555667789999999999999999999999997


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   ++|+||||||+||||+.++.+||+||
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             e-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccc
Confidence            6 46789999999999999887642  359999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCc-cccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          305 GLAIWGPTDSTHM-IREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       305 Gla~~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |+++......... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+   .......   ...
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~---i~~  229 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHK---IDK  229 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH---HHT
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHH---HHh
Confidence            9998765543332 2234567889999999999999999999999999999998 899986432   2222221   112


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                      .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       230 ~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 EGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             SCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22111         11122345788999999999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=391.44  Aligned_cols=262  Identities=19%  Similarity=0.279  Sum_probs=201.5

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ..|++++.||+|+||.||++.......    .....+++|.++...  .....++|.+|+.++++++|||||+++|+|.+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC--------CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCC----EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            579999999999999999987543211    111234555443222  12246789999999999999999999999987


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      + ..++|+||+.+|+|.+++...  ...+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||
T Consensus        83 ~-~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          83 S-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             C-CeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccc
Confidence            5 467888999999999988764  3459999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      +++...............||+.|+|||++.++.++.++|||||||++|||+| |..||........   ....    ..+
T Consensus       157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i----~~~  229 (317)
T d1xkka_         157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKG  229 (317)
T ss_dssp             HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHH----HHT
T ss_pred             cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcC
Confidence            9987766554444445678999999999999999999999999999999998 8999875443222   2111    111


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ...         ..+...+..+.+++.+||+.||.+|||+.+|++.|....
T Consensus       230 ~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         230 ERL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC---------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            110         111223457889999999999999999999999988764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-48  Score=389.39  Aligned_cols=267  Identities=20%  Similarity=0.334  Sum_probs=209.8

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||+|+....   ......+.+|+|.++..  ......++|.+|+.+|++++||||++++++|.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~---~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGL---LPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETS---STTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCC---ccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            46799999999999999999974321   01224456777766432  22335678999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccC---------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEe
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAG---------------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIH  283 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiH  283 (522)
                      +.+..++||||+++|+|.+++....                     ....+++..++.++.|++.||+|||+   .+|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence            9999999999999999999997532                     12348999999999999999999999   99999


Q ss_pred             ccCCCCceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCC-CCC
Q 036172          284 RDVKSSNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR-RPI  362 (522)
Q Consensus       284 rDIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~-~Pf  362 (522)
                      |||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999997655444444444567899999999999999999999999999999999985 566


Q ss_pred             CCCCCCChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          363 GFKNLKGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       363 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ....   ...+...    +..+.....         +...+..+.+|+.+||+.+|.+|||+.||+++|+++.
T Consensus       244 ~~~~---~~e~~~~----v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMA---HEEVIYY----VRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSC---HHHHHHH----HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCC---HHHHHHH----HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5432   1222222    222222111         1223457889999999999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-48  Score=389.69  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=209.3

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHh-hCCCCCcceeeEEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITS-SLEQKSITTLNGVCI  224 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~-~L~HpnIv~l~~~~~  224 (522)
                      .+|++++.||+|+||+||++.+..        +++.||+|.+++.........+.+.+|..++. .++|||||++++++.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~--------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~   73 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK--------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   73 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC--------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence            479999999999999999998653        56788888876544333345677888888876 689999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      +++.+|+||||+++|+|.+++....   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          74 TKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceecccc
Confidence            9999999999999999999998543   48999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+.....    .+
T Consensus       148 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~----~~  218 (320)
T d1xjda_         148 GMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIR----MD  218 (320)
T ss_dssp             TTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HC
T ss_pred             chhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHH----cC
Confidence            999765443322  2345799999999999999999999999999999999999999975432   22221111    11


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHHHhccccCCccccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMG-QVLKLLRGATHATDWVDR  443 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~-eVl~~L~~~~~~~~~~~~  443 (522)
                      ..      .    ++...+..+.+|+.+||+.||.+||++. +|++        |+|++.
T Consensus       219 ~~------~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~--------hpff~~  260 (320)
T d1xjda_         219 NP------F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--------HPLFRE  260 (320)
T ss_dssp             CC------C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--------SGGGTT
T ss_pred             CC------C----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh--------Cchhcc
Confidence            11      1    1112345688999999999999999985 6765        888764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=387.16  Aligned_cols=260  Identities=17%  Similarity=0.218  Sum_probs=207.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      -++|++.+.||+|+||.||+|.+..        +.+.||+|.+++.    ......+.+|+++|++++|||||++++++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~--------~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   71 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS--------SKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC--------CCcEEEEEEEcCC----cccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4689999999999999999988654        4556777765432    123456889999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC--CceEEe
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD--FQPQLS  302 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~--~~~kL~  302 (522)
                      +++.+|||||||+||+|.+++...+  ..+++.+++.++.||+.||.|||+   .+|+||||||+|||++.+  ..+||+
T Consensus        72 ~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          72 SMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEc
Confidence            9999999999999999999997542  249999999999999999999999   999999999999999854  589999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      |||+++.......   .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.....   ..+...   +..
T Consensus       147 DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~---i~~  217 (321)
T d1tkia_         147 EFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIEN---IMN  217 (321)
T ss_dssp             CCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH---HHH
T ss_pred             ccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHh
Confidence            9999976544322   2345789999999999999999999999999999999999999975432   111111   111


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      . ..      ..........+..+.+|+.+||+.||.+|||+.|+++        |+|++...
T Consensus       218 ~-~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--------hp~~~~~~  265 (321)
T d1tkia_         218 A-EY------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--------HPWLKQKI  265 (321)
T ss_dssp             T-CC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--------SHHHHSCG
T ss_pred             C-CC------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHhhccCc
Confidence            1 10      0011111123456889999999999999999999998        88987543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=383.16  Aligned_cols=269  Identities=20%  Similarity=0.149  Sum_probs=200.4

Q ss_pred             eeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccch--HHHHHHHHHHHHhhCCCCCcceeeEEEEeCC
Q 036172          150 MDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSS--AWNDFSSEVDITSSLEQKSITTLNGVCIEDN  227 (522)
Q Consensus       150 ~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~--~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~~  227 (522)
                      .+++||+|+||+||+|.+..        +++.||+|.++........  ..+.+.+|+.+|++++|||||++++++.+++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN--------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS--------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cceEeccCcCeEEEEEEECC--------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            46789999999999988643        5677888877654322111  2357899999999999999999999999999


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      .++|||||+.++++..++.   ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        74 ~~~ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceeehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccc
Confidence            9999999999877776665   23459999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCCc
Q 036172          308 IWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGDT  386 (522)
Q Consensus       308 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~  386 (522)
                      +........  .....||+.|+|||++... .++.++|||||||++|||++|..||.......  .+..... .......
T Consensus       148 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~-~~~~~~~  222 (299)
T d1ua2a_         148 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE-TLGTPTE  222 (299)
T ss_dssp             STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCT
T ss_pred             cccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHH-hcCCCCh
Confidence            765543322  2245799999999998655 57999999999999999999999996543211  1111111 1000000


Q ss_pred             c---------c-----ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccccc
Q 036172          387 E---------T-----LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRHA  445 (522)
Q Consensus       387 ~---------~-----~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~  445 (522)
                      .         .     .................+.+|+.+||+.||++|||+.|+++        |+|++..+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--------Hp~f~~~p  287 (299)
T d1ua2a_         223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--------MKYFSNRP  287 (299)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--------SGGGTSSS
T ss_pred             hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--------CHhhCCCC
Confidence            0         0     00000000111123467899999999999999999999997        99987644

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=384.32  Aligned_cols=268  Identities=23%  Similarity=0.353  Sum_probs=203.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|+++++||+|+||.||++......   ....++.+|+|.++...  .....+.|.+|+.++.++ +|+|||.+++++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~---~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGID---KTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTT---SSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCC---cccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            367999999999999999998753210   12345678888776432  233567889999999888 789999999998


Q ss_pred             EeC-CEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          224 IED-NYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       224 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      .+. ..+++|||||++|+|.++++....             ...+++..++.++.||+.||.|||+   ++|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcc
Confidence            765 568999999999999999975421             2348999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSG-RRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG-~~Pf~~~~~~  368 (522)
                      ||||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| ..||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876665555555567899999999999999999999999999999999996 4577543322


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        ..+....    ..+....         .+...+..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       244 --~~~~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 --EEFCRRL----KEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             --HHHHHHH----HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHH----hcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              2222211    1111111         11223457889999999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=386.09  Aligned_cols=270  Identities=25%  Similarity=0.374  Sum_probs=209.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~  222 (522)
                      ..++|++++.||+|+||.||++........ ...+...+|+|.+++..  ......+|.+|+.++.++ +|||||+++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKD-KPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC-----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcc-cccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            347899999999999999999875432111 12233456777664322  233567899999999999 89999999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCC-------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCC
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGE-------------QSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSS  289 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~  289 (522)
                      |.+++.+++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||+   .+|+||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccc
Confidence            9999999999999999999999975431             2358999999999999999999999   99999999999


Q ss_pred             ceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036172          290 NILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLK  368 (522)
Q Consensus       290 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~  368 (522)
                      |||++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |..||..... 
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence            99999999999999999987655544444455679999999999999999999999999999999998 7888864332 


Q ss_pred             ChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          369 GPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       369 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                        ..+...    +..+....         .+...+..+.+++.+||+.||.+|||+.||++.|+++.
T Consensus       244 --~~~~~~----i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 --EELFKL----LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHH----HHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHH----HHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              222222    22221111         11123457889999999999999999999999998875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=383.67  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|+++++||+|+||.||++....         ...||+|.++....    ..+.|.+|+.++++++|||||+++|+|.
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~---------~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~   82 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG---------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS   82 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC---------CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence            3589999999999999999987532         24577777653222    3467999999999999999999999986


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeec
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDF  304 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DF  304 (522)
                      + +..++||||+++|+|..++.... ...+++..++.++.||+.||+|||+   .+|+||||||+||||+.++.+||+||
T Consensus        83 ~-~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          83 E-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             c-CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEccc
Confidence            5 55789999999999999987642 2349999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCC
Q 036172          305 GLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNG  384 (522)
Q Consensus       305 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~  384 (522)
                      |+++........ ......||+.|+|||++..+.++.++|||||||++|||++|..|+....  ....+.....    .+
T Consensus       158 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~----~~  230 (285)
T d1fmka3         158 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVE----RG  230 (285)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH----TT
T ss_pred             chhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHH----hc
Confidence            999765443222 2234578999999999999999999999999999999999766653322  1222222221    11


Q ss_pred             CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          385 DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       385 ~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..         ...+...+..+.+++.+||+.||++||++++|+++|+...
T Consensus       231 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         231 YR---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CC---------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            11         1112233457889999999999999999999999997743

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=388.10  Aligned_cols=261  Identities=21%  Similarity=0.282  Sum_probs=203.6

Q ss_pred             CCCCceeee-cccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeE
Q 036172          144 TENPFQMDI-PCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNG  221 (522)
Q Consensus       144 ~~~~y~~~~-~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~  221 (522)
                      ..++|++.. .||+|+||.||+|.+..        +++.||+|.+++        .+.+.+|+.++.++ +|||||++++
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~   72 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKR--------TQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVD   72 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETT--------TCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECC--------CCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            356899875 59999999999998643        567788886532        24578899997665 8999999999


Q ss_pred             EEEe----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC--
Q 036172          222 VCIE----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS--  295 (522)
Q Consensus       222 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~--  295 (522)
                      ++.+    +..+|||||||+||+|.+++...+ ...+++.++..++.||+.||+|||+   .+|+||||||+|||++.  
T Consensus        73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~  148 (335)
T d2ozaa1          73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKR  148 (335)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSS
T ss_pred             EEeecccCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccc
Confidence            9975    467999999999999999998643 2359999999999999999999999   99999999999999985  


Q ss_pred             -CCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHH
Q 036172          296 -DFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLV  374 (522)
Q Consensus       296 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~  374 (522)
                       .+.+||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|+||+.||........... 
T Consensus       149 ~~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-  224 (335)
T d2ozaa1         149 PNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-  224 (335)
T ss_dssp             TTCCEEECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred             ccccccccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-
Confidence             457999999999876544332   245799999999999988999999999999999999999999975433221110 


Q ss_pred             HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccccc
Q 036172          375 KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDRH  444 (522)
Q Consensus       375 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~  444 (522)
                        .......+..      ..........+..+.+|+.+||+.||.+|||+.|+++        |+|+...
T Consensus       225 --~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--------hp~~~~~  278 (335)
T d2ozaa1         225 --MKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--------HPWIMQS  278 (335)
T ss_dssp             -----CCCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SHHHHTT
T ss_pred             --HHHHHhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--------CHHhhCC
Confidence              0001111111      1111122345577899999999999999999999998        7777543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=384.03  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      -++|++.++||+|+||.||++.....      .....+++|.++...  ..+..++|.+|+++|+++ +|||||+++++|
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKD------GLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEET------TEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCC------CeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            36899999999999999999876431      111123333332111  112456799999999999 799999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhcc-------------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGA-------------GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSN  290 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~N  290 (522)
                      .+++.+++||||+++|+|.++|+..             .....+++..++.++.||+.||.|||+   ++|+||||||+|
T Consensus        81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~N  157 (309)
T d1fvra_          81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN  157 (309)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccce
Confidence            9999999999999999999999753             123469999999999999999999999   999999999999


Q ss_pred             eeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCC
Q 036172          291 ILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR-RPIGFKNLKG  369 (522)
Q Consensus       291 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~  369 (522)
                      ||++.++.+||+|||+++........   ....||..|+|||.+.++.++.++|||||||++|||++|. +||...+   
T Consensus       158 IL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---  231 (309)
T d1fvra_         158 ILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---  231 (309)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---
T ss_pred             EEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---
Confidence            99999999999999999765433222   2346899999999999999999999999999999999975 4665332   


Q ss_pred             hhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          370 PESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       370 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      ...+...+.    .+..     +    ..+...+..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       232 ~~~~~~~i~----~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         232 CAELYEKLP----QGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHHHHGG----GTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHH----hcCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            222222221    1111     1    1112234678899999999999999999999999988753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=375.89  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||++...          ...||+|.+++     +...++|.+|++++++++|||||+++|+|.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~vAvK~i~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR----------GNKVAVKCIKN-----DATAQAFLAEASVMTQLRHSNLVQLLGVIV   70 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET----------TEEEEEEECCC-----CC--HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC----------CeEEEEEEECc-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            357999999999999999998743          23467776542     235578999999999999999999999997


Q ss_pred             eC-CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEee
Q 036172          225 ED-NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSD  303 (522)
Q Consensus       225 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~D  303 (522)
                      ++ +.+++||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~d  146 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSD  146 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecc
Confidence            54 56899999999999999997542 2348999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCChhhHHHhhhhhhc
Q 036172          304 FGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNLKGPESLVKWAKPILK  382 (522)
Q Consensus       304 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~  382 (522)
                      ||+++......     ....+|..|+|||++.++.++.++|||||||++|||+| |+.||......   .+.....    
T Consensus       147 fg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----  214 (262)
T d1byga_         147 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----  214 (262)
T ss_dssp             CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----
T ss_pred             cccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----
Confidence            99997644322     23468899999999999999999999999999999998 78887654322   2222221    


Q ss_pred             CCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          383 NGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       383 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .+...         ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       215 ~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         215 KGYKM---------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC---------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            11111         112223457889999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=376.20  Aligned_cols=272  Identities=20%  Similarity=0.238  Sum_probs=202.8

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      .+|++++.||+|+||.||+|.+..        +++.+|+|.++..... ....+++.+|+++|++++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL--------TGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC--------CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            479999999999999999998653        5667888877543221 2235789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++.+|+||||+.+ ++.+++... ....+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~iv~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          73 ENKLYLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ccceeEEEeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCC
Confidence            9999999999976 555555433 23359999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhc--
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILK--  382 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--  382 (522)
                      +|+.......  ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..  ..+.........  
T Consensus       148 ~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~  223 (298)
T d1gz8a_         148 LARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPD  223 (298)
T ss_dssp             HHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             cceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCc
Confidence            9976543322  223457999999999987665 588999999999999999999999754321  111111100000  


Q ss_pred             C---------CCcccccCCcccc---cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          383 N---------GDTETLLDPKLSN---EYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       383 ~---------~~~~~~~d~~l~~---~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .         .............   ......+..+.+|+.+||+.||.+|||+.|+++        |+|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--------H~ff~~  288 (298)
T d1gz8a_         224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--------HPFFQD  288 (298)
T ss_dssp             TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SGGGTT
T ss_pred             hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--------CHhhcc
Confidence            0         0000000000000   011123467889999999999999999999997        899864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=385.25  Aligned_cols=268  Identities=22%  Similarity=0.327  Sum_probs=214.1

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC-CCCCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL-EQKSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L-~HpnIv~l~~~~  223 (522)
                      .++|+++++||+|+||.||++.....   ......+.+|+|.++..  .......+|.+|+.+++++ +|||||+++++|
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~---~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGL---IKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS---SSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecc---ccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            46899999999999999999864211   11235667777776542  2334566899999999999 799999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccC---------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCC
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAG---------------EQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKS  288 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp  288 (522)
                      .+++.+++|||||++|+|.++++...               ....+++..+..++.||+.||+|||+   ++++||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccc
Confidence            99999999999999999999998642               12358999999999999999999999   9999999999


Q ss_pred             CceeccCCCceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036172          289 SNILLSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLS-GRRPIGFKNL  367 (522)
Q Consensus       289 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLlt-G~~Pf~~~~~  367 (522)
                      +|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999988776665555566789999999999999999999999999999999999 5555544332


Q ss_pred             CChhhHHHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          368 KGPESLVKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       368 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .  ..+.....    .+..         ...+...+..+.+|+.+||+.||.+|||+.+|+++|++..
T Consensus       254 ~--~~~~~~i~----~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         254 D--SKFYKMIK----EGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             S--HHHHHHHH----HTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHHHHHh----cCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            2  11222111    1111         1111223467889999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-47  Score=374.70  Aligned_cols=250  Identities=17%  Similarity=0.253  Sum_probs=200.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccc---hHHHHHHHHHHHHhhCC--CCCccee
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFS---SAWNDFSSEVDITSSLE--QKSITTL  219 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~---~~~~~f~~Ev~iL~~L~--HpnIv~l  219 (522)
                      .++|++++.||+|+||.||++.+..        +.+.+|+|.+++......   ....++.+|+.+|++++  |||||++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~   74 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVS--------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL   74 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECC--------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence            4789999999999999999987653        456777777654322111   12245778999999996  8999999


Q ss_pred             eEEEEeCCEEEEEEecCCC-CCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-CC
Q 036172          220 NGVCIEDNYLILVSDFLPK-GSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-DF  297 (522)
Q Consensus       220 ~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-~~  297 (522)
                      ++++.+++..++||||+.+ ++|.+++...   ..+++..++.++.||+.||.|||+   ++|+||||||+|||++. ++
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          75 LDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTT
T ss_pred             EEEEeeCCeEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCC
Confidence            9999999999999999976 6888888754   349999999999999999999999   99999999999999985 47


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKV-SDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...     ..+.  
T Consensus       149 ~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~--  217 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEII--  217 (273)
T ss_dssp             EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHH--
T ss_pred             eEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hHHh--
Confidence            99999999997654332    234579999999999987775 57799999999999999999999632     1111  


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                           . +..  .+.+        ..+..+.+++.+||+.||.+|||+.|+++        |+|++.
T Consensus       218 -----~-~~~--~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~--------hp~~~~  260 (273)
T d1xwsa_         218 -----R-GQV--FFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN--------HPWMQD  260 (273)
T ss_dssp             -----H-CCC--CCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT--------SGGGSS
T ss_pred             -----h-ccc--CCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhc--------CHhhCC
Confidence                 1 100  0111        12356888999999999999999999997        899864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=375.19  Aligned_cols=260  Identities=18%  Similarity=0.266  Sum_probs=199.9

Q ss_pred             eeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEeC-C
Q 036172          149 QMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIED-N  227 (522)
Q Consensus       149 ~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~~-~  227 (522)
                      +..++||+|+||+||++.....     ..+...+|+|.+++.  ......++|.+|+++|++++|||||+++|++.+. +
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~-----~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~  102 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDN-----DGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  102 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC---------CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred             ccceEEeecCCeEEEEEEEECC-----CCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence            4467899999999999874321     011223455554321  1233568899999999999999999999998864 6


Q ss_pred             EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          228 YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       228 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||||+.++.+||+|||++
T Consensus       103 ~~~lv~E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         103 SPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             EEEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred             ceEEEEEEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccch
Confidence            8999999999999999998643  347889999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCC--ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcCCC
Q 036172          308 IWGPTDSTH--MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKNGD  385 (522)
Q Consensus       308 ~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~  385 (522)
                      +........  .......||+.|+|||.+..+.++.++||||||+++|||+||..||......  ..+....    ..+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i----~~g~  251 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL----LQGR  251 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCC
Confidence            876543222  2223457899999999999999999999999999999999988887533211  1111111    1121


Q ss_pred             cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          386 TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       386 ~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ..  ..|       ...+..+.+++.+||+.||.+||++.||++.|+++.
T Consensus       252 ~~--~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         252 RL--LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CC--CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC--CCc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11  111       123457889999999999999999999999999885

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=377.65  Aligned_cols=268  Identities=17%  Similarity=0.288  Sum_probs=212.4

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|++.++||+|+||.||+|......   .......||+|.+++.  ........|.+|+.++++++|||||+++++|.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~---~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVV---KDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEE---TTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcc---cCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            468999999999999999998753211   1123356777766432  22335567999999999999999999999999


Q ss_pred             eCCEEEEEEecCCCCCHHHHhhcc-------CCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          225 EDNYLILVSDFLPKGSLEESLHGA-------GEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       225 ~~~~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      .++..++||||+++|+|.+++...       .....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCc
Confidence            999999999999999999998743       122347899999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGR-RPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~~~~l~~~  376 (522)
                      ++||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. .||....   .......
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~~  247 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRF  247 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence            99999999998765554444445567899999999999999999999999999999999984 6665432   1122211


Q ss_pred             hhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcccc
Q 036172          377 AKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATH  436 (522)
Q Consensus       377 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~  436 (522)
                      +    ..+.....         +...+..+.+++.+||+.+|.+|||+.+|++.|++..+
T Consensus       248 i----~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 V----MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             H----HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H----HhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1    12221111         11234578999999999999999999999999988753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.4e-46  Score=370.40  Aligned_cols=270  Identities=19%  Similarity=0.221  Sum_probs=202.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|++.++||+|+||+||+|.+.         +++.||+|.++.... .....++|.+|+.+|++++|||||++++++..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~---------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN---------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET---------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC---------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            58999999999999999998753         346788887644321 12235789999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ++..++||||+.++.+..+...   ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             CCceeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccc
Confidence            9999999999988666666553   3459999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh----
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI----  380 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~----  380 (522)
                      ++........  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..  +.+.......    
T Consensus       146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPN  221 (286)
T ss_dssp             HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCC
Confidence            9976543322  12244689999999998754 5699999999999999999999999654321  1111111000    


Q ss_pred             -------hcCCC---cccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          381 -------LKNGD---TETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 -------~~~~~---~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                             .....   ......+..........+..+.+++.+||+.||++|||++|+++        |+|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~--------Hp~f~~  286 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--------HAYFKE  286 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--------SGGGGC
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc--------CcccCc
Confidence                   00000   00001111111222233467889999999999999999999997        899863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=375.32  Aligned_cols=273  Identities=20%  Similarity=0.224  Sum_probs=199.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhC---CCCCcceeeE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSL---EQKSITTLNG  221 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L---~HpnIv~l~~  221 (522)
                      .++|+++++||+|+||.||++.+..       ...+.+|+|.++..... ......+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~-------~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK-------NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-------TTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC-------CCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            4789999999999999999997642       12345677765432111 11123466777777665   8999999999


Q ss_pred             EEEe-----CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          222 VCIE-----DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       222 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      +|..     ...++++|||++++++......  ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.+
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~  152 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSS  152 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCC
Confidence            9863     2578999999988776655443  23458999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          297 FQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..  ..+...
T Consensus       153 ~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i  227 (305)
T d1blxa_         153 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKI  227 (305)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred             CCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence            999999999986543322   233568999999999999999999999999999999999999999754321  111111


Q ss_pred             hhhhhc-------C-CCccc----ccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          377 AKPILK-------N-GDTET----LLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       377 ~~~~~~-------~-~~~~~----~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ......       . .....    ...+.....+....+..+.+|+.+||+.||.+|||+.|+++        |+|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--------Hpff~~  298 (305)
T d1blxa_         228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--------HPYFQD  298 (305)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGTT
T ss_pred             HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--------ChhhcC
Confidence            110000       0 00000    00000111122233457888999999999999999999997        999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=369.09  Aligned_cols=266  Identities=22%  Similarity=0.263  Sum_probs=196.4

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHH--HHHHHhhCCCCCcceeeEEE
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSS--EVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~--Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      .+|.+.+.||+|+||.||+++..          ++.+|+|.++.      +..+++.+  |+..+.+++|||||+++++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~----------g~~vAvK~~~~------~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~   66 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR----------GEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAAD   66 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET----------TEEEEEEEECG------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC----------CEEEEEEEECc------cchhHHHHHHHHHHHhhCCCCcCcceEEEE
Confidence            35788999999999999998742          34566665432      12234444  44555678999999999999


Q ss_pred             EeCC----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC-----CCCEEeccCCCCceecc
Q 036172          224 IEDN----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC-----SRPVIHRDVKSSNILLS  294 (522)
Q Consensus       224 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-----~~giiHrDIkp~NILl~  294 (522)
                      .+.+    .+++||||+++|+|.++|++.    .+++..++.++.|++.||.|||+..     .++|+||||||+||||+
T Consensus        67 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~  142 (303)
T d1vjya_          67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  142 (303)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred             EeCCCcceEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence            8653    689999999999999999853    3899999999999999999999621     26999999999999999


Q ss_pred             CCCceEEeecCccccCCCCCCC--ccccccccCCCCCChhhhccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 036172          295 SDFQPQLSDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHGK------VSDKIDVYSFGVVLLELLSGRRPIGFKN  366 (522)
Q Consensus       295 ~~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwSlGvvl~eLltG~~Pf~~~~  366 (522)
                      .++.+||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||....
T Consensus       143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~  222 (303)
T d1vjya_         143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence            9999999999999766443322  2233567999999999986542      5779999999999999999998875433


Q ss_pred             CCChhh--------HHHhhhhhhcCCCcccccCCcccccc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          367 LKGPES--------LVKWAKPILKNGDTETLLDPKLSNEY-DNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       367 ~~~~~~--------l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      ......        ...........    ..++|.+.... .......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         223 DYQLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchhhcccccchHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            221100        00111111111    11223322222 2345677999999999999999999999999998765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-45  Score=366.80  Aligned_cols=276  Identities=16%  Similarity=0.185  Sum_probs=200.5

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      .++|+++++||+|+||+||+|.+..        +++.||+|.+...... ....+++.+|+.+|++++||||+++++++.
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~--------~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRK--------TGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            4799999999999999999997643        5678888876543221 234577899999999999999999999986


Q ss_pred             e--------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCC
Q 036172          225 E--------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSD  296 (522)
Q Consensus       225 ~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~  296 (522)
                      .        ++.+++||||+.++.+..+..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~  153 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRD  153 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTT
T ss_pred             cccccccccCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCC
Confidence            5        346899999998866655444   23358999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCccccCCCCCCC--ccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          297 FQPQLSDFGLAIWGPTDSTH--MIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       297 ~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +.+||+|||+++........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........
T Consensus       154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  233 (318)
T d3blha1         154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL  233 (318)
T ss_dssp             SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence            99999999999765543221  122345799999999998765 689999999999999999999999965432111111


Q ss_pred             HHhhhhhhcCCCcccc--------cC--CcccccccH-----HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCC
Q 036172          374 VKWAKPILKNGDTETL--------LD--PKLSNEYDN-----AQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHAT  438 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~--------~d--~~l~~~~~~-----~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~  438 (522)
                      ................        +.  .........     .....+.+|+.+||+.||++|||+.|+++        |
T Consensus       234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--------H  305 (318)
T d3blha1         234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--------H  305 (318)
T ss_dssp             HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--------S
T ss_pred             HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--------C
Confidence            1111100000000000        00  000000000     11345678999999999999999999998        9


Q ss_pred             ccccc
Q 036172          439 DWVDR  443 (522)
Q Consensus       439 ~~~~~  443 (522)
                      +|++.
T Consensus       306 pff~~  310 (318)
T d3blha1         306 DFFWS  310 (318)
T ss_dssp             GGGSS
T ss_pred             hhhcc
Confidence            99874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=370.91  Aligned_cols=268  Identities=21%  Similarity=0.225  Sum_probs=199.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      -+|+..++||+|+||+||+|.+..        +++.||+|.+++..       ..+.+|+.+|++|+|||||+++++|..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~   84 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCD--------SGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYS   84 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT--------TCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECC--------CCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEe
Confidence            479999999999999999998653        56778888764322       224579999999999999999999964


Q ss_pred             C------CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-c
Q 036172          226 D------NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-Q  298 (522)
Q Consensus       226 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~  298 (522)
                      .      .+++|||||++++.+..+.........+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .
T Consensus        85 ~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~  161 (350)
T d1q5ka_          85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAV  161 (350)
T ss_dssp             C--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCC
T ss_pred             cCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCc
Confidence            3      3689999999875444444322344469999999999999999999999   9999999999999999775 8


Q ss_pred             eEEeecCccccCCCCCCCccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          299 PQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      +||+|||++.........   ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......  ..+....
T Consensus       162 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~  236 (350)
T d1q5ka_         162 LKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEII  236 (350)
T ss_dssp             EEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHH
T ss_pred             eeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHH
Confidence            999999999766543322   23579999999999865 46899999999999999999999999654321  1111111


Q ss_pred             h--------------hhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          378 K--------------PILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       378 ~--------------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      .              ........................+..+.+|+.+||+.||.+|||+.|+++        |+|++.
T Consensus       237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--------Hp~f~~  308 (350)
T d1q5ka_         237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--------HSFFDE  308 (350)
T ss_dssp             HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGGG
T ss_pred             HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHhhcc
Confidence            1              000111111111111111112223457889999999999999999999997        899875


Q ss_pred             c
Q 036172          444 H  444 (522)
Q Consensus       444 ~  444 (522)
                      -
T Consensus       309 ~  309 (350)
T d1q5ka_         309 L  309 (350)
T ss_dssp             G
T ss_pred             c
Confidence            3

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=367.85  Aligned_cols=267  Identities=17%  Similarity=0.220  Sum_probs=198.8

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVC  223 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~  223 (522)
                      ..++|+++++||+|+||.||+|.+..        +++.+|+|.+++... .....+.+.+|+.+|++++|||||+++++|
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~--------~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGR--------TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT--------TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            45799999999999999999998643        567788887754322 223567899999999999999999999999


Q ss_pred             EeCC------EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC
Q 036172          224 IEDN------YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF  297 (522)
Q Consensus       224 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~  297 (522)
                      ...+      .+++||||+ +++|..+++..    .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~  158 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDC  158 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTC
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccc
Confidence            8654      579999999 66888887642    49999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHh
Q 036172          298 QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG-KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKW  376 (522)
Q Consensus       298 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~  376 (522)
                      .+||+|||+++......     ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+....  +...
T Consensus       159 ~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~  231 (346)
T d1cm8a_         159 ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEI  231 (346)
T ss_dssp             CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred             ccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHH
Confidence            99999999997665432     245799999999998764 568999999999999999999999965432111  1110


Q ss_pred             hhhh-------hcCC----------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCc
Q 036172          377 AKPI-------LKNG----------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATD  439 (522)
Q Consensus       377 ~~~~-------~~~~----------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~  439 (522)
                      ....       ....          ......... ...........+.+|+.+||..||.+|||+.|+++        |+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~--------Hp  302 (346)
T d1cm8a_         232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--------HP  302 (346)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--------SG
T ss_pred             HhccCCCcHHHHhhhcchhhhhhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc--------Ch
Confidence            0000       0000          000000000 01111123456788999999999999999999998        99


Q ss_pred             cccc
Q 036172          440 WVDR  443 (522)
Q Consensus       440 ~~~~  443 (522)
                      |++.
T Consensus       303 ~f~~  306 (346)
T d1cm8a_         303 YFES  306 (346)
T ss_dssp             GGTT
T ss_pred             hhCc
Confidence            9875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=368.67  Aligned_cols=273  Identities=21%  Similarity=0.217  Sum_probs=199.3

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|+++++||+|+||+||+|.+..        +++.+|+|.+.+.  +.....+++++|+.+|++|+||||+++++++.
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~--------~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~   76 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV--------NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIR   76 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT--------TCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC--------CCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence            4679999999999999999997643        5667888876432  23345678999999999999999999999997


Q ss_pred             eCC-----EEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 EDN-----YLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ...     .++++ +|+.+|+|.+++...    .+++..+..++.|++.||+|||+   ++||||||||+||||+.++.+
T Consensus        77 ~~~~~~~~~~~l~-~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~  148 (345)
T d1pmea_          77 APTIEQMKDVYLV-THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDL  148 (345)
T ss_dssp             CSSTTTCCCEEEE-EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCE
T ss_pred             eccccccceEEEE-EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCE
Confidence            653     34555 556689999999743    39999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCC-ccccccccCCCCCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhh
Q 036172          300 QLSDFGLAIWGPTDSTH-MIREDVVGTFGYIAPEYLMH-GKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWA  377 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~  377 (522)
                      ||+|||++......... .......||+.|+|||.+.. ..++.++||||+||++|+|++|+.||...............
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~  228 (345)
T d1pmea_         149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI  228 (345)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence            99999999765443222 22234679999999999854 45789999999999999999999999654322111111000


Q ss_pred             hhhhcCC---------------CcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCcccc
Q 036172          378 KPILKNG---------------DTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVD  442 (522)
Q Consensus       378 ~~~~~~~---------------~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~  442 (522)
                      .......               ..... .+.............+.+|+.+||+.||.+|||+.|+++        |+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--------hpf~~  299 (345)
T d1pmea_         229 LGSPSQEDLNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--------HPYLE  299 (345)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--------SGGGT
T ss_pred             ccCCChhhhhhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc--------CHhhc
Confidence            0000000               00000 000000011122346889999999999999999999997        89987


Q ss_pred             cc
Q 036172          443 RH  444 (522)
Q Consensus       443 ~~  444 (522)
                      ..
T Consensus       300 ~~  301 (345)
T d1pmea_         300 QY  301 (345)
T ss_dssp             TT
T ss_pred             cC
Confidence            54

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=355.04  Aligned_cols=271  Identities=20%  Similarity=0.182  Sum_probs=208.2

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|+++++||+|+||+||+|.+..        +++.||+|.++... ......+++.+|+.+|++++|||||++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~--------~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE--------THEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT--------TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC--------CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            589999999999999999998653        56778888774322 223457889999999999999999999999999


Q ss_pred             CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEeecC
Q 036172          226 DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLSDFG  305 (522)
Q Consensus       226 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~DFG  305 (522)
                      ....++|++++.+++|..++...   ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceeEEeeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecc
Confidence            99999999999999998888743   358999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhhhcC-
Q 036172          306 LAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPILKN-  383 (522)
Q Consensus       306 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-  383 (522)
                      .++........  .....+++.|+|||.+.... ++.++|||||||++|||++|+.||....  ............... 
T Consensus       147 ~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         147 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             TCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCC
T ss_pred             hhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCC
Confidence            99876543322  22346788999999987665 6899999999999999999999974322  111111111110000 


Q ss_pred             --------------CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          384 --------------GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       384 --------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                                    ......................+.+|+.+||+.||.+|||++||++        |+|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--------Hp~f~~  288 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--------HPYFSD  288 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--------SGGGSS
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--------ChhhcC
Confidence                          0000000000111112223456888999999999999999999997        999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-43  Score=354.83  Aligned_cols=263  Identities=16%  Similarity=0.136  Sum_probs=206.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCC-CCcceeeEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQ-KSITTLNGVC  223 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~H-pnIv~l~~~~  223 (522)
                      .++|+++++||+|+||.||+|.+..        +.+.+|+|.+....     ..+.+.+|+++++.|+| +||+.+++++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~   70 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL--------NNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFG   70 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT--------TTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence            5789999999999999999998653        45667777543211     22457889999999965 8999999999


Q ss_pred             EeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccC-----CCc
Q 036172          224 IEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSS-----DFQ  298 (522)
Q Consensus       224 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~-----~~~  298 (522)
                      .++...++||||+ +++|.+++...+  ..+++.++..++.|++.||.|||+   .||+||||||+|||++.     ++.
T Consensus        71 ~~~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~  144 (293)
T d1csna_          71 QEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANM  144 (293)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTC
T ss_pred             ecCCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCc
Confidence            9999999999999 679999987643  359999999999999999999999   99999999999999974     568


Q ss_pred             eEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          299 PQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +||+|||+|+........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~  224 (293)
T d1csna_         145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  224 (293)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence            999999999875433221     122346799999999999999999999999999999999999999986655544333


Q ss_pred             HHhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          374 VKWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       374 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      .............         .......+..+.+++..|+..+|.+||+++.+.+.|+...
T Consensus       225 ~~~i~~~~~~~~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         225 YERIGEKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCh---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2222111111000         0111123457888999999999999999999999887764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=364.62  Aligned_cols=266  Identities=23%  Similarity=0.269  Sum_probs=208.6

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc-cchHHHHHHHHHHHHhhCCC-CCcceeeEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ-FSSAWNDFSSEVDITSSLEQ-KSITTLNGV  222 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~-~~~~~~~f~~Ev~iL~~L~H-pnIv~l~~~  222 (522)
                      .++|+++++||+|+||+||++.+...     ..+++.||+|.+++.... .....+.+.+|+++|++++| |||++++++
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISG-----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSS-----TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEECcc-----CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            46899999999999999999865321     235677888877543211 11234678899999999966 899999999


Q ss_pred             EEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCceEEe
Q 036172          223 CIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       223 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                      +.+...+++||||+.+|+|.+++...+   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEES
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEe
Confidence            999999999999999999999998653   47889999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCCCccccccccCCCCCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhhhh
Q 036172          303 DFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHG--KVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAKPI  380 (522)
Q Consensus       303 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~~~  380 (522)
                      |||+++........ ......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||................  
T Consensus       172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--  248 (322)
T d1vzoa_         172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--  248 (322)
T ss_dssp             CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred             eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--
Confidence            99999766443322 22346799999999999754  46889999999999999999999997665443322221111  


Q ss_pred             hcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHhccccCCccccc
Q 036172          381 LKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRP-----NMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       381 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RP-----s~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ...           ....+...+..+.+++.+||++||.+||     +++|+++        |+|++.
T Consensus       249 ~~~-----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--------Hpff~~  297 (322)
T d1vzoa_         249 LKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--------HLFFQK  297 (322)
T ss_dssp             HHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--------SGGGTT
T ss_pred             ccC-----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--------CHhhcC
Confidence            110           0111223456788999999999999999     4788886        999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-43  Score=358.32  Aligned_cols=266  Identities=18%  Similarity=0.217  Sum_probs=200.7

Q ss_pred             CCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-CCCcceeeEE
Q 036172          144 TENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-QKSITTLNGV  222 (522)
Q Consensus       144 ~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-HpnIv~l~~~  222 (522)
                      ..++|+++++||+|+||+||+|.+..        +.+.||+|.+++      ...+++.+|+.+|++++ ||||++++++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~--------~~~~vAiK~i~~------~~~~~~~~Ei~il~~l~~hpnIv~~~~~   98 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINIT--------NNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADI   98 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECS------SCHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECC--------CCCEEEEEEECH------HHHHHHHHHHHHHHhccCCCCCcEEEEE
Confidence            34689999999999999999998653        566788877642      12467899999999995 9999999999


Q ss_pred             EEeC--CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCC-ce
Q 036172          223 CIED--NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDF-QP  299 (522)
Q Consensus       223 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~-~~  299 (522)
                      +...  ..+++||||+.+++|..+.+      .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+
T Consensus        99 ~~~~~~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~v  169 (328)
T d3bqca1          99 VKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKL  169 (328)
T ss_dssp             EECTTTCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCee
Confidence            9854  57999999999999977643      39999999999999999999999   9999999999999998655 69


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhh--HHH-
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPES--LVK-  375 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~--l~~-  375 (522)
                      ||+|||+|+........   ....+|+.|+|||.+.+.. ++.++|||||||++++|++|+.||..........  +.. 
T Consensus       170 kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         170 RLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             EECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             eecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence            99999999876544322   2457899999999987654 7999999999999999999999986543221110  000 


Q ss_pred             --------hhhhhhcC--CCccccc--------CCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccC
Q 036172          376 --------WAKPILKN--GDTETLL--------DPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHA  437 (522)
Q Consensus       376 --------~~~~~~~~--~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~  437 (522)
                              +.......  .......        ............+..+.+|+.+||+.||.+|||++|+++        
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--------  318 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--------  318 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------
T ss_pred             HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--------
Confidence                    00000000  0000000        000111111223456889999999999999999999997        


Q ss_pred             Cccccc
Q 036172          438 TDWVDR  443 (522)
Q Consensus       438 ~~~~~~  443 (522)
                      |+|++.
T Consensus       319 Hp~F~~  324 (328)
T d3bqca1         319 HPYFYT  324 (328)
T ss_dssp             SGGGTT
T ss_pred             CcccCC
Confidence            999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-43  Score=350.77  Aligned_cols=264  Identities=19%  Similarity=0.209  Sum_probs=197.6

Q ss_pred             CCCCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcc-eeeE
Q 036172          143 KTENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSIT-TLNG  221 (522)
Q Consensus       143 ~~~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv-~l~~  221 (522)
                      +..++|+++++||+|+||.||+|.+..        +.+.||+|.+....     ..+++.+|++++++++|+|++ .+.+
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~   70 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIA--------AGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRW   70 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETT--------TTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEE
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECC--------CCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEE
Confidence            345789999999999999999997643        34567777543211     234688999999999777655 5555


Q ss_pred             EEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceecc---CCCc
Q 036172          222 VCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLS---SDFQ  298 (522)
Q Consensus       222 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~---~~~~  298 (522)
                      ++.+++..++||||+ +++|.+.+...  ...+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..
T Consensus        71 ~~~~~~~~~ivme~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~  144 (299)
T d1ckia_          71 CGAEGDYNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNL  144 (299)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTC
T ss_pred             EEecCCEEEEEEEEc-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCce
Confidence            667888999999999 55777776653  2359999999999999999999999   9999999999999875   4557


Q ss_pred             eEEeecCccccCCCCCCC-----ccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhH
Q 036172          299 PQLSDFGLAIWGPTDSTH-----MIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESL  373 (522)
Q Consensus       299 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l  373 (522)
                      +||+|||+|+........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~  224 (299)
T d1ckia_         145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK  224 (299)
T ss_dssp             EEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred             eeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence            999999999876543322     122356799999999999999999999999999999999999999976543332222


Q ss_pred             H-HhhhhhhcCCCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccc
Q 036172          374 V-KWAKPILKNGDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGAT  435 (522)
Q Consensus       374 ~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~  435 (522)
                      . ......... .         ........+..+.+++..||+.+|.+||++++|.+.|+...
T Consensus       225 ~~~~~~~~~~~-~---------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         225 YERISEKKMST-P---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHHHHS-C---------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHhhcccCCC-C---------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            1 111111100 0         00111123467889999999999999999999999887653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=356.15  Aligned_cols=270  Identities=19%  Similarity=0.192  Sum_probs=196.0

Q ss_pred             CCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEEe
Q 036172          146 NPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCIE  225 (522)
Q Consensus       146 ~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~~  225 (522)
                      ++|+++++||+|+||+||+|.+..        +++.||+|.+++...+ ....+++.+|+.+|++++|||||++++++..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~--------t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV--------LDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT--------TTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC--------CCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            689999999999999999997653        5677888876543221 2345689999999999999999999999974


Q ss_pred             ------CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          226 ------DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       226 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                            ...+|+||||+.+ +|.+.+..     .+++..++.++.||+.||.|||+   .||+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~  158 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCE
T ss_pred             ccccccCceeEEEEeccch-HHHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccce
Confidence                  3689999999976 55555542     38999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHH----
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVK----  375 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~----  375 (522)
                      |++|||+++.......   .....+|+.|+|||++.+..++.++||||+||++++|++|+.||...+.......+.    
T Consensus       159 kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~  235 (355)
T d2b1pa1         159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_dssp             EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             eeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999999876544332   234578999999999999999999999999999999999999996543111100000    


Q ss_pred             ------------hhhhhhcCC------CcccccCCc---ccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhcc
Q 036172          376 ------------WAKPILKNG------DTETLLDPK---LSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGA  434 (522)
Q Consensus       376 ------------~~~~~~~~~------~~~~~~d~~---l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~  434 (522)
                                  .........      .....+...   .........+..+.+|+.+||+.||++|||++|||+     
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~-----  310 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ-----  310 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT-----
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc-----
Confidence                        000000000      000001000   011223345678999999999999999999999997     


Q ss_pred             ccCCcccccc
Q 036172          435 THATDWVDRH  444 (522)
Q Consensus       435 ~~~~~~~~~~  444 (522)
                         |+|++..
T Consensus       311 ---Hpw~~~~  317 (355)
T d2b1pa1         311 ---HPYINVW  317 (355)
T ss_dssp             ---STTTGGG
T ss_pred             ---CcccCCC
Confidence               9999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=357.43  Aligned_cols=270  Identities=19%  Similarity=0.199  Sum_probs=197.7

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCCCCCcceeeEEEE
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLEQKSITTLNGVCI  224 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~HpnIv~l~~~~~  224 (522)
                      ..+|+++++||+|+||+||+|.+..        +++.||+|.+++... .....+++.+|+.+|++|+|||||++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK--------TGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT--------TTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC--------CCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4689999999999999999997653        567788887654222 1234567899999999999999999999997


Q ss_pred             eC-----CEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCceeccCCCce
Q 036172          225 ED-----NYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNILLSSDFQP  299 (522)
Q Consensus       225 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NILl~~~~~~  299 (522)
                      ..     ...++||+|+.+|+|.+++...    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~  160 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL  160 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred             eccccccCceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccc
Confidence            33     3445667777899999999642    49999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCCCccccccccCCCCCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCChhhHHHhhh
Q 036172          300 QLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGK-VSDKIDVYSFGVVLLELLSGRRPIGFKNLKGPESLVKWAK  378 (522)
Q Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~l~~~~~  378 (522)
                      |++|||++......     .....|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+....
T Consensus       161 kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         161 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             EECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998654322     23457899999999876654 6899999999999999999999996543211111110000


Q ss_pred             hh-----hcC----------CCcccccCCcccccccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          379 PI-----LKN----------GDTETLLDPKLSNEYDNAQMQRMLLAANLCINQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       379 ~~-----~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~CL~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..     ...          ..........+. .........+.+|+.+||+.||.+|||+.|+++        |+|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~--------Hp~f~~  306 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--------HAYFAQ  306 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--------SGGGTT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc--------CHhhCC
Confidence            00     000          000000000000 001123456889999999999999999999997        999875


Q ss_pred             c
Q 036172          444 H  444 (522)
Q Consensus       444 ~  444 (522)
                      .
T Consensus       307 ~  307 (348)
T d2gfsa1         307 Y  307 (348)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.4e-38  Score=321.26  Aligned_cols=272  Identities=15%  Similarity=0.203  Sum_probs=195.9

Q ss_pred             CCCceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhccchHHHHHHHHHHHHhhCC-----------C
Q 036172          145 ENPFQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQFSSAWNDFSSEVDITSSLE-----------Q  213 (522)
Q Consensus       145 ~~~y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~~~~~~~~f~~Ev~iL~~L~-----------H  213 (522)
                      .++|+++++||+|+||+||+|.+..        +++.||+|.+++.    ....+.+.+|+.++++++           |
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~--------~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~   79 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMV--------NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGA   79 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT--------TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECC--------CCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence            3579999999999999999998653        4567777765421    123467888999998885           5


Q ss_pred             CCcceeeEEEEe--CCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCce
Q 036172          214 KSITTLNGVCIE--DNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNI  291 (522)
Q Consensus       214 pnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NI  291 (522)
                      +|||++++++..  ....+++|+++..+..............+++..+..++.||+.||.|||+.  .||+||||||+||
T Consensus        80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NI  157 (362)
T d1q8ya_          80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENV  157 (362)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGE
T ss_pred             CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHe
Confidence            789999998874  356777777776655444443333455689999999999999999999973  7899999999999


Q ss_pred             eccCCC------ceEEeecCccccCCCCCCCccccccccCCCCCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 036172          292 LLSSDF------QPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIAPEYLMHGKVSDKIDVYSFGVVLLELLSGRRPIGFK  365 (522)
Q Consensus       292 Ll~~~~------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwSlGvvl~eLltG~~Pf~~~  365 (522)
                      ||+.++      .++++|||.+.......     ....||+.|+|||++....++.++||||+||++++|++|+.||...
T Consensus       158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         158 LMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            997654      49999999997554332     2457999999999999999999999999999999999999999644


Q ss_pred             CCCCh----hhHHHhhhhh-----------------hcCCCcccccCC----------cccccccHHHHHHHHHHHHHhh
Q 036172          366 NLKGP----ESLVKWAKPI-----------------LKNGDTETLLDP----------KLSNEYDNAQMQRMLLAANLCI  414 (522)
Q Consensus       366 ~~~~~----~~l~~~~~~~-----------------~~~~~~~~~~d~----------~l~~~~~~~~~~~l~~li~~CL  414 (522)
                      .....    ..+.......                 .........+..          ..........+..+.+|+.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence            32211    1111111100                 000000000000          0012234566788999999999


Q ss_pred             hcCCCCCCCHHHHHHHHhccccCCccccc
Q 036172          415 NQSPQLRPNMGQVLKLLRGATHATDWVDR  443 (522)
Q Consensus       415 ~~dP~~RPs~~eVl~~L~~~~~~~~~~~~  443 (522)
                      ..||.+|||++|+|+        |+|++.
T Consensus       313 ~~dP~~Rpta~e~L~--------Hp~f~~  333 (362)
T d1q8ya_         313 QLDPRKRADAGGLVN--------HPWLKD  333 (362)
T ss_dssp             CSSTTTCBCHHHHHT--------CGGGTT
T ss_pred             CCChhHCcCHHHHhc--------CcccCC
Confidence            999999999999996        999884

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=2.3e-22  Score=186.84  Aligned_cols=167  Identities=15%  Similarity=0.088  Sum_probs=115.5

Q ss_pred             ceeeecccccccccccccCchhHHHHhhcccCccchHHHHHHHhhc--------------c-chHHHHHHHHHHHHhhCC
Q 036172          148 FQMDIPCSEGKYDENTLTPSTELFLKLVSSRCRQFSYEELKQATSQ--------------F-SSAWNDFSSEVDITSSLE  212 (522)
Q Consensus       148 y~~~~~lG~G~fg~V~l~~~~~~~~~~~~~~~~~~a~k~l~~~t~~--------------~-~~~~~~f~~Ev~iL~~L~  212 (522)
                      +-++++||+|+||.||++....         ++.+|+|.++.....              + ......+.+|+..+.++.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~---------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   72 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK---------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ   72 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT---------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhCCEeeeCcceEEEEEECCC---------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence            4578999999999999986421         223333321110000              0 012345678999999999


Q ss_pred             CCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCEEeccCCCCcee
Q 036172          213 QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSECSRPVIHRDVKSSNIL  292 (522)
Q Consensus       213 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~~~giiHrDIkp~NIL  292 (522)
                      |.+++..+++.  .  .++||||++++.+.+          ++...+..++.|++.+|.|||+   .+|+||||||+|||
T Consensus        73 ~~~v~~~~~~~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NIL  135 (191)
T d1zara2          73 GLAVPKVYAWE--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL  135 (191)
T ss_dssp             TSSSCCEEEEE--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred             CCCcceEEEec--C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhhee
Confidence            99999988663  2  279999998754422          4556677899999999999999   99999999999999


Q ss_pred             ccCCCceEEeecCccccCCCCCCCccccccccCCCCCC------hhhhccCCCCchhhHHHHHHHH
Q 036172          293 LSSDFQPQLSDFGLAIWGPTDSTHMIREDVVGTFGYIA------PEYLMHGKVSDKIDVYSFGVVL  352 (522)
Q Consensus       293 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A------PE~~~~~~~s~ksDVwSlGvvl  352 (522)
                      ++++ .++|+|||+|.........          .|..      .+. ....|+.++|+||+.--+
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            9965 5899999998654322111          1111      112 245678899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.99  E-value=4.3e-06  Score=78.62  Aligned_cols=100  Identities=19%  Similarity=0.137  Sum_probs=73.5

Q ss_pred             HHHHHHHHHhhCC-CCCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhcC-
Q 036172          200 DFSSEVDITSSLE-QKSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSEC-  277 (522)
Q Consensus       200 ~f~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-  277 (522)
                      .+.+|+.++..|. +--+.+++.++.+++..++||++++|.++.+....        ......++.+++..+..||+.. 
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~  126 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCC
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCc
Confidence            4677888888773 43468889999999999999999999888665431        1122334566666677777421 


Q ss_pred             -------------------------------------------------------CCCEEeccCCCCceeccCCCceEEe
Q 036172          278 -------------------------------------------------------SRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       278 -------------------------------------------------------~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                                                                             ...++|+|+.|.||++++++.+-|+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lI  206 (263)
T d1j7la_         127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI  206 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred             cccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEe
Confidence                                                                   0237999999999999987667799


Q ss_pred             ecCcc
Q 036172          303 DFGLA  307 (522)
Q Consensus       303 DFGla  307 (522)
                      ||+.+
T Consensus       207 Dwe~a  211 (263)
T d1j7la_         207 DLGRS  211 (263)
T ss_dssp             CCTTC
T ss_pred             echhc
Confidence            99877

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.23  E-value=0.00023  Score=65.95  Aligned_cols=97  Identities=23%  Similarity=0.165  Sum_probs=64.2

Q ss_pred             HHHHHHHHHhhCCC--CCcceeeEEEEeCCEEEEEEecCCCCCHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHHhc-
Q 036172          200 DFSSEVDITSSLEQ--KSITTLNGVCIEDNYLILVSDFLPKGSLEESLHGAGEQSVLPWGVRFEVAVAIAEALNYLHSE-  276 (522)
Q Consensus       200 ~f~~Ev~iL~~L~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-  276 (522)
                      .+..|+..|+.|..  -.+.+++.++.+++..++||++++|.++.+..        ...   ..++.++...|.-||+. 
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~  118 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAP---AEKVSIMADAMRRLHTLD  118 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCH---HHHHHHHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccH---HHHHHHHHHHHHHHccCC
Confidence            36678888877733  33678888888888999999999886553310        111   11122333333444421 


Q ss_pred             ------------------------------------------------------CCCCEEeccCCCCceeccCCCceEEe
Q 036172          277 ------------------------------------------------------CSRPVIHRDVKSSNILLSSDFQPQLS  302 (522)
Q Consensus       277 ------------------------------------------------------~~~giiHrDIkp~NILl~~~~~~kL~  302 (522)
                                                                            ....++|+|+.|.||+++++..+-|+
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iI  198 (255)
T d1nd4a_         119 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFI  198 (255)
T ss_dssp             GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEEC
T ss_pred             hhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEE
Confidence                                                                  01248999999999999987667899


Q ss_pred             ecCcc
Q 036172          303 DFGLA  307 (522)
Q Consensus       303 DFGla  307 (522)
                      ||+.+
T Consensus       199 D~~~~  203 (255)
T d1nd4a_         199 DCGRL  203 (255)
T ss_dssp             CCTTC
T ss_pred             Echhc
Confidence            99876

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.62  E-value=0.00057  Score=68.15  Aligned_cols=30  Identities=23%  Similarity=0.464  Sum_probs=25.8

Q ss_pred             CCEEeccCCCCceeccCCCceEEeecCcccc
Q 036172          279 RPVIHRDVKSSNILLSSDFQPQLSDFGLAIW  309 (522)
Q Consensus       279 ~giiHrDIkp~NILl~~~~~~kL~DFGla~~  309 (522)
                      ..++|||+.|.|||++++ .++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            469999999999999876 489999988744

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.58  E-value=0.018  Score=56.77  Aligned_cols=37  Identities=22%  Similarity=0.292  Sum_probs=25.5

Q ss_pred             HHHHHHHHhhC-CCCCcceeeEEEEeCCEEEEEEecCCCCCH
Q 036172          201 FSSEVDITSSL-EQKSITTLNGVCIEDNYLILVSDFLPKGSL  241 (522)
Q Consensus       201 f~~Ev~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL  241 (522)
                      ..+|..+++.+ .+.-.+++++++.+    .+||||++|..|
T Consensus        91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            34688888888 34445678877642    579999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.64  E-value=0.033  Score=52.61  Aligned_cols=30  Identities=33%  Similarity=0.412  Sum_probs=27.2

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCcc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLA  307 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla  307 (522)
                      ..++||+|+.+.||+++++...-|.||+.+
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             ccccccCCcchhhhhcccccceeEeccccc
Confidence            468999999999999998877789999987

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=81.27  E-value=0.66  Score=43.54  Aligned_cols=29  Identities=28%  Similarity=0.366  Sum_probs=23.9

Q ss_pred             CCCEEeccCCCCceeccCCCceEEeecCccc
Q 036172          278 SRPVIHRDVKSSNILLSSDFQPQLSDFGLAI  308 (522)
Q Consensus       278 ~~giiHrDIkp~NILl~~~~~~kL~DFGla~  308 (522)
                      ..++||+|+.+.|||++++  ..++||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            3679999999999999754  4589999874